10-Q

Large accelerated filer

Accelerated filer

Non-accelerated filer

¨ (Do not check if a smaller reporting company)

Smaller reporting company

0001193125-15-372838.txt : 20151111 0001193125-15-372838.hdr.sgml : 20151111 20151110091703 ACCESSION NUMBER: 0001193125-15-372838 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20150630 FILED AS OF DATE: 20151110 DATE AS OF CHANGE: 20151110 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MARRONE BIO INNOVATIONS INC CENTRAL INDEX KEY: 0001441693 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE CHEMICALS [2870] IRS NUMBER: 205137161 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36030 FILM NUMBER: 151217533 BUSINESS ADDRESS: STREET 1: 1540 DREW AVENUE CITY: DAVIS STATE: CA ZIP: 95618 BUSINESS PHONE: 530-750-2800 MAIL ADDRESS: STREET 1: 1540 DREW AVENUE CITY: DAVIS STATE: CA ZIP: 95618 FORMER COMPANY: FORMER CONFORMED NAME: MARRONE ORGANICS INNOVATIONS INC DATE OF NAME CHANGE: 20080801 10-Q 1 d32302d10q.htm 10-Q 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

x	Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended June 30, 2015

¨	Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from to

Commission File Number: 001-36030

Marrone Bio Innovations, Inc.

(Exact name of registrant as specified in its charter)

Delaware

20-5137161

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

1540 Drew Avenue, Davis, CA 95618

(Address of principal executive offices and zip code)

(530) 750-2800

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ¨ No x

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ¨ No x

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.


Class		Shares Outstanding at November 2, 2015
Common Stock, $0.00001 par value		24,464,582

TABLE OF CONTENTS


	PAGE
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements (Unaudited)		3
Condensed Consolidated Balance Sheets as of June 30, 2015 and December 31, 2014		3
Condensed Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2015 and 2014		4
Condensed Consolidated Statements of Comprehensive Loss for the Three and Six Months Ended June 30, 2015 and 2014		5
Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2015 and 2014		6
Notes to Condensed Consolidated Financial Statements		7
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		21
Item 3. Quantitative and Qualitative Disclosures About Market Risk		37
Item 4. Controls and Procedures		38
PART II. OTHER INFORMATION
Item 1. Legal Proceedings		41
Item 1A. Risk Factors		41
Item 6. Exhibits		41
SIGNATURES		42

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

MARRONE BIO INNOVATIONS, INC.

Condensed Consolidated Balance Sheets

(In Thousands, Except Par Value)


	JUNE 30, 2015			DECEMBER 31, 2014
	(Unaudited)
Assets
Current assets:
Cash and cash equivalents	$	12,196		$	35,324
Restricted cash, current portion		1,856			1,856
Accounts receivable		2,951			1,787
Inventories, net		10,607			12,644
Deferred cost of product revenues, including deferred cost of product revenues to related parties of $138 and $333 as of June 30, 2015 and December 31, 2014, respectively		1,597			1,797
Prepaid expenses and other current assets		1,018			1,315

Total current assets		30,225			54,723
Property, plant and equipment, net		20,062			20,166
Restricted cash, less current portion		1,560			1,560
Other assets		695			733

Total assets	$	52,542		$	77,182

Liabilities and stockholders’ equity
Current liabilities:
Accounts payable	$	3,202		$	5,841
Accrued liabilities		6,496			6,321
Deferred revenue, current portion		2,652			2,861
Deferred revenue from related parties		278			660
Customer refund liabilities		1,019			1,044
Capital lease obligations, current portion		1,351			1,839
Debt, current portion		12,749			12,636

Total current liabilities		27,747			31,202
Deferred revenue, less current portion		1,884			2,050
Capital lease obligations, less current portion		151			185
Debt, less current portion		9,489			9,667
Other liabilities		754			847

Total liabilities		40,025			43,951
Commitments and contingencies (Note 8)
Stockholders’ equity:
Common stock: $0.00001 par value; 250,000 shares authorized, 24,465 shares issued and outstanding as of June 30, 2015 and December 31, 2014		—			—
Additional paid in capital		195,264			193,079
Accumulated deficit		(182,747	)		(159,848	)

Total stockholders’ equity		12,517			33,231

Total liabilities and stockholders’ equity	$	52,542		$	77,182

See accompanying notes.

MARRONE BIO INNOVATIONS, INC.

Condensed Consolidated Statements of Operations

(In Thousands, Except Per Share Amounts)

(Unaudited)


	THREE MONTHS ENDED JUNE 30,						SIX MONTHS ENDED JUNE 30,
	2015			2014			2015			2014
Revenues:
Product	$	3,091		$	2,877		$	4,865		$	4,931
License		83			51			166			96
Related party		183			206			382			811

Total revenues		3,357			3,134			5,413			5,838
Cost of product revenues, including cost of product revenues to related parties of $113 and $130 for the three months ended
June 30, 2015 and 2014, respectively, and $195 and $291 for the six months ended June 30, 2015 and 2014, respectively		2,994			2,711			4,992			4,504

Gross profit		363			423			421			1,334
Operating Expenses:
Research, development and patent		3,328			4,264			6,750			8,561
Selling, general and administrative		7,411			5,920			15,298			12,244

Total operating expenses		10,739			10,184			22,048			20,805

Loss from operations		(10,376	)		(9,761	)		(21,627	)		(19,471	)
Other income (expense):
Interest income		6			11			15			21
Interest expense		(659	)		(863	)		(1,328	)		(1,469	)
Other income (expense), net		44			(98	)		41			(107	)

Total other expense, net		(609	)		(950	)		(1,272	)		(1,555	)

Loss before income taxes		(10,985	)		(10,711	)		(22,899	)		(21,026	)
Income taxes		—			—			—			—

Net loss	$	(10,985	)	$	(10,711	)	$	(22,899	)	$	(21,026	)

Basic and diluted net loss per common share	$	(0.45	)	$	(0.52	)	$	(0.94	)	$	(1.04	)

Weighted-average shares outstanding used in computing net loss per common share		24,465			20,775			24,465			20,150

See accompanying notes.

MARRONE BIO INNOVATIONS, INC.

Condensed Consolidated Statements of Comprehensive Loss

(In Thousands)

(Unaudited)


	THREE MONTHS ENDED JUNE 30,						SIX MONTHS ENDED JUNE 30,
	2015			2014			2015			2014
Net loss	$	(10,985	)	$	(10,711	)	$	(22,899	)	$	(21,026	)
Other comprehensive loss		—			—			—			—

Comprehensive loss	$	(10,985	)	$	(10,711	)	$	(22,899	)	$	(21,026	)

See accompanying notes.

MARRONE BIO INNOVATIONS, INC.

Condensed Consolidated Statements of Cash Flows

(In Thousands)

(Unaudited)


	SIX MONTHS ENDED JUNE 30,
	2015			2014
Cash flows from operating activities
Net loss	$	(22,899	)	$	(21,026	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		1,707			1,081
Loss (gain) on disposal of equipment		(35	)		85
Share-based compensation		2,185			2,722
Non-cash interest expense		265			528
Amortization of investment securities premiums/discounts, net		—			10
Net changes in operating assets and liabilities:
Accounts receivable		(1,164	)		(216	)
Accounts receivable from related parties		—			413
Inventories		2,037			(540	)
Deferred cost of product revenues		200			(163	)
Prepaid Expenses and other assets		130			(443	)
Accounts payable		(2,263	)		330
Accrued and other liabilities		223			(843	)
Deferred revenue		(375	)		177
Deferred revenue from related parties		(382	)		(333	)
Customer refund liabilities		(25	)		1,883

Net cash used in operating activities		(20,396	)		(16,335	)
Cash flows from investing activities
Purchases of property, plant and equipment		(1,398	)		(9,425	)
Sale of property and equipment		7			—
Purchase of short-term investments		—			(49	)
Maturities of short-term investments		—			13,467

Net cash provided by (used in) investing activities		(1,391	)		3,993
Cash flows from financing activities
Proceeds from public offerings, net of offering costs and underwriter commissions		—			39,959
Proceeds from issuance of debt, net of financing costs		—			9,621
Proceeds from line of credit		—			4,687
Repayment of line of credit		—			(4,687	)
Repayment of debt		(192	)		(137	)
Repayment of capital leases		(1,149	)		(219	)
Change in restricted cash		—			(4,885	)
Proceeds from exercise of stock options		—			1,128
Proceeds from exercise of common stock warrants		—			50

Net cash provided by (used in) financing activities		(1,341	)		45,517
Net increase (decrease) in cash and cash equivalents		(23,128	)		33,175
Cash and cash equivalents, beginning of period		35,324			24,455

Cash and cash equivalents, end of period	$	12,196		$	57,630

Supplemental disclosure of cash flow information
Cash paid for interest, net of capitalized interest of $4 and $648 for the six months ended June 30, 2015 and 2014, respectively	$	1,069		$	922

Supplemental disclosure of non-cash investing and financing activities
Property, plant and equipment included in accounts payable and accrued liabilities	$	12		$	834

Equipment acquired under capital leases	$	787		$	646

See accompanying notes.

MARRONE BIO INNOVATIONS, INC.

Notes to Condensed Consolidated Financial Statements

June 30, 2015

(Unaudited)

1. Summary of Business, and Liquidity

Marrone Bio Innovations, Inc. (“Company”), formerly Marrone Organic Innovations, Inc., was incorporated under the laws of the State of Delaware on June 15, 2006, and is located in Davis, California. In July 2012, the Company formed a wholly-owned subsidiary, Marrone Michigan Manufacturing LLC (“MMM LLC”), which holds the assets of a manufacturing plant the Company purchased in July 2012. The Company makes bio-based pest management and plant health products. The Company targets the major markets that use conventional chemical pesticides, including certain agricultural and water markets where its bio-based products are used as alternatives for, or mixed with, conventional chemical pesticides. The Company also targets new markets for which there are no available conventional chemical pesticides, the use of conventional chemical pesticides may not be desirable or permissible because of health and environmental concerns (including for organically certified crops) or because the development of pest resistance has reduced the efficacy of conventional chemical pesticides. The Company delivers EPA-approved and registered biopesticide products and other bio-based products that address the global demand for effective, safe and environmentally responsible products.

The Company is an early stage company with a limited operating history and has a limited number of commercialized products. As of June 30, 2015, the Company had an accumulated deficit of $182,747,000, has incurred significant losses since inception and expects to continue to incur losses for the foreseeable future. Until the completion of the initial public offering (“IPO”) in August 2013, the Company had funded operations primarily with net proceeds from the private placements of convertible preferred stock, convertible notes, promissory notes and term loans, as well as with the proceeds from the sale of its products and payments under strategic collaboration agreements and government grants. The Company will need to generate significant revenue growth to achieve and maintain profitability. As of June 30, 2015, the Company had working capital of $2,478,000, including cash and cash equivalents of $12,196,000. In addition, as of June 30, 2015, the Company had debt totaling $22,238,000 for which the underlying debt agreements contain various financial and non-financial covenants, as well as certain material adverse change clauses. If the Company breaches any of the covenants contained within the debt agreements or if the material adverse change clauses are triggered, the entire unpaid principal and interest balance would be due and payable upon demand. The Company believes that currently available resources combined with the additional $40,000,000 in proceeds raised from the issuance of senior secured promissory notes in August 2015 (see Note 10) will be sufficient to fund the Company’s cash requirements through at least June 30, 2016.

The Company participates in a heavily regulated and highly competitive crop protection industry and believes that adverse changes in any of the following areas could have a material effect on the Company’s future financial position, results of operations or cash flows: inability to obtain regulatory approvals, increased competition in the pesticide market, market acceptance of the Company’s products, weather and other seasonal factors beyond the Company’s control, litigation or claims against the Company related to intellectual property, patents, products or governmental regulation, and the Company’s ability to support increased growth.

Although the Company recognizes that it will likely need to raise additional funds in the future, there can be no assurance that such efforts will be successful or that, in the event that they are successful, the terms and conditions of such financing will not be unfavorable. Any future equity financing may result in dilution to existing shareholders and any debt financing may include additional restrictive covenants. Any failure to obtain additional financing or not to achieve the revenue growth necessary to fund the Company with cash flows from operations will have a material adverse effect upon the Company and will likely result in a substantial reduction in the scope of the Company’s operations and impact the Company’s ability to achieve its planned business objectives. In addition, any future breach of covenants included in the Company’s debt agreements which could result in the lender demanding payment of the unpaid principal and interest balances will have a material adverse effect upon the Company and would likely require the Company to seek to renegotiate these debt arrangements with the lenders. If such negotiations are unsuccessful, the Company may be required to seek protection from creditors through bankruptcy proceedings.

2. Significant Accounting Policies

Basis of Presentation

The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.

The accompanying financial information as of June 30, 2015, and for the three and six months ended June 30, 2015 and 2014, has been prepared by the Company, without audit, in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such SEC rules and regulations and accounting principles applicable for interim periods. However, the Company believes that the disclosures are adequate to make the information presented not misleading. The information included in this Quarterly Report on Form 10-Q should be read in connection with the consolidated financial statements and accompanying notes included in the Company’s Annual Report filed on Form 10-K for the fiscal year ended December 31, 2014.

In the opinion of management, the condensed consolidated financial statements as of June 30, 2015, and for the three and six months ended June 30, 2015 and 2014, reflect all adjustments, which are normal recurring adjustments, necessary to present a fair statement of financial position, results of operations, comprehensive loss and cash flows. The results of operations for the three and six months ended June 30, 2015 are not necessarily indicative of the operating results for the full fiscal year or any future periods.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents

The Company considers all highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents. Cash and cash equivalents consists of cash on deposit, money market funds and certificates of deposit accounts with United States (“U.S.”) financial institutions. The Company is exposed to credit risk in the event of default by financial institutions to the extent that cash and cash equivalents balances with financial institutions are in excess of amounts that are insured by the Federal Deposit Insurance Corporation. The Company has not experienced any losses on these deposits.

Restricted Cash

The Company’s restricted cash consists of cash that the Company is contractually obligated to maintain on deposit at a bank in accordance with the promissory note entered into in June 2014. See Note 6 for further discussion.

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents, accounts receivable and debt. The Company deposits its cash and cash equivalents with high credit quality domestic financial institutions with locations in the U.S. Such deposits may exceed federal deposit insurance limits. The Company believes the financial risks associated with these financial instruments are minimal.

The Company’s customer base is dispersed across many different geographic areas, and currently most customers are pest management distributors in the U.S. Generally, receivables are due up to 120 days from the invoice date and are considered past due after this date, although the Company may offer extended terms from time to time.

For the three months ended June 30, 2015 and 2014, 9% and 6%, respectively, and for the six months ended June 30, 2015 and 2014, 6% and 11%, respectively, of the Company’s revenues were generated from international customers.

The Company’s principal sources of revenues are its Regalia and Grandevo product lines. These two product lines accounted for 92% and 98% of the Company’s total revenues for the three months ended June 30, 2015 and 2014, respectively, and 94% and 93% for the six months ended June 30, 2015 and 2014, respectively.

Customers to which 10% or more of the Company’s total revenues are attributable for any one of the periods presented consist of the following:


	CUSTOMER A			CUSTOMER B			CUSTOMER C
For the three months ended June 30,
2015		34	%		11	%		4	%
2014		37	%		7	%		12	%
For the six months ended June 30,
2015		27	%		8	%		8	%
2014		31	%		6	%		13	%

Customers to which 10% or more of the Company’s outstanding accounts receivable are attributable as of either June 30, 2015 or December 31, 2014 consist of the following:


	CUSTOMER A			CUSTOMER B			CUSTOMER C			CUSTOMER D
June 30, 2015		46	%		10	%		8	%		*
December 31, 2014		10	%		*			37	%		23	%

*	Represents less than 1% of outstanding accounts receivable

Concentrations of Supplier Dependence

The active ingredient in the Company’s Regalia product line is derived from the giant knotweed plant, which the Company obtains from China. The Company’s single supplier acquires raw knotweed from numerous regional sources and performs an extraction process on this plant, creating a dried extract that is shipped to the Company’s manufacturing plant. A disruption at this supplier’s manufacturing site or a disruption in trade between the U.S. and China could negatively impact sales of Regalia. The Company currently uses one supplier and does not have a long-term supply contract with this supplier. Although the Company has identified additional sources of raw knotweed, there can be no assurance that the Company will continue to be able to obtain dried extract from China at a competitive price.

Inventories

Inventories are stated at the lower of cost or market value (net realizable value or replacement cost) and include the cost of material and external and internal labor and manufacturing costs. Cost is determined on the first-in, first-out basis. The Company provides for inventory reserves when conditions indicate that the selling price may be less than cost due to physical deterioration, obsolescence, changes in price levels or other factors. Additionally, the Company provides reserves for excess and slow-moving inventory on hand that is not expected to be sold to reduce the carrying amount of excess and slow-moving inventory to its estimated net realizable value. The reserves are based upon estimates about future demand from the Company’s customers and distributors and market conditions.

Deferred Cost of Product Revenues

Deferred cost of product revenues are stated at the lower of cost or net realizable value and include product sold where title has transferred but the criteria for revenue recognition have not been met. As of June 30, 2015 and December 31, 2014, the Company recorded deferred cost of product revenues of $1,597,000 and $1,797,000, respectively, including deferred cost of product revenues to related parties of $138,000 and $333,000, respectively.

Revenue Recognition

The Company recognizes revenues when persuasive evidence of an arrangement exists, transfer of title has occurred or services have been rendered, the price is fixed or determinable and collectability is reasonably assured. If contractual obligations, acceptance provisions or other contingencies exist which indicate that the price is not fixed or determinable, revenue is recognized after such obligations or provisions are fulfilled or expire.

Product revenues consist of revenues generated from sales of the Company’s products to distributors and direct customers, net of rebates and cash discounts. For sales of products made to distributors, the Company recognizes revenue either on a sell-in or sell-through basis depending on the specific facts and circumstances of the transaction(s) with the distributor. Factors considered include, but are not limited to, whether the payment terms offered to the distributor are structured to correspond to when product is resold, the distributor history of adhering to the terms of its contractual arrangements with the Company, whether the Company has a pattern of granting concessions for the benefit of the distributor and whether there are other conditions that may indicate that the sale to the distributor is not substantive.

In some cases, the Company recognizes distributor revenue as title and risk of loss passes, provided all other revenue recognition criteria have been satisfied (the “sell-in” method). For certain sales to certain distributors, the revenue recognition criteria for distributor sales are not satisfied at the time title and risk of loss passes to the distributor; specifically, in instances where “inventory protection” arrangements were offered to distributors that would permit these distributors to return to the Company certain unsold products, the Company considers the arrangement not to be fixed or determinable, and accordingly, revenue is deferred until products are resold to customers of the distributor (the “sell-through” method). As of June 30, 2015 and December 31, 2014, the Company

recorded current deferred product revenues of $2,600,000 and $3,190,000, respectively, including current deferred product revenues from related parties of $278,000 and $660,000, respectively. The cost of product revenues associated with such deferral are also deferred and classified as deferred cost of product revenues in the condensed consolidated balance sheets. Cash received from customers related to delivered product that may not represent a true sale is classified as customer refund liabilities in the condensed consolidated balance sheets and the related cost of inventory remains in inventory in the condensed consolidated balance sheets until the product is returned or is resold to customers of the distributor and revenue is recognized. For the three months ended June 30, 2015 and 2014, 58% and 51%, respectively, and for the six months ended June 30, 2015 and 2014, 48% and 51%, respectively, of total revenues were recognized on a sell-through basis.

From time to time, the Company offers certain product rebates to its distributors and growers, which are estimated and recorded as reductions to product revenues, and an accrued liability is recorded at the later of when the revenues are recorded or the rebate is being offered.

The Company recognizes license revenues pursuant to strategic collaboration and distribution agreements under which the Company receives payments for the achievement of testing validation, regulatory progress and commercialization events. As these activities and payments are associated with exclusive rights that the Company provides in connection with strategic collaboration and distribution agreements over the term of the agreements, revenues related to the payments received are deferred and recognized over the term of the exclusive distribution period of the respective agreement. For the six months ended June 30, 2015, the Company received payments totaling $750,000 under these agreements. No payments were received under these agreements for the three months ended June 30, 2015 and the three and six months ended June 30, 2014. For the three months ended June 30, 2015 and 2014, the Company recognized $83,000 and $51,000, respectively, as license revenues, excluding related party revenues. For the six months ended June 30, 2015 and 2014, the Company recognized $166,000 and $96,000, respectively, as license revenues, excluding related party revenues.

The Company has a strategic collaboration and distribution agreement with Syngenta, an affiliate of a former 5% stockholder, Syngenta Ventures Pte. LTD (Syngenta Ventures). In connection with the Company’s secondary offering in June 2014, Syngenta Ventures sold 600,000 shares of the Company’s common stock, reducing its ownership percentage below 5%. Accordingly, revenue recognized under this agreement subsequent to June 2014 has not been included in related party revenues. For the three and six months ended June 30, 2014, the Company recognized $8,000 and $332,000, respectively, of related party revenues under this agreement prior to Syngenta Ventures reducing its ownership stake.

As of June 30, 2015, the Company recorded current and non-current deferred revenues of $331,000 and $1,884,000, respectively, related to payments received under these agreements. As of December 31, 2014, the Company recorded current and non-current deferred revenues of $331,000 and $2,050,000, respectively, related to payments received under these agreements.

Research, Development and Patent Expenses

Research and development expenses include payroll-related expenses, field trial costs, toxicology costs, regulatory costs, consulting costs and lab costs. Patent expenses include legal costs relating to the patents and patent filing costs. These costs are expensed to operations as incurred. For the three months ended June 30, 2015 and 2014, research and development expenses totaled $3,073,000 and $4,055,000, respectively, and patent expenses totaled $255,000 and $209,000, respectively. For the six months ended June 30, 2015 and 2014, research and development expenses totaled $6,189,000 and $8,053,000, respectively, and patent expenses totaled $561,000 and $508,000, respectively.

Net Loss per Share

Net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding for the period. The calculation of basic and diluted net loss per share is the same for all periods presented as the effect of the potential common stock equivalents, which consist of stock options and warrants to purchase common stock, are anti-dilutive due to the Company’s net loss position. Anti-dilutive common stock equivalents are excluded from diluted net loss per share. The anti-dilutive stock options that were not included in diluted net loss per share were 2,633,000 and 2,871,000 as of June 30, 2015 and 2014, respectively. The anti-dilutive warrants to purchase common stock that were not included in diluted net loss per share were 145,000 as of both June 30, 2015 and 2014.

Recently Issued Accounting Pronouncements

In July 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory (“ASU 2015-11”), which applies guidance on the subsequent measurement of inventory. ASU 2015-11 states that an entity should measure inventory at the lower of cost and net realizable value. Net realizable

value is the estimated selling price in the ordinary course of business, less reasonable predictable costs of completion, disposal and transportation. The guidance excludes inventory measured using last-in, first-out or the retail inventory method. ASU 2015-11 is effective for interim and annual reporting periods beginning after December 15, 2016. Early adoption is permitted. The Company is not planning to early adopt ASU 2015-11 and is currently evaluating ASU 2015-11 to determine the potential impact to its condensed consolidated financial statements and related disclosures.

In April 2015, the FASB issued Accounting Standards Update No. 2015-03, Interest—Imputation of Interest (Topic 835-30): Simplifying the Presentation of Debt Issuance Costs (“ASU 2015-03”). ASU 2015-03 requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs is not affected by ASU 2015-03. ASU 2015-03 is effective for financial statements issued for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. Early adoption is permitted. Upon adoption, the Company will reclassify debt issuance costs from prepaid expenses and other current assets and other assets as a reduction to debt in the condensed consolidated balance sheets. The Company is not planning to early adopt ASU 2015-03 and does not anticipate that the adoption of ASU 2015-03will materially impact its condensed consolidated financial statements.

In August 2014, the FASB issued Accounting Standards Update No. 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (“ASU 2014-15”). ASU 2014-15 requires management to evaluate for each annual and interim reporting period whether conditions or events give rise to substantial doubt that an entity has the ability to continue as a going concern within one year following issuance of the financial statements and requires specific disclosures regarding the conditions or events leading to substantial doubt. The new guidance is effective for annual and interim periods ending after December 15, 2016, with early adoption permitted. The Company is currently evaluating ASU 2014-15 to determine the potential impact to its condensed consolidated financial statements and related disclosures.

In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”). ASU 2014-09 provides new, globally applicable converged guidance concerning recognition and measurement of revenue. As a result, significant additional disclosures are required about the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The new guidance is effective for annual and interim periods beginning on or after December 15, 2018. Companies are allowed to transition using either the modified retrospective or full retrospective adoption method. If full retrospective adoption is chosen, three years of financial information must be presented in accordance with the new standard. The Company is currently evaluating the alternative methods of adoption and the effect on its condensed consolidated financial statements and related disclosures.

3. Fair Value Measurements

Accounting Standards Codification (“ASC”) 820, Fair Value Measurements (“ASC 820”), clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability.

ASC 820 requires that the valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. ASC 820 establishes a three tier value hierarchy, which prioritizes inputs that may be used to measure fair value as follows:

•

Level 1—Quoted prices in active markets for identical assets or liabilities.

•

Level 2—Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

•

Level 3—Inputs that are generally unobservable and typically reflect management’s estimate of assumptions that market participants would use in pricing the asset or liability.

The following table presents the Company’s financial assets measured at fair value on a recurring basis as of June 30, 2015 and December 31, 2014 (in thousands):


	JUNE 30, 2015
	TOTAL		LEVEL 1		LEVEL 2		LEVEL 3
Assets
Money market funds	$	3,749	$	3,749	$	—	$	—


	DECEMBER 31, 2014
	TOTAL		LEVEL 1		LEVEL 2		LEVEL 3
Assets
Money market funds	$	14,746	$	14,746	$	—	$	—

The Company’s money market funds are held at registered investment companies and as of June 30, 2015 and December 31, 2014 were in active markets and, therefore, are measured based on the Level 1 valuation hierarchy.

4. Inventories

Inventories, net consist of the following (in thousands):


	JUNE 30, 2015		DECEMBER 31, 2014
Raw materials	$	5,708	$	5,692
Work in progress		916		1,150
Finished goods		3,601		5,378
Finished goods held at customers		382		424

	$	10,607	$	12,644

As of each of June 30, 2015 and December 31, 2014, the Company had $668,000 in reserves against its inventories.

5. Accrued Liabilities

Accrued liabilities consist of the following (in thousands):


	JUNE 30, 2015		DECEMBER 31, 2014
Accrued compensation	$	1,258	$	1,348
Accrued expenses		4,915		4,771
Accrued warranty costs		323		202

	$	6,496	$	6,321

The Company warrants the specifications and/or performance of its products through implied product warranties and has extended product warranties to qualifying customers on a contractual basis. The Company estimates the costs that may be incurred during the warranty period and records a liability in the amount of such costs at the time product is shipped. The Company’s estimate is based on historical experience and estimates of future warranty costs as a result of increasing usage of the Company’s products. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary. Changes in the Company’s accrued warranty costs during the period are as follows (in thousands):


Balance as of December 31, 2014	$	202
Warranties issued during the period		137
Settlements made during the period		(16	)

Balance as of June 30, 2015	$	323

6. Debt

Debt consists of the following (in thousands):


	JUNE 30, 2015			DECEMBER 31, 2014
Term Loan (“Term Loan”) bearing interest at 7.00% per annum, which is payable monthly through April 2016, collateralized by all of the Company’s inventories, chattel paper, accounts receivable, equipment and general intangibles (excluding certain financed equipment and intellectual property) pledged as collateral under the Term Loan, subordinated	$	116		$	183
Secured promissory notes (“October 2012 and April 2013 Secured Promissory Notes”) bearing interest at 12.00% per annum, which are payable monthly through October 2015, collateralized by substantially all of the Company’s assets, net of unamortized debt discount as of June 30, 2015 and December 31, 2014 of $76 and $203, respectively		12,374			12,247
Secured promissory note (“June 2014 Secured Promissory Note”) bearing interest at prime plus 2% (5.25% as of June 30, 2015) per annum, which is payable monthly through June 2036, collateralized by all of the Company’s deposit accounts and MMM LLC’s inventories, chattel paper, accounts, equipment and general intangibles		9,748			9,873

Debt		22,238			22,303
Less current portion		(12,749	)		(12,636	)

	$	9,489		$	9,667

The fair value of the Company’s outstanding debt obligations as of June 30, 2015 and December 31, 2014 was $22,348,000 and $22,587,000, respectively, which was estimated based on a discounted cash flow model using an estimated market rate of interest of 11.25% for the fixed rate debt and 5.25% for the variable rate debt, and is classified as Level 3 within the fair value hierarchy.

Term Loan

In March 2009, October 2010 and October 2011, the Company and Five Star Bank agreed to modify the terms of its existing revolving line of credit (“Revolver”). Under the modified terms of the Revolver, the Company’s borrowings under the Revolver were limited to 75% of qualifying accounts receivable with a maximum borrowing limit of $500,000. In March 2012, the Company entered into a change in terms agreement with the bank under which the existing Revolver was replaced by the Term Loan in the amount of $500,000 with a rate of 7% per annum, maturing April 1, 2016. The Company’s inventories, chattel paper, accounts receivable, equipment and general intangibles (excluding certain financed equipment and intellectual property) have been pledged as collateral under the Term Loan. The Term Loan provides for various events of default including breach of any term, obligation, covenant or condition under any other agreement between the Company and Five Star Bank. As of June 30, 2015, the Company was in breach of its covenants under the Term Loan as the Company was in breach of its covenants under its June 2014 Secured Promissory Note. However, this breach was cured in November 2015 as a result of the Company obtaining a waiver of certain of the Company’s covenants with respect to the June 2014 Secured Promissory Note as discussed below. The Term Loan was fully paid off in August 2015.

Secured Promissory Notes

On October 2, 2012, the Company borrowed $7,500,000 pursuant to senior notes (“October 2012 Secured Promissory Notes”) with a group of lenders. The October 2012 Secured Promissory Notes have an initial term of three years and can be extended for an additional two years in one year increments at the option of the Company. During the initial three-year term, the October 2012 Secured Promissory Notes bear interest at 12% per annum. If the term of the October 2012 Secured Promissory Notes is extended an additional year, the interest rate is 13% during the fourth year. If the term of the October 2012 Secured Promissory Notes is extended for an additional two years, the interest rate is 14% during the fifth year. Interest on the October 2012 Secured Promissory Notes is payable monthly through the initial maturity date of the loan, which is October 2, 2015, or through any extension period. The principal and all unpaid interest are due on the maturity date, as may be extended.

As part of the terms of the October 2012 Secured Promissory Notes, the Company is required to pay a fee of 5% of the funded principal amount to the agent that facilitated the borrowing and provides management of the relationship with the group of lenders (“Agent Fee”). This Agent Fee is payable within 30 days after all interest and principal have been paid. For each year the Company extends the maturity date of the October 2012 Secured Promissory Notes beyond the initial term, the agent will receive an additional 1% fee based on the funded principal amount. The present value of the unpaid Agent Fee, based on 5% of the funded principal amount, or $261,000, as of the closing date of the October 2012 Secured Promissory Notes was recorded as both deferred financing

costs as a component of current and non-current other assets and non-current other liabilities. The amortization of the deferred

financing costs and the accretion of the Agent Fee are recorded to interest expense over the term of the arrangement. As of June 30, 2015, $603,000 of the Agent Fee, including the amounts relating to the additional funds received from the issuance of the April 2013 Secured Promissory Notes discussed below, was recorded under accrued liabilities. In addition, the Company incurred an additional $66,000 in financing-related costs, primarily legal fees. These costs were recorded as deferred financing costs as a component of current and non-current other assets and are being amortized to interest expense over the term of the arrangement.

The October 2012 Secured Promissory Notes are secured by the Company’s ownership interest in MMM LLC, a security interest in the assets of the Company’s manufacturing plant and all of the Company’s other assets, subject to certain permitted liens. This security interest was subordinate to the security interest held by the holder of a previously outstanding promissory note issued in April 2012 and repaid in January 2013 (“April 2012 Note”), which also had a security interest in MMM LLC.

The Company also issued warrants (“Common Stock Warrants”) to the group of lenders to purchase a number of shares of common stock equal to 15% of the funded principal amount of the October 2012 Secured Promissory Notes divided by 70% of the value of common stock in a sale of the Company or a Qualified IPO, with such Common Stock Warrants having an exercise price of 70% of the value of common stock in a sale of the Company or a Qualified IPO. The Common Stock Warrants would be automatically exercised immediately prior to expiration on the earlier to occur of a Qualified IPO or a sale of the Company or the maturity of the October 2012 Secured Promissory Notes. The October 2012 Secured Promissory Notes could be prepaid six months after the initial funding date or earlier if a Qualified IPO or a sale of the Company occurs. As the predominant settlement feature of the Common Stock Warrants is to settle a fixed monetary amount in a variable number of shares, the Common Stock Warrants were accounted for under ASC 480, Distinguishing Liabilities from Equity (“ASC 480”). Accordingly, the Common Stock Warrants were recorded at estimated fair value on their issuance date and were adjusted to their estimated fair value as of each reporting date with the change in estimated fair value recorded as a component of change in estimated fair value of financial instruments in the Company’s condensed consolidated statements of operations. The fair value of the Common Stock Warrants at the date of issuance of $282,000 was recorded as a discount to the October 2012 Secured Promissory Notes and is being amortized to interest expense over the term of the arrangement. Until the effective date of the IPO, the Company estimated the fair value of the Common Stock Warrants using a Probability-Weighted Expected Return Method (“PWERM”) valuation based on unobservable inputs, and, therefore, the Common Stock Warrants were classified as Level 3 liabilities in the fair value hierarchy. Upon closing of the IPO, the exercise price of the Common Stock Warrants was determined to be $8.40 per share and the number of shares to be issued upon exercise of the warrants was no longer variable. As a result of the IPO, the Common Stock Warrants were considered to be indexed to the Company’s stock, and accordingly, the common stock warrants liability was reclassified and included in stockholders’ equity (deficit) during the year ended December 31, 2013.

The October 2012 Secured Promissory Notes contain certain covenant requirements, which include a requirement to maintain a minimum cash balance of the lesser of the April 2012 Note indebtedness described above or $5,000,000. As the April 2012 Note was fully paid off in January 2013, the Company no longer has a minimum cash balance requirement under the October 2012 Secured Promissory Notes. The Company is also precluded from adding additional debt without lender approval but allowance is made if such debt is subordinated to the October 2012 Secured Promissory Notes or if such additional debt is not more than $2,000,000 in the aggregate. In the event of default on the October 2012 Secured Promissory Notes, the lenders may declare the entire unpaid principal and interest immediately due and payable.

On April 10, 2013 (“Conversion Date”), the Company entered an amendment to increase, by up to $5,000,000, the amount available under the terms of the loan agreement with respect to the October 2012 Secured Promissory Notes. Under this amendment, an additional $4,950,000 was issued in partial consideration for $3,700,000 in cash received and in partial conversion for the cancellation of $1,250,000 of the total principal balance of the October 2012 Subordinated Convertible Note described below (collectively, “April 2013 Secured Promissory Notes”). The total amount borrowed under the amended loan agreement for the October 2012 Secured Promissory Notes and the April 2013 Secured Promissory Notes increased from $7,500,000 to $12,450,000 as of the Conversion Date. The accrued interest of $74,000 for the partially converted October 2012 Subordinated Convertible Note as of the Conversion Date shall be repaid or converted on the applicable maturity date of the October 2012 Subordinated Convertible Note.

In connection with the issuance of the April 2013 Secured Promissory Notes, the Company issued additional warrants (“Additional Common Stock Warrants”) to purchase a number of shares of common stock equal to 20% of the funded principal amount of the April 2013 Secured Promissory Notes divided by 70% of the value of common stock in a sale of the Company or a Qualified IPO, with such Additional Common Stock Warrants to have an exercise price of 70% of the value of common stock in a sale of the Company or a Qualified IPO. As the predominant settlement feature of the Additional Common Stock Warrants was to settle a fixed monetary amount in a variable number of shares, the Additional Common Stock Warrants were accounted for under ASC 480.

Accordingly, the Additional Common Stock Warrants were recorded at estimated fair value on their issuance date and were adjusted to their estimated fair value as of each reporting date with the change in estimated fair value recorded as a component of change in estimated fair value of financial instruments in the Company’s condensed consolidated statements of operations. The fair value of the Additional Common Stock Warrants at the date of issuance was estimated to be $465,000. The Company estimated the fair value of the Additional Common Stock Warrants using a PWERM valuation based on unobservable inputs and, therefore, the Additional Common Stock Warrants were classified as Level 3 liabilities in the fair value hierarchy. Upon closing of the IPO, the exercise price of the Additional Common Stock Warrants was determined to be $8.40 per share and the number of shares to be issued upon exercise of the warrants was no longer variable. As a result of the IPO, the Additional Common Stock Warrants were considered to be indexed to the Company’s stock, and accordingly, the common stock warrants liability was reclassified and included in stockholders’ equity (deficit) during the year ended December 31, 2013.

The debt holder who converted $1,250,000 principal balance of the October 2012 Subordinated Convertible Note (with a fair value of $1,360,000 on the date of conversion) also loaned an additional $2,500,000 in cash as part of the April 2013 Secured Promissory Notes (collectively, the “$3,750,000 Notes”). The Company accounted for the conversion as an extinguishment of debt in accordance with ASC 470-50-40, Modifications and Extinguishments (“ASC 470-50-40”). The $1,360,000 fair value of the partially converted October 2012 Subordinated Convertible Note on the Conversion Date was derecognized and the fair value of the $3,750,000 Notes with the portion of the fair value of the Additional Common Stock Warrants issued to this debt holder on the date of issuance was recorded. The Company recorded the $49,000 excess of the total fair value of the $3,750,000 Notes and the related Additional Common Stock Warrants on the issuance date over total consideration received as a gain on extinguishment of debt in the condensed consolidated statements of operations for the year ended December 31, 2013.

The following table shows the consideration received, fair values of the notes and common stock warrants issued and calculation of the gain on extinguishment of debt for the $3,750,000 Notes (in thousands):


Consideration received
Fair value of October 2012 Subordinated Convertible Note	$	1,360
Cash		2,500

Total consideration received (a)	$	3,860
Notes and warrants issued
Principal balance of notes issued	$	3,750
Debt discount ⁽¹⁾		(291	)

Fair value of notes issued		3,459
Fair value of Additional Common Stock Warrants issued		352

Total fair value of notes and warrants issued (b)	$	3,811

Gain on extinguishment of debt (a-b)	$	49

⁽¹⁾	The amortization of this account is being recorded in interest expense in the condensed consolidated statements of operations over the term of the arrangement.

The remaining fair value of the Additional Common Stock Warrants of $113,000, net of the fair value of the Additional Common Stock Warrants issued of $352,000 related to the $3,750,000 Notes discussed above, was recorded as a debt discount to the April 2013 Secured Promissory Notes and is being amortized to interest expense over the term of the arrangement.

As a result of the amendment described above, the Company is also required to pay the Agent Fee, 5% of the $3,700,000 in cash received from the April 2013 Secured Promissory Notes, under the same terms as the October 2012 Secured Promissory Notes. In addition, the portion of the Agent Fee relating to the converted October 2012 Subordinated Convertible Note that would be due under the terms of the October 2012 Subordinated Convertible Note will be paid under the terms of the October 2012 and April 2013 Secured Promissory Notes. The present value of the unpaid Agent Fee of $172,000, based on 5% of the funded principal amount of $4,950,000, as of the closing date of the April 2013 Secured Promissory Notes was recorded as both deferred financing costs as a component of current and non-current other assets and non-current other liabilities. The amortization of the deferred financing costs and the accretion of the Agent Fee are being amortized to interest expense over the term of the arrangement.

In addition, the Company incurred an additional $24,000 in financing-related costs, primarily legal fees. These costs were recorded as deferred financing costs as a component of current and non-current other assets and are being amortized to interest expense over the term of the arrangement.

The amendment to the loan agreement also amended the interest provision applicable to the October 2012 and April 2013 Secured Promissory Notes to allow any holder of the October 2012 and April 2013 Secured Promissory Notes to request the Company to defer all interest due monthly to the applicable maturity date, and the optional prepayment provision applicable to the October 2012 and April 2013 Secured Promissory Notes to allow the Company to repay the outstanding amount of the October 2012 and April 2013 Secured Promissory Notes either (i) with the written consent of the lender or the agent on such lenders’ behalf or (ii) without such consent provided that the Company pays the interest that would have been due from the prepayment date to the initial maturity date.

Activity related to the October 2012 and April 2013 Secured Promissory Notes from December 31, 2014 through June 30, 2015 consisted of the following (in thousands):


	DECEMBER 31, 2014			ADDITIONS		AMORTIZATION OF DEBT DISCOUNT		PRINCIPAL PAYMENTS		JUNE 30, 2015
Principal	$	12,450		$	—	$	—	$	—	$	12,450
Debt discount related to the issuance of common stock warrants ⁽¹⁾		(106	)		—		69		—		(37	)
Discount related to the $3,750,000 Notes ⁽¹⁾		(97	)		—		58		—		(39	)

	$	12,247		$	—	$	127	$	—	$	12,374

⁽¹⁾	The amortization of this account is included in interest expense in the condensed consolidated statements of operations and as non-cash interest expense in the condensed consolidated statements of cash flows.

As of June 30, 2015 and December 31, 2014, the Company was in breach of its covenants under the October 2012 and April 2013 Secured Promissory Notes as a result of its failure to provide annual financial statements in a timely manner and as the Company was in breach of certain of its covenants under its June 2014 Secured Promissory Note as described below. However, in November 2015, the Company received an extension from the lending agent with respect to compliance with the requirements to deliver annual financial statements to the earlier of (i) November 15, 2015 or (ii) such time such financial statements are filed with the SEC. Further, the covenant breach was cured in November 2015 as a result of obtaining this extension and the waiver of certain of the Company’s covenants with respect to the June 2014 Secured Promissory Note as described below.

In August 2015, the terms of the notes were amended, resulting in an increase in the interest rate to 18% effective September 1, 2015 for the remaining term of the notes. The Company also provided a written notice in September 2015 to extend the maturity date to October 2, 2017.

Credit Facility

On June 14, 2013, the Company entered into a credit facility agreement (“June 2013 Credit Facility”) with a group of lenders that are, or that are affiliated with, existing investors in the Company. Under the June 2013 Credit Facility, the lenders have committed to permit the Company to draw an aggregate of up to $5,000,000, and, subject to the Company’s obtaining additional commitments from lenders, such amount may be increased to up to $7,000,000. The June 2013 Credit Facility expired on June 30, 2014 without having been drawn upon.

During the term of the June 2013 Credit Facility, the Company could request from the lenders up to four advances, with each advance equal to one-quarter of each lender’s aggregate commitment amount. The Company would issue a promissory note in the principal amount of each such advance that would accrue interest at a rate of 10% per annum. The principal and all unpaid interest under the promissory notes would be due on the maturity date, and the Company could not prepay the promissory notes prior to the maturity date without consent of at least a majority in interest of the aggregate principal amount of the promissory notes then outstanding under the June 2013 Credit Facility.

In connection with the June 2013 Credit Facility, the Company agreed to pay a fee of 2% of the total commitment amount to the lenders. In addition, the Company incurred an additional $10,000 in financing-related costs, primarily legal fees. These costs were recorded as deferred financing costs as a component of current other assets and were fully amortized to interest expense as of December 31, 2014.

In connection with the June 2013 Credit Facility, the Company issued warrants (“June 2013 Warrants”) to purchase a number of shares of common stock equal to 10% of the total committed amount of the June 2013 Credit Facility divided by 70% of the value of common stock in a sale of the Company or a Qualified IPO, with such June 2013 Warrants to have an exercise price of 70% of the value of common stock in a sale of the Company or a Qualified IPO. The June 2013 Warrants expire upon the earlier of June 14, 2023 or the sale of the Company. As the predominant settlement feature of the June 2013 Warrants was to settle a fixed monetary amount in a variable number of shares, the June 2013 Warrants were accounted for under ASC 480. Accordingly, the June 2013 Warrants were recorded at estimated fair value on their

issuance date and were adjusted to their estimated fair value as of each reporting date with the change in estimated fair value recorded as a component of change in estimated fair value of financial instruments in the Company’s condensed consolidated statements of operations. The fair value of the June 2013 Warrants at the date of issuance of $435,000 was recorded as a deferred financing cost as a current other asset and was being amortized to interest expense over the term of the arrangement. Until the effective date of the IPO, the Company estimated the fair value of the June 2013 Warrants using a PWERM valuation based on unobservable inputs and, therefore, the June 2013 Warrants were classified as Level 3 liabilities in the fair value hierarchy. Upon closing of the IPO, the exercise price of the June 2013 Warrants was determined to be $8.40 per share and the number of shares to be issued upon exercise of the warrants was no longer variable. As a result of the IPO, the June 2013 Warrants were considered to be indexed to the Company’s stock, and accordingly, the common stock warrants liability was reclassified and included in stockholders’ equity (deficit) during the year ended December 31, 2013.

Secured Promissory Note

On April 11, 2014, the Company entered into a $3,000,000 promissory note with Five Star Bank. On April 14, 2014, the Company entered into an agreement with the bank to modify the terms of the promissory note from a single payment loan to a revolving line of credit, which allowed the Company to borrow up to $3,000,000. On April 28, 2014, the Company entered into an agreement to modify the terms of the revolving line of credit to increase the borrowing limit up to $5,000,000. In June 2014, the $4,687,000 balance on the revolving line of credit was paid off and the line was closed when the Company borrowed $10,000,000 pursuant to a business loan agreement and promissory note (“June 2014 Secured Promissory Note”) with the bank (“Lender”) which bears interest at prime rate (3.25% as of June 30, 2015) plus 2.00% per annum. The interest rate is subject to change from time to time to reflect changes in the prime rate; however, the interest rate shall not be less than 5.25% or more than the maximum rate allowed by applicable law. If the interest rate increases, the Lender, may, at its option, increase the amount of each monthly payment to ensure that the note would be paid in full by the maturity date, increase the amount of each monthly payment to reflect the change in interest rate, increase the number of monthly payments or keep the monthly payments the same and increase the final payment amount.

The June 2014 Secured Promissory Note is repayable in monthly payments of $64,390 commencing in July 2014, with the final payment due in June 2036. Certain of the Company’s deposit accounts and MMM, LLC’s inventories, chattel paper, accounts, equipment and general intangibles have been pledged as collateral for the promissory note. The Company is required to maintain a deposit balance with the Lender of $1,560,000, which is recorded as restricted cash included in non-current assets. In addition, until the Company provides documentation that the proceeds were used for construction of the Company’s manufacturing plant, proceeds from the loan will be maintained in a restricted deposit account. As of June 30, 2015, the Company had $1,856,000 remaining in this restricted deposit account, which is recorded as restricted cash included in current assets.

In addition, the Company incurred an additional $304,000 in financing-related costs, including USDA guarantee fees. These costs were recorded as deferred financing costs as a component of current and non-current other assets on the date of issuance and are being amortized to interest expense over the term of the arrangement.

The Company may prepay 20% of the outstanding principal loan balance each year without penalty. A prepayment fee of 10% will be charged if prepayments exceed 20% in the first year, and the prepayment fee will decrease by 1% each year for the first ten years of the loan.

The Company is required to maintain a current ratio of not less than 1.25-to-1.0, a debt-to-worth ratio of no greater than 4.0-to-1.0 and a loan-to-value ratio of no greater than 70% as determined by the lender. The Company is also required to comply with certain affirmative and negative covenants under the loan agreement discussed above. In the event of default on the debt, the lender may declare the entire unpaid principal and interest immediately due and payable. As of June 30, 2015 and December 31, 2014, the Company was in breach of certain of its covenants under the loan agreement as a result of its annual and quarterly reports not being filed within the prescribed time period and its being in breach of covenants on the October 2012 and April 2013 Secured Promissory Notes described above. Effective September 30, 2015, the Company’s debt-to-worth ratio was greater than 4.0-to-1.0 as a result of the issuance of $40,000,000 in promissory notes in August 2015 as described in Note 10, which increased the Company’s debt while the Company continued to incur net losses, which decreased stockholders’ equity. However, in November 2015, the Company received a waiver from the Lender with respect to compliance with the requirements to (i) deliver annual financial statements (extended to November 15, 2015), (ii) maintain a current ratio greater than 1.25-to-1.0 (extended to December 31, 2015) and (iii) maintain a debt-to-worth ratio less than 4.0-to-1.0 (extended to December 31, 2016). The receipt of this waiver and the extension to provide financial statements under the October 2012 and April 2013 Secured Promissory Notes cured the Company of being in breach of the covenants under the loan agreement.

7. Share-Based Plans

As of June 30, 2015, there were 2,633,000 options outstanding and 2,142,000 share-based awards available for grant under the outstanding equity incentive plans.

For the three months ended June 30, 2015 and 2014, the Company recognized share-based compensation of $1,095,000 and $1,200,000, respectively. For the six months ended June 30, 2015 and 2014, the Company recognized share-based compensation of $2,185,000 and $2,722,000, respectively.

During the three and six months ended June 30, 2015, the Company did not grant any options and no options were exercised.

8. Commitments and Contingencies

Operating Leases

The Company has a non-cancelable lease for an aggregate of approximately 24,500 square feet of non-contiguous office space in an office complex in Davis, California under which a portion of the covered space terminated beginning in February 2014. The remaining portion of the space will terminate by October 2016. The lease includes negotiated annual increases in the monthly rental payments.

In September 2013 and then amended in April 2014, the Company entered into a lease agreement for approximately 27,300 square feet of office and laboratory space located in Davis, California. The initial term of the lease is for a period of 60 months and commenced in August 2014. The monthly base rent is $44,000 per month for the first 12 months with a 3% increase each year thereafter. Concurrent with this amendment, in April 2014, the Company entered into a lease agreement with an affiliate of the landlord to lease approximately 17,400 square feet of office and laboratory space in the same building complex in Davis, California. The initial term of the lease is for a period of 60 months and commenced in August 2014. The monthly base rent is $28,000 with a 3% increase each year thereafter.

Litigation

On September 5, 2014, September 8, 2014, September 11, 2014, September 15, 2014 and November 3, 2014, the Company, along with certain of its current and former officers and directors and others were named as defendants in putative securities class action lawsuits filed in the U.S. District Court for the Eastern District of California. On February 13, 2015, these actions were consolidated as Special Situations Fund III QP, L.P. et al v. Marrone Bio Innovations, Inc. et al, Case No 2:14-cv-02571-MCE-KJN. On September 2, 2015, an initial consolidated complaint was filed on behalf of (i) all persons who purchased or otherwise acquired the Company’s publicly traded common stock directly in or traceable to the Company’s August 1, 2013 initial public offering; (ii) all persons who purchased or otherwise acquired the Company’s publicly traded common stock directly in the Company’s June 6, 2014 secondary offering; and (iii) all persons who purchased or otherwise acquired the Company’s publicly traded common stock on the open market between March 7, 2014 and September 2, 2014 (the “Class Action”). In addition to the Company, the initial consolidated complaint names certain of the Company’s current and former officers and directors and the Company’s independent registered public accounting firm as defendants. The initial consolidated complaint alleges violations of the Securities Act of 1933, the Securities Exchange Act of 1934 and SEC Rule 10b-5, arising out of the issuance of allegedly false and misleading statements about the Company’s business and prospects, including its financial statements, product revenues and system of internal controls. Plaintiffs contend that such statements caused the Company’s stock price to be artificially inflated. The action includes claims for damages, fees and expenses, including an award of attorneys’ and experts’ fees to the putative class. Pursuant to a stipulation between the parties, and by order of the Court, defendants need not respond to the initial consolidated complaint. An amended consolidated complaint is to be filed no later than 60 days after the Company announces the restatement(s) after which defendants will have 60 days to respond. The outcome of this matter is not presently determinable.

On September 9, 2014 and November 25, 2014, shareholder derivative actions were filed in the Superior Court of California, County of Yolo (Case No. CV14-1481) and the U.S. District Court for the Eastern District of California (Case No. 1:14-cv-02779-JAM-CKD), purportedly on the Company’s behalf, against certain current and former officers and members of its board of directors (the “2014 Derivative Actions”). The plaintiffs in the 2014 Derivative Actions allege that the defendants breached their fiduciary duties, committed waste, were unjustly enriched and aided and abetted breaches of fiduciary duty by causing the Company to issue allegedly false and misleading statements. The issues in the 2014 Derivative Actions overlap substantially with those at issue in the Class Action described above. The plaintiffs in the 2014 Derivative Actions seek, purportedly on behalf of the Company, an unspecified award of damages including, but not limited to, various corporate governance reforms, an award of restitution, an award of reasonable costs and expenses, including attorneys’ fees, and other further relief as the Court may deem just and proper. The Courts have granted the parties’ stipulations to defer litigation activity, subject to certain conditions and pending certain developments in the Class Action.

On October 14, 2015, a shareholder derivative action was filed in the Superior Court of California, County of Yolo (Case No. CV15-1423), purportedly on the Company’s behalf, against certain current and former officers and members of the Company’s board of directors and the Company’s independent registered public accounting firm (the “2015 Derivative Action,” and with the 2014 Derivative Actions, the “Derivative Actions”). The plaintiff in the 2015 Derivative Action alleges that the director and officer

defendants breached their fiduciary duties, committed waste and were unjustly enriched by causing the Company to issue allegedly false and misleading statements. The plaintiff in the 2015 Derivative Action also alleges that the Company’s independent registered public accounting firm committed professional negligence and malpractice. The issues in the 2015 Derivative Action overlap substantially with those at issue in the 2014 Derivative Actions and the Class Action described above. The parties are negotiating a date by which the defendants’ response to the newly filed complaint will be due. Given the preliminary nature of the Derivative Actions, the Company is not in a position to express any opinion regarding the outcome in these matters.

The Company is currently unable to estimate a range of reasonably possible loss for the litigation because these matters involve significant uncertainties. Those uncertainties include the legal theory or the nature of the claims, the complexity of the facts, the results of any investigation or litigation and the timing of resolution of the investigations or litigation. Although the Company cannot estimate a reasonable range of loss based on currently available information, the resolution of these matters could have a material adverse effect on its financial position, results of operations or cash flows.

SEC Investigation

The Company advised the staff of the Division of Enforcement of the SEC in September 2014 that the Audit Committee of the Company’s board of directors had commenced an internal investigation. The SEC commenced a formal investigation of these matters, with which the Company is cooperating. Though the investigation continues, the Company has engaged in discussions with the Division of Enforcement staff concerning the resolution of any enforcement action that it may recommend. In accordance with ASC 450, Contingencies, the Company has accrued $1,750,000 in its condensed consolidated balance sheets as of June 30, 2015 and December 31, 2014 for its estimate of the penalties arising from such enforcement action and has estimated the range of the reasonably possible loss to be between $1,750,000 and $4,000,000.

Publicity surrounding the foregoing or any enforcement action as a result of the Division of Enforcement’s investigation, even if ultimately resolved favorably, could have an adverse impact on the Company’s reputation, business, financial position, results of operations or cash flows.

9. Related Party Transactions

Les Lyman, a member of the Company’s board of directors, is the chairman and significant indirect shareholder of The Tremont Group, Inc. For the three months ended June 30, 2015 and 2014, revenue of $183,000 and $201,000, respectively, was recognized on a sell-through basis relating to product purchased by The Tremont Group, Inc. that was resold by The Tremont Group, Inc. during the period. For the six months ended June 30, 2015 and 2014, revenue of $382,000 and $478,000, respectively, was recognized on a sell-through basis relating to product purchased by The Tremont Group, Inc. that was resold by The Tremont Group, Inc. during the period. As of June 30, 2015 and December 31, 2014, the Company had no outstanding accounts receivable due from The Tremont Group, Inc. As of June 30, 2015 and December 31, 2014, the Company recorded deferred cost of product revenues of $138,000 and $333,000, respectively, and current deferred product revenues of $278,000 and $660,000, respectively, relating to product sold to The Tremont Group, Inc. where title has transferred but the criteria for revenue recognition have not been met. Although the Company anticipates sales of its products to The Tremont Group, Inc. to continue through 2015, the Company cannot estimate the amount of those sales.

The Company has a strategic collaboration and distribution agreement with Syngenta, an affiliate of a former 5% stockholder, Syngenta Ventures. In connection with the Company’s secondary offering in June 2014, Syngenta Ventures sold 600,000 shares of the Company’s common stock, reducing its ownership percentage below 5%. Accordingly, revenue recognized under this agreement subsequent to June 2014 has not been included in related party revenues. For the three and six months ended June 30, 2014, the Company recognized $8,000 and $332,000, respectively, of related party revenues under this agreement prior to Syngenta Ventures reducing its ownership stake.

10. Subsequent Events

Sale of Notes and Warrants

On August 20, 2015, the Company issued and sold to entities affiliated with Waddell & Reed Financial, Inc., one of its 5% stockholders, senior secured promissory notes in the aggregate principal amount of $40,000,000 and warrants to purchase up to 4,000,000 shares of common stock of the Company for aggregate consideration of $40,000,000, pursuant to a purchase agreement dated August 20, 2015.

The notes will bear interest at a rate of 8% per annum payable semi-annually on June 30 or December 31 of each year, commencing on December 31, 2015, with $10,000,000 payable three years from the closing, $10,000,000 payable four years from the closing and

$20,000,000 payable five years from the closing. The notes contain customary covenants, in addition to the obligation to maintain cash and cash equivalents of at least $15,000,000. The notes provide for various events of default, including, among others, default in payment of principal or interest, breach of any representation or warranty by the Company or any subsidiary under any agreement or document delivered in connection with the notes, a continued breach of any other condition or obligation under any loan document, certain bankruptcy, liquidation, reorganization or change of control events, the acquisition by any person or persons acting as group, other than the lenders, of beneficial ownership of 40% or more of the outstanding voting stock of the Company and certain events in which Pamela G. Marrone Ph.D. ceases to serve as the Company’s Chief Executive Officer. As of September 30, 2015, the Company was in breach of its covenants under the August 2015 Senior Secured Promissory Notes as the Company was in breach of its covenants under its October 2012 and April 2013 Secured Promissory Notes and June 2014 Secured Promissory Note. However, this covenant breach was cured in November 2015 as a result of the Company obtaining an extension to deliver its annual financial statements with respect to the October 2012 and April 2013 Secured Promissory Notes and the waiver of certain of the Company’s covenants with respect to the June 2014 Secured Promissory Note. See Note 6 for further discussion.

The notes are secured by substantially all the Company’s personal property assets. The agent, acting behalf of the lenders, shall be entitled to have a first priority lien on the Company’s intellectual property assets, pursuant to intercreditor arrangements with certain of the Company’s existing lenders.

The warrants are immediately exercisable at an exercise price of $1.91 per share (subject to adjustments) and may be exercised at a holder’s option at any time on or before August 20, 2023 (subject to certain exceptions). Proceeds from the sale of the notes and warrants will be allocated to the notes and warrants based on the relative fair value.

In connection with the above transaction, on August 19, 2015, the Company amended the October 2012 and April 2013 Secured Promissory Notes. As a result of the amendment, interest on loans was accrued at a rate of 12% per annum until September 1, 2015, and thereafter is accrued at a rate of 18% per annum, and the Company is permitted to prepay the outstanding indebtedness under the agreement without penalty at any time. In addition, in September 2015, the Company provided a written notice exercising its right to extend the maturity through October 2, 2017. The amendments will be accounted for as a modification of the loan agreement with the effective interest rate adjusted prospectively from the amendment date.

Separation Agreement

On January 14, 2015, James Iademarco was appointed as the Company’s President and Chief Operating Officer, effective January 14, 2015. On August 20, 2015, the Company entered into a separation agreement with James Iademarco whereby he resigned effective August 31, 2015, but agreed to remain available to advise the Company in a consulting capacity for an additional period of up to 90 days to assist with the transition of various pending matters. Pursuant to the separation agreement, Mr. Iademarco is entitled to receive, among other things, an amount equal to one-twelfth of his prior base salary of $290,000 on or before the 15th day of each of the twelve months following August 31, 2015 and certain premium payments for health and vision insurance coverage, in partial consideration for Mr. Iademarco granting the Company a general release of liability and claims.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion of our financial condition and results of operations in connection with our condensed consolidated financial statements and the related notes included elsewhere in this Quarterly Report on Form 10-Q and with our audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2014, as filed with the Securities and Exchange Commission. In addition to historical condensed consolidated financial information, the following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to these differences include those discussed below and elsewhere, including Part II, Item 1A, “Risk Factors,” in this Quarterly Report on Form 10-Q, and in Part I, Item 1A, “Risk Factors” of our Annual Report filed on Form 10-K for the fiscal year ended December 31, 2014.

Overview

We make bio-based pest management and plant health products. Bio-based products are comprised of naturally occurring microorganisms, such as bacteria and fungi, and plant extracts. Our current products target the major markets that use conventional chemical pesticides, including certain agricultural and water markets, where our bio-based products are used as alternatives for, or mixed with, conventional chemical products. We also target new markets for which there are no available conventional chemical pesticides, the use of conventional chemical pesticides may not be desirable or permissible because of health and environmental concerns (including for organically certified crops) or because the development of pest resistance has reduced the efficacy of conventional chemical pesticides. We believe our current portfolio of EPA-approved and registered “biopesticide” products and our pipeline address the growing global demand for effective, efficient and environmentally responsible products to control pests, increase crop yields and reduce crop stress.

The agricultural industry is increasingly dependent on effective and sustainable pest management practices to maximize yields and quality in a world of increased demand for agricultural products, rising consumer awareness of food production processes and finite land and water resources. In addition, our research has shown that the global market for biopesticides is growing substantially faster than the overall market for pesticides. This demand is in part a result of conventional growers acknowledging that there are tangible benefits to adopting bio-based pest management products into integrated pest management (“IPM”) programs, as well as increasing consumer demand for organic food. We seek to capitalize on these global trends by providing both conventional and organic growers with solutions to a broad range of pest management needs through strategies such as adding new products to our product portfolio, continuing to broaden the commercial applications of our existing product lines, leveraging growers’ positive experiences with existing product lines, educating growers with on-farm product demonstrations and controlled product launches with key target customers and other early adopters. We believe this approach enables us to stay ahead of our competition in providing innovative pest management solutions, enhances our sales process at the distributor level and helps us to capture additional value from our products.

Although our long-term, global vision for our business and our commitment to that vision remain fundamentally unchanged, to date, we have not achieved anticipated growth in sales of our products, which has resulted in an increase in inventory write-offs, higher proportional levels of operating expenses, increases in cost of product revenues and decreases in product margins. In response to the business challenges reflected in our financial results for recent periods, since the second half of 2014, we have been implementing a prioritization plan to focus our resources on continuing to improve and promote our commercially available products, advancing product candidates that are expected to have the greatest impact on near-term growth potential and expanding international presence and commercialization. Our goal has been to reduce expenses, to conserve cash and improve operating efficiencies, to extract greater value from our products and product pipeline and to improve our communication to and connection with the global sustainability movement that is core to our cultural values.

In connection with this new strategy, we have significantly reduced overall headcount, while building a new sales and marketing organization with increased training and ability to educate and support customers as well as providing our product development staff with greater responsibility for technical sales support, field trials and demonstrations to promote sales growth. In addition, while we believe that we have developed a robust pipeline of novel product candidates, we are currently limiting our internal efforts on five promising product candidates. Simultaneously, we are seeking collaborations with third parties to develop and commercialize more early stage candidates on which we have elected not to expend significant resources given our reduced budget. We believe collectively, these measures, together with our competitive strengths, including our leadership in the biologicals industry, commercially available products, robust pipeline of novel product candidates, proprietary discovery and development processes and industry experience, position us for growth.

We sell our crop protection products to leading agrichemical distributors while also working directly with growers to increase existing and generate new product demand. To date, we have marketed our bio-based pest management and plant health products for

agricultural applications to U.S. growers, through distributors and our own sales force, and we have focused primarily on high value specialty crops such as grapes, citrus, tomatoes and leafy greens. A large portion of our sales are currently attributable to conventional growers who use our bio-based pest management products either to replace conventional chemical pesticides or enhance the efficacy of their IPM programs. In addition, a portion of our sales are attributable to organic farmers, who cannot use conventional pesticides and have few alternatives for pest management. As we continue to demonstrate the efficacy of our bio-based pest management and plant health products on new crops or for new applications, we may either continue to sell our products through our in-house sales force or collaborate with third parties for distribution to select markets.

Although we have historically sold a significant majority of our products in the United States, expanding our international presence and commercialization is an important component of our growth strategy. Regalia is currently available in select international markets under distribution agreements with major agrichemical companies. Going forward, our plan is to focus on key countries and regions with the largest and fastest growing biopesticide and plant health product markets for specialty crops and selected row crops. We intend to work with regional and country distributors who have brand recognition and established customer bases and who can conduct field trials and grower demonstrations and lead or assist in regulatory processes and market development.

We currently market our water treatment product, Zequanox, through our sales and technical workforce to a selected group of U.S. power and industrial companies. Due to prioritization constraints, we have not committed resources to Zequanox sufficient to market it full-scale. However, we are seeking sales and distribution partners for in-pipe and open water uses, and are currently in discussions with large water treatment companies to further develop Zequanox and expand it commercially. In addition, we continue to work with state, federal and bi-national partners to further develop Zequanox in the Great Lakes/Upper Mississippi River Basin as a habitat restoration tool and potential harmful algal bloom management tool. We believe that Zequanox presents a unique opportunity for generating long-term revenue, as there are limited water treatment options available to date, most of which are time-consuming, costly or subject to high levels of regulation. Our ability to generate significant revenues from Zequanox is dependent on our ability to persuade customers to evaluate the costs of our Zequanox products compared to the overall cost of the chlorine treatment process, the primary current alternative to using Zequanox, rather than the cost of purchasing chemicals alone. Sales of Zequanox have also remained lower than our other products due to the length of the treatment cycle, the longer sales cycle (the bidding process with utility companies and governmental agencies occurs on a yearly or multi-year basis) and the unique nature of the treatment approach for each customer based on the extent of the infestation and the design of the facility.

Although our initial EPA-approved master labels cover our products’ anticipated crop-pest use combinations, we launch early formulations of our pest management and plant health products to targeted customers under commercial labels that list a limited number of crops and applications that our initial efficacy data can best support. We then gather new data from experiments, field trials and demonstrations, gain product knowledge and get feedback to our research and development team from customers, researchers and agricultural agencies. Based on this information, we enhance our products, refine our recommendations for their use in optimal IPM programs, expand our commercial labels and submit new product formulations to the EPA and other regulatory agencies. For example, we began sales of Regalia SC, an earlier formulation of Regalia, in the Florida fresh tomatoes market in 2008, while a more effective formulation of Regalia with an expanded master label, including listing for use in organic farming, was under review by the EPA. In 2011, we received EPA approval of a further expanded Regalia master label covering hundreds of crops and various new uses for applications to soil and through irrigation systems, and we recently expanded sales of Regalia in large-acre row crops as a plant stimulus product, in addition to its beneficial uses as a fungicide. Similarly, ongoing field development research on the microbe used in Venerate, our insecticide product, led to our October 2015 registration of Majestene as a nematicide. We believe we have opportunities to broaden the commercial applications and expand the use of our existing products lines to help drive significant growth for our company.

Our total revenues were $3.4 million and $3.1 million for the three months ended June 30, 2015 and 2014, respectively, and $5.4 million and $5.8 million for the six months ended June 30, 2015 and 2014, respectively. We generate our revenues primarily from product sales, which are principally attributable to sales of our Regalia and Grandevo product lines. Various factors have impeded anticipated growth in sales of these products in recent years, and may continue to impede growth. For example, we believe adverse conditions in the U.S. agricultural industry, including low commodity prices, may have reduced demand for our products. Further delays in regulatory approvals of certain of our products in Europe and other jurisdictions may slow international growth, and any delay in a product launch that causes us to miss a growing season may require us to wait a year to enter that market. The extended drought in California and other markets has reduced demand for our products as fewer acres are planted, and certain of our strategic collaborations have not resulted in anticipated increases in sales of Regalia outside of the Unites States. Due to prioritization constraints, we have not committed resources to Zequanox sufficient to market it full-scale, and our collaboration efforts with regard to this product may not result in increased sales. In addition, the departure of our former chief operating officer and significant members of our sales staff in the third quarter of 2014 and subsequent turnover in our sales and marketing department disrupted the 2014 launch of Venerate as well as growth in sales of our other commercialized products, including Regalia and Grandevo.

Since 2011, we have also recognized revenues from our strategic collaboration and distribution agreements, which amounted to less than $0.1 million for each of the three months ended June 30, 2015 and 2014, and $0.2 million and $0.1 million for the six months ended June 30, 2015 and 2014, respectively, excluding related party revenues. We have a strategic collaboration and distribution agreement with Syngenta, an affiliate of a former 5% stockholder, Syngenta Ventures Pte. LTD (Syngenta Ventures). In connection with our secondary offering in June 2014, Syngenta Ventures sold 0.6 million shares of our common stock, reducing its ownership percentage below 5%. Accordingly, revenue recognized under this agreement subsequent to June 2014 has not been included in related party revenues. For the three and six months ended June 30, 2014, we recognized less than $0.1 million and $0.3 million, respectively, of related party revenues under this agreement prior to Syngenta Ventures reducing its ownership stake.

We currently rely, and expect to continue to rely, on a limited number of distributors for a significant portion of our revenues since we sell through highly concentrated, traditional distribution channels. Distributors to which 10% or more of our total revenues are attributable for any one of the periods presented consist of the following:


	CROP PRODUCTION SERVICES			WILBUR ELLIS			HELENA CHEMICALS
For the three months ended June 30,
2015		34	%		11	%		4	%
2014		37	%		7	%		12	%
For the six months ended June 30,
2015		27	%		8	%		8	%
2014		31	%		6	%		13	%

While we expect product sales to a limited number of distributors to continue to be our primary source of revenues, as we continue to develop our pipeline and introduce new products to the marketplace, we anticipate that our revenue stream will be diversified over a broader product portfolio and customer base.

Our cost of product revenues was $3.0 million and $2.7 million for the three months ended June 30, 2015 and 2014, respectively, and $5.0 million and $4.5 million for the six months ended June 30, 2015 and 2014, respectively. Cost of product revenues included $0.1 million of cost of product revenues to related parties for each of the three months ended June 30, 2015 and 2014, and $0.2 million and $0.3 million for the six months ended June 30, 2015 and 2014, respectively. Cost of product revenues consists principally of the cost of inventory, which includes the cost of raw materials, and third party services and allocation of operating expenses of our manufacturing plant related to procuring, processing, formulating, packaging and shipping our products. Cost of product revenues also include charges recorded for write-downs of inventory, which has increased in recent years, and, beginning in 2014, idle capacity at our manufacturing plant when the manufacturing plant was placed into service. We expect our cost of product revenues related to the cost of inventory to increase and cost of product revenues relating to write-downs of inventory and idle capacity of our manufacturing plant to decrease as we expand sales and increase production of our existing commercial products Regalia, Grandevo, Venerate and Zequanox and introduce new products to the market. Our cost of product revenues related to the cost of inventory has increased as a percentage of total revenues primarily due to a change in product mix, with Grandevo representing an increased percentage of total revenues as Grandevo is early in its life cycle. We expect to see a gradual increase in gross margin over the life cycle of each of our products, including Grandevo, as we improve production processes, gain efficiencies and increase product yields. These increases may be offset by additional charges for inventory write-downs and idle capacity at our manufacturing plant until overall volume in the plant increases significantly.

Our research, development and patent expenses have historically comprised a significant portion of our operating expenses, amounting to $3.3 million and $4.3 million for the three months ended June 30, 2015 and 2014, respectively, and $6.8 million and $8.6 million for the six months ended June 30, 2015 and 2014, respectively. We have reduced the size of our research and development staff compared to prior periods and are reducing costs spent on various research and development and patent efforts as part of our efforts to streamline business operations and focus on our pipeline product priorities. However, we have made, and will continue to make, substantial investments in research and development and we intend to continue to devote significant resources toward the advancement of product candidates that are expected to have the greatest impact on near-term growth potential. Simultaneously, we are seeking collaborations with third parties to develop and commercialize more early stage candidates, which we have elected not to expend significant resources on given our reduced budget.

Selling, general and administrative expenses incurred to establish and build our market presence and business infrastructure have generally comprised the remainder of our operating expenses, amounting to $7.4 million and $5.9 million for the three months ended June 30, 2015 and 2014, respectively, and $15.3 million and $12.2 million for the six months ended June 30, 2015 and 2014, respectively. While we have reduced headcount in comparison to prior periods, in connection with our new strategy, we have been building a new sales and marketing organization which provides for increased training and a better ability to educate and support customers as well as transitioning our product development staff to undertake greater responsibility for technical sales support, field trials and demonstrations to promote sales growth. We expect that in the future, our selling, general and administrative expenses will increase due to our expanded product portfolio and due to additional costs incurred related to being a public company. In addition, for the three and six months ended June 30, 2015, we incurred $2.1 million and $4.6 million, respectively, in costs related to the Audit Committee’s independent investigation and subsequent restatement of our financial statements. We expect to incur significant costs through 2015 related to the Audit Committee’s independent investigation, which commenced in September 2014, and the restatement of our financial statements. In addition, we have engaged in discussions with the SEC’s Division of Enforcement staff concerning the resolution of any enforcement action that it may recommend. Accordingly, we have accrued $1.8 million in our condensed consolidated balance sheets as of June 30, 2015 and December 31, 2014 for any potential penalties arising from such enforcement action.

Until the initial public offering (“IPO”) in August 2013, we have funded our operations from the issuance of shares of common stock, preferred stock, warrants and convertible notes, the issuance of debt and entry into financing arrangements, product sales, payments under strategic collaboration and distribution agreements and government grants, but we have experienced significant losses as we invested heavily in research and development. We expect to incur additional losses related to our investment in the continued development, expansion and marketing of our product portfolio.

In August 2015, we issued and sold to affiliates of Waddell & Reed Financial, Inc., in a private placement, senior secured promissory notes in the aggregate principal amount of $40.0 million and warrants to purchase up to 4.0 million shares of our common stock for aggregate consideration of $40.0 million.

Critical Accounting Policies and Estimates

Our condensed consolidated financial statements and the related notes included elsewhere in this Quarterly Report on Form 10-Q are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). The preparation of these condensed consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, net revenue, costs and expenses, and any related disclosures. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Changes in accounting estimates are reasonably likely to occur from period to period. Accordingly, actual results could differ significantly from the estimates made by our management. We evaluate our estimates and assumptions on an ongoing basis. To the extent that there are material differences between these estimates and our actual results, our future financial statement presentation, financial condition, results of operations and cash flows will be affected.

We believe that the assumptions and estimates associated with revenue recognition, including assumptions and estimates used in determining the timing and amount of revenue to recognize for those transactions accounted for on a “sell-through” method, income taxes, inventory valuation and share-based compensation have the greatest potential impact on our condensed consolidated financial statements. Therefore, we consider these to be our critical accounting policies and estimates. There have been no material changes to our critical accounting policies as described in our Annual Report filed on Form 10-K for the fiscal year ended December 31, 2014.

Key Components of Our Results of Operations

Product Revenues

Product revenues consist of revenues generated primarily from sales to distributors, net of rebates and cash discounts. Product revenues, not including related party revenues, constituted 92% of our total revenues for each of the three months ended June 30, 2015 and 2014, respectively, and 90% and 84% for the six months ended June 30, 2015 and 2014, respectively. Product revenues in the United States, not including related party revenues, constituted 85% and 87% of our total revenues for the three months ended June 30, 2015 and 2014, respectively, and 85% and 80% for the six months ended June 30, 2015 and 2014, respectively.

In some cases, we recognize distributor revenue as title and risk of loss passes, provided all other revenue recognition criteria have been satisfied (the “sell-in” method). For certain sales to certain distributors, the revenue recognition criteria for distributor sales are not satisfied at the time title and risk of loss passes to the distributor; specifically, in instances where “inventory protection” arrangements were offered to distributors that permit these distributors to return to the Company certain unsold products, we consider

the arrangement not to be fixed or determinable, and accordingly, revenue is deferred until products are resold to customers of the distributor (the “sell-through” method). The cost of goods sold associated with such deferral are also deferred and classified as deferred cost of product revenues in the condensed consolidated balance sheets. Cash received from customers related to delivered product that may not represent a true sale is classified as customer refund liabilities in the condensed consolidated balance sheets and the related cost of inventory remains in inventory in the condensed consolidated balance sheets until the product is returned or is resold to customers of the distributor and revenue is recognized. For the three months ended June 30, 2015 and 2014, 57% and 48%, respectively, and for the six months ended June 30, 2015 and 2014, 46% and 51%, respectively, of product revenues, not including related party revenues, were recognized on a sell-through basis.

License Revenues

License revenues generally consist of revenues recognized under our strategic collaboration and distribution agreements for exclusive distribution rights, either for Regalia or for our broader pipeline of products, for certain geographic markets or for market segments that we are not addressing directly through our internal sales force. Our strategic collaboration and distribution agreements generally outline overall business plans and include payments we receive at signing and for the achievement of testing validation, regulatory progress and commercialization events. As these activities and payments are associated with exclusive rights that we provide over the term of the strategic collaboration and distribution agreements, revenues related to the payments received are deferred and recognized as revenues over the term of the exclusive period of the respective agreements, which we estimate to be between 5 and 17 years based on the terms of the contract and the covered products and regions. For each of the three months ended June 30, 2015 and 2014, license revenues constituted 2% of total revenues, and 3% and 2% for the six months ended June 30, 2015 and 2014, respectively. As of June 30, 2015, including agreements with related parties discussed below, we had received an aggregate of $3.6 million in payments under our strategic collaboration and distribution agreements. In addition, there will be an additional $0.5 million in payments due on certain anniversaries of regulatory approval and an additional $1.6 million in payments under these agreements that we could potentially receive if the testing validation, regulatory progress and commercialization events occur.

Related Party Revenues

Related party revenues consist of both product revenues and license revenues. Les Lyman, a member of our board of directors, is the chairman and significant indirect shareholder of The Tremont Group, Inc., which purchases our products for further distribution and resale. In addition, we have a strategic collaboration and distribution agreement with Syngenta, an affiliate of a former 5% stockholder, Syngenta Ventures. In connection with our secondary offering in June 2014, Syngenta Ventures sold 0.6 million shares of our common stock, reducing its ownership percentage below 5%. Accordingly, revenue recognized under this agreement subsequent to June 2014 has not been included in related party revenues. For each of the three months ended June 30, 2015 and 2014, related party revenues constituted 6% of total revenues, and 7% and 14% for the six months ended June 30, 2015 and 2014, respectively. For the three months ended June 30, 2015 and 2014, 5% and 6%, respectively, and for the six months ended June 30, 2015 and 2014, 7% and 8%, respectively, of total revenues were recognized on a sell-through basis arising from sales to a related party.

Cost of Product Revenues and Gross Profit

Cost of product revenues consists principally of the cost of raw materials, including inventory costs and third- party services related to procuring, processing, formulating, packaging and shipping our products. As we have used our Bangor, Michigan manufacturing plant to produce certain of our products, cost of product revenues includes an allocation of operating costs including direct and indirect labor, productions supplies, repairs and maintenance, depreciation, utilities and property taxes. The amount of indirect labor and overhead allocated to finished goods is determined on a basis presuming normal capacity utilization. Operating costs incurred in excess of production allocations, considered idle capacity, are expensed to cost of product revenues sold in the period incurred rather than added to the cost of the finished goods produced. Cost of product revenues may also include charges due to inventory adjustments and reserves. Gross profit is the difference between total revenues and cost of product revenues. Gross margin is gross profit expressed as a percentage of total revenues.

We have entered into in-license technology agreements with respect to the use and commercialization of our three commercially available product lines, including Regalia, Grandevo and Zequanox, and certain products under development. Under these licensing arrangements, we typically make royalty payments based on net product revenues, with royalty rates varying by product and ranging between 2% and 5% of net sales, subject in certain cases to aggregate dollar caps. These royalty payments are included in cost of product revenues, but they have historically not been significant. In addition, costs associated with license revenues have been included in cost of product revenues, as they have not been significant. The exclusivity and royalty provisions of these agreements are generally tied to the expiration of underlying patents. The patents for Regalia and Zequanox will expire in 2017 and the in-licensed U.S. patent for Grandevo is expected to expire in 2024. There is, however, a pending in-licensed patent application relating to

Grandevo, which could expire later than 2024 if issued. After the termination of these provisions, we may continue to produce and sell these products. While third parties thereafter may develop products using the technology under expired patents, we do not believe that they can produce competitive products without infringing other aspects of our proprietary technology, including pending patent applications related to Regalia, Grandevo and Zequanox, and we therefore do not expect the expiration of the patents or the related exclusivity obligations to have a significant adverse financial or operational impact on our business.

We expect to see increases in gross profit over the life cycle of each of our products as gross margins are expected to increase over time as production processes improve and as we gain efficiencies and increase product yields. While we expect margins to improve on a product-by-product basis, our overall gross margins may vary as we introduce new products. In particular, we are experiencing and expect further near-term downward pressure on overall gross margins as we expand sales of Grandevo, Venerate and Zequanox and when we introduce new products. Gross margin has been and will continue to be affected by a variety of factors, including plant utilization, product manufacturing yields, changes in production processes, new product introductions, product mix and average selling prices.

In July 2012, we acquired a manufacturing facility, which we repurposed for manufacturing operations. We began full-scale manufacturing using this facility in 2014. We continue to use third party manufacturers for Venerate and for spray-dried powder formulations of Grandevo and Zequanox. We expect gross margins to improve using this facility when sales volumes recover enough to reduce overhead and unused capacity charges from our facility.

Research, Development and Patent

Research, development and patent expenses includes personnel costs, including salaries, wages, benefits and share-based compensation, related to our research, development and patent staff in support of product discovery and development activities. Research, development and patent expenses also include costs incurred for laboratory supplies, field trials and toxicology tests, quality control assessment, consultants and facility and related overhead costs.

Beginning in the fourth quarter of 2014, we reduced our research and development staff and prioritized our pipeline candidates, focusing first on those that can be in the market in the next two years. We expect research, development and patent expenses to decrease in the near term as we have reduced headcount and will focus our efforts on select pipeline products. We are working to find partners to assist development of other pipeline candidates.

Selling, General and Administrative

Selling, general and administrative expenses consist primarily of personnel costs, including salaries, wages, benefits and share-based compensation, related to our executive, sales, marketing, finance and human resources personnel, as well as professional fees, including legal and accounting fees, and other selling costs incurred related to business development and to building product and brand awareness. We create brand awareness through programs such as speaking at industry events, trade show displays and hosting local-level grower and distributor meetings. In addition, we dedicate significant resources to technical marketing literature, targeted advertising in print and online media, webinars and radio advertising. Costs related to these activities, including travel, are included in selling expenses. Our administrative expenses have increased in recent periods primarily as a result of becoming a public company and incurring significant costs in connection with the Audit Committee’s independent investigation and subsequent restatement of our financial statements.

We expect our selling expenses to increase in the near-term, both in absolute dollars and as a percentage of total revenues. For the three and six months ended June 30, 2015, we incurred $2.1 million and $4.6 million, respectively, in costs related to the Audit Committee’s independent investigation and subsequent restatement of our financial statements. We will continue to incur such costs during the year ending December 31, 2015. Further, as a result of pending litigation, we also expect to incur additional costs relating to directors and officers liability insurance in future periods. In addition, we have engaged in discussions with the SEC’s Division of Enforcement staff concerning the resolution of any enforcement action that it may recommend. In accordance with ASC 450, Contingencies, we have accrued $1.8 million in our condensed consolidated balance sheets as of June 30, 2015 and December 31, 2014 for our estimate of the penalties arising from such enforcement action.

In the long-term, we expect our selling, general and administrative expenses to decline as a percentage of total revenues. We expect our overall selling, general and administrative expenses to increase in absolute dollars in order to drive product sales, and we will incur additional expenses associated with operating as a public company. Such increases may include increased insurance premiums, investor relations expenses, legal and accounting fees associated with the expansion of our business and corporate governance, financial reporting expenses, expenses related to Sarbanes-Oxley and other regulatory compliance obligations.

Interest Expense

We recognize interest expense on notes payable and other debt obligations. In August 2015, we issued and sold to affiliates of Waddell & Reed Financial, Inc. senior secured promissory notes in the aggregate principal amount of $40.0 million with a fixed interest rate and warrants to purchase up to 4.0 million shares of our common stock for aggregate consideration of $40.0 million. Accordingly, interest expense will increase as a result of the additional debt outstanding. In connection with the aforementioned transaction, in August 2015, we amended the October 2012 and April 2013 Secured Promissory Notes. As a result of the amendment, interest on loans was accrued at a rate of 12% per annum until September 1, 2015, and thereafter is accrued at a rate of 18% per annum. Accordingly, interest expense will increase as a result of the higher interest rate.

We have also acquired equipment under capital leases which results in interest expense over the lease term. Our capital lease obligations were $1.5 million and $2.0 million as of June 30, 2015 and December 31, 2014, respectively.

Interest Income

Interest income consists primarily of interest earned on cash balances. Our interest income will vary each reporting period depending on our average cash balances during the period and market interest rates.

Income Tax Provision

Since our inception, we have been subject to income taxes principally in the United States. We anticipate that as we further expand our sales into foreign countries, we will become subject to taxation based on the foreign statutory rates and our effective tax rate could fluctuate accordingly.

Income taxes are computed using the asset and liability method, under which deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. As of June 30, 2015, based on the available information, it is more likely than not that our deferred tax assets will not be realized, and accordingly we have taken a full valuation allowance against all of our U.S. deferred tax assets.

Results of Operations

The following table sets forth certain statements of operations data as a percentage of total revenues:


	THREE MONTHS ENDED JUNE 30,						SIX MONTHS ENDED JUNE 30,
	2015			2014			2015			2014
Revenues:
Product		92	%		92	%		90	%		84	%
License		2			2			3			2
Related party		6			6			7			14

Total revenues		100			100			100			100
Cost of product revenues ⁽¹⁾		89			87			92			77

Gross profit		11			13			8			23
Operating expenses:
Research, development and patent		99			136			125			147
Selling, general and administrative		221			189			283			210

Total operating expenses		320			325			408			357

Loss from operations		(309	)		(312	)		(400	)		(334	)
Other income (expense):
Interest income		—			—			—			—
Interest expense		(20	)		(28	)		(25	)		(25	)
Other income (expense), net		1			(3	)		1			(2	)

Total other expense, net		(19	)		(31	)		(24	)		(27	)

Income taxes		—			—			—			—

Net loss		(328	)%		(343	)%		(424	)%		(361	)%

⁽¹⁾

Includes cost of product revenues to related parties of 3% and 4% for the three months ended June 30, 2015 and 2014, respectively, and 4% and 5% for the six months ended June 30, 2015 and 2014, respectively. See Note 9 to the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q in Part I, Item 1, “Financial Information” for further discussion.

Comparison of Three Months Ended June 30, 2015 and 2014

Product Revenues


	THREE MONTHS ENDED JUNE 30,
	2015			2014
	(Dollars in thousands)
Product revenues	$	3,091		$	2,877
% of total revenues		92	%		92	%

Product revenues increased by $0.2 million, or 7%, primarily due to an increase of $0.4 million in revenue recognized on a sell-through basis that was deferred from sales to distributors made in prior periods. This was offset by a decrease of $0.2 million in revenue recognized on a sell-in basis, which we believe was primarily due to changes in the timing of our customers’ orders as a result of seasonality in the agricultural industry and the impact that weather may have on the timing of the application of our products.

License Revenues


	THREE MONTHS ENDED JUNE 30,
	2015			2014
	(Dollars in thousands)
License revenues	$	83		$	51
% of total revenues		2	%		2	%

License revenues increased by less than $0.1 million, or 63%, related to additional milestones that have been achieved upon which revenue is recognized over time.

Related Party Revenues


	THREE MONTHS ENDED JUNE 30,
	2015			2014
	(Dollars in thousands)
Related party revenues	$	183		$	206
% of total revenues		6	%		6	%

Related party revenues decreased by less than $0.1 million, or 11%, due to a decrease in revenue recognized on a sell-through basis that was deferred from sales to The Tremont Group, Inc. made in prior periods.

Cost of Product Revenues and Gross Profit


	THREE MONTHS ENDED JUNE 30,
	2015			2014
	(Dollars in thousands)
Cost of product revenues	$	2,994		$	2,711
% of total revenues		89	%		87	%
Gross profit	$	363		$	423
% of total revenues		11	%		13	%

Cost of product revenues increased by $0.3 million, or 10%, and gross margin decreased by $0.1 million, or 14%. Gross margins decreased from 13% to 11%. Our manufacturing plant began full-scale production in 2014, and as a result of actual utilization of the plant being less than what is considered normal capacity, $0.6 million in operating costs of the manufacturing plant were recorded to cost of product revenues for the three months ended June 30, 2015 and were not capitalized as inventory. This was offset by a decrease of $0.3 million in additional reserves for excess and obsolete inventory.

Research, Development and Patent Expenses


	THREE MONTHS ENDED JUNE 30,
	2015			2014
	(Dollars in thousands)
Research, development and patent	$	3,328		$	4,264
% of total revenues		99	%		136	%

Research, development and patent expenses decreased by $0.9 million, or 22%, primarily due to a decrease of $0.5 million in employee related expenses, which consisted primarily of salaries, wages and share-based compensation, due to a reduction in headcount, and a decrease of $0.4 million in direct testing costs.

Selling, General and Administrative Expenses


	THREE MONTHS ENDED JUNE 30,
	2015			2014
	(Dollars in thousands)
Selling, general and administrative	$	7,411		$	5,920
% of total revenues		221	%		189	%

Selling, general and administrative expenses increased by $1.5 million, or 25%, primarily due to an increase in outside services of $2.8 million for accounting, consulting and legal fees incurred as a result of the $2.1 million incurred relating to the Audit Committee’s independent investigation and subsequent restatement of our financial statements. This was offset by a decrease of $0.3 million in employee related expenses, which consisted primarily of salaries, wages and share-based compensation, and $0.2 million in travel expenses due to a reduction in headcount, a decrease of $0.1 million in general expenses relating to a reduction of franchise taxes and printing fees and a decrease of $0.7 million in expenses associated with the manufacturing plant as a result of such expenses either being capitalized as inventory or allocated to cost of product revenues if actual utilization of the plant is less than what is considered normal capacity as we began full-scale production in 2014.

Other Expense, Net


	THREE MONTHS ENDED JUNE 30,
	2015			2014
	(Dollars in thousands)
Interest income	$	6		$	11
Interest expense		(659	)		(863	)
Other income (expense), net		44			(98	)

Total other expense, net	$	(609	)	$	(950	)

Interest expense decreased $0.2 million, or 24%, primarily due to a decrease in interest expense recognized relating to capital leases. For the three months ended June 30, 2014, certain of our capital lease lines used for the expansion of our manufacturing plant were not yet fully utilized, and as such, the lease payments were being charged to interest expense. Other income (expense), net increased $0.1 million, or 145%, primarily as we had a gain on disposals of equipment for the three months ended June 30, 2015 as compared to a loss on disposals of equipment for the three months ended June 30, 2014. Interest income was largely unchanged.

Comparison of Six Months Ended June 30, 2015 and 2014

Product Revenues


	SIX MONTHS ENDED JUNE 30,
	2015			2014
	(Dollars in thousands)
Product revenues	$	4,865		$	4,931
% of total revenues		90	%		84	%

Product revenues decreased by $0.1 million, or 1%, primarily due to a decrease of $0.3 million in revenue recognized on a sell-through basis that was deferred from sales to distributors made in prior periods. This was offset by an increase of $0.2 million in revenue recognized on a sell-in basis, which we believe was primarily due to changes in the timing of our customers’ orders as a result of seasonality in the agricultural industry and the impact that weather may have on the timing of the application of our products.

License Revenues


	SIX MONTHS ENDED JUNE 30,
	2015			2014
	(Dollars in thousands)
License revenues	$	166		$	96
% of total revenues		3	%		2	%

License revenues increased by less than $0.1 million, or 73%, related to additional milestones that have been achieved upon which revenue is recognized over time.

Related Party Revenues


	SIX MONTHS ENDED JUNE 30,
	2015			2014
	(Dollars in thousands)
Related party revenues	$	382		$	811
% of total revenues		7	%		14	%

Related party revenues decreased by $0.4 million, or 53%, as $0.3 million was recognized during the six months ended June 30, 2014 upon the termination of one of our strategic collaboration and distribution agreements with Syngenta. Syngenta is an affiliate of a former 5% stockholder, Syngenta Ventures. In connection with the secondary offering in June 2014, Syngenta Ventures sold 0.6 million shares of our common stock, reducing its ownership percentage below 5%. Accordingly, revenue recognized subsequent to June 2014 under the remaining agreements has not been included in related party revenues. There was also a decrease of $0.1 million in revenue recognized on a sell-through basis that was deferred from sales to The Tremont Group, Inc. made in prior periods.

Cost of Product Revenues and Gross Profit


	SIX MONTHS ENDED JUNE 30,
	2015			2014
	(Dollars in thousands)
Cost of product revenues	$	4,992		$	4,504
% of total revenues		92	%		77	%
Gross profit	$	421		$	1,334
% of total revenues		8	%		23	%

Cost of product revenues increased by $0.5 million, or 11%, and gross margin decreased by $0.9 million, or 68%. Gross margins decreased from 23% to 8%. Our manufacturing plant began full-scale production in 2014, and as a result of actual utilization of the plant being less than what is considered normal capacity, $1.2 million in operating costs of the manufacturing plant were recorded to cost of product revenues for the six months ended June 30, 2015 and were not capitalized as inventory. In addition gross margin decreased $0.3 million was as a result of license revenue recognized upon the termination of one of our agreements with Syngenta for which there was no significant corresponding cost of product revenues for the six months ended June 30, 2015. There was no similar transaction for the six months ended June 30, 2015. This was offset by a decrease of $0.3 million in additional reserves for excess and obsolete inventory.

Research, Development and Patent Expenses


	SIX MONTHS ENDED JUNE 30,
	2015			2014
	(Dollars in thousands)
Research, development and patent	$	6,750		$	8,561
% of total revenues		125	%		147	%

Research, development and patent expenses decreased by $1.8 million, or 21%, primarily due to a decrease of $1.1 million in employee related expenses, which consisted primarily of salaries, wages and share-based compensation, due to a reduction in headcount, and a decrease of $0.9 million in direct testing, field trials and lab costs. This was offset by an increase of $0.2 million in depreciation expense relating to new equipment purchased.

Selling, General and Administrative Expenses


	SIX MONTHS ENDED JUNE 30,
	2015			2014
	(Dollars in thousands)
Selling, general and administrative	$	15,298		$	12,244
% of total revenues		283	%		210	%

Selling, general and administrative expenses increased by $3.0 million, or 25%, primarily due to an increase in outside services of $5.5 million for accounting, consulting and legal fees incurred as a result of the $4.6 million incurred relating to the Audit Committee’s independent investigation and subsequent restatement of our financial statements and an increase of $0.3 million in fixed expenses due to an increase in rent and directors and officers liability insurance. This was offset by a decrease of $0.8 million in employee related expenses, which consisted primarily of salaries, wages and share-based compensation, and $0.3 million in travel expenses due to a reduction in headcount, and a decrease of $1.5 million in expenses associated with the manufacturing plant as a result of such expenses either being capitalized as inventory or allocated to cost of product revenues if actual utilization of the plant is less than what is considered normal capacity as we began full-scale production in 2014.

Other Expense, Net


	SIX MONTHS ENDED JUNE 30,
	2015			2014
	(Dollars in thousands)
Interest income	$	15		$	21
Interest expense		(1,328	)		(1,469	)
Other income (expense), net		41			(107	)

Total other expense, net	$	(1,272	)	$	(1,555	)

Interest expense decreased $0.1 million, or 10%, primarily due to a decrease in interest expense recognized relating to capital leases. For the three months ended June 30, 2014, certain of our capital lease lines used for the expansion of our manufacturing plant were not yet fully utilized, and as such, the lease payments were being charged to interest expense. This was offset by an increase in interest expense as we issued a promissory note in the amount of $10.0 million in June 2014. Other income (expense), net increased $0.1 million, or 138%, primarily as we had a gain on disposals of equipment for the six months ended June 30, 2015 as compared to a loss on disposals of equipment for the six months ended June 30, 2014. Interest income was largely unchanged.

Seasonality and Quarterly Results

Sales of our crop protection products have been, and are generally expected to be, seasonal. Regalia and Grandevo, which accounted for the majority of revenues in recent periods, have historically been sold and applied to crops in greater quantity in the second and fourth quarters, with lowest sales in the third quarter when there is the lowest pest and disease pressure in the United States. We expect this trend to continue in the future, but this seasonality could be reduced, or we could experience seasonality in different periods than anticipated, as a result of various factors, including if we expand into new geographical territories or introduce new products with different applicable growing seasons, or if a more significant component of our revenue becomes comprised of sales of Zequanox, which has a separate seasonal sales cycle compared to our crop protection products.

Notwithstanding anticipated seasonality, we expect substantial fluctuation in sales year over year and quarter over quarter, and seasonality could be reduced or enhanced as a result of a number of variables on which sales of our products are dependent. Weather conditions, natural disasters and other factors affect planting and growing seasons and incidence of pests and plant disease, and accordingly affect decisions by our distributors, direct customers and end users about the types and amounts of pest management and plant health products to purchase and the timing of use of such products. In addition, disruptions that cause delays by growers in

harvesting or planting can result in the movement of orders to a future quarter, which would negatively affect the quarter and cause fluctuations in our operating results. For example, late snows and cold temperatures in the Midwestern and Eastern United States in the first and second quarters of 2014 delayed planting and pesticide and plant health applications. Customers also may purchase large quantities of our products in a particular quarter to store and use over long periods of time or time their purchases to manage their inventories, which may cause significant fluctuations in our operating results for a particular quarter or year, and low commodity prices may discourage growers from purchasing our products in an effort to reduce their costs and increase their margins for a growing season.

The level of seasonality in our business overall is difficult to evaluate as a result of our relatively early stage of development, our relatively limited number of commercialized products, our expansion into new geographical territories, the introduction of new products and the timing of introductions of new formulations and products. It is possible that our business may be more seasonal, or experience seasonality in different periods, than anticipated. For example, if sales of Zequanox become a more significant component of our revenue, the separate seasonal sales cycles could cause further shifts in our quarterly revenue. Other factors may also contribute to the unpredictability of our operating results, including the size and timing of significant distributor transactions, the delay or deferral of use of our products and the fiscal or quarterly budget cycles of our distributors, direct customers and end users. Customers may purchase large quantities of our products in a particular quarter to store and use over long periods of time or time their purchases to manage their inventories, which may cause significant fluctuations in our operating results for a particular quarter or year.

Liquidity and Capital Resources

From our inception until the IPO in August 2013, our operations have been financed primarily by net proceeds from the private placements of convertible preferred stock, convertible notes, promissory notes and term loans, as well as proceeds from the sale of our products and payments under strategic collaboration and distribution agreements and government grants. As of June 30, 2015, our cash and cash equivalents totaled $12.2 million. In August 2015, we issued and sold to affiliates of Waddell & Reed Financial, Inc. senior secured promissory notes in the aggregate principal amount of $40.0 million. The notes bear interest at a rate of 8% per annum payable semi-annually on June 30 or December 31 of each year, commencing on December 31, 2015, with $10.0 million payable three years from the closing, $10.0 million payable four years from the closing and $20.0 million payable five years from the closing. After this financing, as of September 30, 2015, our cash and cash equivalents totaled $27.8 million and we had restricted cash of $18.4 million in total relating to cash that we are contractually obligated to maintain in accordance with our debt agreements.

We believe our current cash and cash equivalents, available proceeds from the August 2015 issuance and sale of $40.0 million in senior secured promissory notes and cash from revenues will be sufficient to satisfy our liquidity requirements for the next twelve months. However, we may seek additional funding through debt or equity financings that may be used, among other things, to expand our product development and sales and marketing efforts, to increase capacity of our manufacturing facility, to complete strategic transactions and/or for working capital. Adequate funds for this and the other purposes may not be available to us when needed or on acceptable terms, and we may need to raise capital that may not be available on favorable or acceptable terms, if at all. If we cannot raise money when needed, we may have to reduce or slow product development activities, further reduce operating expenses and/or reduce capital investment.

Since our inception, we have incurred significant net losses, and, as of June 30, 2015, we had an accumulated deficit of $182.7 million. We expect to incur additional losses related to the continued development and expansion of our business. Our liquidity may be negatively impacted as a result of slower than expected adoption of our products. We have certain strategic collaboration and distribution agreements under which we receive payments for the achievement of testing validation, regulatory progress and commercialization events. As of June 30, 2015, we had received an aggregate of $3.6 million in payments under these agreements. In addition, there will be an additional $0.5 million in payments due on certain anniversaries of regulatory approval and an additional $1.6 million in payments under these agreements that we could potentially receive if the testing validation, regulatory progress and commercialization events occur.

For the six months ended June 30, 2015 and 2014, we used $1.4 million and $9.4 million, respectively, in cash to fund capital expenditures. In July 2012, we acquired a manufacturing facility, formerly used as a biodiesel plant. Repurposing of the facility was completed in 2014 and included the installation of fermentation tanks and the construction of a dedicated building to house them. In December 2013, we produced the first test batch of Grandevo at this facility and began full-scale production of our products using our own manufacturing capacity in 2014. The facility now accommodates full-scale production of Regalia and full-scale fermentation of Grandevo and Zequanox.

We had the following debt arrangements in place as of June 30, 2015, in each case as discussed below (dollars in thousands):


DESCRIPTION	STATED ANNUAL INTEREST RATE			PRINCIPAL AMOUNT BALANCE (INCLUDING ACCRUED INTEREST)		PAYMENT/MATURITY
Term Loan ⁽¹⁾		7.00	%	$	116	Monthly/April 2016
Promissory Notes ⁽²⁾		12.00	%	$	12,575	Monthly⁽⁴⁾/October 2015
Promissory Note ⁽³⁾		5.25	%	$	9,773	Monthly/June 2036

⁽¹⁾	See “—Term Loan.”

⁽²⁾	See “—October 2012 and April 2013 Secured Promissory Notes.”

⁽³⁾	See “—June 2014 Secured Promissory Note.”

⁽⁴⁾	Monthly payments are interest only until maturity.

Term Loan

In March 2012, we entered into a term loan agreement with Five Star Bank, which replaced our existing revolving line of credit with the bank. Under the term loan agreement, we are obligated to repay the loan at a rate of approximately $12,000 per month through maturity.

Under the terms of the term loan agreement, all of our outstanding debt to Five Star Bank is secured by all of our inventory, chattel paper, accounts receivable, equipment and general intangibles (excluding certain financed equipment and any intellectual property). Among other things, a payment default with respect to each of the promissory notes and the term loan, as well as other events such as a default under other loans or agreements that would materially affect us, constitute events of default. Upon an event of default, Five Star Bank may declare the entire unpaid principal and interest immediately due and payable. This loan was paid off in August 2015.

October 2012 and April 2013 Secured Promissory Notes

In October 2012, we completed the sale of promissory notes in the aggregate principal amount of $7.5 million to twelve lenders in a private placement. In addition, in April 2013, we completed the sale of an additional $4.95 million of promissory notes to ten lenders in a private placement under an amendment to the note purchase agreement in exchange for $3.7 million in cash and $1.25 million in cancellation of indebtedness under a previously outstanding convertible note. Maturity, currently October 2015, may be extended in one year increments for a period of no more than two years. In the event the maturity date is extended, the interest rate is 13% in the first year of the extension and the note matures in October 2016, and if extended for an additional year thereafter, the interest rate is 14% in the second year of extension and the note matures in October 2017. These promissory notes are secured by a security interest in all of our present and future accounts receivable, chattel paper, commercial tort claims, goods, inventory, equipment, personal property, instruments, investment properties, documents, letter of credit rights, deposit accounts, general intangibles, records, real property, appurtenances and fixtures, tenant improvements and intellectual property, which consists of our patents, copyrights and other intangibles.

As of June 30, 2015 and December 31, 2014, we were in breach of our covenants under the notes as a result of our failure to provide annual financial statements in a timely manner and our being in breach of certain of our covenants on our June 2014 Secured Promissory Note as described below. However, in November 2015, we received an extension from the lending agent with respect to compliance with the requirements to deliver annual financial statements to the earlier of (i) November 15, 2015 or (ii) such time such financial statements are filed with the SEC. Further, the covenant breach was cured in November 2015 as a result of obtaining this extension and the waiver of certain of our covenants with respect to the June 2014 Secured Promissory Note as described below.

In August 2015, the terms of the notes were amended, resulting in an increase in the interest rate to 18% effective September 1, 2015 for the remaining term of the notes. We also provided a written notice in September 2015 to extend the maturity date to October 2017.

June 2014 Secured Promissory Note

In June 2014, we borrowed $10.0 million pursuant to a business loan agreement and promissory note with Five Star Bank which bears interest at prime rate plus 2.00% per annum. The interest rate is subject to change from time to time to reflect changes in the prime rate; however, the interest rate shall not be less than 5.25% or more than the maximum rate allowed by applicable law. If the interest rate increases, the lender, may, at its option, increase the amount of each monthly payment to ensure that the note would be paid in full by the maturity date, increase the amount of each monthly payment to reflect the change in interest rate, increase the number of monthly payments or keep the monthly payments the same and increase the final payment amount. As of June 30, 2015, the interest rate was 5.25%.

The June 2014 Secured Promissory Note is repayable in monthly payments of $64,390 commencing in July 2014, with the final payment due in June 2036. Certain of our deposit accounts and our subsidiary’s inventories, chattel paper, accounts, equipment and general intangibles have been pledged as collateral for the promissory note. We are required to maintain a deposit balance with the lender of $1.6 million, which was recorded as restricted cash included in non-current assets. In addition, until we provide documentation that the proceeds were used for construction of the manufacturing plant, proceeds from the loan will be maintained in a restricted deposit account. As of June 30, 2015, we had $1.9 million remaining in this restricted deposit account, which was recorded as restricted cash included in current assets.

We may prepay 20% of the outstanding principal loan balance each year without penalty. A prepayment fee of 10% will be charged if prepayments exceed 20% in the first year, and the prepayment fee will decrease by 1% each year for the first ten years of the loan.

We are required to maintain a current ratio of not less than 1.25-to-1.0, a debt-to-worth ratio of no greater than 4.0-to-1.0 and a loan-to-value ratio of no greater than 70% as determined by the lender. We are also required to comply with certain affirmative and negative covenants under the loan agreement discussed above. In the event of default on the debt, the lender may declare the entire unpaid principal and interest immediately due and payable. As of June 30, 2015 and December 31, 2014, we were in breach of certain of our covenants under the loan agreement as a result of our annual and quarterly reports not being filed within the prescribed time period and our being in breach of covenants on the October 2012 and August 2013 Secured Promissory Notes describes above. Effective September 30, 2015, our debt-to-worth ratio was greater than 4.0-to-1.0 as a result of the issuance of $40.0 million in promissory notes in August 2015 as described below, which increased our debt while we continued to incur net losses, which decreased stockholders’ equity. However, in November 2015, we received a waiver from the lender with respect to compliance with the requirements to (i) deliver annual financial statements (extended to November 15, 2015), (ii) maintain a current ratio greater than 1.25-to-1.0 (extended to December 31, 2015) and (iii) maintain a debt-to-worth ratio less than 4.0-to-1.0 (extended to December 31, 2016). The receipt of this waiver and the extension to provide financial statements under the October 2012 and April 2013 Secured Promissory Notes cured our being in breach of the covenants under the loan agreement.

August 2015 Senior Secured Promissory Notes

On August 20, 2015, we issued and sold senior secured promissory notes to three affiliated lenders in the aggregate principal amount of $40.0 million. The notes bear interest at a rate of 8% per annum payable semi-annually on June 30 or December 31 of each year, commencing on December 31, 2015, with $10.0 million payable three years from the closing, $10.0 million payable four years from the closing, and $20.0 million payable five years from the closing. The notes contain customary covenants, in addition to the obligation to maintain cash and cash equivalents of at least $15.0 million.

The notes are secured by substantially all of our personal property assets. The lenders shall be entitled to have a first priority lien on our intellectual property assets, pursuant to intercreditor arrangements with certain of our existing lenders. The notes provide for various events of default, including, among others, default in payment of principal or interest, breach of any representation or warranty by us or any subsidiary under any agreement or document delivered in connection with the notes, a continued breach of any other condition or obligation under any loan documents, certain bankruptcy, liquidation, reorganization or change of control events, the acquisition by any person or persons acting as group, other than the lenders, of beneficial ownership of 40% or more of our outstanding voting stock and certain events in which Pamela G. Marrone Ph.D. ceases to serve as our Chief Executive Officer. Upon an event of default, the entire unpaid principal and interest may be declared immediately due and payable. As of September 30, 2015, we were in breach of our covenants under the August 2015 Senior Secured Promissory Notes as we were in breach of our covenants under our October 2012 and April 2013 Secured Promissory Notes and June 2014 Secured Promissory Note. However, this covenant breach was cured in November 2015 as we obtained an extension to deliver our annual financial statements with respect to the October 2012 and April 2013 Secured Promissory Notes and a waiver of certain of our covenants with respect to the June 2014 Secured Promissory Note as discussed above.

The following table sets forth a summary of our cash flows for the periods indicated (in thousands):


	SIX MONTHS ENDED JUNE 30,
	2015			2014
	(Unaudited)
Net cash used in operating activities	$	(20,396	)	$	(16,335	)
Net cash provided by (used in) investing activities		(1,391	)		3,993
Net cash provided by (used in) financing activities		(1,341	)		45,517

Net increase (decrease) in cash and cash equivalents	$	(23,128	)	$	33,175

Cash Flows from Operating Activities

Net cash used in operating activities of $20.4 million during the six months ended June 30, 2015 primarily resulted from our net loss of $22.9 million, which included $1.7 million of depreciation and amortization expense, $2.2 million of share-based compensation expense and $0.3 million of non-cash interest expense. In addition, net cash used in operating activities resulted from an increase in accounts receivable of $1.2 million, and decreases in accounts payable of $2.3 million, deferred revenue of $0.4 million and deferred revenue from related parties of $0.4 million. This was offset by decreases in inventories of $2.0 million, deferred cost of product revenues of $0.2 million and prepaid expenses and other assets of $0.1 million, and a decrease in accrued and other liabilities of $0.2 million.

Net cash used in operating activities of $16.3 million during the six months ended June 30, 2014 primarily resulted from our net loss of $21.0 million, which included $1.1 million of depreciation and amortization expense, $2.7 million of share-based compensation expense and $0.5 million of non-cash interest expense. In addition, net cash used in operating activities resulted from increases in accounts receivable of $0.2 million, inventories of $0.5 million, deferred cost of product revenues of $0.2 million and prepaid expenses and other assets of $0.4 million, and decreases in accrued and other liabilities of $0.8 million and deferred revenue from related parties of $0.3 million. This was offset by a decrease in accounts receivable from related parties of $0.4 million, and increases in accounts payable of $0.3 million, deferred revenue of $0.2 million and customer refund liabilities of $1.9 million.

Cash Flows from Investing Activities

Net cash used in investing activities of $1.4 million during the six months ended June 30, 2015 primarily resulted from $1.4 million used for the purchase of property, plant and equipment to support growth of our operations.

Net cash provided by investing activities of $4.0 million during the six months ended June 30, 2014 consisted primarily of $13.5 million in cash provided by maturities of short-term investments. This was offset by $9.4 million used for the purchase of property, plant and equipment for improvements to our manufacturing plant and $0.1 million used to purchase short-term investments.

Cash Flows from Financing Activities

Net cash used in financing activities of $1.3 million during the six months ended June 30, 2015 consisted primarily of $0.2 million in payments on our debt and $1.1 million in payments on our capital lease obligations.

Net cash provided by financing activities of $45.5 million during the six months ended June 30, 2014 consisted primarily of $40.0 million in proceeds from the public offering of the our common stock in June 2014, net of offering costs and underwriting commissions, $9.6 million from the issuance of a promissory note in June 2014, $4.7 million in proceeds from a line of credit and $1.2 million from the exercise of stock options and warrants. This was offset by $4.9 million of restricted cash relating to the promissory note entered into in June 2014, $4.7 million in repayments on a line of credit and $0.4 million in payments on our debt and capital lease obligations.

Contractual Obligations

The following is a summary of our contractual obligations as of June 30, 2015 (in thousands):


	TOTAL		2015		2016-2017		2018-2019		2020 AND BEYOND
	(Unaudited)
Operating lease obligations	$	4,060	$	526	$	1,970	$	1,564		—
Debt and capital leases		23,816		13,484		1,259		610		8,463
Interest payments relating to debt and capital leases		6,911		688		1,020		935		4,268

Total	$	34,787	$	14,698	$	4,249	$	3,109	$	12,731

Operating leases consist of contractual obligations from agreements for non-cancelable office space and leases used to finance the acquisition of equipment. Debt and capital equipment lease payments and the interest payments relating thereto include promissory notes and capital lease obligations in accordance with the payment terms under the agreements.

In September 2013 and then amended in April 2014, we entered into a lease agreement for approximately 27,300 square feet of office and laboratory space located in Davis, California. The initial term of the lease is for a period of 60 months and commenced in August 2014. The monthly base rent is $44,000 for the first 12 months with a 3% increase each year thereafter. Concurrent with this amendment, in April 2014, we entered into a lease agreement with an affiliate of the landlord to lease approximately 17,400 square feet of office and laboratory space in the same building complex in Davis, California.

The initial term of the lease is for a period of 60 months and commenced in August 2014. The monthly base rent is $28,000 with a 3% increase each year thereafter. In addition, we continue to lease a portion of the location of our old headquarters in Davis, California until that lease expires in October 2016. We expect to enter into agreements to sublease portions of our current and old office facilities that we are not currently utilizing. Since June 30, 2015, we have not added any additional leases that would qualify as operating leases.

In August 2015, we issued and sold to three affiliated lenders senior secured promissory notes in the aggregate principal amount of $40.0 million. The notes bear interest at a rate of 8% per annum payable semi-annually on June 30 or December 31 of each year, commencing on December 31, 2015, with $10.0 million payable three years from the closing, $10.0 million payable four years from the closing and $20.0 million payable five years from the closing.

Inflation

We believe that inflation has not had a material impact on our results of operations for the three and six months ended June 30, 2015 and 2014.

Off-Balance Sheet Arrangements

We have not been involved in any material off-balance sheet arrangements.

Recently Issued Accounting Pronouncements

See Note 2 to the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q in Part I, Item 1, “Financial Information.”

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We currently have minimal exposure to the effect of interest rate changes, foreign currency fluctuations and changes in commodity prices. We are exposed to changes in the general economic conditions in the countries where we conduct business, which currently is substantially all in the United States. Our current investment strategy is to invest in financial instruments that are highly liquid, readily convertible into cash and which mature within six months from the date of purchase. To date, we have not used derivative financial instruments to manage any of our market risks or entered into transactions using derivative financial instruments for trading purposes.

We do not believe our cash equivalents have significant risk of default or illiquidity. While we believe our cash equivalents do not contain excessive risk, we cannot provide absolute assurance that in the future our investments will not be subject to adverse changes in market value.

Interest Rate Risk

We had cash and cash equivalents of $12.2 million as of June 30, 2015, which was held for working capital purposes. We do not enter into investments for trading or speculative purposes. We entered into a promissory note in June 2014, which bears interest at the prime rate plus 2.00%. A change in market interest rates of 1% would have an impact of approximately $0.1 million on our future annual interest expense. All of our other debt, including the senior secured promissory notes we issued and sold in August 2015, is at fixed interest rates and thus a change in market interest rates would not have an impact on interest expense.

Foreign Currency Risk

Revenue and expenses have been primarily denominated in U.S. dollars and foreign currency fluctuations have not had a significant impact on our historical results of operations. In addition, our strategic collaboration and distribution agreements for current products provide for payments in U.S. dollars. As we market new products internationally, our product revenues and expenses may be in currencies other than U.S. dollars, and accordingly, foreign currency fluctuations may have a greater impact on our financial position and operating results.

Commodity Risk

Our exposure to market risk for changes in commodity prices currently is minimal. As our commercial operations grow, our exposure will relate mostly to the demand side as our end users are exposed to fluctuations in prices of agricultural commodities.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed under the Exchange Act is accumulated and communicated to management, including our principal executive officer and our principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. As of the end of the period covered by this report, the Company carried out an evaluation under the supervision and with the participation of its management, including the Company’s Chief Executive Officer (“CEO”) and its Chief Financial Officer (“CFO”), of the effectiveness of the design and operation of the Company’s disclosure controls and procedures in ensuring that material information required to be disclosed in the Company’s reports filed or submitted under the Exchange Act has been made known to them in a timely fashion. Based on this evaluation, the CEO and CFO concluded that the Company’s disclosure controls and procedures were not effective as of June 30, 2015 due to material weaknesses in our internal control over financial reporting, which are disclosed below.

Management’s Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as such term is defined in Rule 13a-15(f) of the Exchange Act. Our management assessed, with the oversight of the board of directors, the effectiveness of our internal control over financial reporting as of June 30, 2015. In making this assessment, management used the criteria established in the Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). Based on this assessment, management has concluded that our internal control over financial reporting was not effective as of June 30, 2015 due to material weaknesses in our internal control over financial reporting, which are disclosed below.

Material Weaknesses and Remediation Activities

A “material weakness” is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. In connection with management’s assessment of our internal control over financial reporting described above, management has identified the following deficiencies that constituted individually, or in the aggregate, material weaknesses in our internal control over financial reporting as of June 30, 2015:

•

Control Environment – The control environment, which includes the Company’s Code of Conduct, is the responsibility of senior management, sets the tone of our organization, influences the control consciousness of employees, and is the foundation for the other components of internal control over financial reporting. The Audit Committee determined, based on the results of its independent investigation, that relevant information related to historical sales transactions, to which certain sales personnel were aware of, was consistently not shared with the finance department or the Company’s external auditors, certain sales personnel executed inaccurate representation letters, and certain sales personnel mischaracterized expense reports to pay for storage or freight charges associated with certain sales transactions. As a result of these findings, we determined that certain former sales personnel did not project an attitude of integrity and control consciousness, leading to insufficient attention to their responsibilities and internal controls. Further, effective mitigating controls were not in place to discourage, prevent or detect management override of internal control by certain sales personnel related to the Company’s process for recognizing revenue.

•

Revenue Recognition – The Company’s internal controls were not effectively designed to identify instances when sales personnel made unauthorized commitments with certain distributors, including “inventory protection” arrangements that would permit the distributors to return to the Company certain unsold products. In addition, controls were not in place to identify instances of management override of internal controls by sales personnel related to the recognition of sales to the Company’s distributors. Consequently, revenue for certain transactions was recognized prior to satisfaction of all required revenue recognition criteria.

As a result of the material weaknesses related to the control environment and revenue recognition as described above, the Company did not identify that information provided to the finance department by certain sales personnel was not complete and accurate, which would be necessary to enable the Company to correctly assess the timing of revenue recognition. These material weaknesses also prevented the identification of instances of management override of internal control over financial reporting by certain sales personnel. As a result, the Company’s controls were not effective to prevent or detect a material misstatement of recognized revenue.

We have developed and implemented a plan to remediate these material weaknesses, which includes, among other things:

•

We have enhanced our Code of Conduct and associated training by supplementing materials with examples of improper conduct and resulting implications to individuals as well as the Company. This training will be ongoing.

•

We have enhanced our whistleblower policy and associated training to ensure employees have the appropriate awareness of its purpose, how to access the whistleblower hotline and the Company’s anti-retaliation policy. This training will be ongoing.

•

We have enhanced our training provided to individuals in the sales organization, including those involved with executing sales transactions, on the Company’s revenue recognition policy, including illustrative examples of terms and conditions that that can have an impact on the timing of revenue recognition and the need for timely communication with the finance department. This training will be ongoing.

•

We have expanded our formal internal certification process to additional individuals in the Company, including the supply chain organization, and incorporated a more comprehensive questionnaire of circumstances, including illustrative examples, which require timely communication with the finance department.

•

We have identified customers where facts and circumstances exist that revenue recognition criteria are not satisfied at the time of title transfer and have implemented processes to determine customers’ channel inventory and have implemented internal controls related to our accounting for revenue transactions accounted for under a sell-through basis where applicable, including the performance of physical inventory observations at distributor locations and review and reconciliation of sales and inventory information provided by these customers.

•

The personnel identified as responsible for accounting improprieties are no longer employed by the Company.

With respect to the control environment and revenue recognition weaknesses, while we have implemented a plan for remediation, we are still in the process of testing and evaluating the effectiveness of the remediation measures we have taken to date. In addition, many of the remediation efforts involve continued training and communication of the enhanced policies and procedures.

Also, in connection with management’s assessment of our internal control over financial reporting, management has identified the following additional deficiency that constituted a material weakness in our internal control over financial reporting as of June 30, 2015:

•

Stock Option Grants –We determined that a deficiency exists in our governance practices related to ineffective controls over the timeliness and accuracy of documentation related to actions of our board of directors (“board”) and compensation committee specific to approving stock option grants. While no financial statement accounts or disclosures were misstated in connection with our stock option grants, the potential impact of not accurately documenting board and committee approvals could have led to a material misstatement. We are developing a plan to conduct training with our legal department and those charged with governance to ensure that board and compensation committee minutes are prepared more timely and accurately and reviewed with sufficient rigor to ensure that the minutes of actions/approvals by the board and compensation committee fully and accurately reflect the actions related to stock option grants.

As we continue to evaluate our internal control over financial reporting, we may determine that additional measures should be taken to address these or other control deficiencies, and/or that we should modify the remediation plan described above. Notwithstanding the identified material weaknesses in our internal control over financial reporting, we have concluded that the financial statements and other financial information included in this Quarterly Report on Form 10-Q, fairly present in all material respects our financial condition, results of operations and cash flows as of, and for, the periods presented.

Changes in Internal Control

Other than the remediation actions taken and the controls implemented for sell-through accounting described in this Item 4, there were no changes in our internal control over financial reporting identified in management’s evaluation pursuant to Rules 13a-15(d) or 15d-15(d) of the Exchange Act during the period covered by this Quarterly Report on Form 10-Q that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitations on Effectiveness of Controls and Procedures

In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable, not absolute, assurance of achieving the desired control objectives. Because of the inherent limitations in internal control over financial reporting, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision making can be faulty and that breakdowns can occur because of a simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

Part I, Item 3, “Legal Proceedings” in our Annual Report filed on Form 10-K for the fiscal year ended December 31, 2014 describes certain legal proceedings to which we are subject. There have been no material changes to the legal proceedings as disclosed in our Annual Report filed on Form 10-K for the fiscal year ended December 31, 2014.

ITEM 1A. RISK FACTORS

The risks described in Part I, Item 1A, “Risk Factors”, in our Annual Report filed on Form 10-K for the fiscal year ended December 31, 2014, could materially and adversely affect our business, financial condition and results of operations. These risk factors do not identify all of the risks that we face. Additional risks and uncertainties not currently known or knowable to us or that we currently deem to be immaterial may materially adversely affect our business, financial condition and/or operating results. There have been no material changes to the risk factors discussed in our Annual Report filed on Form 10-K for the fiscal year ended December 31, 2014.

ITEM 6. EXHIBITS

See the Exhibit Index immediately following the signature page of this Quarterly Report on Form 10-Q, which is incorporated by reference here.

SIGNATURES

Pursuant to the requirements of the Securities Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Davis, State of California, on November 10, 2015.

MARRONE BIO INNOVATIONS, INC.

/s/ Pamela G. Marrone

Pamela G. Marrone

President and Chief Executive Officer

INDEX TO EXHIBITS


EXHIBIT NUMBER		EXHIBIT DESCRIPTION

31.1		Certification of Principal Executive Officer Required Under Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended.

31.2		Certification of Principal Financial Officer Required Under Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended.

32.1		Certification of Principal Executive Officer and Principal Financial Officer Required Under Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. §1350

101		Interactive Data Files Pursuant to Rule 405 of Regulation S-T: (i) Condensed Consolidated Balance Sheets as of June 30, 2015 and December 31, 2014, (ii) Condensed Consolidated Statements of Operations for the Three and Six Months ended June 30, 2015 and 2014, (iii) Condensed Consolidated Statements of Comprehensive Loss for the Three and Six Months ended June 30, 2015 and 2014, (iv) Condensed Consolidated Statements of Cash Flows for the Six Months ended June 30, 2015 and 2014 and (v) Notes to Condensed Consolidated Financial Statements

EX-31.1 2 d32302dex311.htm EX-31.1 EX-31.1

Exhibit 31.1

I, Pamela G. Marrone, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Marrone Bio Innovations, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 10, 2015

/s/ Pamela G. Marrone

Pamela G. Marrone

President and Chief Executive Officer

EX-31.2 3 d32302dex312.htm EX-31.2 EX-31.2

Exhibit 31.2

I, James B. Boyd, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Marrone Bio Innovations, Inc.;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 10, 2015

/s/ James B. Boyd

James B. Boyd

Chief Financial Officer

EX-32.1 4 d32302dex321.htm EX-32.1 EX-32.1

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Pamela G. Marrone, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of Marrone Bio Innovations, Inc. on Form 10-Q for the fiscal quarter ended June 30, 2015 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of Marrone Bio Innovations, Inc.

Date: November 10, 2015


By:		/s/ Pamela G. Marrone
Name:		Pamela G. Marrone
Title:		President and Chief Executive Officer

I, James B. Boyd, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of Marrone Bio Innovations, Inc. on Form 10-Q for the fiscal quarter ended June 30, 2015 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of Marrone Bio Innovations, Inc.

Date: November 10, 2015


By:		/s/ James B. Boyd
Name:		James B. Boyd
Title:		Chief Financial Officer

This certification accompanies this Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

EX-101.INS 5 mbii-20150630.xml XBRL INSTANCE DOCUMENT

500000

15000000

0.08

10000000

20000000

40000000 0.40

1.91

4000000

0.05 24464582

0.07

500000

24000

465000

1360000

1250000

12450000

2500000

3750000

4950000 113000 3860000

1360000

3459000

3750000

2500000

3000000

5000000

57630000

600000 0.05

2633000

8.40

250000000

24465000

2142000

0.00001

24465000

668000

1258000

12517000

9489000

3700000

754000

1750000

195264000

22238000

12749000

2652000

3202000

6496000

-182747000

323000

40025000

52542000

1884000

323000

1019000

27747000

1351000

151000

916000

695000

52542000

304000

10607000

2951000

20062000

1560000

3601000

30225000

1856000

1018000

12196000

4000000

5708000

1750000

278000 2478000 0.70 4915000 1597000 138000 2600000

-37000

-39000

12450000

0.0700

116000

0.0525

9748000

1560000

0.1200

12374000

76000

0.14

0.12

0.13

2000000

8.40

261000 0.70 5000000 282000

4950000

66000

603000

172000

278000 138000

7000000

10000

5000000

22348000

3749000

382000

3749000

12374000

3750000

8.40

0.70

331000

1884000

40000000

0.12

0.18

24455000

250000000

24465000

0.00001

24465000

668000

1348000

33231000

9667000

847000

1750000

193079000

22303000

12636000

2861000

5841000

6321000

-159848000

202000

43951000

77182000

2050000

202000

1044000

31202000

1839000

185000

1150000

733000

77182000

12644000

1787000

20166000

1560000

5378000

54723000

1856000

1315000

35324000

4000000

5692000

1750000

660000 4771000 1797000 333000 3190000

-106000

-97000

12450000

0.0700

183000

9873000

0.1200

12247000

203000

660000 333000

22587000

14746000

424000

14746000

12247000

331000

2050000

2023-08-20

40000000

74000

5000000

352000 1250000

3700000

435000

7500000

2015-08-19

-16335000

-1.04

20150000

811000

219000

9425000

-21026000

5838000

-10000

922000

443000

-19471000

540000

-85000

96000

1334000

-107000

49000

-1555000

648000

216000

-413000

-21026000

4931000

21000

834000

646000

4687000

1883000

2722000

177000

20805000

1469000

3993000

45517000

-4885000

8053000

9621000

39959000

291000

-843000

33175000

1128000

330000

4687000

-137000

12244000

528000

13467000

1081000

4504000

508000 8561000 50000 0 333000 0.51 163000

478000

0.31

0.06

0.13

2871000

145000

0.11

0.93

332000

600000 Q2

-20396000

<div> The following table shows the consideration received, fair values of the notes and common stock warrants issued and calculation of the gain on extinguishment of debt for the $3,750,000 Notes (in thousands):   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="68%" align="center" border="0"> <tr> <td width="89%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Consideration received </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> Fair value of October 2012 Subordinated Convertible Note </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,360</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Cash </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,500</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> Total consideration received (a) </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3,860</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Notes and warrants issued </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> Principal balance of notes issued </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3,750</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Debt discount (1) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(291</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> Fair value of notes issued </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,459</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Fair value of Additional Common Stock Warrants issued </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">352</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> Total fair value of notes and warrants issued (b) </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3,811</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Gain on extinguishment of debt (a-b) </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">49</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table>   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left">(1) </td> <td valign="top" align="left">The amortization of this account is being recorded in interest expense in the condensed consolidated statements of operations over the term of the arrangement.</td> </tr> </table> </div>

2015 false

<div> Revenue Recognition The Company recognizes revenues when persuasive evidence of an arrangement exists, transfer of title has occurred or services have been rendered, the price is fixed or determinable and collectability is reasonably assured. If contractual obligations, acceptance provisions or other contingencies exist which indicate that the price is not fixed or determinable, revenue is recognized after such obligations or provisions are fulfilled or expire. Product revenues consist of revenues generated from sales of the Company’s products to distributors and direct customers, net of rebates and cash discounts. For sales of products made to distributors, the Company recognizes revenue either on a sell-in or sell-through basis depending on the specific facts and circumstances of the transaction(s) with the distributor. Factors considered include, but are not limited to, whether the payment terms offered to the distributor are structured to correspond to when product is resold, the distributor history of adhering to the terms of its contractual arrangements with the Company, whether the Company has a pattern of granting concessions for the benefit of the distributor and whether there are other conditions that may indicate that the sale to the distributor is not substantive. In some cases, the Company recognizes distributor revenue as title and risk of loss passes, provided all other revenue recognition criteria have been satisfied (the “sell-in” method). For certain sales to certain distributors, the revenue recognition criteria for distributor sales are not satisfied at the time title and risk of loss passes to the distributor; specifically, in instances where “inventory protection” arrangements were offered to distributors that would permit these distributors to return to the Company certain unsold products, the Company considers the arrangement not to be fixed or determinable, and accordingly, revenue is deferred until products are resold to customers of the distributor (the “sell-through” method). As of June 30, 2015 and December 31, 2014, the Company recorded current deferred product revenues of $2,600,000 and $3,190,000, respectively, including current deferred product revenues from related parties of $278,000 and $660,000, respectively. The cost of product revenues associated with such deferral are also deferred and classified as deferred cost of product revenues in the condensed consolidated balance sheets. Cash received from customers related to delivered product that may not represent a true sale is classified as customer refund liabilities in the condensed consolidated balance sheets and the related cost of inventory remains in inventory in the condensed consolidated balance sheets until the product is returned or is resold to customers of the distributor and revenue is recognized. For the three months ended June 30, 2015 and 2014, 58% and 51%, respectively, and for the six months ended June 30, 2015 and 2014, 48% and 51%, respectively, of total revenues were recognized on a sell-through basis. From time to time, the Company offers certain product rebates to its distributors and growers, which are estimated and recorded as reductions to product revenues, and an accrued liability is recorded at the later of when the revenues are recorded or the rebate is being offered. The Company recognizes license revenues pursuant to strategic collaboration and distribution agreements under which the Company receives payments for the achievement of testing validation, regulatory progress and commercialization events. As these activities and payments are associated with exclusive rights that the Company provides in connection with strategic collaboration and distribution agreements over the term of the agreements, revenues related to the payments received are deferred and recognized over the term of the exclusive distribution period of the respective agreement. For the six months ended June 30, 2015, the Company received payments totaling $750,000 under these agreements. No payments were received under these agreements for the three months ended June 30, 2015 and the three and six months ended June 30, 2014. For the three months ended June 30, 2015 and 2014, the Company recognized $83,000 and $51,000, respectively, as license revenues, excluding related party revenues. For the six months ended June 30, 2015 and 2014, the Company recognized $166,000 and $96,000, respectively, as license revenues, excluding related party revenues. The Company has a strategic collaboration and distribution agreement with Syngenta, an affiliate of a former 5% stockholder, Syngenta Ventures Pte. LTD (Syngenta Ventures). In connection with the Company’s secondary offering in June 2014, Syngenta Ventures sold 600,000 shares of the Company’s common stock, reducing its ownership percentage below 5%. Accordingly, revenue recognized under this agreement subsequent to June 2014 has not been included in related party revenues. For the three and six months ended June 30, 2014, the Company recognized $8,000 and $332,000, respectively, of related party revenues under this agreement prior to Syngenta Ventures reducing its ownership stake. As of June 30, 2015, the Company recorded current and non-current deferred revenues of $331,000 and $1,884,000, respectively, related to payments received under these agreements. As of December 31, 2014, the Company recorded current and non-current deferred revenues of $331,000 and $2,050,000, respectively, related to payments received under these agreements. </div>

<div> 6. Debt  Debt consists of the following (in thousands):   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="80%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">JUNE 30, 2015</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">DECEMBER 31, 2014</td> <td valign="bottom"> </td> </tr>  <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Term Loan (“Term Loan”) bearing interest at 7.00% per annum, which is payable monthly through April 2016, collateralized by all of the Company’s inventories, chattel paper, accounts receivable, equipment and general intangibles (excluding certain financed equipment and intellectual property) pledged as collateral under the Term Loan, subordinated </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">116</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">183</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> Secured promissory notes (“October 2012 and April 2013 Secured Promissory Notes”) bearing interest at 12.00% per annum, which are payable monthly through October 2015, collateralized by substantially all of the Company’s assets, net of unamortized debt discount as of June 30, 2015 and December 31, 2014 of $76 and $203, respectively </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">12,374</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">12,247</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Secured promissory note (“June 2014 Secured Promissory Note”) bearing interest at prime plus 2% (5.25% as of June 30, 2015) per annum, which is payable monthly through June 2036, collateralized by all of the Company’s deposit accounts and MMM LLC’s inventories, chattel paper, accounts, equipment and general intangibles </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">9,748</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">9,873</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> Debt </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">22,238</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">22,303</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Less current portion </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(12,749</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(12,636</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">9,489</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">9,667</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> The fair value of the Company’s outstanding debt obligations as of June 30, 2015 and December 31, 2014 was $22,348,000 and $22,587,000, respectively, which was estimated based on a discounted cash flow model using an estimated market rate of interest of 11.25% for the fixed rate debt and 5.25% for the variable rate debt, and is classified as Level 3 within the fair value hierarchy. Term Loan In March 2009, October 2010 and October 2011, the Company and Five Star Bank agreed to modify the terms of its existing revolving line of credit (“Revolver”). Under the modified terms of the Revolver, the Company’s borrowings under the Revolver were limited to 75% of qualifying accounts receivable with a maximum borrowing limit of $500,000. In March 2012, the Company entered into a change in terms agreement with the bank under which the existing Revolver was replaced by the Term Loan in the amount of $500,000 with a rate of 7% per annum, maturing April 1, 2016. The Company’s inventories, chattel paper, accounts receivable, equipment and general intangibles (excluding certain financed equipment and intellectual property) have been pledged as collateral under the Term Loan. The Term Loan provides for various events of default including breach of any term, obligation, covenant or condition under any other agreement between the Company and Five Star Bank. As of June 30, 2015, the Company was in breach of its covenants under the Term Loan as the Company was in breach of its covenants under its June 2014 Secured Promissory Note. However, this breach was cured in November 2015 as a result of the Company obtaining a waiver of certain of the Company’s covenants with respect to the June 2014 Secured Promissory Note as discussed below. The Term Loan was fully paid off in August 2015. Secured Promissory Notes On October 2, 2012, the Company borrowed $7,500,000 pursuant to senior notes (“October 2012 Secured Promissory Notes”) with a group of lenders. The October 2012 Secured Promissory Notes have an initial term of three years and can be extended for an additional two years in one year increments at the option of the Company. During the initial three-year term, the October 2012 Secured Promissory Notes bear interest at 12% per annum. If the term of the October 2012 Secured Promissory Notes is extended an additional year, the interest rate is 13% during the fourth year. If the term of the October 2012 Secured Promissory Notes is extended for an additional two years, the interest rate is 14% during the fifth year. Interest on the October 2012 Secured Promissory Notes is payable monthly through the initial maturity date of the loan, which is October 2, 2015, or through any extension period. The principal and all unpaid interest are due on the maturity date, as may be extended. As part of the terms of the October 2012 Secured Promissory Notes, the Company is required to pay a fee of 5% of the funded principal amount to the agent that facilitated the borrowing and provides management of the relationship with the group of lenders (“Agent Fee”). This Agent Fee is payable within 30 days after all interest and principal have been paid. For each year the Company extends the maturity date of the October 2012 Secured Promissory Notes beyond the initial term, the agent will receive an additional 1% fee based on the funded principal amount. The present value of the unpaid Agent Fee, based on 5% of the funded principal amount, or $261,000, as of the closing date of the October 2012 Secured Promissory Notes was recorded as both deferred financing costs as a component of current and non-current other assets and non-current other liabilities. The amortization of the deferred financing costs and the accretion of the Agent Fee are recorded to interest expense over the term of the arrangement. As of June 30, 2015, $603,000 of the Agent Fee, including the amounts relating to the additional funds received from the issuance of the April 2013 Secured Promissory Notes discussed below, was recorded under accrued liabilities. In addition, the Company incurred an additional $66,000 in financing-related costs, primarily legal fees. These costs were recorded as deferred financing costs as a component of current and non-current other assets and are being amortized to interest expense over the term of the arrangement. The October 2012 Secured Promissory Notes are secured by the Company’s ownership interest in MMM LLC, a security interest in the assets of the Company’s manufacturing plant and all of the Company’s other assets, subject to certain permitted liens. This security interest was subordinate to the security interest held by the holder of a previously outstanding promissory note issued in April 2012 and repaid in January 2013 (“April 2012 Note”), which also had a security interest in MMM LLC. The Company also issued warrants (“Common Stock Warrants”) to the group of lenders to purchase a number of shares of common stock equal to 15% of the funded principal amount of the October 2012 Secured Promissory Notes divided by 70% of the value of common stock in a sale of the Company or a Qualified IPO, with such Common Stock Warrants having an exercise price of 70% of the value of common stock in a sale of the Company or a Qualified IPO. The Common Stock Warrants would be automatically exercised immediately prior to expiration on the earlier to occur of a Qualified IPO or a sale of the Company or the maturity of the October 2012 Secured Promissory Notes. The October 2012 Secured Promissory Notes could be prepaid six months after the initial funding date or earlier if a Qualified IPO or a sale of the Company occurs. As the predominant settlement feature of the Common Stock Warrants is to settle a fixed monetary amount in a variable number of shares, the Common Stock Warrants were accounted for under ASC 480, Distinguishing Liabilities from Equity (“ASC 480”). Accordingly, the Common Stock Warrants were recorded at estimated fair value on their issuance date and were adjusted to their estimated fair value as of each reporting date with the change in estimated fair value recorded as a component of change in estimated fair value of financial instruments in the Company’s condensed consolidated statements of operations. The fair value of the Common Stock Warrants at the date of issuance of $282,000 was recorded as a discount to the October 2012 Secured Promissory Notes and is being amortized to interest expense over the term of the arrangement. Until the effective date of the IPO, the Company estimated the fair value of the Common Stock Warrants using a Probability-Weighted Expected Return Method (“PWERM”) valuation based on unobservable inputs, and, therefore, the Common Stock Warrants were classified as Level 3 liabilities in the fair value hierarchy. Upon closing of the IPO, the exercise price of the Common Stock Warrants was determined to be $8.40 per share and the number of shares to be issued upon exercise of the warrants was no longer variable. As a result of the IPO, the Common Stock Warrants were considered to be indexed to the Company’s stock, and accordingly, the common stock warrants liability was reclassified and included in stockholders’ equity (deficit) during the year ended December 31, 2013. The October 2012 Secured Promissory Notes contain certain covenant requirements, which include a requirement to maintain a minimum cash balance of the lesser of the April 2012 Note indebtedness described above or $5,000,000. As the April 2012 Note was fully paid off in January 2013, the Company no longer has a minimum cash balance requirement under the October 2012 Secured Promissory Notes. The Company is also precluded from adding additional debt without lender approval but allowance is made if such debt is subordinated to the October 2012 Secured Promissory Notes or if such additional debt is not more than $2,000,000 in the aggregate. In the event of default on the October 2012 Secured Promissory Notes, the lenders may declare the entire unpaid principal and interest immediately due and payable. On April 10, 2013 (“Conversion Date”), the Company entered an amendment to increase, by up to $5,000,000, the amount available under the terms of the loan agreement with respect to the October 2012 Secured Promissory Notes. Under this amendment, an additional $4,950,000 was issued in partial consideration for $3,700,000 in cash received and in partial conversion for the cancellation of $1,250,000 of the total principal balance of the October 2012 Subordinated Convertible Note described below (collectively, “April 2013 Secured Promissory Notes”). The total amount borrowed under the amended loan agreement for the October 2012 Secured Promissory Notes and the April 2013 Secured Promissory Notes increased from $7,500,000 to $12,450,000 as of the Conversion Date. The accrued interest of $74,000 for the partially converted October 2012 Subordinated Convertible Note as of the Conversion Date shall be repaid or converted on the applicable maturity date of the October 2012 Subordinated Convertible Note. In connection with the issuance of the April 2013 Secured Promissory Notes, the Company issued additional warrants (“Additional Common Stock Warrants”) to purchase a number of shares of common stock equal to 20% of the funded principal amount of the April 2013 Secured Promissory Notes divided by 70% of the value of common stock in a sale of the Company or a Qualified IPO, with such Additional Common Stock Warrants to have an exercise price of 70% of the value of common stock in a sale of the Company or a Qualified IPO. As the predominant settlement feature of the Additional Common Stock Warrants was to settle a fixed monetary amount in a variable number of shares, the Additional Common Stock Warrants were accounted for under ASC 480. Accordingly, the Additional Common Stock Warrants were recorded at estimated fair value on their issuance date and were adjusted to their estimated fair value as of each reporting date with the change in estimated fair value recorded as a component of change in estimated fair value of financial instruments in the Company’s condensed consolidated statements of operations. The fair value of the Additional Common Stock Warrants at the date of issuance was estimated to be $465,000. The Company estimated the fair value of the Additional Common Stock Warrants using a PWERM valuation based on unobservable inputs and, therefore, the Additional Common Stock Warrants were classified as Level 3 liabilities in the fair value hierarchy. Upon closing of the IPO, the exercise price of the Additional Common Stock Warrants was determined to be $8.40 per share and the number of shares to be issued upon exercise of the warrants was no longer variable. As a result of the IPO, the Additional Common Stock Warrants were considered to be indexed to the Company’s stock, and accordingly, the common stock warrants liability was reclassified and included in stockholders’ equity (deficit) during the year ended December 31, 2013. The debt holder who converted $1,250,000 principal balance of the October 2012 Subordinated Convertible Note (with a fair value of $1,360,000 on the date of conversion) also loaned an additional $2,500,000 in cash as part of the April 2013 Secured Promissory Notes (collectively, the “$3,750,000 Notes”). The Company accounted for the conversion as an extinguishment of debt in accordance with ASC 470-50-40, Modifications and Extinguishments (“ASC 470-50-40”). The $1,360,000 fair value of the partially converted October 2012 Subordinated Convertible Note on the Conversion Date was derecognized and the fair value of the $3,750,000 Notes with the portion of the fair value of the Additional Common Stock Warrants issued to this debt holder on the date of issuance was recorded. The Company recorded the $49,000 excess of the total fair value of the $3,750,000 Notes and the related Additional Common Stock Warrants on the issuance date over total consideration received as a gain on extinguishment of debt in the condensed consolidated statements of operations for the year ended December 31, 2013. The following table shows the consideration received, fair values of the notes and common stock warrants issued and calculation of the gain on extinguishment of debt for the $3,750,000 Notes (in thousands):   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="68%" align="center" border="0"> <tr> <td width="89%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr>  <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Consideration received </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> Fair value of October 2012 Subordinated Convertible Note </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,360</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Cash </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,500</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> Total consideration received (a) </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3,860</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Notes and warrants issued </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> Principal balance of notes issued </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3,750</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Debt discount (1) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(291</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> Fair value of notes issued </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,459</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Fair value of Additional Common Stock Warrants issued </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">352</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> Total fair value of notes and warrants issued (b) </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3,811</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Gain on extinguishment of debt (a-b) </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">49</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table>   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left">(1) </td> <td valign="top" align="left">The amortization of this account is being recorded in interest expense in the condensed consolidated statements of operations over the term of the arrangement.</td> </tr> </table> The remaining fair value of the Additional Common Stock Warrants of $113,000, net of the fair value of the Additional Common Stock Warrants issued of $352,000 related to the $3,750,000 Notes discussed above, was recorded as a debt discount to the April 2013 Secured Promissory Notes and is being amortized to interest expense over the term of the arrangement. As a result of the amendment described above, the Company is also required to pay the Agent Fee, 5% of the $3,700,000 in cash received from the April 2013 Secured Promissory Notes, under the same terms as the October 2012 Secured Promissory Notes. In addition, the portion of the Agent Fee relating to the converted October 2012 Subordinated Convertible Note that would be due under the terms of the October 2012 Subordinated Convertible Note will be paid under the terms of the October 2012 and April 2013 Secured Promissory Notes. The present value of the unpaid Agent Fee of $172,000, based on 5% of the funded principal amount of $4,950,000, as of the closing date of the April 2013 Secured Promissory Notes was recorded as both deferred financing costs as a component of current and non-current other assets and non-current other liabilities. The amortization of the deferred financing costs and the accretion of the Agent Fee are being amortized to interest expense over the term of the arrangement. In addition, the Company incurred an additional $24,000 in financing-related costs, primarily legal fees. These costs were recorded as deferred financing costs as a component of current and non-current other assets and are being amortized to interest expense over the term of the arrangement.   The amendment to the loan agreement also amended the interest provision applicable to the October 2012 and April 2013 Secured Promissory Notes to allow any holder of the October 2012 and April 2013 Secured Promissory Notes to request the Company to defer all interest due monthly to the applicable maturity date, and the optional prepayment provision applicable to the October 2012 and April 2013 Secured Promissory Notes to allow the Company to repay the outstanding amount of the October 2012 and April 2013 Secured Promissory Notes either (i) with the written consent of the lender or the agent on such lenders’ behalf or (ii) without such consent provided that the Company pays the interest that would have been due from the prepayment date to the initial maturity date. Activity related to the October 2012 and April 2013 Secured Promissory Notes from December 31, 2014 through June 30, 2015 consisted of the following (in thousands):   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="49%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">DECEMBER 31, 2014</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">ADDITIONS</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">AMORTIZATION OF DEBT DISCOUNT</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">PRINCIPAL PAYMENTS</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">JUNE 30, 2015</td> <td valign="bottom"> </td> </tr>  <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Principal </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12,450</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12,450</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> Debt discount related to the issuance of common stock warrants (1) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(106</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right">69</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(37</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Discount related to the $3,750,000 Notes (1) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(97</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right">58</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(39</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12,247</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right">127</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12,374</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table>   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left">(1) </td> <td valign="top" align="left">The amortization of this account is included in interest expense in the condensed consolidated statements of operations and as non-cash interest expense in the condensed consolidated statements of cash flows.</td> </tr> </table> As of June 30, 2015 and December 31, 2014, the Company was in breach of its covenants under the October 2012 and April 2013 Secured Promissory Notes as a result of its failure to provide annual financial statements in a timely manner and as the Company was in breach of certain of its covenants under its June 2014 Secured Promissory Note as described below. However, in November 2015, the Company received an extension from the lending agent with respect to compliance with the requirements to deliver annual financial statements to the earlier of (i) November 15, 2015 or (ii) such time such financial statements are filed with the SEC. Further, the covenant breach was cured in November 2015 as a result of obtaining this extension and the waiver of certain of the Company’s covenants with respect to the June 2014 Secured Promissory Note as described below. In August 2015, the terms of the notes were amended, resulting in an increase in the interest rate to 18% effective September 1, 2015 for the remaining term of the notes. The Company also provided a written notice in September 2015 to extend the maturity date to October 2, 2017. Credit Facility On June 14, 2013, the Company entered into a credit facility agreement (“June 2013 Credit Facility”) with a group of lenders that are, or that are affiliated with, existing investors in the Company. Under the June 2013 Credit Facility, the lenders have committed to permit the Company to draw an aggregate of up to $5,000,000, and, subject to the Company’s obtaining additional commitments from lenders, such amount may be increased to up to $7,000,000. The June 2013 Credit Facility expired on June 30, 2014 without having been drawn upon. During the term of the June 2013 Credit Facility, the Company could request from the lenders up to four advances, with each advance equal to one-quarter of each lender’s aggregate commitment amount. The Company would issue a promissory note in the principal amount of each such advance that would accrue interest at a rate of 10% per annum. The principal and all unpaid interest under the promissory notes would be due on the maturity date, and the Company could not prepay the promissory notes prior to the maturity date without consent of at least a majority in interest of the aggregate principal amount of the promissory notes then outstanding under the June 2013 Credit Facility. In connection with the June 2013 Credit Facility, the Company agreed to pay a fee of 2% of the total commitment amount to the lenders. In addition, the Company incurred an additional $10,000 in financing-related costs, primarily legal fees. These costs were recorded as deferred financing costs as a component of current other assets and were fully amortized to interest expense as of December 31, 2014. In connection with the June 2013 Credit Facility, the Company issued warrants (“June 2013 Warrants”) to purchase a number of shares of common stock equal to 10% of the total committed amount of the June 2013 Credit Facility divided by 70% of the value of common stock in a sale of the Company or a Qualified IPO, with such June 2013 Warrants to have an exercise price of 70% of the value of common stock in a sale of the Company or a Qualified IPO. The June 2013 Warrants expire upon the earlier of June 14, 2023 or the sale of the Company. As the predominant settlement feature of the June 2013 Warrants was to settle a fixed monetary amount in a variable number of shares, the June 2013 Warrants were accounted for under ASC 480. Accordingly, the June 2013 Warrants were recorded at estimated fair value on their issuance date and were adjusted to their estimated fair value as of each reporting date with the change in estimated fair value recorded as a component of change in estimated fair value of financial instruments in the Company’s condensed consolidated statements of operations. The fair value of the June 2013 Warrants at the date of issuance of $435,000 was recorded as a deferred financing cost as a current other asset and was being amortized to interest expense over the term of the arrangement. Until the effective date of the IPO, the Company estimated the fair value of the June 2013 Warrants using a PWERM valuation based on unobservable inputs and, therefore, the June 2013 Warrants were classified as Level 3 liabilities in the fair value hierarchy. Upon closing of the IPO, the exercise price of the June 2013 Warrants was determined to be $8.40 per share and the number of shares to be issued upon exercise of the warrants was no longer variable. As a result of the IPO, the June 2013 Warrants were considered to be indexed to the Company’s stock, and accordingly, the common stock warrants liability was reclassified and included in stockholders’ equity (deficit) during the year ended December 31, 2013. Secured Promissory Note On April 11, 2014, the Company entered into a $3,000,000 promissory note with Five Star Bank. On April 14, 2014, the Company entered into an agreement with the bank to modify the terms of the promissory note from a single payment loan to a revolving line of credit, which allowed the Company to borrow up to $3,000,000. On April 28, 2014, the Company entered into an agreement to modify the terms of the revolving line of credit to increase the borrowing limit up to $5,000,000. In June 2014, the $4,687,000 balance on the revolving line of credit was paid off and the line was closed when the Company borrowed $10,000,000 pursuant to a business loan agreement and promissory note (“June 2014 Secured Promissory Note”) with the bank (“Lender”) which bears interest at prime rate (3.25% as of June 30, 2015) plus 2.00% per annum. The interest rate is subject to change from time to time to reflect changes in the prime rate; however, the interest rate shall not be less than 5.25% or more than the maximum rate allowed by applicable law. If the interest rate increases, the Lender, may, at its option, increase the amount of each monthly payment to ensure that the note would be paid in full by the maturity date, increase the amount of each monthly payment to reflect the change in interest rate, increase the number of monthly payments or keep the monthly payments the same and increase the final payment amount. The June 2014 Secured Promissory Note is repayable in monthly payments of $64,390 commencing in July 2014, with the final payment due in June 2036. Certain of the Company’s deposit accounts and MMM, LLC’s inventories, chattel paper, accounts, equipment and general intangibles have been pledged as collateral for the promissory note. The Company is required to maintain a deposit balance with the Lender of $1,560,000, which is recorded as restricted cash included in non-current assets. In addition, until the Company provides documentation that the proceeds were used for construction of the Company’s manufacturing plant, proceeds from the loan will be maintained in a restricted deposit account. As of June 30, 2015, the Company had $1,856,000 remaining in this restricted deposit account, which is recorded as restricted cash included in current assets. In addition, the Company incurred an additional $304,000 in financing-related costs, including USDA guarantee fees. These costs were recorded as deferred financing costs as a component of current and non-current other assets on the date of issuance and are being amortized to interest expense over the term of the arrangement. The Company may prepay 20% of the outstanding principal loan balance each year without penalty. A prepayment fee of 10% will be charged if prepayments exceed 20% in the first year, and the prepayment fee will decrease by 1% each year for the first ten years of the loan. The Company is required to maintain a current ratio of not less than 1.25-to-1.0, a debt-to-worth ratio of no greater than 4.0-to-1.0 and a loan-to-value ratio of no greater than 70% as determined by the lender. The Company is also required to comply with certain affirmative and negative covenants under the loan agreement discussed above. In the event of default on the debt, the lender may declare the entire unpaid principal and interest immediately due and payable. As of June 30, 2015 and December 31, 2014, the Company was in breach of certain of its covenants under the loan agreement as a result of its annual and quarterly reports not being filed within the prescribed time period and its being in breach of covenants on the October 2012 and April 2013 Secured Promissory Notes described above. Effective September 30, 2015, the Company’s debt-to-worth ratio was greater than 4.0-to-1.0 as a result of the issuance of $40,000,000 in promissory notes in August 2015 as described in Note 10, which increased the Company’s debt while the Company continued to incur net losses, which decreased stockholders’ equity. However, in November 2015, the Company received a waiver from the Lender with respect to compliance with the requirements to (i) deliver annual financial statements (extended to November 15, 2015), (ii) maintain a current ratio greater than 1.25-to-1.0 (extended to December 31, 2015) and (iii) maintain a debt-to-worth ratio less than 4.0-to-1.0 (extended to December 31, 2016). The receipt of this waiver and the extension to provide financial statements under the October 2012 and April 2013 Secured Promissory Notes cured the Company of being in breach of the covenants under the loan agreement. </div>

-0.94

<div> Restricted Cash The Company’s restricted cash consists of cash that the Company is contractually obligated to maintain on deposit at a bank in accordance with the promissory note entered into in June 2014. See Note 6 for further discussion. </div>

10-Q 0001441693 2006-06-15

<div> Inventories Inventories are stated at the lower of cost or market value (net realizable value or replacement cost) and include the cost of material and external and internal labor and manufacturing costs. Cost is determined on the first-in, first-out basis. The Company provides for inventory reserves when conditions indicate that the selling price may be less than cost due to physical deterioration, obsolescence, changes in price levels or other factors. Additionally, the Company provides reserves for excess and slow-moving inventory on hand that is not expected to be sold to reduce the carrying amount of excess and slow-moving inventory to its estimated net realizable value. The reserves are based upon estimates about future demand from the Company’s customers and distributors and market conditions. </div>

<div> Activity related to the October 2012 and April 2013 Secured Promissory Notes from December 31, 2014 through June 30, 2015 consisted of the following (in thousands):   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="49%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">DECEMBER 31, 2014</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">ADDITIONS</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">AMORTIZATION OF DEBT DISCOUNT</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">PRINCIPAL PAYMENTS</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">JUNE 30, 2015</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Principal </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12,450</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12,450</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> Debt discount related to the issuance of common stock warrants (1) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(106</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right">69</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(37</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Discount related to the $3,750,000 Notes (1) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(97</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right">58</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(39</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12,247</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right">127</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12,374</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table>   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left">(1) </td> <td valign="top" align="left">The amortization of this account is included in interest expense in the condensed consolidated statements of operations and as non-cash interest expense in the condensed consolidated statements of cash flows.</td> </tr> </table> </div>

<div> Changes in the Company’s accrued warranty costs during the period are as follows (in thousands):   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="68%" align="center" border="0"> <tr> <td width="91%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Balance as of December 31, 2014 </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">202</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> Warranties issued during the period </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">137</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Settlements made during the period </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(16</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> Balance as of June 30, 2015 </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">323</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

Smaller Reporting Company

<div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> Customers to which 10% or more of the Company’s total revenues are attributable for any one of the periods presented consist of the following: <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px">   <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="67%"></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">CUSTOMER A</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">CUSTOMER B</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">CUSTOMER C</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> For the three months ended June 30, </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> 2015 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">34</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4</td> <td valign="bottom" nowrap="nowrap">% </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> 2014 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">37</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">12</td> <td valign="bottom" nowrap="nowrap">% </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> For the six months ended June 30, </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> 2015 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">27</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8</td> <td valign="bottom" nowrap="nowrap">% </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> 2014 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">31</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">13</td> <td valign="bottom" nowrap="nowrap">% </td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 1px 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px">   <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> Customers to which 10% or more of the Company’s outstanding accounts receivable are attributable as of either June 30, 2015 or December 31, 2014 consist of the following: <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px">   <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"> <tr> <td width="48%"></td> <td valign="bottom" width="12%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="12%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="12%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="12%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">CUSTOMER A</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">CUSTOMER B</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">CUSTOMER C</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">CUSTOMER D</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> June 30, 2015 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">46</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">10</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">*</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> December 31, 2014 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">10</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">*</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">37</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">23</td> <td valign="bottom" nowrap="nowrap">% </td> </tr> </table> <p style="MARGIN-BOTTOM: 2pt; WHITE-SPACE: normal; BORDER-BOTTOM: rgb(0,0,0) 1px solid; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium/8pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; WIDTH: 125px; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px">   <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="2%" align="left">*</td> <td valign="top" align="left">Represents less than 1% of outstanding accounts receivable</td> </tr> </table> </div>

<div> Basis of Presentation The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation. The accompanying financial information as of June 30, 2015, and for the three and six months ended June 30, 2015 and 2014, has been prepared by the Company, without audit, in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such SEC rules and regulations and accounting principles applicable for interim periods. However, the Company believes that the disclosures are adequate to make the information presented not misleading. The information included in this Quarterly Report on Form 10-Q should be read in connection with the consolidated financial statements and accompanying notes included in the Company’s Annual Report filed on Form 10-K for the fiscal year ended December 31, 2014. In the opinion of management, the condensed consolidated financial statements as of June 30, 2015, and for the three and six months ended June 30, 2015 and 2014, reflect all adjustments, which are normal recurring adjustments, necessary to present a fair statement of financial position, results of operations, comprehensive loss and cash flows. The results of operations for the three and six months ended June 30, 2015 are not necessarily indicative of the operating results for the full fiscal year or any future periods. </div>

P10Y

<div> 5. Accrued Liabilities Accrued liabilities consist of the following (in thousands):   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="74%"></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">JUNE 30, 2015</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">DECEMBER 31, 2014</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Accrued compensation </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,258</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,348</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> Accrued expenses </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,915</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,771</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Accrued warranty costs </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">323</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">202</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,496</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,321</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> The Company warrants the specifications and/or performance of its products through implied product warranties and has extended product warranties to qualifying customers on a contractual basis. The Company estimates the costs that may be incurred during the warranty period and records a liability in the amount of such costs at the time product is shipped. The Company’s estimate is based on historical experience and estimates of future warranty costs as a result of increasing usage of the Company’s products. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary. Changes in the Company’s accrued warranty costs during the period are as follows (in thousands):   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="68%" align="center" border="0"> <tr> <td width="91%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Balance as of December 31, 2014 </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">202</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> Warranties issued during the period </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">137</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Settlements made during the period </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(16</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> Balance as of June 30, 2015 </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">323</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

<div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> Concentrations of Credit Risk <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents, accounts receivable and debt. The Company deposits its cash and cash equivalents with high credit quality domestic financial institutions with locations in the U.S. Such deposits may exceed federal deposit insurance limits. The Company believes the financial risks associated with these financial instruments are minimal. <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The Company’s customer base is dispersed across many different geographic areas, and currently most customers are pest management distributors in the U.S. Generally, receivables are due up to 120 days from the invoice date and are considered past due after this date, although the Company may offer extended terms from time to time. <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> For the three months ended June 30, 2015 and 2014, 9% and 6%, respectively, and for the six months ended June 30, 2015 and 2014, 6% and 11%, respectively, of the Company’s revenues were generated from international customers. <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The Company’s principal sources of revenues are its Regalia and Grandevo product lines. These two product lines accounted for 92% and 98% of the Company’s total revenues for the three months ended June 30, 2015 and 2014, respectively, and 94% and 93% for the six months ended June 30, 2015 and 2014, respectively. <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> Customers to which 10% or more of the Company’s total revenues are attributable for any one of the periods presented consist of the following: <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px">   <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="67%"></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">CUSTOMER A</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">CUSTOMER B</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">CUSTOMER C</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> For the three months ended June 30, </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> 2015 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">34</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4</td> <td valign="bottom" nowrap="nowrap">% </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> 2014 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">37</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">12</td> <td valign="bottom" nowrap="nowrap">% </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> For the six months ended June 30, </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> 2015 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">27</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8</td> <td valign="bottom" nowrap="nowrap">% </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> 2014 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">31</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">13</td> <td valign="bottom" nowrap="nowrap">% </td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 1px 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px">   <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> Customers to which 10% or more of the Company’s outstanding accounts receivable are attributable as of either June 30, 2015 or December 31, 2014 consist of the following: <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px">   <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"> <tr> <td width="48%"></td> <td valign="bottom" width="12%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="12%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="12%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="12%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">CUSTOMER A</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">CUSTOMER B</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">CUSTOMER C</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">CUSTOMER D</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> June 30, 2015 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">46</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">10</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">*</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> December 31, 2014 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">10</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">*</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">37</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">23</td> <td valign="bottom" nowrap="nowrap">% </td> </tr> </table> <p style="MARGIN-BOTTOM: 2pt; WHITE-SPACE: normal; BORDER-BOTTOM: rgb(0,0,0) 1px solid; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium/8pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; WIDTH: 125px; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px">   <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="2%" align="left">*</td> <td valign="top" align="left">Represents less than 1% of outstanding accounts receivable</td> </tr> </table> </div>

<div> Deferred Cost of Product Revenues Deferred cost of product revenues are stated at the lower of cost or net realizable value and include product sold where title has transferred but the criteria for revenue recognition have not been met. As of June 30, 2015 and December 31, 2014, the Company recorded deferred cost of product revenues of $1,597,000 and $1,797,000, respectively, including deferred cost of product revenues to related parties of $138,000 and $333,000, respectively. </div>

<div> 3. Fair Value Measurements Accounting Standards Codification (“ASC”) 820, Fair Value Measurements (“ASC 820”), clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. ASC 820 requires that the valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. ASC 820 establishes a three tier value hierarchy, which prioritizes inputs that may be used to measure fair value as follows:   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="5%"> </td> <td valign="top" width="2%" align="left">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left">Level 1—Quoted prices in active markets for identical assets or liabilities.</td> </tr> </table>   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="5%"> </td> <td valign="top" width="2%" align="left">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left">Level 2—Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</td> </tr> </table>   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="5%"> </td> <td valign="top" width="2%" align="left">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left">Level 3—Inputs that are generally unobservable and typically reflect management’s estimate of assumptions that market participants would use in pricing the asset or liability.</td> </tr> </table>   The following table presents the Company’s financial assets measured at fair value on a recurring basis as of June 30, 2015 and December 31, 2014 (in thousands):   <table style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"> <tr> <td width="68%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="14" align="center">JUNE 30, 2015</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">TOTAL</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">LEVEL 1</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">LEVEL 2</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">LEVEL 3</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Assets </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> Money market funds </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3,749</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3,749</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 1pt"> <td height="16"></td> <td height="16" colspan="16"></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="14" align="center">DECEMBER 31, 2014</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">TOTAL</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">LEVEL 1</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">LEVEL 2</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">LEVEL 3</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Assets </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> Money market funds </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">14,746</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">14,746</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> The Company’s money market funds are held at registered investment companies and as of June 30, 2015 and December 31, 2014 were in active markets and, therefore, are measured based on the Level 1 valuation hierarchy. </div>

<div> Accrued liabilities consist of the following (in thousands):   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="74%"></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">JUNE 30, 2015</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">DECEMBER 31, 2014</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Accrued compensation </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,258</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,348</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> Accrued expenses </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,915</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,771</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Accrued warranty costs </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">323</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">202</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,496</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,321</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

<div> 1. Summary of Business, and Liquidity  Marrone Bio Innovations, Inc. (“Company”), formerly Marrone Organic Innovations, Inc., was incorporated under the laws of the State of Delaware on June 15, 2006, and is located in Davis, California. In July 2012, the Company formed a wholly-owned subsidiary, Marrone Michigan Manufacturing LLC (“MMM LLC”), which holds the assets of a manufacturing plant the Company purchased in July 2012. The Company makes bio-based pest management and plant health products. The Company targets the major markets that use conventional chemical pesticides, including certain agricultural and water markets where its bio-based products are used as alternatives for, or mixed with, conventional chemical pesticides. The Company also targets new markets for which there are no available conventional chemical pesticides, the use of conventional chemical pesticides may not be desirable or permissible because of health and environmental concerns (including for organically certified crops) or because the development of pest resistance has reduced the efficacy of conventional chemical pesticides. The Company delivers EPA-approved and registered biopesticide products and other bio-based products that address the global demand for effective, safe and environmentally responsible products. The Company is an early stage company with a limited operating history and has a limited number of commercialized products. As of June 30, 2015, the Company had an accumulated deficit of $182,747,000, has incurred significant losses since inception and expects to continue to incur losses for the foreseeable future. Until the completion of the initial public offering (“IPO”) in August 2013, the Company had funded operations primarily with net proceeds from the private placements of convertible preferred stock, convertible notes, promissory notes and term loans, as well as with the proceeds from the sale of its products and payments under strategic collaboration agreements and government grants. The Company will need to generate significant revenue growth to achieve and maintain profitability. As of June 30, 2015, the Company had working capital of $2,478,000, including cash and cash equivalents of $12,196,000. In addition, as of June 30, 2015, the Company had debt totaling $22,238,000 for which the underlying debt agreements contain various financial and non-financial covenants, as well as certain material adverse change clauses. If the Company breaches any of the covenants contained within the debt agreements or if the material adverse change clauses are triggered, the entire unpaid principal and interest balance would be due and payable upon demand. The Company believes that currently available resources combined with the additional $40,000,000 in proceeds raised from the issuance of senior secured promissory notes in August 2015 (see Note 10) will be sufficient to fund the Company’s cash requirements through at least June 30, 2016. The Company participates in a heavily regulated and highly competitive crop protection industry and believes that adverse changes in any of the following areas could have a material effect on the Company’s future financial position, results of operations or cash flows: inability to obtain regulatory approvals, increased competition in the pesticide market, market acceptance of the Company’s products, weather and other seasonal factors beyond the Company’s control, litigation or claims against the Company related to intellectual property, patents, products or governmental regulation, and the Company’s ability to support increased growth. Although the Company recognizes that it will likely need to raise additional funds in the future, there can be no assurance that such efforts will be successful or that, in the event that they are successful, the terms and conditions of such financing will not be unfavorable. Any future equity financing may result in dilution to existing shareholders and any debt financing may include additional restrictive covenants. Any failure to obtain additional financing or not to achieve the revenue growth necessary to fund the Company with cash flows from operations will have a material adverse effect upon the Company and will likely result in a substantial reduction in the scope of the Company’s operations and impact the Company’s ability to achieve its planned business objectives. In addition, any future breach of covenants included in the Company’s debt agreements which could result in the lender demanding payment of the unpaid principal and interest balances will have a material adverse effect upon the Company and would likely require the Company to seek to renegotiate these debt arrangements with the lenders. If such negotiations are unsuccessful, the Company may be required to seek protection from creditors through bankruptcy proceedings. </div>

<div> Inventories, net consist of the following (in thousands):   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="74%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">JUNE 30, 2015</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">DECEMBER 31, 2014</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Raw materials </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">5,708</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">5,692</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> Work in progress </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">916</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,150</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Finished goods </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,601</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,378</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> Finished goods held at customers </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">382</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">424</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,607</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12,644</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

--12-31 MARRONE BIO INNOVATIONS INC

<div> 4. Inventories Inventories, net consist of the following (in thousands):   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="74%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">JUNE 30, 2015</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">DECEMBER 31, 2014</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Raw materials </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">5,708</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">5,692</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> Work in progress </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">916</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,150</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Finished goods </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,601</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,378</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> Finished goods held at customers </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">382</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">424</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,607</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12,644</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> As of each of June 30, 2015 and December 31, 2014, the Company had $668,000 in reserves against its inventories. </div>

<div> The following table presents the Company’s financial assets measured at fair value on a recurring basis as of June 30, 2015 and December 31, 2014 (in thousands):   <table style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"> <tr> <td width="68%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="14" align="center">JUNE 30, 2015</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">TOTAL</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">LEVEL 1</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">LEVEL 2</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">LEVEL 3</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Assets </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> Money market funds </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3,749</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3,749</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 1pt"> <td height="16"></td> <td height="16" colspan="16"></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="14" align="center">DECEMBER 31, 2014</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">TOTAL</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">LEVEL 1</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">LEVEL 2</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">LEVEL 3</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> Assets </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> Money market funds </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">14,746</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">14,746</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

<div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> 8. Commitments and Contingencies <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> Operating Leases <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The Company has a non-cancelable lease for an aggregate of approximately 24,500 square feet of non-contiguous office space in an office complex in Davis, California under which a portion of the covered space terminated beginning in February 2014. The remaining portion of the space will terminate by October 2016. The lease includes negotiated annual increases in the monthly rental payments. <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> In September 2013 and then amended in April 2014, the Company entered into a lease agreement for approximately 27,300 square feet of office and laboratory space located in Davis, California. The initial term of the lease is for a period of 60 months and commenced in August 2014. The monthly base rent is $44,000 per month for the first 12 months with a 3% increase each year thereafter. Concurrent with this amendment, in April 2014, the Company entered into a lease agreement with an affiliate of the landlord to lease approximately 17,400 square feet of office and laboratory space in the same building complex in Davis, California. The initial term of the lease is for a period of 60 months and commenced in August 2014. The monthly base rent is $28,000 with a 3% increase each year thereafter. <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> Litigation <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> On September 5, 2014, September 8, 2014, September 11, 2014, September 15, 2014 and November 3, 2014, the Company, along with certain of its current and former officers and directors and others were named as defendants in putative securities class action lawsuits filed in the U.S. District Court for the Eastern District of California. On February 13, 2015, these actions were consolidated as Special Situations Fund III QP, L.P. et al v. Marrone Bio Innovations, Inc. et al, Case No 2:14-cv-02571-MCE-KJN. On September 2, 2015, an initial consolidated complaint was filed on behalf of (i) all persons who purchased or otherwise acquired the Company’s publicly traded common stock directly in or traceable to the Company’s August 1, 2013 initial public offering; (ii) all persons who purchased or otherwise acquired the Company’s publicly traded common stock directly in the Company’s June 6, 2014 secondary offering; and (iii) all persons who purchased or otherwise acquired the Company’s publicly traded common stock on the open market between March 7, 2014 and September 2, 2014 (the “Class Action”). In addition to the Company, the initial consolidated complaint names certain of the Company’s current and former officers and directors and the Company’s independent registered public accounting firm as defendants. The initial consolidated complaint alleges violations of the Securities Act of 1933, the Securities Exchange Act of 1934 and SEC Rule 10b-5, arising out of the issuance of allegedly false and misleading statements about the Company’s business and prospects, including its financial statements, product revenues and system of internal controls. Plaintiffs contend that such statements caused the Company’s stock price to be artificially inflated. The action includes claims for damages, fees and expenses, including an award of attorneys’ and experts’ fees to the putative class. Pursuant to a stipulation between the parties, and by order of the Court, defendants need not respond to the initial consolidated complaint. An amended consolidated complaint is to be filed no later than 60 days after the Company announces the restatement(s) after which defendants will have 60 days to respond. The outcome of this matter is not presently determinable. <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> On September 9, 2014 and November 25, 2014, shareholder derivative actions were filed in the Superior Court of California, County of Yolo (Case No. CV14-1481) and the U.S. District Court for the Eastern District of California (Case No. 1:14-cv-02779-JAM-CKD), purportedly on the Company’s behalf, against certain current and former officers and members of its board of directors (the “2014 Derivative Actions”). The plaintiffs in the 2014 Derivative Actions allege that the defendants breached their fiduciary duties, committed waste, were unjustly enriched and aided and abetted breaches of fiduciary duty by causing the Company to issue allegedly false and misleading statements. The issues in the 2014 Derivative Actions overlap substantially with those at issue in the Class Action described above. The plaintiffs in the 2014 Derivative Actions seek, purportedly on behalf of the Company, an unspecified award of damages including, but not limited to, various corporate governance reforms, an award of restitution, an award of reasonable costs and expenses, including attorneys’ fees, and other further relief as the Court may deem just and proper. The Courts have granted the parties’ stipulations to defer litigation activity, subject to certain conditions and pending certain developments in the Class Action. <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> On October 14, 2015, a shareholder derivative action was filed in the Superior Court of California, County of Yolo (Case No. CV15-1423), purportedly on the Company’s behalf, against certain current and former officers and members of the Company’s board of directors and the Company’s independent registered public accounting firm (the “2015 Derivative Action,” and with the 2014 Derivative Actions, the “Derivative Actions”). The plaintiff in the 2015 Derivative Action alleges that the director and officer defendants breached their fiduciary duties, committed waste and were unjustly enriched by causing the Company to issue allegedly false and misleading statements. The plaintiff in the 2015 Derivative Action also alleges that the Company’s independent registered public accounting firm committed professional negligence and malpractice. The issues in the 2015 Derivative Action overlap substantially with those at issue in the 2014 Derivative Actions and the Class Action described above. The parties are negotiating a date by which the defendants’ response to the newly filed complaint will be due. Given the preliminary nature of the Derivative Actions, the Company is not in a position to express any opinion regarding the outcome in these matters. <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The Company is currently unable to estimate a range of reasonably possible loss for the litigation because these matters involve significant uncertainties. Those uncertainties include the legal theory or the nature of the claims, the complexity of the facts, the results of any investigation or litigation and the timing of resolution of the investigations or litigation. Although the Company cannot estimate a reasonable range of loss based on currently available information, the resolution of these matters could have a material adverse effect on its financial position, results of operations or cash flows. <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> SEC Investigation <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The Company advised the staff of the Division of Enforcement of the SEC in September 2014 that the Audit Committee of the Company’s board of directors had commenced an internal investigation. The SEC commenced a formal investigation of these matters, with which the Company is cooperating. Though the investigation continues, the Company has engaged in discussions with the Division of Enforcement staff concerning the resolution of any enforcement action that it may recommend. In accordance with ASC 450, Contingencies, the Company has accrued $1,750,000 in its condensed consolidated balance sheets as of June 30, 2015 and December 31, 2014 for its estimate of the penalties arising from such enforcement action and has estimated the range of the reasonably possible loss to be between $1,750,000 and $4,000,000. <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> Publicity surrounding the foregoing or any enforcement action as a result of the Division of Enforcement’s investigation, even if ultimately resolved favorably, could have an adverse impact on the Company’s reputation, business, financial position, results of operations or cash flows. </div>

2015-06-30

<div> Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </div>

<div> Cash and Cash Equivalents The Company considers all highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents. Cash and cash equivalents consists of cash on deposit, money market funds and certificates of deposit accounts with United States (“U.S.”) financial institutions. The Company is exposed to credit risk in the event of default by financial institutions to the extent that cash and cash equivalents balances with financial institutions are in excess of amounts that are insured by the Federal Deposit Insurance Corporation. The Company has not experienced any losses on these deposits. </div>

<div> 7. Share-Based Plans As of June 30, 2015, there were 2,633,000 options outstanding and 2,142,000 share-based awards available for grant under the outstanding equity incentive plans.   For the three months ended June 30, 2015 and 2014, the Company recognized share-based compensation of $1,095,000 and $1,200,000, respectively. For the six months ended June 30, 2015 and 2014, the Company recognized share-based compensation of $2,185,000 and $2,722,000, respectively. During the three and six months ended June 30, 2015, the Company did not grant any options and no options were exercised. </div>

<div> Net Loss per Share Net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding for the period. The calculation of basic and diluted net loss per share is the same for all periods presented as the effect of the potential common stock equivalents, which consist of stock options and warrants to purchase common stock, are anti-dilutive due to the Company’s net loss position. Anti-dilutive common stock equivalents are excluded from diluted net loss per share. The anti-dilutive stock options that were not included in diluted net loss per share were 2,633,000 and 2,871,000 as of June 30, 2015 and 2014, respectively. The anti-dilutive warrants to purchase common stock that were not included in diluted net loss per share were 145,000 as of both June 30, 2015 and 2014. </div>

<div> 2. Significant Accounting Policies  Basis of Presentation The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation. The accompanying financial information as of June 30, 2015, and for the three and six months ended June 30, 2015 and 2014, has been prepared by the Company, without audit, in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such SEC rules and regulations and accounting principles applicable for interim periods. However, the Company believes that the disclosures are adequate to make the information presented not misleading. The information included in this Quarterly Report on Form 10-Q should be read in connection with the consolidated financial statements and accompanying notes included in the Company’s Annual Report filed on Form 10-K for the fiscal year ended December 31, 2014. In the opinion of management, the condensed consolidated financial statements as of June 30, 2015, and for the three and six months ended June 30, 2015 and 2014, reflect all adjustments, which are normal recurring adjustments, necessary to present a fair statement of financial position, results of operations, comprehensive loss and cash flows. The results of operations for the three and six months ended June 30, 2015 are not necessarily indicative of the operating results for the full fiscal year or any future periods.   Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents. Cash and cash equivalents consists of cash on deposit, money market funds and certificates of deposit accounts with United States (“U.S.”) financial institutions. The Company is exposed to credit risk in the event of default by financial institutions to the extent that cash and cash equivalents balances with financial institutions are in excess of amounts that are insured by the Federal Deposit Insurance Corporation. The Company has not experienced any losses on these deposits. Restricted Cash The Company’s restricted cash consists of cash that the Company is contractually obligated to maintain on deposit at a bank in accordance with the promissory note entered into in June 2014. See Note 6 for further discussion. Concentrations of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents, accounts receivable and debt. The Company deposits its cash and cash equivalents with high credit quality domestic financial institutions with locations in the U.S. Such deposits may exceed federal deposit insurance limits. The Company believes the financial risks associated with these financial instruments are minimal. The Company’s customer base is dispersed across many different geographic areas, and currently most customers are pest management distributors in the U.S. Generally, receivables are due up to 120 days from the invoice date and are considered past due after this date, although the Company may offer extended terms from time to time. For the three months ended June 30, 2015 and 2014, 9% and 6%, respectively, and for the six months ended June 30, 2015 and 2014, 6% and 11%, respectively, of the Company’s revenues were generated from international customers. The Company’s principal sources of revenues are its Regalia and Grandevo product lines. These two product lines accounted for 92% and 98% of the Company’s total revenues for the three months ended June 30, 2015 and 2014, respectively, and 94% and 93% for the six months ended June 30, 2015 and 2014, respectively. Customers to which 10% or more of the Company’s total revenues are attributable for any one of the periods presented consist of the following:   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="67%"></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">CUSTOMER A</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">CUSTOMER B</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">CUSTOMER C</td> <td valign="bottom"> </td> </tr>  <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> For the three months ended June 30, </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> 2015 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">34</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4</td> <td valign="bottom" nowrap="nowrap">% </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> 2014 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">37</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">12</td> <td valign="bottom" nowrap="nowrap">% </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> For the six months ended June 30, </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> 2015 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">27</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8</td> <td valign="bottom" nowrap="nowrap">% </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> 2014 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">31</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">13</td> <td valign="bottom" nowrap="nowrap">% </td> </tr> </table>   Customers to which 10% or more of the Company’s outstanding accounts receivable are attributable as of either June 30, 2015 or December 31, 2014 consist of the following:   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"> <tr> <td width="48%"></td> <td valign="bottom" width="12%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="12%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="12%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="12%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">CUSTOMER A</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">CUSTOMER B</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">CUSTOMER C</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">CUSTOMER D</td> <td valign="bottom"> </td> </tr>  <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> June 30, 2015 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">46</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">10</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">*</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> December 31, 2014 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">10</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">*</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">37</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">23</td> <td valign="bottom" nowrap="nowrap">% </td> </tr> </table>   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="2%" align="left">*</td> <td valign="top" align="left">Represents less than 1% of outstanding accounts receivable</td> </tr> </table> Concentrations of Supplier Dependence The active ingredient in the Company’s Regalia product line is derived from the giant knotweed plant, which the Company obtains from China. The Company’s single supplier acquires raw knotweed from numerous regional sources and performs an extraction process on this plant, creating a dried extract that is shipped to the Company’s manufacturing plant. A disruption at this supplier’s manufacturing site or a disruption in trade between the U.S. and China could negatively impact sales of Regalia. The Company currently uses one supplier and does not have a long-term supply contract with this supplier. Although the Company has identified additional sources of raw knotweed, there can be no assurance that the Company will continue to be able to obtain dried extract from China at a competitive price. Inventories Inventories are stated at the lower of cost or market value (net realizable value or replacement cost) and include the cost of material and external and internal labor and manufacturing costs. Cost is determined on the first-in, first-out basis. The Company provides for inventory reserves when conditions indicate that the selling price may be less than cost due to physical deterioration, obsolescence, changes in price levels or other factors. Additionally, the Company provides reserves for excess and slow-moving inventory on hand that is not expected to be sold to reduce the carrying amount of excess and slow-moving inventory to its estimated net realizable value. The reserves are based upon estimates about future demand from the Company’s customers and distributors and market conditions. Deferred Cost of Product Revenues Deferred cost of product revenues are stated at the lower of cost or net realizable value and include product sold where title has transferred but the criteria for revenue recognition have not been met. As of June 30, 2015 and December 31, 2014, the Company recorded deferred cost of product revenues of $1,597,000 and $1,797,000, respectively, including deferred cost of product revenues to related parties of $138,000 and $333,000, respectively. Revenue Recognition The Company recognizes revenues when persuasive evidence of an arrangement exists, transfer of title has occurred or services have been rendered, the price is fixed or determinable and collectability is reasonably assured. If contractual obligations, acceptance provisions or other contingencies exist which indicate that the price is not fixed or determinable, revenue is recognized after such obligations or provisions are fulfilled or expire. Product revenues consist of revenues generated from sales of the Company’s products to distributors and direct customers, net of rebates and cash discounts. For sales of products made to distributors, the Company recognizes revenue either on a sell-in or sell-through basis depending on the specific facts and circumstances of the transaction(s) with the distributor. Factors considered include, but are not limited to, whether the payment terms offered to the distributor are structured to correspond to when product is resold, the distributor history of adhering to the terms of its contractual arrangements with the Company, whether the Company has a pattern of granting concessions for the benefit of the distributor and whether there are other conditions that may indicate that the sale to the distributor is not substantive. In some cases, the Company recognizes distributor revenue as title and risk of loss passes, provided all other revenue recognition criteria have been satisfied (the “sell-in” method). For certain sales to certain distributors, the revenue recognition criteria for distributor sales are not satisfied at the time title and risk of loss passes to the distributor; specifically, in instances where “inventory protection” arrangements were offered to distributors that would permit these distributors to return to the Company certain unsold products, the Company considers the arrangement not to be fixed or determinable, and accordingly, revenue is deferred until products are resold to customers of the distributor (the “sell-through” method). As of June 30, 2015 and December 31, 2014, the Company recorded current deferred product revenues of $2,600,000 and $3,190,000, respectively, including current deferred product revenues from related parties of $278,000 and $660,000, respectively. The cost of product revenues associated with such deferral are also deferred and classified as deferred cost of product revenues in the condensed consolidated balance sheets. Cash received from customers related to delivered product that may not represent a true sale is classified as customer refund liabilities in the condensed consolidated balance sheets and the related cost of inventory remains in inventory in the condensed consolidated balance sheets until the product is returned or is resold to customers of the distributor and revenue is recognized. For the three months ended June 30, 2015 and 2014, 58% and 51%, respectively, and for the six months ended June 30, 2015 and 2014, 48% and 51%, respectively, of total revenues were recognized on a sell-through basis. From time to time, the Company offers certain product rebates to its distributors and growers, which are estimated and recorded as reductions to product revenues, and an accrued liability is recorded at the later of when the revenues are recorded or the rebate is being offered. The Company recognizes license revenues pursuant to strategic collaboration and distribution agreements under which the Company receives payments for the achievement of testing validation, regulatory progress and commercialization events. As these activities and payments are associated with exclusive rights that the Company provides in connection with strategic collaboration and distribution agreements over the term of the agreements, revenues related to the payments received are deferred and recognized over the term of the exclusive distribution period of the respective agreement. For the six months ended June 30, 2015, the Company received payments totaling $750,000 under these agreements. No payments were received under these agreements for the three months ended June 30, 2015 and the three and six months ended June 30, 2014. For the three months ended June 30, 2015 and 2014, the Company recognized $83,000 and $51,000, respectively, as license revenues, excluding related party revenues. For the six months ended June 30, 2015 and 2014, the Company recognized $166,000 and $96,000, respectively, as license revenues, excluding related party revenues. The Company has a strategic collaboration and distribution agreement with Syngenta, an affiliate of a former 5% stockholder, Syngenta Ventures Pte. LTD (Syngenta Ventures). In connection with the Company’s secondary offering in June 2014, Syngenta Ventures sold 600,000 shares of the Company’s common stock, reducing its ownership percentage below 5%. Accordingly, revenue recognized under this agreement subsequent to June 2014 has not been included in related party revenues. For the three and six months ended June 30, 2014, the Company recognized $8,000 and $332,000, respectively, of related party revenues under this agreement prior to Syngenta Ventures reducing its ownership stake. As of June 30, 2015, the Company recorded current and non-current deferred revenues of $331,000 and $1,884,000, respectively, related to payments received under these agreements. As of December 31, 2014, the Company recorded current and non-current deferred revenues of $331,000 and $2,050,000, respectively, related to payments received under these agreements. Research, Development and Patent Expenses Research and development expenses include payroll-related expenses, field trial costs, toxicology costs, regulatory costs, consulting costs and lab costs. Patent expenses include legal costs relating to the patents and patent filing costs. These costs are expensed to operations as incurred. For the three months ended June 30, 2015 and 2014, research and development expenses totaled $3,073,000 and $4,055,000, respectively, and patent expenses totaled $255,000 and $209,000, respectively. For the six months ended June 30, 2015 and 2014, research and development expenses totaled $6,189,000 and $8,053,000, respectively, and patent expenses totaled $561,000 and $508,000, respectively. Net Loss per Share Net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding for the period. The calculation of basic and diluted net loss per share is the same for all periods presented as the effect of the potential common stock equivalents, which consist of stock options and warrants to purchase common stock, are anti-dilutive due to the Company’s net loss position. Anti-dilutive common stock equivalents are excluded from diluted net loss per share. The anti-dilutive stock options that were not included in diluted net loss per share were 2,633,000 and 2,871,000 as of June 30, 2015 and 2014, respectively. The anti-dilutive warrants to purchase common stock that were not included in diluted net loss per share were 145,000 as of both June 30, 2015 and 2014. Recently Issued Accounting Pronouncements In July 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory (“ASU 2015-11”), which applies guidance on the subsequent measurement of inventory. ASU 2015-11 states that an entity should measure inventory at the lower of cost and net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonable predictable costs of completion, disposal and transportation. The guidance excludes inventory measured using last-in, first-out or the retail inventory method. ASU 2015-11 is effective for interim and annual reporting periods beginning after December 15, 2016. Early adoption is permitted. The Company is not planning to early adopt ASU 2015-11 and is currently evaluating ASU 2015-11 to determine the potential impact to its condensed consolidated financial statements and related disclosures. In April 2015, the FASB issued Accounting Standards Update No. 2015-03, Interest—Imputation of Interest (Topic 835-30): Simplifying the Presentation of Debt Issuance Costs (“ASU 2015-03”). ASU 2015-03 requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs is not affected by ASU 2015-03. ASU 2015-03 is effective for financial statements issued for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. Early adoption is permitted. Upon adoption, the Company will reclassify debt issuance costs from prepaid expenses and other current assets and other assets as a reduction to debt in the condensed consolidated balance sheets. The Company is not planning to early adopt ASU 2015-03 and does not anticipate that the adoption of ASU 2015-03will materially impact its condensed consolidated financial statements. In August 2014, the FASB issued Accounting Standards Update No. 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (“ASU 2014-15”). ASU 2014-15 requires management to evaluate for each annual and interim reporting period whether conditions or events give rise to substantial doubt that an entity has the ability to continue as a going concern within one year following issuance of the financial statements and requires specific disclosures regarding the conditions or events leading to substantial doubt. The new guidance is effective for annual and interim periods ending after December 15, 2016, with early adoption permitted. The Company is currently evaluating ASU 2014-15 to determine the potential impact to its condensed consolidated financial statements and related disclosures. In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”). ASU 2014-09 provides new, globally applicable converged guidance concerning recognition and measurement of revenue. As a result, significant additional disclosures are required about the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The new guidance is effective for annual and interim periods beginning on or after December 15, 2018. Companies are allowed to transition using either the modified retrospective or full retrospective adoption method. If full retrospective adoption is chosen, three years of financial information must be presented in accordance with the new standard. The Company is currently evaluating the alternative methods of adoption and the effect on its condensed consolidated financial statements and related disclosures. </div>

MBII

24465000

As of June 30, 2015, the Company had debt totaling $22,238,000 for which the underlying debt agreements contain various financial and non-financial covenants, as well as certain material adverse change clauses. If the Company breaches any of the covenants contained within the debt agreements or if the material adverse change clauses are triggered, the entire unpaid principal and interest balance would be due and payable upon demand. The Company believes that currently available resources combined with the additional $40,000,000 in proceeds raised from the issuance of senior secured promissory notes in August 2015 (see Note 10) will be sufficient to fund the Company’s cash requirements through at least June 30, 2016.

<div> 9. Related Party Transactions Les Lyman, a member of the Company’s board of directors, is the chairman and significant indirect shareholder of The Tremont Group, Inc. For the three months ended June 30, 2015 and 2014, revenue of $183,000 and $201,000, respectively, was recognized on a sell-through basis relating to product purchased by The Tremont Group, Inc. that was resold by The Tremont Group, Inc. during the period. For the six months ended June 30, 2015 and 2014, revenue of $382,000 and $478,000, respectively, was recognized on a sell-through basis relating to product purchased by The Tremont Group, Inc. that was resold by The Tremont Group, Inc. during the period. As of June 30, 2015 and December 31, 2014, the Company had no outstanding accounts receivable due from The Tremont Group, Inc. As of June 30, 2015 and December 31, 2014, the Company recorded deferred cost of product revenues of $138,000 and $333,000, respectively, and current deferred product revenues of $278,000 and $660,000, respectively, relating to product sold to The Tremont Group, Inc. where title has transferred but the criteria for revenue recognition have not been met. Although the Company anticipates sales of its products to The Tremont Group, Inc. to continue through 2015, the Company cannot estimate the amount of those sales. The Company has a strategic collaboration and distribution agreement with Syngenta, an affiliate of a former 5% stockholder, Syngenta Ventures. In connection with the Company’s secondary offering in June 2014, Syngenta Ventures sold 600,000 shares of the Company’s common stock, reducing its ownership percentage below 5%. Accordingly, revenue recognized under this agreement subsequent to June 2014 has not been included in related party revenues. For the three and six months ended June 30, 2014, the Company recognized $8,000 and $332,000, respectively, of related party revenues under this agreement prior to Syngenta Ventures reducing its ownership stake. </div>

382000

1149000

1398000

-22899000

137000

5413000

1069000

-130000

-21627000

-2037000

35000

166000

421000

41000

-1272000

4000

1164000

-22899000

4865000

15000

12000

787000

-25000

2185000

-375000

22048000

1328000

-1391000

-1341000

6189000

7000

195000

223000

-23128000

-2263000

-192000

15298000

265000

1707000

4992000

16000

561000 1.25 0.10 6750000 0.05 0 750000 0.20 0.70 382000 <div> Concentrations of Supplier Dependence The active ingredient in the Company’s Regalia product line is derived from the giant knotweed plant, which the Company obtains from China. The Company’s single supplier acquires raw knotweed from numerous regional sources and performs an extraction process on this plant, creating a dried extract that is shipped to the Company’s manufacturing plant. A disruption at this supplier’s manufacturing site or a disruption in trade between the U.S. and China could negatively impact sales of Regalia. The Company currently uses one supplier and does not have a long-term supply contract with this supplier. Although the Company has identified additional sources of raw knotweed, there can be no assurance that the Company will continue to be able to obtain dried extract from China at a competitive price. </div> 0.20 4.0 0.20 -0.01 0.48 -200000

-69000

-58000

Payable monthly through April 2016

Promissory note ("June 2014 Secured Promissory Note") with the bank ("Lender") which bears interest at prime rate (3.25% as of June 30, 2015) plus 2.00% per annum.

2014-07-31

2036-06-30

Payable monthly through June 2036

0.02

64390

0.0325

Semi-annually

Payable monthly through October 2015

The October 2012 Secured Promissory Notes have an initial term of three years and can be extended for an additional two years in one year increments at the option of the Company. During the initial three-year term, the October 2012 Secured Promissory Notes bear interest at 12% per annum. If the term of the October 2012 Secured Promissory Notes is extended an additional year, the interest rate is 13% during the fourth year. If the term of the October 2012 Secured Promissory Notes is extended for an additional two years, the interest rate is 14% during the fifth year. Interest on the October 2012 Secured Promissory Notes is payable monthly through the initial maturity date of the loan, which is October 2, 2015, or through any extension period. The principal and all unpaid interest are due on the maturity date, as may be extended.

0.01 0.05 0.15

2017-10-02

382000

2014-06-30

0.10

0.02

0.1125

0.0525

0.27

0.46

0.08

0.10

0.08

2633000

145000

P120D

2016-10-31

0.01

2014-02-28

24500 2013-09

0.06

0.94

2016-04-01

-127000

0 0.10 2023-06-14

49000

3811000 291000 352000

44000

27300 P12M 2014-08 P60M 0.03

28000

17400 2014-08 P60M 0.03

4687000

0.0525

0.0200

10000000

0.70 2017-10-02 0.75

40000000

290000

0.083333

0.1125

0.0525

0.10

0.23

0.37

-0.52

20775000

206000

-10711000

3134000

-9761000

51000

423000

-98000

-950000

-10711000

2877000

11000

1200000

10184000

863000

4055000

130000

5920000

2711000

209000 4264000 0 0.51

201000

0.37

0.07

0.12

0.06

0.98

8000

-0.45

24465000

183000

-10985000

3357000

-10376000

83000

363000

44000

-609000

-10985000

3091000

6000

1095000

10739000

659000

3073000

113000

7411000

2994000

255000 3328000 0 0.58

183000

0.34

0.11

0.04

0.09

0.92

0001441693 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2015-04-01 2015-06-30 0001441693 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mbii:InternationalMember 2015-04-01 2015-06-30 0001441693 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mbii:CustomerCMember 2015-04-01 2015-06-30 0001441693 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mbii:CustomerBMember 2015-04-01 2015-06-30 0001441693 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mbii:CustomerAMember 2015-04-01 2015-06-30 0001441693 mbii:TremontGroupMember 2015-04-01 2015-06-30 0001441693 2015-04-01 2015-06-30 0001441693 mbii:SyngentaMember 2014-04-01 2014-06-30 0001441693 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2014-04-01 2014-06-30 0001441693 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mbii:InternationalMember 2014-04-01 2014-06-30 0001441693 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mbii:CustomerCMember 2014-04-01 2014-06-30 0001441693 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mbii:CustomerBMember 2014-04-01 2014-06-30 0001441693 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mbii:CustomerAMember 2014-04-01 2014-06-30 0001441693 mbii:TremontGroupMember 2014-04-01 2014-06-30 0001441693 2014-04-01 2014-06-30 0001441693 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember mbii:CustomerCMember 2014-01-01 2014-12-31 0001441693 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember mbii:CustomerDMember 2014-01-01 2014-12-31 0001441693 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember mbii:CustomerAMember 2014-01-01 2014-12-31 0001441693 us-gaap:FairValueInputsLevel3Member us-gaap:VariableIncomeInterestRateMember 2014-01-01 2014-12-31 0001441693 us-gaap:FairValueInputsLevel3Member us-gaap:FixedIncomeInterestRateMember 2014-01-01 2014-12-31 0001441693 mbii:JamesIademarcoMember us-gaap:SubsequentEventMember 2015-08-01 2015-08-31 0001441693 us-gaap:SubsequentEventMember 2015-08-01 2015-08-31 0001441693 us-gaap:RevolvingCreditFacilityMember 2011-10-01 2011-10-31 0001441693 us-gaap:SubsequentEventMember 2015-09-01 2015-09-30 0001441693 2015-06-01 2015-06-30 0001441693 mbii:SecuredPromissoryNoteInterestRateAtPrimePlusTwoPercentThroughJuneTwoThousandThirtySixMember us-gaap:SecuredDebtMember 2014-06-01 2014-06-30 0001441693 2014-06-01 2014-06-30 0001441693 mbii:OfficeAndLaboratorySpaceTwoMember 2014-04-01 2014-04-30 0001441693 mbii:OfficeAndLaboratorySpaceOneMember mbii:AmendmentMember 2014-04-01 2014-04-30 0001441693 mbii:AprilTwoThousandThirteenSecuredPromissoryNotesMember us-gaap:SecuredDebtMember 2013-04-01 2013-04-30 0001441693 2013-04-01 2013-04-30 0001441693 mbii:JuneTwoThousandThirteenWarrantMember 2015-01-01 2015-06-30 0001441693 mbii:JuneTwoThousandThirteenWarrantMember us-gaap:WarrantMember 2015-01-01 2015-06-30 0001441693 mbii:OctoberTwoThousandTwelveAndAprilTwoThousandThirteenSecuredPromissoryNotesMember 2015-01-01 2015-06-30 0001441693 mbii:TermLoanBearingInterestRateAtSevenPercentageMember 2015-01-01 2015-06-30 0001441693 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2015-01-01 2015-06-30 0001441693 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mbii:InternationalMember 2015-01-01 2015-06-30 0001441693 mbii:OfficeAndLaboratorySpaceOneMember 2015-01-01 2015-06-30 0001441693 mbii:NoncontiguousOfficeSpaceMember 2015-01-01 2015-06-30 0001441693 mbii:NoncontiguousOfficeSpaceMember us-gaap:MinimumMember 2015-01-01 2015-06-30 0001441693 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember us-gaap:MaximumMember 2015-01-01 2015-06-30 0001441693 mbii:NoncontiguousOfficeSpaceMember us-gaap:MaximumMember 2015-01-01 2015-06-30 0001441693 us-gaap:MaximumMember 2015-01-01 2015-06-30 0001441693 mbii:WarrantsToPurchaseCommonStockMember 2015-01-01 2015-06-30 0001441693 us-gaap:EmployeeStockOptionMember 2015-01-01 2015-06-30 0001441693 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember mbii:CustomerCMember 2015-01-01 2015-06-30 0001441693 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mbii:CustomerCMember 2015-01-01 2015-06-30 0001441693 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember mbii:CustomerBMember 2015-01-01 2015-06-30 0001441693 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mbii:CustomerBMember 2015-01-01 2015-06-30 0001441693 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember mbii:CustomerAMember 2015-01-01 2015-06-30 0001441693 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mbii:CustomerAMember 2015-01-01 2015-06-30 0001441693 us-gaap:FairValueInputsLevel3Member us-gaap:VariableIncomeInterestRateMember 2015-01-01 2015-06-30 0001441693 us-gaap:FairValueInputsLevel3Member us-gaap:FixedIncomeInterestRateMember 2015-01-01 2015-06-30 0001441693 mbii:JuneTwoThousandAndThirteenCreditFacilityMember 2015-01-01 2015-06-30 0001441693 mbii:TremontGroupMember 2015-01-01 2015-06-30 0001441693 mbii:OctoberTwoThousandTwelveAndAprilTwoThousandThirteenSecuredPromissoryNotesMember 2015-01-01 2015-06-30 0001441693 mbii:OctoberTwoThousandTwelveSecuredPromissoryNotesMember us-gaap:SecuredDebtMember 2015-01-01 2015-06-30 0001441693 mbii:SecuredPromissoryNotesInterestRateAtTwelvePercentThroughOctoberTwoThousandFifteenMember us-gaap:SecuredDebtMember 2015-01-01 2015-06-30 0001441693 mbii:SeniorSecuredPromissoryNoteInterestRateAtEightPercentMember us-gaap:BeneficialOwnerMember 2015-01-01 2015-06-30 0001441693 mbii:SecuredPromissoryNoteInterestRateAtPrimePlusTwoPercentThroughJuneTwoThousandThirtySixMember us-gaap:SecuredDebtMember 2015-01-01 2015-06-30 0001441693 mbii:TermLoanBearingInterestRateAtSevenPointZeroZeroPercentThroughAprilTwoThousandSixteenMember us-gaap:SecuredDebtMember 2015-01-01 2015-06-30 0001441693 mbii:DebtPrincipalMember mbii:OctoberTwoThousandTwelveAndAprilTwoThousandThirteenSecuredPromissoryNotesMember 2015-01-01 2015-06-30 0001441693 mbii:DiscountRelatedToNotesMember mbii:OctoberTwoThousandTwelveAndAprilTwoThousandThirteenSecuredPromissoryNotesMember 2015-01-01 2015-06-30 0001441693 mbii:DiscountRelatedToIssuanceOfCommonStockWarrantsMember mbii:OctoberTwoThousandTwelveAndAprilTwoThousandThirteenSecuredPromissoryNotesMember 2015-01-01 2015-06-30 0001441693 2015-01-01 2015-06-30 0001441693 mbii:SyngentaMember 2014-01-01 2014-06-30 0001441693 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2014-01-01 2014-06-30 0001441693 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mbii:InternationalMember 2014-01-01 2014-06-30 0001441693 mbii:WarrantsToPurchaseCommonStockMember 2014-01-01 2014-06-30 0001441693 us-gaap:EmployeeStockOptionMember 2014-01-01 2014-06-30 0001441693 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mbii:CustomerCMember 2014-01-01 2014-06-30 0001441693 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mbii:CustomerBMember 2014-01-01 2014-06-30 0001441693 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mbii:CustomerAMember 2014-01-01 2014-06-30 0001441693 mbii:TremontGroupMember 2014-01-01 2014-06-30 0001441693 2014-01-01 2014-06-30 0001441693 us-gaap:SubsequentEventMember 2015-08-21 2015-08-31 0001441693 mbii:OctoberTwoThousandTwelveSecuredPromissoryNotesMember us-gaap:SecuredDebtMember 2012-10-02 2012-10-02 0001441693 2013-06-14 2013-06-14 0001441693 us-gaap:SecuredDebtMember 2013-04-10 2013-04-10 0001441693 mbii:AprilTwoThousandThirteenSecuredPromissoryNotesMember us-gaap:SecuredDebtMember 2013-04-10 2013-04-10 0001441693 mbii:OctoberTwoThousandTwelveSecuredPromissoryNotesMember us-gaap:SecuredDebtMember us-gaap:MaximumMember 2013-04-10 2013-04-10 0001441693 2013-04-10 2013-04-10 0001441693 us-gaap:BeneficialOwnerMember us-gaap:SubsequentEventMember 2015-08-20 2015-08-20 0001441693 us-gaap:SubsequentEventMember 2015-08-20 2015-08-20 0001441693 mbii:StrategicCollaborationAndDistributionAgreementsMember 2014-12-31 0001441693 mbii:OctoberTwoThousandTwelveAndAprilTwoThousandThirteenSecuredPromissoryNotesMember 2014-12-31 0001441693 us-gaap:MoneyMarketFundsMember 2014-12-31 0001441693 mbii:CustomersMember 2014-12-31 0001441693 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2014-12-31 0001441693 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member 2014-12-31 0001441693 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member 2014-12-31 0001441693 us-gaap:FairValueInputsLevel3Member 2014-12-31 0001441693 mbii:TremontGroupMember 2014-12-31 0001441693 mbii:SecuredPromissoryNotesInterestRateAtTwelvePercentThroughOctoberTwoThousandFifteenMember us-gaap:SecuredDebtMember 2014-12-31 0001441693 mbii:SecuredPromissoryNoteInterestRateAtPrimePlusTwoPercentThroughJuneTwoThousandThirtySixMember us-gaap:SecuredDebtMember 2014-12-31 0001441693 mbii:TermLoanBearingInterestRateAtSevenPointZeroZeroPercentThroughAprilTwoThousandSixteenMember us-gaap:SecuredDebtMember 2014-12-31 0001441693 mbii:DebtPrincipalMember mbii:OctoberTwoThousandTwelveAndAprilTwoThousandThirteenSecuredPromissoryNotesMember 2014-12-31 0001441693 mbii:DiscountRelatedToNotesMember mbii:OctoberTwoThousandTwelveAndAprilTwoThousandThirteenSecuredPromissoryNotesMember 2014-12-31 0001441693 mbii:DiscountRelatedToIssuanceOfCommonStockWarrantsMember mbii:OctoberTwoThousandTwelveAndAprilTwoThousandThirteenSecuredPromissoryNotesMember 2014-12-31 0001441693 2014-12-31 0001441693 2013-12-31 0001441693 mbii:SecuredPromissoryNotesInterestRateAtTwelvePercentThroughOctoberTwoThousandFifteenMember us-gaap:LoansPayableMember us-gaap:SubsequentEventMember 2015-09-02 0001441693 mbii:OctoberTwoThousandTwelveAndAprilTwoThousandThirteenSecuredPromissoryNotesMember us-gaap:SubsequentEventMember 2015-08-31 0001441693 mbii:SecuredPromissoryNotesInterestRateAtTwelvePercentThroughOctoberTwoThousandFifteenMember us-gaap:LoansPayableMember us-gaap:SubsequentEventMember 2015-08-31 0001441693 mbii:SeniorSecuredPromissoryNoteInterestRateAtEightPercentMember us-gaap:SubsequentEventMember 2015-08-31 0001441693 mbii:StrategicCollaborationAndDistributionAgreementsMember 2015-06-30 0001441693 mbii:JuneTwoThousandThirteenWarrantMember 2015-06-30 0001441693 mbii:OctoberTwoThousandTwelveAndAprilTwoThousandThirteenSecuredPromissoryNotesMember 2015-06-30 0001441693 us-gaap:MoneyMarketFundsMember 2015-06-30 0001441693 mbii:CustomersMember 2015-06-30 0001441693 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2015-06-30 0001441693 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member 2015-06-30 0001441693 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member 2015-06-30 0001441693 us-gaap:FairValueInputsLevel3Member 2015-06-30 0001441693 mbii:JuneTwoThousandAndThirteenCreditFacilityMember us-gaap:MaximumMember 2015-06-30 0001441693 mbii:JuneTwoThousandAndThirteenCreditFacilityMember 2015-06-30 0001441693 mbii:TremontGroupMember 2015-06-30 0001441693 mbii:AprilTwoThousandThirteenSecuredPromissoryNotesMember us-gaap:SecuredDebtMember 2015-06-30 0001441693 mbii:OctoberTwoThousandTwelveSecuredPromissoryNotesMember us-gaap:SecuredDebtMember 2015-06-30 0001441693 mbii:OctoberTwoThousandTwelveSecuredPromissoryNotesMember us-gaap:SecuredDebtMember us-gaap:MaximumMember 2015-06-30 0001441693 mbii:OctoberTwoThousandTwelveSecuredPromissoryNotesMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember us-gaap:SecuredDebtMember 2015-06-30 0001441693 mbii:OctoberTwoThousandTwelveSecuredPromissoryNotesMember us-gaap:DebtInstrumentRedemptionPeriodOneMember us-gaap:SecuredDebtMember 2015-06-30 0001441693 mbii:OctoberTwoThousandTwelveSecuredPromissoryNotesMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember us-gaap:SecuredDebtMember 2015-06-30 0001441693 mbii:SecuredPromissoryNotesInterestRateAtTwelvePercentThroughOctoberTwoThousandFifteenMember us-gaap:SecuredDebtMember 2015-06-30 0001441693 mbii:SecuredPromissoryNoteInterestRateAtPrimePlusTwoPercentThroughJuneTwoThousandThirtySixMember us-gaap:SecuredDebtMember 2015-06-30 0001441693 mbii:TermLoanBearingInterestRateAtSevenPointZeroZeroPercentThroughAprilTwoThousandSixteenMember us-gaap:SecuredDebtMember 2015-06-30 0001441693 mbii:DebtPrincipalMember mbii:OctoberTwoThousandTwelveAndAprilTwoThousandThirteenSecuredPromissoryNotesMember 2015-06-30 0001441693 mbii:DiscountRelatedToNotesMember mbii:OctoberTwoThousandTwelveAndAprilTwoThousandThirteenSecuredPromissoryNotesMember 2015-06-30 0001441693 mbii:DiscountRelatedToIssuanceOfCommonStockWarrantsMember mbii:OctoberTwoThousandTwelveAndAprilTwoThousandThirteenSecuredPromissoryNotesMember 2015-06-30 0001441693 2015-06-30 0001441693 mbii:SyngentaMember 2014-06-30 0001441693 2014-06-30 0001441693 us-gaap:RevolvingCreditFacilityMember 2014-04-28 0001441693 us-gaap:RevolvingCreditFacilityMember 2014-04-14 0001441693 mbii:AprilTwoThousandThirteenSecuredPromissoryNotesMember us-gaap:SecuredDebtMember 2013-04-30 0001441693 mbii:OctoberTwoThousandTwelveSubordinatedConvertibleNotesMember us-gaap:SecuredDebtMember 2013-04-30 0001441693 2013-04-30 0001441693 us-gaap:WarrantMember 2013-04-10 0001441693 mbii:AprilTwoThousandThirteenSecuredPromissoryNotesMember us-gaap:SecuredDebtMember 2013-04-10 0001441693 mbii:OctoberTwoThousandTwelveSecuredPromissoryNotesMember us-gaap:SecuredDebtMember 2013-04-10 0001441693 mbii:OctoberTwoThousandTwelveSubordinatedConvertibleNotesMember us-gaap:SecuredDebtMember 2013-04-10 0001441693 2013-04-10 0001441693 mbii:TermLoanBearingInterestRateAtSevenPercentageMember 2012-03-31 0001441693 2015-11-02 0001441693 us-gaap:BeneficialOwnerMember us-gaap:SubsequentEventMember 2015-08-20 0001441693 us-gaap:MaximumMember us-gaap:BeneficialOwnerMember us-gaap:SubsequentEventMember 2015-08-20 0001441693 us-gaap:SubsequentEventMember 2015-08-20 0001441693 mbii:SeniorSecuredPromissoryNoteInterestRateAtEightPercentMember us-gaap:BeneficialOwnerMember us-gaap:SubsequentEventMember 2015-08-20 0001441693 mbii:SeniorSecuredPromissoryNoteInterestRateAtEightPercentMember us-gaap:MinimumMember us-gaap:BeneficialOwnerMember us-gaap:SubsequentEventMember 2015-08-20 0001441693 us-gaap:RevolvingCreditFacilityMember 2011-10-31 iso4217:USD pure iso4217:USD shares shares utr:sqft

EX-101.SCH 6 mbii-20150630.xsd XBRL TAXONOMY EXTENSION SCHEMA 101 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 103 - Statement - Condensed Consolidated Balance Sheets link:calculationLink link:presentationLink link:definitionLink 104 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 105 - Statement - Condensed Consolidated Statements of Operations link:calculationLink link:presentationLink link:definitionLink 106 - Statement - Condensed Consolidated Statements of Operations (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 107 - Statement - Condensed Consolidated Statements of Comprehensive Loss link:calculationLink link:presentationLink link:definitionLink 108 - Statement - Condensed Consolidated Statements of Cash Flows link:calculationLink link:presentationLink link:definitionLink 109 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 110 - Disclosure - Summary of Business, and Liquidity link:calculationLink link:presentationLink link:definitionLink 111 - Disclosure - Significant Accounting Policies link:calculationLink link:presentationLink link:definitionLink 112 - Disclosure - Fair Value Measurements link:calculationLink link:presentationLink link:definitionLink 113 - Disclosure - Inventories link:calculationLink link:presentationLink link:definitionLink 114 - Disclosure - Accrued Liabilities link:calculationLink link:presentationLink link:definitionLink 115 - Disclosure - Debt link:calculationLink link:presentationLink link:definitionLink 116 - Disclosure - Share-Based Plans link:calculationLink link:presentationLink link:definitionLink 117 - Disclosure - Commitments and Contingencies link:calculationLink link:presentationLink link:definitionLink 118 - Disclosure - Related Party Transactions link:calculationLink link:presentationLink link:definitionLink 119 - Disclosure - Subsequent Events link:calculationLink link:presentationLink link:definitionLink 120 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:presentationLink link:definitionLink 121 - Disclosure - Significant Accounting Policies (Tables) link:calculationLink link:presentationLink link:definitionLink 122 - Disclosure - Fair Value Measurements (Tables) link:calculationLink link:presentationLink link:definitionLink 123 - Disclosure - Inventories (Tables) link:calculationLink link:presentationLink link:definitionLink 124 - Disclosure - Accrued Liabilities (Tables) link:calculationLink link:presentationLink link:definitionLink 125 - Disclosure - Debt (Tables) link:calculationLink link:presentationLink link:definitionLink 126 - Disclosure - Summary of Business, and Liquidity - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 127 - Disclosure - Significant Accounting Policies - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 128 - Disclosure - Significant Accounting Policies - Schedule of Concentration of Credit Risk Percentage (Detail) link:calculationLink link:presentationLink link:definitionLink 129 - Disclosure - Significant Accounting Policies - Schedule of Concentration of Credit Risk Percentage (Parenthetical) (Detail) link:calculationLink link:presentationLink link:definitionLink 130 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) link:calculationLink link:presentationLink link:definitionLink 131 - Disclosure - Inventories - Schedule of Inventories, Net (Detail) link:calculationLink link:presentationLink link:definitionLink 132 - Disclosure - Inventories - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 133 - Disclosure - Accrued Liabilities - Schedule of Accrued Liabilities (Detail) link:calculationLink link:presentationLink link:definitionLink 134 - Disclosure - Accrued Liabilities - Schedule of Changes in Accrued Warranty Costs (Detail) link:calculationLink link:presentationLink link:definitionLink 135 - Disclosure - Debt - Schedule of Debt (Detail) link:calculationLink link:presentationLink link:definitionLink 136 - Disclosure - Debt - Schedule of Debt (Parenthetical) (Detail) link:calculationLink link:presentationLink link:definitionLink 137 - Disclosure - Debt - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 138 - Disclosure - Debt - Consideration Received, Fair Values of Notes, Common Stock Warrants Issued and Calculation of the Gain on Extinguishment of Debt (Detail) link:calculationLink link:presentationLink link:definitionLink 139 - Disclosure - Debt - Activity Related to Secured Promissory Note (Detail) link:calculationLink link:presentationLink link:definitionLink 140 - Disclosure - Debt - Activity Related to Secured Promissory Note (Parenthetical) (Detail) link:calculationLink link:presentationLink link:definitionLink 141 - Disclosure - Share-Based Plans - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 142 - Disclosure - Commitments and Contingencies - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 143 - Disclosure - Related Party Transactions - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 144 - Disclosure - Subsequent Events - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink EX-101.CAL 7 mbii-20150630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 mbii-20150630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 mbii-20150630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Accounting Policies [Abstract] Accounting Policies [Abstract] Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Accrued Liabilities Accounts Payable, Current Accounts payable The maximum number of days from the invoice date that receivables are generally due. Accounts Receivable Due Period Receivables due period Accounts Receivable [Member] Accounts receivable [Member] Accounts Receivable, Net, Current Accounts receivable Accounts Receivable, Related Parties Outstanding accounts receivable due Carrying value as of the balance sheet date of obligations incurred through that date and payable arising from transactions not otherwise specified in the taxonomy. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accrued Expenses Current Accrued expenses The amount of interest accrued on convertible promissory notes. Accrued Interest On Convertible Promissory Notes Accrued interest on promissory notes Accrued Liabilities, Current Accrued liabilities Accrued liabilities, total Additional Paid in Capital Additional paid in capital Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: The carrying balance of unpaid agent fees relating to debt. Agent Fees Unpaid Unpaid Agent Fee Amendment Flag Amendment Flag An amended lease agreement member. Amendment [Member] Amendment [Member] Amortization of Debt Discount (Premium) Amortization of debt discount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Anti-dilutive securities not included in diluted net loss per share Antidilutive Securities [Axis] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] April Two Thousand Thirteen Secured Promissory Notes [Member] April Two Thousand Thirteen Secured Promissory Notes [Member] April 2013 secured promissory note [Member] Assets Total assets Assets [Abstract] Assets Assets, Current Total current assets Assets, Current [Abstract] Current assets: Assets, Fair Value Disclosure [Abstract] Assets Assets, Fair Value Disclosure, Recurring Assets at fair value Basis of Accounting, Policy [Policy Text Block] Basis of Presentation Beneficial Owner [Member] Entities Affiliated with Waddell & Reed Financial, Inc. [Member] Business Description and Basis of Presentation [Text Block] Summary of Business, and Liquidity Capital Expenditures Incurred but Not yet Paid Property, plant and equipment included in accounts payable and accrued liabilities Capital Lease Obligations, Current Capital lease obligations, current portion Capital Lease Obligations Incurred Equipment acquired under capital leases Capital Lease Obligations, Noncurrent Capital lease obligations, less current portion Cash Cash Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents, end of period Cash and cash equivalents, beginning of period Cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Net increase (decrease) in cash and cash equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Restricted Cash Total amount of cash and non cash consideration received for debt issued. Cash And Noncash Consideration Received Total consideration received Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Supplemental disclosure of non-cash investing and financing activities Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price of the Common Stock Warrants Warrants exercise price Class of Warrant or Right, Number of Securities Called by Warrants or Rights Number of common shares to be purchased from warrants Class of warrant or rights end date of warrants or rights exercisable. Class Of Warrant Or Rights End Date Of Warrants Or Rights Exercisable Warrants exercisable date Commitments and Contingencies Commitments and contingencies (Note 8) Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Common Stock, Par or Stated Value Per Share Common stock, par value Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Outstanding Common stock, shares outstanding Common Stock, Value, Issued Common stock: $0.00001 par value; 250,000 shares authorized, 24,465 shares issued and outstanding as of June 30, 2015 and December 31, 2014 The expiration date of common stock warrants. Common Stock Warrant Expiration Date Warrants expire date The fair value amount of common stock warrants relating to debt issued recorded as a debt discount. Common Stock Warrant Fair Value Disclosure Fair value of Common Stock Warrants The percentage of the total commitment amount used in determining the number of warrants issued. Common Stock Warrants Issued To Purchase Common Stock Funded Principal Percentage Warrants issued to purchase common stock funded principal percentage The percentage of the total commitment amount used in determining the number of warrants issued. Common Stock Warrants Issued To Purchase Common Stock Percentage Common stock warrants issued to purchase common stock percentage Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive loss Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentration of Credit Risk Concentration Risk [Line Items] Concentration Risk [Line Items] Concentration Risk, Percentage Customers accounted for percentage of company's total revenues and accounts receivable Concentration Risk, Supplier Concentration risk, supplier Concentration Risk [Table] Concentration Risk [Table] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Disclosure of accounting policy for concentrations of supplier dependence risk. Concentrations Of Supplier Risk Policy [Text Block] Concentrations of Supplier Dependence Convertible Notes Payable Convertible debt instrument, face value Cost of Revenue Cost of product revenues, including cost of product revenues to related parties of $113 and $130 for the three months ended June 30, 2015 and 2014, respectively, and $195 and $291 for the six months ended June 30, 2015 and 2014, respectively Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Current Fiscal Year End Date Current Fiscal Year End Date The minimum current ratio to be maintained under a debt agreement. Current Ratio Current ratio Reflects the first customer identified with a significant concentration of the Company's revenues during the period or accounts receivable at the end of the period. The risk is the materially adverse effects of loss of a significant customer Customer -A- [Member] Customer A [Member] Reflects the second customer identified with a significant concentration of the Company's revenues during the period or accounts receivable at the end of the period. The risk is the materially adverse effects of loss of a significant customer Customer B [Member] Customer B [Member] Reflects the third customer identified with a significant concentration of the Company's revenues during the period or accounts receivable at the end of the period. The risk is the materially adverse effects of loss of a significant customer Customer C [Member] Customer C [Member] Customer Concentration Risk [Member] Customer concentration risk [Member] Reflects the fourth customer identified with a significant concentration of the Company's revenues during the period or accounts receivable at the end of the period. The risk is the materially adverse effects of loss of a significant customer Customer D [Member] Customer D [Member] Customer Refund Liability, Current Customer refund liabilities Customers [Member] Customers [Member] Customers [Member] Debt and Capital Lease Obligations Funds borrowed Debt Disclosure [Abstract] Debt Disclosure [Abstract] Debt Disclosure [Text Block] Debt Amount of debt (discount) premium related to debt issued. Debt Discount Premium Debt discount Additional percentage of total commitment amount used in determining the amount of the Agent Fee owed on debt issued. Debt Instrument Additional Fee Percentage Additional fee percentage The principal amount of additional debt issued. Debt Instrument Additional Issued Principal Amount Additional debt issued under amendment Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Basis Spread on Variable Rate Debt instrument, prime rate The amount of debt issued in exchange for the cancellation of convertible notes. Debt Instrument Cancellation Of Convertible Notes Debt issued in cash consideration and in partial conversion for cancellation of principal balance Long-term Debt, Gross Principal balance of notes issued Debt Instrument, Covenant Description Debt agreements financial and non-financial covenants Cash balance requirement if less than indebtedness identified in debt instrument. Debt Instrument Covenant Unrestricted Cash Balance Requirement Covenant requirements minimum cash balance Debt Instrument, Date of First Required Payment Debt instrument date of payment Debt Instrument, Description of Variable Rate Basis Debt instrument description Debt Instrument, Face Amount Debt instrument issued, principal amount Debt Instrument, Fair Value Disclosure Convertible debt, fair value Fair value of notes Debt Instrument, Fee Amount Fees amount Percentage of total commitment amount used in determining the amount of the Agent Fee owed on debt issued. Debt Instrument Fee Percentage Agent fee percentage Debt Instrument, Frequency of Periodic Payment Debt instrument, frequency of periodic payment of interest Debt Instrument, Increase (Decrease), Net Increase in amount available under loan agreement Debt Instrument, Interest Rate, Effective Percentage Rate Range, Maximum Maximum rate of interest Debt Instrument, Interest Rate, Stated Percentage Debt instrument, interest rate Debt Instrument [Line Items] Debt Instrument [Line Items] Debt Instrument, Maturity Date Debt instrument maturity date Debt Instrument, Maturity Date, Description Debt instrument borrowing terms Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Debt Instrument, Payment Terms Debt instrument, payment terms Debt Instrument, Periodic Payment Debt instrument monthly payment Debt Instrument, Periodic Payment, Principal Principal payments Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period One [Member] Debt instrument maturity period year three [Member] Debt Instrument, Redemption, Period Three [Member] Extended fifth year [Member] Debt Instrument, Redemption, Period Two [Member] Extended fourth year [Member] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Debt Instrument, Term Loan term for repayment Debt instrument to be issued face amount. Debt Instrument To Be Issued Face Amount Debt instrument to be issued, principal amount Debt Instrument, Unamortized Discount Unamortized debt discount Information on principal balance activity of debt. Debt Principal [Member] Principal [Member] The Maximum debt to worth ratio allowed under the debt agreement. Debt To Tangible Net Worth Ratio Debt to worth ratio Deferred Charges, Policy [Policy Text Block] Deferred Cost of Product Revenues Amount of cost of goods produced and sold that have been deferred as of balance sheet date for which revenue has not yet been recognized. Generally, an entity records deferred revenue and deferred cost of goods sold when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. Deferred Cost Of Product Revenues Deferred cost of product revenues Deferred cost of product revenues, including deferred cost of product revenues to related parties of $138 and $333 as of June 30, 2015 and December 31, 2014, respectively Amount of cost of goods produced and sold to related parties that have been deferred as of balance sheet date for which revenue has not yet been recognized. Generally, an entity records deferred revenue and deferred cost of goods sold when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. Deferred Cost of Product Revenues to Related Parties Current Deferred cost of product revenues to related parties Deferred Finance Costs, Net Additional credit facility financing-related costs and primarily legal fees Deferred Revenue Arrangement Type [Axis] Deferred Revenue Arrangement Type [Axis] Deferred Revenue [Domain] Deferred Revenue [Domain] Deferred Revenue, Current Current deferred product revenues Deferred revenue, current portion The carrying amount of consideration received or receivable from related parties as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year including sales, license fees and royalties. Deferred Revenue Current, Related Parties Current deferred product revenues from related parties Deferred revenue from related parties Deferred Revenue, Noncurrent Deferred revenue, less current portion Non-current deferred revenues The carrying amount of consideration received or receivable from customers as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year relating to product sales. Deferred Revenue Product Current Current deferred product revenues Depreciation, Depletion and Amortization Depreciation and amortization Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Share-Based Plans Information on activity of the debt discount related to issuance of common stock warrants. Discount Related To Issuance Of Common Stock Warrants [Member] Discount Related To Issuance Of Common Stock Warrants [Member] Information on activity of the debt discount related to issuance of notes. Discount Related To Notes [Member] Discount Related to the $3,750,000 Notes [Member] Document And Entity Information [Abstract] Document And Entity Information [Abstract] Document And Entity Information [Abstract] Document Fiscal Period Focus Document Fiscal Period Focus Document Fiscal Year Focus Document Fiscal Year Focus Document Period End Date Document Period End Date Document Type Document Type Earnings Per Share, Basic and Diluted Basic and diluted net loss per common share Earnings Per Share, Policy [Policy Text Block] Net Loss Per Share Employee-related Liabilities, Current Accrued compensation Employee Stock Option [Member] Stock options outstanding [Member] Entity Central Index Key Entity Central Index Key Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Entity Filer Category Entity Filer Category Entity Incorporation, Date of Incorporation Date of incorporation Entity Registrant Name Entity Registrant Name Equity Component [Domain] Equity Component [Domain] The percentage of the value of common stock offered in sale of company or initial public offering used in determining the exercise price of warrants. Exercise price of warrants as percentage of common stock Exercise price of warrants as percentage of common stock Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Asset Class [Domain] Asset Class [Domain] Asset Class [Axis] Asset Class [Axis] Fair Value, Hierarchy [Axis] Fair Value, Hierarchy [Axis] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Fair Value Disclosures [Text Block] Fair Value Measurements Fair Value Inputs, Discount Rate Estimated market rate of interest Fair Value, Inputs, Level 1 [Member] Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Level 3 [Member] Fair Value Hierarchy [Domain] Fair Value Hierarchy [Domain] The estimated fair value of common stock warrants issued on date of issuance. Fair Value Of Additional Common Stock Warrants Issued Fair value of Additional Common Stock Warrants issued The fair value of common stock warrants on issue date. Fair Value Of Common Stock Warrants Issued Fair value of common stock warrants on issuance Fair Value Of Consideration Received [Abstract] Fair Value Of Consideration Received [Abstract] Consideration received The fair value of notes and warrants on issue date. Fair Value Of Notes And Warrants Issued Total fair value of notes and warrants issued The amount of the fair value of warrants recorded as a deferred financing cost. Fair Value of Warrants Recorded as Deferred Financing Cost Fair value of the Warrants at the date of issuance as deferred financing cost The fair value of common stock warrants issued recorded as a debt discount. Fair Value Warrants Debt Discount Debt discount Fixed Income Interest Rate [Member] Fixed rate debt [Member] Gain (Loss) on Disposition of Assets Loss (gain) on disposal of equipment Gains (Losses) on Extinguishment of Debt Gain on extinguishment of debt Gross Profit Gross profit Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest Loss before income taxes Income Statement [Abstract] Income Statement [Abstract] Income Tax Expense (Benefit) Income taxes Increase (Decrease) in Accounts Payable, Trade Accounts payable Increase (Decrease) in Accounts Receivable Accounts receivable Increase (Decrease) in Accounts Receivable, Related Parties Accounts receivable from related parties Increase (Decrease) in Accrued Liabilities Accrued and other liabilities Increase (Decrease) in Customer Advances Customer refund liabilities The increase (decrease) during the reporting period for the amount of cost of goods produced and sold that have been deferred as of balance sheet date for which revenue has not yet been recognized. Increase Decrease In Deferred Cost of Product Revenues Deferred cost of product revenues Increase (Decrease) in Deferred Revenue Deferred revenue The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue from related parties yet to be earned for with cash or other forms of consideration was received or recorded as a receivable. Increase Decrease in Deferred Revenue Related Parties Deferred revenue from related parties Increase (Decrease) in Inventories Inventories Increase (Decrease) in Operating Capital [Abstract] Net changes in operating assets and liabilities: Increase (Decrease) in Prepaid Expense and Other Assets Prepaid Expenses and other assets The increase or decrease in the percentage charged for amounts prepaid in excess of the statement amount in the loan agreement. Increase Decrease Percentage Of Prepayment Fee Decrease percentage of prepayment fee The length of time that the initial base rent is in effect. Initial Base Rent Term Initial base rent term The initial term of a leasing arrangement. Initial Term Of Lease Lease agreement period Interest Expense Interest expense Interest Paid Cash paid for interest, net of capitalized interest of $4 and $648 for the six months ended June 30, 2015 and 2014, respectively Interest Paid, Capitalized Cash paid for interest, net of capitalized interest EX-101.PRE 10 mbii-20150630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R39.htm IDEA: XBRL DOCUMENT

Debt - Activity Related to Secured Promissory Note (Parenthetical) (Detail)	Jun. 30, 2015 USD ($)
October 2012 and April 2013 Secured Promissory Notes [Member]
Debt Instrument [Line Items]
Promissory notes, issued	$ 3,750,000

EXCEL 12 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0````(`%%*:D^Q4T!0%<2K MTMWDT3N>>Y-QSJ:G=T^.PFAENCY,BS9&=\)8J%LR*I3649^4F?5&Q73KY\RI M>J'FQ,1DA&^7BE3&K!5AT;A/61EUEG_V,8G"?5A)8HFJX, M\:FCL,U_K;PZ7]!,/73Q1\8O[Z[TU`TUH=7NQ>IRE;J$]-NT2&KXEL/FPJ^2 M:9.'YOKYAQ7Y_I?/LO$2EZ:[\.I1;Q@L=S:F?"Z-TOVV43U:O[BW=O&?VX3R M4S74C)U/A3[J+;LD%=\D-;#4^D_>KSNEMIZ^99@+=_A1M,I3YRY+D.UY\-?1`#&TX[A,2/<@B0'!(D1P628Q\DQP%(CD.0'$<@.8Y!P902P,$%`````@`44IJ1TAU!>[%````*P(```L` M``!?.0Q M(OW[CMB`PD.MQ-*O>X^NO`ZIK`XTHO8<4M?'5$Q^#*G*_=ITJK$"2+8CCVG! MD4*>-BP>-9?20D0[8$NP+,L5R*V.V:SGVL7.U49V[M,41Y26M#;3"&>6X9MY M6&3I//B)]!=C;IK>TI;MR5/0!_ZS#0//>997'L=V+YRO+0O]C^AY%.!)T:'B M1?4C9@,2[2F]@OIZ`(4QOCLEFI2"(S>C@KN_V/P"4$L#!!0````(`%%*:D>[ MF$,ZMP$``*X:```:````>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'/%V<`94`*S=LU1MH8*`$^I/.&/7NK2P,_LP7%R3?IDW;Y,R[ M:)XTTT4;R_EC.%7IT+6Q/O1Q\M:JV$?TK)X[89CK$-( MT9U/&H+8!MX;@M`&[AR"V`;N'8+0!OX>BM0&_EZ*U`;R5] M:Z./;8[>"O16CMX*]%:.W@KT5H[>"O16CMX*]%:.W@KT5H[>"O16CMX&]#:. MW@;T-H[>!O0VTEX)VBSAZ&U`;^/H;4!OX^AM0&_CZ&U`;^/H;4!OX^AM0&_C MZ.V!WIZCMP=Z>X[>'NCM.7I[H+PZMBI[41EOW[73F&A32+"PWC!L<^YU_?[W+"%X=*`Z\F^Z,=N*A]S)*4RD8=4*K^$$PHZU>.G+[RD`.H_>` MP$#+,V"9$6X3]PI,>2M@9HQ*&*.O>$FEA0+U;S-@QCI)J=I$Q=.]4,_V5SK7 M$^J@S-H_**ROJ0&.3O>L[S8#YL<&XY2>.UY3M0)>QGX\W&KQ!,;Z2,_[9SW\ M[238[A>V@7*A5E,JC(V'N;O*@3EMWM*4NV.SQ#7S2;=/<[R?[9`%M>"7UYV< M&D&5ZQ`K_N!COU.X+7;#6J;6F?BW-L]V#>#L,-IMAF496UZ+B_AB$!"XVD=& MN\CB-]GVXO8[<^$DV)_+*37N/TD18MH*<3'HE*+?FB!4<7*K')8CN5.%*TQ> M69+=:JRQ+Y0%3G!EM10LE,#ZP(HD(\9TAFE5*S)%CPRG M6"7G.Q8H>:(R`_(`U&;&*^RJL7FPR1DSE=R)J`2YG:XCX=FK)F@L]=,Z*Q/@$``&D#```1````9&]C M4')O<',O8V]R92YX;6S-DTU/PS`,AO\*ZKU+LPD$4=<#($Y,0F((Q"TDWA;6 M?"CQU/7?DV5=RX!+;]SJVN_CUW%2"L>$]?#DK0./"L+%7M.UG=X M*7J\V_DZP:0@4(,&@X'0"259]6*VQC:F)(.^*J/CF@=<6*E6"N1M.Y3]3L7. M"%Z'HQQDWS[]_=-#RI"LJ]P'U5#],=N9O,*R[(?ZMXY/!M%U4 M6,/(W2:-3,M-GPDD(0BO'"IK1N$2YILXP<+NXQ,$C@=UPG39MM`VULM0I?LU M1(>7$U>VMKX]IGY$9Z^J^@)02P,$%`````@`44IJ1YE&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I M=MNTF83M3A^%$5B-;'EDD81_OTV23;J;/`0LZ?O.14?GZ#AY\^XN M8NB&B)3R> +]O6N[!3+UES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5 MRU2-9:,!$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$ MP&IG/U9KQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C M\7@XMLO2BW`A(5 MM>5`TR``6'!VULS2`Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*= MD`4.`#?$T4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7K;YH]5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5`9<8WS2J-2S% MUGB5P/&MG#P=$Q+-E`L&08:7)"82J3E^34@3_BNEVOZKR2.FJW" M$2M"/F(9-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)> M-T(^8LZ+D!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/ M)J<_Z3(T!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]': M-\*K^(+`.7\N?<^E[[GT/:'2MSAD6R4) MRU3393>*$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.WF)&Y"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A M[J&&F,_#0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@ M,5O&`RN0HGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'! M51W/55ORL+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4S MMA*7&+SCYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M#`DL6XA9$N)-7>W5YYN< MKGHB=OJ7=\%@\OUPR4TB42 M%(JP#`4A%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB M5,V[&KXF8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'YA,L0Z1^P7V*BH`1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW>`,?-2K M6J5D*Q$_2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+ MK#F-"F]!U4#E/]O4#6CV#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_`5!+ M`P04````"`!12FI'$GF8J$@"``#D"0``#0```'AL+W-T>6QE@%T\^9TY__?3BV$D@2YMU MI?ZBTZ.[YQZ=Y+/C!M:#`-PUD@"),XC64KY@(:E*M60H(O!PCY^%M5T`0_GG_\U2JX M^8#\>/;I["Q\O+C9Q\_=P@5&GN-;D>!H=H6#YY-.0OLPEF+TSP-_8] MZFM+'?1%2N-2R;%64^R!-&Z>T(IPXQ]9]UQQI1&8PS`:'"*)H-[CEG"6:6;! MD@C&UQZ>6L"=7^\GF%3:Y?89]O-,PC&3KK($A_WS_'39R.X&NSW&^>[V#)#& M-0&@6L[-!/7V8EV;S4DEJ1?I_(YX5YJLH^G55H`;3-Y,Z8+J(7.$-U`:*S4S#^UZ5_`%!+`P04 M````"`!12FI'7"*.`_,#``!Y#@``#P```'AL+W=O/`+A:J@BM;-368,.##X7C@0(N@K/%+M?+9FN8/H?F5`R']$B#4NH/50IGL M_3L_62@-#^`\@IE8K?X3-4RS7SIC6OAP+54`. M8*(*Z@GNQ7R:#3,FFF`_*AW`78D`GYQM5LH\(BMC"^5\F,7NMF_6RJA:_8EQ MXY5?VN?/UJD_U@2A9Y6S6K>MXH.V$7[!_[V#,095]5X,8GX71V*:C8<(?%)> MS956X?IB;&@"_?R/;# M;J+PQ-W(O$L5!7VP1H+Q(!F>>:N5Q*Q(=BFT,!4P`N($Q(\%%014$%!Q,&@6 M\(!=)J"2@,IC02,"&A'0Z%C0F(#&!#0^%G1*0*<$='HLZ(R`S@CH["5HUM2U M<+^97;#+QBL#WK]IG?JB?C9*$M`Y`9TG0.K1*"P^`IV\J"K;H)/FD=UB;)4" M3X4<4B.'+U$?A7+L0>@&V%<0OG%QV$,/T9,Z8?6-><(F^+?VOTP5SA,.8^"N M@=AYT?Z96\VIN'G"W"N8!_H^]3-/"#I;"@< M^LM3_NY%T8K*JKULH"AJY&P?8UZD>]VF<9>412UO4C8OD;%&5]) M!1%;2\3MK^8)'=WD-I> M%NN-P;^]`&Z'L`C+N%/R[6=PJU'%[1,>NJ5..8IS9;S^BENJ:1;W/;C%:;3^ M@/>^F2]6M+N#CKS9,+W_'U!+`P04````"`!12FI'("&\G$P"``#T!P``&``` M`'AL+W=O,>B."_W^^`P(GZ[AXDP5CRGNOJT9N M_$*I]CD(Y+%@-95/O&6-_G+FHJ9*=\4ED*U@]&1-=17@,$R"FI:-GV=V[$7D M&;^JJFS8B_#DM:ZI^+=C%>\V/O*'@=?R4B@S$.19,/I.98^(D5C%[Y)U\N[=,\D?.'\SG9^GC1^:'%C%CLJ$H+JYL3VK*A-)D__V03^8 MQGC_/D3_;J>KTS]0R?:\^E.>5*&S#7WOQ,[T6JE7WOU@_1QB$_#(*VF?WO$J M%:\'B^_5]!W:LK%M!U](U-OIUL3&%7*L]N>9@%-Q/F08&M8@<*-"H"'=L)P+[+ MCJT=?PW8@R*:!T2/`!C<1M9.YNWDT4[`3JP]=N4'BATHDGE`[`3$UKZ:`(`B MG0L)`"A0.$]8.0DK\*-'1&,E,2!`@D,4ST-2)R0%B'.G)`#I)0NV MRMJ)6(.?3"Q5+UDP"Q0Z&7981T@F((-FM8""W)3^5*83OV30$(*2]8(U0]B- M@O.)IC98K\$+=AB*W!0XQAA-47H-7D!Q'W8$9QE'7R_;?M`0DI`X_@2M]U=L;^SJHO_07EPS_G-JN[H8QL/N*>PO MG2N.T.^_9YJ,K&?>V"_KFNB^Y7YJKV>K\3N^7$ MM_+I/$PGPL,^7,L=R]HU?=DV0>=.][N/XBY7>D)FXGOIKOW-[V`*_]"V/Z:# M?X[WNVC*X"KW.$Q5%./7B\M=54TUC5?^#RO]_YI3P=O?2^V?Y^:.\1^*WN5M M]6]Y',YCVF@7'-VI>*Z&;^WU;X=M,%.%CVW5SY_!XW,_M/529!?4Q4_X+IOY M^PK_)!$6HPM(+"#7`D*S!1064&\*A)!L;M>G8B@.^ZZ]!OVEF$9;W(UX-U4R MUAR,C>G'?IKK[.:>.NQ?#E+OPY>IGE>(G)$,D6TB1\*L2#A>GPPA7X>`DQ\E ME(_?+Z]>E]=07D%Y^SIB,R,6&@&(D"*-MZD<*&7438=L9M%D%@U9$NHJ!K(` M(A)#1@$H)Z#-)(9,8B!)RB19$".8)``)F]CWD\1DDABZ-6*2`"*B.")'$:,@ M)6/M,3Z6S&(A"]/@#!!A4BX*0C;UZ)6$3))`$LDD2;!7!#.=$Y1VVDDG09!,E7C40"M3@.L4Y\R%D1';(*!,HH5'&EJ;`G2G.6\B M$VOZN;:D04I)GS2T.`483W/F1$;&ANT;I)+8)PTM3P'6XR95AHRTG#T1BKWN M25J?`K2G.7\B,ZJTIP7F: MLRD1'\U%F7KQY9:!=+,"@W)3)D4IVP$P>I./98 MJTG:Q1(,:C@7(V,-.TP`)=HG"VUB"?ZD!P#W.\CH**(7;+CA63!UNP78SD.[ M6";XC*>VB!KS(*.VF?Q/9CO)&Q,O&\EE`>JQDZ3MJ=X*B_:E`>X:TT3)[-+\B7F:0WEP1ASB[%D_M2=$]ETP5.XT3#_MU&YXNP4' M0WM97M:M;PP/OP%02P,$%`````@`44IJ1Q6\1$&_:3AHJ=*+\6!R%$`K:VI9R0*@HSTM!O\LK![SZ(L^%&Q;H!G MX">,VG_O?U1*MZ?+;[7TW<Z1`R4A?`G2=57E M4JVRI$Z6%%D25Y446=+YLP7X6U=6:\I5ILS)E"&3L_.9"251DF3I;:05X2I1 M[B3*D2B[093_+]&*$(G(Q>$K.N+FUQ/+EO==!L@MPO_*6]<4A4_CKOVT$7+ M5L'.O>27HOU>7?]RJ$'W#I^KHAG^!\^7IJW*T605E/EO^#R>AL\K_&(8FOD- M!!J(R6`:QV\@T4"^&2C20*&!6CJ"1@/]:800M`^92_,VWZSKZAHTY[R?3_RA MP^O>2>3V3#EQS`EY$H.]C&[;:\^VBNP5V#//X9X&I`8 M,@&(9):`$H"$B>-Y*`5(F4C/0QE"5BXHG?9JTJ!)^`8!NRT@1LXC"2#:*QJ0 M%!`>1?-,!HR-;HN)O&(B$$-$N@6$DVJ`$8P(-05&&B)Q&3"&+RA.[-43@QY% MZ`%$2NV=2R@((2X)3RE`6G$B-1E"1IK;FHQ7DP%-WEF-F@`1UA+A)@C%G)IT M!I\/2Y4)("6**S:5BKXB53 M4_L?6^S58H$'?POET^SW-]+N<'5C-*&[8WJIM+.CJB.L_HJ%L; M%HCR-U,.[;5)J"M&F(EV"+3 MY=!2A4W>./H=:.2$,);(5C9QG(D%;^#"W_8%-EBJ[2-#%"6YC:2WD>P/9%Z- MO]4+Z*G&FS?<\B$S7R_<];UQ,_7"C=_(S=8+]WX3M[!>_H8OH*]:;QHM*@3F MCMTKKT"+`B=,>Q\DB_HFS$K[X6_>*!N-^/V2MW3A;_\">JQ_;S[.3=R<*^7? M>(_S$S$64SN9=)FW;/+&]>>Y&KX[%"I=O1^.XYK@N;J<6CCGF.Y.1WY?1'^H M].G^EC\DW',_Y0\9'.B]N=^LS_G>_9/7^^.I"9ZJMJW*X<3II:I:UT7$ASKP45;G<=3RNFH=/,_4$L#!!0````(`%%*:D<6]*A9 M]P$``&@%```8````>&PO=V]R:W-H965T&ULC53);MLP$/T5 M0A\0:K,3&[*`>`G20X$@A_9,RV-)"!>5I*WT[\M%EI=(3B\F.7KOS>-P/%DK MY(>J`#3Z9)2K15!IW9)Z)@Z8UAS>)U($Q(O\N@8IV$43!*?!>EY6V`9QGN.?M:@9I< M06('67K(]&DSV MV?!%'S&0I?L'*U2(`]>^-'VT'Q+/L>W#F_@RFJ^B@?C:#!4_`\[R>=:0$GX2 M6=9_V!PE[;[:.MN9\$_J!%)3EH0H\,5H+1=>J50SAU`6)6%8OO"&U/K-C@N& ME3Z*/92-('AK28S"T/<19+BJO2RUMC>1I?R@:%63-P'D@3$L_BX)Y>W""[R3 MX;W:E\H88);"GK>M&*EEQ6L@R&[AO0;S-3(("_A=D59>[(&)?;9I2%>[D_JWVVV.OH-EB3G]*/:JE('ZWM@ M2W;X0-4[;W^0+H78"!:<2OL$Q4$JSDX4#S#\Y=:JMFOKWB1^1QLFA!TA[`F] MGV'"I"-,SH3H+B'J"-&S'N*.$-]X@"YW6[D55CA+!6^!;+#YG(*YA@LCHI6! M+I?4G;":PO8B2X_9+$[AT>A<04(+63H(2L8A*P<)>@34_@>#"+TA#Z&EA^,. MR9T>H>=ZA)[K$7JN1VB\1_#BOV=$[.W$E:#@AUJY3[FW M]D/]-31SX\:^#.9Y,&!?Z4O`S>RS?)8V>$]^8;&O:@DV7.EI98?*CG-%=,3^ MBRYSJ:^I_D#)3IGMU-3?36YW4+PYW4/]99C]`U!+`P04````"`!12FI'0)!B M[N\$```&&P``&````'AL+W=O]BJJ3GLGDFLQ*X!XP4RGOWW"ZA%/J;3TB6VR:O6 MVPT\^MI>V^Y[?[1V6/ULZG-_NSX.P^5FL^D?C[:I^B_MQ9['_SRU75,-X\_N M>=-?.EL=YD9-O8$TS3=-=3JO=]OYVM=NMVU?AOITME^[5?_2-%7WW[VMV^OM M6JW]A6^GY^,P7=CLMINEW>'4V'-_:L^KSC[=KN_4S5X7DV16_'VRU_[-]]5D M_J%MOT\__CSJF';^WU#TLY9%/`Q[;NY[^KQY=^:!O?9+UJ MJI_N\W2>/Z_N/R:E9GP#H`:P-%CZX1L@-<#7!GK.U#F;\_JM&JK=MFNOJ_Y2 M37=;W8SR;@HR1EZ-R?1CG>:8W5RIW?;'KBRWFQ]3G'<2F"7W3J(6Q68,SO8` M:ZXYS,WA\P[V3I&7X1[P?0_NXATZ@VD:#J#?!]`N@)X#F`]%.,^2PF7A)`F` M*J5+(TQA/&9M41DE%U#UGD\HI`'!>,Y<5:8JT^"0GI]O[6$9% M952PA@H*@H(AITDPD_TXF"BGO)%?*F/+N,Y`K#1782K3#.#<]!IF)QZMR4$3Q MWA5^&'N?/V.*HF'DO>,AJXBR2AJ$2`00LN1TB8FM$\]91:!5TCA$H@2+`&I] MM**(\@0\:\$Q4DME(DV"!F1+BQ#CZ@2*]^20JZ4RD2:!0)5(IXR)M,0C'(!N MG31H@R=SBF4>L`4+#3!N+@'\#!0(XRJ+",&S%XB]2AIN290H+$T@-5*6&B(S MX^D+GKZ%9,N)`N,!J6*\\-0%3UUIL"21:,0#MXRK#,];H/FLDH!+(M$-Q4&= M1S*$9RT0:T$:)TDT/4`J<+<,#2=EY"M;\F\&\1$BUC'(PQ%I`@D2'3$\$27) MF%$6=^.1!R,2S$`B(XE$/[3VSB%N584\%)&@"!(4223:<1*=F[C'$/D9+1(* M05K'8'A&2Y(DW@_/522N@L15]%PM`V/K(L1(4SQ5D:@*$E71SU65_FS+P;O* M_&(D\L'F^8K$5Y#XBF&^HN>KB5RA(T]8)#**2S8,$];'49$+8N0!B\;/YR4[ M)FS'2;*XF37RLU@DKJ*T`B'1^+3J`.U)J;-,Q3W8FF>U)E:CQ&H2)8`?[LBO MODB*J(JX1TGSS-;$;)2832+,$`*K?U*"'@L69XMGMP8_]DNV/.!5:#Y+RJS( M(Y=MFI_.:F(X1DQG]2=;JH1=E+#K16D>`!P)R\@--LUOJ6JB+D9L(FD>D=JO MZ25$>E%@+"&901V7%`])[:>/XNZU$Q7FLRFZW[MVNEPSFUJ;-\<+C>V>YV.7 M?O78OIP'M_>_7%V.=NY@.I[XW>S=`W^!U!+`P04 M````"`!12FI'Y6[/CLGW/FC.TA'Y5^-QV`11^"2[/!G;7]FA!3=2"HN5,]2+?3*"VH=4O= M$M-KH'4@"4[2)%D109G$11YB+[K(U6`YD_"BD1F$H/K?#K@:-WB!CX%7UG;6 M!TB1DYE7,P'2,"61AF:#MXMUF7E$`+PQ&,W9''GO>Z7>_>*YWN#$6P`.E?4* MU`T'*(%S+^02_YTT3RD]\7Q^5/\5JG7N]]1`J?@?5MO.F4TPJJ&A`[>O:GR" MJ81[+U@I;L(758.Q2API&`GZ$43*O)#L>V*;^8J_B.]$(N9,H@$``+$#```8````>&PO=V]R M:W-H965T&ULA5/;;J,P$/T5RQ]0$R"[5420FE;5[L-*51]V MGQT8P*K-4-N$[M_7%Z!)%;4O>&8XY\P97XH)]8OI`"QY4[(W>]I9.^P8,U4' MBIL;'*!W?QK4BEN7ZI:900.O`TE)EB;)#Z:XZ&E9A-J3+@L;NA2>!9M9WV!E05;>;50T!N!/='0[.G=9G?(/2(`_@J8S%E,O/Q&G3)PWX\8.FCH,7A:GHZ>!GGY/SR[I6728S0[S[P7R2X$\"N1?C1@QAP6S M_=2$G>VI`MV&JV-(A6-OXY:NU?5VWJ7A3#[@93'P%OYPW8K>D"-:=[+A`!I$ M"ZY]2#K*RW?`5!+`P04````"`!12FI' MCJC4(Z,!``"Q`P``&0```'AL+W=OP)%W);7=T]ZY8<>8K7M0W-[@`-K_:=$H[GQJ.F8'`[R))"59 MGF5W3'&A:57&VK.I2AR=%!J>#;&C4MS\/8#$:4\W="F\B*YWH<"JDJV\1BC0 M5J`F!MH]?=CL#D5`1,!O`9,]BTGP?D1\#&D6;W[GC56EP(G;@X>PV M.P\W0<0K$^_-^K&CIHF#5^6IVA1W)3L%H0M,(AYFS(I@7OUJBYQ>H^>1GG]- MWU[2M\GA=G98?"U07`H42:#XWX@)'4LJ7'4+FWI6EUO MYT,\1/8!K\J!=_"+FTYH2X[H_,G&`V@1'?CVVQ25P)$W);7=T=ZY8#+&C M4MS\VX/$:4=7]%1X%EWO0H%5)5MXC5"@K4!-#+0[>K_:[HN`B(`7`9,]BTGP M?D!\#S8`$DU"XH<+\[,9)0VT?)3N&:='F$?8!,$:I8U?4H_6H3I1*%'\+:U"QW5*?];%3+M. MR&="OA#NLF@\-8HV?W#'J]+@1.S`P]FMMAYN@HA7)MZ;]6-'31,'K\ICM2KN M2G8,0A>81-S/F`7!O/K5%CF]1L\C/?^:OKZDKY/#]>SP^]<"Q:5`D02*_XV8 M,/L9L\D^-6%G>ZK`=/'J6%+CJ%W:TJ6ZW,[[/)[)![PJ!][!;VXZH2TYH/,G M&P^@173@VV&UL MC5/;3N,P$/T5RQ^`T[1=H$HC4=!J]P$)\0#/;C))+&Q/L)V&_?OU)0TMJMA] MB6#+$#DIQ\V<'$L%P9'8 MGH>S6VP\W`01KTR\-^O'CIHF#EX6AW*1W1;L$(3.,(FXFS`S@GGUBRUR>HF> M1WK^;_KRG+Y,#I>I^_H_^J_.!59)8/7=B`FSFS#KKR[9R9XJ,&V\.I94.&B7 MMG2NSK?S+AXB^X271<];>.2F%=J2/3I_LO$`&D0'OGUVM::D\^]G3B0T+H37 M/C;I2J7$87]\(/,K+?\"4$L#!!0````(`%%*:D<#WQ[@H@$``+$#```9```` M>&PO=V]R:W-H965T`DBHK%?@;CG!/4CIA5SC]UGSLZ4GGL>+^D.8UKD_ M<@/W*/^(VG;.;$))#0T?I7W%Z1'F$;9>L$)IPI=4H[&H%@HEBG_$5?1AG>*? M+)MIUPGI3$A7PL\D&(^-@LU?W/*RT#@1,W!_=IN=@VLOXI2)\V;COOTG`FG_"R&'@+SURWHC?D MB-:=;#B`!M&":Y_<;"GIW/M9$PF-]>$/%^MXI6)B<5@>R/I*RW]02P,$%``` M``@`44IJ1]3.ZP.C`0``L0,``!D```!X;"]W;W)K&ULA5/+;MLP$/P5@A\0RK(=!X8L($Y0M(<"00[MF996$A&2JY"4E?Y]^9`4 MNS":B[B[FIF=Y:,8T;S9#L"1#R6U/=#.N7[/F*TZ4-S>80_:_VG0*.Y\:EIF M>P.\CB0E69YE]TQQH6E9Q-J+*0LQ&3X/V$^!:2'_6!9L$"2*A<4.!^ M.<,32!F$?./W2?.S92!>QK/ZMSBM=W_B%IY0_A:UZ[S9C)(:&CY(]XKC=YA& MV`;!"J6-7U(-UJ&:*90H_I%6H>,ZIC_Y;J+=)N03(5\(#UDTGAI%F\_<\;(P M.!+;\W!VJ[V'FR#BE8GW9OW84=/$P)\R"8%[]9HN< MWJ+GD9Y_35]?T]?)X7IRN/M:8',ML$D"F_^-F##'&?/P3Q-VL:<*3!NOCB45 M#MJE+5VJR^U\S..9?,++HN&ULA5/+;MLP$/P5@A\0RK+LM(8L M($Y0M(<"00[MF996$A&2JY"4E?Y]^9`5NS":B[B[FIF=Y:.N6''F*U[4-S>X0#:_VG1*.Y\:CIF!P.\B20E69YE6Z:XT+0J8^W95"6. M3@H-SX;842EN_AQ`XK2G*WHNO(BN=Z'`JI(MO$8HT%:@)@;:/7U8[0Y%0$3` M+P&3O8A)\'Y$?`W)CV9/LV`!)-0N*'"_G.`1I`Q"OO';K/G1,A`OX[/ZMSBM M=W_D%AY1_A:-Z[W9C)(&6CY*]X+3=YA'V`3!&J6-7U*/UJ$Z4RA1_#VM0L=U M2G_NBYEVFY#/A'PA?,FB\=0HVGSBCE>EP8G8@8>S6^T\W`01KTR\-^O'CIHF M#EZ5IVJU^5JR4Q"ZPB3B8<8L".;5;[;(Z2UZ'NGYY_3U-7V='*Y3]VWVN4!Q M+5`D@>)_(R;,8<9L_QV27>RI`M/%JV-)C:-V:4N7ZG(['_)X)A_PJAQX!S^Y MZ82VY(C.GVP\@!;1@6^?W6THZ?W[61()K0OAO8]-NE(I<3B<'\CR2JN_4$L# M!!0````(`%%*:D<)Y[UVHP$``+$#```9````>&PO=V]R:W-H965T6CG-"\VA[`D7U#9?=,<:%I5<;:LZE*')T4&IX-L:-2W/PY@L3I0#=T*;R( MKG>AP*J2K;Q&*-!6H"8&V@-]V.R/14!$P"\!D[V(2?!^0GP-R8_F0+-@`234 M+BAPOYSA$:0,0K[QVZSYT3(0+^-%_5N;$9)`RT?I7O! MZ3O,(^R"8(W2QB^I1^M0+11*%']/J]!QG=*?73[3;A/RF9"OA*]9-)X:19M/ MW/&J-#@1._!P=IN]AYL@XI6)]V;]V%'3Q,&K\EQM[O.2G8/0%281CS-F13"O M?K-%3F_1\TC//Z=OK^G;Y'`[.]Q^+E!<"Q1)H/C?B`ES7##%/TW8Q9XJ,%V\ M.I;4.&J7MG2MKK?S(1XB^X!7Y<`[^,E-)[0E)W3^9.,!M(@.?/OL;D=)[]_/ MFDAH70B_^-BD*Y42A\/R0-976OT%4$L#!!0````(`%%*:D=P^;&?HP$``+$# M```9````>&PO=V]R:W-H965TZ:EE42$Y"HD9:5_7SXDQ2Z,YB+NKF9F9_DH1C1OM@-P MY$-);0^TZ(K.A5?1=BX46%FPA5<+!=H*U,1`Y/W,(3RM^B=ITWFU%20\,'Z5YQ_`[3"-L@6*&T\4NJP3I4,X42Q3_2 M*G1PTT0\[-^ M[*AIXN!E<2Y7NVW!SD'H"I.(QPFS()A7O]DBI[?H>:3G7]/7U_1U'.Z^ M%MA<"VR2P.9_(R;,<<;<_].$7>RI`M/&JV-)A8-V:4N7ZG(['_-X)I_PLNAY M"S^Y:86VY(3.GVP\@`;1@6^?W6TIZ?S[61()C0OAO8]-NE(I<=C/#V1YI>5? M4$L#!!0````(`%%*:D>]9$[.I`$``+$#```9````>&PO=V]R:W-H965TLV(717,3=U#/$#DIQ\V<+$L<-7=!3 MX5VTG0L%5A9LYM5"@;8"-3'0;.C38KU=!40$_!(PVK.8!.][Q$-(?M0;F@4+ M(*%R08'[Y0@[D#((^<8?D^97RT`\CT_J+W%:[W[/+>Q0_A:UZ[S9C)(:&CY( M]X[C*TPCW`;!"J6-7U(-UJ$Z42A1_#.M0L=U3'_RQXEVG9!/A'PF/&31>&H4 M;3YSQ\O"X$ALS\/9+=8>;H*(5R;>F_5C1TT3!R^+8[FX>RC8,0A=8!)Q.V%F M!//J5UOD]!H]C_3\>_KRDKY,#I>3P\?O!5:7`JLDL/K?B`FSG3#WV3]-V-F> M*C!MO#J65#AHE[9TKLZW\RF/9_(%+XN>M_"3FU9H2_;H_,G&`V@0'?CVVQ25=W3^5T?J.0/E+ZKP<_3+HA4#KC#1Z$LD&QN^`5W MG7*2Y+_6]).I`N_[SOV[7JY,_X`X?J'=G_8D&IEM%(`3/J-K)][H^`/;->@, MC[3C^A<MZ-YDB8VS!\0VX!X"B@BG;@!Z32_(8'JBM$1 M\`&IS8-;*6?*1#H#F1N7R]:>3"^\KFXUS&$5WI31@\8$[JUF4H32W8N(`U]X MK,/CY?#D,3PQ&2:&GJ;+!NFC06H,4KO$V+=$H]D[3;(,R;R0S!JD,Q"GR98A M&R]D8PTV,Q"GR926X-B!N(TY3*D\$(*8U!$,Q"G6?'BE5Y(:0WF-MYI M5FP\C+P4/2TMHG(&XT3%BK<80C_''L,BF^,XT68%)_9S8FN1SW&["+V?_-BLIH!<=__*$]VZ6WQ#F.$ZTH4]!?`:`]WF4RQW&BK^]!>%>\"687 M?4=Q<*377IC:/LH" MT,B;>AIT^"Q4-Y=]9NXN,Q!T<%?Q]#U0_P=02P,$%`````@`44IJ1Q$]X9"G M`0``L0,``!D```!X;"]W;W)K&ULA5/+;MLP$/P5 M@A\0RK*N6'/F*U[4-S>X0#:_VG1*.Y\:CIF!P.\B20E69YE]TQQ MH6E5QMJSJ4HQHOZ]SBM=W_B%IY0_A&-Z[W9C)(&6CY*]X+3#YA'V`7!&J6-7U*/UJ%: M*)0H_I96H>,ZI3^[?*;=)N0S(5\)7[)H/#6*-K]QQZO2X$3LP,/9;?8>;H*( M5R;>F_5C1TT3!Z_*<[7YNBO9.0A=81+Q.&-6!//J-UOD]!8]C_3\<_KVFKY- M#K>I>U%\+E!<"Q1)H)A'O+\U8L(<%\S#AR;L8D\5F"Y>'4MJ'+5+6[I6U]OY M&`^1O<.KU>UJ`$``+$#```9````>&PO=V]R M:W-H965T==TS`X&>!-)2K(\RQZ8XD+3JHRQ%U.5.#HI-+P88D>E MN/E[!(G3@6[H$G@57>]"@%4E6WF-4*"M0$T,M`?ZM-D?BX"(@%\")GMADU#[ M"?$M.#^:`\U""2"A=D&!^^,,SR!E$/*)_\R:'RD#\=)>U+_%;GWU)V[A&>5O MT;C>%YM1TD#+1^E>.7U*-UJ!8*)8J_IU/H>$[IS\-"NTW( M9T*^$AZS6'A*%,O\RAVO2H,3L0,/L]OL/=P$$:],?&W6MQTU36R\*L_59O=8 MLG,0NL(DXG'&K`CFU6^FR.DM>A[I^>?T[35]FRK99]8HH+3:LRUEY,5>+HI-#P8H@=E>+F]Q$D3@>ZH4OA572]"P56 ME6SE-4*!M@(U,=`>Z.-F?]P&1`3\%##9JYB$WD^(;R'YWAQH%EH`";4+"MPO M9W@"*8.0-WZ?-2^6@7@=+^K/<5K?_8E;>$+Y2S2N]\UFE#30\E&Z5YR^P3S" M+@C6*&W\DGJT#M5"H43QC[0*'=GBU;&D MQE&[M*5K=;V=C_$0V05>E0/OX`&PO=V]R:W-H965TS75V;8E3ZTW0`%GT)+LT! M=];V>T),U8&@YD[U(-U)H[2@UBUU2TRO@=:!)#A)DV1'!&42ET78>]5EH0;+ MF817C,`;/&^\L;:S?H.4!5EX-1,@#5,2:6@.^'&S/^8>$0#O M#$9S,4<^^TFI3[]XK@\X\1&`0V6]`G7#&9Z`FI[]UF[^#:BSAEY+(95W;0U*'P MLCB7:9(5Y.R%KC"1>(R8S8(@3GW5(L5K]#1:W*9OK^G;F'`;W?/LMD!V+9!% M@6PJ,5\K,6*.,V9WVR1?-<>Z;+@T%@_O7=S'>]M M7%C5SZ]P^164?P%02P,$%`````@`44IJ1U87^9^_`0``>P0``!D```!X;"]W M;W)K&ULC51;;YLP%/XKEG]`#22D6T20FD[3]C"I MZL/V[,`!K/K";!.Z?S]?@"85:OJ"C^WO$ MF*H#0#43(`U3$FEH#O@AW1]W'A$`OQF,YB)& M/O>34B]^\[,^X,2G`!PJZQ6H6\[P")Q[(6?\=])\L_3$RWA6_QZJ==F?J(%' MQ?^PVG8NV02C&AHZH.714];^$5URZ1!)V5=CX96:I2RX.R3NQRCSKT$RX9# M8WUX[V(=AR-NK.KG45_>F_(_4$L#!!0````(`%%*:D&PO=V]R:W-H965TLX[*&WY@O?YGRT5'E6Z*72(/@M&-%75M@@#(DHXV?5Q7 MMN])U!4_JK;IV9.(Y+'KJ/A[SUI^6L0P'CJ>F]U>F8ZDKI)1MVDZULN&]Y%@ MVT5\!V]7$!G$$K\:=I)G]Y$)_\+YJVG\V"QB8#*PEJV5L:#Z\L:6K&V-DZ[\ MQYM^U#3"\_O!?66'J^._4,F6O/W=;-1>IP5QM&%;>FS5,S]]9WX,Q!BN>2OM M;[0^2L6[01)''7UWUZ:WUY/[)R^]+"Q`7H!&P5@G+$B](!T%!9@58"_`'Q7P MK(!X`;E6D'E!]D60N,FR4_U`%:TKP4^1/%#S`,);C0MCHITC/;]2+YWU%';Q MZNJM1C"KDC=C](E!EKD?F'R:63H&CD2B$P1CH#A4`OD2Q4P)STP3#YX@T\BC M0[)R&ED-6(KFKX9!OL$`YS@$`T^C#@)*RP,4Y.IDJ"Z;*W'-$LIE8V3#TM)@(15RH M`4Q!>E6D/!@I'UQF5F-@\.4B1;!(X0W(S+@]@_/K)K@,%BJ=R=RR.P3J'9#- M+[H#4Y(B/`L^EOY9R\PZS(`KGPYC0JX:(P3!0=IN,YW9%18PN(DAO'X70Q1. MX=\D#_(2=G[_2.B9T]?F6TYL=>N5?ZV#L>\7?VA$\^\+HZT!W[ M2<6NZ67TPI4^6>P!L.5<,1T"W.@-L]&PO=V]R:W-H965T M?M&_`Q594^&.>FDE"?C__CY??"^E[5/YNS4JWWJ\C+YF5Q;MOKRO>; M_5D56?.ENJJR^\^QJHNL[7[6)[^YUBH[#(6*W&>$!'Z17T?^)NU/Y8[7`I5-I>J]&IU?%E\ MI:N=&)"!^.>B[LV'[UXO_K6J?O8__CZ\+$BO0>5JW_8ALN[C3<4JS_M(76++R#.F:WO/U1W?]2D(/L`^ZK MO!G^>OM;TU:%*;+PBNR7_KR4P^==_R`%.!3@[P6$M8"` M`L)5DH0"TK6&``H$#P5\W5A#4R=9FVW6=77WFFO6#T"ZZO"Z#])%]KKV;;JN M&V+60^=MUF\;QJ*U_]8'^L2P@=EJ)K`@B4;H2/B=`%0%6V`U,*UBNH)8$\'2 MHF$V2#H?9`=!Y'PF_',F7+@7!N&2;`A%/M"*-D#@/9 M&@L"-]5+5/425(OI&;0UC)QF8L,$EIEHF'":2?^,,YD0)6A&P^,^1&3I"(`L MG1#/(PD@H9P:7YI+_P@UG1/%9Q%%_!J03UUK;7$"?AW/C2 MH"!2SJ2IP8!&RYD1IL&(2+>5D^+K/0T@370),FD"-"G>V!]P9$J[\4#-R6#* M3XP'`D-`QW@!L[8DX3FN-VQ,T.QM+;L8$"RU1* M$6A:#.XNW-PQ6#;&,4!S]Q`ISDU+PB\B>&0[3)D.BYPZ+'JNPW#OXV8GY.`S M@J#C6!#W<2SP,[2@9C]FNRPTT./^TO]P7URH^C1<[3?>OKJ5K;[>')^.KP^^ MLOZ^^>'YEJYBBCQ/Z"K5+P?>PV_6U^RDOF7UZ5(VWFO5ME4Q7$8?JZI5G5[R MI1LY9Y4=QA^Y.K;]U[`?4OH5@?[15E?SQF-\[;+Y#5!+`P04````"`!12FI' M&FK#[K.;.`DJX"QVFN[?K_&%I-4$W)>`S3G' M,X>Q,Q07UKWQ(Z7"^VCJEB_\HQ"G>1#P[9$VA#^P$VWEDSWK&B+DL#L$_-11 MLE.DI@YP&*9!0ZK6+PLU]]R5!3N+NFKI<^?Q<].0[M^2UNRR\)%O)UZJPU'T M$T%9!`-O5S6TY15KO8[N%_XCFF]PU$,4XG=%+_SFWNN#?V7LK1_\W"W\L(^! MUG0K>@DB+^]T1>NZ5Y(K_S6BUS5[XNV]5=^H=&7XKX33%:O_5#MQE-&&OK>C M>W*NQ0N[_*`FAZ07W+*:JU]O>^:"-9;B>PWYT->J5=>+?I*'A@83L"'@@3"L M`Q,B0XBNA'B4$!M"[+I"8@B)ZPJI(:170JK,UV8IJ]=$D++HV,7C)](7()I+ M>->+2&5/^LOEJU.:G7IY9?%>XC0I@O=>Z!,&*\Q28]+\/F2M(>@^8F,72@=, M((,$(\4^%`76`O>76&E$.AN)T.JE_FWI:=6Z'[@6%VZ,D?<=_$?9E?HOD* M`?-K-'_2'?=5OBQ.Y$!_D>Y0M=Q[94*VCJK#VS,FJ(PW?)`]YE%^90R#FNY% M?YO)^T[WW7H@V,E^1@S?,N5_4$L#!!0````(`%%*:D>@-^.&PO=V]R:W-H965T*VSOL0?N3!HWBSH>F9;8WP.M(4I+E67;/%!>:ED7,O9BR MP,%)H>'%$#LHQ![?:!9L``2*A<4N%_.\`Q2!B%?^/>D^5$R$*_W%_6O ML5OO_L0M/*/\)6K7>;,9)34T?)#N%<=O,+40'58H;?R2:K`.U85"B>+O:14Z MKF,ZV643;9F03X1\)J0Z+!6*-K]PQ\O"X$ALS\/L5GL/-T'$*Q/OS?JVHZ:) MC9?%N$V8U(YA77RR1TR5ZGDI\3E_?TC?)X7IRN/M<8',K ML$X"FR1P_Q\"VT4'VR2P>5SZ1PESG#"[QW^*L*NA*#!MO'N65#AHEV8R9^?K M_93'H7[`RZ+G+?S@IA7:DA,Z?S7B!!M$![Y\=K>EI/,/<`XD-"YL'_S>I#N9 M`H?]Y87-S[S\"U!+`P04````"`!12FI'I`B2BP4"``#7!@``&0```'AL+W=O M)_7C!ATSJ$X7'BK=]U4D^`J@2GNJ:G>!`]&P*.VW7X#%!)G_4##;QA[UX/OS3J,-`,F>"NU!5+-`=>8$.VDOOS;F?[[IBX\[Q_=OYKE M*OP-$KAFY%??R$[11F'0X!;MB7QCTS?LUI!IPRTCPCR#[5Y(1H\E84#1AVW[ MP;23?;.(7)F_('8%\:D`IG<+$E>07!4`2V;6]05)5)6<38$8D?[;<*7D7)LH MYT`M1JB)+"COY'#L* M^-@@N31(K4'B#*X@!Z,I[#*L)BG2Y6U1;44P+=+\,4OJ94D=2_+8(/.FD-PLM2.);TL<'"F\9B?AI++\%R1AI6$]V)XEIQ M$P)&7@HSK3%F;!((O4E`.#\*&/LIXAD;Q8F\:;AM\DEB0<#9$32B'?Z!^*X? M1+!A4IUFYM!I&9-8641/*MA.W3*G`<&MU-U")V[/73N0;#Q>(Z>[K/H+4$L# M!!0````(`%%*:D>M>J/B"`(``%X&```9````>&PO=V]R:W-H965TT20&JI1^S!2U8>99R>8@&HP8SNA\_?C M+9FDHM`7O'#O]?&"*2;&WT5+B/0^>CJ(K=]*.6X`$(>6]%@\L)$,ZDW#>(^E M:O(C$",GN#:FG@($80)ZW`U^69B^5UX6["1I-Y!7[HE3WV/^=TNM# MC4`H.4B=@%5Q)A6A5`>I@?^XS/]#:N-M_9+^P\Q6T>^Q(!6CO[M:M@H6^EY- M&GRB\HU-S\1-(=:!!T:%>7J'DY"LOUA\K\FHQ0ZV0RN5FILCB7*$\* M<-9!=QID-#NG^5I1.45\E0`%,$N![BELYR-R%.EZ0'@?$-F`T`5D]Y"#T:1V M&E83IW!!5#E1DJ-UE&@6)7(H^=PHL46QFCQ(OM945A,$,5PGB6=)8I,00KA` MXC0)#!90K"@.TVP=)9E%21S*PB@[JPE@`M,%%J="212MPZ2S,*F#^<869[/' M-?O^<R;5K6(^_H8Q M250&?%`+VZK+_MJ@I)&ZFNH5M_>?;4@V7F[SZR^E_`=02P,$%`````@`44IJ M1QW+="*@`0``M0,``!D```!X;"]W;W)K&ULA5/+ M;MLP$/P5@A\04I)E%X8L(%%0M(<"00[-F;96%A$^%)*VG+\/'[)B!TY[$7>7 M,\/9I5B-VKS:'L"ADQ3*;G#OW+`FQ.YZD,S>Z0&4W^FTDQ<*I*[(S&NY M!&6Y5LA`M\'WV;HI`B("_G(8[46,@O>MUJ\A^=UN,`T60,#.!07FER,T($00 M\@>_39J?1P;B97Q6_QF[]>ZWS$*CQ0MO7>_-4HQ:Z-A!N&<]_H*IA3(([K2P M\8MV!^NT/%,PDNR45J[B.J:=F6-U M9?2([,#"96=K#S=!Q"LCWXSU$R;]'-!.B MG"'$&[CI(K]VD8KW>>1G9?9_@>):8)$$BJF-Q;5)%3&KU$;"+)<_**7?PYJ; ML&2'7$QX8'OXP\R>*XNVVOG+BC/MM';@9>A=B5'OW]"<".A<"%<^-NFW2HG3 MP_F1S"^U_@!02P,$%`````@`44IJ1Q04_KGE`0``4`4``!D```!X;"]W;W)K M&ULA93+CILP&(5?Q>(!QF!N24209JBJ=E%I-(MV M[20_`8V-J>V$Z=O7MV22$4DV^,(YQ]]O@ZM)R'?5`6CTP=F@UE&G];C"6&T[ MX%0]B1$&\Z85DE-MAG*/U2B![IR),TSBN,"<]D-45V[N5=:5.&C6#_`JD3IP M3N6_%V!B6D=)=)IXZ_>=MA.XKO#9M^LY#*H7`Y+0KJ/G9-445N$$OWN8U$4? M6?:-$.]V\'.WCF*+``RVVB90TQRA`<9LD%GX;\C\7-(:+_NG].^N6D._H0H: MP?[T.]T9V#A".VCI@>DW,?V`4$)N`[>"*?=$VX/2@I\L$>+TP[?]X-K)OUG$ MP39O(,%`SH8DNVM(@R']8L">S-7UC6I:5U),2(W4'G:R,G)I0TPR,L4HLT\N M4[J=JJMCG<9YA8\VZ$I#G.;%:\AM11,4GR'8`,Q2D&L*/_E,G#_)L\G+\)J$Y(O;HB:(TFSQ&"6;1><,FR!*R=<] MP1NM_.`0:MMM[3U^C_>#[08 M3_?7^1*M_P-02P,$%`````@`44IJ1P&ULC91+CYLP%(7_BL6^`Q@(5420)E-5[:+2:!;M MVH'+0^,'M4V8_OOZ%2:IT*2;&)MSSW76GF5=B5G3D<.S1&IF MC,@_1Z!B.41I=%EX&?M!VX6XKN*UKAT9<#4*CB1TA^@QW1]+JW""GR,LZNH9 MV>PG(5[MY'M[B!(;`2@TVCH0,YSA"2BU1@;\.WB^(VWA]?/%_:OKUJ0_$05/ M@OX:6SV8L$F$6NC(3/6+6+Y!:*&PAHV@ROVB9E9:L$M)A!AY\^/(W;CX-Y^3 M4+9=@$,!7@NP#^Y!+N87HDE=2;$@-1'[WZ5[(Y?6Q#@CDTV9MIVG=(W7U;G. MTJ2*S];H1N,+CUZ3KHK8N&\B<+15C@/B/PRR6X/,9\P\O\CO&^2W!KDWR$," M?-LD=YK2I_0:G.#[D&(34@1(M@4I/,1KTJR\#]EM0G8!DG\`\9I/Z>X^I-R$ ME`%2?/"Y@@9G_T#BJTW(0/;NK"G4B)EKOP?7U?4X/V*WB=_E=361'GX0V8]< MH9/0YBBX'=L)H<'@DP?3ZV`NG'5"H=/VL;0?P9]!/]%BNMPHZ[56_P502P,$ M%`````@`44IJ1X$?;?P_`@```@@``!D```!X;"]W;W)K&ULE57+CILP%/T5Q+X#MGE&!&E"5;6+2J-9M&LG<0(:P-1VANG?UR^8 M)'(2NL'VY=SC^,U(<+[Z-J>K_U:B&$5!'Q7DP[S)SJ07KXY4-9A M(9?L&/"!$;S725T;P#!,@@XWO5\6.O;"RH*>1-OTY(5Y_-1UF/W=D):.:Q_X M4^"U.=9"!8*R".:\?=.1GC>T]Q@YK/UGL*I`I"`:\:LA(S^;>TK\EM(WM?BQ M7_NATD!:LA.*`LOAG52D;163W/F/)?W<4R6>SR?V;[I<*7^+.:EH^[O9BUJJ M#7UO3P[XU(I7.GXGMH98$>YHR_73VYVXH-V4XGL=_C!CT^MQ-&^RT*:Y$Z!- M@'."<>)F`K()Z"HA,,IT75^QP&7!Z.CQ`:NO#582SA2)9/9D,5SZI#F9=JHL MWDL$DB)X5T07&*@Q&X.!MQ&51<0S))`"G"K@I0H3?(961?J8`%T21(8`:0(0 M7Y71:TQJRC`8""'*;J.J"85"]%A,Y!03V6JES+"WE>M.0@U#15YILKRBP$':8;=[[VRW]02P,$ M%`````@`44IJ1ZP#/=IR`@``*@D``!D```!X;"]W;W)K&ULC5;+DJ(P%/T5B@]H2,)#+:3*1TW-+*:JJQC3_-LVSTLS-O9J&EN0G0 M$N!`&.*X"<@2T$!`LX>$R!*B:X1(I\9L12=BBP7.,T8[C[=8'0^PD'"F1*2R M)W?/96*U)M.IS;-+CB#,@HL2NL-`C5D;#`3I.&9C,&!`!-*!TP;T72&@IB?S M!Q$,Y('/K47$STV@>Q-F<85L+M!S@>A>`!F!R`C<)&I4('8ZB*V#R+5+@]D8 M#$R=_X;!;+]C1HTD3B.)-1(_,-)CDN=!4F>0U`I,<#ESYGLV/=]SIX/YA'P; M#)PY3Y[-]W?,J!$0.IWHY6<9'T"S"7&`.TY?\%]*K=&@U,8QH#09QVPM!H83 MJ@5`MQ=3L`B%$R20\P0`-/T(@,CMPE8M`N.97P^@!Z=@XP"-FW%_`,"4+T`/ M0E-2[ZYO,*7`>Q"*OL0);CI-3=A)MVSN[>FY$:;1#*O#M6`%=:>ZPO.LQ2?R M&[-3V7!O1X7L=[HM'2D51,8/7V+?*^3%99A4Y"C4,)5C9EJYF0C:]C>3X7J4 M_P=02P,$%`````@`44IJ1W;Q=/??"```X#P``!D```!X;"]W;W)K&ULE9O=4'B-#X1\IVU8X3V=$X,ZZYV+U68CI6 MC61Z)26>??L5Q6[&5AJMYDUL*Q^`)L!ST`1;YR_MYN_M8]/L)O^L5T_;B[/' MW>[Y_72Z_?K8K!?;=^US\[3_GX=VLU[L]G]NODVWSYMF<7]HM%Y-K3%QNEXL MG\XNSP^?W6TNS]OON]7RJ;G;3+;?U^O%YG^_-:OVY>(,SNB#OY;?'G?=!]/+ M\^G0[GZY;IZVR_9ILFD>+L[^!>_OP-F..2#_7C8OVU>_3[KHO[3MW]T?G^XO MSDP71+-JONZZ/A;['S^:JV:UZKK:#_U?[/7GH%W#U[]3[[/#]>[C_[+8-E?M MZC_+^]WC/EQS-KEO'A;?5[N_VI>;!B\B=!U^;5?;P[^3K]^WNW9-3;@VHO MSW]<.A?.IS^ZGMXP]L#\1DRL,U?$I#KS@9A<9S[VC`6!F2%3)ZY[(I8ZL M-\;4J1GV9&1LSF+UJ`,;=<"H$S=0Z>/IF?S.UYGYKTP]DLA&$C&2S(T2^OGK MF:2\XL2.DW`<5D0],T,FL&K%.^97IAY)9B/)V`.K0QPECQBEL*,4[(%5,HY" MC%.,`H8=YO!QUP=[E^#Z(>1CT*T@`#\6NDH(=7G<(.2+^TD\W[&O0^`\=;RNNQKA'R,:?*#`2<@1X4 M)NGW2E]"X+RU`7I;8!V%EJZ'((=X8NF4X&T%%,+G_1#0$(-@5/,!4BF7-T1` M)XN2VR%D4]`,Q/L=H)E%R?`(TET1;WF`?A8EST/(YJ(8R/*F9]'T(IL"X4`# MI,J!>,>SZ'A1RF$&*&H&XOW.HD-%-ONF@0C*FH%X"[-H87PRB_LP0:KMS_+^ M93'ILJI9.;(2RD'#B"34\GJVD;R_;AX?$?+&:'<(RXO:4IHC)':?$8)W!30C M\:JVO6!MT3B#+?S\EC%)/J]%AS)+(-@]0M;N\TS9[]7D[4`&[8;E>)$[U&^R MFC[XIR4WZG&I\KR$JDN2JPV0KT.W#"1$P^O7X7..:N=QO'[=&/TZ7K\N:F8% M(2=`MPPD1,/KVZ&^D\;57.9G)8^9%7ZK=:C-1V MEK(Y@IS&TGSE8`4-(*OZX`W`CS$`SQN`1]EF0=N?!DCC>)[7MD^2IA(.U$/A MA*3^>,,)X)\TJEY[?#[@T56RZM[B\P$_)A\(O`<$](`L/;DC=')VYA50B(KW M@8`2SZHKX_?X,&:/#[QZ`ZE7.FY#",`IKYD7<"`!:VPM\`(.8P0<>`$'U&81 MK'%&D'CVQT!"-+S*@R)#GR%TXNSU5TB(AE=M0-46RU)WX-2P<$TEISY/2B/V8,R+Z%,SWM"YOD!H:2^=S._#V6+%RT= M(0^0YE@A\X+,FO?M>*LKF"V`Y.\(@?5!.QKO M=05M#%3SR.?<94S.77B'*NA0(.3<,X3LZ;7@02$JWLX*VAD(IZ-7"(U8>-ZG M"EF0:AKY!*.,23`*;QPEGT[=9F4P!,'&&$B(IE*4@QD(:)X6]AL%.RW]Y]IY M`5,IIC&@F!FBK'3Z.>:.AJ/L@']>!4_P;([SY>P]>/=$+5_;M&6#-:J\ZCRSDH;+%%6 M_6`'M0H]JIBSPDO8*Z)0!#_5U-]55N:J046<6'J&!.MY,>5\S1JM@QAYA0*8<#*G63\PRBI/J2 M.4=)$55A["&*B MC12$$R8ZKY%]9--7W_][7GQK/B\VWY9/V\F7=K=KUQ?=%_X>VG;7['LR[_8; MQF.SN!_^6#4/N^[7U.TD_?=O^S]V[?,%?I]X^%+SY?\!4$L#!!0````(`%%* M:D?5>B.3@`(```<*```9````>&PO=V]R:W-H965T6$\[]>3`>$ND6O)C)'I. MR=X8M4T$XSB-6E)W85F8O1=>%NPDF[JC+SP0I[8E_/>:-FQ8A2`<-U[K8R7U M1E06T<5N7[>T$S7K`DX/J_`9+#?[E2/_ZU(;7\Y']BPE7R=\203>L^5GO9:74QF&PIP=R M:N0K&[Y2%P/6A#O6"/,?[$Y"LG8T"8.6O-NQ[LPXV"=Y[,S\!M`9P(L!2"8- MD#-`_QA$5IF)ZS.1I"PX&P+1$UUML%1PKDD4(;8&98=X#W14&_*->G<$:M`/*G!LTO-TC\*I+'J=DX$$KP MO)<;^+L5C.V:3OFR((CCF=E-_:E)/_#6^)L1N&Y,LBFY%H0R/%-N[O>5NZ]4 M/N7+@C[!Q;Q/&?"W.)CL\='7XF,EA['7%W3-"[UQN>^)`R$,[S2>.W/\."LI MNCJR>W*DWPD_UIT(MDRJT]\IIYD.WMY3[$*R M?KQV7>Y^Y1]02P,$%`````@`44IJ1S;?T?;K`@``0`X``!D```!X;"]W;W)K M&ULE5=-;]I`$/TKEN_$WEE_$1E+2:JJ/52*>FC/ M#BQ@Q?92[Q+2?]_]@H`TAY^B"G5[450D?O0S^J1;S5>G>? M)&JY%4.K[N1.C.:?M9R&5IOEM$G4;A+MR@4-?0)I6B1#VXUQ4[N]YZFIY5[W MW2B>ITCMAZ&=_CZ*7AX6,8N/&S^[S5;;C:2IDU/9C+,?T+2#TX; M>'Y_S/[5'=>4_](J\23[W]U*;TVU:1RMQ+K=]_JG/'P3X0RY3;B4O7*_T7*O MM!R.(7$TM._^VHWN>O#_5&D(PP,@!,`I`'SAGLB5^:75;5-/\A"I76L?'KLW M\,DF,9DC4YLRQW8Y)W?PIGYKLJRJDS>;Z`+C`Q\]AIT0B8K1Y)XF M#S3`J]LT!4I3^'8`H1TEVL^2WL\*K:"ZUL]P4(]A`!F!9H[2S$,_V14:CTEO M4[`4Y7#;E@2ND`00H[2<,9R'$<010`QXF1&8`&>"P,2O,0&Y;QQGX8&%4FB& MRI!E=!TRW'$L)R@Q@!B<-___3+CI6$$08P!16$JZ MACN8S2E:)'L8<`_#T<,Y(05#M0B,KD7`?0=`T&(`S5A:$(APZP$G2#&`*$W% MWYF0$:080,6<0(,[&"@OS0":<8$'H[[CJ<$(080H:<Y.S+_Q!3!LWR*AH*?>C]A_XI]W3L/0`;D+X@#?UKMV('^VT MZ485O4AMY@PW#JREU,*PIW?FM%LSSIT6O5AK>UO:-O@!QR^TW!WGM=/0V/P# M4$L#!!0````(`%%*:D=9&O]2EP$``'X#```9````>&PO=V]R:W-H965TLVH6!5@=QEYR9G>6CF=!\V`'`D2\EM=W0P;EQS9C=#Z"XO<,1M%_I MT2CN?&H.S(X&>!=)2K(BR^Z9XD+3MHESKZ9M\.BDT/!JB#TJQ)Q1H*U`3`_V&?LO7VRH@(N!=P&0O8A*\[Q`_0O*]V]`L M6``)>Q<4N!].\`A2!B%?^'/6_%,R$"_CL_IS[-:[WW$+CRA_BLX-WFQ&20<] M/TKWAM,+S"VL@N`>I8U_LC]:A^I,H43QKS0*'<J&G8+0%281MPE3 MYOF"85[_9I'BNDB5BA1)H*C_+5!>"Y1)H)P=_(=`==-!-;?Y<-VFCI@ZM9DP M9;W*_/=7(7:QMR,_P`]N#D);LD/GCRGN9H_HP.MD=RM*!O\8ED1"[T)8^]BD M^Y$2A^/YMB]/KOT-4$L#!!0````(`%%*:D??Q_B/2`(``)L'```9````>&PO M=V]R:W-H965TF%WGGBK3G60DWX9>&/OGW3XHXWM`,,'Y;>2[C8Y$JA M!;\://"K>Z#8MY2^J\&/_=(+%`(F>"=4`I*7#[S&A*@@6?B/S;R45,;K^W/Z M-]VMI-\BCM>4_&[VHI:P@0?V^(!.1+S1X3NV+20J<$<)U[]@=^*"MF>+!UKT M::Y-IZ^#>9)EUN8V0&N`HV&LXS9$UA!=#/&L(;:&^'\K)-:0W%7P3>]ZY2HD M4%DP.@#>(_5W"A=2SE2(3`9RN;A\$SJ3Z7=1%A]EG#P7_H<*NM%`K5D939I/ M2RHC"4>%+P&<%-!S58#:#J<+K(TBG<&L'H9LOH1,8D:WF)%9K,ATF0:/`^+; M@-@$Q&:UKP*TIM,:8UP9#4RC*`AF=)5;-PF4.($2"Q3.`!D-#&,X#^3630*E M3J#4`D%7HR$56I1M/G8$=/G3`?TS@[GBLO4&U= M=_.K<+$.'?.5/(?,L7&)+XL>'?%/Q(Y-Q\&6"KEAZGWM0*G`$C9XDM"U/"G' M`<$'H6XSU8TY/,Q`T/Y\%([G&PO=V]R:W-H965T<*.'UFO?MGQH:NE>ASVD3@.K-Z:H*Z-((X7 M45NJX>_%6OY>162<%QX;O8'J1>BLHBFN&W3 ML5XTO`\&MEN%#^1^3:F&&,2OAIW%I_M`DW_A_%4__-BNPEAS8"W;2)VB5I#G^S'[-].NHO]2"_;(V]_-5AX4VS@,MFQ7GUKYS,_? MF>LAU0DWO!7F.]B3I!<)K"+#XE-D,67+'N#R6PG%D.R-%:?Z[@UCKM**$4)I8X0P0JE MEE!ZBY#%K7'<54(+E-#"$8*9'7*8.+ZQ0SCN*J$,)90Y0O1V@AP53>XOFB7* M8.D8)#/_D<5`DOHT2F*TCEG6A5*/%`3ME1#_9@G@+)Q+,]3MB7NAC*#,HP[% MZS@S9QYO`Y+@W29?Z!;W'TE]NAU!/G5P6Q'GA=Q''AG>;?:%;G.UFD`> M]@;<,^`\DR^NOW6K$91XO70!/RC!62M'S_.QHQ'D86'`_0?.6OERKHX#+7WZ MP?T'SG_+&>57$\A#^8"?5N!,NO11/GY>P1<.+,#]!QY'5N5`)$M\=$+Q,XO& M'LJ?0![*I[B7*?%0O@-![J5\BGN9@HLY_UL&]Z$;QPJ88:,WOL.)=,U8_O ME%8.:CJ='EJVD_HVTR*R\YI]D/PXCI_3#%S^`U!+`P04````"`!12FI'86_N MH28#```W#@``&0```'AL+W=O(K;U[;$V/">*_*NEV;)R'.*\MJ=R=6Y>TW?F9U]\^!-U4NNL_F:+7GAN5[ M9525EF/;OE7E16TFL6I[:I*87T19U.RI,=I+5>7-WT=6\NO:)&;?\%P<3T(V M6$EL#7;[HF)U6_#::-AA;3Z0548BB2CB5\&N[/-Y:RLI2>NI[_H-.//J7A[7OO/5/A=O)?\I:EO/Q=[,6I4VN;QIX= M\DLIGOGU.\,8/.EPQ\M6_1J[2RMXU9N81I6_P[.HU?,*_P0$S?0&#AHX@\'0 MC]Z`H@'],'`G#5PT<)?VX*&!M[0''PW\3P86)$NE>I.+/(D;?C7:@?'#<60#"!D(JQ.@5>&8 MNAX<9>Z,=Y`"X4<3&F:=;.>=9.C$FX^$WD="(9\4\[G`@7OOP`4'+CKP[T76 MB@D@7<"0D-JV/8ZE@#FV/XEM`*.A,XEM`0L)N<5&@_.TP7DP`(ZN&P]B`X30 M<$0-8)LY#$1G@%%*%XGVM:)]2".E$ZJ1"694+\,RP'PY;@M4!UK5`:J.)E0# M,UI&0*5`>60Z-*"(/U9L@&T!B_Q%D87:R$*6:6 MI@A-5^@6*4J=12DA1"^(8%*T:YN+@A#R[7%HJX'&Q3AZ,0YF)Y@H!(14C2_I MBNJ[HE-EW@\$7300]&L#H5^^2;]^+ZA.XFG+DWA?J$_]DD7\J?K$V8_0[#:" MG&//K`#(S6XDO;C[57`\1/WZ1@(,<6J!0VA2]2R2_8>,:]6O6"20F=WX M%G(91WIH=%O#@\9"+D-.N_]9-X?.&B.YJK$_2! M<\$ZR?:W+NNG[A8W?)3L(.1K((<#[C7P(?BYOZ8-=\7D'U!+`P04````"`!1 M2FI'5`[6]WP#``#5$0``&0```'AL+W=OE`HP+&+-_O\`T1E,M##[( MQ7/Z]/3TF1%F)U6^5WLI:^LSSXIJ;N_K^G#O.-5Z+_.DNE,'632_;%69)W5S M6>ZS'K[KV4BYDZUEE:R)?2JHYYGI3_'F2F3G.; MV?V-UW2WK]L;SF+FG'F;-)=%E:K"*N5V;O]@]RL>MI`.\3N5I^KBW&J3?U/J MO;WXN9G;;IN#S.2Z;D,DS>%#QC++VDB-\E\,^J79$B_/^^A/W7";]-^22L8J M^Y-NZGV3K6M;&[E-CEG]JDXKB6/PVH!KE57=M[4^5K7*>XIMY!?0J M"P9*"U.]"K17`3=K$`.E11`$!DL@T%:%WH7AT*`TB)D/BK8B]"XCF]-#,3Y5 MC/8CH!]A8$^.$03F8O2.">A<&%C,XC,(#'1H>P/:&TS:.""=`,$$)]!^!/3C M]^:\VK40!)%A82-:"GT+`TO,\@PR6!\X;6Z.Y@:#C88SLK"6TV[D,.[Z M!P1!.+"A+4U`S[U<%!ED?.,/,EH:#)8@+NBZB0EUH^W'>V<-+2P($J96Y[0% M.5J0FX2@+<@G6)#3%N3A^)-)C"#FD4-V+IY%#\E._DK*75I4UINJF\?:[NES MJU0MFTCN75/#O4PVYXM,;NOV-&B+J]\ZZ(M:'?J7*.&POMN MY$IV)OK;\11$HVI&U:"T\Z;;;KL!E4JU1^VZJ$NJW9@QS@]F)B71.Y-,DTRI MU)@?_1#^,X#]YSS">83S*/TD9]WBQ@AFIE3;?3S`&'"7MD0&(U9$K.NWUOK[ MIFF3;\M%V?S#;^[;=O7C#S\TL_M\F34'U2HOX2^W5;W,6OC/^NZ'9E7GV;RY MS_-VN?AA-!@<_;#,BO(WR;HL_F6=GU?KLOV'WQR.A[_Y_=\WQ>__OOW]NVJV M7N9EFV3E/+DHVZ)]2BY+'K.HRF0_:>ZS.F_^_H?V]W__`[[#[QTE'ZNRO6_@ MG7D^[_[U#^OR(!D/TF0T&!YV__BI>CA(!J/X'\U\SN+S^:>S:=/6V:S]OWK? MO'E:Y=T_#@?[?^S^[@R>GM,;[Q?97?>OM]FB"88QW[C*ZZ+""PR\#,G>?E.]&G_WCJ/N;FSJ;%^5=?DXN/WWZ_//9S>7G M3]?P\WG/@.>PAAKF?PFGY5ORC_E3][GS=5UW*=)'W?W]X6A_/.SYU/MBD=?) M.;QW5]7!=ZZ7V0+__B5?576+Q#FOEJNL#![4$Z^62SAVUVTU^R5-KNDN))_7 M;=/"A8'7@W54L,*RR>?P9ME4BV(.$YDG;[-%5LYR&`"N9@.WZNOUNV3OU9OD M55*4R^Y+#5Q0RGB8^FR4P&)@I597!O9C/D(TU2Y[,5LL:;3.]_V<-)6\/.""+W* M8,[P*WCLU7!\0@1X-1Z/@4KX.[B8N6%,]$<@<;Z=-LV\#/--U-TXS_31^X19%-BT6!=`Y.G3DT-L]_E=5["[L=JP_QYH9L(#^K MQ3ROF_]*MZI]"GDF<_L&G_TQ>34X&,#_#?$()<`\U_GODM'A((7?B5:49.OV M'MC]LY(JM MEVL^_,`[BUD1L`W>B29"DJU[1K/=Y589GZCYO"Y#[;W:6C-G0 M#-D4WYX_8)<`/]45\'I8VFW(-^2$``DN1/\)-@HT$M#=9Z"*S($JBVIEK,L5 MT*4,AKS.%PL8,$V`S>=H(N"CV7Q9E&2!X!SC&UB9N6A=+#@0")<;_O8I!WT#QNG^_FW6%#/:B'FQ6.-I+N7)9(6*KC`?Y`S=5_^4%W?W M\,9^]@`DO\LCO"E9(Q]"^066UYIV<.?AG\O'7BI>A&I6RO3+DSZ&L9,8V6$U M:)_6^3T\!UREV5LYW>&*75:*1^GY1/3JKBUJT MM_2,>ZM1JT)>%E4IS^;_#(H^?X8V!'3*6;'([9&#W^+/9"7KDQD;.>`)[W)8 M.&@=I&\0UUJB8OSG+*8NSYB]":SYN`FOSU3[W#'LM M2L%MQV[;)>`]W/S.U1H$6R-\_Y MIS=LM._HENWUWZ:@]MT598E3P*M)(8%GO)TC[^I[[WJ]6BU(+,/VH0``&;FN MF7CZTL`R3$`F^EWBJ6B4:(%D#J\<#+1^K;1"$VG"ULS1Y.37M68VK*>T8M-P M#!AS1U[0ST/%4&26GG7\H:PH;'>"7IC1LAG\B%*$V,BVJ_5,7>M7<;\XXVU0 MDY]_,,*]7"ZS^@D??[MN@%TU#5O#'PH@T3SB@Q(=`S?S"HA!;L3^*0X/DNV? M4!^!;51P$-\6%6C19?6@O:F@4A\D>W_]R[])1.FO?_EW,/'PIN3UPK[WN;[+ M2A`=P;LI<*2&;+EZ5=6T;[SE>!D6V6.C8%;X,Q$?I_@.-"7@8CEJE'0YAH=X M.09'/.>B`0UW1@,5I7J7/13PI7,@,LRI++(#^"J\MGC":S1*:6B9.L\:#FKR M>%\M%D_[U6.9SU6SGC9`!"!0FNCE?"QF]P6L"'Y1KF^!K&N2?A\^G!,M/G[\ MJ.!GIL7C/3R@6V5F?0!'U,YZF?T" M&SPM*E&:5W"(%`P,=JCU0M#(]WFV:.^U?MCXP[19?8?SPBDNLW^N:ABC_H5_ MD[6HK:%G&K50]L=B/!ZO#WT/#MG<\Q:I&7"*#%G!'8BZ]0)6*%Z.QPPU`CWV M(VB3(!1;;P$R/X6;3!((3@C,/*]+\HPTN%%I`A=J67R#OSX6+<;O8I-3=G+^ M:K-%4YDEE_FCF1#>4]XQ5'1SFD-9)=E#5BR(E6TG`E)P3:)7;7L8/OL$P[<@ MW$"_:(J:/@&T!T9+&A/^YS2?93R>WD'BO.5#`6=1F#P:>$`?X&UV"W`I%=^[ M#(YS@EM2W!:H=@`G;]X@!?78.&?7=46B$LX1<*0"71B@DL$Y!*$#.P,#X./Y M[2T,/'MB%>,YQ)_G"]C&NDDNKL[VLQ5J'&)=U!2"![K/%9P'\[XY$HX)$IX7 M/JC9?%YCW`:OT=VBFJ($S)V7NBG(7 M4.!$DCP##@=J%3I\9O(7/(MPKQ?%LD`.9&P;=0_KJFHV)9"2]IER32$04=10 M;1.)8._I&;(+Y6D"/N>ZSY!^*&*[01!\\=7P9)0>3XXQAI/2U^&0K,E(:XJ[ MLL!]+-DQ`$<2!,",O&OY2AOY"DWK&3L3.#RUSO%G&D:_IS48=,XU>G##%<%%["JM3DK M40?WCW!Q\;[#N'A7<7?I-PKWF.RY196AG`."/^:+!?V+D^%/=R?3B-4)S%!Y MYUU,C$8$(SF(X9[,8"X+X$E5+D\?MW\+&`"94Y MWN5*O-!M[AX'I>/*=W7UB),&)@A"#WY)DT*$%3%X]IFS2O>TXU%]K.I?R)83 MM0YUX5$Z.3ZA$ZJP9]N[RUEO`%&PKX+.XU4_Z(IDOZ'G! MC<#S!L,S>_C$G$;?.]8DF]K!>H5>0N+-_.J<@(>"D-8I8NH3@X2Y;,0P?J$`Y MRG&QRRFNU=ZMS$2-U:L)1:YI6_FP\JVKLP)%A[E\KN.AR/W:2A'8PMF_O_[E?S5\INN<#!WQU=[7 MU?H.3GQ+EDY+1UC)$3[R91`Y"I'H,J4,E8.'@N37G<@`$C;%W3THXN1*;0L4 M?23^D10MBD+8@:*R6I$6Q^V`C?Z/D,> M84\5RUQ5E0$%6#PXUV8ED6PR;T%K)&;B\VD0<7/,W:?&NVD M@8^1,H3:?54W:IH_5;$S`#>UKA9I@@;QG?BH89&+K%C"Q4/7.5PD]^9K1S&) MWQ;8"-!VC:2SUCF%'%DPL10!?F;%`86!B4;,*R.S(?'$(R/+@0)V! M)DJGU9_=K`(1\F=]?D`!H1NQ*'[)X6AJ@4/73]E[2@*\T?O!QR)E#1PVO,0+ MA4HX7-*:=H/&;M:S>P6'"Z;7./<.]JQI;M>+A/21K$WUL"C/6GX5_O,)SZRR MCS-?0[%M8#@\.W;2PK<<)PE+3]+;U;J\S1XJTMQ!_*$9R:>:`2+.2ZCK\['& M&5&0$;<;V$/^K6!7#(7_!&+"3A-2EX%Q^\.(L\7E=-JK2!=<2P*9$#!-G)&] M)"[E]<`*Z(5+<@0]4J2C!I0YT@N]!?!LRZW^X*:U9'F+_:]9./ M!-V$M6(I2EX$ZY%F]66#B$Y$1#=JAYU)XCN#0\A$\GS7S@06>9W M%6Q62X\TK)0HMQIO7O;[6)X(ZA)[.W,S!$7IX M-!6[_8$_&]$[S+N`9BX5R M#4,Z+=K"U2>&!0=L7)/->$OH]$SSO%0YVK:E^."<6<-CK,3@U&@X)(%=B.-B MCV$&4Z7->`LE(F#>CCYSA:8O3A#-.M"?.,CAD":ETU>MX>J!_<&2`Z=:SUF/ MA3\J0>R@,DK:03[7[FZZ?'S-%KD19E_+PCBC&S)J?SH[NR*KEAC\:@4'@%7: M]4+(:N6SWCQU;4/5E+3RC34R@NIS:(T\C]<7Y'7$$;*:O$"T><72H7*MLP`. MDG,Q/SS"P_"HZ"H;.&C@%_62%NVY^^0CRL(N^KN#$,"=6*KW!.A$Q@?T";GQ/!;_PG.S*@:-0? MUZ#7H[TIR1KHY7X/CR>8S(.Q8C&E,.5)+EC1:@ MKD0ZX\V66=T6"]PO.[=_U/=2W7(RRQ,FL_!U#&"^)"?Q`]6J*,459#W6J5BS MF[F>)A7/`/N%\5*@S@L&*EE!SG.^IB0G M`H0K*&.UG;L3V^XQ?QQE)54A,LEZ1TCCXA,6?9O<&L]CG+3&5NF5%'3_YW"C M2,L4L6+Q&_JSQA.X7B!WP..@Z#A4M:L3Z6NHOK)S^P)TX"5QR1MRD"$#,:B= M'FF'AP-O$^IIAK,<)Y+=(MO4,^5[9N50=]I7RW!>N8<5;(OD8`BHH., M9ZM1;QEKEO,"G:]*O")5XU#K0)G@.OUP87UQGEL"+VO!Y@LJE.1\@"5C'-$3 M]&"LK$52F!B7.,^7#(\1+X.#%X;C0RD9L)73G`Z]G!]0#+87V[1 MDKG7<<,"QX?]JAK645D=3>JB^<4W6NGSMQFJ_=,GAP>Z`^,`],:WUMBY_?Y3 M1_%O[WNF2@P`YI%_FY&=$@.NE?N./N\2-)U<'7A)NO!;NR MN\".F(PN!1Q821CB73&N;GMHT$.7D:V@(OJ-^/==KR$Z3'-6A\AQPYR69>&U M]A\>$>>\7=?D0D)>LB;-#NX>AO?*MK8Z(6.;DB]P5-3[V+WB5:XJ/`P%+0I4 M?#14.\:9F@5CN\=0B&?MQ\63IF,:7,'47@X'WTB0:K#SND%`WD^*=_2?4R(H MLA$]*]"\R"J?5TMRVZF>LTLO$A*`_E-KXW`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`;WE$J4C@L=2B MH@P?YF""L-WS>Y!MGH"DCS8PIT5.822:N``[,0+[J,PG:(02Q&&-871$`1&/ MT^R+8L9YC88>(V^^D:[&KI:*E5/VG^C)8K"*P:W)O$;(D[PB42F8UWVQ6I%^ M%\3U(J`\L)=0**)CF%QD+3MK]*HBKX'ZD).]Z[Z'FU)G\UQ-VF,E",RCO..:#' MGHS^J[45))$,@`YA*X6-TDPXHCEJEX0IZ@WHN6>+XA$N MU@C>($8`&R9!+']C[2%DY=P->(-`G.7H=#))-.[/Q&S(TIXG,@O@%1J2A3Q$ MXQ4YX3G9*W.$QR!,BZ;$OZVPJH)!$M&;;R388GSR.D='V1!+24M`P>Z$9O`_ M"-HC6!OW9%$"!)H$#1WD>8[;2``(B<[<%G73[A=E*C^A/WN*T07?\!*@?R.N M428'1=>PF`!!,TLW"BJ>'[M7JN$L5B:OCKE8)D=KG?/NK>Z?&L(^TG0+L013 MV,JF@C=FR,E2-[.*QUP@))$,?PZK2S3]0-G"`*@1N`?'+,LLA'!_;,*BRM#` MYNXOX2&8N5TVT.Z>72S,'[1).A,C$$/+U8+X!8,@>3NSNB;_*1O&)*+,EY+X MEV`$5+^T9X733+NGR?CQ>`EX0AGLB#$XY?BPIKB[XE#3.$?-QV-F!*/3/`6? MCQB=;[O=!\HD5&#+S:*0:F6>2NPM=T*Y;@\$$>MYXRV MW$(*`JREAZ>$PE2GPHHT]=PMYN:2:"025H%;U M0X$2@Z03!85JBOYJN!ES@P(1=M_X%2F MHEBRX^GQ"L,H!^U#3*31D".I=.359:'%B4ZD.:,R4LS,%T]9=,ZI.9DT4R'T M7+$%3!$O9W+XMC,GO%:WZ\4MR$@>&3A5@3C;J^ZI<]1@\[N.6:D5BP"#8''5 M5<@PYO"]F>-'H)P619^9&N\Z>7-,0NT!!HOLY\SPRVQ.8MW]AL_3PX.H+8&* M0"`@A_;1/U>32-JWL?R&!"2JRI0W)K`0N`+HV"5IPC)A5M2S]9*![L8E[P2W M]YHWUK7GS!.6)/@NQYLAC"LEAB0Q%(/V;BO4I'.:/)T41FLH!AZ15X,%3N=+ MPDKK-:H!XBVN:H:JDU3BBRG[3V<*&68:C*.!Z'A?Y_>(` M#1LTM^OQM,,,H6BHS>"8!$)F_06)W.B0%`TUA2-YRV#U8-WEW/U`S;:AN9): M.Z&KAZZ\0$UA8'6$HG(]#83H@51$D#-+"B[D_8?0'44?2%@O,3=B[>0ZQ?12 M*N^`P1^&XW%F)49&>`$1Z:2,^+(1KHW?QHUQ5\GCZ<-LYR,D9I_;IN5'-N!WYB:R%E>4 M%,_@.\B"'E9J%2<+WL%ENV>2W67.Y?'8%1T$QB!36DVK(PK.0XK$*%RM4D_4 M6%9"P'5)"H@%?;J8`1OUPM^Z0E`0==.\3PP@^^$``EK*3YY<,-)_3?D3-BN@ MSN5^DP/?>%]T+-'9.._`"&,$\BE]:KY;\]'UT#K8 MK/GTC6LUGUC=!/[8L:/['!T-(KI/$]*4)T+<,.?\,3,UDG4+ M>$M,X2;0VU3P#7'0],`<-'2>JMI*:%.Q:TC+;;OM#B184JN<;=",D2+Y=6Z! M""!+A#=B^,N;_:R_3*!ZSKR=H#7/D)7^6\_*'PU\GDC!QQHN$$GPO.W%$1Z^T MBI*G'8'4Z,9,?*E'3-7FJ=ACS%J>&+.!>HAH8=(*+5K&&KQ,9N$?8,09X&[# M4)EN#3(&0@<)Y!0]M^.(?4GII4`/TH<<.:>YICPNV\GKP,V>YEQ:@&3(09\= MM.#2:W90#Z>F,[-4)S/+M;@[J5J-A,#@10\Z[6#@DWP9"G1O`"SC`DH:AL^K^?>T9,K\,6\V_`K,D*K+'^%4M: M+UG!.&,B2+7>/#8X\'W4PB0&5CC0=2DWV/[="$\\%X8G.FJV=J_G'(+T&+B] M+/09U?V,7:TW.X[LZ(?LM51F6H9Y;+GJ:>P`.%M@<]6.I1ZGR91O7"H<))\J M9=[2C(`'B[\1+<^G^KB;?3"&(?-B)A.[]FV,4UG&&=6Z092?C*U8/QQ&U`>5 MA3`9'R&ZM7PZ,A.D5,3@^CEQBFJGBEZ_(AMJPWW MQSNA]B#RO;M^(DA:EA)/O;T%5BK8LTSJ-B2'K]UBIZG2KR0_P_\2#/:JS0^2 M#S?ODKW@;V\H&;-SVX,@2X,UR>9<=4)J![FHF-1,4YEOD@@7-=)4V`M#BVZY MFY1E"XV.[..Q!*%T7ZSPUF)H#5.WISE6=SE\?4"P_*X:KIP#J"\/IG\;FJ+Y MF/_+6B"&9@&)X)K8F^7"?+<=PAVQJIONB3Z#ZM5X/(H=0O+3Q*;AK-$Y-ROT MV./RPH,0IR\"7'\!.3$>#^T]&Z8G)Y-0QT]=O3CD M_SV\4Z8F:$YO9RUM]*X`157=/^C>.%B*_035^O2"4OBT4 M!JQ+8EIZJL%$%ACRE-IB-!D6V,8SN[A8514V"6%@XSX'1YB-#@-!]A![_B. M11REPY-3.P/@.8?C9R_B\&AHAS@+CR\4_Z8I;9U35.3/T_"@]&EN]'`N/]D17Y*)TG$G^ M[&(T5MZN[33C#AW8SSF<'#HSG%:@T\7U5)0*,T:%7')A?C?QL*Y*^%G7/7&J M8HF(MJABYZUKO`Y9#6?U;07_4#[;^[/KMURE)?B(??SK"ITWZE-U0)_8'PZQ M_I=V^.S=5"NX.N/QX,V/R76Q7"V*VR>YONICGF'T3AN\YBV<\QFH)@MWTC"7 M9\UC,,9Y<#;L7__RKY?(0LR%-A6N>7[J9'RX'YNBE[/)ZL.T)9H+]KUA"MNR M$9,737>RC^M\YQ7T^UJ*;X9M=L(#9*6ZH$X^G+EE\YC/-:"&+(B?*FX%1*6C M<'X?LZ?OF1P((0T.$#B.Q)`D:&1A@D+/H\%14._X?5;4R<^$`G`V/LBH=1Y[ MYZ3G]=>Y&V.L+CJTBB[NO)IS]H=.K3R[YM3*DQ'<,QQ*Q8:Z/L<'$I.!9*)0 M"&S@P=I\=D^=R1JN;H8I!CP&)X5/+DN@V>!/S#(JOM=-VWV<_=^:R!&+ATI2BG68RBRB>$F\.P;S656HG3)_<\ M"(H';B5'\)SJ"(LG,L$I)<]SGFTCZABYHC\O)P?:.V+D''I:2;DYG4!I\PJ0 M&QGLDF33^=EWL@!3VX8<6!2YPR-=(-RSF&FF2U-W9_[$;A);E8:APP9_V_44 M..6:B`I*#B\YDYT#3+YSF^7)L((^_2`$!>]1.$-JBK[Y4?WAZZ<+Z_:Z^7QS M]B'Y3T[MO[!G_\K_J]Y=G%]\?'OQ MQG-"_1ZJ_D6*7;'K_W1XE`S3X>$` M,\60X\^3NPKMC7%Z-!C"6^/CD^Z?])[9>-GX9)1,1A,%)V$`[QWCD0#E>3(1 MEXDN/N=7$TKSJA M#B62-NS$G&58?:?1%:HSM53D&5`;**N/]6DG0EL2CMOBD"1DZ:[`0F';>^WE MS&QB.Y+J<)+S*?8&ROTE6@Q)/D`%^:@%12)T*='&K&71J;$#T^;D# M3`61V@36:22ID0M=<(G7@KV0[/8T4^DFP7,%A$99NM%$32V$@^3<8KR[\E@" MO-V%.GGL>L-J5ZL,+IKNMI;%7;EP$_!>_,D>0#%RP@\-Q\?J.F_;A<3)"*H8 M/K8'#/9-Y[,^&WR%US'693#VN]UDS-$!F9F*WG!SG%_"A6Y0)?Q096SJF/\B M@V>:9Q*?$6LX:]7QP6#PFAP36`1FJ8V$PI9\)W_CXLGP"&.I'Z4<'F]1A:2` MQ?2)(7%A+*=P!>?L'M&$"[7*5EBS)9(QE3KUZ`F%(-VU,'^[O,.:K8W:L^%` M#6I@/3"?=]Z.EM=[HU:+?'XG.!FS#J=HN2%>BOHW!91(50=>/B0]ZF3,U7R8 M8?JU)9'ZGV=MA><52WVSO-*DLR]>V1U;#@V'51<44:0RC'1Q(]0<>-ZX5#961\/,%_ M1I/C/@H3@6V0+B2G0G+V49.J"F.YX'63C%XG>X<'H\/7O``_5?#-+E=#:7K+ M?,9',6+WD#>H1H%4^?CQ8T)UYWNN3L)7QV1<[G!?DE/0^D_@?T^.Q\QJN%`N M_C,>C-6'2(]4X(T$]'8^2.KV",R0G:*Z?IT=$Q6VJ.C;4Q1Y2/C`.( M5SNW%*7^`EC=%_0H)V`R2@]/HKD7O%OXD@4L&8&=*7UL$[L] M<6K_.GXE:^-8IL^^/XS[C`;HQ',X$+O%G5\,_4@HVF;OT?ZZ;K,Z>9N5OW`T ME9U!Z$-[,H`=@RTW]2[K_*%:8'Z4\AOQT#7]0G_$[,I_?W.0?#4,ED;%M7+2 MOYP<_70:G*,I.DQ0%C8.E]:/LTO=HO.3XT-*8G<4TEA^,I>J4>2?6R_M)W@D MXE2'C%0@-(0F;J?CA/*J@F22_T:J$=W$2FWU(JGM M%"?<67[SPBS5-)B-&BOHDM\,H',+]%@(LRWZ2:568"!,>-0\+#6E0*GBKTYE MD)D0]I*<@O802-:PZMR_Q+]_44BW?^RXY8HS/T[XT(5)([30`"(4L!P4\P\%+XSR$B1EW#QT.K4F8PYWT_9HB$)IXB)R9B M$=DIT\D74:!1@ULG3U!OKM.3SQE)U#TUN!#TNCY1'R"X;+>=`N('O4J=^EQ: MSIM&&M8PVT'=\CC5-U@#4A75/*5*YCVJ98_RP[JD,(([T%!6E,JAJ['BZF+# M=$DC]4")VW"#!^MVQE@#%H3366+HUU:FE@N7SW`3RK$`"3]/59CX9;9X!9W* M"X<"C"3K,%FYH)SV*=AZ%[2ZUNH(\N:\K>M4C@<$9=4Q"5-I7[7R;[; MP%0+3&C@KQ_GF.00JL":M'T0LOF8G2,TEVV8WXE-1PXDX) M^/2MG9%1@,K>Z80':8-5Z>ZIKANGG%IZU(+#4<']ZW28,@Y8<[A+CH$BJ\(5W?,^\'[KKE;-IF[8B/*%.=7^7VZ4.5:F@A<#X M*%/:7JCA:]HI+SC1W2E1UO1YI(B6\DPG.9*&@*D=<.L!H'OP:G0DH&I;EA+= M4&1_]9"D5W:)!FJ2/!BG8F"1MNJ\X\Q$%SAP=^FF:9&5B8NL=!O5!K#+H#NM M8',Z+8!Q%7HJRE;6MYA$VK89B!?W#7LTO4P23('IM"#NR5.P:8$]?7)>'0T8 MBM3]HIL81X[9I5:B&0QI+G"WHX*?,D;G4U`IVFZRSJ5^R=11<:AGG\V\$84U M#(UTNO*X^J-QR_NBY97@YXUZ#VO;=Y/'@.O9SDX,"X6KTT%YFMPG??;Z]_IY MQTXY95RI)$!=4]"JI/HPKW@7+`Y8^"9?0<)@;>;F8!A!2G M4$KY7S/F<*9%C[8$34_"KO$.0#6FA8K])Q)%E_H")_H+C^"P=* M-I*`D$CXY`]``DQ4H#M"<@N?5/2D]A8:MRKFA5(WMLB:>#.P,Z0?PZ*79"(F M(B<]-1$P>$W@28E7L'HNY.B*50_2F5EL&[0* M=6X%U?`0$26U?[.:"GAAWQ:LED('6WD$X9GU3-E3:F0+=MJ^YUAY,[W8E=P8 M!VRNRWD:K8@:85E]HC9++&Z[6]V[,D6T,#F+^-UYA>GTF(QC8G4@%K)V[14? M#*\2@;$K>0OU97+"(HJEQ0LORC&="N-]Y3M%T6"Z4VDPO',0J%R%6RM3A.79 M];F:G`P(RXGR>UT`V\8&LDXXE23V!341>H:(T"WI-+_5#@[E-AHS!I%N(Y0X M?_5*'F<,+%PON42O3KW6QA6&BNNDJTDP6\2R./D4UHU-O#G5K-K.7W2&,\T31T1+GBXFTN>G9$%0DWV#+ M!P1,Y=RPM$*C>`ZTRZ1E4-[?5=`*?)=Y=AH*'J#'3)S3K%2/18YBTTXRZ]]E M6F#'_/"HC<*YF.M[H+N>I2C(N+JQ/;6IZT2WG0GMD?)L^@5Y47V'ON]NW)4W M?RUM&J*>;-HQ*5]-TE-)$B97K=%R"%K)#8.I8@D+'*SB^VJ<'MN]E^:$.EFZ M[+ZLZ:FC4S,\O0N;"_,*`4P#UYCA`@5V4WU>TEF\>]K/G9:KQ!4L+R%S1.U) M[2^)X&D-;;-10SX'8JP\,6'VQJ5JMY&(C):-OX-ZY3NJ[F)5AC.+^+M,KSWB M)XYS%\_?<)1.A++&3E>=$RYFKYAD;MCQU?%$]SAEZ.]+?%RER=9R[I55T M]F'9WT=U`*VM6ZU2BCJJH=E<5$U]55-L_M4%K3$!K M/%!>HOINT_==(JVR&`4?Z`ZC%;6]-:9B/T^*T'VYKIH,#T:'R2P>V#:>H9%L MBRH3Z8Z.X#ION@X:_6;/$FY[FBQ$FBSVU#!RFNY4;@.E@Q[,RE;BZS9BF"R% MH5)-7!]DPE7"7DV.#EDE=C5-YZE[+[=FURD(-B6Y^M/%EX_*(MZ-BSB2*Q1` MZ7<_O5%`2C3@9,1 MJJ5TP*+I<26R@/I@FFG(!!Y=3F'M$,T,B!]ER@];$_?<^?ZZ-29Y^FAA?;/V M@%=?0Q)YN]7ER*GO\E0S;XM[%M>]V4/EE.,E/=`I#@("[G_I5K=[8!$4LZ)] MXT8D-_2!&_.-(E-$7'>/]Y6C)CA*Y*^A-^Y)4-N[/PH^,CX23;4T%Y5ECU9I MWK"AAQI@UV>MP&8Z[.C-F1_;VRB<)>3:T6'Q-=`N4"<7`EBEE9*AC>_0DQ.\ MNT81RW2U?'$Q+(WE-FUCC8M(P!P/]@\'^Q,P;SXZ*9`<:[GPAFJBZ5;-/6*R M92:.C:&-B=2AOT%OE49)CA].K8417,!-NB>6<"?=F>(K-93I4A.QT>_SV&0>.TC>.!MPZC8Z)NB%C(TZ99"][0_E<)_".-1LZ1`!]-7(5I($C MDXERP@X'C-H7I38-.$X[/&&6"Q:=L3551AA:57YH58.O@VAU-TALY.MS9*=31'?* M4!=:@ZF2UX-=V3@F02)`K2+_0(_;;$,R1*\![X$DDHT@";YEQU(D:P?`A&-W M6Q];JC8C)G8X$VI'O$1?X%KMBI>(1+6?A9<(IP)Z0;L=+['AMJN=81.J#U"0 M]`$*1A.YKZH/4)#L!BA0,4#!]GWIK1`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`Z*29. M,HF*5B/5\<[$(L$-\UE('QD-Z&WOE1/!1:D/FI37!=H%73CE^1.F7;S1NV[C M+<@8H`5R;),"`W-F%H/-'9#K$K>E.@3T4[QY/-:6*A:86Z^G=GUQ?I"\YU[3 MVBTHZ4B;4G"DT(U_0FS:#5U&2SKM3S6Y.,K/Q>D4[MV6BZ-ZDG9[-]XONB:[ M[=D7[)K@Z`9K0ZDLC'-_%26P<#Q6OI50C96+EJU;V2K9*.Z"L M/\#5W7_A+@)NEG(:$)833=-D5^^U2];K=+-KAXGG8_$\HJ4`2Y*;2G)R)`"6*8\ M-5><3VVF(Q<0PLXM?B$)-U&T=R8>"D61JH%RCW"IQ.),FQA/N\1FEJ1$"R0& M-Y!`(RP5 MMY]7@=E+8+T]4`L@B2L3*Y+?*1,9!_-J'WZNI=D#/<1C<241LT66L,K-H#`% M<$C9)/\888;]8@%RM()T&?U%`54]V!:F/!X#+[PD,9-3JX9N.89=\XNLPR@H M&>$Y922"$;=KG'9%U&.V:D6?EE5V!C;(U&!$@V5SS(8,D6T9+A:>_>=*D,\> M]H1M"=F97BA#,(\6.WFXMI`E1N_AZ\6#['96!"V($*NSW[DD,(6]?_54`-\.!O\'* MB@7_D/;SUP#Y_NO@S5V43;AHC:OIQ;WK.-MWHWVZXL7,@.4*Q\9]_54YFL5H MK)T*D<_%,#NJ'](=F40'I<.`;O4"E(X=7.V.RTD"7(Y66L?]2)PX`$8C<=1V M)`X_N`&)HS8A<9+-2!RU"Q*G9PFW:A,2IZ/Z/\L>YT,8!L+"$Z$<[$WB8F_( M?S\^-`C9;F@KFC`F1`@]N!+;C,6T7I(<^%6W-%/6JG#C"08W$L4'=3:AYZIX MB*`D1`2I'1%!T6M(:)5H49IG88!4!`/$S"6*`8IL_V/F=4C_SX7ZZ:%6N'#P^M$^*QW#\]586SE=-9CY M6;<0BAU]$BL\ZH\>H/-Q(E1N)U+)2,6554D`2?#0+DS7,8Z]T`KZ"A[9_,$% MH<\[IB>CTK6Q.;:VGEGAZ&0[_=Q64#W5F=A+(7-,.D69B)F)*X2(TZEZU$V0 M(.W7:>F$M'\U28^X\)9%KY2;/_M(<"I)_]'11GJ&/%3`(O*Y;?<7UD9AC3HH MCI(E4^2!6+^L&QLKM]2-ZSO.UL.ASPYAQ#^(88I_I%V>2BV3;F$Y,A'WQE)5 M3G4]PV^D\IQ?T8^%H>>34D7CY=ZRH+[M=GKD:!-7Z9YY93F5G<_ODGM;GZ?K M^V*0/QJ24\X&2RB-B`J788GXA5K706,%5. MESSCCGGM70K_>RKR/4UR7_OR5MM9@Q5,G>$HN^N7/%_QM+I_;#7`1!B[G27J M-0LS*?&,*%>U[_>S4JD179H#9J[+&=HY@6YU-$G'IP/N.,D*5&$[C$Q2>TMH M)LH$]!-$I*&*JASE53&TVC<\U@G1!!VJDG!Q+ MO1#-$0UQ/D@'9`&3*%"=TPF(L[8(.^@Q^R/71-<%9W M[IQ7,]+;I7>%7!*4O[,\GXO&0MT?;CG%AYO4AW68:,LBY02H,3J/9=V"5#F+ MX4$F&9770MJ47FGG!.Q0^HR*C0_3D\,C@<%ICSPQOL*C8V=T(;PJ?&MA$^$[ M1'\^?&4\V(Y?L:5!OEZ_.TONUADJ>GD>^H54;V6,9_B%-@*,.@AJ8VYY`!?U MO(H9@7WD%4]`G[AX,9UT*;_D@W8TXK$R:<"V()#V9L+GLT6+;@@79R"N/W0- M:<`:<)(:F4!QZSR(+A`\QC0-;=H4-2R,RW=I<$EG:!ISG@MO!@$S?.U,S98' MQ8':O%1+;&A!Y9+,YMXH6(YTOZWVAP<8PR!P)_[G M8X7UQ)QW$E"3,D[K!V).#@;R$F\QS0A_(WD\/>^1:\Q/R!#1RH[3>)ZUNS"* MMCYQ.%/'%#%:5&.]A0<^<"4ZFKD)61@9I[-@=;X.WI545[(T>[*=N?ZJ=?4^ M)Y?9*;^R(9Y!<:$^*LJ'3J(@@ MQ2%R_,F7X!UB]_"'*&3'U016C[5!N#.''^+P*T+ZD6P*OH-./QPX91LD/S@V M;7QHD7?B/=SV2_@MEA+1S>5R4PQ"\Z!Y-[U'L=D?1U&$]'-0%!+W5T:NBS[3 MC>_O`)U0"(+PX1-QJ,.>J5P(+[FH"3:A4@9-]/)%V>"`)WKC!O`<,,WP9L#0 M_M@Q+FK-)'M^U,;1CSCGAPF[:@WH2:BKW5<6=F%1.G$:!?@@M0$)%ZDQ0K_V MX@2W*G*3V0>UC=L$[5RHQ^?^6SJ*5R"K@V8N?@.\<[=QRA=1C*AV*5Y MI<5T?TN%XX,D^'AO#^.P@:1N1NDH']S5/!U.1K9KMZ0^<[9P!,KZ.U3= MG`"GJ\>(]PWN+\J6AYS49U`J=^VPGMCVE2YS<#I'N].;N61E`V1P>NAV71X- M(NV+=VUV;R>C.KQCI\D`24_,9#`%[W@4:73M@Q9Z6]9'-M?X".<%!\IY8^BL MKRPF$-0:_9_D\S8EGH)#?>X`//!-[L1XA[9QV*UHX\.[=0K`."$91+9MO%(%``W^"F6Y)@WH"&2$M:X`P M&,[@;HUULRO0U6;8"DOI-D@9^)!6;/D^OWY75%J*^]]/JUU^:")9JQB!:I.$@V/1"JZ&0XU54%C/2!L)'KHKK$V'4H#V'?+U76N M<\=ESIOF5RWI;-=Q.O:W"QV/LAD9-^C&;H/(_YD>BVI&*XOM$&>GAB6?]?$I MN&-BIEOGP!^/!J9>&-QE\1C)(FW#5":S)AJR!:(<#OAJPD8R%F&F!SIF$X@V M^8"@S\:OK3?,V%J*>#J5+#N@IJBB%XA&XE?;"3>@)ZH0;`!/H;30-H.YA]4O MP#!'Z2TO>?LT/$XGX;6R^Z2"?9*#1A[`Z;I8<-.;#=>+3:-3IS.`RJZ M-8FS->H#S(XKZ&/TR-Z40VT,V5^=$/[2^Y6-,SF_DU=)6!N5<1PQKL`RQ@A? MXIF=VJYR$K"P8QKY[7!SI,SY'+39&2(6Z;_(:R+>LQ(V:,[F\"VG!]0'7ET"D%$U_7-@/Z(L/^ MBZ7],^I/SMW]7"K#'H=C1Q[B:9Q90>>'Z4%87&/O..!BUT6[%LS\>^#5R>7E M9?+'JS3Y<'!UD&"+@4V*HH:=FJ_A M,-7H$N&.NQ:%]8@D35G96I>(@<'"FB50]U[BUUDQUS]-N[83U@* M:98Q$J(3<15(*$T:R7^;+1H6AV`+`3V4@*UE$6V4GX;+1$S M%7ZEE<]KI`Q=>G[=.@:4.#:>MPU-GO^2JL[!TGEAV5AI"ND-ECPT,RS M9<:Q0G$\IU3$D/R)II%.:EJDS"K\&$JZ.UPZ=6U1A"!9-O01/3"YTH&!L'O< M_T/65"5IH3;I5#?#=#W@60OGM\R?"*Z`_N_4"5]42NZU;"0&0)Y.++Q>II.7T,9KZ2LA2-S45<&&'%?6H)U"BA M6>6413;M7_B&KB331/]YCNB9:N7CI_!4*-[7`[=5B(`=#JGBL^6,2<`9N;PF MI87LPA>3/KZH@"\>`E\9:K;$E_IX!_=0#/Q"T11(-T)5^/ MZ40,\YTNBIF.\;`/$_0>AP,>JN`>I<`!&?.EW54]]XU50QBGAXGZM]>YO)&/ M"C=R>LKK!?,99W(EEK&JYS)6BR_4O%49WOH"5JDLJTRZK#*ZYI"`BO.4NPMW MMW_COJKNOMH5P_V^S9N&`VU@KRV*.]-^=9DM5FA6`T%%)^YR]LA<-6-/0L:N MXHR]5U;JX^LP_FX%72$C,R"*K6F;DW%]?>3T)9ZET@/E]ET!)Y:#%C!!J"[.75:;G@?5NH5Y:=HUA,)H$6/?C7\)*Z'N]#I+V[3?Q3R,DKOC M&J'R!&8_'`3R<<`/1EMVF/`&V6U--<5=2I23RW0E+T^44<..] M7^H(L1A6=Z#LPD]HMLEW?8J"RE\L&X/H0^/-UO/&)*Q66L%P^(%8)(>4,4-* M+Z#R99$&5Z,.K%FO7]^&]W_@#'"1G"XR9<@<>L[E``-QXJ)G;*X=& M[>;R32R7.ULC_.U<.%:THW-$]B'"P=KAF2"+$&3C[2CS#YR!\S")7G)6>6=' M2*Z$Y(+>,9S%NWQ5I1V+=/CU$?%'U`&I3JU5:A1>WF5W;*E)3!;WP^:M]I&4 MZ0X#PTTKM93RSHUB[XQ]1;0@HG?!*B#ZGY$:<\[<\>NC*0+Z'P[2CBOUBD0- M7LH&#G,E)>[I=E;`PRJZ8MS2+_+Y+$0(]ZS10)H,(5.*3ZOB-L&$57$4T:*I M)E'V`'KW%.'`[B4IS>4H@.QT.8(^'G7.W@?\A(9)IB^^/EWGM([27('T>DIN M@#,T8JOO_N0&W_?I0=+_'G:L33X\+;$M6"9J902I%+E9*4*NB`O?9X@S*"68 M8'D_J"+TL*=VPQ!XTV[J'/U?ZB?,?&5/1_+\R`V0&S:<,QY>#4_&-AX#?XZV MLY7[RQR9][T(XV( M]$>+[2;M3ENIOMUYI(!N6V#>&(JA%EF&3`2=&Q1?J@O2+DA!U"=13A>Q:'-:Z?4":V61H$.#)M MU!^^=N$EJ=*O)#_#_X+6RRFSL2Q1+^LE1X<)6!_83S6O#;S8I!H$P_(!.!(, MCLT#[2I4;EXDGB2TF''TUFVO!?<78_"@IRBJ,P&KZB3_=4X'\AX=U"^$:&6^SU?=;8@^0B2C7V$PV_)\T.FZXHV1KE[@^[OW+NUW@<":JG;"XX MT[#W/;9&FT>N-T693>FA+["U7_(0%V)I=4%=E[<^L$%'&`X.DN!Y=2U)J;9. MI@J^38PUE4*^9' M*;6YEP)@3W]=6MX&)P,IS:YEQ[%Y/FE69UDZQS:)X=E7([4'-UY)_)&R$,KXYODD)?AB@P,8R\C"/YGMOTV,#A)+TQC;W! MQ3#L"\IY06M\X3OH=XE_Q*68:1(%)*V6Z,0Q,"T*;6L$NJYF8)N6>YABKG5= M"NX=X4D/<'\D`T37@U"OADY"F)V#`:AM:J:>*B?&`$<7Z4Z!T]1IMV[26$@# MT0>]JDT"4=KIQ`[&#=<&-:X1.?M/&H6LP11BM2&7+N;D.;7=V2V#@Z=TEH2& M*'(X-B;&2JX`FR46E.G/CFMRVG[P,+I#?_M]0M'I[Z8Z5*`PZZQ>K]H9,.I% M`7LR%S.NSJOZ+BM-Y;1:)Q_192[;NEHHW@!I;#2#E\5!ATE:F!0"E.=7^2>. M1.-Y;+BB3RI5(TS*EREC`Q^9YB7EC>+F&%8/OY\@;%]RQ21?V55M'ZJ6'<@1 M1D.'3R((K^X-T!/$\H'"H34#_D4I3,4P+.[XL< M+.]OP%_)D_F97>M:8XX`B#UING-U-@?SJZZ9IV\JRK;M&P&T&[^[0ZW#L!H] M/KRR$<*>:(.5EHGF,O!.YU@_8@#YF1VHU]\8:FD*;II M@-7I1+";>ZGPF>K;[(>#]156IJ,3Z34+QBJ+WY6!5J3IH1\,>[M*],^[6,B1 MJ= M4ED%7]<9C=5>I(\NYAHQ\O3-`9ZE3@*=4UU%1:KOZ]0Z3,*=N44[PV>5UY:< M3>L'MVA#;UD?;O386M\;*K5Z<:JX2F!K+O.,Y-8V3V6IBR7*XH]#IJ.@WJ M/"OU!.=8(?T%&7!=W]VU?^4'MGNB6'R2, MJ-D6YSAZQ76X@Z?3@\3->NNZ'O#WMEB*GSINBN7`JJP=:[-2G'X!5#88").) MM7)FS)#/MN^H!5C\`5YMDLMLGH,6/:M(Y&6K5570(B*:Q17,JIAKH`/K&1:) M+7I&:E>BNM_DD@^;#%'!GRK!GS9V,1V2!9/'8PS"Y![1.>C6AB58DLHWK:E# M?4M-F32&4#MM,(DS8EC,/^@E:[ZZP.8L6V44.6%8N5L2T6),N:[$Z0"VYXGK M9C=87-EN//&80H=YM#6A030Z3IQ<.:8F,P.(0PL<&G<6_)KGNH61,H*`ISD\!#[ M`&1/QA*52X"C/IB@@2DOK3K[Y*G(P%:6!1O!4FH2OG6?`ZL@.TY)U*G`@@@4 M]2)$/2@':;*Q=:A/,@)(=7$BFA#J3KF7#:LFBE;B#,%"=0`LH0;+Z=M5$><6HT'.-A M;'4N$V^7YGU^1HP25-9S/(QNU.:>*F/E)X2F?J,VI M]0[G]Z`/&./QBR?/![S)^#$4CK3W0@(XI2SL^487`RL?RG7'4;%!1`C$*:1K M3O$6*&<+'.+BJ=&D8([>>':C-?RFB,I\\.%MEA!4IVN.?)5++B^S7W*!J1@2 M*G'KY)RR9=%GND2.);9+3C1>L3:>6,6D,9[S9,BO&9SES^T?3A_@6J`4/;NBW-S$] MO#7""BO*9&7&EI6&&&WF>FY1OABO2'IYA=HI-5%7QT%;TS&M4O'J$-"-02HU M7LV:6ZW;YQ+8%E"/4:ZR(DT%:KGIGYT[8\$#-$,213.0WQ=&ND=?Q(.`Q(S? MDR$.DD<6PT+H=(#=&2>ML55Z)07=_SEIP0\&%V9P-N:S)NL)2Q7Q<>#VB^+& MO%T3KDQ?PZXD_,IE[2XD9!B$5[I_YP2`VBI1'DW];@!PEO#R4=4YS8ITXZW& M.8/F:NO`I>Z]T*R7DFC)Q<%)+Q78&^.-);3!SF=;M=8M.*C-+LM8E#@_"O5]_(C8K$R9ST>MN#3U;H],@!-A5HG>883Q@$=W:K'J,Y!IJ MA7FGVD=//UQ8'_W.#WKQ8:W[43X'J+-WF,_%;N9XWUUE8122?&>L0R*C`WQ! MA"'EQE.11FJOYL04#I+SWG"#=%NQW34H3X)N=4K57[%,3/U+WE([K\;HQ&Q9 MYA)QZ!23HNFR%J%8BR!)CPD_).K]Y4K:0J>.?X'>J!45J$/?#=>SJXOF%ZVE M!.5%ID\.JW4'-GTAT,Z65CG]`1BM+;(S,CY5]H2Q*ZGA:R-G5=??5V0)6'7M M?3XG%?Z=T.K2&`KGDN-A@(6VWA('LO&XUX7&)#Y)[0EQ*S6Y)G\,*V;**^$! MV/)G][`*D,VOSA0<%9.0Y($82XH:2W"0HR^Y7U#''C'V]%"UOXC2U=Z'52*] M%%$7N("^!^T%3GJ\P&&R.!4$L#Q8*E)_@6.V\=FF\[!Z'RW72P1:57CJV+UL MO)'.06\K-0O&=L^[T-T&Z!9/>@O2X*ZG43P3H4_R::>"OSXX'`#IO1"T%\BO M]*S00J<2?M42N>=,]5P2>I&\I/2?VKK`M+_K-95-D>\OLR!8[VY>![@D,.1 MPJ``V5$U:C1+O*\L6Y##W.456/*K>TR.01BWA]+"OCX(^M*C,C-984TC1Y@; MK%!5^Y3[21MSJ;/!/,9\G2MV^`Q'XO$QCCK$VQ=N+>S,KY:[PG@SU5&Z;34. M13H@.#`LKW08X8<26WV%BKL&E3)?5&3C]#7]Q]%KOT*&KR%OMZ$EA?F(1QL. M7X=PG,!H,)`Y2N9ATYFT>%R8X,'%S69V,#PR-IC>5"#%\XX2@](#3MT7S&`H M,O(1_`2G?)X_6-@=EFDU->C:Q\X??(>O.AWQ&D]/7L<6Q2T7S/<]&V-7VZ*[ M#:<3^J0Z';]^QI88,*I;:N3<7(6V$FS\T(MLQQ>D/()F+5\88SL3(J`TKXON MGAA+5VG&JO-!M"/P1W7^]?KF\\>++\E98GY\:W\\W^5,<_^B\21Y#2SEY[8_OE/^A"2UX(+3X;>2K],??,I%'2)G?H@.`][QQ*D@- MJ<'$%B#P=B7@>HT.FQR13YQ)-WO92^)CE!#,'0K:G/LM=/=-F(;'#K"P)N6H MYDX[Y;L"G5&_@-KTB))5*H:&J2<,&Q#6?7X/\M$3LHP:Y:K4H0K(CQD2@R.;#TJB*O@0J2>C/KME%[1`_0`JM'*H+":9*K;*)(KN;)'0K8-J'P58D$?!%,0*/&7ME"Q MUMFRYX.9>F;<@46!3_DPSE"X0"%>'PR.)1_@F M>\'=3$0!\2N;0E?2BBAW3)Z6_R!(N&`=W(-&N?D@"7&DPFN\4#GU4/>+,I6? MT.5/&1B^T6B*#[/WF,E!B4V(V&JXV+N3,B_.,:>Z!.9X2%Q@EFM$AN6;M-8Y M;^;J_JDI9J2MMY3\SG@YV-FF@C=FR-A2MSXZC[G`E'QR6DAQ@8R2A`[4F3E\ MBZ=H4+VQ"\'UB?F-6D@#F[N_K!YT@SM>-B46E'/#+K0Y/1.3%%:FLQL(3RW; MF=7UD]\YV'XIB7\)<3=8Q]9T$\$JD=W39%R=O`2JZDO^'6R0H1R_W11W5WR. M&!LL';8>LTP:Y>47Z#Q^.=]VNX/+\TYGC)Q+'LJ52)4OHEH]^P7U;FMJRY:; MB5'<&/6\:^$_6(L+NUL1^E@8K7:34&EZ((:.KE.&FTYV9TF7SZG/@N/I*YC,[9YLL4;KJ>8C.>PI#.Y`A_;.>4 M<5>Z6Q#2/#)W(CM05]USZNCRYG<=V]AD8W6!.VYF5L"B).O3,#(,0E$5O3J? MFA@&N:1T"V[)V#&?,\,OLSGI%>XW@O*ZG8.HS9F*VKAA=B/Z)^M8HB.7RI#\ M!;+8N+S/C`L)\.$IZMEZV;0,-]!P$XLXV&N<)B?./`^P"1ZU9'5<,L+J!"[$ M@2VO2A#<(0'1F'XY2K>CN=4]D#I?$N:+?0;6IAYXS14M2`[RQ93]+W1V9AJ, M`ZHEBUBXK_-[3B23G`?3$H?!V_::A%A4'\E@U^.IIV#K$`Z)7+0&(D-.4TYQ M-_X'QLFW&@OOK;N%-I%`E>N%HZ``;XB'JP9[HCAW-?9[K0+`R5>9IY7;;-0ULPHBS#9HQ$KS"I($! M;VZQ7S/QQJ+IS-X$3NH3C23^\RWS?C##<>ED8[A51RTRRL7I&,.3PA'W[A\-?)QPR<<:+Q$/\4(%I M>R-ZI564/.T(I$8W\.-+/6*JC0.GU<>8M3PQGP/U\`X;T=6FT0)>&6MB,YE- M1QXVX4W$OWM3I--C:;(,+(36ZPN!!74-`;:XA8*'7C5?=VY4H0,0MV%N$$D+Y5LU-`A\W5B>AVVF'\# M9DU6(*5$L*3UDEN,^R<"']Q0<4'U42O>)\G\W0C/1CD\T5&S=8P@YSBJQ\#= MFBD/N>#7G,_8U7JSLYA]/FSZ6MILC5UKO@0]"GBBMK4=WG#S#\:`?5[@9[)[P1]E&6=4Z\8R#4[M MG\-8Z1^L;]J]H2EOW)Q1@[$2#M[^[!95C<]0O1H>'=DIGAY%Z[YLG&)/E8G_ M;!5+DBM,W_QP\R[9"_[V)E;.)(CRF'(FR99R)K9R1G\YDTY6JE/.1&TM9Y)L M+F?B]@J)EOK84LY$;2YG$CF$.P*(-]T3VR6DMYQ)SS2<-:H-Y4SL08C35W$Y MD]Y&,F%A):<8KG);[1D6[9D3X_'0;PDI,'67Z[E5&8,H+P>*^^$6EGQ20FGW8P'R- MSS][JH%%F2:.IHJU`H,#U?*:.-B._L=ETRM3&Q@B= M1./T5(.)4.51*:>M*V8IHR&T!LW,/V/F@0WQN4TE69_ET>FF]BS@\&MHA#@>1NGC!#?F4M\D']$]=P7VB%EB]3ZST M$^J3M)!S\N().[MS:U,'7'.0$3J\<<]634-SG'T.ERK*66B#4' MWJ*3730^GCP7V6(F24E49@1,N9D(_L5:1S'U1)69*'M#EP*S6BQ";)6NN:%K MR')4P$!A_1)('GR531@GWB#52SB%@78F6F[)KSY&9@9\:I\60LKV6CMOO>"$ M7:`DLH#X]MYSQW6!MG)W11Z3)R5&--X)2=OV!O;6)<[%7!RCKIQW1E6=,]-I MHD;W)CTY%N'@RIXL?S9Q6BLO%W;:<8=.K"#=3@Y=&8XK3"A.JH@1\31 MC.$QEUPRS$UJK:NRPF+1RUB*QLXOHN=>]]H6'<-BNYVWKO%:41>ZMUCME+(D MWY]=OZ7\AB+XB'W\ZPJ]3]2[!#^QCUUU+HW':N^F6L$5'(\';WY4UP7V=KQ] MTFS@8YYA^%%;[.8MG+.I\*`G#7-YUCP&8YP'Y_[_]2__>KG456P5?4J*`LC\ M3L:'^SC%I#M%-Q.8]9]IJRYU.T]J+4BSM?V-7C3=R3ZNTV]F^-4M%*X80@&6 MR06FH$L^H+A[X$B?:T@2F4`_89UA=#HR`%>VOR]@TAO\/WL.?`>B$-'OL3'%!@B>T2(!;_#Q[W_^!Q_W?` MX[['4CH_$SC(88[]=^/,)BE^<)(4Y5UR_CI#4E-4G2A+Q0ZZX]VX=$QX6\S: MNAML,T\X5U(MG<_:HD",1;`9NHP^Z)/F(<'W*.I1K1OXPZ&R/]CO;`!^[L0,G>?3!#3P#>,1"J7WPO23V*6$^I(]FJ8* MN+3#]'AP0O\>G8[4GZKZ%X9$BF/]='B4#-/AX0"3R8H&&\?<5<@@Q^G18`AO MC8]/NG^Z1[,WC9#*:*"#@`-X[1DJ"ACB9!%=!HB#N/=B%BI'W^H9V M\X"_DY9ZR)G;S1:6EHX.3^C?\>3$/&3LNDEZBCPJ/3X>FC^:>I5L@8^!)XT& M(Z#743HYQ8-WE(Y'PXU"U>)9]:!_TH.2AA.(4_M"ER=D\5D%!<\E;B)T:P*J MO9589A;W.L&R<)$R36JDPNJ,DT$M'QJ.C]5UWK8+8:6$J@H?VX/3^J;S65\T MO$+:AO#1:;O3,<,'HR^[6:@O.4DW&(KY@`5`464W_T5Z.U;"90^R*8:KC@\& M`[<`F<;J-:9RK.[-J0.B1A4_2CF`UV+"'KE4IUQA,"+]"Y?Y@+75MCDVMEUA MJ8^(($S):+9.-5TA"#-LRSOLQ]-@8W0#@I"P*XL@O"+>V]':@F_4:I'/[R22 M;];AU.`TQ*.^;.3R)K\<5#N3*G7V41-=]4ML-;9NDM'K9._P8'3X MFA?@:X!O=KD:2M-;YC,^BA&[A[Q!=0&DRL>/'Y,/'\Y[KT["5\P\V`=6A-_33T1B9XBL88W*" MJM)I>G1T'$D'#*XYX;GPD'H_ M29+]Q3>T&->@,&B708RKQG38YAZ%C&!GG-G69K967Z7F$N2E-`4P/3^1\20Y M9=Y]OR,%]>YDTGDP:;I$.K+\"M1/B5ISI=D]ZMUKN?YY=,+JO:-?W_H%,J]= MW@6O/V!Y"Z0"%1,@Y>)HH*B$Q@C;LZL;@LC$*9/L96](23Z!=SZ%Y4.9".K* MY`=K%%)UJRL:,9E(T09E\)W'0O:&<-)&IT,X9OZ*O'?'Z>3PM/.`S:WI.5/Z MW<.1+/`V\H'(6I*]J:QX.%0_;=[%O6R?'IZ<*EP)N1V963H'N##)S0C,83R- M"905I653HN=M@7DY%6;\XD)Q$(C%7`;>QS-I0VI:)&$D,RZF>E_MX$E>4JF5 M74JAT/"8K#$215_*Y]L5)L^..WOW[O+F\O.GZ^3LX^'`M=KT_\J?.N>Y0XY">PHKOTN",F>.+L!P@'P6ASTZ MI7_VQL?PBW<]HX8\`PG"5_K@;^HQ=KY=+*;#YUC0Q8[\)5BS"H[SO\I1+IT+;H/P?TZP,;WZN_^;C08'$6M M%!<39=T^5*:PW+>_,97/0T?5%L`#-K(BEFK17*RNT#%':6FQ@*2Q+YXX<\R? MG&YGH0N_[C19`A\]8A>6S"(Z@_:14NUQML#NGPVE3+D+,*W%&1TJET$7X9=Y M"4)0[DIW\HC)Y1>W?)QL@+8N[NYL*A@&(JE;[RHKYDZ]#I.MBY=*"^='7<-P M+FF(6L'%Q$W)T.RM3$/^F;!3)V*).<$:.-W4K)6ED+U8;J\9=A=QO?(ZHP+I MML"+PSIW:'+C]$](]AI=.6DX>&,J2C=K+*E<""")\-L!1`KYAY2BTQ6/6`;I M%B;>$3X*N`PZP:26<0''>%M7HN2?/I+,"^[M58PJSZ#(G],K7]Q/8GD5Z@GD;RTGD3R_?4DDN^O)Q'0:>=Z$LE+ZTDDWU%/ M(OG^>A+)]]23\$"E+ZDGD7QO/8GD5ZHG<;XM$>G9+T0SC`(69I&DW2P,#U)> M1K(ONF,=GJ`K+/CM,/;;2?19D\0?(`N:\CK0\5#>!2F^"/?3## M7H!80&8?^A5P9P^4XT8C^T2/CQ9J;,WKW5$Q@53O9OZT>1_)CJ^G0^=ND53.O[E`V6^VTL5MZ=D-K/_S4H9Y;9:MJ; M@L6GL8-^%/OE,'I3-A-$I\QOH$A3#^P0$?;=9S]FWXKE>MD[E2].,4/4LCG.%.R,%#9\OL+V`EB, MJ\WMH3&Q['?CJ*_'4?O17P=9Q$( M2]]")O%;.-CXM;@X\TRN+GZ"F]C1UN6M*/$"_8DMO`^T!(8E=\)3W(9 M5@1=8Q9CC-/D%6HF-]H''(=+]8&H7-!2]YD/J(HEPU["\-]'6_X^[OV[B_WQ M#TH7Y1,QR;>LVJ)Q-W%3#]T3\VNXX)[@"'@PGHU`)-)U^A6FW0CT8F_%%U.K M#.-S6)O.CKL+HLC?FRCFZ+G;$X,"]3W3I^;'P4`[X)AZ]F/[TK>"ABPA-B^? MO,_:)]RS:V_!!"A+9@ODP.RQ,#8!@0)VO143U'WC@@VGGBF0F]RG$8.#GGL> MZ*U+4\M[XZ6-Q?##A;*/D,9UQ8.!]3#PA9H(QZ`3C!CJ-:MZAG]>FU4)9#WW M(UM[J?:.V+M=/?(6GXU.8N=K_NN0FSYN*[T[?2S14M[ZM.Z/326M0E_"-@!8 M]XU?=9/[/N\>I2!\]K4/G13A,]]S5#PB$I8H1N^H(DM8HUT7:Q!%/0?VQ9*/ MHWR3>)P1MNT``;;1/P+Y#Y(!-^P<1=\<;WI38IL!!)6BHKIO9738T0DC`>*S MG<3_^#&KS3?#V5)KG]L\=UPQP3.6PM(?XC:;<:*-Q`[+NWVW<(\X[N%0<'\F MSJ:%CP07[*+;35C[@D/X2I]$=MO6;HOZ&+];IXMQ_]J/HR9J.&W;0;D)G5K& MK1?:]QM@5+V^P?[9CJ*S]6%"<>@6!BDDFM9]?3/B)_@8&2+3JL:Z/H'&X$\% M]]ILB>YKIP/T.K;GUL@RQXV.6:C*4HAI;EJ+3..*R14W$/:WR?4$VU@QRJ3X MZ\OM]^:"&Y[XW[%CRR`A6\,85I,'[[E?#=0>E)T4UN'BMSUC#P?4`J\WP$$6 M;^B,B+H&WS$V(7D$87,??W,RB)Y'/Q!"8A_&X5,1':]_FEN$DL3:D`:7!".J]1'=DGNJU]]@NA9T)QU!TIZ_#Q;<_3 MGP6D\7 MQ/#"S)0-2T+GW[-H=\UHDS[%^:U8,2:K^@LU96J3 MD]?N-W=&OW09(&L(J0MJBC+"[GNFO6",?*2;CN3:!J#V[S)LGK/68=13;Y-Z M`MINM1!9.Y:%!69$U(B-$Y+ULKYNW]RJ[47>@&=;AOT2,6K'WG2!R+T?9)A( M::ZE14YCVC4I#X+O)RR'Z0W&Z=\N&`0;6O'SI#[RRQ@OU]YP4?@X%-_A$@?) M.^M\,G/!.>S3,#BM-,17]RYKRM^V)V8X$$99R;7R'Q0PV0I4T1@B.43+[NQ)189(>4#/C'U2)"@]AAP1SV]+F\JA("5 MUBB:K&&Z@*7O9DO@*W^9C>WWH?K>3='H-?TPS).[8-;^;PZCRHBO&N]D:)\+ M9M?'@5(O1=!J""':8VB)TJ*-04DLS)9\2$GQ-S"5_QB^"2]L@R4XFT@J]Z8% M799BFZ%VPXNS<%]>W=]H5;V27;)WF4L2T_XN/_4N<[FP;,;'EVL>\[DJCMW(NX-\!0/VZ;7Y*4QG-U521`@CW]! M*3##8[RPV8.K;EI:>-MM>AS.,]T0`P[\P([`L?94Z#_I@M5I>9LYU8[);2\Z M;5YJ\\Q9_\:M[A+*(P38.8%Z'+!N8V)68+V9.]WX0! M@.Z%^XW3S`1[.,-+'ZC=#OZ!Q/-4-+QN7C'I%V&85)]VL8LH\]C.Z`PFK MF?Q:T:,L5Z$7>QR?!?1.S M1ZJ_9[5L5&JH0]2FM[PB0@(1"CB7@3;K*=&P$187/*BCAR'@%PY\[-K)WTB(C/G(D,[.=#3K04,.`F MT(T#V)+E2Y$(9_7]811*Q^="XZ8-WZIJ&M*L,(\BU<;F]XW!JD0HP,I]FNC= M&E/0*DR)Q,YOJ,#U<@I^R#CM%V03VBKH_S.)47^7+Z&]*H9U/W"2MJ7RYL"- M!E>%2.LX7.M]/B4(08\:L^O\MMC3&N+0XVX5VDD=;DQ?0:;$7T$OX<9E.S2. M>;"15>\/3E_Z233]M!VV\SSBI#X:2&G)0*$5Q13Y%+:NC-2H8\>8>8!<@6%, MMF=\/ZB%2C75P+%NB]X/1R'5$IL3J6YJ7/PS>U@\[68F"G6-8[K7R=DE,Q_# M".?0@+>>@.T'SY5J?63]8PU/1>SL<-8<3^*OL-_!K8PTD/E;S^EO<@8E1?NE M$>GN\ZF)&CD1QYSD8`S_]ZP9TV7_CT++1R`X?VN&T)=) MR]?'Z`I<2>"Q)Q37M0W^!NOXM9G(#TW3_O[_`U!+`0(4`Q0````(`%%*:D7!E&UL4$L!`A0#%`````@`44IJ1TAU!>[%````*P(```L``````````````(`! M``(``%]R96QS+RYR96QS4$L!`A0#%`````@`44IJ1[N80SJW`0``KAH``!H` M`````````````(`![@(``'AL+U]R96QS+W=O&PO=&AE;64O=&AE M;64Q+GAM;%!+`0(4`Q0````(`%%*:D<2>9BH2`(``.0)```-```````````` M``"``:,/``!X;"]S='EL97,N>&UL4$L!`A0#%`````@`44IJ1UPBC@/S`P`` M>0X```\``````````````(`!%A(``'AL+W=O&PO=V]R:W-H965T&UL4$L! M`A0#%`````@`44IJ1Q6&PO=V]R:W-H965T&UL4$L!`A0#%`````@`44IJ1\\R MF@\P`@``&`<``!@``````````````(`!]R4``'AL+W=O&PO=V]R:W-H965T M&UL4$L!`A0#%`````@`44IJ1X0BYDRB`0``L0,``!@````` M`````````(`!?R\``'AL+W=O.J-0CHP$``+$#```9``````````````"``5&UL4$L!`A0#%`````@`44IJ1U16<(RD`0``L0,` M`!D``````````````(`!,3,``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`44IJ1]3.ZP.C`0``L0,``!D````````````` M`(`!P#@``'AL+W=O&PO=V]R:W-H965T M&UL4$L!`A0# M%`````@`44IJ1W#YL9^C`0``L0,``!D``````````````(`!3SX``'AL+W=O M&PO=V]R:W-H965T&UL4$L!`A0#%`````@`44IJ1Q$] MX9"G`0``L0,``!D``````````````(`!>T0``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`44IJ1PO/A$6Q`0``%@0``!D` M`````````````(`!$TH``'AL+W=O&PO M=V]R:W-H965T&UL4$L!`A0#%`````@`44IJ1SO(:\ZD!```@AD``!D``````````````(`! MLE```'AL+W=O&PO=V]R:W-H965T@-^.&UL4$L!`A0#%``` M``@`44IJ1Z0(DHL%`@``UP8``!D``````````````(`!D5H``'AL+W=O!@`` M&0``````````````@`'-7```>&PO=V]R:W-H965T&UL4$L!`A0#%`````@`44IJ1Q04_KGE M`0``4`4``!D``````````````(`!XV```'AL+W=OMD!``#B!```&0`````````````` M@`'_8@``>&PO=V]R:W-H965T!'VW\/P(```((```9``````````````"``0]E``!X;"]W;W)K&UL4$L!`A0#%`````@`44IJ1ZP#/=IR`@``*@D``!D````` M`````````(`!A6<``'AL+W=O&PO=V]R M:W-H965TB.3@`(```<* M```9``````````````"``41S``!X;"]W;W)K&UL M4$L!`A0#%`````@`44IJ1S;?T?;K`@``0`X``!D``````````````(`!^W4` M`'AL+W=O0``>&PO=V]R:W-H965TMZ``!X;"]W;W)K&UL4$L!`A0#%`````@` M44IJ1^C?H7DG`P``#P\``!D``````````````(`!:GT``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`44IJ1_^M);0`` MQ*H!`!0``````````````(`!V(<``'AL+W-H87)E9%-T&UL4$L% 3!@`````T`#0`'@X``%/U```````` ` end XML 13 R33.htm IDEA: XBRL DOCUMENT v3.3.0.814

Accrued Liabilities - Schedule of Changes in Accrued Warranty Costs (Detail)
$ in Thousands
6 Months Ended

Jun. 30, 2015

USD ($)

Payables and Accruals [Abstract]

Beginning Balance $ 202

Warranties issued during the period 137

Settlements made during the period (16)

Ending Balance $ 323

X

- References
No definition available.
+ Details

Name: us-gaap_PayablesAndAccrualsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 8

-Subparagraph ((c)(5))

-URI http://asc.fasb.org/extlink&oid=51674963&loc=d3e12565-110249

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.15(5))

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

+ Details

Name: us-gaap_ProductWarrantyAccrual

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Represents the aggregate decrease in the liability related to payments to satisfy claims for standard and extended product warranties.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 8

-Subparagraph ((c)(2))

-URI http://asc.fasb.org/extlink&oid=51674963&loc=d3e12565-110249

+ Details

Name: us-gaap_ProductWarrantyAccrualPayments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Represents the aggregate increase in the liability for accruals related to standard and extended product warranties issued during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 8

-Subparagraph ((c)(3))

-URI http://asc.fasb.org/extlink&oid=51674963&loc=d3e12565-110249

+ Details

Name: us-gaap_ProductWarrantyAccrualWarrantiesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 14 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } ZIP 15 0001193125-15-372838-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-15-372838-xbrl.zip M4$L#!!0````(`"M*:D<`+85TJ-T``#&N!P`1`!P`;6)I:2TR,#$U,#8S,"YX M;6Q55`D``W+\059R_$%6=7@+``$$)0X```0Y`0``U%U;<]LXEG[?JOT/6C]L M[58M;-POJ7[\'E"Q+%$'1$F6K MTP_MA`2-[P/.%<#!3W]^O!\/OF=%F4\G'\_(.3X;9)/A=)1/OGT\^^TS"C[; MR\NS03E+)Z-T/)UD'\^>LO)L\.<__>N__/1O"`VNKP?1=#+)QN/L:?#[,!MG M13K+!I<3UV28P/EQ<_/CQ MX[PH1L^?.1].[R\&"#W_BK\NNO=A,)#GE)[SM4?7T_ED]&&@UO[)%EDZ@]<' M(^C'AP'%1"!"$,%?"/O`S`=&_V_][>G#4Y%_NYL-_F/XG_`R%@A:L,'U^?7Y M&K!_'WR>3DIX^_XAG3P-@O%X<.U:E8/KK,R*[]GH?/G1QZ_%>`"D3LJ/9VOP MW#^?3XMO%_`KV$6^9.=L\>:'(<"8%4^K%M7;938\_S;]?K%\>.'ZA3!!C*R: MS8L"1LO7;OG4->2;#4=9WMP&'C2\GCT.[YK?=T\N*HHW&N23[UDY:VZR>-:` M)B^GG!+51MOBC><&]U_S?./M^[0H8(I^S:?Y9#+]7DV#LII-KHM8,OS<=)+F MP[*Y?]4CUX!L=F^2?8,)-?)VSUP4TW%VL7QMU0JFT/R^N=%H5ES,GAZ@S72" MX*VLR(>K=KL;;38H\V$S'GC0@*:]^%)0X-YB;ZEZ<.JS6U:?JTZM'S0 M,`O@B>MIV=BF>M+4:%:T4`Q/GU]T#T:U:;Q\3UXL'FZ\.FM\52Q>G:V_.FZ9 M@N-\\G>GR%;ONW_8>/\'J]XFQIB+ZNGJU3)O>A$^2RY^_^7GS\.[[#Y%*]4` MRF0PJ-3)^$-9/;O.;@?5%S^DQ=!-MF[]K%K<%=GMQS,G,>A9%LX?R]'S8S<: M'\_*_/YAG!V3BHL%JN6<^?!S/LFN;D%CC_)9D@[S<3Y[^B5]S._G]^$49/D' MF"&;/L"3V=-@.)W,LL?9M0.23<<"(2((1O^#831O/G^);O"-F[X$ M,P(_$LD8-N212,Z`Z;/!*!OF]^D89N7EK\G9(`>)SD?X]'8-)+7^=3A9*?O9*<@36%"_((5SI1QA/ M3(UR?Y>$.[(84U*ZOQN&>46>XH!9(^]A7H#JP.=8OS#6'7E-.J>3;U^RXMZU_R6= MS8M\EF?E=?:0/KD/E5>WGXI\,LP?TO'EY'^SM/@"6N8=V,,'<$>]$P_7)]Y^ M=!Q(:3*=%W\L1MD1&75L'$IH_OT/-D6YCU#:`Z'`QH)0YQK4-,67:9A=EN4\ M&X'9RH)[%X>(JR`$*PT_)3$GL12!B*U>&!;L(X^OR.N( M?(VF7_*)L]XO>O/J-AB"!2IS%W%#U+G^P$(GD(U"\ MHZ",OR_&(LINT_EXYGY8_^6G07'W^2D;S`]_YO6X5&WJ`CM.2WCW;Q`%II/9 M55%%Z/$C_.J\S&#B#[/5PW+YM"3[L[W.[BXV50).9*0I8MJ`6QD*<"LIA0G+ M8D.".([`O;PA+1/VYB$K;LJ[%"PW:-)S0UZ$?B_8'9C[=7[_-2NN;C]GPZ4B ML>EXG(W"I_K7^N%PS=MD3$*#8RB%+=?]F5->UZ4';KZLY_B(/ MU]FX\L'2XM4ACI_'_GGC==.^?9]/A MWS]7@W$UGU7Y1HB+7LL(1'W4B5`[XBCD28Q#BJS%"2"6"NG0!"B,E<(0\@6Q M`L]P(RAYGB:4<\F%IC]==`/P1C$(Q6P9[<*`4_%(M&&2FUZB71AZVCSTJH<8 MXW@9@*-SXHT=^LL`@-W+()8=)?G$)87LM(0`-WNMBP!*E>!-L=AV2+FT5-'$ M(H"A$-=@]8T&\0A$A(6REA,:W+0X5)1O8/;T?$TM)FE>_#4=SQTU+Q+TK$<7 M[M),"!A@8A$35,:4R$`%P0UM\1RE>/$;NX!HTP&K]OLA M77E]Q!!A#'^9[))Q0G0[$RRF$0]#AJ2-">(X5BC`AJ!$PL=B[:P`77@EWF07 M`4M=&_=&>#5_8PK&HICE7\?9K]-95GY*GU+X^;0Y\$X(0D7-=6B&UQRY]DB` M<_T5-Z\C(`P8CV-&D1*109Q'#.F$62Q"NC#_WD"44%YCH`G<)OS_ MAD]-B\_SK],"[*0S$=6[?3`@\!&F`&W-%M&ZRO?`V^2@[Z$_'G!O4H>IVLAO MCWA#?!V,1E7\EXX7&G*5E=@KR=`+%YW$@+;J0FZ$-Z.P`W&367PV(NY#45X. M#V*&,Q!1QX12@K_CI.0M0+>)>9\,L_[Z/.\!J[@!BVXX/-1Q3P9&F'*1`4P@$ MPCA`S(J81R1.*#6[I$#+M9'O`.1(+@%[I3G%LFH@UDS4\$^3EQV-U=`@?FS8)?#IJ? MOW[Y&\LPPDP2%(5.]VMJ46!#B036UH8\"25E.[QAMK4HL7?T>UQ^J#X>/W37 M]H!>^&E>``]6(K6/`N5N:\A.FRD$8X)9AD3$$L2MB9'6*D8JM(:)2*I`Q@L> MF/$2H23;EI"=>-8\AO6LXA=P+7J`Y"^P;I MZ`X,T0/X:=SEL&?R^7G"56R%;E^JV]F9`:6.T<"YJ=\R][7PZ>653XM%U.!' M6HRN'JJ]A6N)WL4PO#J#OR5LC1EZ$5-,L44*M!3$)L8@311%5,26JQB>BGIJ M;I6O=OIM7<9ZA_P>:W"=6.N4YVO+;FVLN>EJ3;//-;?ZJD$PG]U-B_R?KPYS M.O+!>4)C&Q'P9))J#5*@$.,(&1G'B0AA+D%[P%>);`+^!^4"_`\2)"BTB44A M28B,0V-")MM6O:34&Q#]O=]$&=\_C*=/V;-O\G.>?G6.O]M0L.>.WB[#:;5. M(I!ND'2#0>8%A+7@MR$9,<(D#XTUK6M\A(I-N#MAU#2D&_H[<$[!17,>_AY; M'OJW,U-5;/:0S]+QSQEH M\JNOX_S;XI#-,40SME1AS0PR`M#Q"*+NT#*)&&9""HD9C<2.U4FF:DY+.XI- MQ%>SNZQ8F]$G,JS>C*,2FROP_O[7IVY96@`$_HP[+A8,A\4\'6_$W'U"WQYH MHB/#!6@EK*V&&#`&3R2A`8J#R`DBDTG(6K52/<'X*D2;9+RLTWQ*\]'E9#E3 MWE5->069&`AE-@?=TW^_LCH*LI!(8BDA2"N2@)VQ"?PD(I0824,A8Z$9NVF1 M6THITUX5Y0=S3-O953[])PJHXGZ]VV@OGS?17&?@5;BR;V#\5T]%\.%NF M>YZMS5'P!@$H?!-K%,9@+CFF$AD2*T2(`B*B)"%*[3@TPNAF/K"Y]_5UF-7H MOZMJ]>H>MQUS,]14:=V\FW2K M_][4R#YK7_T.IM>[:JGM(+S:]11`>C=L456W^KL\'$_*X!10MFS$$J2VP-X&HA/@$S$= M+04#.D'V69!5_O9OT^+OEQ.0^F%6NH,+5[?]I:$;<$=$6:D$Z"?"+8*Y&2-# M;8@2*UD@X@0+$;=%S(9L^NT=<#1DNX*RS`XJ*]%GD.)5S=)L^GJ-7:^%8=73 M=X7CU47;OMVBM\[HT`110DE''&3,$!$-!)"D)"'";S%=B5>\2M. M`VW-V5YP[3]4?MV")5;-8K8%YCDYL-CQZ_(#\,H)6`M_-0%3TYQM"+;\O(>L MF#U]&H-K!)ZJBT`>G-OZS@-)_(?5,):T[M]Y,;Q959X^L?N]`E';GKUO19W5 MY`>ISLN[;/27Z71T.K;2[]I+3)JEV`^DR9R<@#1[$P8,TUI&9*//KYO1A^TH M[3>J]J<,A'S5K&[<5OJB#;*'-!_%CVXS2P:-UWR,$QAV_\(UV.F:6ML)Y/A[ MBOMU_?WK*Z26O-YCX&M+A]=N`]/5[2?X5W>:TSU=;LU^QX50+P-;-2PZH_$H M]NOTQR_I+"MRZ/#)Z'6O41<*>S;C>'&\>O`7Y6S>WV=\U(.MEEM;W%AF4R_SEX1BWM_(G/*2, MF,B=C8D0ESI&(94&A<3$4@6!ME'#2?KGK?SJ&5QG#&NXEZN42RMW"EOH6@X) MD[7R$][1]++L6=E%!-Z=>"S.@"J^"ZQ3I(@%JX`0BS!]T@X01I3@B*J10BR;03C M[AP2]2=0$*NM*'3:LG0H6HTU5_1(:%D;6O]>IB.BU8;B8XWM7A5.MO$>L=!P MC0UCF"*B[6ASXQG6P%BB`HU`G!7B@:)(QS2&7QEI`2HN8%K?B'IZ]Z7HE_\H M]WZEA8_/0L.9HS0AYE1DA'AFF:$8**$YP1K2SL.R-D:\T'HWC7 M7:MODG)[#2/;SD!D0\%#",))2"%F"66(C)(1:%$=:QP;;F*Q/./=6ZJY-3?S M9F*TJ*.ECR)&JFYGGL6(T!-3K!U8V%>,5'NA<,H4WTNU_C9)[Z?@3/\S&^U9 M,>FM2?"&46K3N.S$^:ZBXDK.,2&(=/P80VBK42''RXX[\@8!_7\>F73A;&M*PY>E,T?FS&JCS3'O'6."3N< ML?5R@+TI:--4-_LUO'!)PL"$$;+.NG.F#0JYC%$8BPCTL,)")SNV>]#ZPD,= MZ;L5B7A-;VKVYOW4T!EY-+^'B>CC_-OX[S8?6O>Y>7>`TEVVGP[C.F*;S>E09O MQ^LMN&FGW[-)ZAR'8L,##].QVX]UG8$+7F1[W3[1PRSJI(':*TZNJFH=!'Z] M&N56->=5R3[GPW-5 MO76?L^*][LX\C(I.*KG]C)BLQQX=-F_6REMF^]X7]*8,>"<#S)B6\&N%[KC& M^'A"X-]#H^@.8^S?'=K'+H&*`*G,(]%*"+7S7IU(&)W@B",CL02?7D@4X("[ M4Y$!(#:1$M6:L_#[KJT[7KU;!HZW4:*-@@9K("R/(QAD$1J#>)PPI(-`(V9Q MH+`5<1#K7<[[`3LGWF[9MHV6II.RG7GQY_?[6:ZV=IR]\U4G':C8%J)$ M!M9HS%UJ&URJD&L42&L1Q8(GUFI,[*[:[Z3N.W0PF>M<]0.SG@IHA]UI_+=N M&.U>S-:?F=ZWNO<:;*YD5<_>W=ZTPRS&U":AH2\VV38XT]?N\K##PM-U].[O2BSN_U*4D1V:,7&FD3G'R`0P MZI$-41C$!$4BL"J.`YK$E=T#%+8'Y44#M$B.1(I+<6N M6;WDS6NI.=H9DRJ;S(4"U2F4D;O\B6Y[DW=<$K%YXFC/4R?'F29'F!:M==D. MG!:]+',>8P\1;]M#U'U9\X";@3K@:RB#&6DL5!0C86T`(3,3R(0R039((+R2 M-HACL:ON_^Z;@-XG_\^940S$'!PDO+->NX[B1(L(@F89N*+1S%V)%%B48!H$ M4!B9`(W&T9!%MDE+L\47+#PA`"ML`>-^5] MC()I"PZTA(B3:;"B.V((#?:$6%"(V":(NVM#M'5W_8*JB#`#)1'&NR2(D<8@ MHJV`6L^%?8Z%V1\W[5GIIWZ;SO[WDR_O"&V]/'N7UH`((G0[.U#(+020X"Q` M)`7Q))686IR$<13P'8/_KM]H%^0WK,ONE9/\11N'^BDD3K576B3T9.[?:!? MH6VY?8#A_V?O6I_;-I+\]ZO:_P'GV"FG2G#P?EB7K0))T-&=(_ELW>9R7U(0 M"4JHD`0/`"WKO[_NF<$;`X(42%![KMK:B#0QF.[IYTSW;\S*-NZ1;Q_H1EFG M[@N-G%NTW$"@5DJ`CGD#0;\ZVH*08ZC\GL7CW4#0*WDM-Q!8QOX;:+W<0-`O M@5R-TRVM&:+O%#<0]$LC_P8"5:G1.,@-!/U:T98;"'3;JD1Y@]Q`T(W>3C<0 M[&H6J2$O'O$&@GY-*_\&`K4*GWFJ&PCZE5,NOI)IRI7SZV%N(.AW/?EHJ%*M M&OP4-Q#TNYCG=`-!1MF!*W5.-Q#TFOSSNS0ZVK<`$#7D#0;\T\U'"K>I9RL`W$'2CNU.%6TNI MGRQ7/.8@5Q#TFZ5P;;.IEC<'CG4%0;_D<(U1/;AKNH+@&?C\O=+!USS%J'B. MD^#S]THO\9D'#YG3`#(S/W^?BOSA\_GZC&J[#,UA02_P[KUNVO'AW2&5RND\*;Q[KPO)/_4WSQ3>O5?RN<=U*DO\SPW>O9,)ZP3O MWF+`57(S[&GAW1EAIX!W5UM;646\_>_HB.DGP^$^-1.X\:[2B@2W$XB[9YBT(EN. M`)-FO`"8M`XL.!PFK27^>TX">[KTYT@P:6U)03\949.).10FJL"+_F&B6EBA M*+K%-YBG@HGB4+\GRHL&/U;M\424#445-1@4K<54U`W7-"83RQUIHQ<$$]7` ME`-@HKHRY87`1-69<@A,5%>FM.V-:J963JZ'QXDJ,.<(.%$M89>F<&H8!L.) M*K#B"'+1EI8_6RYZB<./L1G18C?WB[O[Z\\Y#OA+:^@P'.#-D6ENZ7[8K["< M8K0W(4?%[GH^@7"J#AK%,*7V`P^3&82)PA#ARI`E%4:84WEL3"Q%5"V;;*-/ MP,PIECC%NU0 M@?6#L71;XF8]#L%90'`-/X/'5T$<8^T;/KPG6U1)DSO<:JUJKJLJHJE/0">T M"60/4UD3'5.=V-ID+.DCI:U>C\'A[4M*^V[4+,)"VXE/_SL-HT]^%(3SO4K= MBBSH^[J=3DQKMYLUU-WN/"@(3^9$;Q9YWV[]-HB]X2[XS-L7T!X")\N6Y*DH MH1'15$D5G:D%YF2D2:9JJ*,1WL7<#D"J%P#M]Z.8?YD*0CHOEZ2,&Y'J,CE] MAJ(]CU'=%'''9I]>VM_H3C#?+",?\=&;Q6%A6(5!?3.$)//\TRT)W0+%L,C:;JC=K3D:2C.&R%VL;G M7:+3Z2ZX=B-,RWGV\]5UCK& M9[+-EKDVQPHRK9]@O1X0^S6`E1\]_5>,7OMFXT<>EC(YLR3X2IN82&W3%KYC M_[C7W4"R10C6ZM?6'PR"UE*=)"(CRY69SR.T@C[$&KE3@*F1%P8+E- M]O*M7*[445DM5YM*LJ2)JCG!_'MJBI9AZA"4&H8QGFB.9KI_:MSFK1**EBB_ MDPJ7;.Z@ITS\[SX&\F`DP&MX]_[U=G7G1S<+\F`!>^P(/&F0E*Y,*;J%#&!+ MJK8X'49:M;B;Y'UH-0X]%SD&![B!@B67DW;N_*MD;KPGTDB<^\QG7R!V#"/! M0Y6#]9?M"N6=2:IX0O;8;>C,R-USW.:685G![^NT-:52Q]Z9I)H[@70E7)%Z MUX%UGNOJ18@Y%*/J'?)Y-RKTP-1P^\AT2ZVBC13+-8N[SG'"TDF@$PAVZ%$W M2P/2\VY8VT^1OPKVJ;H^AK"V(*R4C?8!E%590_I*>\68*+W)4,8KYEE M_]PP^UT"D)XX'2\(Z;K.7/G6M:I2MQ!1IO>#%ZR1"S=K4/1-&`=4Z^G*[W'- MQ%$4FKNP%5"!=B*JD!@STG[`#/W`7I:/DED^\BI/NK*$$9`.$<9B'U2O8U## M=3JRJI9/<0M3;D`]N`[785E/F5T:V-!PR^+`J3;@?7+)V!'_YBYY8(/#QVNI M7%C41D+U*I_S7-HV1+H*&GS'92W&&"P/V@_]_2@6E6MP#*W:9=XX_5W.LEX- M.2S!W#TN139VN,PZ*?L3?Y(]C*[A`S^CT^1=<6*W*M>LE3E<;2+_`90B^.IG M><7-XM;[=B0>V*[L&K9BB(HUQJN61K+HZ)8E&JZKZ^YD))NZVN9O&Y+:%B)J M@L!"2=SV:=K_'/F+,&)CP.-^['Y+(B^,YL':BYZN$G]%8"O@R2A<+HE=H=HW ML%7D=NXWL.N(7*C`N'O++!!*B[\&YA/?35:!W!OFWK[3<":2P(>&E*6V[83F M)60.A?C->9!L\3(&6N@S'VV3ZS#YPS^'_00NT99:A6[H1D\G1+?TR8&)Y]:I M&)4BQ!UDM&Q\!VL_WO_*YZ-L<_,/?8U*$3N7@B:G`&:.!8 MR38?LE`S[,8LM#'#YM0DT!#DS(LO^("IJFV7[=/SR&S87FM(;#!L!XO_"0]^ MPK63)%%PMTTPS;L-(<,#;W>LK>".B5N7#J)G$-=)L+)JKG,6+/X--9J.O7P= M)*LCG?QZMF*(5`:V:QAZ8'9QMSA%S;*JZ'0'DEC#+_2]:(98;Q/P0LN0%`+T M:)GK!7ZF9)N*;MBBK#JRJ)F6*8XD92*.W9%D3"7@E`81/[^Z#[R-6@F"6VCH M4@*[9^GK,2PP-T*TC4I2RR>A"ZF%DNJ!*>;C.-FV;G<@N4`*GW+00OX.:JFIG>Z)/6/([<`#)AW&PJU5KE7EWV.FN7$,T<$K`#:=$:V<- M1)V8+B"CM(FD.IK[;;;?.B4FDL]P;/H=#14 MI(:_]&>TZ<>]1:>^Z<>EH%L0_`7;L?&ZLJ&#'OXE2!`:\DGFT%+9%_/)HO[54E852+ MZWLMW2A@1G])4M&D9)&=F\;!/^7Z-U7PW:PQR;A^B<'O_ M@'UYO7"CWGRICZ:6/5$5<2H!'[0Q6`=;TPUQ8DFN-$7[+(\K^X\I`*DNI[9N M/T(Z"<0S@>:/(A#\^\J-3@+1`CY_M";+_>`GN^)OMFQ(:V9CU]:NMLMQN$89 MH@<8GX/XKURH#C[?(MWGDJ9\`P;(IB(3K!Q-PL]XQXO$/B-VC@9!M]*N*8HY MTB:..A8M/\N&*#-:!`]L?GBMJ,[*P>PA5GG01S;-P&IYMG1'03T)_3RL_5 M9INPYL%J:SPD$GNA']?99T/.0H`>;#Q";X]"7-49*9)JB+;DFJ(VD72(0DR( M1W79-,?Z6'''#:!L68.[5>D=ZX7VLV2GI:F\PCP5//TOYVBBCMCB3/^ M$Z/1O_^G\F\_M\YI4.@DO;\D36Z#3@(':=?`,7J#3OHR>_#G6ZQ(<+_AL]L@ M?D!>TVJ46V#(:'E(G0EO]<&EC<%6@ MVP=?6(3+9?B(.,YDGUZ('\+'6$@>B*F+@>64DT+$MHHNA(471,)7!&^+88QP M07Z\)G"%WAKM!>ZMP>R1DX_I;F%`@1_)#[SE;$L!`.%I&`*?O_<"^+06_-+" MX.AS//9;A!'YV6OUPM2E"U@`@0(DO@W69(1P&\/8\4_OD7<_;PYAI()?%%DE MY9SZT5MM+G_XYDB7M?$9V^@[]ER8T>%@*1UP$?MYX\WGZ^3&8)P^_O#*L-Z\$;QG##/;`S M!$;\`,X#0H17S=0EX>95D[PDM/."O+H5;][]OQ:OKB7L-WXCP5?$U M=_CWN%'%"`ON,M9L2IQI7R+R4"ZK9:GM\NS1?]?/VI[+2DXS6XBFZF:6A!!Y M"(@L*7S9WM'F3`2@*^"<$L-U\H5]W4G!V<<(D>C(8_*%:DB='EV'CY&W^>45 M_>\>\_UG5W:,7DZOQWL]45]WY4*7SF#=-]\XRWB(*7H&.ZO2POPVB1)^(*F' MA),5XG`9S)L68-^U/^H+=PG(/Y>)O@T3;\D)9H6WWD\OQ12K%]9W4]Q3W'6= M92N5!.5[Z/5B]/I3%*QGP09T^\Y;8H,%1F`T#2VLY8M0;$AIOROVT/\ M]J($15>&%Y/OQON[\>XGS5XTF/"&-$MX>_>2\F[YX+CJNXY^U]%S=K(?VH]= MWWKBRU%4[0P"KI>DI2HHS3S,?3K7TE0:2V)9%Q7*P"<0D]E3_V5DMF;:]A3[$R1C MA!>0CL31U+%%8ZI/3$.U7&NJG[R,S"H41RW9L0K^$>`?:;5L@3E$H(/,_S6? ML1QKMD:YY@U+X[WU$S$$I`,NAC]9^]KC@[\60*OCK8<8>(*/98?L=,'#6K." M2H/1".(DOA`2^"I>@/ZCV@<)&/<'#RS"C$$1AQ`K^-'7`'%='[RO/K%$/AY# M@I&)L*8.;<4F@A^`G1(6P3?ZT-Q'6Q*LB;N`-`J>0VOOSQ**M?.$O\8&MA!_ M\B1XD%S!<.^$JP41OLB;)5O(RL(<5_@"*9C-_$U"CDPV6%894_L%LT<(0/(D MV!8@&NN["8G`E6#V`+9Q'LS`_/T-*^Z\I#QK2/::9WZ1,I?.-FTZQ(DLX%=" MO(6A"U/$YPOS\B)?6&R7BP`()V.#I0XB_]W)A*=8,?*,8F8L^_N M">8%EOTLHG`EQ(A:SAP"#,&$CSD[4'O[,D9Z<=P87".>8U",Q3"BR?,L$"TG">'QXGNH!/+U M0O`#(AO@6#V0Y>52Q+PA0G^('Q+:.BKHV(0$(K2T_QGE&,04W[X@@P#W*V\C0^'=U3/$ M)2>_@.`!(H8-!`B4C]1B,,$@(@[Q`M/IXD@0C/2QZ/`1'T$]!.)+QXL`=\QP5KG1&%\R+"SRP1BL4P)244F9N\5\89Y9W)(\%6Q67$T0""MAS#N? MYT>IX<2,!@M+[Y%%!=)VB1JKS(_DAK=XL(VBQFS[T76 MPD"IM`D.&>K?MVL_3^%4Z0+K8'6R_!-_YF-/3N&?9?+/VD7%ZU>R#;Y`EF#TH16A<8_Z`[)M,A M%A_$8AF'^02)=U_"#P^\46*%SF"))$ M[;O/GC"(6C$Z2^0*#9!R"Q'Y*]#.F";]Z9>[LOW*>ZAFT;"WX._1&E!]S=Q_ M!U4C=K$I,J:A&XL+'B+?%U80$#Q`++Y&S6C1,ZI1NO6&?-+E-U71)#8D<_QQ M\*WKT#`.'5PK#%X9&FDDIT!Y,N5'OE`*^?,`LA0S#N/WL?F3^:J0_+?L^XFC MB#.[GBL8C;G)"F.X5@O8[Z/PD<3I-&U"A4:P^1613;KLS,IY,5D@')>&46%- MC^F2>6NT^PBTFNG)$]W3RL>BOAV.J0+S(H)-!E<,)L MAFMG`.$T3\DC9FST$,(/TC"2A5PB0G2/5MWML;V-1";PPSAOC$(`* MKP*DTT-BT/8Z,0TUB'//D-WQF6P&Q"E4'(>/W?YDDX(<@M`(AH7P*0]9\$G, M'MBV-8V1F.-)^5;G6C$]K/"M>9\S^_#L1WM;^#1**JYJQ*INU M\N99[&/\YD7,8Z.\@+7#]6&C(UY;J8CJ0'``ZN,W[@OXO_OUJ=> M+J.'+"&-M,D>`=OY(L=9N_2D9!4Z:4R;7J=*@CJCJDJ3GI`]RJ8Y%4@N"=D& MS'B$]-9EIIGE]$SNKX&VCMI2WSKG2IDM9=PZ7(NUC+24XZJJG%LC^<*RM*:D M\Z+H;.N.EN.5,@IV9.@]4P&BHC>FSMVI*`I-Q:S2_S6?H.X\M:O"$]\EDR"> M+4,\6>G_:$^R%%76)%=T%5T6-46SQ9$YED5#EBQ#M31''SFG/MJ3&D[VC'>D MQZ+EZ.Y?15'X=AD*CB`F6`NW9+J_^O_7WKLV-XX)6P%WN&`@I565EYJ\PG MW6%V(\LP)+0CQ)`X;OB*YH9YO1MGGC\KH2R;PB4.0W1W^Q&$=DW[I.C3&<^W M7"`R<">P9$#`95F6$\0B^?&/W[_V%%"4]$.D_,PG@*(R)V2VGH2_QAM[($"W MU^E]:?>^913N(C6L[5(CRYIXXGN@CQ?.>Y$X:"_(]=>7#GN#<8;/(7@V'^4[ MD.1G^0+D$UC?+G`X915_LZWIC"[G'.Y-VFZZJ:>YB5:^K[H4W M]$%NG_AQC%%?5O:2D2`99"`\*X M,ZF9V:C#WJ7&2XL`=:-FVM86SMH>9,D6UFI8]F[7^MJK=DID3E;DI/'"1?$" M8Q`*V2KY@M&X"8B/\3Q6C`_*Q_JY4?_`CF[9+4+]T[-L'XKK,F'$)VPVBN30 M:LDS]*9A[,]2,P>%PY8VOKDO\_DMTNYU&>E)[/J4A+4!EI+Y1J0UK-74CD!< MG[)5^!D3C<0EW!2]+EYU=4I,_Q'\`WOS2NZE.%;'PNRXQH:Y<<3H36!UO5:] M6MDDQVV3[(/O-PS'.C6KN0V(BYWQY,;K:C2V$1!Z"[)P?Y@=6_GHD4G#5T:] M99>YTFTM>W1-1)2MMY?)`(*5WER&\QE>,]`=(]T32/7@9^^67A:LNBIXA)=_ M0O_":LJ%8O!+O6D7I2RR4"6^EA9MW+I8'(0)LF?ODCL,C]=)2I0H8W\!+S^X$8^ M;7'R&*L06:BO^HQ-OQ63TF=YG1/N!@V!^W'O>Q$V!W_:8^;D4M2(])H=YW,$ M6!$7@?(%*02,I#FUE+>DVSR6T"C]H&?S)5EZ9!_+%:YG;J2TW>!/EKA(*8[` M-?[H*:EQ2"K`"76!);X_A.,'EE(^]@,Z18/(&_JS;+3_&SV7'``6TC]7?D]N MV.E+R!GTG;.D<9-XL59^.&_#**(\NEBZL1?OG?&JVK347K&!7V'T?\]!9HZ> MZ$`LIAZP;'(\3A/WAS^93]+/L+'HCJ_.$K3/Y:T`[RE7ED'I-90`#5]W,:0? MW#$D'Z)I+H.=2MYQ&Z0*H+-WO+:$DUVLCL1`Y$W'[H#=0V22%43YH$O=-!E- MQ93Y^L2Y5^SB.UJ0$?.(;2]=":S]S>YQWA>NH>4[`%C;)3ND9:O MGSTC\8.M,R6M*%R",5#VH=0+YS$OF6(`=2-W/IY)A;VWD>[)&M(W>FL&Y\O?PT>-''ZO_V*"/5)K+CA,\]T!Z ME6M:TL6H+I'P67T.=$96H=,.8V"%,,DJSD'+X4_2%="IX?I8E(VML1:JB0:U M/(]13U/E19ZA<%VC.68Q3%V?2E%'6!ZLM.9W*%HQ$568A!-"DEW'_->I.I#+)YY\MQ(`.[`242>]G[,6`7-B,JZ%3<% MJYX]AOP-`MIDKZ/,BGB-'ZO:17:Z<`<7<>^E\HI"6*@#4?IK!)C/BB=4A&/+:F0**E)PD)'C[:"V;G$$G-BKH2.>(A8=WFNP]P[*N-#H(R1.\#R?5;EA+9H M8O=2Q7=J]\!"W;NTV%S@6Z!/C*6&B3&;EW;P:D:2MNC;?<_+.0B7((N0;5G!(Y@034QF,%\8A\2(;+=NHHD-T MZSV%O-Q9EM4UB>*/_G@LZL;SY8``;!#J*\9M4X)/(DT_.10<]@X!]Y\-B5&+#,3S@KRYVK*3\U-%8MG_^\C&#$ MCA/C'@[-DX+)R0R./">53Q*F#YV6&$VP@9>&`=)\Y'*>RAG8-62R,PF`A/M1 M.9@28H&+5./FW2)8UIS#/\A3_XG7X"?>)ZQ0E?%]2%)C?B)XAJ`]Q]X=+MCC M#!=[?&,3"!IQ$@37%3'!\P[!V3OI&!![,`"5-.49=F0ECW!]LX`4?`B0@/7, M.X)$Y']D(9$RORZMBT_(`/O)DS)KA`0T8.)?_/TL07[BI%T6-8;US!%2DIEF MT['+=XHEBYXM@0R0A1B5G/R+^YL)V`\AP#$0J+$/&\?5Y<*$2=)*-2OB%(H' M93%Q[XV3(!(#1V"X":!6'C"Z`6PL!\*GLB5+";Z\>P9ZK>*\&APVA9MKRC^` M)@B%0$6Q-#"Z;(9F)^`2RA:!K^1@-\+SR/Q27Q5#PQ=4E"M$$ MA:ZDM1+8=N)6XP<"&,4"]1?#FC0;?M1>-!N,MU]=)N'.@GDP;$9P,=SY#+AD MQF`BDTGA"/YDX@T1D`3#/`))@@"#N>7!9`O8I'"HZ8\$TDS'$%[/D(;-KV3B M&=LUV8ZU-O-YP8B!6/24GW$)SH=9Y9+YBSIMSF_1R&B,DJ7ZH_S6EZX/F1.I MDB!3X;>'(<)0(BJ)-YN-F5L>8GX_NZYY>+:(>I9Q(GY/8"B]T8A=7&><1"[799&5;LYL M?3K!&/Q"&Y=TRV$'U3\\S-V!H7H_,$P/__"-`>)^(4#8?/CAZH_>MR]9E8N? M9@(Y<93G07B+(/ET_/U@.I\QY$.^D,B#4^VM/%J%-^!DPJ6G7+H+7[@)5WX' MWDX<[T5R+BK`)1,B9X/A]XJ3"G+\I^:YI:%]R01;XGDF!H8P+Q@4,+=OYE.* MO"7?YU]^E#\6A,HX!":)$CE*`CQW8B!]NX?`'\!2&I[UX$/FWN&>W,#&*:=4I MHD7W]]R0R`^27,JA+X_6#;^4D[V8[)52RN0,R8XO@19PE@+VRFM.;U;7O##( MW+FCX"9/8XJ<28Q(=@+#V9%#%D@/;DZ#&\?]",6=8D@7VY1C8P)$)*()^KP5 M`]AE9'I3O@_=-L@`",L4S2*'(``Q^2$PL7OY(3+?7<7 M>7?P7=2G%]Q4?D@:PK'[]B47'06DK'%.8BX57A$,\7S3'#Q,W(!-$O'3S"V$ M[#?+5CU>0G!D5))P!SFTE\%"M@:+X)EY_S,`=4[7+5UWP>'.FMPBB07#8*+K M$+,0!MCB!8/*3Z`&\*?T8-6R^2?N@^N/28.F/)^Y`AE35D$V'R9[V[Z^%_-[ MD&(6B@G7%F+L/UDUAR.C4O)"$L$@5'5X0"@:9@^,J*G(3V;-3EF39%,*&1OD M7QYP2I,U8WO<&EF< M9N$M)N=-+A*E6W[D4MVH69SJR:4&V0V90\'O!WC46$Z._,DFI,,D.Y)O^9AW M4[V2Q#B'^#RSP0Y6-_@.>+;N=6WER53(;+QH/U M.LGC0,LW`N7W`07[G]7,_&A+9U^R\;).](IFW@OQN30.AY'0O*%<&HYW/0M%&;$E,;LV9Y?S$Q0CA MBB`0AIRR8:"5TT<](`6$Z")FW9!0+B"$-_XK/[^7 M!D"J2,YV(CDK=T0*ZK!`3D+Q;"X_%.G*!CK69^S!1CW7..3F&4@CD^0$0]`/2$,AF`1#RD.6CC?2B989(9OQW+ M_2//%\T<<_0_])K9X/Y"D`D5I^[&)Q850'L[G[R`(QB)*2P\&#>;FK;4X!#N M<]Z3P!=E2PH=)4Z1`M<;!3*`BV4A]VII: MUU1+OF#Y0I4F`][,DW%_MEUQO.1V)1UR<2W2OA3*YL1!6,<]2'P`B1_X9N=] M`Q;)E:#ON<@JG$1^2U(;FV,R)":I7(RUKDSELI#$#O5\H]T1R0197LWH/Z'Z MSQ=:[/"K*)J[Y=#$O1_8)#+K*Z]>*9=0^">1J+-R/7S*T@T,FSTER=!WL_&! M-`R`%LP=E1;DV99I?Q;T6MI%K+27-XM"G$#D.(4XYQ#C]^%C+)9<0+::M(U2 M$5B0^/[%6DFX=I3T/A[,D\@*IU+Q/B2[(,3-PM'XZ+-TXK>*S-YH[A:8W3E" M8/8*@GHIBD]2#=0I/,!+"G]V#NVS\^=>%^A8/Z,PU[=*][ZQF\)#HRVV!=R. M-PS9A4U7]W^.7XK5AI[-X??]Q)!;*B2FHQ74-\O\C(_NIU,1R&:M60GD+5E? MZ6UHS@FJ#+"3.==713'"@)??)GMY$@<;W.;J8+\4`3A-W\6/QO.BSS;K'WY1 M_MG[=G/1:7U66Y\O?OOZ%T5,]Z/.=`&\>A@!\%+@4.Y"QG M'>N#"O27GDBS9M6W@>GYAB5[EAO6O$`Y/4:I&X=GDTJ$5R)\FR[WJ$"0%[A< MRL?;4_+!]8UMK.JD5B?U^!7N;\LO>S^ZZND<0+D( MRYI'<\FSD+#PB_+YXFM/_7OOXK>_W_`NX7]<=&_^CH?XP]&G,[!&\]D$AH3U MR\67>-U*DR'&WFB6,/X6(C7K'0::3'X&-_=%Z%58],32Z5C1'BOM3O*K_6"Q MLGMI+A(,49J-M!)5:A57'PS]/?(F'!-V@T1JGHFIFZS0C7>4+2Y?+QGL[-U" MYAS6%8$S14E((DN-)_$6Y+.ED%=4U5HKP@3(1!;Y4&NU]WT&+`",LAX7'`!O M,0\(G%8OYFJ"\^5"E$![EE0O)_B*1,`4]RP%TUDL"Z2W\^AF:Y3RU-+*.3QY M,&6!%1ZO7V^+L&9G[W+`9KDDSQ0^+@_3EJ2HGCTK99D@)!,D'*R&I96%8$G[D^K.".-NA'=H/PWW,[ M\&,-:W0/.)XW&87#16NN!IKJ-$1]-&6;I\0CN%U6`)$4]Q:"+JPM[O!M@GF@ MC@(IS%_YB&?O5M2=PHBH(]$>D%DP\^=27`)J!024.DP5[F\`-RLW=K%=$FY,DMA3[*!9:,@I@MT]UP3SR?SM5'7[K&3.HR M'B-$>J2ZZ#@%6T;YRQ`\>/8Z`Q3&Y'@LTN60%IFRJUOOWAV#Z8ZR^Z.?_Q9B M@M"KXCL0[*JD^%.P9=SJQ.Z1]FV8(E'2&%DTQ% M+&7"*>1L[PWWE=:^I/F3W%L^`[?+SER=97U1_:VP+Y**BH_DL+W5T@3FR^^N M-L':H#;!WG5M0O7IM_/I-4*SS0WOT[;577CYN]F(:6&<<<9O.!:(#.(`9`#\ M8.3/N"`6I3AV>YW>EW;O6T:RTE\CY6<^&Y2S-+_;=;?XQ70Y$#5:W>[%S<7E MU^L]+_?P"_]R^>WFXO]KX>)SNW_95[J]]DWNU^[%=>?R]Z\W;XU05]\NOG8N MKEJ?<_2X:OWOE][7FS?'./_X_6LO8W8MRH[Z=FE251>NEQ*]8&T>Z04MPQ!; MZ]V-+VFWDK%5\/7UEIQ[<9$$J9>`JG;C-6V]*WA%GXH^>Z//D8N0UY6=ERV6 MR$5J9*1`&2V"KDLR^'V<4F^QT$+7&ILRW-)"BUVIJI>-\$IESCX(U=A&`MHK MH,.K8)BMB`[3WHGD>.U9J=T2=56"D/:&=9.S&P:K5-,K$\GU9D6'5\,PVU%- M&QLK5?7P"1>T;"LR7=&NXL"*BA453YN*^PCU[6/O-H^F&M;&'D1U(7,L!N$. MZ:,;V^"/TUW_J^"/EXD(T[9V*R)>H<_PR@IK]^PUO#7J572LZ%C1\>3H6,$- M5'`#FW(#D3L6%0R\MF[]1JJT!BC]=V9QTJ`[+NM`O7X%H)LML\?11ZX_ MQJZ+6#3/"LG.L/].@+TOTT9]THY0.\49$&?\I`!=`BP<9!N^8BVBX7C)LO`W M)"(1YJP4[H"5R&8ZY9XK?P\?O0YUS MI3^/L*I1M)-CNR+V#7>1[<,B:?/L%-[..$P'29J4OJ*=TZ-+E&$5[2DWE':^ M2UFDH,,T,0N;B?4<9EG0/GNJ+V_-[^8@`U.>S&`B,-0ZULJ3E1C7.&61GE1F M[@9)HV0AFQ/)&O%"3;WY0?%&(];I#:@RG>79*.$BT4TI!5>1"[Z#Q0;VO'M] M*)K7NDG%*SR,#1UA4LD7V3=@1L0%;/NSK8ZI42F78^G\#!*,]AYWJ2E548YY MP0'^`_65ZP!3^3.E#T8$=E.D6?F)994\NY>9-C*-X[/Z!E4)BOZLM!.]X(%- M0L0.8(L9\<7@%B;%[9G^>4(,FTI^_A0\VIF5F3L8O]1 M8C+V+XH[`@'DDX;'5VO`&W[,^?L!N#B,F$TBKR'M#^\II=.J)<+;HR&HL!F3 M2I$]&1X,]@Y=+'N/W$<"=K@#.MQQ6`]8"['F3]37E0&(4%?5>'[[+TG\%$JL M1`2>9;K7L[DP04S*AL^UQ@0VKTV?N$^L)RCOA@YCP+=H/M@3G<^&'DVX_;3IF9%**N[)P@I.#C35%FAN!6I.L`# MQW0"'4OPPE(FF'+;9"(`=1($'+3BQF.!II,,)D,!?&8F@(R32D MS<(!.-8`7W9N:)@92H]P<4QNPB`'2V`+L.@QG!M<^L3]5TA/RWZ-@#(1VW56 MWL5]82[P8Y"!DY")4LJB![,U@"H!V@"P(8FMM]Y!$DHA0=%R$;4&Z6(DV$FB MH:9@=D&\!"B"G[GSY\/JZ-KQP.K```LP.F2@C>;8&W8IT!J#C4*I5NK[G29S MI@"L@F\0-"IJ@PUS.DA:J&\P%7DYF@W/)&PC)+)AEP!J@9YW/!4N!V9.& M*4!K"KY-/=$Y7LP0Q"4Z:A@5\F:S,;,I1QX*;6]Q8^36[D@;]@Z*&O\'4116 M[LW7P9N%`0GJ0T@<5B9)&(,\E M9Q;.47!'5D/1&#GQEQ=Q2]]E'T_#"'X0SZ)Y$OY9XJ\_,U3(6'41AW.155`O M,?M]H2TU0?:99*T7XFHRN2\K%)+\G"J+@&D<.[X(4//LW:*D7XF7!A[,S!]S MU9@ZYS*,($F0C.>6[,HL3R`NM`I.TYS@"5WEZH_>MR_T/`O]"OA#>',>A+>Q M%SW0.?*#Z9SI-?IXY,'Q\&JE9Y7IU,$8B,1D#9#HL_?@C153AA@4'")-^AZD MC`MR'[VY*0@:FX;_Q;L,:"Z+1X8!3ACB(QPE M?^#//H&MG[AJ:6/S9<;./EN;+XWGE,0)CRBN0X%\21$7W13D`SL_F2(XL.BB M,7W1IW`@J%2E[09_GA=]R)(^!,,4?TK&0TP4T2T,B:P["8?^Z"F-;:9637Y. MY)V#18,L["D";8[P%FE!D?<0CA]8&&4,QYM4%EES8&C=^^@$([R:EW$LZ32% M410^IC$<,XV:+"[9:*ZF;9")DA4L4BPQF7)NPD)K\,`MT8LFR1[%J!2/\-33 MN5X$Z56(V)"?K%JC25&@M`]AL/S3>.C)EP]'(PG'E9ZBP#Y(833FT;F52<`F M"'_A_AA]%"QW5+@S%I5RE5M4-UX<+\!D!L.%_2[T$I9<\A3$&06CP4N9T3[G M(C+T`K'(+8BF.!,30[%U=9BO!]4V7A,891; MC'/%%'<-E#JN#)<5`;-&'ON1Q5!^^)/YA+TL#A`X0Q(FY]A]!.X3P)79SPD> MYO8V(WP-HY8U)"[>WS'LSUKR*&>X7!1+@(J*13Y;PKR9VWIS)H75I+:$;D!8R3WGYXW95/+_W&6 M`H1SQ9O.%:\OES)VM=X0T$"/S(1_8&;IC-/-P3..L$`LX'J)$M-$WDW)T7@&6+ M#M(,^`=QT&,)574Z]H9W9"=3N&*,02Q\6MR\Y:1D-E1,5$X`[9?P*><)B M74(/)!3\S)%F@?QZK=[@MQ=,'%+"A^P;(9>#E4V!-9:FD2:#R%C2+/RU@%(_ M%UY-"C?+[@;!+`\'Y"TR]T,<:F:;##QOR`WA>M"[)`R)P=0W,;`HMWQ#$.#,HHTOT#`&&[:(`)D;(3"T1])CV*, M$D\R347$$?P("(J?D5'&<\/3N$./:U4P$/0/TO2$P&5#S3Q@I>M9BDTB,-PL8Y<_"\J,LD?DY5$NU1._ MRDO2@3!'(`++SG]@1RW`JSK_P5.*LN`X/Z:^1Z[/#CE2%%9Z2%K+C5R*U?#3 M#702_A5':O.#1[+SOI9(Y\(S;,9\QU!CI7>B*\2K[E0O93H1[/&H(% M1X<'&S,'0#XXB[V+I-@T>>ZI%PUD6+A<]C/)8=F<-9 MKY4?\_HG?O;@@R5?+!+JJ=>?,B0.LM8W&Y_.>7LUV)KI+$D13_9'1,_33,XT M2[B8M`L9RNP(E_5B6#S1[.?,%2<>H0(9PN+>JV1=5JNS_Z.?AOX#_OC7G^>Q M>N>ZT[\@6B&B/\%1@#GR\]Z4_^. MVZXU3.V[]AZ/G#\!'4E0R/[P;^_]X7='U^MFP_C>[%E]3=_@S']'23R=W;M\?Y753MW MK'31*]:377P'W!'X&_Y7#PXAF`BXY]\2?Z7X[U?AV!\\;4Z9'#%LH]5H]+6V M:CM-6[4:IJTZ6L=4C7:[TW,,O!P@R/TS%W,C@EOQ_Z=`%!+A!A(D,0-QCPM'M!%\497 M6EE1GX\B9R+SOA0B/R=MSWO0-@V^@W^OU.N]OJ,+['4?_Z;M?X`F\>_]O;WOGLMJU^3VL;:J>C]57+;H"P:CLMM=VS;:T% ML^S9.LS3>/\KC*A;EMYP3#;;PGGEIWT1`)^`34JAI2XPV.4H\]/6UM'HMNIM M4S=4T^DV5*MNZVK;UDW5!D'3;VBM3J_98/0V-*VAPO_I=7D=JR::%:T7//SX MQ'@IT3Y;6XY>;^F-=LM1[8:CJY9A--66UFJJAMYK:!W;2'Y/#5I:,[K2:'/>/X%=XH[9E'U^A#`R'][& M(;PS\$!SU.2;-#;J&/-3Z&Z&!?>0&F%$5$A[_8YSN>3)XI+EX"HQ,A6+=I@Q M;+8Z"1]$\0);/E#QGMG,+A$8O6:,!`YF28(*S):[':#)Y@.^O6X4/66;U*5? M*_D6NU;&B%F2*H2.7)Z_A(7/%T*12_+LYBP11[P=HP<-NSV:4\K>T)O@IQ,' MK3C="US6<,)*+O!IT+6@)V_G2&'.?W0`4CY81P>7B<*LP+P>W`/]QB!5T6Z_ M2!/4MB\Z^TZOZ=AV1]4;3=1H3EMMZ8:C.H;=;.EZJ]MO-O>*^R%YZ8 M9]7LKOKT$7[ZE3:[^[\:_4_5Z6Z;I#BE-G=;7/4K[G&W/2J]@@9WVR/&H;O; MO;XF#E5[N@H-M4(#K>ASKVM-5[>E>FWI\@I-QC=/`Y][ZL;TX@^^F`>/81&G1[6* M?A7]*OH=+?VJ!G15`[I78/)5#>@J_MB=B*@:T#U37>VOS]++OWA,?L&;HEM% MP8J"%06/G((;=M8JZB*WX,M4+>2J%G*GTD)NL4)I=>U16:W2510.YX,9QP-^ M^BS@>:EQX_8KE\R^HS?[MJ4Z6LM2+:MGJTVKU5`=L]'HFO6^4>]W#UFYU,D` M7Q87F;'6)DG'@2>.ZY5"$,,X#'*&]1B*>;E1_,:+C1K-E]4:.?KS:XT:1U!_ M(!!]ADLO(:TS(;?WG7_I M=:J^>:;//EG@>&7"==)0)58F[M![!3SQ4=]-WNAK"Z95ETW'*:>S:KH8U_%4 M5+1IF(>7SZ=T*-]0C&>9Z[N>*YN';^K[8R_J@&M^AX`3>\:CUQQS`# MY5O24XL[G3)T4V:265?^FQ=[V,D((?(06B8D+/@>"TIL&>G.,7J]>EUOJ&W- M-%6K;_95IP5^O-%L:NV^V33[>GLC[_V/OU_<]-3KJU8'SEX01D`3+NQNOK6^ M7OS0WP>_*)S'2$[*7OJH_>[9_^3$7:JO$L"O_T M5/([Z>_R8;H5XD+`[]&6U11IQRC`=`5;#/_(=V\+*%/'0=C&+N@JJ,B`?B1" M\H!1QWN!Q*Q'5CEH#DZ!H3U'*RE- M'3"Q.X]9TVR3MWW"IW^R:EJ=M1$2,+H^O/]4DU>X.(S!WA&#&)JS.$2ZJMC_ ML4[VARX/4M6;!FA;UYX+"6T/@%P=[X\M1)PP&A&:( M/'(Y^N;'?[:?\#_[A$*V_7AOW30=O6'8*@@@T!B:KJM.HVFK[5;';'4,H^'8 M]BEK#&,7DJTC4,Q0*C#\:^HVR[LG+6E'DK2BC1!??L[AU=P9`T&CZ.^(D/@0 M&2X9B?GL,>&F8UQVR"XQ$#)K`3#KF4'K76V3\:QMTG:BU[<29R]81&FD_1F4 MDPBQM77O#52LL00UJBS0+^YD=Q?I?ZO?W@AA:X&MU_"F=Y<[48R7DXJ5+4#F M='Z_AD%EF*U6SF;?22+7,2Z\_587WMGNPC>+4"Z>O-U>)!0HL&?$+9_CF.P] M?GFPYZJ9ON"Y;1V;?1X2<^DA.4CP_J4W:N;&:>H?=CW9;2Q/UU_U\G:S>:]# MHZT\K/M/AGGQ8=TX(^(DN/EUKT[?.*-I+X?U^(S-U?'BRM2L9KI'4_/(]=GI M&9^;E\F>A,3?&"#H#:_N%-79:[0T7[??M'$6Z4FL3M\X,>\91W/MNCYVT;6C M"\;IC^==`__8ZP7C"5R-[^3.]04WX^%\%L_<8,C2;7C!8,R;0--][<)5.4NF M]7SJTT:M/9,6Z2&V$1;5,$K2B:JZ-:]NS3>\-7>,%W;B:FYP:6X<\.*Z^G9U M87]4U[?5A?U;6_B6+^Q/9^'=[2[\=<3!E@>/CZ2FZL47>Z_<0]VXW\Q)+.]U M!_[^WZ:KVV59]C%?:!T1'$-U<`_)VL>RS%>>1[!Y8?(NXI]&::AHF3&9X)V] M/)XT\8;^?/)S5&1N#PAD%H'#+!5LABMLWCQ<:Q,/Z,<+EM/UW9C'UYNL=G!1%G1'?O/ M'930.4W#ZEF.JFM]2[7Z_9[JF!U'M9N-CJ-U=SG1O2L'_E)$?N,$`"X$EJ#Y1MLM@W1*.S-XT4$6G#S\_ MWH-`>%+#QP`!_^:WL3_TW>CI7&F-L2HOAH/@C_R!BU"%Z*V)2$ M?C!":48HCX$4N;"3^S9LBO=WDL,/0U,IYG*($ M_A[X^,PU<@T"4'Y,;YXZO_S6:EVE_][]Y1-#DIQ.05J0,HI0%M&/O,R<]ITQ MV!F"+0WFD4\(7/A,[\>`(`IQ11,_CI&^F>]=]SK9S\&H;L2OO8CI_(FT3Y&` MG3A7.EXT(47OZ?N1O!7('J#"M$@/3)QA)=\%6'$[]@./.PN/N'5&L MM@11-J7P609;=JE(+!>(,,BS1"+PPF@,/``VV!CX\U_S>$;?1UG)KL^1<=EI M1BMK'A&0F_RD`CP$5AIH,>1KSL"*JXQ($1KL'FOEP\.$@,>`'F(.8D]&\_&8!H M;%EVAVT]/[MC24+(MGX_V*KE2^]\__'[ MU]Y"2XF)\?^.P>1/KXE'T5KBU/"S7X]8/85_8Z_&<`16X>- MFN5LG!=Z8I9PHV8:1V`BG)*8J'&&5['4+0+?B\+YW;WB3Z9C'PQ?_@,;I;2U^6G9J'R[SGLUH@N30=)J2I>H].%1>0.9G@W>HM7/N>Y=7CQ MS)]@`@&_38QG_*IYXC[AK:X`<^?-EL[H]BO=)V&NI[^(%H1T-8[W[;".)%3_ M).YPW0E>R\!H0!BZ5.?0\NR*&Z;D)4OU8R6^]Z=3!)2_*;G^A8'$0O!Y6"F[ M_KWW@1J1C]>]Z%%'OD?=:F!NZ;KQ`I&NSV"07&]%%^?.;N%H!X-!Y`$1@KY<]I-+A)EH>M6U6ZR:C=YXM&'JMWDFXZZ5NTFJXAD MU6YR*4]4[2:K"-/!CV35;K(*![V%8,9BNN9V\QBS.9*9=30":>W_X+$]?E*BMJ<3A8H/R`43[B MQX323WF]!PV%C[CQ?8W^$P-4_Y[[((A8=GLA$!RU!+R=9>-%0X^2VF,>/Z0\ M]21A71J3%5O<@WX1,Z.HX`Q&""<8[1J)F9(`$Q0!6' M\*]8NR"J1F(O-U^Q:R[%ZB9^X`-+/+,PXSA8?#<-_,JBHTE0F`*C&"`=^C&X M,#%5F$58`C%AU49#?S3R4%4H=UYX!_;&O3]`$4FU5,A"U#-7D!"$GOI"N:O MN&&U!$H4([BY\VC`KETRW4)1O7S#)L6^>\9JD)=I.09C`J?Y877STG0RF0JXL^=7ON79V+$^<-9TS`^;,'529KR\ M9>^;9;JJ;VV%P'ORZ"@ON#&L^M8>T[-][LZUY=U;>VZEO[F@RXTYGI M&]%GIV=\5GUKJ]6]`G7V&BW-U^TWO?*N0$?5MZ'J6WO,5^-5W]KJUKRZ-:_Z MUE;?WO>WJPO[ZL*^NK"O^M8N67C5M[;J6_LZ/=37W?[R=0?^JKZU5=_:BK6K MOK5'N[RJ;VW5M_:48TQ5W]KEZ!#Y[F`C#Y$B._=N=.?%N^I+V^OT^T:]W5"; MO9:F6LVFI;:M;E=MU[66U6NV.DZ[=12ML_`?"(U!$$;IA"S6?<7+%K_QJC,B M_!$TJ4TF.N`3%?65F?(X:KTW%%"=X_#1BPCK(*2"ZS!2`@_?`#;^#TD/8.XY M*]$636W%L"!9A\KC/5;:SOP9/'KO$FXE-J+E,[F=L\\,(A_[9;I4C\>G0_"8 M=P$U_&-M/+&[)6]:._%FYTIK"4X0S:C<(JQED3T3*$YEN))(\-M/>JWNV#7@ MZ3-6RPH_V.R'?(DH(PJ>W[*1SZ3ZQ%D(_SRF#9BZ$2'6T>?,)H[-/F6:)GWH M;%7%Z.)A7WZ&L^>][_K1/W%O4YR9>/O'76]U[:YIFZK6KW=4JZO;:K/;L=5& MNV'H1L_H]K7>41QW\UQ!BBA$$N6+YR)!"*_BL(C))X2.. MK>+]\`E.9>#A@>$:4,#O,51;]NXC[S]+W(YZ#X$;0B7VL/5H0`B[,Y1*4]>G M/PCIDD(Z1$0L<@, MP(4DRT[6>)@&MGS[86O^/?YQ<6:I.YC&2 MX8<_\?_#NASCRK%!ZVWL1>Q2V@^F<]Y+F/!A^),P!G]V'BP\?9[,THO1'O+C M>U1UO,@*9&S$)@"#W,._N-'@'CMZTW4Z$#W$-MG_(31E^K:,GIU;#XR`*Q(J M,8%,WAPCN7&*$,G/L*OY&_4/SW%(5QGAB3`RC/4'TI\_A?QW/X,6'RMZ*@NM M7_YG'I(N1T$7LQ[EJ*W1@*'SSN`H_"$*/T0QIW,=RP<;A.CYUGSDBKU.GKT, MF;TN%R1CB-DY:&2C%_GO8NY;SGL,RT1BOUING.Q;\"\QR&%0^"GS9M_'#_M! M[M/P&DTU(U71_4C%-_,V!BZJ:."2*`IAS\DTOGV2=0+7G$-WQMR'>'Z+/C-# M?#M[E[;61CTLF]?KIJW?Y>MU;V;E<+2H9ZKYES->4N'^EB.\)*)>NTC-2@*[LA2I^MBIXV>UU>E_:O6]*IJ2G"F!6`1.MVKVYL`-)Q:F/+W%OKXX7$6? M*DYYJA&.BH(5!2L*GCH%MU2&\))2O]+>OY,%0Y(*.>Z],65.1]Z='\^P:3<, MX@>T4I]]DR>!_6S7FQO@7>HSKOR!N%$38&9XWE15HW M*]T,6=]R7KR%6\_K%I-BP'4JJY=62V<+JZ\']]YP/O8N1ZW!()I[P\]I!RTPX1HJD9]8VA*$\M M'%4SK1VO]76%605C>S^0K[T#W)D\+_2SL.-6S>$2_H2X^^6+MNV-6_/LD\V/ M7Z(_NE'D!K,G@KTZ/?8W-T>Y/%7F-[2-6VANC_5/*5Z?KMPW8Y8NNP4;.,(3(13DI.O*2)?47"[LG(-J.+U`^?9@'M[ M'ON!%\==+QY$/@'LM()A&W%;+D=7#!F&`@[;#[PWZT[/Z.@]M=7OV*IE:'VU M;;0=57=LH]VL6PVMO7]X4Z,`WE0_5Z[GDXD;/6'$75"L1GO`'@C<+AWOL+0&([4?*\!_-";!.W7=!Q\^VX&S M"U,,?/<S.8$9??[$[PSC#)[:B)!1Y2&G M8Y=`466TY>D\&MS3[9LOK>9`RG%VH!EB'7/HIXG[+X*G$S>$!+.%8%IPX!\0TBX,W+$"W/,LO@;O18&+UY>$L%>C+I[^#W2@_=E]K7B",$@ZQ>RJW7$<)DL/X`3)H']L M]^AFE,\C"!7WP?7'=+FUFA@I.BM28\7CA);*L+L5^%<_HH_0/DP1&C>.??SA MUANX',65[R=2U`L>?.!8W'`<'='JHR#&6\!T.W!)(3NN!+N&VX/PPT-E$(73 M^!/24HR.,Q_B76\X)29"'&[&6:`(?`0.'!!0.?PK[!/"N$+W@C1E`=/#`C] M>1LQ],:PJ5&L]*Y:JCN%_4<(8UQ:YF8<."09(6$2>HSA)"YR$$>C&PXCUC:` M4.G&X2U,:^A-\$VD"TR=(837E-@=>8LT)9BZ>(K7K0QT,3E%"T)^SVD&`BK: M1Z!IB&H,5PH[F/Z5#"G]K2TAQ,0 M]XCVYO]'HBA'E#\K:V^6%;?W[I`0J`>#^63.,-N''O")/V-C_*0WC9IM<53X M>Z8SYH0`'X,E1@#=P(#C$$1G##\AX^%_D('" MQ%UF5^1HRGATN$9SD$G>.8SP.[PU9AC[,.^Q1X-S]>0CN#X>53#O0-.%P"H1 M(V)&!UQ<76:D/PKMUOP.X9KA!W.1*I@$PH"NV;X@H.$T\D$"^6.^=]A$`,@^ M\#Q0(*,HG-`@\-`#:DR0Z@.&.\YT*9TY.-,L#M]@BJE?;R+/+84OJ5W?_1A4H''<*49R"00 M1&*8LZ1=`+P?/N+407:#-H[$1@5&S[*;H/I"V-ABX,9/6]`^(!0[>!JV9NA<8-=UIX%MDO6!2`Y(&]X!M M;Z:9].)$AMXM&!`AS`&_]9-AU`S>#V%$2B319FPKQD^LVP*$!$?CP\2Y0&8 M,)QG\!YI6X(P4-/?!K!)`6Y.AE&$VD?`SHA>':)DAZ-U[P9W*#L'8U0RL*47 MF=[;RFWDP191KM.3.'W)-\3 M&$E1::'%$1!4/ARU`#%%Q[QU!^HA4H.@/T@'/B8`]KR]!S`\R98YZ`JN8;*L M>PN:#IB0>GR@:B)A%\S@R*>F!7PD!../$GPFMX2*GQP_P1BD3G^R-.(SW&;& MR^QH1JZ/2C`YH7#,YS1?H"HXRDJNN?`1YJ7R%OX#*^L2. M'BPXGJ.Z]PG+/T3S8AX,RX%#B>4Y_OV$8XQ&X?SN'I/?QIX+WT+^AG$XAS<. MKU@31%E.$Q?3($[KLM(?_IW]^04T;7\S*?L.K2ID+(SCS50\(,A$)1K M7,$#PC@A]L0!B$'9Q](CD&9U`;_B`2.>HUXO;LKDS(0Y>R=2]8KQ6TGC2<=Z M&L948&HDL>.8S5T3R9%@*H!VY]QZ]JY\,4+1@)_EN63^I89@#-\EVQ-= MK##"TW;K/85+613D2Q2.:PK&2NZ87L+%CUU_`J+B#E9*1U^66*(-#5D;,Q"` ML`5S)&N$%)R!*XG<0Q(R48LDC5/]!D]S^C%IOVR*$NGC^13\ZEF&RDS3':C' MQ1C3#>_N<^2AWD3_$9P.1A^)C['_IP?'2"APDE9H?22BC6?(82D"#B%DSP")LAJ2R\7OB*,'A9#8).7`PR#P8N0\A.7%@5&#<@1T]%(&P M@^EKZ/:QLX>S&OKC.>L'$I)A"V8Z/A3?P]0PCH`N$F4"D\\$FB\[D&@NE5$2 MJ++``V=B2:A3/BG0.#BK]"S+>R"&/F,=K<*9;$0A97(F5N`AW3`Z!L_E]0'7 MVI(P8>I)$C5$P;Q<$\H[D6^D664NHY""Q%8I-5T9YI[YJO@E.C3,D9%:3"V`:&8*B[#0\:`KW_Q5S.&!V0K,67L@LSB9AU M+PPAOLE#OHBRB>0-(V8`,N61DHC"<1Y:A#`.LU:0,(9BVN*5 M6UBR@3BOLW?I'I*ID'F,&AIY?[+V7X%W%\*NSNB1F)F!%*6)4(7R%0N;B2V0 M&9QT:L7;;%\C=F#SYSZ-L5$;&SZE83(/2;LC)Z/^IJZ`H&X2Z^;6#?Z,YM/9 MX$D89T#=7-"`_5]Q-/_Y4?FR-/H+"LB`CNXP@W-'2?1.O6=J_:ZF6O567[5T MNZZV+:VCZF;;:/;:35WK[3V6+\7`!16H8P>ZUU4&_=%DT-N'RZ#?^:>K#/HJ M@[[*H#]\ON4W]S&Q2TX&RJ%>L[6WDCI?KS6<(TBL/)W4^3_"Z$\>^[O#.ZZ] M,_5+$VD=_>22X5ZZ9+T&]O,I,/GQ"O*^'V"+TJ%R%X8'`.5Y<<)\K:'M."_R M^!9=KYEV51:U,9,G8`&#>0Q4\J(39/OFCG7[\2W9,JS#L_PIY3^_GCJ'BG[' M4"?R7!OFB)TC70.SP3XU";KI8HU:PZIDYYNM?*@HN%WY^:S:D>6W1>R.:>CY M?^%_[OOQP!W_K^=&O6#8Q5NY;=TG==M6OZ>U#;73T?JJ93=LM=EV6FJ[9]M: MJ]UM]6S]N_[=?/\KC&RHIO[7GY?-*YUY+YCYLZ=OE%V,&89?W9ZV__Q6\ M@6^77WM*^^)2N?CZ]?*?K9N+RZ_7\,\=MI*B>6;O^)*]2E&UMG^OU[8LW6AT M=-7L.)IJ.=VVZG3[FMHR';/;=73;MO<.CJ4W"VITK'/YDH_XO+@8I[IME(5) M==N8DZM;^+VZ;3S6R[7JMK&Z;:QN&ZO;QNJVL;IM/'K>KFX;#\[VU6WCZ;%] M==M8W396MXV'8/E3BIB_GMNRBG[5;6-UVUC=-E9W9:`HV00IT0A<^D'DC@!8V`_GCF MYH1.YV)I.R,T-DA""*;BUDS\+F$%TQWM]=_*6Z)MW/XYQLMN_QI+^M^47<$M MN3#K.\[UNK;ST3`"D:`K[O,A[[<1??K]ZJZ: MC_.&45"S!J[]6J^>?L3WY-9:-(_UUIY[<9$6:70`PQ%;G6%%G\WI4UT8'&^X MNZ)@1<&*@J=.P;4D["PG8>\]5`Q_>Z\WRJ6K](P4H"M[H8J?K0I>B@(%1=R9 MT#2J`&85P-QI&$MY@W%+Y0V&*Y4J2EE%*:LY5W.NHI1[/,Z;YFI:-=LZN3*N M-[/8UQ>'J^A3Q2E/-<)14;"B8$7!4Z?@"Z"\MI`YGDM*QV94;>PXAHG47A!3 M`YI6VGFG_90^W6AX2?UKXM^HH>=%<.5%?CC\+0KC>//4]*$W\"?N M./[;^XNO_474*J.M=;26IMJ=GJ-:MF.J;MV__/8%?P\\>!2.$3UY\?4W?/O'+TKG\O/EM[\HT=WM1ZT&__N).3W,`5+^ M*^?S_!>,<=&]_.,:_KX(#_:+\KEW
[9_^3$7:JO$L M"O_T5,I>IK_+0H#"1,US1=HWRO#/[!R=RS2@M'8Z_W$0K[%3VN$_^/@/EZ(G MM?(9>Q@RHOD)T2KRR>23FY.RIMW8CW>`O==8WUALI$HMKJGE]MU=Y-TA%B.U MT:3.G#]\A",:/RF&5:N#PHK_/<<>N"//(TPZ&@YY^&Z.W7]#[/#J*5C"@6VP M<9!`_,CZ9/_`DJBN^^#'-:4#.A,^'?@N;_;,&LZY"O:I3/MIG[VC5G;4FIH& MQO:*?D!M-&^].S\(D!M@V+YW&\VQF2"Z,JR';N1AVV;6D3`[*A^+VL\E`RJW M3\KE8!9B/W-J*4N#$)'.1&-FV,ZDE1RV50RP?:=HJ9ETH)P`4>ZI+1TV[,2O M\[[6SVRV>1S,R:J$MLV=%X%R[4UG5.)$+<]%+U-@Q0DVX*.&A:UIY(_32CNI M.R2%YNDA;)W(>3GI7\BX.LO#=LW,\O`9-%15N[XY+GX,G5(=4
\M+1HA8ID:[@32LU:P&6=IV>.*S6#3@(T%4H]])F/X"&.@PSB,J$TB M?RVS:[I=LQ8E3[IG-$1NUT2W3H1HO9W[8]9.?8D$.N?2-F"NS8`GA+B7!F_J0=5[/G/Y2\%"3%ZBN>$S7UQE, MYY\D.V&H?`4MGRMWK2T*_IKBCD/JGHR]@;V(FA##8?2I`E<(,!P/CNL$-`N3 M%+P-\M"//.KOG;;^!AF)7:(#D!6@SW&0H3<"H<=;YRK3.39,?0!I@@XO.<'8 MXQM\4)?U!-;-@.^`L0*QHMMU%=(TC@;'Z#3<#WUL&09_GSM MS^:\GVT?.R]?7%PH_W-54SZ?7YTKV%5]K#R<*U_<*`(>5]I^"/HZ"!_8*S7X MEP'*3'HP/6PH4F%:7T/%^(MNJ8,'53/JMJY^Z?34__['U_,2UC-$V3.V,DYD ML+P>)KQAJT&5N(+2(?;UOG?'(V:P?O0_I4.Z8->!I(Z).OFY[`# MM.^//A%0].@M[XL\G=^._0%([EGD#ME40):#[$#7FC'4&#MILT;M\-#`(^,: M]%EI\3C3#M+&UI@%)-;.ODGFRAWEVWR,L]"U6Q6%3.3' M.-UPGB"K^W$\1[\8_YU-9CC&=O?C6!B9$S\&2Y`LR1@T`F\9#I;G?%9^MI+N M[6P,L&MCD,"SN,:]27)=9S*81#IV#1_'#O1`\P='QFP^`81[NX,_^X2$?SIG/%93@DG>`M2"S$ETD,&"KR6-0\"#P@8A+A#\30,AF("R[D=%6`=X3(T+B;`;@>.!'W"5ABQ'Y,(STNZ.DYL#+#+H&9B2W_&'_BCU.D M);L4BH3;PG_X#8_*,$2AL4"8=Y^2L M1MSXS-B8-5*@(+=1.2O_&XY#Y2,WWLZ5SC_!>M.MIOXI40TEUBPW+);;LVQD M>!3&EFR>Q$2T;4?]1^N+VOGO[J<:*G^,U9$`Y@J[1"\QZZ^60"L)M;A*\4V( MR#$S&U'\WH9BY&VN:YB(9@:` M="9O(PP!,!GM1["WH`U\-*>&@1CP`8\R#?X%Y.<:P#.S& M/04JX?_]H?@GD'H4/V4?(&6;&1WC:R``4440)I(D7D`LH++TBM2DI"0SNH8) M$'IM)44PUCMVI_C^_!:&"&9,V_"85(A?FO$I\*%D@POH%P\B_Y;Y0+)9])ZJ7ZK@3DP(U$Y]F';<%_# MFO(`U@@&SP/`>1,DY".B3G'OP9T!P8XU]P3%'VA.FA M!T7E\T.%$X%#1%$__N6B#VXLBY: MU$2IATYV_VI-5*J'4$7]4Z^#)C+,]15#7BV@)_1LQ;#,Q2S0%EMUH(I43QU& M69!5-5GYT!RXD"P5;L++E$=?I=.RXE.2GH5S2EPYH=(2*C&IPL@M:3G4-,_4 M:U;,'6A=`M4+AEX14JWU*(11T%2 MRF36<+6<4(>TN&L!0V M1/^&?-CA'+[^&TR9.WVHVM!9`7X+W-D\$G=32XZ/X"GN^?@!W5K'25P']&W$ MO'Z05%/P!D,$`KT#L<&Y$B-[W)UBY(3I,W^JNB$NSE\`4G/I#9L[#T2$%0TA MO"A$A$V*_LA&T!-=^\-1H5P'3!L3\7?)K+CU*!"2W01$:`W'#[A/L7\78,P# MXP?H5I,F0:Y%%L:#D?E1Q#_XS>$=Q=KAG_%NDG\[RV0L3,*B6?R&TF>ZD*YS M70P6<2<+6&H^GI%V(HH$#[AZOHPP:ROQ0SA#SKYC]BB\'H[G<@Y$9H0X.\2Y MTAHCPNC=?8[G!QA?F&4(GQJ=R1X0M6]9"#=(8Y&P=^Z#Z[/L$S]`'>PR*Y8O M,#O#=$/H>G4^'C)KTDVZ9"GN$$077I:.1A[ZG4$NGB:.98U10!`P9'E$?-D# M-[Y71N/P\41/WY[N5S&2>B'S3'7-NJ;T`B[U1;`5%.PH\2.[X-+$G.%[>!X& M+&$BL4"1YGXN4\9*;8L6.',SGE"),Q(X.`^B.:SS M)[UFPV`<8AP%'GJ_Z.(/\]?`M^Z8YA'?>]Y,AIU6"@'.$[@$4I7L4CT1]9QG MP6QUQ]QN8Q1!Q>FGI..^? M*!4*__\T)?=.[*8KIY'. M:TW!6RL\Q2,%!A+I7'2V'H`%1NY#&.&&US*:/4@TN@]\3QI]V>5UY+'+'OR> MN&RK;4O]L_\KKI=X7@I^VD:\&P[F^!;+[=]V]_.FT>R:>MU23:VCJ5;?,E7' MTFW5ZC;ZC7Z_T^ZV.M]AA/>_XB"JUH`'6=OPPGEEJPY^C[W+48^?X1>48.3F MW.NT;:>EM]5FS^JH5J_34=NM;E>U[+;5:>JV[5B=`W8'6#2#@`YT#`0E7FX% M;:=[^`WS9L&I3M1PT;VRPH*EJ+E11)"*_*W5NJ(30@D6>+<7N*Q4!07PQ/W3 M2X0W\_#!MY]/ICQ8BWK0)?L[\518H$YQ)QC$8"X+51.Q+-NTGBCQ5(;)H:&L M%Z[M[T@NE;R9Y`@,,PFEA6L6GRF:6>YZ703+E>$\2BT"2A^'?V/IG^<8$<#, M;R%3F`@;^ICG@G-`A5*HEB^B,O M'^K]\**!SVV!`U9)Z2NJI)Z]GEP1%$AM%+WP7SU@VP=WC#M]!;;/X&D'/4QT MV[1LLZ7VZG9=M;1>1W6:5DMUM+K5-ANZT[/-?4LI]/O*Q102AE49X3]()#HF M>95$%6"?_2'%X3$/P;_#5.FQ#Y,>2@<:P_D1J:F87=#Q+#&>Y3[!R$H2/8D\ M3^1G8V3#$\8DJ7L\YRE%SI6$6&0+2']B,XN9I*`_TATCV15H5$P64#'8,![+ ME"&!B0X7>T.$=7EB_N^!SZSTZQD]^%&.R^.->R82GR,$OP",SW-Q,B;"0G(W M0V40>>@A@J'^IXC,(5[82[>CP%N"NH&+HR9)HF8[\=:Z<#<\/M]#Y@#QNER.E[@G\FQZ?![ MT\1%32M$T.>@6!7F"_G"PWTBQP*W141>^>:L):'7DCI9097:@Y:T;J?1Z38ZC:.0X8D9^A7LHL\8R0,=S,3ZL=B?.+.QF!F=.!:.GDSG,V9Y M`/W\)'86B,>928(V#F'VHNQ^`./D#AZ94PR5W%=6=D#.3$9H\RM(M%^9*YD> M`[1>!NYX('*381QL%CC@V?ICFE8@S1JO)\6\9Z+@D5XN531JB;%\55>4,'.'U=LH,$(N0*-1F&<9\:L MD>F'^04J+0=UUG`N;N[+;BW2%?-@GD2R5F8L^5M9"Y\^#`8GWLT.F7M>1%!& M3E&TD)UH9L7,5&658Y0!P$>F&XAD7!@CQV`Y(X&9`TU;9_^VNB?A#=VJ2Q.^#<'47Z'KUA'(*V1H5N#"\6XE*3)7 M4I,;XK">PX#=-V3`L\?]M4+!%EEG[C<$D6O4?F0>]'&&V!X,1-I MZ+>NV]E(@[^P*>D0OT\QWGJ6R^:G^P1=+[K@3-H7*Q]OPBFH,]/4/OT%HQ[^ M9#KV1T]"PW)P*7$!GKPGL4`R>F8!K>O?%3Z!S#I0=')4D2E\"3;J;NZS>UF> M0(H);Z`F\(N3[-=%C^8G*M=)/\"BRB)6$2#R`=VTW5,$F`^2OJTDB?WC\%'8 M!CQ9&@5LY+EC_S_D\#T@Z-8YF27Y7[F"ERYCP:;VQF.*2%.%%H_MA)ABAJEL ML'$1NZ=(K\4P!D;>2Y*O,\7HT&`F)8PSVV4Z]MB=VM"/0>MBG@VY&C-0*S&& MPJ5X2T)2KEYC:?%)1V3*QT0BN/%,]8,:`ZI0J0(OXB'V&7B^F7=G]Q1IEVC/ MHEMDOZ">HSMJS%?P)^Q6@L&QY*/UL0040P50Z*8L-%?FY>B-<8":+S<.MI;R''(=1]CLKH6*) M9*F%QB]%,9E5OO4GY2Z5D97>@43,N9&N6TXTY6E7D#0)Q(F0IR`;-Q6'FEDL M#C'5-Y;NSJU?+B;B&IO=?HEGA,1LFG45A>:"R+QBQGWB+W2]6[0Z+T0Y*WFQ MZ\M/S5RH9Y+^EMX/DO`;PK?2PEDF/@1_\4I+*:1!3XO[NR>,PZ>."1=>F5P5 MD8?`4I7@=2R%Q57RNS5TE:*(",'"Q\RA$?-*OE3C9P,SK`42#3V!1X#"S@(K MBJ::I$]*Z@!&2(0SDJQXHM:QG;L[_&`@O.( M![,@S\JE69T5\P@AR>4AC\^S)O*(`$:CL[%7B+_?IRS3G?\UFXM%2=9`2$S] M!B8M)!1N'SJ=>%'MIW7`4LU14J61WONR/X@?1(**X`B2E[%)ZE>@C4E>Q@IJD^=F[)2E< MA9Q1B>R,R$ZAEEXJLRUP!HMD=AHKQ!W]7<[X/GO'00#`%NR1+9B#^N`"#QBJ MPS,8B8.5WT*F^3LL^7!=(8U3+!/2^+>R)`YN;3!Q0]!2W%IBEIV0$'G;">QG MCYW*M+X.!W@@"76'\BORJ?CB+%.Q2;BVL[R5?,]#4&Y*E(%,%)2T(0/K(J(( M,848-(2$-0K'8$<3;(*$V$"I;=(-YH+1PRG"ZS0'LOFS4)A1N%!1&P037E@D MTQ\!G`"A)<[>+4KXE-IY::SP4L75IBE/H_6R`KK8.&5S*+(V,]Q2;FOB`,76 MYGJV)HGHRMI<*KJ^N$];DEN:4R2WOK'4)F8SH?C!XK!8)"5W0&R&$TRZX&9F M0VM\6E\.:4ZY'-(YF--N1N'MZ3SR!,?<(\3G+T($[>E@R/E8B\Q MR:2\K7.\G75Y)A9:>W+%CD#;P;,JG7D,Q7*I,)0P7%AI#H[!3,J:**#!KZ=U M/D_2U]-$"$H@%2G1(@=LD*$Y'$=.\469L2`QR+0HE1FI!3S(?:3()AU3:3L=YQ@%L<(IHE<[)WI-_3:22 M<-\O1O38PNNR?3E`*Y1L2;PP9":NG+U(^BDI%E(FJ.[S#D0NYUZ4`BHQ/SVB M'K*PH$P2CJ2>QE0#0?-DZ^!@$4VVWZSVU:SEFIVUUVW:_=11WEL:Y M(I$F$Y+FQ%D2@OX_JJK\N(W&M=MP^*2HZG[O,A<#[`3+CZ=(#A$."[O\&?!&L8#Q-NTNE9LGM M(HL2\!O<42;-YAF9&YFD%K3RD5@\&SW-XDM04U!"D\^$Y6NU`O&-CH`78,H? MF@R#`9:_#>6B^&D$/.%/QVEI.TNFY*F4^2L.3'#/7G%0O#BU1:+YV!,B^2[! M(4G+\%*@.7PF`9NC,A`J-\M^[[K7R7XN\3(D7RO=I\3K`B7-L2HR6T?9+F3Y MR58,,T`)B2V]O>4V0]$Q$F&7J%AC(HU23I?.)X(P,@_CC+)N$S`U*OG"DL!B MZA&)DRVCKR>;)I%>CN)S\^9<^3O8)F`4AB(% M_]@13T_WHCDIR@,/(^DN!'XG@U2`TYG&.&K+8G]E%MC2M,Y2@7CV[ID9B)$W M&J.9B&DY[A`A2QC"8WH]26D85$H;B;XZF2?!E,5D:;S9PYP.QL!8?^OZD;RF M;-%/4OU67/O&0N,3&.T>:(;&+J5[9#T:$1TOJIU+`>`V4!@L\P0OT/C2?))D M0TR:)_]BQ#=;=/P0;QT!?/79VC_"\YC$#DOD22RP<&0F--8-3PD*Y MZPP[U-SC4Q\(<_2(AS38^ MN0`;/PFDT4R4B6XZ!PN+E"67R)/G_BYC&,9C$IB>&'7S0\*15NQ&6HF<3,P"NF.]=A.$'E/\C8)!F!1Z]2YROZ5Q%?003H M:_3XDSE,7$)>!,&(/A:7>>(`^(G,([C;G."7'/FL=80$1"LJ#@>LQYHX+K%7 MK%JY!)Z`3PC^T^%"<(6R1ESXL+9/($4PH1+A3="YITZF$R;\F8V&2NO."^\B M=WJ/=1^8JLD'@D[0KA,;#C%,R;\GHYLUGT"!"?$J7)H-U'0*<'M?M M(CZU*V'*):R`^$G4((2I;?09\4(Z3@Q6V`52[/#?A]G>EU0?.A_H7QH?\H6# MV0##,^*L9[P%$XQ)0^CZAUINY"6-01*_XHP7<[`XZTR4Q7#\+WYIFEY8'M>Y M2B2K$H=@5WLYCPDM-I`,WQ"`T7=Y8QSK`^<"Q_RP"?\DR]!^=N/,:^ MB+"FO[W7V+]/,3&"_SMEIOSMO:YI']XKO)'Y@&S1]\HM]4#!QX2EAO><;4P^ M4*CGM_)WC'-GKCLSK<=G0S%^P_Z0#+*J@7HZI_)WMO7[V_QVMD'\+"I@N^8J MKGN_="W9%*)U5I][8_F[?+Z<[\513%.]%'TZ4^@&X/T"E>%LP(&`'XP\PPMB MD6/2^?T:!NU]D\I-.`UY/5MZMKV2.ZI*NN9=_:PK=\ M+7LZ"^]N=^'5??12/ZLXB>[D/"_KE?LFVJM>WNL.]_R_35>WWH$ZM;C/S11>"+[\HGR^^]M2_]RY^ M^_L-=R__N.C>_!VEUX>C#\VPM/5L,*8DVB++;?&Z%-@9>Z-USBZ]G7_EF\=+ M"F)>NGWO!HK^@:'&R>U_"@)UJ_CC&8'/_=9U7L^IJP+"#D[Q%AW^3O,]@OI. MAHE%.")`=2R`](+94L0<7BN4J0$Z(PQ58"S_091'X?MW/N(?_1F$V))^2)C1 M,]$B22YL"V^Q*#BI8^O<^X%[7E[3A,B+>)`$5=T!A[V(W$<8(_D>#1;,)UX4 MS@F^EI5JB4(HK/"9>A$":<0$O?N#RI8%]%'(JM@9GI&8^R#R&,:*JPPCWQN* MEUA%+#P7W_O3*14[GRWIQ@X[,A]AB30A5-#8YTH+BQ&C.<=-G`D<);',92/$ M_HQP)EUY"-S$R!WBYMQZ2!&INI'P(Y#,'/DB\.Y<5M\DL&QC=^QQ,$>^X]FZ MU+3.'0`BZM`+R+*TO MQ]I_?XAUQXBU*<.6RO5M[F/"!;SKY!F6``<($Q&$A'["*FX3=*P,,GL"M@3XQ\/YHTT);J&(\% MD^L$@Y<]#(_C@5J]?&2-PQ9:P,!SD0=GBN%\TKN?.#1L`H[(1T3N%C#S]`@6 MUD:!#"6+_S)V;T/&U=EC1T#]Y\2=\8Q)0(X0/11]ET6S4L0=2@J!76*\!I$88$15:R6'$ M$DSY5"6+2Y9#X.H,*(35:,:PV>H$'D/(\F3Y0,5[AOW#Q*N`_1AP0`E8'\R6 MBUMJ=."5M;Q(OU;R+1H#JV'3UD'%C8N-O`BKVCOL8&%S,C(/.++VT4B< M9*)<`B1V3*8^=HD@$>!0TV!EO$,5G1 M3Z*(#H>`S9:QO0ES$H\`1UB=>+/SI2V7:4;EL9!\&UG\5C2D'C2KB,0Z_]8= M&_L;P74#]N];^GN'A3 M@?."5ASXO1YV8F.-,?PX;=/VQ`P[CX&I2S!$`H1(8#DRG%PR`$DSQ:*)12@Z M>##L.D2R9DOD3HM0NF3;<^&0S!H/9N',:\EAIMF*3D\X$<+]('18:8KXOC0O ME$>C^7@$EBD;&Q0@N#N'`2*XR@L"*?,E^2V'E"%-4T+AT^!>T'F]M ME6C'&N\92]^\34`-"=I'ZE:%.>S)MY,/3-PAM^;E[V3ME<5S(;*!T#4C.TM% M%*N(&UWJ[#XB9X5,.T3VX:U*1/=$T4]E1"T.."?[T6`^B6<,2IMG#DEHVA_C M3RD$EC176!BSN<[>R7`R7/'42)UPT%"&*$2F4BUI4$-,R[IT(Q\C@@R#E>$] M#K)?X^HPFJ/1R['GP@AE;AAPNXM)#,X8Q.*H]&H+(X&#QXPZ$"1#F`GO$\.X M0LQ#]`=(SJXD;N*4'BE"=KJJG)OHPBIG:,'CJ-09/6F8$\<"EI7U4P-^'?G< M'UA8?S"4/Q*Q?+%$4@A[G.0!PWE:,,V)"XMHRZ5&TBGGX4"G^B(`.V5"$(I> M^5&09YYT]8B9O.BOF!&ULY/6ST84 MQRR=)=]P!L6TG#`%#/%+(BF8#^4'9PRWDQ%HE"1Q%Z2$\(&B>@3`(Q`*2D!`G[CP@HU=(W#PT>8H) M2BU$)&L"2LJM`&-VH-L((E&]RLZ8ZVW`8O&UFVP4EQ%UGA MABU9X8V&5FB%\[X590Y6#K,.[1]4QS0=DOC8628.TPF2=F?-$NF0Q0M^!(N@ M9+_SO#:''08WR*X;A.F2LHK4L'/HC>$)>4N$\.=`W9&7`H^#YN3R'Z$Q,VM( M,.\B#Q%F973DLW?/FKV$C\QF*1S542:4A/";1);TQZ5?03,]^QUVLC@F9ZKO M41JP\YJH_S6.&FN#4&`9GXOR0U+'SX>2JS<9`%E=WP&8G"4-7H`FE\4T(WF; M,?E3`S)C,QX(KR\/&YC5_:0HXD2NIP>,V=Q)P&S!8+^+,&(2UR34_C2HQK:= M2SDW/I,ZE,8,M#][CFN\937*_0A;OJ7-<7WVMAB+1VLPH(M[07:II-N%)N"/ M)RS&UH,L>.N1T<[TX\&1_&3;:PQ.)IS/="F9]B)XV>C=$50IW0O?\GAN-HA( M/]S!<6*V]!Q][\7;N%0&QL)-2"UE=W"/:*2B@\(,=Q4HAE>^PR2"S%N;<*L$ M/BAZ)803$`4(2^K_ATV/-8TD_4FF!BEW.$TIMGPR`U(*.<5!C=1CUEKS[I[C MTF;OW=+0W@N<(>T+"3SD@9_L M.AD#G*^8Z9B2Y5SYBN(B>4](1C9<\3NYKB)LOAAB7Z4&TG>*.FV2K6N?/ M!S#E9E?:FW+A[(*9U#13DZFN%QAG.,KB&:^QK1ZRGAZI*?:4/)'9S[/G0F86 M3Q>&^4EO--(9.XTB7CPM_` MH;A8$%;+T@EB#^TW-^(:FUUKI:CHM>3S,$@R`3+2N/,`YIT;I4&HXKLID-XP M%UI832AM^A3*Q,<`]/V]/T4QA-DO[ATZ\./P$8AQ3AT"\Q[;6:;KO1``H(13 M>F-!N+ZUWDF6*2GU%;HS\/%#I:YOHN4B[CV3+"!6&@+GBD&1_7-/54&NFU M9M,J@) MRPFG$TXBY1"UWV*0%6H8G_$`[B#X-&C MQTMI))04`CP3_O"Q6.?N2?PBF<7\%_2UYV/>\X]^8UV2W%N>6B*HMC"9,:9D M\5=H0FR,Q,R<)5V3V#]C9[LT8X4C>?,OHG/&QN=.N]2XS*5/TB7>\XPCYB[G M`+I74)I,28]B6)IMRD$M./#U>J$5DJYP<1B#O2,&,31G<8CG6,0O6E.CIC<= M>3J@/.KFL]=4;^CR('6M6;"F(Q$&7[V9\IGBW2"SKM'".)93CS,;BYF1[<,: MUTRF\QEK3C0$)W0HVH<%XG'6M8CBZ.APHLL&/AK:.L&<``$H1X392=RBDE*: MTU:2O`M9RET4+W7'`]X2%,?!L-"`VZ/CN1&^G M:YK[M`NWN(I-6KADK+MLRQ46()"N>=DSK+^W2%1ZI#`^N[X5_;NR%B-SX.%C M*BV'W->YE][_%=JE679KP;0@.T0H_\UBDT3=OP/*5+^(8HXARU_),8_AC$5(7 MZ,+!?%-+.FW&)$W^&L6+&\%Q;X?P7V>YAL[]UG5;OK;Z!!(CO_YTB-^G0Y;> M\C64CAK.0-7!'%Y()7Y2/MZ$4Y!3IJE]^HMR[4^F8W_TQ`4GC//%GV[K^7>&?R\R:RR$\FI0A'BMW0Y\-0GZAPZ]`>LQ(@9=DP73<<> MZVR+#97"F*4VG_$$1.R**;782TC*Q64L+9Z3`UR0F-F:8W4E$S&^V9VC/RE$AF@Z*0RS&"'AFBI>^G9D[Y7G&4@F$AULK MC'#Y2;HMY#GAS#1/-"ZOL\`.=BSCA5W`G:W;\UKX(5)?[X,EC[2`<\>RH`*A MLZFS*'DU:YW.R-M MP!M.QK+LS\O19%1$C),L$>"HD%6T@M8+V MTS@#39*RI^A>G0>?TM[*++%*_!`3;PF.(#%T*^KZF(A9)R[:,/)PLG-_-01RED:_1[P>WEV5TJU)I2?W2,S)NM(M;A0@2WKB.(VXI'?0IP+E:Q& MP4KIAQ,JEG[X%Z6X_SCJ>:8?V4GV7`J8D'Z7#UY>UXNL2\ZN?I(;S6Z-E3MV M\1N3$YFD4&))4SB_G>6LNC/6-IBN:E-:##*TN`N3!-$H$.=5X/V5*VE&$11:(@=84M@8$W2C),Y0N,RQY[('D)`+RV1G-`#.3`3P@NA, M:4UZ)"OF>*(RRT0O-Z5J_,8=S[M\>$O-J4+K2.86)D">:1WETY-.PCKZXCYM M21QHCB0.1(T)JS_E&=,\13K%RTS,HH;6^+3"Z\(/E!UOS4E3*8#=,#1Q-PYO M24:32S;@K@=8_=$=K"WA1WZ@V"UVQH#`^[>LJ\9O3"@C!!48AL=K2NS#2Y@4 MBQHO*3)D*1K)46*Y/734$9@A])F4XO:\HR@.8A(-E&T6U(K1JC/9/.?'C1?/XK%$`<73 M3="_8Y0FCTT4,"!-)N&0)2&"IQ:%(J#$RAE&\_$X]WMRV(4?=S%:]AA9O,H` M[2:R?O"R@!EE0&*Y,S'>EC-C?((:<]'@+>H%CO2-^5DIESFISA&RU1WS=JTP M4[8.UJ)>K$VDC8@0*2VC5/2L%#Q9YLR*'O9_]-/0?\`?__KS/%;O7'?ZE^N4 MU5/A<`6?Q5JD&^_'K#T.!W_^"N\K?QUZ_E]N(M(.UT^3VY`5KL,SW[S1W]Y[ MX?C[5<]N6I955T'>ZIKZ/YJFU;]?WW2_ZTW].QI<6L/4OFOO%7_XM_?^\+NC MZW6S87SOMJU^3VL;:J>C]57+;MAJL^VTU';/MK56N]OJV?IW'5[\]4O[XN*O M/R_,A$TP6=3@'DS1L7+X%N2I6QMS@VK;YM]S53[?;VG6F:]JSH=S5"[ M6K/3;CIFI]/NLCDCY3GAUU$$?_S]XJ:G7E^U.J`*`N39,4>>NOG6^GK=O_SV M!7\//'CT\EN7GKSX^AO'5^YUS$(LI(:<>\P,FXF[=IT1[4AR4@#+&+`-6&Y($ MUANU,Y[;#R/CC1*+GU)%Y9*D33_%UR$L%_#4T6^:NC")6A'&6HVNSM.T+5;* MC=8ZV-QW/CR!L8R/:6*R*`YA!C'F167>1TI0P3ZZ/>!`PG=G3Y]P"F-O>,?K MH))EI?EM*>%K&/1@EV%@5R\HW%W#=_ZTECY81.W4-X82W@?>XZ:K:FZ,\[@/ M07(\8N/:&\QY@>#$CV.\!`U"O&O.2)'+P2S$K"'X%X-.2W+<36F,JW2,KSC& M.B)'-U;('(R6E`D=/BVN06L%8D<*0XY7"B&,2]"M!,$VX)/SP)U@J#>Y]1(W M365Y,'*I17FB+J79V@V1[6=FLV7V+CE>#/QKU$Q[XZ:RIP6/"VLUK(TA) M<'U:YDJ)W,F*G;208E'$4-AYYJV4,9BK,@$1,I['BO%!^5@_-^H?V/$]*VL' M\.E9-M#9NT0@\0F;C2)9M%KZ##U*'TS-'1007[Y\43Y_[JPVE[BQ=);VCEK# M1CHY8>/4;&MC_/S3DC5.K6EOPXQYH:B1PDGE2]T#Y^3%$_=3*7I6A(M=M`?/ MY?1=?W-?9O1;I-WK,]8Q"GYR`ML`B\E$Q(;UFIJ1R"R3]TZ_(Q(#")UC))M M."SE*3'^1_`5;,O9E!L^G0+#XQH;YL81I*5KK&R3X]:OE6UR[+;)/CA_PP"M M4[.:&XO&(PX\.[5&8QOAH;<@#4TX79@;.O;V>*0W_^B1R<-71KT5'9(*$M"6 MY&IEL[K^X#70+58"_94JH"]'5.A]F98]M[&.N14,N[RV=.-\KZ$W\"?N./[; M>]5H[ M3=5I67W5[MIUTZD;7<=R6,;;S3I=GI9V>-I&?Z?2[DYK=7;:0E^G+71U*J;8 MVOVDD?IRUT<7I1#Z<7=W!Z1SS9T6Q*@K3?TCJ'K:M/6^R#U.GWXIWI7[3L-HUUO].I- MTP2I9[[_-85I4HK1F>Y=?A>;`OJQ$!.5^V/N>GJN*4MC_,3Z><`K$F(?K@R) M_.!&/I[.-$^:RJ3#0$U_&7#*Q(0F]^C!SKDIVFC:EVD(4ACA)*@5$6+H(J]2 M%KJ\@-L("XOH_#^)"Z'D"V)>'#F22[[\Y+$&F;VXXN-T?3X#\_0N[5Z!'!TA M;:AJ#U@GP)HW*=9-7EJ;G MUGUP_3&]BKB[[``!#]\F:V79[^DI^\EBP%.XK3X7B=X01:P?R$=KG&*O<"G M'AXE60V^7/965S[&GD?7B.!M?6)'$ALUS4%PH3*GR@E=R<(Q) M?@\("Q][+GQ%YN.&=$!7GKSL0?W&%=MM/4^_H9D?O66"C MZ`X9>`)YIS0+[A:!,?`)5BI-F/]4\$\RXM[UHXD;<%#`M-((VSA0 M9379B0S+$0?!4WD#K!E21?5OP)K3FG(1##9`#TV!7OF*&%2,FX!Z9Q_./#ID!DP&X.BY<+.E M]#";1DH/RRX`O3H->FRQ40`J;+"%5O3,)05#,KU\42^9U%D6;?FY'<28>7$F M>A>8I8!H*[LAG+TK;T]0A+"8V_\4LKYL/W,]W(HZN)V]>V8/-][!K;C5:5HV M'Z=6/):DR;V2%F=[]HZSJE3>+/A_T>P#24<]%3D6C:C-3[HF,O@#^GP%W=?`YB4&78K.NPXV[UD)4EH6:VTE-N_9NQ7HO*NP><_>K4+G78'-FPKX M,G3>M;!Y"^3/`CKO$FS>LS*N!G6F:WV]1;_7K=:I]P;:7>W$F5H+"D M=>U<2?=(89NTJ05]'!3;235J0C#\!T(IN,:^.2#X*.^=CO(?'-^0B/8BD+Y7 M3,A+X8[+\!%%01\.0T$"EQE`#"Z%=2!*-"0/)/SA#H=@3>>NL/#_P5.$AQ)X M0F8QU2B@6KOYM,L"LL0^@H]8KJ'"SG)SWES'0Z,B!&BM0&"AZ&K16]`TPXCZ07 M1-R"O2)"!(MO802[^#/G&?J*D"T#,F&(DTE@%E$X>.PPQ>I->]7B;]A5C`V` M@;L$.T6&X$4+F\?NSK"]2%W,]ER:!X>7H3,GPL<<`PE#-][(13"8LW=I)SM" M=<'-P`L"F"Q_AL*:##J?>9Y":!#`B6"B&H\8L[[&:/E-,_B`D9`D3QSV66J# M0T@NK`S*'_I(,F8NDMN66(L(A!<.*!0I]8RCGHY%[@-1H497$,QM&^9FF("_ M"9@H:EF<[D4ZAS$6K(IOUT1('8U^-_@3;Y4&8/V._7_/1=!]3"^B8&F6P/JQT-Y#:S_"[I7W`025.P.Q6?CM7OL!NH\*ZNC_OGL,;+F_1B8VK/0Z@7>9]=>Y];Z3T M?H`JHXNC2XQTTPT8\>ZU-YVQ*&5R]Y+S6QX):%_:;P8](VXOTK)8*]E7B)^RW\%O+RE-+*\:8B;:LO(B>NQ<^7OX"%L1U9A_);Z/_,FF M]DC=$=EI@5<>&/%8/"H%ALKM-`DFW&8F%?&&SPOB!/Z0SA^MC8,P%4'X(%_@ M>>1^HKCP?0$U\/5'E[Z-1XDSXO)&.WP[2B:S!GVOQ?U+X^P=P\:<1W3LL-!R M3MV/*U.CP-2@7M>=4K1VF_(TG,Y>&M=^^.1X(+A`@\ M(TQ_=EE&9OB8I1SPNW?"668A"(0O'/M>P+&OR\128?%]4HPK6:M"+0XP-80U M_")5NL;]B8)6Z/(=$S?X8>*Q9PJ=S%$[L@CFQ0F/NU3/. M#1)1F5!'W!@CG-U`[I^X^"S9-#&[[F'8XV.&\39R_8CCL%<\*'BP)'#MWH+* M81<:+.:(KOO"INM.L>T"%A1%:-=4E/!VWD[)P#TF'35Q6&:_)GX?S`I-6]*, M:`CPAK`9=U`W"OU!UKDXL<2D98DN&S6AK\$&(>1%O^P+A1YGC=]B9>,K*4`J MNVWRP#%9,%_]`#-1O&'`4/U3:R][?X&0EE,P#<:S)_FHTGV$<-)XS_C4XEP, M^G`_"Q:E/$8XM0#/E3](9`5#=T9+B1*P*2J$MM10I,;,20'EX"(DZ4!\8B>] M5,1&2@>;751RX&XRZ1@FY2`)K)!B#-V"6YP4I9'E,W+>H-UA4I!%D])(/QI! M0O@DLZ%0S&G*AMV&J]/H*S`KCW2UQ!94<=?E<==_N.!;1$^2>+%$3.@?+L[M MPL7LKF@0,@DVG8:^U*&IS)+#U@64-"DR/L'=O&1MVD!^<'>SEAX+&*=T)N?K MQX<):HRCL5),,TY9(G"/A;EK4!"YWPCGK*P$6\PAF/X=((:1)")_ M'W'Y8TG42$"Z9(2)T-24(V=/$"4"T7^OI.@OF3D%M$(E\2628)U3@B%6L&3T M\Y:/F1`7NLO!'35$3R_IO7^C=8_IK8&GSAZ]\6A&OCWE-]-])1I(:'2Q!K'* M3X;#(H5T19X:>3AGO8[-']RG)/3))3&.^Y"D-"4(H?!^V3YFXBZ@]R8^"\JF MC9WO/=!D]QR)&;:393J+S%[T@C'WOL:B>1'O4B:'WT<4SRLAYQV:AP+\-S%5 M$JP.L!,QPL.V-&VZ09,>N_[D.9"]9=>O^61#NEGN@R*2;GI]'H`]6$6$*15$ M^'%H&;K]_??K[OM?S::1J8DHG7]^F6*3+T>?@7,1QZWC3OV9._Z,%+],XI6[ M6GB];IIULV.J]:[95ZV.TU.;3;NGVNV.8]:[#;O5Z'W7OYM&V]U38,AR_?6SF[M6NLIE&H' MWE&K;(EU2S>+I%AN)[$M'0N>L+V&36\QA#HZU9>C+@>H`_Z^XKKLH`?6+ENP MM-0-%I6G"G.MKK"@X:#+MNEZEDEQLXL?)/E94F4N!3'(JKU4N&E&GK#R,JO@MFO MXH"+%/#MP!M=RN&JH>7D]-)E9%?\&UC?2(?+H$OM'WUV\MG>ZP<^U*669[88 M=_D:LNO]#'XP-DL3O7$.:V>4"JU&([/"W*QS6QC!VD$UC_Q=&8EK+J=4Y\`_ M93=G7+%['"_D]U\H'EC5&J6);9^M+T M<];]D6YJ*<^JNF%G_=LUMU2V+[@/2.GFAQ6EI:+&*C6.I,FOTI*\$U'\+2TK M.NARG7+/O9%?\.JU/'_U>XG?K&LXE#JSSR3#LJ`.QL\B[Q[3:1Z\Q)NX'-VX M/W:T>J>G]QH..+5&L]-0K49;5UOU9E-M]'KU>J_;UNVZN4S%%GCR2Q:QP`+< M?,1@%^^7"5*!VY=A$+@]>]N(=H`J)C]\7,F\0@3GC>W)@$"K^E.JPX M;#Z#7#ND0JY\!8O+N.GS6Q@.8VR;?E@ZE4K39@XHIFCNRT,+1\()I<:W7L]Q M0?'T<_*!Z1)2F$.?RJ'@<2S9'+;GLZ_A['^]8X@BE"\Z:PJLNYQ"(N0CPN+- M`Z^]7K9VNVD7+;YL&4NB_7[@P7]U*(?LP+']=91BZ=R+M`'(-VX.MBE)^=#G MM]0$6I#@"S-?9>^(WK&MX0/>Q!W:OEFBL_*B:M5*^O>&):^^EW8&L6U:1L MXA:FC%!58I$9>N!`2BD-5-UTLJ&CEZVS()96X-*@P0XB_XJA>[=F#`Z!8!Q# M\.U`W>TJ[+NFRU9Z%O(QMLT6MQ9G\4K5X^8LLUP\ZJ:U%F>MN=&@WO$_@3],PXIX6&+,GD1 M@L'6'-NH-QS8^Y:N6F"UJVW-Z*J=7EMK]#4@D67`Z2HU?!MZ,Y_4LF0-Y1QQ MP6'A&#[L@65OJ6U8LN79R:^SR`X5AU_/7H2FL96UKG/EOW(-Y4O&2,;EZ%CS MDTKC?`L9+.LNJ!P)L!/&.[N=6=.P*I7\NE//'>+>\7APJ5UN M0AJ&N<(%6%Q+/B`3HW3#_^JEQ>A7E/J;'ZTG&MK"/U#A\S>@:X^RE0^LULJO ML`Q3SUG96UKQ$BF!0N22U7;UDLJRPQ*H-*I7)AB*UK#N)=`50U>X(3CFPYZ< MTG6KAM%8X^PLK*=\VX\HM&>L$_DJG?MZEBZO5#N\@6.69P7ICE&J^DK6D@M_ M>70G\QM+B`>IT1I._,`G=#UPN(XCP%!JSNIU(Y>8O-YZ\OD9/LC%__:#X8ZO M9=;<[U*];^3NG18GOMRR`W)\X75[EZ,O;O2G1UXS,<<16`'&LV7X.FO*H[)/ M(Y@J>;SPSV./0@C`)E).[(%/>RFSVUK6SEUG+?D;_'B&;NX1I,656GR6DY-I MF4FODWLO$I8.GG-?OI6-O-1>L@RVY,FM[\.!GZ7>^5;6MW&(H50GU1LL*%4P M86DE'8;D^PV9=!OK,!;YL&NTK)YCJ?6Z!NMHFDVUV:G#KG4Z=K-N]CNM=I_0 M*M-U3$%'PN:<&W4^?7F6TN31F!"V1-\=4-$8I5G3AO4][RJ!6-W-VO1>HV/8 M74/M&[JE6D[?A#W2F[#4NMZVVGUXRLR)$K8V[5P76_.,14A+%_$B*5B$A0-; MY\O-!4NI9=B@VR2Q_'46(JT[VU-@#UO<@PW6FJ:C@J_?5:UN0P?.-1NJJ9GU M1KVAF4:W7LB^VKDFV'?)I*6E??5FLE(5SE`F8B0`-P^L&DN5AMC5YZPE%$F]*VV8>I.5^VV02%;C69/ M;8,IHK9UIP=GI-7L=`V,"110Q!84>>Y*)"*LO'X_JHS8THB9*&G>9$VR!2.W M@4(7FW>!PHY05^'8'SSM`(';:+?MAJ&I'1NXP#+,NMHT.J`".QW3KO?-NF[I M1]$V)D$/R5*)8!!%9S%P61`R"/[^4>22PTT>WE,L#P_PU#I&M3EZ^=K+[>[C>=K@FKU\#ZM#J:I3I6 MO:%VFUI/ZUMUS=([N2PF:MM4`/M&Q.VO;<%2G"89[6VNWM7JSTZAWM._&6@F1ZZTS2YL,(``_ M7@AA\D*R=/K]5J_>L]46B!+5ZENZVM0,7>T:S7J[T36=NFD!6;RXL56LY'=UN-=6&9=BJU;(-M=DS>O"5;K/>K[=; M9A.HQV#N?N7);`RF=)PB5"<@Y(W2\R"M;1D-I%;BEZ-_NI%/R`GNS'N1SY&C M2F,E57IZO:4Y'0=,\+ZF6CV[JS:[O;ZJM^M=&*+1@.\B5="*^E5"6T?\?.7C M^\4.(GE(]O>?4@!<[!D$+WVFC@[X!PI6[4/R"H M,>\LG'2^^:1,Q_-8,7]G!?3O"E6P4/78[ZV#3C&VLF+^[!-BZ` M>O8^=3OMNM76@%W;!LKO1EMU[$87SFVS!QZC8SF].N->_?VON"&J9JNF7DJ, M\B4MHX3(DL+7CW#I!B[=;*@:7G&7+5U>PYZ%U.JUKB6D#-IFK5Q*\5-IOEA( MT=&XGH(W/;P,Y#.S0\9??J&[/H&:15D-1AE%RE?Z#"-O'T19O-!;_WR4EW19 MIK.NA9>)H(*<_K936;"<&];77D7WV9J9)&DE*UFVV_V(P+D'3Y>C;6\\6FN& M8^/Z#9@XKM^TS$5[K==R^AT;1%RG7V^IEN-H:KO>Z:N&T=.-1KO;TAN:6/"O MUW*[RK+=+5_4WH0CF:I6&7P%[&=MN1KPC&+\MY&VCLBW! MSI4NNXW%WY*YX!Q4&@:G55ML%E2ZK(7.K[HA&X[*!>]0D*QVW8&QX8*@07;] MU.^5SU_N+@-OZ.8'99BN#UNSSEB#V"W-9,ENE$W)RD[)'Z4SDAHG/6LZTY)S M*.]IT@AHR/LBB98](K?!E]I(BN8>892,10U&DAZ-K",'NUR7VCP#OV)'O'F` M2,82&T0>K-D3Z\I,I89N1]+]C)&UU+\HD06E^9^M9%^VD@FZ6G8LO8UJM>&_ M+%/M],!OL)K=NMHR&[K:-(QVLVFTNV:K*P1)@2+5"Y-%2U:XVXS8?=%A"TFS MS[N=[V,SKV$27SLTI5I]O6,;MJ.:AF6I5M_LJ4ZSV5=;_9YIV-UZOZ\[Y932 MZQME*)328&].:Q)6RVW75:W>;ZI6I]-4VPW=4<$,;33J=J55;VA.UZX;N,XE^!$;MH,IJC7H_9CZ+,FG^U*GU&CJ%KHAFJTO,KO6 M!1HYAJ/"4XYJF=V^VC2;/;7?[S6[5K?1!/]+"D%@]"4;@EAC\JM7*W0P^BG, M,F(6^_:6O;06QFEI'9`,:JRVU6V9';4)=@+HD$8+A4A?-;M6TP'_WJFWS<7BQR3OS9;+.LO7>F"J-!O/ MI$K'TIR.U0!1TFCW5*O;=M16"[WZ;M?2VSJ0!D8TRPZ-U3@^JC1-#?^T%UXQ M"GE%:YX$57;&*\5Q3UT[/JHX==-DF1V[YQ7S9'BE@"H[XQ6SV+7?B"JM8.8/ M_?$<4_93%`6&$^0-&0K\!-083Y;HN5&`[4AA/`*C?5E-()+/T9HZ!=$=1-5< MH:7-5INN#1VM!SY_5P.?OV7;:A.TMMVI=XQ>I[=HP\4XT1CQ-,PL0LY6UGZ4 MY&P:NJFM-GK6(:>1UV."G+I5WQ4U*=ZPV*VB._=>[D8YIF81OS6T>H&38%D- MLVVJ>D]K@1FHFVJ[W=35-@BKMJTY+;W5%@SVZY5N:%T>'%DRV9Q?Q&"XMN8, MR\M!::.#R\?NZ.Q%`=,U'%LS#%TUT,"U^OVNVK9@MM_S^'\]L.0E[-08_+KJ3OPZ,67 MG-;O%BN=]H MV[K>JJMM76NKEF5H8"^T;+5GVKH#AF17TUNXG1C7P^TT5WDZ'6>!KBY!=G1.[UNTVBH9J_>5$%HM]1V"TOPK);>M.V6T;'JB]'-Y!0? MDP]61@6S6<_J\`([6L>`7A^VN-'`:*=FJBV]WH$#W&V:':/5;72[Y51PK$VH ML).0/;_.:#IFPW(6;S!T,(B[S8[:,6#'K5:[JSIZIX$9)%VP#622:";SWQV5I2&:'G6L8>+/U[!ZO>.-W[(&74 M1`/0M!25M>L6_;MC@[##`+[F+!=V6@_<8)3Q]190P]*UCNK8*`]`9)A@IMOU M5F?YM<:V*JT7A\A:1R^B3X8>>:YP&MU^RZF#(.R#O&\W+;5E6FV0AEJWVP)= MW^ZG_HFA&:@85-TJ77EVVHMMA&-LON#%ET'O!YH-*36 M:G"D7KW=;K5ZNNKT3`NVM@M\CVF#W9ZM]SIMTVCVC&7@2%:V3G#E(J1=3>+V MER/*B6D%PRR#;&'!!2?=,AS0_W5+;1K(UDT#+!EP352S4^]97;W7-PQG6?]+ M$VRJM+)VY2)R.1T;R_3,$K.7[G5)HR\F*&Q,`F3KRF5 M"L=.D=)V"&;=*&2+-=9CO+ MA,-:KH^^%(O3RO:*+5S;3GS;CS@.!4SW??][6VA@C.-`N]^?P"%K<.UW\YHH>/ M;W58R=?062:V1Q0%E.035M: M3O,X9%$94VXH>TQ>B[@]X;.%1L!BT6O`YFJ-=E?##.]N&_Q:,(D[:JO3;JAU MK=GIM*U^NV$L[0YO-7)-C]?L!9R-GM'3J M#;O7=U2GU>FK5MWNJXYM&7C=TC>P3%%OM@B=*5,9\<+%K.BUP$5).XRB\!%, MBHX+1A+\G@6Q7LS`>`:-*`BKZQK\`]'(A)72_3IP]RJN6>MRJC0L;8ORFFVN M?.M"A0>IFX(^61Y:"G:O-_2.H>MJT\9++`MK$>QZ5^T[#:-=;_3J3=-FPS2*,8A5\T"*,14+LN=R@U"P]9`IY&54<6+2UCV1IH(I5#,EL'B%5 M]I5"3@E!150Q-RK8R6?RHK,SP`[CF`S\'%7CZ"7!@((2QW6Z0V%^5+%>_3[U MHN\BD5G5SNM2>=^*Y637_H>'QJPW;#UX$5#FZWQRZT67(WI1PO7>/DDV[9AE M9/MJ)[GQFFUGT[DW6]G6*Z!W0(#2NT%#RS;J6[/<^:L'GOX@G'B89W#8K2TU M(\%3LWF:0.&T"_?ML(LI;0]JZJ95M$^Y120AZ"/9G"78Z([=R.Y-P=SSY=74 M]BM^=G//77!=:6_([*)R<\YE&T6P1G#M1L^)'N]@,:5]I*Q<:WIIPCF^PZ8K M7\,@S.[AL^\#=L&"I>DS:JZQ\O)%Y.3?<:ZU=">QQV)6$JZW3BQ?BKQ[Q"YZ M\-AS($,O1S?NC]VLU.GIO89C-%2CV<$TQ[:NMNK-IMKH]>KU7K>MV_6EL9," MH;]D#=G%IH*'56Y15R"@#Y=,81"WO5$8\3'@=2SU`FLQC,`J`)_\8N9-8B`L M-3H*J4OW\]MM[X(M2O.E"JBU0R(L1*L2N?A;&`YCV)3#DJG\SM[.WJ(533W/ M2@^P8'9YA'0Z#CXH-2\6>*!X]D7'!3B`2XZV%WB'5F5Z:>+%`HLO3#S'GMP/ MPO8L$WSLF8W3G[,XRP+KKJ,YJM&&D:Q&1U,=O=M56WVKJ3>;O7J[F>^VD]T^ MT6AF^>1+;,7G-S7>Q<:5GCY=TYM6L:68[6*<;B_CUJ/0R*7]?)L-,W?F,K,N ML*\*]!B*:>#C*RSN"(/6;!;YM_,9W@S<_"`-^!FEZG3N<%:\M[<*S? M-7KF:60R_@42.W#&0H36<^($?4TSNX3B,[-+MK#M&3@ROM9J\Q8W-P([!QRT5 M7<:BA2W-6M&,C.5UJ(.)?2H83=W/KR-M^K4K/',AI6 MNL!UUK';IO&E:R^Z'%NK:[Q5+E]?U#!^5VT8GQ'Q7ZL+HU&88U'7"_(;U^[" MN*M@]F[0/)=H6/CT)N'M[5QZ+2Q]SR!UI?>CF]UY[90H>T-CTTOOTH^/*'N# M'2N]'=6-XR'*`9`TBF7K(9$T%HBR>R"-8B(X&T&O[4"A\)8D8!,T'&>Y0K%, ML]5IPA+KK;:A6G7'4ENVU5.;W8[>LIOM7K]O+PJ(K-N^B3K9SLW5,]=:U^O] M3L]4&U@[;X%?KCI:MXE65*-A=]N=3L]9//=+UKKT*FO+^1!K]:A>RS36U\Z' ML.H;YD,4!]M:F/I[1^9F^RE]A%NM-T=0K,YF5=DR MV#8-&M,?^4@\GWHK_/4">A4A!O9R#I%OLUY/]'7/7&&^C64UCCC?9JL$ M*,VW04-WW_DVV]W:9?DV3C.[P3O(M]GJ8LKS;A>0PR$Y2+[-=I=: MGF_3T+*@3/O/MUEOI6M=Y"TY?@5"_Q3S;;;+%LOR;?+4.JE\F^V2J50*:DXV M:KN_?)OM+K#4O&AH!TNWV>X*CRS=9KW%K95NL[3"V\F>X;VDVVQWXY:DV]BF M4VPG[B3=9KO+*KVS;M0=[1C3;;:JI4\WW::`#!O>]2\YMUB9?K!TFZWR>7FZ MC9Y?X0'2;;9[I$NWT[9R:2A[3[?9ZD++TVT53I-CMMGKO, M,MXLNKW-J_'#]82TRE`\S(UZ3NR4*'M+M['*(3R.CBA[2[>Q2OO9'1&G'"#= MIJ3]E'-$1-E]NDTQ$9QG)6+Q]=$4MK@^&AR&]Q!EZ(G_&_R[/\1?1KX7*?'@ M'G3^W][?SV;3O_S\\^/CXWGL#<[OPH>?.Q?_#2N!!5H(\VG^]>?TM72HV+M# M$R'Y`7[Z<1N-A_Y?O!_3L3_P9U\\O"56AOX$W=,+B?N-&? MK1]^_/[7HH#B5X\/^=>?"[^TK:GDP?_Z,^>VE[+> ML^1-Q8I;9<7./)Z%$PP,;<2+SYG/]0P8"0G[FQ?>1>[TWA^`LTZSX=C#,R\* M7-:NX6T>A>?9(]51.-6C\,7]5QB)[\72&4CF\*;Y?TTGI>+_5\O_[3?-_VM& M+BK^?[7\WWJC_)\)6AXY?\M7;#>1&\3N@&Y0T]V\B;P)D.*W*)Q/W^"&[GP# M3Y,Z954]I\GNVOM=6^K@-I;"*@=(^M5`;4W M844>6T#M"(]"%5![&T?A*`)JQ\O_54#MK?/_/@)JQ\O_54#MK?/_/@)JQ\C_ M54#M%6WH<074CH`Z+^PN=.3G87UYO]@5L1+Y^S+Y];7.@&ZHIK[?,[!>W['J M#+SF,]!]VV=@S8Z$U1EXS6=@3Z;_\9V!I>U)CYSGDY:F[:?D'_\.HV-5W=-G M+*O+,ERN!2H]86Z?V<`M06"R%C@F#T"V(M87'>^SD`[8B[7BPX)VP14?[H@/ M^_X/;_AFF?!9C;R/G`>?G7GQ#W?BQ1?NT`,+81#NX.)Q?AM[_Y[#>GH/\!^+ MO)=[8#^Y3\WULGN:!^&Y8^>Q:DO+MU37-;&EB%"%;H,)6W'L6]J)O*$_Z[L# M?^P+\2#59X?C!]`@V8?VL*NZ"A1>O:OTV*YV56,'U4DNB:J#^L*#ZJQW4)V= M!8*U8\X[;1PX[Y111[X5LNSF#QU,(%LG:\@TC3I9Z+K>//8#T/5N9Q=!/(OF M!*LBY9MZ@SEBC43AQ(_C,'KZ&LXRIF]K=A7!>%?C>7SS&/+::0[*\8]YX,&/ M-_?A/':#X=QK-W%:;KW*K+X,=A*>_>:@:!C/6<&'L MRND#+7AZ.-F/470T'&8F',;4/@4]ZMJK4?NM:>2/\ZK;\X)"E M[EOG.-3KI.>/WTDH5I_,;AS,0GA+YJ]';_R`EN0NE/XKY0.]Z9@-Z^@ES1(^ MN(&?/X=NT/;<2.IRP4(ZUYCEGN+@O=6MKJJ-WT2U\5'R7E5N_"9J;(ZMW/@X MST(5M'L+>WOT^[/RK>3WF_$J@54VV5J8Z=B:K= M6]@]K8G9#89N'G]`J@6C#?WQ')O'4439Q]9%O1^#\7SH#5F[WLET/B.=QAJ!/Q0-(A8.WFH%.+_9YDS[WH`7U;Z_("\V6PZAI8:FJ?N].(?0#(&`W^Z;KWSRYFJ MWR(]:TV*9E*^#'_V8<@2X&7<3[M6MKAAS>XQI.[99?T6",L^8%W$\=X,! M7@2D52^B)*9BV%-AV.-"=SP>\E@2+!,%+IJ.UG".'H'KV6UFKI^"._B8NP?> M7[NET%XWM\+<>@N86T?)>Q7FUIO(`#PVS*UC/`M5:?E1E98?,8M4I>4'+BT_ M2MZHRFK?A"H]BK+:(SX`54GA6S\`^R@I/.(#4)53O?4#L(]RJJ,\`%5:^6O: MT>.*RQ\#>:K.W-N^B6JJQD$[<]..&KJF&54"_9M(H#>H;[BQBN>2QW;%V:[8V>S:D>+=I1ZD5NZP>,^ENDT&WC3U;0;NY>Z+[8:1EX$ M^I='Z%N8U7%'N4"Y'.9K#)I[=_Z@$X['K%D;QD.!FC[8'/[MG/[U+O+HY1UE M*OM@W[CP-$7RP`O'L(_X;9<;>D+Y\:>;AGZ8S37M.I._-OQR[)LK@6FUXMB; M28V#$OLV#+RG+V[TIS?KSX/AZ]JKNE6W,8G&=HY?5][XL[%W.;H(AOZ#/YQG M$BJ3Z\%7M3LAY@BQU0BQ4[5Z5EG1"VU3!R'EO$$;ND-Q6@7"]11"NPW/R:K,+`J;ML;MU7`5A47'HH+#YYEM<\UF\>W9G/7:ZYK3D$U M2+,H@8Q;\!8HO].5/B:SRE?>0 MKYP@`N]E0VWSAXZ=.K6CQP.F%);+$0]?7$;?\)R7]^H4)A=__G5MVPE%JUY% M4&B/FUNEF9W07E5IYL>\.U6:^1$D<.X^S?P`+%6EF;_N-/-#L%259OZJT\P/ MQ5(GQ$+5[M'N&4W=POP^\,J-/-;,L>_F9S_`;`-PT?Q9WQWX8S_3HB?GH[=2 MQR[[RO:%Q+X!7HZ`=RI>.;W]JTI,3F.;*@BZUYQMUO<':7>AZQ<9;XJ7LQ+YY0V]"7;>N:#^S3+;\65C"T9^R$^=\ M<.A>3R7SZ^'\RV`'F6L5YTN<;SKU2N8?(>??W$=>Q?O;Y_W7(^5//C_Y57-; MA5?QQO$J#L1QKR<,4>%5'#O#57@5+^>4*DUW%9-5>!45M^V-VRJ\BHH+#\6% MQX3=L/,UI[V(>7.?IJ,UG*,OD7I.P9LMH M,OU@:HY.I0XP]V/GTJ*,KY2#'\+Q`SA4>\[QLK!]F-'/WN^]G@'WX]N]?\]A?N#23L,` M_C57(+4O@(*D0^KNMZE2FV]`RNV=E:K\Z(J57LY*E056,=0V&.KH++!=KMG0 MS$R+6[WIF`WKZ..A2P+\:]S?LRM[]V[-1+<7\*RA:N9N,=QT';&(CXEGZZJN M[QI^MJAS>AK3AW\';CYV'GY.3%^\T_8";P3#NN/+Q\"+MB_NCQ,%T=CI+5@9 M-RV469T4=[VPI*CBY-?"R&P!_7>%>:Q7>8]/?XW@71DXQ& M6+)>NG9\[RN(LLB=A9GSMG+FC"[%[].P72\`(1B4#^'2 MH/]!YP*''G".XZ3;=H/=%GG; M17#9M>&X+[@OA2+1,;$RZ26E;'R__H:4;$FV*%&Q9(KI?FDW,E_F&0Z',\,A M^>;7IT7@/"+&,25O>\.CXYZ#B$=]3![>]GZ[ZY_?7=[<]'[]Y=MOWORCWW*$H*"`*V>31Q<#I]]?=_1X3=N;\>'1R^]?4/CX51]JG#J3H\E1!N,_G3M*.)1>+%VR!4>4/0R@F]/!NF#OVV^Y"E].U\6'@S\_ MW-YY<[1P^YCPT"5>KJ)HK*CJ\/7KUP/Y:UR:XS,N6[FEGN22!H&.LH3XJ[\N MUA>?^L.3_NGPZ(G[O5]$AV\8#=`$S1Q)PUFX6J*W/8X7RP#UDF]SAF9O>XM[ MC`7G7QW_>'HLZG]W1;UH@0A`]:])B,/5#9E1MI!4]QS1[F^3FQSY"Y8@WH/L6J#$@27,MD=DLTS-M MML??$33-A#)E:(X(QX^H88XK.V@P? M_F0(Z)I@_FF,F/C!?=A3Y;1"42?YE)^ZG6-::YKEG8O9[VX0H0_(%7\+S<;/ M.4=A/-/=>QR`K".>_.Z?AYLJ(S)!7L08@+IP.>9-L:U1FAKDU0UY!$HHRPU> MYN-'M.?J6*^K=I"UJE4K^VD0$\PX%J&LN*2ST0WLNY2QX0V"E) MH3\`%RBEU27EX4&@EQ/0(!>NT'V8=BO^:@I>0I\2Z>8WG(.LPYJ5"1B. M9M,Y>N]B,B+73\(>B#"?Q_Y$T])Z4+J;EAPOQ(_@8DP0=(_\*;T3RSKRQXPN M,.>4K03QC8J27H]&<+:F"Y[3?9/V^QQ:OA!Q\W'@DI8].IV^&L0FYA4.8]L5 M9A*5QC\BK7NNM?MM$',B1B`OX6H*JH2[GB2X5<#U.FTT*G//T><(.'W]*-G= M;B!&I[-F0FAR79C238!Z$_/BZRC0%>(>PTO1)PB9]+1&LS%#7+BKXNL4/847 M`:PI^^%OE)*VF5/J[K?.$,W>N\&$]0>SS-A0T0VF3-W[P#1+$AK:9LC&"DT5 M7/LSI+Q3HY#;'7J=KMN&OP[]K%(:6A_PTCY-`FYWN#5Z;AM\HF'XV%V)#G=# M0[!6RTW,S*>,"1LQX7"T+A\-4VD74]N5P59H;9O!PB,^H'I2=6<(9KL"4=YI MZY`W/8OMML42@9<81\6D[RC#T)D`@;N2M=J7@#W):IMM);&$`\Z3FE2TS115 MO.&`'*E#0NN^S59@HGU'5]EA`M5+H]8B.S<'&D3C-Y4E($-`'W1Q'4?$2A'O6%50QA MV++"*@$HRANA?A/Q'+O8OR&7[A*'8CNDF'9%:2.4R]P5%:'QC^;HJI"!7!D3 M5"8C=XO`!AK=!_@AUGKE9%=4ZA".CY1XSX&2J6< _+'6(^O_X<@7H+I'T6 M7L(*M0+[3,:;E(ATZAI!E6Z&EP+8+F:$UHB'=($86'51FA:WJI@7Y97JX=BU M%<67OZ[0#$%STGT1>S'4C[QP@L!8B]"V%M2H8(*W:XH2(LIYJBC<*"_S;6?L M?US.TM)Z'>!LI?93ES=!_2:T*G,]"PG.%3%!8RZKL9#$W0Q$8Q3",B#5Z)P& M/F)<+`?AJIKLXFJ&L91KB8Y8T;>4/$P16\@$L7*""TJ:IKA272@*FZ!;AK=C M\[F2[.*RQJC.R*H>Z<453-`_9F@)#M_UDPBFHO4N@XZGHU/3#"*Z1"Q15LZG&@V8P1>ZF"#_VF4$ M&"TV^J)%),U*,-6PA]6X*BN:P*-M?939&YF8[CG+D^XR;]T@_',GH)N_<2`I M,>#BU*5HK8]#M%C7GS&ZV(D;K3NCJI"-0QF0+&^]^.GXN.=\0>)F!_DW_+5D MF#+`\K9WTG,B#L3191PVZRJZ66 M^9$%J[DJID,\?$'@:QL'*1M.7A`;RG>84LRG+PAS/IZ28OSA!6#4B86FB%^] M`,2U?+`4^H_V0"^(K66!%P6#T@7+(HND`F=)$#>%:Y$54@%78^=N`_O$(K.D M2IH5@;<4JT562`76LK!7BMTI1VSFW2U"K]K!3R'9.["I3NWRK/$5OD8^A-^!5"2$I M=(N<#4WH%3EB*70[G8T2Z(4;NBE>B]8OO>5Z-T4K7:PMFM)Z8)4YKREFB^:R M'F:=':84_G/F<_5\S.A, MN1&:+6$FATV,X"T0\0YF9WR<*H*)-EHF5T7Q"S2C++E2>.H^(7[]%#(7YAP( M+%O=@"A(_QAJ@G0`?0\W)$0,<75*7'L]FN,@T)E$."\00>KQ5I4V0WG,MH04 M)<7Y4J8R+;D\]!?SKU+$%,7-Y`1Z@F^\7%=MES)!Z4<4II-306>^C!$J82F* M5868^(*424;?= MSZ]@@@=4YJB<$S#M0G%TM5@6].N9R?V2FDHLXJ4G$*K+&Z2^@E@SM-VYP68A M>$^IS]6YG85%C=",I"7V'LP9Y@8@H>?^`A/,Y47FCQ7S3[.R47>UP)3/^ZF[ MN_@6!2`JT&UY6XI$A7ZW,1[`U+.#J^H11\78O:RD,.)8&%+`]R9JF5.:*:0`LD0G&"H^.:;=NOSDET MH5]KY3&&,I@[`5\K3RB4(2P)_>QW,J%3VYK=W795OOAIYI*<;3)@6H]F8)LK MMV75-;YN>Y0&M@M8)P@"SHTID^HA#!F^CT*1S#FEL00/RZ+>SVS1J&K2$+E< M/"$_OE:N-S4A[R4LBN5*U_#HB([BC1'PT(<182)#\0K%_[]^\H+( MER:@)Q_(FP"6Z]E,/K-_*V!K M5362[>-B(F;8B%QAODS2N$:S^*B;2@M75#*4T9*3'?E08_:8P)2YOCI=1*MR MMW"EIVQKH\I4[2HFK>W99S34&;P[S[?J(RQ^@]4TIG7R_KG_Z!*O!J*=BHWD M+NSV4_M6Q[I-=&,>Y\C+-)8UHI=)1:E53J!07GOG"XB=0.&;A7=2+QX[UWX M#CF)5\&JK-<=-/)A^CHP,B_9FZ/_5KQK#"P%(T]YIDA=WC3U$[!28\$7V:/9 MB]T*+!D-=/7:ZQ+Z.^1%3)Q9U1)"54W3B,0./BBK#VX8B3V`T>R#RSXAN8$@ MR=0=1[UVNH!61B;JJ?H:+1A'*'3T2.[?\+6EX^O@*JQGYAQ'.E-T=*6ZO''J MDZL;%+=7Z."I:,'(N9#-@Y79)RT58!2%S>Z\-KN%M[4QO9>G:.6]'H?GIW8$ MPLJKW0[/3^W(UH:?IQ;QLYEPWM8=Y57.E977ZQV*4['-;.6]/NVR:,O>L?(6 MH.8Y5&(1*BX*ZGA*=;M"I'12K;SULF5QJC+14Y[]_%7`GA<#2EEHT971[7)0 MX:6GYI5%9XF;X]0S=GM2CEF4^MO,OFI.MFKL9B@NK+=3H^W#LSIQ02NOO3^` MG.5V_A27Y/_M)4LCOF[EG?O-Y$6\M(,=S7-%+[/>RC.)S3.K*F5?<9S13B6U M!Y]487PK+SMJGCU%.3E6ON;4/&N>E1"J..K_MYMV>B=6%'=@?.66QED8Q>T9 M7WF7S[JW\S**YMCTO&,PBMO>_C9,H)77 M9AV"63N'WFR]=?$PNE]Q^$YQ[^)7W55PN'6_!YFZ>N%$Q^X/$GY60'G$T)T0 M!+8:S2XB+C;(Q>N(M_ASA'U@<_K(T`V9419+3*>HQP\$SX"GX#+&JR#(X)@& MV!/O/%I-_9TW1WX4R.TKF!DD9(F/'")JK.3YIV+F7QB M[`-H,?A;[F+$ANHYR5H6R>_^>;BI,B(3$;UGP)0+EV/>)5P9-R\=J,Q'<4>? MH7/$\BWX=^+.2Z!K?6&@3")`[+'D+'AU35,GH]/7[J`>HI*;A2]EWQ6D[[EHUE%;NF&D#+QMS*[>_ MM)&7Z4Q[+^@L7+,Z;_#MAA[29;8@+-'$$?BDV?55PEO/Q68/NRM*FE#5)<]R M%RIH=7D3U%\OE@%=H7440!M%=3U#1P1%(#M)G%M)5KM!^B!I.2;=VD9U::6X M916KQNA:N91J,:%4I5BYCM8:>^VY\!(6UK+%ZE*>&..;8/J:(V+OJU,>K3B^ MD)(M#S,8T*'9E]@5BC)7Q,C3I$6OQ5>2:G)ERM(A7CS2)CI3V*CN*1*+W.,! M14-BY>)2!VEV*/=;4KJJ@CH;UQ3$==Z)DK,!"F$_V6J*$WJ0OPFQ\M'L(PW% MMM3.N0]QDA3Y\HSTANC1;#I'(OES1*Z?1+`Z`HDHL9C+_X@$1*[:],]DQJRFLRMSU9*7.$WX7W7/T.1)O M#CY*SG>38&G[3&ERC-8--GDI?)WC<86XQ[!4@"`]]':)42GCW^;[9KDS)MX+M971W MG^M;F>.[$=]U$G[F4\8&B:,T5HQ3LTB[/[+")+=L*BE(MH#7&Z+E52.;$[&) MG2OW1#+^Q?HB!!O&I,3-L$RZ5$Z'93"V71`-HM\,!#'W('OPQ_\!4$L#!!0` M```(`"M*:D&UL M550)``-R_$%6_OBS#@V>0(!A'GPY/WKP]/`"1'P
OIT^,O#T>3A MXN;F\*]_^>,??OJ/HZ.#^_N#RSB*0!B"]<$_?!""Q$O!P7QP=+29[>\%71\//KPY/7WSKO:7^SB+@H\'/]1^NDB`ET\<8(H^'IR^ M/7E_=')R=/)V=G+V\>S'CV>G_ZRWCE?K!#XMTH/_\O\;-W[[_@CW.#NX?W/_ MI@;Q/P\>X@CAULN5%ZT/)F%X<$]ZH8-[@$#R#((WY:!A"?<`,S1"GPYK"%\> MD_!-G#P=XVG.CC<-#__XAX.B\<<7!!L=OI]MFI\<_^/S[8._`$OO"$8H]2*_ MT9$,QNIZ\N.//Q[G?ZVWQG0$:=6\3M;[X^*/16L$/Z)\SMO8SWDJ`>>`VX+\ MZVC3[(C\='1R>G1V\N8%!8=_(1/^E,0AN`?S@YSBC^EZ!3X=(KA"P_&V1 M@/FGP^4CA.0[O7_[X>PMZ?^GR]C/EB#"C`FNHA2FZYMH'B?+G.K#`S+N+_XYV\/*5ZJ9([I_!I& M^-M"+[R+4;Y_+D(/(3B'(-@-AN0Z%^B#?XH%P" M;4#*X08B4R_3:V,.Q]\I'CHA1V\"%B!"\!EHYCAW`NU0+CRTN`[C[^@F"F`" M_%0;AO;(PQ.O=RVQA]>WK"XA\L,890EXR):8OO5T?IXA&`&$)E%P"[]E,,#' M^R0(\N/#"_5=(;O,K!,W?(KP@>A[43KQ?2PZI5B\NXM#Z$.`AL6M/O-KX292 M59"%`"_`&$M549KD\^-_)@#3=0_1USN0D#]X3SL>.8-09"6?FEO7.J8-=K)< M>S#YNQ=FX#/PR+_)R88F"(&TV.G>(PSQ6@>H_'LP2:LNT^@>^%F28%#G'H)( M%]NTTJ215S?1,Z8D3AH?K_;C%[#C[:@VU3#(!CU5.^?1B`GON"0#]>5".=G^ MFRZ$BK.^$MZ+A1<]`2RGE(U^Q;CPH;2^B%'Z*M#%!&CDPB5X3.FTY%^ZX#%& M'I3N06ZDKFDT(QKT,.%/H!D%OI\1#$!Q/^/K!6!]*ZAN'#2=?XE3@+`ZMHRC MAS3VOY:K&]T@A-[6^*MVZ M5XZ?PF>L8MP#/#T(9O$#N=9!<)?$2XA0G*P)\5J7DMR,1G`.=A;TF5ZG_+[` M(Y\3*_M=Z$4#:W0R^D.!?^032XYJH\KT;,Y3+"ZR5=S_!1 M@CP_)WA0P&J3:K7*/"+P+<.F,65@;JR>:&-%>@2 M(#^!*S(G7F2YIC6=WR4`$765_#H#+^EYB.^4W?!KI61HY@C5_<$9(CF['4S8 M_&"6&145=C!EYCV&IEE2TC`T0RHIE!YPP^\0\:1&(0_[Z66F'AK^QO2SIC0, M_L&% MXLNBY<1^;J)*2=#G^YP)7A@>'I0#UR%5O6"4'@=P>5RV.28=!J0'3T4"O^+H M*`!S+PM3->K:W5^'UGCIP:@WJ47O(2G-9SA:@N4C2!3);'0=D,8%'B+QLT=P M5'%&C5+6`"6]014%3X+@&S3C30:B@`3U%K^2H?2')Q=D'#?I>#W:)&..G:"R MZ;2QA^0R4M4V@FQE%S?4UQX2VY&\%M-FU7?>*?L2)\SK M);\4YAYZS&^&#!T]>=[JF(A[QR!,T>:77``\>GM2/G;Y4_GS;X2;>5@`6EQA MVIZ],!?*TPN,=XV%\MS(N)DX]!Y!^.E0K>^Q`51$-;V)4)KD]])%C*5*+TIK MCB4.HNY^_=$@X+]YBI_QRH0$R#OR/PC][VKTXY]^VURA?IRLXB+2XQ(O_N)4 MJW[:`J#0T<3WN(VCIQE(ED4\#)/UC28F:+Q+8A^``%TG\3)754I#%X=>;G,3 MM-^#%(NJ(+CRD@AO/&*KRY99KE&29Y`^Y'%=HJ,:GK:R27[YK1ZA5FTF>C3B M\QC;9&IUO_L"V\%4Q)IUEZY6RVJ6:FX-$F:\V.]OGWS%O\?'B57O3\2$0T$GP[Q M10_HCW&48CGP*LP%3:S3@R?R/PX/5@F,$WRU?CH\/3S($`8;KPKA;2AF;5DM MM+!-1;;8\.W-VQ/"M7$P0.6RI`PX'1\#FM(8A7HV/JA\H8["?C<^V!+Z#\7_ M?CSXF3<>1?IA/$@5]7?*@Q_,\(!IXU;E1$/XKG.!*RU2W&\-??N6IZ0.6E+: M[8"Z$2_-@^4O=&GI6(!UH[I0G'^6PFF%-5#]];D.Z7\3M%.\%2+;YS(#=P!S MK`)75P5$S4WH4A/,I@"&60J?0?Z.)8\JNGKQPPQ_'G*I$SMZEI;OF382':8X MC[&8+`D:CMZE9VP'N7*^9@\@T*^'G-$>#G[QEF)5O;/;B+#\=FH$32-S`LF8 M<`XB?X'/VZ]"-)W=[,"RKL@2;+;.;I9@Z;#)B7I8@8#FXCB1A5#O8@6&AVRU M"B'7GLMO;P7UG;9140\C"#*4QDOBO=^B2VA5[^JEQ8@28H(4_)<+@XR M/[T'6&[.`-.M(NXP/$VSN!;SB*^>,D).&;\S@6A)6T3\OC^*3OEJLP7@.09RB9YK8:X?W);Z^%HS=1"I+(*PPP3$*XS33- M_PQ0_AAB^CT""5K`%94SZ^\"V%3)=M9"ZRW$0R,P>4K`YA%0L;HV+UDV26E8 MM,IW-A*C5%"'RGW""U/::F6"TL_>"UQF2^&>:;;1\NWO\%J*TJN75 M:J%GUFHU3^RDF+1 MTJ$+*VW,!/)1X]LH2S*:*AEOW$>HGW)"$OR-XTDMQBQ MZJ*'.`S.UUTWU&X#FOX&];=X3=)$BUQ^`#/X$/`2G_B-+_%Q&,:K)3VVN9!$ M?N.8RL^DL MOLOPO>0A4$M[RB=%IMOPH4";!][%",T(F5?P[M=C;+K=Q^;#BJ1BJ"SC&[XC M+.!<=T"6;/A`';O`@%=!/K4OK+0/9/FSAB(W%&(I@5PVNJ(1A,>65"E<4T\$ MI$X%V1B,1DQM)Y?,;^R^X$6AI4+_O'G(/9:W.+RTTYM/U[A]KT!Z8NZR,U+( MIH+EY:0D>4][\UV$C._7_%*7VMW#L<`5V47%E4]?#O93N>C&,/5>2&I1M.SO MC9=O=?.W"Q^88:^OX]ERA%6(3GZT%Q'7OD\7Z)8^35>>J0=Z?)39 MYHL+*[33IEA]5F:8`?VVAB!RGF4K&2;IRI6P%([V278_E@D?Z-C_#%L9M%PT MMOW/K_4!IR'<]K_$[K?&.T*3[7^)/0!L;O2S_>^R=^,&)V[1_D?:6F!SPF&- M/\\>"+UR\);JTUY7&*$0-TE98)\6L^/=UPJQI!J;?1+^+I];(:27LF`T,IZ. M.#+*EM%)@(+`)8IZ-!)@UP,5"GDTTI_$RQ&*>C12GF1T(44^+D%O.SJ>XAR- M2*_!A.0>$13F,[Z'Z]A%Z<9T&;F-X)_PG0=A.M M\YYWSWL^Q+P7W?->F+R_[$V4XS MG3>($9X,_/9.4V\H'9C&Y^7F7S1H>*1D81S9+G#YJHSY.)K]LZP>X-U]EM4* M()97+,0@1QLNK(E!G(!90U$DG896.5VG^;JC+?$87^X#X)3V'%GL.-."NN4W M,.UCNEMX1IRMO*#LUG2K"I65:L3EPOS^\ M\S8\^V*T^L.[:,.S+T"I/[S+-KR1%(E2\J_=>23.<`%2XG3<.]OVSC;-6*RI M#K1W'>Y=AWO7X=YUZ#@"4^>I!6XY-W+B[[.C;[>PGL+ZGC)O'=+DU3&??$AD M&]J[=32#M\.*U/OCN^O6>FU/GA4?>N_+V_ORAO'V./4<;N_"V[OP1NW"3O7IAAE![Y=YX$9X(0P/\9!;?0>X1A_ARN M_'LP2:LNT^B>O)9+8/14I`TRX=_(2:U(HL`FCPB?##ZO.FAW/Q-Z-9>JBM&J M<&A'$W@J@D0KJK:,<(,O<90T5E67,5OO'*YR261NUC>^!=QAT)L3^$L4/R*0 MY.::FVB5I23!6>1CE/DI>+[.NU^$'D)"X_!@T^UYUWLZ0U;Y"DZ=(H'5F-_> M,/75__Q?"!(L_BS6MR0CD!P446>CN/*E@W)B3H2V:%$/6Q"<*B,XM0S!F3*" M,QL0U.7>]E*7.^ZDQC#BCRZ=1V-#=:'DI7M&\X;"1': M^.,WFYA0MC?(UV5.=9%)GMW6*-77>.4@_!5_CN.`?#I2*81< M;H!G(Y3I:111E^>(T=`HO62_=%!*FABE\=[[_ME+00*]4&V1\#L:Q?-KG'R] MB>Z2V`=(#9"@IPE$,Y@6QV\`GV&0>2+K/KNM%53_"M-%GK&:]#ZVA=.+[6"BH.XNHU:7] M-S?HOEB0"&MT$Y6-?O5(^9)T36KU6@3A$CRFE&CR+Q.QSF3>FPAAT9!(?P+] MCM'0A,K3)*/+&L-K;9YRDOU(J)5QFYNG762$9+4T0?%M'#W-0++,]Q6;U$83 MTS16-3,[2=VT-$UQO>1E)]&UQJ;H3DM2.A+Q,)O:0+/PM.`T-I*>G+BS04`H M$:L M5/ZW+`+XQ]DBSI`7!;,%3-+U`WSA.XF&G&XX?J`FA;/O('P&3=JF?AIC(FKD M7<-Y"D"DR`L-4VGA`SF);F,O.@<>B;5H4O5`LLO?8=$M_2=(8O+_30HG6.T( M:_3A;R1FQ8"S&55O^>)BLWP@3]0QKL)R+:\=@B4?WOB-KPJL:8I=QL--AP/7 MKG%NK"C#8!B91'#!+;$;EW2)G,8]&M)> M68&18/N$:>MBQ@4#W3!9DI+Y:'DI(4^D+8N^I#5"GL3F%FO7S4J_+7U6U1MG MI[G9>!YQMVW/>;3^PRH!7C"-_HX%"7(2D-.>EU]8NKMY;/7+*R^+'=3*.\N@ M$PY@'M_>;^`4[89R-33)N?/6^86/+PVY9=/H8)Y^%[PV33I^B;QEG*3PW_CV MQ?<8R9\K13^KGPT6_+W78>]UV'L=]EZ'O==!-:S0>;?#:WA7K`@1W/M7!C7/ MRZN@(_.]J.BG(W/)B-00]]PR"E"9\K]J[3_SB/>.J+TC:N^(7&(ID;7/._L,1!DCG:D<>:R.`]&(;A#"E\8L MOLL2?^$A4&M"LD"28Q!&/EQY(=>-KG5H`SAU`C,<*E"[\O-+Z\Y;B^LN,UL; MH1S?N!"O?)(M,EV++K=V0_/TBB\#5E,':5:^N;CYZ_+`['MR`#-W7/WOIESY MDRBX\%8P]<);@+?X]#&$3X6&(/#C"SIIX=R6VE]I(EC"%A]B/AW]AZ`X?@:11SP` M1`O'PG`*\*&`%N=>2&BY!]\R6&1+E:!>?BSSZXJ(TM/Y-4Q06A(6E`X?N84E MZF\!.H#\!*Z*=51?]D6I/RF`XB',8\37/6">RYW-;:"]U)DD2=^TMH!RH,1T MT(_G4F>7HARQB_0P3.BWGQ"YZQ(4_WT=)Y@^&`?\3+(*`]B`C[K#KN9SX*?P MN?8%R,]%A=:B#JLD9+4Q[>+"/L#_UJ(`_\]>FA$?#L,0)]'!+OIKE[4RE'I? M\ZA\I%`AWE""8-M6EELWB& MY>[<5`727^,D77`-YJ+F9O@W!TD"@FL8$3-5GKQ4I(*Q6YN@_.I;!DFVU>4J MCHC%1G0)L-LZ2;4NSPXG!F""J()%C+"5MY2UF)7',,'QWTDQ\4WH^CU?H1/U ML`#!OA2WI:6X7QVEKC.N&G\ZI[Y);I`(ZX13'$$WU7UI?3T*-\.3\J%)`(() M:LH(,'HB4D('O;*CZ*5^,RN1R3@O_R4Z&-F1$5$#_OQLO'N0GQV"ON80/$S MWNKH-D8(H&ET]9+BKYQ!M"!'0YFIGHVDNY^6=;+M8:@+-7<)6!4VJVO`]+[( M=]9"Z]:KF@F-D&Y&!_$CK!5'&(+JS83E-I.FE=W/Q(K&A,$X><@>\2F&#ZX4 M!*S8AZ[61A)RP(C<&_FGYI#;:&*:1HGH0VYS6V@GMS1,NYRY?4:P!6$S>)L7 M6R+3TQ9$]:OS,B.O:0N[G0(T[A"V8+PE;[$2<4J>KFXCPF+(.\`BJ_3LG\=) M$G\G0K&WPG])UPK(N$-HN=%59FR:B29^+DX3%0#`9X;E6?_X@R%N"'CB*!V5 M[GKHC;T(S>)S0M:#@.KNE\CD7[X":Z(8D.O/`N>PRAG_^*!1,6D'X##8EA\U(RF*#2 MH*)`-Z.S'EHKD:BP$7'7YV*:9:B%"\$HD]UOUS:;4#-F+IF)=*7&(34")JH MADO`<#)N_='$C927)@!Z`+! MEO[=&'5"^:K>P@B%FYV-\$+$.B+J,,[RVYNAOOX$+G]JBQ8DG.79"PF-D_0" MWPYK?$*)-#;54I[4&N6.HF\PKDJ^EI$^$M_]P M1E8C>>A#SK*M`#@DN$_$?8R@J*DB`MFCU?^*0[7W>L>WY[ M:Z@7KAY1#^<1&/(M;C(:*(:0=78S@444+<1N8[;(1&>&R'HR5F$Z0_-Y9Z72 MZ^H";$7A"8E4NQ(I**M4VG(1"+[JOA/-JA>IK$2;N5;T0HA2^)7.O=@43 MZP#Q:<9K56A>ZTH1AZI%`2P'WZ_RTPB+7C4S`XVLR!7?I3KJ$E?<;$GNE;GB MG^W"_'@4Z(\C`\I-+5Q!/K%7V9"%W*I?0L&-0@#CIIFD.)T6OFA33KH1BM-I M44IOZ0;*%*=%K%TB)BD+G!:U5,J.4,BC$+EZ5K.A7'!:'MLQZSCE@M/R&3\F M@@)T6B[C:9&B),<5]%/WY3/%2A(4^BBD-YG`8PK9:4&N1]T'BMQIT6[;(LPQ M'YRZ+ZHI%;>DP-T7T!1>Q%#83@MI/5,!4O3N"V?]"]!1+C@MG"DD':.(1R&M M<4OP53C/G!;-.-8EAAOS;!1R&#?]$L7IM/"U:NT4,6*)JB#Q.BU625=PI6J>%J]Z9C2G^4/^/2!4]BLQI2:V[7"`%ZK00)IUGFN(=H1B&;Z5V M%/<'5Z2N=B7JZLOVRT5+6>#*"2Q@0;]7*C2#DU`YI[2@G7+DK>FR>WFG,*^[\V7SV#%&&$''Q:[GT"[SR[\93,?3) M.*&3!:YD&)'[G*H\H!7O:[*&*ZJ0+B;4BL_3`],535\;$Q8):*^%'PRMA07N MF?C9(SBJS@<99LSJF;ZWX\_;U6.,[WO=,%F)>4J0IZ,!*4B-5F(]&PU6F7NO M!/UN-*`[4AF7>-^/!F\M[7^)[<-HL+%2OY4@?Q@-2)9?I0'USZ.!6L7ZG*_; MA>AOP3,(&\!_'`UP00;A*NG;:,!RDX1OH%JM*FU=&WR)F)<1:>PS'C`.OQ`]7+`6*'UG`E2*Q8<[!L_8FL3NM+O].EKN_ MFS60S7]WJ9V@$[0KR[W[XVW9D;?4"!79`JQ9XE+?&MA M0=WJ"_N#:<9]*?F!QD:@.5=&USZL!K!T?M_L\ MZJQ")4#;/J5,!17(+>+.FD^=YAW'%K(NP*XL9HFB4@VU%KZ0_$R\XDUT6=L; MZ*^(N+MB%14*Y4#_=$PQ8\7K:_%C\[<&(\!+2G2Q8$->@Q7?OW]_L_22!-^2 MCS"&410_%^_ZWV!ZCU/O)8[BY?HXYPY-]DF$V@O<"&+2\^9%=0$05'8+-)WG M@3[<-`GYFY?0SS;YUV8+0#)H<%)GZ*BVUR]"J1BX7F^OUS@F*HR1-T5;`!I_ MTE+#L'R_]"6.?/R_F(N"Q429;EKHJZJVY>=H; M'CPAV45++:>::DJB]H&G.()NJIDG_N01L\KSMP\.M;ZZ*KL4ZT*.0[F^"\R!VPQ6QF4QMH%I[*G,9:UL4N M[W3:"V6'T4Q\!8;O@/D!VNTL>B*P+TH)]D4I.9EZA9?_2"KTJ5YO(ZO.IY(/ MU9DB?4,_+'6F+.MPCXQ-56O=OW<9SWL7P7+NI8BJ)26WL!+GSJ@+6[+-93=[ M0Y0W8]M\O?.96UCC4A\K>'8^\\4L M][&G6H,O)8O>V^)GWT0:W(.0J!"SF"E'JWG(]5BI\-6`=9E_EP[\;D>K?#_S M7AW7/*][WY\)VK<2]%99*Z60<#N;QV7$ITD&KIC`-^6SFNF9OSR$JH.6BA4, MX4A`8)]QAD'0X141MC?E?:*E1[D^IZJ)%J[51^0[=QFM;/#/[7V*&GR*O=.7 MR3L:^TZQ]^?M_7G6NG@XE:*=<6+PW7:L.\&XAT+OQY/0WE159LL1R\KN[CEB M!=XXIE0]*L=K/[G=9E?&[BS@N%8-N2WVKM41N5;WUFAI:_3`.9,E_9QLLQ'.+2&6EK1GD1P7>"K`D9/(/(A$%&^:SX)/%^PK&7E:=_PVTWT MO)@D?/5"\G'NP::*8GMN5C.=\Y,!I_-;4L!2,'V]E1&IE\R,UP1A@1=>O:SP M:<@3(MEMC5&-"8!%!/)E4?:<3_1V4S/Z!4)TYZTGOI]D7M@H8TRBJXL*F5RU M0V4,"U#FR06G\SO\*WG40_Y:E2:702CH;RFZHAIF?W1E?Q/H/GO_BA-\1V,! M-UWG)4P$]@9.8SOH%NKNW.8.TV[(\K"5')1#5YP.^.-310X_=)A\6W^*WWF."BGH*0&YH87($TRJ!,T'H(<(^/A&42"IUM[)5;[&3_MT8=<*3N=[" M"(6`V/#\-"-YVHFR+^(ELZT55`O%"EYK9RDW)`\]^`L09"'>_\Q#2N1RE.JJ MY6Q[^)9Y";B.X^*DJLD9Q82LHZVSCUDSM%AS:::SY\G;YBVT4J;HW:&Z8H[N M4HTJ@W27H$U?J-H;F"H-5D)^IWCMC5[<&2^K(O*)H<027`^PG'S;>)@K=8., MV#,LSS+)R\RXQU@K:+$%W(40?,4/+-2[70C`5\3+\AZYD/"MYQ)NNYY<>%W0 M[YLV/9(NO#%0Q"EA-;$Y"926$ZIMB7/A)46/W:OFSC3^QN(UF"#R!]J<'VI0 M!FS831NV+^[5,!$W/F,V)K&01<CW/;: M$:@KQJL.*S9-!KL=)&<\G9IT@+.*L5MLE[0DYGEPY+6[Q?@[Q>'!LG=Z"?Q, M%K@-X;/EB[P[#R_86>)%R//S3AIB9S5EFO/SY\VH2,5*ODB-9`AX[LK.;IKR M5LT!U@*"BQBE6#9,X@"OBGM2XCH#:!8WI[Q@QC_V'TDZZSB/_T4,<,AVE75W,>-3I)^QPIK<:.D:O(;\_YX(01HKP>UB$0)K] M[3ZC0&'7>FJ98N2@W!I]=<\3GL[7];^H;Q76`&;PY3?.-1::I80N?GNS$4MR M;)8+85(92T],TYH8(%./'R:\U4++K+,$+.,H_3F)LQ5_9D8KDW8)WMU*7>I; MO#1ONI>UH75>PDW]5'A7&+=&R-K3](%VQ[8F<A@%TU]',)\-UK9S; M=9(?;/X:ZV_-.@52*`3=S6.[B5*`A?#T'J^;AS2_ARJ]1`J=<`#S^%ZKH)V@ MC%HM+V=\#HH")M>>#S;%?-N[6Z+7>`,Y.+3^#7\9=.,%`(LFOB!#"[.=IM)D M7E1%4/+RGK0;F4D=A@7,,HVM4.!A-#25#GM3X>>SEY87\CU8%>1BO\#:/PRPG!=,4*'>DR)EN?6PJ%9&I176I3CP MC'JX$D?I(EP_>*&7K(DP.XM_74!_<;5`=N'=PFYK`=7"Z%U64QMH%BMFO-:64"Z\VOGMC;K;G2]KKK-T[$Y'MO', M='HY,=`E7G'IU%1DW;YFJY1UJ8FR;<^F'W*?XL7ZA"CVYF'JF;3FU(T09?Z6 MXH3%T$]F;_XPB6=%;&\A_7JF0HN-1"!:<+1PGZ!T:6F-IR=,_6+$+TMDF",= M9N#"NQ*5U;!SK)@+STU4&,(W\+OPFD1ZK?=Z2F'O4Q*5+ZP2NN7",Y+^V$4A M>2X\)5%!WC=@POQ+$\-\*,)EC#^_-BM.ZNO"*4A(FP5E\#2,O(EI";CK*-+<0S!7*@$B^@;Y=8:).0]C_^NAM5@>X%,$L1J$Q=HR M\1!)#!Z'6#'"/<9"_^8'UW'DYZ?%**X]F.15AFB^`Q<6D9!LVWE.[/P1J`Y2*J;>?X)D-;Z3?*JVR!X!9ZCS#,C8SX-IBF"Y#4?J(PRW1>#GPCO3AM M_ZI$!'5J"W$(MI[/%\:+#__A_4$L#!!0````(`"M* M:D?RK&':B'H``*__!0`5`!P`;6)I:2TR,#$U,#8S,%]L86(N>&UL550)``-R M_$%6V_C.)+_?X']#KSL8+<;G M9Y%'-Y!%IA,DZ=G9:QP:BD3'O)8E'RDG\7[Z8U%O60]*ED4U,`-,M]LFBU7% M^A5?Q>+/_WA;6>@%4T8<^\/1X*1_A+!M.":QGS\A1?W-L9[5%-_H3MABZ(?;W)YWA'H(_ M3>38Z/>+^QNDG0P06KKN^NST]/7U]812,Z!V8CBK4W1\'+3TF\?3&9J<:-K) M*/;+O;.QS3,TC7UU2;'N\M+(Y-R<(:T_&!\/!L>#_N-@>#:%^^-C7F.([D_N3V+B_14].#;CI5=KW=ZB<\M"]U"+H7O,,'W! MYHE/U/+%15R9-OMP%)/P[8E:)PY]/N7-#$^#@D=__A/R"I^],9*H\#H,B@]. M?__UYL%8XI5^3&SFZK:1J`C$LJH.YO/YJ?C5*\W(&1-4;AQ#:$F"091;`OYU M'!0[AJ^.!]KQ<'#RQLRC7Z#!GZECX7N\0(*',W>[QA^.&%FM+7SD?[>D>)'- MA47I*=0_M?$S[TL36IA#"X,)M/`7_VMA9T<(2GZYO\X5:)Z@Y54Z]9BTX!]@ MIPDV\9N+;1.;`:-0O4!=@KK0M"`*9!TC0=`"G3LT4W!!:Z&S)T%PPXZ?=7U] M"L9[BBV7!=\<"W/N#WPE_\7_^MNY87`DN!RI=XY%#(+9^1-SJ6ZX06M"Q@]' M$A5.0_ZA2D("BIFSH0:NI!*O>RIR\-$1RZHLY*RIJ!]1UHII^KPP^[TK?YD8?Y/ MNN%.@NA/Q"(N<&B;M^X2T]A75X09EL,V%%]N*,6V^\@]Q@5G\GNQ,3352/LX M;8AS6=/G?PX'"6PSY'/00SX/*-9B#^FVB00?\:]1Q$D/^;R@K\`-$NRH=0U* M=!JXD[0&.^!#&H9@AM]I4N,=\%4^7W)6%A16YSM\#J2'O\FP/\KS`3ZM3N"W MEEQ:0JZU1ZE#($S95@&8XN)7`\7JB1!AZGVN$F'H\$U(_QX;F+Q`$U<;?(01;-<7-"N>\`;WL8[C7876N6(=VB?(PA"\@I0B5`Z6 M$4^_8L!0B5/?*:Y@P$SS(#W%&\\F_7RL?/6H*9[U[B=<3553BJ4D+[*6-N[/ID5X\JDBGVQ7(+6/L`)6 MMQL7#FG@Z`SI&>,4G]EU"V;9%EH,M0PM-;7T@XV9CV]K;#/,LD>?HI(*%GP9 M;$B:S9Q+SZD6W#DA]@28]=;YO%?G">+ M/`NN&%\"&M"LR8M39_.\]):!HB3LBOI["WPM2!@TX"T=J6XSW?`(V(Z+'-C] M>B6,-[3&!ED03H_8@@/7/]8]05_@%-=UN#DO+&RXXE?#WU9=.U2PFGDE[I(3=&R,MECG*UD:?`7%;8>N=`LY:SA)!BZ-K<%Y)@MD.?8SIN_; M7[CNW:^#^%9K0$G-%*(QF1+;Q]BGI'*)6N`NXJO3/,&;]%K7-M<_9NZM?>G8 M+YC#@)/=\1A.QY/8!I>^@K$%W`;Q&X%A M4]@7]R9&U!Q:A^V!Q\),C4MH7A4)/Q&01[`0FG$EH! M[_UTCZMV-%40GO8^TFI3M&Y)'8B5+OQSRK>[4LEF0OXD9C*<).&7.%-6O=IO M0KH$MJSB\][]A7)=.:7;=`+9+$C;TWBL!8?,(24$I&#UXQ-3Y`":D$Q+2;;V)3/R M)6L-*<6FEL!)@2K4H.1_-\R%B3-[=.XQ"$O$_N.U;3@K?.,P_OVESI9\?'\A M)C8OMK!TOK9O@_7M.5]ZOWB1)R71FH=HJE5\-L^_](G12!MI`;A#-F`#(V0$ MMO61QPIZ!\R\AY^!'Q0PA)ZVZ)W8^2#V>Q2RA2*^U,>:*E>REJ%D&BK9YDJV M.!/P+7PV0+\;3Z6Q/1\]9.),K6,Z'+J37NU`O=;,IL8S9^P3QNR+#8-&YH(P M5:3US8ED^]*;]=/):!IM0!C!SFNPT^HLT$801#HT@!:\!6[,EF>DW(1-_.2V MO?FPCZB>!Q2R``GDT5"Q@["/%,+%>!51*(RZ'8%L>$2K_@Q1ZT]5 .GIV7 M4Q,3F*6,X`-@=A2;G/"OOIUSO)B`F4^6_ISJ@=W?6Y@&[#0J/:SP<278&@OJ M(R#0KMGNR;\FQ_^A+3;7-,!*L>COE:#9]E"QCT0IP*F)&-M?#$U>C'9&BVP@1*-% MAK!*%K8K.,7]CT#+[>**SW/@%@0FTO.,F;DHSHF6G", M&Z,)$T2@B@*RZ)U/^'VS.,FZM]J.R*,LF6':BTR?KM(%FJR5)E9;4BI2`CK; M)2:Q-GPMAQ^PL:%B1??QS;`V?%#YQ$6'R^<;UV?]HTYMOA!A=Y@^+'6*S\4! M:IYA-$*[3?`VP;#\WL4D'/-B[:*H812T[(7-Q-H&1`2MPPT$)-KO(8\#1?M` M[2M/"Y1W'&J/1=J#R")B^QHD-A)E^,=P0VC-%<>@;:7^I$D`)GQ.8_WQ`_JE MBVTV@?,WDAL'>\`6?QP?5B2&-#CG_=F@V+-]!7JJ-JR[HB&MGH9^$,\D`\$& M_55IMW3'BWWF2_8K9Z63]*:`=#7E_B3B13ZAR+!DNM-#0!5]]>AVRCG4%;<( MX1+BJD7ZKIF6PS6EJ&8V\M:46(^OSN/2V3#=-A^7A+H8VZ)5;*;"V`IV^^K0 M:7U+L`:3A/QW[$OV@&\790T!`*6D)^4SM1GX?=D,O?4CRX1@;=U$C) M%N7!U:)%:A&YZ9BOA51@;`\BA%:.O71,NC%/:%5*=29?<2TB4:=V@*P:SC_O]P2ANSP>^ MX"A^E892"1E&]UF%2P(ST7$&;A)E0?<@` M523(QO*;=@1`C4G MGV5)PR4KMX@[.8ZJ)/3SCZ,$88BHB4CWO$SW6_35_UMYVNY#2*\EI+_C?`,0V7A"#Z-;MJXUI84+0[+)MHBV+@0KW#X;^#F]$!PE" MBO.`-B"60,U';E\B3.-\L2`6$$#KQ<<6BM"&`_;%8KG6Y!_*`][WV/&_)_ M&V(2=ZL4MK7M/X'I>HI4`7@_V8+(GL:5S^?5[-K/.'BQ<3\[[K^Q>[=[0[AR M]1;!+Y4HJ"VL5S7].,(K*5DAKF_@SN)M ME$ZT^("MI%+[&,[A1-YT9\$%^0"Y@B**D52<"*Q)0;6XH-YM52P M5V*>&8@K4E2'`? M80ZPL4V^!C?B(.S"(%=FGQ)(2^BI0U#[[-A&G5$M5D\]W")FJKC\6>G8%M'M M%.;JBELVPEFPW.[^,+=KLA+X2^E,#0+9,K>C^4^MXH@MY<_$.,D`*FRI"@E5 M&=:*&&[/@J,N3QJI+XXJ.SRW3?@+AN`7W8(T:^=N\,R"."DLZ(?RNBU;KYBA]W'_`?X&I+\P=6IV[+LXQ+9G_`SL>%:YX$U(.4.&Y9=*Y1=M1.5 M]E=I+RNGI>ZX8>]A2+Y:H#"!N<+>W]XU8\XR_[#DG8GO=1=_7"QP;L1?4]25 MN_+*+,M/$V:30:FS]YI'0?OH7<#!^QX*F4`!%PC80!X?:N+4E2A11+A#MF`2 MJLD,U.1EU/YAW$IM_)4[GGJ=T"'7)!69)5=7O5NI%YDTTJ:3>;G3Z%ATU@%4 MH!6JH(.X+H_/DM=2=S!YCYE+B>%BLXC[2F8A25(Y@N7XK)"Q:UX^&XC:1#\\ M_`^A/_^M]H22NN<+JH&FW$54T&0C&4?\5F!+DW^Z=&Q&3)'UWK&]9TAW3LZD MJ[6=3T2")]E'&$?]/K?`8>P*?/AZ7CC_M!U_,FK$6_*?H(5$A@[U4GD2QC;8 M;#D[<>/*B-P9)XM\NBA!&`64VUVN'$;>^$W;S`Y6E@.D`F3#E!^RZE$U&_ED M.:\^<]?V"_>!\.J&;?KQQ/$7.*3O*>Y-MN59R3Z\RE^@'<_CF]+09B\$<]BL M\&]AP_$7>#IT$;)=G?D1L^NU)5+.2V?L=O$OG5+==F_I/7E>N@5I4_/+M^DJ\IBH<(D^R$DD M:('U^M3@L7!!3VG2TH8DU.I*V!H6R\PO`;)"I70&/86Y/HMJJ$90Q927P\%$ M*\60TNR>C4E9AJ,.)/64,,52+-5.Y7E`-'U\P]0@#-]18N#P1^;_R@95NKZ4 MEFH$EC$H?W6Q7SJ^P7F;UQH2S<7*L+!0RV^_MZ@<+V0VT,`ZT("[Q/#RPHHO MJN0@BGC!],E1KHJ!T$78]SBAE,[Y-%F'4.KMI)38&3_X>0-7<6\7 M4?+E2]VRX*'.-.-5#*D"5=6^49Y5Z;&]KXT'I5[2:Q=^BZ7K]YJ&YWH[[3(/ MI3/A,"+%&)[#%(^KB(=WG[CSX!(N=1:\9O-:X$:5NI/JN"IU+!6UWLP91A8C M[*-M7NENAG/S?1]HW;9/05I24,R/WD9^]#;PBHBWB*#)V*\L_G/4KH+TZFTI*7.F M):XD@^VH.T[9VWM$IRS[:5+)?(L/7\1['!T.FQV13`C;!G?<>8-M08TVYTGY M;$B/YY/Y.-C%B:AY@1AQ>HHF-4T)J&4):,3IH7>0Z1_-,M_5;&V&4FZ)B=E' MB7HZ!B;Y8\M*-+H!N#T.U_J3^50"@ITZ>#R<(C*A6E,1'<"MY/EA97UV%MNE M`P>#(*NRO%6KCW$\H"[*$=YY+!<'/E?7G2HT.[;8Y;[3Z2U] M<"&OH;C$%;RR6&`<935;QFT)._*IX?KSV'0X.`7H(4X85O,>:3]E<_@2LSJ( M-BJV%A.;>6*O]0ZD:JY@J&D8RNA',?8$(^Q\XRX=2OZ3GZ2GH(8:K*79J)!7 M=3S.PIA'$$44E>-J/Q$S\.1OD>N%(BK`59X1YN`I4R^=P-&U"#27[5F_M$K\ M>"S(3Z#FTVD^=GK((]<1X-21+1\T)%13A)D:S(^"I+64^@IQB(97!*,,6"[&45HUB0!4F^$D7 M4P.<2@E,1I/9:)(%%D&E,V-,#9EVH'&&?NJ?]/E_@VBI\W>DC?L]_MWN;*V' MM%%O-!DGAR2Q?Q'#%M+%&?$_-S9&PWX/GE,>BS)7V!`)]=%P(+X==02%^1E? MLK3=3+Q"1-D_$OSXMB;>;2PX*$';@02-2KOC7L*0@8BJB!=0$0W0J*3I,W].2?5QOR3XHD-]&84< MR"]D/+8EUV=9%=5[B`RN),UIIHWFTW[D)J)WU.)7L[,)W\>& M>[P.A23Y?,32O5_@2A\04^Y<]E94OH?)?':O$WYF;Z&%L_D4608W">EP=D6^ MIP#@!0XH3U,'\D+^^OW1N?/C6F-%/D&:;?..$ML@:]VZP]Q(N$]XEO13]4BK M]V2U^)8-EYN-1N-)Y.O6(8'@DH;KIR4(CMH"'[AAWIL?)N;86Q&171+*VV&T MG10T'S287@NH?QC571L&\/YOTQW_XXKJ* MV\/Y_D"^MJYV=K;DTC:1[VE_.,?:F"?=RW4VMO^]IGB);49>\+7-.P9_QN[M MXE%_R]^ZS:W1[JYX'AM5-I,C7$?4D$<.O;MQ&'O?0Y#"ESLY3KF'SEV7DJ>- M*RY[<).^TP_W#DII4N.F5##950%?BJD.WRNSR]0.=Z$JU$#+!G3[J01]/_1N>SQ38F?`3$X[8MD[Q3` M=JVS$&`II70"8#?$QM@AP3!KB"HIH1Y M8U29A,HPM&.`A1!*:J43"(KV+7/S-A9548FB&!\5[K//IOFCE*K-_>9%]("T M8:ZSXHTBW1`11/[[#\GC(L-9K75[^S?F'QI1_(+M#?;N`/L5F?^^0%XN(&7X MRS#?0@2F%=H)#(H$[@136:L(RZM$7\"$?-K>2;\`>@&YC@"OGG09PQ<5TK$" MZ91A)VUVA MOF#*4/*8SJDFH8ANX(.W6.UT*E9#*5)"-N17W]J\;`NO6\=1=64LWL3KXB'4 MKAD6@RBIF(9"T&*-L-M%,):)"6'ADZ^5J[C%EETE'A/R MUP(0,K;V=NY@,6$D.(!RP60'F7B-;1/SW\4TJ/50L@.I9M?/B/RJ`7T/D,$> MI[+-SFBAVQ5&*\=VER)1/*^SFQP`\@'T.$VVQO!0(+:V/9_2W"OPDS8? MA"09>:M.4"V2,^"0Q&^Z-Y6@5IP[?M(-8A%W6Q22LENP3?SNM%[AR9_P)6/O MJ#B@HC;P9$^!M&H"M6;UN>:4,/ULX=7;?_&.3E9191BHN+\QC/)\IHU&[=[- MWD)E(Z$+FS4%II6/AD8B@QDV3IZ=EU,3$X#""#X``D8Q!/"OOEUN*-S*^$28 MH5O_QCKUWZU(=59AT1804-2^?*SY=!CL8GJDD$<+`;'PM99V4="<8%H=P0Z- M!!D3`R24JJ&9C4JOA7O8=LC71/%2ZX_'\^<89+R33(?J(_\YDZ,-;V]F%M<1,(%O55[/S59C^!4YK' M?CM;>!EXB/;HTA(V!$$O9N;\5Y$7+ENUR2+M`S'1OG3O#J::OZ]_CQ<67X$R ML6Y=$,H7U(9/E-?C;9,%X3A\)>Z2PY"19YM_84">GL1N?^QU5C^"*%R+FQL: M7"U?8TH<$U*U9P03(=T5A>"M-I^:5_X$@<.`8P-$/#Y7W-52HEO6%NGF"Q@_ MPHN%$(/7A$N.XI`BR:XO5=NN8X\.&L0CM]#Q^3'ZZI%1X2T+_ M<"F'<"FU.BCI4BZ[X%)JR:%5D*-5EW)9XE(N:[N4AC:F`S[2,5R9'DFV5IO; MU<6LR%^OG?5WX)`1W*H$'P>1-0F9I*NE9;*VMKDM9YZ)?6X))34Z>%^5#]Y7 MB@?OJVH^E=O'*&OP7G`.^2#]Q^C]_^V]?W/;.-(G_E905WNU,U6>>23J]_/] MRW&2N3R7B5V.=Z?NF[]H"9)X0Y$:DK+C??6'!L#?``E*%!O9N]K:26*3C>YF M?QH-H-'=_^Q]UA9\GA=)!CT-G[? M5;-U@V9ZG:SC]LDZ1IZLXXX+H,5J+DMZYW>%KSH3M$YF9TDP'E`"L[GL+#$< M M?C9VY%3VGI^;0P=O09)PFJ1`%&^;I]CM@A;Z\)!S<,#8Z?.@7FM#">=/3AF"O?=OJ6TD/9K^A#,Z2[8 MD'C1FUD5)QI%X.-#=V^T[6DTA'2][C>?3);+I08BZ(7;>I$M0XD]>%!>3#01 MNI?U3CH`;*(]1/3@G0ZJ4%?UV-#K'@4/IHUD9LO52&Y4WF:]VGC&X4]IP[6? MR5'0S.X5E9NU#9R1>+&P911SF26=?@59"4$"N@.E:==*E\LSS01*/QG:6JD! M--EZ22=P;ZC]E-T6O=UL/`"-ZW^DM+FICMF+&,ANY%8[9:382H1`GUA4/]&SZG+/D1,F!56"X*B=<:X@LU,QERVE M-O2WZ83SDNLQT\]5G9%HH)/U&Q,3;Y?OJ29@BW-2YI MW-P:[7,O/0C?YF9D;ZNUE-J#DI;W<6/F9N:,^Y6.5^F5QJ?2DKP8,[&U._V^WC-"-*O5LRX, M+VJ@YW6W`N``-:;N4SG*Z;TX`)0NK-530X^H^U1!P4%E%K%VXSU\]=AC`;70 M`QR8L]_PTE%\)PC&C.$WO,QEQ6+RY=FSZ[N8=0[/\1J:4-Q`Z_B1R)T;16]> ML%-N'AB]@A9QE/DPS]US%A+(G\-@]POL0Q(@?$-^BS2]78<.)BZ1C./SH8HG M`!EWQ1*U]H01:@/4APX*W5B`HO"%!FZ0O*?Q.O*.BEG;_#T\/-69Z="PP1EI M0O>4+"G0M0)DEXJ;SX195968;#U&`GA=M%7E"MI(L;VU])4^HX/W5D MQ=$(UZ<D:I@8[9$\IT=B2ZJ[Z96_-@$BJK= M;S]"72+)W.;!?8/?F&TV-KV/%JLT,-6A>+"*=6N!)B!X3.DE+9?@=Z[C`QM3UW+I:- MC?8<#B#=6%R7S(3)-M=M\@45.#6Y@J(2+/`$M-,D2O'G4-IQEIF-)Z7[(R5/ M0*V:0<\33>"#0M=SV^;(JG$UX(*>/T,:[6UWO$MBTPV2LRX"C.>+D4S)?OB_ MXK+(!5I2;D!;=B_D`O%$5C;_<%9>!.ER_>/22Q]7F4-A6YX&Z[?[[0.OS.:M MY4Z7F=O7OXXWRVIY,C^U'2^U*]>4.GB5E+Y-^[U]B:_.+]T6Q3^FXLO=7_B9 M%S!^:6S33-YJX@U3>[,R\?'[*5A'4,/D/15_?@PCP>@7:H;@1@)H&&[BRCS+ M:;)8:5";_-`-\M04 M>Y!K8MQZ[+;JT0;T"F<)^],?>+53[Z40(\"/'R&!^G?W.QR7&YI/-YJ(&._$ MJ/&!QWP!!0HTL!=#\I.>&Y*-6@B6Q2$0'_B&R*'M\`I7U!9W%/)-?GG$SIG\ M3+@TN8CN2K7+:WQ-H-:'=G?@#`)6^(,J5\;FO%HN=1MF%?"+(="6R=?6@3I\ M3S%MV0TQ$XLV0[%2:?B0_>P%]%-"#V:9&?G3:&#,6#"WNO%8'6V3;T",<&I6 MW&T^4S;U!><6V7#P5#,W/7C*RL!'RN]N[EM`99+$(95O8]5$I+(^/79J.K$+/EWO&.G>M0)4YUR^&8^G1OBZ ML>W&42^"*W$GBC;S\S$:'2S*0V@Q7#,07G;/Z!IX_.(>Z/L0FFP;??C"XVBH MRWGHDF,ZUP`-J)%O@IX5T=^YXJG"/P/Q<-!4-SL]@"H*P<>,/&%Y`@=E]$E+ M+Z#AILB%>82T&NE.&B4]\J1SU$,CYWP!-;5JI("6S40J\].CIZ84"_!SQD&^ M-:?W9YY9ST;SN6[CS\93^HO$5*^HPB#9^V_VW<3J?.ANYTE[A:NL<,8YGSM_ MV1:<91R96^+,T=VOJ@+N)B\=:B'VSA2]4CY%PLZF>:S%8(T!6%80/A(?Z88> M^")/,&I<(U3Y(AH"5=R8AU6SL6[%E=--D6A17='+A5:OPSH)C8/')K/58U&K M,/MPV&&?0_.J-5CLMD$P=:::DG]JP[1H-Z0/P]L>G*8L=2A)WPFEKZ'=&#U/ M_@I"&=<_$$2K-MP!H"5MX=9 M^N72U`7@Q>0;IV\%P,Z0U.E'4AQTE4Q0CZ1<+1:@AFG6[%O"@WB88:-W.7S6 M'0H"'2N0T5D>1U2D=P-^<,Z[)$34NE._HCDU`""5_@I5,Y["=U2T-M.66S-] M"[>&AHHETRH*\]%BL1*E-*HK_R0DSS3MS;&%@FSB>BAJ)8S+955>07@*R3N: M]C%$*SYW%7F5NSK%;VM');J.`-64T-"J"W_^_$?`E!LEWK_H)FTV;30!J-Y# MFUT5S!@O@5:+F>[>;8%LU@/=ALGW8G$Y^(K2;2AR5_3.QJF?G'7:Z6VNSA(+ ME+LGVLR(JX?@B M*7/HYUDQ.)L\_FXPF?S#OL'\$D]9] M`-WC&!#6\&+:U&ZVF(^=O.EA6BV!.WP6;KT"0<)[VA'7]WF%.5%=!4K/\:>R M"BL(R.Y%^!SA+)Y.Z4'9',(I$DX2">J]")C'TN4OBHKY%LB5L-^D!9P0>4NC MB&[N]FZTH_%#Z'OKMR?Z/7G'!OU3&Z,UOC1H<-S$B?&VS6*ZS)+U!$$B*=X0 M09-\DW\"<<*IH^W;]B>R4Q8YC'F%N(\IE=UK8`/U=>^MF:\7_+&W M8RC33=[8(YQ(1-?A+H"%T*_D-QK0B,WP;S=L3,)T`"$[/!`Q=K+14E+`5O;# M,NN;[>W#X,' M*+T9R[CN9"R[U=2HCE+&Z)HR-A3.[_U+FHD)-8W6_FD#8*@! MK?HP`""B/B_\Q!M.4^X4_C:>+#E2_S:93*2C^*]30,ED=$/`-?-?OF<0A045 MF8SY3Z=Y\"ZF?^_:?'?:UKLQ:P4LZ4B0`?]R,&('(W(X6R;2'O1 MBMG$HP"9G5-`B[/C)MB4KN!5 MDN*XC5'+5_<@FFCTL-EXX."AR0 M&_-F"*O:YIVD2@ID"=!%OF?;K\C.I2(/C;9VDU4!KT5=]F&PY9:MP:O6X+#C M9=.1LQAKD(A]I;9O*=7@L^/^K+EQFN,-_?YLB3GU?D3+PWBHZK;(F4_GCFY& MN\%9U_4IEV@H*M[,MQBP-T=[_7)EYQ"EGVXMA3Y"SA9V2^\F/#6XA?.7E2W[ MD&7ZY;5LTRY#XWM8^XQ-3)GF.*V6T_$D3V=9NU'T!CMG;F&3L;CE)G?B-H3O MF\'?>0,AOA-7W6L4>XJ0]Z+85X3?(,2N#T<* MOK>F04SY0I)3C\(WUP?9D+8`^_OBZOA)$KZI[O,A[N_U)[+9E*`T9=1#M!X_ MNG+*,)9XT#U,$T]=V[-L594%4>47IH`N@67A>;S8,F>B0^?SR4(77N;DK(@P MSY5.$X&QN2,V"<,0(LVSOR,7E;W]R[KJ0)MB::1`LPZQAEBSHI)KA)OR$,7@ M?%O]`G*`6>;&S'#8:*/E:-%39)F>\/YX,26?5GF?A3`+-7ATB1M!7O))U:%C M>EJ,?R+<@XCG[QY@Q$AJ]Z(+CA1ZP8F*C@P^'L<^^[M/X2^WP>96W#53^:9. MKPX:*[7S8UQ4>#S+$S)RLM":1A+F+JE(&BN$ZEMHIRHTE]1MD72X$,/<7LO1 MAJ&>4$#HQ6L_C$\1O=_>A8PMW8Z,?R)SE/!HTVL\FB2PF(0=^"J&B"RSI.5^',/B:L/'^ M<"%%((D;:D.<0V?P+94SF#0M`+1:3&;JZA+%6A+9_?.T+$FVY9^$O$00WTWA MVS+`#XF!(?(J.1IZN^+JZLK<(U=%Z@R?0I*.!!?&Q%B$#T;2T5"K65Q=+\YU M]#+,OL@%'B7?+CE7Q==QBE_"A'9Q?L7GT9U<@1G3D\K1$;_VURLYB-;D:CD8'(.#Y&`5"]+ZEJJ1^?(7%Y M&VP^\`MW!>!H]FK,WQO MQ1U;(&Z+[^A=9N=RF8=Q'AV0FCL14W6=OZ<3T_6ON_#E/S;4@^V<*?P%',VT ML(O#?I2Q\I'Y-=<79=\_LI]5;GQU@QZ61`>/J->.\NUYJ6X)8VL"`DQL6 M03U*YIPCV;5Q8F1F@(UV10R-A_]%W<@,#?F3*%C(AC>VE\EX,E(C`6C9@8,S MI5*BH%FJX3%0,RTU`LHJ&,[^!?(^!)OW+,QM^%#EYP:V_=+@YAO#H\FJ8OG2 M17Z`8C",%)[=7R"1TU6B(6U>:4Y5BZ\+/YR]PUVUAN_"?SVP=<.8YIU5%M/J M0@'>Q[/D[MP[1MP/:;5%HZ@::R8?QKGK!YD)R1"3'NQX:[::>._YIX1N-"=O M;6\->&[:PHJYX4P%418DO01?GQ+-783E*`58T)\XVAE3,KPTGF.@AJR$UK>Y)/9+MQL4).)";A*8D3 M%BC"A24;>M6VFI\*16JU7']S0!S.W#&X1J[_*=C0[_^3OBG6O.KG!MHN4`[> M8>4]DZ4#Y/F:)$0X)<)(#;^%T(-$3E>)AMA6:#2G=']!+_Q@]I[G1/$`,;[/ M?8C^:S6]-"P2&C@Q[\FWS#XS4IXR>D0((0%C4O$<;J),QP2U&94MGN%X"A[5G^=1!!W#`.V M,&HLE*Q^=LB]*A4#YON@(R>-I#@=DA%"+H7<@UA.9[$&VY5J,K#2CI16"[WD M_7_X3J.U%].'R(/;2>F5I%LXK%E#COVN?&>I\JW.HS'T?8"N#)I>/G'&SFB6 MEZ!CV M4D^Q>&5#&7(.7L`+0NVAGI00#EI7B/M*2/^!(&4?I/R$&)/WL!_930@ZY-2K]C#!BO],IXAT3MF4P_A_$)9^"& M"!9X8E.!"9)R07B1"SDP?ZK("4_WBLDW8(9P;I!")42-.A@:'2I*NPJ,B]%= M_Q_N1_5V3U"I\XKF+>C_8%Z.,VV,1_:_<=7#I;CC!5ANFI#WC0_V`SNP,Y3E M7$%9/Y)O*H&N;[^4?P\+?)*"9\[D/X+P.:81KQ/\*3B>$O9KIGLF*5]-OGOC MK]_Y;APW;@)=;3@\C]6;#,:87,S2>U*A[%"*TT4I2!ZH=X@U.*1^ M/P.J?RKRU-`44_\\AH>H,M'!FJ=C!<01FUWV)%,=H>C=+%M-3`DPI1J0$9+] M]7]X-&(:V+]]IB],D49P:7H9!SL-''4X\YXKMC,R@K9`JC=1:_L,)J(B(,W` M5#6P:U,5*@;SBI]MI;L;7\'`FX*/#K>PTF3EPBJQ0!"]G'9_4E;7PN92#HZR M!F-48DNG&UL0U7:IL_D=9$QUOMH(\9+3#"KT6YP]"MJTQV0;FAJO<;;K!!5/ M?+D79]42ZT5D3-[`P%*=#7,#6ZWJ.[Z"W@W)ZV$.7F"F=QG%>7><>`=^'_7@ M1G^RA5:497LR3FBLO)(Z.)ST=J@$DT8S%D")1Y_CQJN:36_@0:G(AG$,-'&F M-2C=9%CB),D8^=)F;W)R.)G(A(0>E>DUH*>F"%O0XW1&CV,'>IR.EX$7RN2* M,GH<"]%SEIP%]#3+A(D>IQMZ'`O1,^F,GHD=Z)ETM*KI8KYH0\_$0O2<)6QYGJY1I&-<+^]W6P\.&MV?46K%^@#4ZN6>`Z%H:]0=&// M-)E].9E/I_D%"IHM\+=@H.K;$UF.N\>'@GS23;H/()NV#'SQX9JZJ7JH^RW) MQ]#T4!+C(-QYN*8B4\@N.YRAS;Y]V;D>S$J_=;$A M+ISEI'#=R\1'L9]P(^0N"L\M]22ZPAG9ZX%ZDEGA=QH_-N([?2 MS6#(W<'7]"8\]S=E<2-)T`ZW8H!9M6MI4U'?[H7WR;L--ITB%\U+B`Y%S9'I M)+::.(N1+F;AC2WYY1;;`I8^A%:X$='_$7J[616J]"$M]QM/8<(60ZT?V9YU M43-&57ZD05=].Y!T"+A#$&V8MXK?TRV-(KKYZ`4LSO."'70Z;_FXIE0078PA MBZ8&.9O#E97,Y[@'GH4B2V*4C3,SR4@.#94+7+*1PY-M.CX+NN,$SQ]=14-5 M!\7TD;FEQX(^TJ%(-A:!P7!]UE4THEAL@9A88ND@N54I&(#ZS?4"Z`5U'S!L'\.8GPK=;\6EZ+'F^[:\-""DFCDQ MSF&=31?R9!0(DI^`Y,^P=5&@R@\(.=U^0;424@9TQ]OL#"7LE&=-01>PGW:, M+I=VP\FR!3\3E?YU\HX'35NFH4!F9IU%E!GH"`MF,?!%&6[^%F;7ADS>_-S#8&IDQ-L'Y8CS.\18+P%$!N3)A,$4@C3.1]2RQDWD8)B>M MR;G1R#DDVHR,M`JX=A6A8"YB7#U$X=;3HJOPQ)`XRH<[_4-X^275>$Q+!@$2T"N#XRUN_"@*'KQ`!V?Y3' M7O$[N@TC*IY[.5/IBHZS=4-*C(D2EC>DS%NV^,/Q M!]9H>Y[%M%*3GM!D`D-B^IH!@%ST7=?^('B^\&O"%DD06[34#-$]/;@/JK%@ MO/TQGJ5W>*0_R$BAUPCI133G#-&&Q:O6V.I84^L"#R<,TQ^^0^]A^HX&5!\! MZYX>'"'R*W(VNS(?AR\-"QX`C4UN;C4:S988D3I#\ ME)+^&3J%I-2))']#^`!HDU#OPJ?=VX641T$'&6L=#+8"/5/UV(5$DFS%WR/UP00> MW`B*M%]@!!5"EF&SS)WYCOY\->^*5&@!P`''V&Y7B[1^@Q[/0+O8A,BBR/;%\A!-@=A[454 M"%:YZ;+5T;S\3"F3E+0M\+M,9'%!+Y6-F=B)`=!:Z.FLM!EX2@WUDE=>'RM- M9(?\]?OM0Q1N3NODD;[0X%0#U5DDALX][\B?F?6Q\4>+T3C/1O>G9]?O4BWE.:B!L9,,3KWEOOV>A<-O9V#/?/R!M[A!.! MQ/A=X/V+;@;.@[_J1RE[P70(\BG(K^[<267+<4@ZT-`KB@&4,14Y]%+PU,J. M4O"H0?!!\NK/]$!9IOTYRK,C8DGYE*P9SY?5]U#CE0HSYG/W?%D%:CE$Q4@O&5Z$HK'*Y@!%I90KQR=RJ,9=MK-(V!.?*/DS;DP^6SBC ML^.3&T*_K_W3)OT]_VT8D,3]DX4-7I"$,COH!K`*3Z0A]QO$X#Y=@78$-Y\"QA\;KT&S*C[+`4V!J#WG%N=+*I-J&F7"BV(4YM<*9,II ML+MSCU[B^NUYFZ8$4/&EX\H\!7(U;S[GST8@<@@;LCZOH@6^I/C"0JGUGCW- MPBJX'Y5)[_*;>WP3J;`G^I]V@;7-RIN1VZA&.V#\P,)KU]ND<[=,Y[L--O<0 MX(K;E<9F8T0,%=XF')K/-LZX>5Z5HV5)JV#K?"#D^\:#Z(7/PA4-Q(4S2%>K M`CRX=T%#,_2-%7J5O8@'RHR&+>QW%'89&2=OL,[_2*L[>1U?QMY_T')F6KIE M.5O,52)#G M)^DF1.@&Q-U%E/\2>>7?DR(U:_Z<.E12S.D3-H`5B_V^Q)?+?"EVP6+X*48F M]E8M-LHRO]4S:!?XS4KKR8VQ&-#UW['1'AGM)QH=U)^S_MCPKJG&@W'UWN5D M/,F=D$^#7;+G[L.#6R![6;K.$R.09["M".S(XQ$TW6[I>G@'0P%M@ MP71_=SR934H!A+``^.Z`8)>AV8WYZA9JJ^UPYOK+A"LA%:C`),[IX`'U;&%D M"SD`:!9[R7,D;)PJ8%*%:55LG"T#<3],OR2R29ED2A>E&&6UXK+:>\;JY+C&GD#VQ)U_)Q^",(Y@WC&EO$=+68 M56P;WL?:7CY7`I%`"R?N?*T-Z^^T@?L-":C(311;JY`HF/T2?OZW*=]K^MM\ MNLPR&F/O.SF$0;*/"0W@//Z_3@$ED]$-`;O@S[._3&]8,!::`[Y,%Z1!1*[/AP21!32KUP"7MC;>LS(GFFPWA_\BDXN6K MN$&F8[#?T1T/\;-1F?&F^<1,>IK]XE?RZ,5_PI8*M!&-6+#MOQ%W\P((DULL ML5S1A6)S5[#&?Q1[NX"QM7;92#L:[B+WN'\;?)EWX:?+'5BF?9SBTOV(XW03 M9Z"5GM83%)9Z:L%Q9G*1:?)V=XI@/^NIL5B#ZME!9W$%`^8-YD_!5< M)&5\&+OGU:P92D"1<)+V@.E,*1VKLG#;S:X%.F4MH&+GHQ=X\9YN?H/KN%]H M_5I`JH&Y+2)9SP#?DB-BU2XLC(ZDMJV4%' MBLKO9EN!L7;S5$*M12VHB/OL!9373F[[MOF#&'C*1C?VU,O1=%Z=C[X!&5&/ M''L2.E,@IYM`@R.D9DY*0)2%1[5_!L>V3P6/8-@\&]?<;8[SF]W99,$((%MY M9Q&JH17?EL=J$7"N$/.:$'PP*P!:L'^LUX^51]'`.L%1[, M=[66X_ING2!&OLD_[5DZ722EEM9G!ZI:#5.)KV:=H"(-V@KSDRQ3 MA-5?P$!6C0OS+*5I7M0[76UDU&P!T87B"?#(5XD+/45CN-5DUPRE-3TEAM0J M0<7.'V'T)UP;#.$R6:=IJN%-##3IV>E0/7,^K4U40%=##OHS>9%I90@I1L M2'ASY3:#)ABZ7#:GE)`I2H!AXZ;)R*I@T6K`!H0PW-X>H-#:OUS1=QL.QN!Z M\VVP>8CHP3M5;VI>0@D15P;LF8=/R^52"SDVT`TI#L4;8LO!>"JZ'`[O-LJU M-2-:2514X.6JBNGZ%/&J,'";&@:(_V,C!]7O>6+ANP-$FJ!OJN:>4I73P>]? M`^:F]]XQO^9=*.#V5K&1CB\/G]9LR)EIBNEJM!@5*E:6;_J'Z1AIJ0?V*R]Y M^WM,XB1<_\D3Z,OU(7D2<;$0(`MO7_?,XY,PH.('9.U"90DVD!=3(ONU0C9S M,??8"[;^B4)M[?`%*JH$HK(*)S!X.O)55%[UGAGQ8I&)8CU)Y76=ZX4PUY1= M].[8;CW?@YKI64J[M+ZK",K,Z#D<7M0QES7_N#G`$'.W.[K&0D9W%QWUX\?C M^`0U]N^W7\*$IHT`V8SQ![^'GL2:9-6.+P_NQTTY,[XJ,!Z-%L*/I[3A=CNG MGO:^)(P^20>X=G*KWI]>1_2Q/:*W^-3KR"]*$G*9(<1^367UV'#J2WO#.)NN M^,V=32<]]>)L_LL]T/B3NZ$')EZHO^"F?&YH%Z)BHD.7BJ7T%IP,R>A<]Z:4 MUBE<+LQX<&&:87ZY1$Y7B08!=!-&,NQJA>\'IJ>`/KV&3_OP%#-?QUS"T]Z+ M$DJ#NXANO.2CN^9%\1L`W(W"X-#NQ%Z'@)1%HP+T4!V`C4#2(?C\F`Y"Q"@D M'0;+)UQ1"V/;M-#B3*ZH"B=3!4/:A*R%U%L3J8=Q.&>A/7=%W55W#2>5#BJ# M%V/7I'X/V2$IF3*U.F9THY7.#67@DZ3M<#T]R*MQ.,/*V\G)]"!TQ;5D:Q+; M?$HC.'6>1*\?C&,MQIP71E]/SV&T\0+8B.&K)LT)B.[I`8^G-"R8%W29KQ89 MJA@E4B0E%O\X9[Z]""9[ECW#3CA;Y7+O?$/<#9NP1`4(1CT*7[U@AYI!T6)U MQ=.@)K5@`(;7'F31`!0+=?WF&H#J9P<$BY(!\^R;9;H_EG?HX!3C&U&K]BK5 M`4WQTH-L'"V_0_DS_RVO68L)C$;K*L)"+ST:*!@3GCC.>\]@.F[Z;-5'AX9$ M97SS4_IQ6KA95%#-Z1`@A`B$BR3*:\)N2+C=>FN:KN,@TX#F0N+5B36QM!H^ M5$I!@4?>S4?W#0M/#`F&?%ACBYG/5S(5]7-SX_;++;_MJMW9[/.;=D^\6IHE MW><5)E(RYXJDR%;,)IZOD,FQ#_T-1M/40$JO+!MQUE)FR_AUBW#7N9O>?.G, MF_"'7H+K.A([*HE_-#`V5>CJI#9D<,HR?.T&D#Z(`S@YNOG5@>E\4H-65C$1 M?6([2YS"5+:6E1_MB_LJ]J2!15%^.P!@/A]57T`%1&_*"!;0$+!_-(%@$B2%2702WG[6;.*R-OM$RB#?HKI#7D^ M)80]!I<-;LB:1HGK!6G+R>R^@<=$#78>9'+*[LJO>P^*I4>4;*1D/(ABXX>[ M@%?OYS<'@$K:PXI3_+[V3S'CD&P\9DH>&SW?$$L?RALJ54BZ,4,25VR:M#[P M980K?5;I#85D.7&24B9+21SB?OI+L\JA-"GI,!8T:!!WDC+JS8\H.JKLI M"B?XX!PR1CB(M#-A^:E!PXS2T.:'M[.T>6Q*@4@26,'$!7(X!3F&OI/3SX>0 M%3XR_UUQWL@K!B4&RO%/77@'P`A&#^%Z2PT'JN,(Z\<'P232`/'H^O-I'[BFOB=;LIVW=%7FSC3I-!;[][ M^A,^S>-(1E_DP7B!Z"S'Z=D?M(N+R!?W`+T`&`VT56\?(CGF(F%@0&5>.CS4 ME&`+-N["`W,OLD-Z?OVSPW?544!&D(8M\TX;[']I[%><2[(;!#T!72]:$'M/E9L$6TIYWSW;T-ABT&T`;5*8+9@U3.DR>!,9HV>F1TV6R^FD M!9MVY(#U+;,2B3P3[(UL-&)B@M$D)\];13[PW<8.)J`E M@0Q''5_F)Q7S-#59B\NL\!D,0L0HY$&;P(B#T7X4H02KNUY')TN:T9YCWFW0 M;52=+1@6:XKWX<'UJLS7+;@4RZWO@G*%BT?SQ?8N51@3#RJ M3+4-@S55V8*[W]WOWN%T>)?>=KISC^PW#3FJ'4@@XU''E_D6]W32-G?*,4@V M"$E'L0>F_>BA!-GJ'?:#5$-V:8[XWD&]R8N)W#9C;T-QHR9[2I8P'_4VSA?# M]]O;M2AN*8X>%=V7^Z<_?,I%?\R;WK.>SIS1),_*J!OZ6@XH.[YK`.+&[)?E MVH^NY$D>A`-3@^31DA.2^:%D M5_G%9>&$V9@]._O"FD:/7^6J[GXAXC*O)BF+?_. MK]O@H#6\F08?R^5J.<[]+]_BSLU]O7>C'>3"A9%,F./UGF$3'"KJTN_0."!- M.HL37KE`)M;)@KM^Z`9Y.IH%#K@7?37ZUWP$U#.2ZVI`.,9I4G:4#1_&25K755D0K>'! M(3=O:J.;'X8OI]/<[O-JQ#A5OOH2*#=_S$)>[594VB]1R]S;)!0_A=!ZC3[" M'/"[%T`4WQ(IM[^%,4TULV1<6G*RF,\*^Q*"C@AGV7+O!48@_,"6+?/^.GF1 M6`8^PQ8&W/5@L<2&G/@^NTLV4`<++0CN62<%;_`4\I:*E'"Z1!)&CGA[%E>Q M`Z`P`M3IT@RZI?G30$,X$VJP>Z+1`0K':7U_X9%!)]%\W"ZE\";5/&T@ZLH'*$S6QA@]>2[_(--1>Y_')N(A('JIKH0&NFQ,?[1]2(> MZ!A\M?Q9))QG#)@;3EX)HH)TH"6"6#3'U4Q+AX>R M^#TMV'/RGWA_)/52J/;4\`OR*@O&YZ_SF3.7_<"";1@=9'_&("LB'<,:S&<# MB/H(8!N#+ZTODRY#+GE*D4L^:=M=77WA?)DPX@9G^FT0%\0Z:!06P$I)L>>J M/"A[3`^=XOOM0^0%:^_H^I^"_T7=Z*/W8C*7F=-"FNN,&32_1CR>C-5S83X6 ME`O/"F2P^20;#XZK840"0^+/F%?2CJHH/SEF.A`G]S=00H1O\F^ARLP;&PFW MS,`E$-'-R=T4_&-X!F:2O9D6T++:,[#AN^R1].$9V)`_BF?HK)VNGH$-\"-Z MA@)$+O,,J8)_",_PQ$;O+6@0Q&SV#9Q#<_,?9U7D+W`.?,P?Q#N!@)X3D'YIU#5O.Y&L$?H%8B/ZJR<>/[ M7%$+>]^^Q;O%=2'X\:K%2ZT!@45AT8,U]Y3T99D5<6YA<&N"%R"!NP=S71!2AE M\:!U7G@02MJOLR&QVZ:<8]=EE'95H`7P?62?C]YO']A/H:4!_%9>_#4SDX;W M\6"K9\K4;F=CQYGJ(,O)\]U#.0"!9[(2)U;`MR\5<.A^B!/OP*\$1ZGH$77C M,&`3T1LYIEKPN18.>BT@0;G=QAM@W*)(2R$L[@&<;RKR?;L@+)@RM]]YUEG9 M',)B#&LA?(X*SH"P7@L60;ALXQTA7%`D!H1_=_]W&-V=XB0\,*MHV*-4/#@@ M*.NCFS>7'$UES)N^C[HG>:DDCJ$D0^%#;T!%(&BD1K/XAR@\TBAYN_/=N-7J MZP\/;?DU#HR7/>/Y2E[_5M1M>,%^3]>KD0:RS847YF4&P4 M!C8V&19MS%)`B.)^N`4Z+I#",95B.%M7F$O9P*O"HEBU6)LT6W7IF2&MNCBP M^:'^8BKS=M/*$LA6?;X4CJD4@UFUREQ*5ET3MI>;:[5:$U`,\J^3%_-K0_?; M=S2@6V_MN?[]:\`^R-X[WLG^O'1S&W]X$>EV[^G6/?D)_.4Y^93E)%8^W!`C M#GVC[KKBF%[Y6LZ=^4+7-?LGSE7)&.+Y'Q!D5_!&3PL>1-_A>N'&7L( M5Q!MTK?3NVT73!OM=N0P[C>[:3G`!T6)M<*`OOWN1G_2Y.,IV,3-09?ZX2&C M+R4'QF'YPDDO5G)"1%`BG!1V1-:#9$XNV4%(MFV5;+`HK='02N&:7A/]Q&UA MD.S]MZ^N[T9OT.GH*?QC[ZWW'PY'/WRC-+Z-Z(<@\1)?78N@T_N#QU0=F#,S M+C;X:#6:%@H(BB&@6AQ5=BL(@A.;0&+.`DGV+N2Y$"H9(!Z;0R0#4/5`5)8? MNGSN]=24>A>N(D%?=$M["@D?@F1C$#8(24?!B%&NI@3NB*3PW$SD%\?*-SP; M]_GTWU57&),YM%F^WY;.O!IWT/7/#SBE:YDPSP@?I:E*^?DDZKYY3R(YQB(- M-8FW&EAQ'F_6`@H^:'+GQON'*'QA\'N=IUX+_Q* MG4B>.+&?W;/)C<^VNJ/:"XD.B;2+.#6VW=5D(B\QL@$)C$C2( M\#/)!B;YR#2S[A8[E]CI.(?=&K6&%&_(=Q-"G''0[;G%'?#H=\2]G`BB$0="@" M#M#?U@]?8P)H_S=S.E6L]>=\2BJWR`E]"EYHG/03XDHJAJ2!Q>OT,L%TCFI='!/'"VP.9?[>1OW`WJ%NO%7 MP%T1LI?4+T:6^8LUI9OX(V/HPW<:K;T86J6'AT,8?$W"]9]_N%'D!DD5D]W? M'SKUJPMSICVVG=EL/LE3OWA\ZP4PWQ`WCL.UQRLJO'K)GB3L]Z)ZPINPG]C+T/] M6QH3-^#_@&JQB?M=9BPG-^25YU8!$SS7"#(@W\C>?:%0YL'W_@79R\&&_0-J MR[)_Q/3H0FJ2_S9PZMGU/E/F>E/Z!`8@Z0B0&"_&('P0DHZ"D'IV/26()K>I M`K@!TE0!X59M?XHRPEK;,.<<*O&-L_*F=]#J2&318ZL:;\9SMK&;94=,KR<<@Y4%NB!B`?)-_PDB$ M#X6V&KJF1CC"'^E:3`RBZY5>.[AASGG&7XZ$SM!E/\$2$Q!63KM3>(KOMUMO M3;\>W3557A$Q>6/P@*B1G0Z]TQ>."($8P5]RBD20))SF=6^/Z(.)'D4CD#,4' MG,QU3'1H0K7,L91OQZ7;(9+2YJQ4IR;!GF&0W-SSX4+>RWH%I4GB$GOMX_4AZUC?F7R[>O>91_N M:^@K[UNWO3+XLK*9']/%R&@\719N50><*FQ1QIQ4;;,R9K3A@-PED1B8'%TH MI;YA>^%FZ/WL/M4AW)=0Q?V62)KBDO0;$50)D,58@_8IJ#B\E]]7 MB!5KQ!IFR6F&RWS-::",7AS&_3H)V4A/K^'3GBUOW6#S]$K]%WH;;&Z/D><7 M?['WHH32X"M=GR*ZR9TN=V7Z;:N^AQC:(?7,O_E5_\5".C#)`4E>0^:(Q%#L M'\`$/W5S@8W*;R4G)!:LP*6`TAPYL!M#5>*XJ$0V$DF'(H()PK@@G(W*;U,E M2E9((=`002#BGAVJ1IVB1IE7<;@="A6R?T[.T]@@KOA*'B]SW=?X+E=U]7WY M\Q_":?<$@>FJ[)E53@7':73VP/UII-7-_DANM#^UU'WEC^<<>_&`R&[N]!Q& M&R^`>/HN#%YHE$"WEG.=73LU:UQ>*ZNF:ZOQ;+6JA*3"G@LCD,(0=OJ[GM71 M[O40M7.F[^M9174/&!=ULB[H!-8F%KM!8Q_2[@S-=-R/2^2'UBP`99801O#: M&S_!O@\:LDW:7QK(.XV-,09F[$B,U7=5C,#?6W6/D+]GB,3*.NAC6M-UC MP/1OE\*V^HQDA9Q43U\M'J.L)HSL@.P>H4Q7T-W1 MJS\W8)Y`;7#CP^GE:IJ"*,NK28G@I*9=*$LQ)2V3B#9(--0YN]:0BH?M:N&M ML/N6U#/]\Y@XZ)QXY8RO_AL!TTC0]_;\'_'!LN M9V2CDWQX_)VBX97G#*2\P;Q*GV`L.9_>O@V*CX+[J,)A0KV!4Q35FY0W/SND M#U$Q8'Z>,)W*"J7B$JX@=$-R4DC@OERJPM5BEQ-"15J32960HQ4<#0DL/C]& M=$^#V'NA^1[YRW/1ASZ0X-*K.8[-+MY!I$7NEX$#0K%K_BP@U0870DE!70'67&M6!U$5]-<6>N2LK"+?/:`DYH3N$"C:*[B ML^<^>SZO1&PV1I?(LB%!)R@A#/4G:4/`&O:*4F4'64&5?;:D'U]M\ M"OZG%[#_LJ]+8]TUI=G82>_X`9%?O.`7($-2.C@XN52>O%JA MJ+TM:*29;9C(T!M4$0T:^7LYQGQ@47B0:!(T54\,?4Q9'M[TP\\7\V+1=7>W MB_B"@\7W<1*#BX1)>@/E7A+7"WCUEU"4/H_;&#FI`LQ?D M4^%K("K-\)HQG$7X%3,I/_02X@:\*UH@]NHBXD)I!EYP?2O^Q:O,\/>]`]3, MI&MOZXGN+;[[^BOY>EKO):]9$?9GJ%+`C78C&-EX$5U#`5_W>(3_\MKLO&Q\ MRI)@_@8>=M=_G=CS)`;*Z<\9,T"';AG-XF\&/JF]Y!M+9\7%O6[V;>,Y["4B M.`41,--M&QQ"=L2JD!-G)N9%M6(HN+!>1R?7;SO$:7ICT+E9RX;Y\>)RN4CM M7E`3E3DD/?03E-YD=,Z5<;CYN]4,RQ-YLV*0D,1/1Y["6S%#B&Z6_&?Z[ZM_ M95@L:?GHL'I*ZW:GY&!*E`1)@2+6-FB/4O)]S@?&X]X5K3SB?1@EOS!`IUU< MT>O]FYAC!5+-VK$"4P\1K&23MP?VF1*&_@_LI\>#?@^S`P%,O&FY,N^I-5FN M].A+Z=\0/L(-GP*R0:P!9%]J*,&35Z\\9@HX`FTN/VV2'PVFK1;>"-IF#?:S MT*41M#MQ=^7N/O?;+5M1\R;.7N*Y_L/IV??6_*=L4:B,],\B-/BR^1PN3>UU M.9TY3KZZ/F9CI2OB%]<_U7M%A6)P:.P;NW[Z^R.T(PMAVY)S1(Z<)?$PK,O3 M7L`;"O.47*N7JKVF/:AD1>"A%Z_7U[1PD+F6JUW(Y%@L6B%R-"*&(^EX&"OB MZ^N%KP_^J;0U9C!N9F5@+G>YI;GD+Q9ZBPT7C=7A+;\O<5/Y*OULW5_3UZ93 MV^8VEDW5.MB-XF5+?&J=,]/"!'"G=/[__.A5M=OF.S/ZY#9.VSG:XRTOE9Y[ MR+2#8=[%\1A!%8S;B-`KKW:U]"M81),!_"A[S_="V#ZM^"=.- M*3DR-;'I=#Z2MSP?2J[+#0(VP<(I"R<.7N<9_H2T"$2OTH.P56_"A/U4D/*Q M<`J![$1Z$-;I]F6M<"*-N%0Z#[VB>G<:C_2%!B?Z2-?A+H!^RO?!5^K[3_LH M/.WV[]S84Y_`=B2!Z5`,^#,UPN5LL9HU14=W3 M0/P["C>G=<+"G)B`'GQ^B+H^L:#J`,VU)57*^S#\/28;+Q:)D&$$1ZCL5_\M M9J+\D@A9_ALYT&0_>*^0JRI;$2S),4@^"+F'8OF^3^0XA`^$[.YZ5X7"^?%R M&BJ+@\B\8!G@$M4*&=P==O`X2N=HJE:47?:('EUOD_9""S:%.PYWC2G")F\. MN:_>SHYQPM-HE;8`DE33<(3O'9[=S@=BK[A_I3$"=,O;ZK-(D+OZ/JW M!VBSK736%Q$YD/`DEV,0?S0A:B;T8:BE7LW(=X6 MTM8HA;RP5\^'.2H^^8G8!#UFHI`M';H&QX!ZS)V>$);I$$8D+.5&%'` MKW$L>))R=T7\'FRVZ2.X8>$?HGI8PPP]< M/WE#\X;]*ZCJ_LJK.+6[@U%0G5W_:LBCP+>*=]-/IA:XN2X>0>'7C/78DR/S M#O114^4L_^7P[D>.;#H?CD?.4AZ_\7?SJR$17!5@T1/=;NF:+1D2N3.T22,S MIGFX+`NFA-$P]DQ1Q[FHCSCERLYDW,D9CS#KD=4LOX#%HF`XVR$AQ'3Q1\;N MIS@^P?*@=#2F78BWO3?H5D@+,^8W^V>K-$E>TA0E:E.J@.3B03#6+DBO\CIU M>2MI`#&_#Z+1H3.^2B^BXZS(C;DYKA:K-KP!87'[PS;DG2\R1R#?^!-9 M;!#&']V(I\0Q),3>1I:HOR%P'=P^U*F,MAU]-85AH_"S%]"83;H1W7@FX"L_ MCX2Y$A/FQT^3V50%-4Z-QYF<'CZ^+A!/,;'Y4,*V43H,("GM3H>?ND*P8<-[ M@\I[H@9?M/0X$FB*/)@7YI@LEBK,B'ZYDMI5$',,8R_Q7HQ!<[YXDS)H(M># M-.-:4!C3P`LC]H=H&'[,&X9#H]R!$VOZU0!7P%UQUDTK5,C%)EN>RMNH69^) MJ\C[0J/G<`B)QX7X(XB3B&]9DN1N=KZSI!-M5/J:[ MWS'D*4&NWAKZ++.@[F.ZLKI=,Z3SNFP&'[T;/21GVXE)\\AY,E=ZXY_RX9BG M^IGD(Q(8\H9D@Y)\5'R'=44E"8^V9T_R`X(H5XA-JXFSH*$#?G=MVN09OHII MU7`+0/>F!6@OL&,>NB\<(UQ+VI9L`_0B-0?J8S$;:*,1#AN@"@LU@6)5,]B@ M^^KZD)3XNYN<(B]YN]_^[D9_4EY%F+-J.@V;T4$"I!%S':H3SF,(H_$`F M'0?,-Q^)Y$/A@_4*&N'0E00]L8-B8:&:U@X53'3Y9AHKD2GJ*4BR)*,K@5PO%Q:&_M,WO30LYAHX,:[EN60K ML@QP_`INB2(!DN2;((I5LK1'29VBI.N2I%&;I`/BS,`P*R!KTQ`BPF2MCS=9 M5K7Y*UQ!-%X!\8/(T7\G M;KA=4:"OB1LEUQ9I!B*]HSLO"%JD&AC[&L@H,*^2WQZLW_EN'/-B;FV7OLW> M1O<&-9;,#6Z5)_FKW0/ZI>\K",SG6TX*KK^F`MN04]G%6MMQIU:3/4!,J[IV M^O;92^BP2SDQWZLLKB,U:$N)HM4J[E-4/CM_I4GBRV[#!W=#R>84I:4$Q;1J M'^BJEMF.M9*&[(&8_*='XT\\N;735Z^]C`ZY*D?F];(7DU4;]'+B1%"W:03V8Z_P!(U!EP.R*5&D-"IGI_]PMM"#WUKPR+0BT?72Z:Y3D%Q6., M\BG&#?FB[CHX".1Z$M,IBZDHPH_>7-'$'"OH:E8.!J8>(9_J]GNM_&']]P.B M)1O4>/MO-4E+A/)WR3=X&VE'\TSN'1/NA[+MFED4#;DL()K5-F[E%Y\8VG([ M;EU/E\MER7;?AP?7"S"M]QP)'#,)!K5@_:9Z54P4*Z8^K"(?7#8IW,&FB>Z3 MU)X;TJ*K@W?)04CM6M`@G`BYT^T/#6#9LB\X8WD!!18:DJU9,^U<*&<;IBR;C;0F M:8`K.^>HSUY`/R7TT'&BRE_#QU?&B[GI+1;*Q4W)](`LX73M@MF9XK8AK45< M9+35S-0`<&5%]5+"4S/2%]X++BN5MG>9/7P-_Q*VA MN2Z7L^FRT+\F[[,7<\*UMGZ\(\WS&W%+"_BW^K'>P,5&!U16BRL30Q9;^`E- MPK#DW1LIO8E0W71`37$O^"4SJ=20A#[`DM!JI/;B6K*ZJI>KU*(8);Y]CI.( M_;W;1)F_AA^C9+P83]JC=F#';,TIR=H5HIPI;7.(TB8MR5`0L0&&=*V,+=58K]0ZP?5M;%XNIVA>V=7>KP51-$*A1E4U8?._% M:S^,3Q%]HM^3=[Z^)GD7"A:@4<&6>4*?,QFU3H_Y`.0;#$'X&):!]6(MM$R; M-F*VP:1-0*M3&0YJ\]HRGPV*M^J?'Q21&B:,+6^Q7&;38:$FDAW%6WL2KUX+ MR9>U6]=7$,[\=D)?7V]ZAGS#>8X66)7]1)-"T+V"K#%]YQZ]Q/4_0]?L^V?? MV_%]-GU@;4X!RW,TLV4^BTT64Z4OR>JLRQ$('X(4QK`"@KVJH0[*M13>!\+( MTWEGJ];"U$!I.,"-*=/(_C;8O*^MJ\=C7=ZT M!6*"'>.LHMEB[)@![88(TN2;_-."U6S/>BA!\::D!%#*`YN1[B$=[LIV; M%_!^]QORT_AGV0>\Q-R,:+U^$+ MC7CYT8"^DC^#\-6GFQWE?73YB?0^/,HFY/&)42T^X?O0>?<4T^T)ADAG)%X% MGY-+<]=Y\X/HQ5LS]Y#]9DWC&'Z3T/4^\/XZL=^Q?S$RSW`:SHD\0R=?E\3> M+O"V3!`&*^_`7GWAU],A$]X-V-SGQ:)19SZ:)/__P=]_S?:,0K\NH`F;&##_F^Z3F*N M^9\F7$]P=]#U>"D;T!J,^7WMGV+OA;*X?L>,*?)V>V:`.[BM*P;@K>Q?`W%2 MS=,8A`]DOV*1B1]ZX!FY$0;<`+F64IF%SB37\#XT`8V/=,TK84"^A.^^_DJ^ M@O4)TX>6SWN7\?-,:2!BGXU@9.-%3![_C;C'HR]J4,IV%"E+@OD;_BW6?YW8 M\\*NTY^#GAD=NH5>L(7?#)Z2T;,7YL'86OHVN7.CZ(VYEG^Z_JEAC=J)RK`A=1?6 MS.O9+Q=Y>%WLO\'ME/^E,`IRB:>K*D%"ECMFF*MX+R?R?,5*<0:-@Z[[V9W* M=U_SOBMK\8D)G]5#E`[V%\*ZLJ+HK$$;/=B7,%@WUJ#K0,`BOY5SU>&BZGC2 MQ67E0]CIM,*P_9W:V+:C]F`\A_@_DS.H( M[^+'*LI#P_41E#!Q96I<98A9J09'+3QJCZB]5^60JKO MHZ=_?E!L:9CHDD"4K1XY+=&QII@:?*W>=R;=P7L2<.(4)8SH.MP%WK^8?'"1 MC_K^+\D^"D^[/7EV8R\6ET+EN4MZ-I1VST:J;=N3(DIYW\>KW=TT6OWV8[IU MB;("7;C^L<6=E-UBDRX0O>&C0`IL%8AL@_;;)&WO#>\=]0^]L[XW.> MW@.T;9H_FJ8+]-FA_8Y]Y3$$Z^UZJWRR&(TK5FS!C?E+9"EZ[_@_;;#IYEOO M"EF1;#ST7]@B0-P*^NBN/=]+WIIK4#>^,ZSUZQDQ]HN3T2C;U9?TY!4]DE)$ M[B79HYQ.64Z_=*O-BD:21A99P5*+=E"`Y<5_QK?!YA],8)[@"`N=MIFD\9TA M@=7$B'DAW=DDG6.`'C^E+E'$GW+ZD],Y7\[!D&5BDB5DM:H'`UE?7=^-@)%@ M\X>[TRXF:H\-B)_JV.9MT<8367[Q+CQ`=J6K6X%>'QR7"<'QA#,R06+4L&"%L$PD%$S,ATTRGI`P<9Z3S"_3)-SX" M_A''M93@&"@!%8J=;;J$SVY:PP7M>_J; M]PIVF1>Z@0%(800+,=J/#F0>5.*]P,YC>N:?A.0K79_@EA(+(@]>'(?1&_D2 M)LI;2L/CM,V,U?ALU!@^+CM.GXI7T+!XWNPPG4S'TSH*.?;LQ-LEGV[M"5,TP9,[2HQ6PZ M62Y$]8S,HN[!HC+B\,^4_/5[J*@\Q14%'ULC>/.E_^M([_0E_2"%`+KB.2L& MT$EY0[@>[O'.^,SB/YDKRGN1@SE# M:'/GHA?:!K]2`JNI3\GUA;L:^/`=,N5/7KP'B,MXRWAAT/PVRAJAD27C!:NS M&L_KRX4R;8L7$#TJ0?;0#F)O0R-1]NQ15(+:W)"/KA<17FF"5^^%53M459$M MIWBOKC_<".I;Q>13',-&G*AJX*_AVA`O824*7?WF>@%!O'-(%SX<+6XN_4A<+[F_O@$79JX'[E.[AHTW$7H8\Q4%Q* M#XP;8VXU7REV"W.VL^OHXN"[M$Z^2&$9OLLA71V_5\CJ*(VKFR1@0R]E4$=QDQ+.R M:!;ZC3XU4-LE38E[5)^1,SSQ8C60#=>&"]/[(@\I@Q[L!;(3#4>U^='H5 M!9QZ?LP#[JEJ\L\(BUX8FS0"0-D+N)[<-3B>(??PZ&PW8#4R6[2&BTJ9S2>7 M;F_I[/_6<0HU)(."5C/>NAQP+^O(E8.D:^"W+.I\LW!JO89&:IB^V[.W*!1= MSS)S,N7<04UJ.U#=#0!JA'?0)R[:S?IDFDW*76BAX+X#@UVFKTD=_/KVC#=0 MB[W2:]6.N?QJVJDY@KZT,[QO.`,N:@?15=F87@+:ZX&2@D3L`3/NO?A/QBG[ M[T?&=QB9A@5=*"%XB`[L=6AVXU36VZ)=9G$"7[LZ*-,$SX*'R"5UUB^(11+(F'&`TWU:I/3M MXW$:R,NL5''$AWL_Y3)QG$[B#(8=G2&5D*&4O)\4'$$Z3SJ&T\M/`?L8-$X> MV?Q[FSQ$WH$^^*?XZ364#N=)5)K[KU-`V0^?]N$I=H/-T]YC4_57[[L2$E@SS2R1='C?P]%MZ0XV:)M[K"YEIC;FNKN1Z!Z\:%<:)Y/=>6/ M<[TY)2YS^?1*_1=:YN^>Q7:,D0*+'[UM0FG0<3[I82@KYI++Y3`#'.-SM)@N M&^>1N.[?!#\UOR99*KLVR95-$\C0VFV:/'X$[9XQ:PRM8E&51&J(^26')[G< M'B//AW].='-(;.DDTI_/;)Y`>OI..`OQ'3C6WVBXB]SC'MK3-G;BT#\_Z,)< MPX3Q!3=G[LA\^2(1Y#X(BK?HK"=\025K,("7B:5=;+)#U M+[E3DGQ7D-PM$UE= M;D*6_]V&AZW[+?QO?OKB>#QDF'\/H-TA4[&0- M/0R'[H$NE\$\SV6:[EWH?!@I<`.90,7G)$>$LW1#!%.0%R/8(AE?9,NF=,Z9 M32YQ:#W77(\+0\3$+:EIIU,3K@/J#\?M+JRG#_-#.<%[7HXAYMS'GP(6T'GA MYK#=USTOK_5L[1'MQ;2U?X$?T:O>G)$[<8,-6[L(DKF2U]7%^((]6 M8][\0L-L.>G?GQ7X26.['].77:A8$;;QTC&I%PMSBC^R)]/"LD\_IM9^/[O[ MWB[PMMZ:.6R%R"V[ZE>0V^E#[F%VRCLA-]\4-U?:]1V,OB1F^UM6.98NMR>7 M\]&<_6GF5%!*8?8LJ9DOP2N"V;.X9BX$N_RE,2S-/`?RC=9&UMHNL9J]/.0R MR(BC#KU4LSH6K5:)?B/U"J*;`!)U#=+)>DL+"W-M]3.9_W5BRY2/80AW=.^W M]ULV-OUZ=-=45+Q1NM>V=P:?R%L8,C6NQ73DS,0T_K2G).9DR5;0Y1MVG#*) M@31)]FY"O)CX?(Q?!Y[1>Q59N!(AKJ0)I9T%5<+)RNI.&+-YKZ**%'PAV#;M MK\T_(7%W$>6+=[PYW!"-^0QNHAN4^9NAE>ORPU\GIF'8)0D#Z+%S^]W3'MXT MOC/D;-W$2(<>+S.9"B/(D)P.^0:4L";D_J1SNDHWV`1L8GZE>;=5*:@H*B;J MFR"H]CP&>JI,&-O6>#D>JRZ/V`":RX127!VQ!RLZ(U/B1*D'5(S<;^_<>/_1 M#U]K7>5U'U/U"@92%'QT6!"E/=LSW76`@.$NYJZ!L[$R<9`=KO_S(G\GCJ>3CH# MQH+9JQ_!G;K@`CW_:1=\FB>?1EV@P4GT]WM_@@O#(HM:W!;AOY39B1^^TVCM MU4__+B`T-/PZ<6=>_F4RO$=B92/PC4)1/Q>47.:ZP\TI8:.[K/`44-]=PWV M9Q$:_-#_'"Y-\[XF MR\5$#(!WM,MC:#J0D1?:'"B[$]?]#MB$V^<,D'612YX:9I-@8_\;#D>.E'@ M^FJ2<4JJB;N:)HI#D7PLU/H=UU>+4U:+L8%84++C$D^2YR:]O\:M5*&QHU*4H!(?R>ACMK*"M`?H0/E9GU8@)CFWBK*9_&PTK$IR60QG^N` M@MMGY7*Q-`BQH=]*DX$U0`,_?"IRTYJ!HWL<#QV=4U+`DA9J@%B0<].+<$J8 M6)-ITV)R#6"Q(,.FPE#KE2;M\XB(Z7Y[9^ID&ZAUJ\*_JM2/?&K4V`25YBM( MC5JP`"R-/6Y5C^)!I%L/UO%BM=)%7*B=9R\62A-O6=`PML&T&D"!?#FVP@P; MK^E2@.9I1%1(%HQM:#Z>:J8-`K1P;P;T(9L:'RVR86&D8FY-,"DJPQ*D-'=? MT3Z/BY9N;4H@>%\VX@6W#4L_\C5AQH9^+&VFUX(;['XLI^/1YR3/@4 M;,/HX)K<`C!\>U!4&;%D?B%EF15"*5#.+Z20`G$+M@.N(+Q3$W[CQ6L_C$\1 MORW/CV2VH`HO'PH7DIULN@Q09L M.<`3*QYE/L6&)\J09$_)D6?+$/AJ(LV";LC1Y3UGY6A#9T]<(*3P#9(`:J[# M!4(X)2'^R?Y[BJQH1ZB$1YY[4!>Y%U0^T>CP.70#V7&EW'3D*QBT;#KB[J@> MN6=0&1K=W5DTMJO)?"H]P%T8<*]Y8E-'^.Q[.S%9)B$#_1LY!1L:$9>PD0_$ M9[R09]GGAOW52UO=1++530P\@0/AG8$.G*6!G<6U=<8="@Q"8!2B[OISFQ`^ M%,G'PO0]U]:)TZ(39AF+7T\Z,J]VIC*'\GPA`^7_3Z,0_E]NSLH[ MW!9:LW[UOC>WS;[B:!9ZTC-%Z=*M/BUK9>P]@"<"#(G_5-L\BY[%I2;/DC>D MOG6VJ+FCD[94S1<[]4%T+1(!T^[9<_)4BQ2\'W(>N-"1=IDO+OE.&-M23U[B M4[C/N_%>O,VIL1J2^MD!MYR4#'1HCS23Z26<#NRHY)10CSQZD,OI+M=0NT2- M)E;<$]*KP0ID_.$E^T=^5R4,XKUW?`H_!(F7O#4>@'2E@HFF9M:ZV*,\+"D2 M@U6H((=\6G)5L9TSQ4;#HIE1-Z+40'\H^(U<:`=RNTX8G\G;N[>68WW]\T-B M4L>$L1DNEC-YC")ID908[A37CV!.1\$&PU6;L940U*@+:[#2/*\UO(&-EXZ. M>SZ>+M2(N8$;YQ8<\/N_'P`;M4'-3Z'':>WRU$8$@6&M_D+^'3/^KVW/ M6M,`ZU6+V,^^&C`Z*X_Y/O(R+A`"D(IF7Q>]ER60)!L_A0_L:^W= MF`H=\7IQ^C61R6M#+Y(,>#*-O)WQ9+20/57IFJV7V(J(MUS;>2\TYDLG45Z3 M_S7R=ON$9P[*<4G,:^[Q//2BQ7D!<=?K,-I`H2#RZB5[_CXD&?*'X1]>$"<1 M%Y2F/6NX:)KB%N"!]0%F;D0R(%$@.HQRFJYQ=7JB>=&O)!R`D*]+*Y@3F`XXE7]PQH0OPP MCF&#+O,+\")JB'(1@DJQS/G:[R?H":,_&?T[]^@EKMKMEY\8/)0I#6^:F.A, MEK-YWD(62D.[P=O?8_(JR)&UH$?<+-J@#(CRKW(O>.WZZY/8"6:/L=B'5W=W MXYBRZ>K@!:?\ASY;AT$/4X\.75CV$OT(KR4U(BE@!!87B.`415CK11@F4%"" M*8\)ZG(*-$F&/[.GV;_9O]A?H%8Y^\?_`5!+`P04````"``K2FI'(/A?%1<[ M``",9P0`%0`<`&UB:6DM,C`Q-3`V,S!?<')E+GAM;%54"0`#`L``00E#@``!#D!``#M?5ESXTAV[KLC_!_D&F_=G;]_NY_MK M1ME/9]^_.S]_]ZGTE\HJ`MG$'J;II[/S#Q^_>_OQX]N/'Q8? M+WZZ^/&GB_/_*[<.M[L(KM;QV;^Y_XX;?_CN+>YQ)J+ M]_N&;_[YG\ZRQC^](ECI\.UBW_SC^[]]OG]RUV#CO(4!BIW`K70D@[&Z?OSQ MQQ_?IW_-6B/X$TI'N0_=%"4%`L^X+OOQ_.W%QW>OR'OSGV3" M/T>A#Q[!\BREX:=XMP4_OT%PL_7!F_QWZP@L?WZS>8:0(/_=A^\O/I#^_WH= MNLF&K*+`NPEB&._N@F48;5*JWYR1<7]]O*N0OW&B*`S`,PQA$(0O:4N4KJ4X M7YGO2;?WPI'?MZ7[$??\_0DO?D#FF"]O88"_%G3\AQ!!,L65[R`$EQ!X[=A0 MG..8##TX$6CY<30FBM<@AJ[C=\_B'3[\-J`S1O+A>B*S6]!+8_:'[QP/'9'# M-`)K$"#X`CI&G#M!YZQ<.6A]ZX??T%W@P0BX<6<\U$?NG_ANUQ)[^.Z6U35$ MKA^B)`)/R0;3MYLO+Q,$`X#0+/#NX1\)]/#Q/O.\]/AP_.ZND#8S=\DW7`7X M0'2=()ZY+A:&8BRR/80^="%`_?*M/_.Q^"9RDI?X`"_`$,M)01RE\^-_1@#3 M]0C1UP<0D3\XJY9'3B\4#1*GZM8='&B]G2RW#HS^ZO@)^`P<\F]RLJ$90B#. M=KKS#'V\U@'*_^[-XJ++/'@$;A)%F*E+!T'4%6R=TM0A5G?!"Z8DC"H?K_3+ M+Z#E[:@W53^<]7JJ2N?ID">\XZ($E)<+1;+^MZXXU)SU2/Q>K9U@!;"Z_C.NG)\ M-_'S^WVQ!K\X,)@'-Z]$'D@@6F?OB:Y7ZU'I[GKEN#%\P4^,1X"G!]XB?"+7 M.O`>HG`#$0JC'2&^TZ6D-J,1/GL["YI,WZ7\OL8C7Q*]^8/O!#V_Z%3FZI`W MLJ]@G,FN>">%J?`/@MY?KMKS=LASOHSP>HEW"WR4(,=-">Z58;U).]7*/"/P M1X*1OGE)X>Y7$:,R636(2%@KK0>:&]%N@:(#>"6S(G7F3I2VN^+-O% M%N`UOO3QG=*._TXIZ1L9>J^V=^K?G:4AMX_N'!.DPSW^[D59NZ;^?R$00_. MCDQ85PWANSHU8I9^51)ADX@\.'I?'QU3>5J@]KL&>Z&U;X#)B_B(QQ-O.D-L M]KL@Q)/VSG(Q,S&W;;8`OQ(SK5CZ=DS5T"4%@;-+>_6_`EJ2U3=L`EW"$?>) M)A5]@\+3-QP1$1T2>G_;'"@F^G_H)7VH852'/)T^=3Q%PWZW"E_<>@._Q5_A$?B"?X]/;#Q]S MU]-_Q;_Z?8:G]LCTM[ZSV@_G.\_`__E-_>_O>Z-=. M#!BD<9OJ45E?J.0WO^\_RXSQ66;/*(XYX]"WPL`*RTC_W3TVVZJ]21R3_#A^1 MK_\#=@RRV.V.1A^U5J:"$9HG,8D7(+$TVSZ'/(*OZ]X*>L@`PBZJT.9&[ M'PC_6+O]JQ$@>8OWV]0`^M9=0[\0')91N-&Y._94A(S=?19&'HC2T*2/'SZ\ M.<,,+`&^);W[C%XEBL_W$SY\J8+"],,$DT#D MICC]:<))K%R@4/TX0<5]:Q0H8>%R0DGQ+4E!ZULD__/[0XWE,?68JK'<^>0P M)O-\)%+3A[.W9T7ORL_A\JP8ZVP_V'^.LR7OQ^_> M`S]&^]^D2L'20S+_]>\')LG\4#EX54H:-W_RMJ<[\^`FU'P!L1KUS"Z&>#BP M_TH9X+0W0GWA:_G@0.\NN'*V,'8.%1*RUD8H3Z/F>(1F?S1'%T^+>^`@,'_VX2J[HL1@2SH-B(\O8>`V8:74SPPW:)U& M_J#US1\)OCS\U.X>7V%Q8H<%H]2/D,N12E\C7/%="'B\"'J8XB`75H6?X+"9 M$5H3%(<;$#V"94(#MG>2G2WNU(UQ.)?AB6,-B1((O<2-'\$+")+:0E#H8`+; M/44Y$6),.8T[Q;(Z=LDSI;ZWU/L-`%GI^1F5^IJAB=%:7<@\JVV1*LBPQ[1>BG6A1-3I42_:ZO3H#HP MXDO.5J=!=7QTKI56KH,O('H.3Q\OCO!MJZ^@[@G4UA,P).:.$T""\T0O`Z(H MD%(G$KO\D[3QTA;E"^3.&_@LG=!QI("=V`&$`F6S%*``4U4#3F&Q^?(7P*)B M\*(@V7WG*ZP>)0T0QHE6`2B> MCRM%J8'@>A+J"C6<-/QO*60-Y%:+("M$"8EK>H'7A?7RJI*50QRB0]&R4_>L MAQ;329)"9+UXJ@*1Z.Z[:"*(#E^4TO$5JNM8&0+[A9W*YZ8XJ0OZ%$&[\MBH M>T0=OJJK$67T43/A(XCZIC#9^:K1@TG%M9,B9N?SIJU6IHQ0$YV\SB5X"ME& MJ@7GS$;;8EKF44JVEQZ3#R!*L\5PG$Q5>AJ.'\Z2W(U7RC_H1^5S4NLQ M"`ZR,I6JU.>M!T$Y/VFM4I?^8Z$78561P(Z!:3Z.U3[[)R`[MU@!MGN=-WV& M*%T9MKND=P!>_7:R-:EMYZ#M+T3;_=4[`XR=\*_W++>#$<'O`OSG0I+=Y_8[ ME^7VR[J=_1O^KY\0\,Y^B4*$SCX[T0H&_VY&8"=W6'YY<66J-?03V*N*"OK98*3](-CD6')C=PLMS"3$(4LTGM,Q"T^/#*GD03# M.-^"*-L;EV`91B!KMW!>`;IYQ4<'/@;PF1+M[O!Z3UV9<$^\;S!]J[L`;W.` M^/E5^IO1'(+%SI?(R+S6YBC'".?NW)<@`/R5RFMMAO+L@^>D<"FNMC*5<`BE M3ED9?M+-P6EN)AV+2W!#XOOBL)4)2K^`F!XK'#JK;8Q0B<6+[)`C1Q8A1;Q^ M^>T'1;WDQ)/W,Y**94]23@QOU=3;#8):">;\]D:IE^Y15DMCB7ITMZND4R?J MR$?\],$OP/4U/FS]<)MG='_`TD00C\S*4_26X.(@L*DB/+V!JF7$&N6 M-LE146MF1.GL^(4`\4L8>HB??HG9U`C-('U[_(+%X,CQ\6Z:>1L8I*5<8O@B M.2L4.YO@ZS<`5VN\KV8OF+05^))LGD$T7Z9OZI(F2.U1WG`PDVHSR7NN:M0_ MW&*VJ_TUP#G0-=FNT]=`IJ(5:J>V'[Y?GP8N`BG7=EU]$Y3*TK3M&64*Z!5J_ZWW81Z%:M2JZNM5F8^8\91@%8D2>0-2@=Z/':A9-;M7ZD-C'; M0\@UL&KZ@CE>+3LS$"IK<`_S1;$-&+;[P3>$Z\`RU/-X"6U@!3^FFHJDN>":%REIB MJO)MS_"J@DS-G:)5\E9+0!'8_VQ/V:H!3P6-)A?628:^92*.\2BWTW7P*^VH M'3''\.W4A^U.Y*7/8/!X%KC![)/T+745;O#$:WS#8(F-[;'^Z4^?Q![KE3%R M_W5#<:6'O&`I8KY<.*]CFQ(".$(21>PBC=-O'<02?DYCD+%N$ MV7'\4>0#U7!$P]&.&:%IYL0:^>J!CTJC#"0J2(=C)2V]G7):!XBUVFC-/"=. M28/8`<+"*^-X/A:#D0E(X9!;/_R&[@(/1J`$6BX,?$?>$4)A`(]PE@YA0@28 M>7]/,K-#&F/MAH$+TXH>I8T3$A(?HO`%8O`N=[\BX-T%A5IFYL;P)YG*2`*%+/5.JH_R8)R06-7&4Z:%^D<;FG.WKGZ_7Q`?#T`?!'@$\"-R,JZ!ME_;U[S0%_\P]H)5N`1 M'Z#EX>;E@_$:(M`F^V(9+=/]+?<_A5ZFHD=MF!`;G[Y@$&>9OG#9@O MLWR+O/>?I).A*-?*/KH+#O)P+R+'XX>0*G4>%E^T`IHV5Z6N0^5)*4RHP4"# MX?<@^[D.AX==A\'3/IOTS'O!Y[<&1[6.G<30U>>1U'^K4-MHB&%\AX- ML=1-C.'@[-UH?NX`/"A:&N M;K\^5`<]/1R:K0_=P6UT3N!(_'A(C)8+@)?&&MZ\@LB%",R7I823OSE1Y`0U MT4J_OPEIKFB(1=X,/JLQ,GQ$%EOOSL1%]!ZDJ4DJGZ'=7&&0*WJ995[ZC7 M&,$XA^2,GJ?.16@OZ?!4-/)^9IS/Z4Y1.2OY[8U3GU M1@"DKG8@0"(K-:>Q89?=PLE-W3^WWL4(#\EVZZ<4.?Z>HKM@&48;1Z7.BF)O MDRZ=??KO58L@JWA>V![M>RRT93XAS0*$3\E5^5A(\T[G=B'&TTH6Z6IL3VAR M+&P;6>SLSY/2E<,DH_2X@LNW[?FA>D27[W1N>\8H?;^/@YQW"AZ*S3+]G-+& M[Q]%;NH$K6Q`8\:TXI75+%N)_?`U_Z7BXH4$QM#-%>K>^ MI17-DMQC@X)K:7+3(X.;V>XIJDU2H$ZH,MU:**AV)F[L#U2!_;L`]<+6%]%Q MUBK7C8<";*=>[DBK5N;W0&&V-3/1\=>Q@C,>A=W.Q]9Q0.=X6%%P[7R(=0]N M`^=^"K*=EM;^5G#;V$"*?)-WW?!3E'<;$U;U&%"/-*`HVVK3ZA%G'3]?"O2H MWGQ]+.=*\`_%U58+V/$6L();?@'W)SN=,_H#NVTL-$6^R4OQ9._#AC&P*EF` M/]EI1>L/R'[<\NCW&-4CL8/OH6- M"O8=X:HMNC3+XCXZ7+55).URN]N':V<)BRFP=A:SZP;86H9K"EN#>VF;?B9, M612/$+S?S\OP-=!/9O#=!`-7/>B"IQPM2L&STZ^DR:IK%Q-"$;53OZ@9B,RJ M='T07O2A;S^1X998&4"E0OI)\J"VRSXG,F1O%]S;A!PWZW"E_<>@(213^0'0O^G$OWX5[_?X!=B MO"/ZTF@;9D_$:[P)LW)BQ:\.&-#H:.)[[+VO!(FI*DV,%)",5DZ0AW7C9SH* M?>AE1VT:V5V<'?-E+F\Y?G$ZRL[W;L8VG MC1,%^#A",]=--DD:7W$-EM`5I&^2=NPDB^B3NP9>XJ=>W\410R\,?$N!.[P( MF!E$E?L>@](%8TFH]S.3M>@9@3\2O+]N2+#L9[!Y!A%/.F.V'0#5"SS?[!7R MLG;Q6@^$\NMP@W>9.NUY^T[6\V]A])7:P%@K]Z"%22&\TYNI\')4V])4;K?+ MFZ/1^4NPTQ'1;+4_-09/YV:VUC9(GM'VJVO@64WZ@"G/8*A.,960=CYX"K`&*9G<2S9#F)\"'^@-^H+O'A M'8J=@T&:6&4KZ-")!J*>^.XZ`9EK$TL=(6IN0I\SP]!XT$^(*$RC/S(G+.`1 MF9OD^DWVBHG]0P]3G&8#GFT(-SSH.QG[!%&YW+$'$.CX^IQQ.`A^<39B=:&T MFPE>KL+`Q2=QI@UZA.CK)0C<-3YAOPIYD78;!B^[@BS!\I1V&P@O$DVZJ,<@ M.,#[F?S"68&/JBR4NPR"A]1_"W*M,/SV@Z!>:M$0]3#"09XGK4:7T!8FZ]6) M;*1=P[[+BO5-:"*Q;N6\?5!;WYL*!PS[`XF M$+W9;/UP!T`I5Y'PIN&W[P31U%,U<#+E!),0;K..YM^GJ)A_"T"$UG!+);+2 M!MBQJ5+MW`FM]]!-DW:O(I`Y%>Q7US[Q1J:5J'EG:W8VXIF848>*Y,7,M7C8 MR@2EGYU7N$DVPCU3;=/)MW_`:RF(\[3MS#/\H$4WLQ:KF621RS,CN^$J(-[D M\^`)^/YB'87):GWIH)HDTF@(0]Z5Z;&L)8)+.AGQM"3RD$`DI'\W1IT0TG(+ M,YZJ],@62J*,AIWLM_*X"RS=(L[H=H-:/H; ME"A&5=)$BUQ]`#/\(>!$+K&]7^/CT`_3M&/YLR_@'`5.=LUB0@4^^YRVW?CBRXR.-X+?>;5 M>O9/)=]?7M[+:$AC^9N*/,^Y[;O!ED@]8`7=J]#',^?^MN20@B3A\'.2_K-X M8@M^$$+`Q^9(J^`=4L)(9XVTO[*B)ETQQ M:GO)-W7C?#6X1\4$;OO6U'$$H,^&9D].VTMAUA3_E2C/LM[=]E7%,#*4L3BP MWC6KRGU":'`-&G1''2A`;"^[JV]?J$9,UP&U?4M)]WW1D+FNU+B<=SN_S5(X2,ZY!M=_*" M=DARG$OMSF30"60[,NN3@(_K]TM?Y`U> M"R\@>@XM0TK72YT".+T>]O"U=*NDD$YOBXHNA.L#2!%K\+:P<1?+(L4H8-/+ M@@]7.?R+(M;@!6'S$I,X&%/#1L-GL\;/.'-,"/[F?U1ZU\PDU-3^K/6`7$V`*X08%7)\FN+2< MA_:X?3?A=ARW^3W@WT^`ZXF+(\C>*HN^JIR%?*>)X_F+G$1N4IH@N'+AXG]B M3&!37,L1 MO#:(X&?G[V&T)T24PIK1T`2])+QTOJP0(SP9^.V-Y$7!BXQ4&/X5+[R(%->* MY2GNQ7U./#_*$&+8.@C`M0K1Z*4[CR%*YL""NA/58U(L(N1S"U MQT\UZ*\N`EEK9M6'1]TZ.)Y]U\XH:)T5M0.<1F4JZ"WMA&6Q6O)':ADFP=/0 M=L%`^BHN['4U19:M06O-H;FL0V-7%%IS:*[JT-CE`MDD]5[LGI/5N_)ZCWV6H5=647[K>+3D35Q MJNL&BY5&*.1D35$WT5D7CM:/A[.XZ#(/'DG<:@2#59:>SX2!("6U((DR)GE@R_N94!5PJ2J`UF6' M=C3!3T&0:$65EA%N\"4,HLJJDNFVNYWC5%$2:9^[&W\`Z##H30G\-0B?$8A2 M[=)=L$UBDD@T<#&7Z2EXN4N[7_D.0D)M=V_3&<6N3(]`E_0!!A MP6"]NR=9Q=18$74VRA<]IF7Z8&$7HSRDBQ^E@'X4JN%%/8;"P;DV!^<#X^!" MFX.+(7!0EC[KVU7MP%8:PXB9#XODN\].]!7$MTG@L4L02QH;K<"I*F-7;#X* MHJSMH5J]B+]*(-,O8[MW:>?"8Z%\**5:'_-S'&"[.7_L5\CW M_=:LZ&@Y4H'M+A'2-ZE@!7?X06RW$.@]GIF8JPGEHP%2\%KO^M`]NCG",+0Z MSS\FUBPMA.W>++V@=SX6FV$OZ%T1CFXA0%$>!W^$H8>67RDP!P1 M$0'/8*#2TRA',D,HHZ%1>LF.EU!*FABE\='Y]MG!YRUT?+U%PN]HE)_?PNCK M7?`0A2Y`>@P)>IK@:`'C[`+QX`OT$D=DZF.W'035O\%XG58'(??G&FX7X4T0 MPUALT=`=Q:08);SGRN(2YX-:KSE5!HAUSMNO<5.0.)@@5=&T_:',EP&8X`AN M-=L?Q9I(B>Y+VU_`FE")!&K;'<\UH4HEWW9Z_#!V_&%C(I30A#>_3"BR_31O M*"76<@$Q3$9]V_@'J&V:>1[,:+P+EF&T27N;<$6W2'E"])I9;(3BZ['>81#' MM:90R6#[>/+24+;6S'6C!)2-5E2?6_];)SK=?-A]Z=NB'G5=MQ/4WVRV?K@#("]=JLR%O)\);AZ<'7D($F-K"C-^]TB.7E$/(QQ$H9>X M\6\.J;\8[W*:4H\%N(3`$W\5U=XF#V6%;U0^E!46J.UO647$A$>H[8]8S56E MO,UL?]%JXB:X[([WSCT%">EJ32*ST5V0-]JOM*L0Q48"9&V]&K5NPE.E^_?S M`5&.UT7J)*/%0=%I.'SD_\3;]@ZAA)X,2OS4.I_0(>D2%+W,YL.@6;A:<%I;*0*+PE,`AZA1%R!M]:ND_K6^;!82MI`A(AO M11B#NP"#`U#\B*7!6?P0P0UX\!.T^!;FZ6P7ZRA,5NO_3@*`?[E8APER`F^Q MAE&\>X*O_-"!/J?K#P]4I7#Q#?@OH$K;W(U#3$2)O%NXC`$(-+'H8*I.<"`G MT7WH!)?`(5%S5:J>2`GE!RQRQO\'HI#\KTKA#$O#?HD^_(W$4/0XF\FGBEC* M+;]2F!*#[7XZ?&&:#TU9$!P7/C7AO0Q257ZS/2=)0V`8)A6=O#BGI"1IB%!9 M2+6]-J#L@5F8?ON\"FTWL2N#W)O<9;O^N!W"74GZMIOS!1J=P[.T_G"V/@9+ M$1V6O&=]`JI&V-R/*41-I&T2;:ZQ/`/$FJTR0@Q=TO&R70W7P&6\RNYD[3)! M;YKIZ0DO/\>;!W_%LCLY>XF@PZN!JMS=/&]EN>TI)N]16FA,B3OA`.;YFRR5 M)FC/W4C(@U<-^$H'\_2?@J6U2L>O@;,)HQC^`]_:^,PG53R5Z&?U&X+5;;(4 M3I;"R5(X60HG2^%D*9PLA4,T]ZB_D28K8I.WD_5%-QK#5GU=C,N\J`$3\TE` MT?K3"-":C+$#-!5.QMC)&#M$E!N9&\FV`[2 MQXFS6NUOS7EP%08O`$O.>%\?B"XL39).]TX49;,5QOX6`/1KL'7@85@\LTDW M\QY(O:F\@(4RMI3'5[TU&L>$HCQ--S-?YB&_\^@1KM8BZS6__6"H%]HH1#T& MP\'-*Y9A(<);"[J@^"/*_XIX-OEF8W6R;Z["S28,GN+0_9K/J*,441+C3Q6QYYHS%,Z+,*')'+7#@*E)J1"'SE"8.#"K>-SG1DZ M'=H`GUTR9MAAHW1=I@=^GI>!MX\YK8U0CF\KB%<^J5\8[T070[VA>7K%5P&K M:3?K/(L+>21'&7/MEO]NRK%B%GA7SA:2G&<`;Y;YLP]7F9PJ\*H0=#+%QW&= M!3E?_$!_4LCQ6#X5'V-J'7NE,3LVBT-_MF%XUC08P+S#T.2$V7AER9>/I'\?%(,36A[!'PG,:B\J M4*\^EOEU183I^?(61BC."?-R^Z+:PA+U'P!W`+D1W&;KJ+SLT_V@QJ!X"/,\ M8B$%,,]E:?,AT)Z_FA1)W[<>`.5`"W30#'.ELTM3CF@C/?3C@N]&1%Z\!ME_ M;\/H(4T*QZ_+J#'`$/BCULB;Y1*X,7PI?0'RZT>2B_>S\PHWR48[ZD!ES&&A M,`5:W`\HT.*S$R?$"L)0Q2ET&!;]IG%SI'/$'5""8-.WN_+,(%EE!3I0Z(?PNC>,U5B8N:F\$O@*A".\@40^C''P&#C%:I84+Z@M%N,?UQNAD[Q>CSY?42L0UV+-VON8( M75/=E-;C4;@?_A&XQ%?2FZ'J'02#%;F%)/2JCM(M]?M9]P99GKU1W,'(?H2O MQ`O2#3>5``3QF2+L8X*+7_!&1_\F7_$(%MICVX!4P]N'KG3F@]""^944_/JG<)WU-4,>RV0TC_ M-:4LZW^%*`0(,)N:H#D_T(3OWVH;$U0J(-H"2<[I5<_OD&6!(*4X.PHR['J* M7OGNBCF#')0>C(?^R@WXD(_6"3<<4\E\N<3"L'<7W`4PAH[_D#S[T$U_BP43 M%B/-!NJ3AWV6'W]E*N9)C&*\$,@+1!YUT6[` MCGF2S4JD+S$32B-T1#7<`(:YZN"/)FXD?'JY`'CH%I]BQ$!`C,;SI4)A486. MIOE1N&VYS4W0GCK1"@1;^G=CU`GEJW(+(Q3N=S;""Q&_$9%$G;+JCF.'T)?1?B-9!;IE0ZS,E=IX2.X/4 ME"(G\X9DF\CI$_';?#@CJY$$*9"S[,"1"@GN$W$?(UR4GB("V:/6S!"M"/R1 M$/A>>$M)W'8`5$M4:;S6`Z%1K-2.07 M/BDN=Y)UPV\_&.J%:T?4PP0'^TA@38N M696@J;B2(*W'5$Q);F!L5TKI!43/H44P*299&5=!)?XM*DS)14'Z<0))G@FU M@.OC:&5\=J$#"LSH17MN-CZ*T6C%>MJ4DZ>"8C1:(;W;W/H4T-$*[VT<2BE\ MHQ7B=>I14+A&+\PW+)%"$1QMT=262;`I@J.5^_DN,A2=ZM@EX$8OQK>L"DR1'+W<+ZDV2I$:O<1_L%GQHIHO;V&$EUWFR^7E MH)6/N.]&+^YKYWVCV(U;Y-?-!4IQ&_<#@/6^Y&;?IZ"-5O+O(IDNA7'<3P.- MBEH4,IVGPX\99`%8$7O=R8/&R=Z1%M&E`(WVF9"I?I*(#)47]*6HC/8-(*]Z M3$$:K7BO7-B%8C4)^`=.(VX]#O+[,$B M?P0>V*1D97I=M0R!A[W&F2V0AX(N>O,`U,6@,;QHNP(0[_'ZN3@&-5-G`*XC M4%^#/XQA#2[*M9$.PP[K]3;WX'P8QQ''18>55W:/S4B.?RXV@HSI>XC.1PZ1 MBA"RQ^IBY%A)"MOL8?HT/VD'PW@%_%ZT\CQTM0(F@/T8\CAXA;>RL'Z'P2JSFFJ.+= M82U"!](-_RG+JY'SO9WZ9-5C6'"`?P8.R628^NS7QQB+\DX3#@&>67F+%/N+ M^C*TTR>1+R^IR5;W(,``C66MR1$X,&,<6,UFU%HA*>OT@Z4`,K5OQ4HH%KNN_L]`8N:5$X*I8:$I;NL`JS=2QR]^?Z MIK'3=T2ING89'XXX;_NJD527ECR&1XR2X!1FEQFG.\Y.#QAIQ6FI[FDLJTFA MNG7E&0=?2;Y47AUINJ[L#)+21$M>>)N*1'T#]N?W9;SP&^MK]NO#WU9@!*\Q M>7@5:-2`W#A1A.^H9QC"(`A?LHQ([S"W[V/G-0S"S2XCE9:$(`+A%6X$,>-I M\ZPB(_`*#0&:+U.G,FYRJC3*T7>3?0;HQ1J0?&F<1&E:1`\1V$`2DU_'D=7,%&[L,LL,S`X:FJ=W'UZ]CV51H/R@ MBWD>2@E<%JFY>=HK)C@AV5G+3DXUW026 M]0-/5)QK0J]OUY2FT@>^8K4@Y70RL5H5LNA$BT*]LPGD1::'`["938=`L_!4YC3N9%VTB;^K+Y06HYGX"@Q[`?,#U-N9 M=DWAR_R"'`R'5;SMU"[Q17L^-&7!:%SXU(19=A$/H11!$;/3`*F<*D;]CJ60 MC2'^FPF9AN!$T1I#A%/?T?(?['1X.E;&A@]VFAFF*+LIRFYRE>X6H4;:&+V: M5Q\:N*_@Z^$YM!:SS(Q$`;++R[PQ/.K6+PI=$T>-D)2K&2YTVGHP_G8\M,+0 MJN86GF*-<.-;!BE6.L+H*:3*['J5L0[]CPU$T.$?^LV76.,Z8Q_M<@KN#D:> M-88B9Z>J9PIC.(8O_H>^M]V0',_VCGN/P">WUB)DZAGT7,:Z,7]@P26*X3]R MCS:Y!X]ZOW&X0DVN2),SC!G:#VJZ%,G[E3CA=C;/EQ$G'S)P`0+?MLUJULW\ M^>%97!!4@F/(L`("FXS3#P<2-P%A>U/N&(M;%::]IO#Q_'8OT:CR8%]?$4U-W0779_XE!;:3(IT2T9S8`7AJ9C@8UDB2D^#YE@CG\<1H/ MA^X9T:6OTLS0E[O2TLN0GGUS(N]+0K;B?)G^%'.B3"^0VC'XA>G@MSCN8 M[J2PFZ=G#/HE"YK(RR/^$H6(]\KK8Z931&R>Q"C&MP0,5MF"Z`FO^CQ&T")V MK,S#.P`Q( M%BB220L$+@1=O"EY2>KQ?!Z94Y!__J")D=3R?&R4+79Z8W23M#7`G\WQR?'R M2/1X(&(F560_P^(+IRZV,F*G(S/C+$`@<_^:5'#P\NP^[K3&J M,0$PR\)RC8_(CR*B#YN:,0@B1-?_;N:Z4>+X^W0H:08!DF$FB1@]1N`51O+OR M'80$AG9.XV'0+32VW6VRW;F@M+ M^*0^7N+0D\"*99:QW:K<<-O5[4&VIZ9HMI:J)D;;$U1H8J2@`#I>8.Y)("93 M2-J>PJ/!::5G4[4]N4=K`$4&35L+=?0*WM[6W:QRQ^F`5U.1EW&J:*AMU\TP MU/$5I575DFIK30U5-*K6;XJ&G5*FT!!2V3$\VX/UNT=L=*'5*`\]*&TOL:)C MTQ$KR4>2RJLI8*6;S/J47HTQ8I]C>[RL31#0%"^9:'G,Q`%#<;S/`QL>''PN M+2(G0(Z;=AI,)#=^3)(TD2@K\4@^;8ED"'@.#-)N'57?R-8'B0O!3XXH]/!V M?`0O($@`6H35*:^8/L7-Q^F4@WRR?&PAQ.K].O+C?\'G7%I1_5N`M]@:;JE. MJ[Q\V>[]JIV-^#%#EVC@4`XBSUOYH%4W/IUY\&*.P0U^/L>[/"@I])EN'[(N M9KR#Z">4.`;5&IJFMW3<"CVQ^#T&Q($R^/4^`^*BIF=28^3>:")![A4N#@F3 M=AL2+Y>[\E_TMPMK`#/\I6?X+99GE<08?GNS'HUJ,*NY..J,U8W/XXYHBF.' M[XI_T**361<1V(1!_$L4)EO^S(Q69A5!O/N5>M4B^3*O-3F/'N%J'>_S"3Y$D-2D MW!>BS/^*>(FZFHTU&*Z+I*PD43],7Z:.[P/O=C3SA;$$MAY&0_/TWD;IP>;NYLN#$L-*7`BZF^?M+L"W#7Z5 M/^)U\Q2G]UKQ)%?B3CB`>?[JY6J%W)2:=^2+4RE\$UZ"+&_LK>."V8:H+]F> M.-)>]OKA<&C];_QET)WC`2R:N(*46\QVG5!P'SI!X1W-2V15;V0FFR(62_/B M6T*!A]'05$F_?9G[STZ<7\B/8)MG8R:ZZKQH^5WPO\");N$+U[>JT5BGP768 M\#]DD[%.@NL%GKVSCYT--H2RE5.IS2GWIY'9^P&E3"(U_[NR?&=:$>$ MV47XVQJZZYO-U@]W`*!9!%*KB\_.H*;5W\1J>XA"%P`/$0\#A5*TW.93GLA3 MS!-IA4^U13ZC^/""+BD_XJ`U26J(_W.#3\07QR=GG31=O<8`1KQ*R2E("GT$ MWF_XN.<6FSMLUHTO*+.@9UE/,8NSJJ#YA81EPC!9K>NU0V_ADE0(%3B5]C15 M1S@$,(R8)%8IO"$ZPIQ`$:_-AS.R!JL&B9JCP.%:Y#4?`.W"NX7==@!4RZ(5 MN,T'0+O0S9W5=`@TBQ^5O-8#H5PHEO#;&ZTLQK5J$N:E_71MKN#R#3Q--Z@ MS4UE>T94#11[DGL*A,_M]/\5:>:J6:G8VC#;][%8"UA%J&YWH*MG2M!E]SII MFI+*TJ"R9NG*SNT/5>&?'QQ?+;I4[(\7XUSN;/,W736C"C&97+#Y7JX2K4_T?8P MP^:XB7Q>;0\UU$&MJ3>3[0GZ>\4P\X.S/8M$OQ"F#I2V)W;1@5#')F][QGYE M*:5O7S+;L_NW?H'(0$:52*T1CIL'8-E>ST!91`981#6IXC7V*5UUR?;:R^H M7Q9:+K:V5P65>Q@\.7$XZ9+V48&`F\C`2^D6.[\(6^1AP?:6H2MSOS M3FHV6X2W,'`"HE])C1NIKN\R07AK(70-D!O!E&;\&+ET$$S5@)2X!2;FT@_= MKP:+P)`R1Z$/7?)B$KN+"SJ8<&%N@#*;KP8#F=RC\N]6<>AI@-+QO`Z&NH.? MX"J`2^@Z6(:HP3WMVC:!!VK(LGE1['PZNU,5C6E'JB&U_\6T,QO MY^[1'L90P@F`I4AR@%Z#%^"'6T+@S>N6Y,<7'LLJ/0V677L$;HA%,W)@J7TN M>3\3W/R*P'QY@V*XP1(G+X+[H-'IO#-493O;XPWT4#M<$[8'$.BAHRA7VQY/ MT`5HJF*[[06--+$4B?^V!Q:H0:7_)K$]M$!OB?&E:]O#!_1PDKT+;8\4T$-+ M07*V/2Y`%S"%QY/M(0%ZD$DU'+8[]NO!I:^*:.75/R*33.J--!ED6E2&QR); M182;+XGD=KDC_W^+B0LCJ=VTP4BGLW<;X3195&\=&/W5\1-`2XB9=6U@$239 ML<(N)O:L&%1U)H:Q#U6^2'DG2KB?]IP0(',WI0T[CU:7+$B;(01B$@=V#YUG MZ*<1V9^!0VCUYL$C21D3X3LF58ZGX*O>H]W,<4H[NV-TIY.@T"S1#V#T\F70 M(SD!1#V,6L)9B"JS,(SMJ?`UF&I*)NO39A/A8^[6/?TM1V^%@K*K+$.'YG4J MZ7Y"6U$=DFE;YL_\?>XY_,\H`65Q`@L7\W@-HM*OZ%?8PSH`;_RN.!"JI;J: MQ$CIJXQT0FE*ON/+WA>B'B:/`P5.RL=!UPMD.C2Z1=3<[=_3EC!R^]<_@N;] M+QW`+'\/4>@E;IRG)]KMR=QI4&/G#9""31D1G)YD3ATYU/]%CO)IZ1A[+ M+.]HGA]-`8?1Q2P/-Z_$B2"!:)WF<<\(5&9'W/LTSD#Q][1=)FN"DV3-V!X$ MTG1IL8^^XT5_#/:F+;`D[DD;XK*:!2QD2=RN0A2CU$/STD$DI]ON`$(3=[$J MR<]EDF5W=KM!CT(LD?3Q/_X_4$L#!!0````(`"M*:D?-DK4#ZQ$```_! M```1`!P`;6)I:2TR,#$U,#8S,"YX31++Q(Z\#QV7/N?CF@ M)=HF*I,N227Q_?67I%Z41-&2'ZU\H0]M9'%F.,,94C/#UZ=_O*P"\(08QY1< M]H9G;WH`$8_ZF"PN>[\]]J\>;T:CWC]^_>M?/OU7OP\F$W!+"4%!@#;@#P\% MB$&!P!2^4$)7&_#H+=$*O@8SR)$/*`%_7$_NP=NS(0!+(=87@\'S\_,98WY" MY,RCJP'H]Y,*_AVQ<@$^G+U]>_;.*)G0D/@7X!?CU0U#4$AHX$LF+L#;-\/W M_>&P/WPS'9Y?G'^\.'_['Q.:KC<,+Y8"O/+^)H'?O.]+C',P.9N<&5+]-WBD MA$OHU1J2#;@*`C!16!Q,$$?L"?EG,5&NA06R!0F_[!GR/9^?4;88R"J&@S^^ MW$>-TOOK7T`$>_$R8P'.8:@W"<[Y`!,N(/&0@1)@\LV!H8I5FYN5E%!BMH8? M/WX0 M,4K0#%-,"'W26N7:-A3^FP_G;PQL(G45KNRMX0LV4!4/)%!?0B&&/1-U.UX) M1\'X(D4S&_[]("HTH#UIIH)M\N`<>6<+^C2("Y50YZ5&\4+&9-^K0HU+%>Z[ M$JZ/L!U-%M@QT(NWM*.H$KO:,'E"7-BQHC*[9`1BC]O1=)'"&I:P./;L.+*@ M`D.L606*+"GB",@62'R%*\37T$.[V*,<_U:(B#O*5K=H#L-`-L[W$`9XCI'? M`U`(AF>A0#F`D&0@ORHJGZ"L0^@Z]&_U9KW&9$[CG_*%ZJX7C`9H*HT4J(?? M)J.:+(MX=!XHM,$M]4+%-"3^9R*PV(QD16REX7L`^Y<])T3*4L*4C^:88,W\ M\,T0]$&";CY*4B"B!0QBGP9%"D7BH?R,C,FO^MF#@1<&&O%>_HZ18P@7XIK) M@9N('3`SSJKQXK>);HZALD?)NS:T\?P.$_EEP#!XH%PS=A-`SF-[4\J;2(0_ M:R*X=7DN%9@2`NK[27Q$U'==/G$:8/75]<$U#-2W"CPN$1*\4^DA5?H`Y9@O MEDA@V5*-]:NQMRCYW2Y*!J]RC/VM4WICI8^DD[U"=I7&96[%O:^GN!2$`SH' MX[7RUQ5WGU6 M\R^[J#E7#;BGO.NSS=5[`_GR+J#/?$1\S)`G['HM@[D5^O>=%"HK`;J63I'[ M*[+&.&S'V:+:C_NIMAN2=U/U5RH0G]+4F\W:]SKDF"#.;Q'W&%XK`E?$OX8< M\_'\P9![BE[$=4"];X8U')2LTW"&;U2\B[D74!XRI*PH7$GI-\H^DLI>ZT#X M'G\/L2]CXQK`7<0LW_#($19LS=4O)N"6]]OB_I6Q("F!KX@J%[J.CH][ZOG M$7F2?RC;9,W=3,U.`FXMGQ>UG-#J>O`!-!L/B_P!;N`L0/(G"Y%_C^$,!Y)O MQ.5W60=>QJM,&S=Z7D0TLX4#5^FVGG=%ZXFK`P;QSHKVM:);-!.[#@U5N&Z] MOB_J59'I%+FW(M,FE1$<7:UE\*6I3%"@(J\;RJ6OMI1!UK5:8R![L,9JJ/`] MZW`;QH>2$ZA(]34M\!#`+ONZOY5(K:VPB`9S(A6FW6I$O-Q`W_LX=][2'NN0^0B MF<'>^8!PQM'W4#Y^?FK^6:C&=JOX8SGUDQ`"$:5.LS\FTY.\.&#&)R7IM(&W MY?2?._,#7B5/78[X!QG'5,5ZAS2-F*#;,)JF!,&KB&QG%L?-#3:PACITW$90 M-T_8*?^')`P;Z+X&&;?J7=D_TQGY*]_7O,*@O"I^'PIN%9<3AEN7#JA. MG]9DKJD'KVZ1@+A;>;*#9;B<_GJ6T9R"VS)*:<1MP4-G%C_6+-3>/C\,]#P" M\:3$T=)<^9,AJ8<)YM\>$%,%<($:F4LSRFXS*N4@MYM14GVT%-5@0+_0+`#% M`\B8Z&RL!39F61=Y_&K2LE6)5WD1U,S$+M860R5\`"@,)&E M&::,`,U)9VP[&YN1#LE&(./E5R2*-E0'Q6T:I:2LF93)#S]&R6L@*7>J/H2J M:[G36^'=2BXE7?-*[ASE`ZNWG/K*>F>YK*CLAMANU9>2KK8,6;Z?6W-HG2T< MP19NEI`L$!^1&.AW25VZ@AN][*J)6;@)N2VD5@ZUX(A&U0%,4N"D1J"K[.QE M9WM12I7T1`L$&X-VQ.G>95&N=1.:P?3FC/\W`;NUF(`-8A)^0GP;7?#S7$UAJH2HECX)Z MW^*O&Q]Q+C]V:E%LUI+C^72)_@DQ&9//+RI]$V*^C/;=5HW>/[1^M]V5$J*Q MW>58!`F/KXW@7^_WU8R^!A&K0/.:N`(<1-Q&BWPS?A6:')*`8EDE$/),=]^B MPXQ5GL!/6&SB);93^JC2-,A_8'2%.:=LHS1G';SJ8;JMJI3H3$:SF'BZ]%=0 M$-,'607:JCH#^`$&L-5)V86,TS3>E7*1NYA&Y]<<:KHEV]NCMN/4F]NM@^,V M@O)2T.+&H,[U.;RR'?MZ:BF^,;[;"$I92>?.H,X@#F\057M[:EE#,V2W*92R ME-5;@SH[.,)7H+#=I^;BKSI(;KV70>8I?/=)UX,UHVO$5%)WD)!-")2P\T=K:Z,IM%_,54)AR=#\ MLJ<.M>XGQP/_*3'.7E9!`B*P4+68`:$BI);U!4%OT%[)\VJL(;A$L`A^FY(Y M$;D#.$-!39$EK$7D>T7A1*0M=O,:0DL4B]#FR5DVV3\-S*.MY:_\T=>?I.B4 M"4"LIW)7G)(/HH/X[ZFG"3E0U*]^@M=7K_K#M_WSX=D+]V,6FW"0M70S#A*\ MIAPX3]>OXD'7;SW.?X`"P5-:_8Q6\^:P'KM?JU5,S*\1HFJ6CZI9AA_VX60W M+G9CP7HI0%VK2!!4I>\;&T+Q=H8][$"]:6H&V^XW<+)CPTM^]#,B.S!BN2VA M'BA<&E%+082'/6P7^6%ZR_JU9X@Z:>*^N,;,#0#E[UD M+UPT<:)V*-V&Z$$.J#2^G4"Y$'\ZH2(72-^0<^&'T43,2*"5B@]Z`,ZX8#(D MONS-8:!='`VXULA3C9H@]0#!0:"H7_8$"]5'6D99TDT)5>D_&0W723U8TJ\4 M2*WS^/RBC@A"/-ZMEY?%"F"*L9)AJ8!LTTB,R$L12=$L.H#_LN?IQ<^'%&Y$ M!))>FQB3&RJ[FG0B)=E\IIN7):Z'M7\O:#5#S!2G6!*)$]VG=.'3%<36OA:Q!Y/GX]9=-G: M9^+?0H'2]SPM>$',PUQ5:K;&'D1R7QP)_O.^-N6E#_*[@J,*E""FP%M!VRR6 MY4`-IVQ6^),P[JK%+%/Z$#)O"3DR0.Y"XJNA"A,/KV%0W#A8T3@[4HR'/CGN MK:.W;3(0ETP':);6MH.QTTT.9X_A>AU@Q/36.QI@;U,XSRP6O0%6[H,GDO<_ M4>3(89XHBJ9,N==M4E'(!5TA=E5R0$HEK?(M8N:N*]F^;C/;-Y5LW[29[=M* MMF_;S';9N2Z5M(GMY'`5E5-X8&B%PY7!NK7T>&&ICV8'L7L"9\B\;2*HZC#W?JM%RME.YJ2%J!=PI^8EZD&T4_2-8Y&_F58BZF M&=I))&,*(M$G1&3;_T94KHEA3YW.+>/=^#[*"?H>XF@7=W6K-"!Q-%,YUK!0 M;S`XE2%@2J]1U(GOH(>V]'L[\*ET]G24*GUKK:5M^]Y.Z122A1Y;D/B=,K$L M>O!.J%99X!S)6$.?^:\N_J)^Z(D)DF-&6!AJG7`G,7(X))A28V$CMLUT[(9^ M0NT2RY*$GCEY+.W@!C^-<2@G2:S2:LU7P)V$J'$$D&[H4%\.58N^_Z.8.2J/ MR3NAMVK0+DI@GT5Q@[5*(.I%[C_Q/Q.)NS$6R5[%K)B"U0(W35GYBF3QT^2+ MIRAD;\.>,8-QQ3-/+F=\AJS-45OT/YIGD5UE=M>0NBGB241#AE`-V^"8 MDO^``3LGB65NT]+%ZZ.TJ)L;3.NA5HY/=;1;!7MJ1IWP+W5$F2]UQ!-G(SY% MF2R4OVEOA-K(IY#N2^5*I#(3ES;Y[7`GX&^/B+0ER-$MBOZ.2-T8K#'F272' M:JEB02I#D<:8)]D>IM?RP-`ZNHWO#B%'2SAP6N3KC-2.&!AKXZW*>:$ZHVSGX=)?V.'$+0--K6?D]RTT;F_EB\P08X+7('_Z76 M<8^@CU:0>;1DDO;B-MGDOT*"C%685]E"S.C4YCOHJ^QIY:W7RT82BXTB?R,Y&I!6N MKBEC]%F%&W`M2\0FGVHI[W?(-=,AR;;(N;$)EG/%K!.7C;#:)"V%)%U>7UBK M:RG+^4$_=7&N8HY/J0XI]>S<%TR4\=FU4P.X54HA"^5^ZHGC8C;%5G@2`U&I MS=50\#W$'$<+/ZX107.L+J!*7;PD'Z9R)-$!$^J4O#D,@_BXO&Q:W6BA8U?4 M'@?S"R5B&6P>I;;81AHVFM+?E]A;?EZM`[I!B%\QI*<-@IP)-4-K4NFML^HXY86H?3%QG-IS>A1;:,L^6S;`-OD MK7T-%4_C>1S.1?-=^J@Q_D@#TX"W0N9"(_W^YQGMV!-4%(QW9Y[ MQPY.N4W64"7LW0PTBK6H,/72IFW:@9!RJBVWU M.#8FY3&O!NPIB"9U5ELT`[95HJWU7"99Z#1J&E(7X@PGE#F2+_X'0::=EY\X MFN>850X$DM_VK5*5`=LFV(/D2N_&U`<"&((4"T[!/ZI8,2*[C_+Q1R3.\3^$ MLP![^JU4E"GS;OCMB0PJ!$CV%,HP)W9XMPMMPVFGH,ELVHA,,HNM$+`"MD7! MCLEM.B_JT07!_ZL.(WQ$03!=2E*+I7%A74G.6IAMDCI-FD6!=YQ3-$4:AT+9 MCZ_N@*S<;+,GG5:VR#;F59K+V@3U$%LE,UZI3%VN]V;O6L1IQ;FZ280:CZ-I M:'J]J9C@W)/.G@'O(4?D">+2F_&6MW+D">@Z7KU:Z5[4`S\%I\.$HA[#*_C M=&-\$[J:(E`LF\+71VG19.\6IJ>%F:)ZX#]8/E]<+#=J\`AGNH4K)+4E"Y(3 MI-10="7TJ/00A%R&8/$P&W];;=.EFT?\4@KJCEI+F$!>^XE+VF4GLC+6$YB MW.&YRF;5:\I#U-"N9B28LAI6\UD=&A0+:FFJ/:BTJCEY+>B/5C?A6B4?9MVBE&A;)G6J1)(6"O0/0@V]0^32(3D.6 MC_\'4$L!`AX#%`````@`*TIJ1P`MA72HW0``,:X'`!$`&````````0```*2! M`````&UB:6DM,C`Q-3`V,S`N>&UL550%``-R_$%6=7@+``$$)0X```0Y`0`` M4$L!`AX#%`````@`*TIJ1[Q[$@0B$0``\?```!4`&````````0```*2!\]T` M`&UB:6DM,C`Q-3`V,S!?8V%L+GAM;%54!0`#`Q0````(`"M*:D`L``00E#@``!#D! M``!02P$"'@,4````"``K2FI'\JQAVHAZ``"O_P4`%0`8```````!````I(&` M&`$`;6)I:2TR,#$U,#8S,%]L86(N>&UL550%``-R_$%6=7@+``$$)0X```0Y M`0``4$L!`AX#%`````@`*TIJ1R#X7Q47.P``C&<$`!4`&````````0```*2! M5Y,!`&UB:6DM,C`Q-3`V,S!?<')E+GAM;%54!0`#`Q0````(`"M*:D?-DK4#ZQ$```_!```1`!@```````$```"D M@;W.`0!M8FEI+3(P,34P-C,P+GAS9%54!0`# XML 16 R25.htm IDEA: XBRL DOCUMENT v3.3.0.814

Summary of Business, and Liquidity - Additional Information (Detail) - USD ($)
1 Months Ended 6 Months Ended

Aug. 31, 2015

Jun. 30, 2015

Dec. 31, 2014

Jun. 30, 2014

Dec. 31, 2013

Schedule Of Description Of Business [Line Items]

Date of incorporation Jun. 15, 2006

Accumulated deficit $ (182,747,000) $ (159,848,000)

Debt $ 22,238,000 22,303,000

Debt agreements financial and non-financial covenants As of June 30, 2015, the Company had debt totaling $22,238,000 for which the underlying debt agreements contain various financial and non-financial covenants, as well as certain material adverse change clauses. If the Company breaches any of the covenants contained within the debt agreements or if the material adverse change clauses are triggered, the entire unpaid principal and interest balance would be due and payable upon demand. The Company believes that currently available resources combined with the additional $40,000,000 in proceeds raised from the issuance of senior secured promissory notes in August 2015 (see Note 10) will be sufficient to fund the Company’s cash requirements through at least June 30, 2016.

Working capital $ 2,478,000

Cash and cash equivalents $ 12,196,000 $ 35,324,000 $ 57,630,000 $ 24,455,000

Subsequent Event [Member]

Schedule Of Description Of Business [Line Items]

Proceeds raised from issuance of senior secured promissory notes $ 40,000,000

X

- Definition
Date when an entity was incorporated
+ References
No definition available.
+ Details

Name: dei_EntityIncorporationDateOfIncorporation

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
Schedule Of Description Of Business [Line Items]
+ References
No definition available.
+ Details

Name: mbii_ScheduleOfDescriptionOfBusinessLineItems

Namespace Prefix: mbii_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The Company's working capital as of the end of the period calculated as current assets minus current liabilities.
+ References
No definition available.
+ Details

Name: mbii_WorkingCapital

Namespace Prefix: mbii_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3044-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Description of minimum financial levels (for example, tangible net worth and working capital) and achievement of certain financial ratios (for example, working capital ratio and debt service coverage ratio), and adherence to certain clauses which generally require or restrict certain actions (for example, entering into a debt arrangement with equal or greater seniority, and selling or discontinuing a certain business segment or material subsidiary) to be in compliance with the covenant clauses of the debt agreement. May also include a discussion of the adverse consequences that would result if the entity violates or fails to satisfy the covenants.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 470

-Section 50

-Paragraph 3

-Subparagraph (g)

-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 22

-Article 5

+ Details

Name: us-gaap_DebtInstrumentCovenantDescription

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Carrying amount of long-term debt, net of unamortized discount or premium, including current and noncurrent amounts. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20, 22

-Article 5

+ Details

Name: us-gaap_LongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The cash inflow from a borrowing supported by a written promise to pay an obligation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_ProceedsFromNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.31(a)(3))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 17 R42.htm IDEA: XBRL DOCUMENT v3.3.0.814

Related Party Transactions - Additional Information (Detail) - USD ($)
3 Months Ended 6 Months Ended

Jun. 30, 2015

Jun. 30, 2014

Jun. 30, 2015

Jun. 30, 2014

Dec. 31, 2014

Related Party Transaction [Line Items]

Revenue recognized on sell-through basis relating to product purchased $ 183,000 $ 206,000 $ 382,000 $ 811,000

Deferred cost of product revenues to related parties 138,000 138,000 $ 333,000

Current deferred product revenues from related parties 278,000 278,000 660,000

Recognized license revenues 83,000 51,000 166,000 96,000

Syngenta Ventures [Member]

Related Party Transaction [Line Items]

Revenue recognized on sell-through basis relating to product purchased $ 8,000 $ 332,000

Affiliate revenues percent 5.00% 5.00%

Common shares sold 600,000

Recognized license revenues $ 8,000 $ 332,000

Tremont Group, Inc. [Member]

Related Party Transaction [Line Items]

Revenue recognized on sell-through basis relating to product purchased 183,000 $ 201,000 382,000 $ 478,000

Outstanding accounts receivable due 0 0 0

Deferred cost of product revenues to related parties 138,000 138,000 333,000

Current deferred product revenues from related parties $ 278,000 $ 278,000 $ 660,000

X

- Definition
Amount of cost of goods produced and sold to related parties that have been deferred as of balance sheet date for which revenue has not yet been recognized. Generally, an entity records deferred revenue and deferred cost of goods sold when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.
+ References
No definition available.
+ Details

Name: mbii_DeferredCostOfProductRevenuesToRelatedPartiesCurrent

Namespace Prefix: mbii_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The carrying amount of consideration received or receivable from related parties as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year including sales, license fees and royalties.
+ References
No definition available.
+ Details

Name: mbii_DeferredRevenueCurrentRelatedParties

Namespace Prefix: mbii_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The percentage of ownership in the entity's stock for consideration of a related party, where one party can exercise control or significant influence over another party.
+ References
No definition available.
+ Details

Name: mbii_InvestmentOwnershipPercentageRelatedParty

Namespace Prefix: mbii_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of shares of common stock sold by a related party during the period.
+ References
No definition available.
+ Details

Name: mbii_NumberOfRelatedEntitySharesSold

Namespace Prefix: mbii_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
For an unclassified balance sheet, amount of receivables arising from transactions with related parties.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k)(1))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.(a),3)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3

-Subparagraph a

-Article 5

+ Details

Name: us-gaap_AccountsReceivableRelatedParties

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Revenue earned during the period relating to consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(e))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_LicensesRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_RelatedPartyTransactionLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(e))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Related Parties

-URI http://asc.fasb.org/extlink&oid=16382449

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 946

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.6-07.1(c))

-URI http://asc.fasb.org/extlink&oid=6488393&loc=d3e606610-122999

+ Details

Name: us-gaap_RevenueFromRelatedParties

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mbii_SyngentaMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionAxis=mbii_TremontGroupMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 18 R37.htm IDEA: XBRL DOCUMENT v3.3.0.814

Debt - Consideration Received, Fair Values of Notes, Common Stock Warrants Issued and Calculation of the Gain on Extinguishment of Debt (Detail) - USD ($)
1 Months Ended

Apr. 10, 2013

Apr. 30, 2013

Consideration received

Total consideration received $ 3,860,000

Notes and warrants issued

Total fair value of notes and warrants issued 3,811,000

Gain on extinguishment of debt 49,000

Secured Debt [Member] | October 2012 subordinated convertible note [Member]

Consideration received

Fair value of notes $ 1,360,000 1,360,000

Notes and warrants issued

Fair value of notes 1,360,000 1,360,000

Secured Debt [Member] | April 2013 secured promissory note [Member]

Consideration received

Fair value of notes 3,459,000

Cash 2,500,000

Notes and warrants issued

Principal balance of notes issued 3,750,000

Debt discount (291,000)

Fair value of notes 3,459,000

Fair value of Additional Common Stock Warrants issued $ 352,000 $ 352,000

X

- Definition
Total amount of cash and non cash consideration received for debt issued.
+ References
No definition available.
+ Details

Name: mbii_CashAndNoncashConsiderationReceived

Namespace Prefix: mbii_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of debt (discount) premium related to debt issued.
+ References
No definition available.
+ Details

Name: mbii_DebtDiscountPremium

Namespace Prefix: mbii_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The estimated fair value of common stock warrants issued on date of issuance.
+ References
No definition available.
+ Details

Name: mbii_FairValueOfAdditionalCommonStockWarrantsIssued

Namespace Prefix: mbii_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Fair Value Of Consideration Received [Abstract]
+ References
No definition available.
+ Details

Name: mbii_FairValueOfConsiderationReceivedAbstract

Namespace Prefix: mbii_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The fair value of notes and warrants on issue date.
+ References
No definition available.
+ Details

Name: mbii_FairValueOfNotesAndWarrantsIssued

Namespace Prefix: mbii_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Issuance Of Notes Payable And Warrants [Abstract]
+ References
No definition available.
+ Details

Name: mbii_IssuanceOfNotesPayableAndWarrantsAbstract

Namespace Prefix: mbii_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_Cash

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of long-term debt before deduction of unamortized discount or premium. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt, with initial maturities beyond one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 16

-Article 9

+ Details

Name: us-gaap_DebtInstrumentCarryingAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 10

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13433-108611

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13476-108611

+ Details

Name: us-gaap_DebtInstrumentFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=49170532&loc=d3e12317-112629

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=49170532&loc=d3e12355-112629

+ Details

Name: us-gaap_GainsLossesOnExtinguishmentOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=mbii_OctoberTwoThousandTwelveSubordinatedConvertibleNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=mbii_AprilTwoThousandThirteenSecuredPromissoryNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.3.0.814

Summary of Business, and Liquidity
6 Months Ended

Jun. 30, 2015

Accounting Policies [Abstract]

Summary of Business, and Liquidity

1. Summary of Business, and Liquidity

Marrone Bio Innovations, Inc. (“Company”), formerly Marrone Organic Innovations, Inc., was incorporated under the laws of the State of Delaware on June 15, 2006, and is located in Davis, California. In July 2012, the Company formed a wholly-owned subsidiary, Marrone Michigan Manufacturing LLC (“MMM LLC”), which holds the assets of a manufacturing plant the Company purchased in July 2012. The Company makes bio-based pest management and plant health products. The Company targets the major markets that use conventional chemical pesticides, including certain agricultural and water markets where its bio-based products are used as alternatives for, or mixed with, conventional chemical pesticides. The Company also targets new markets for which there are no available conventional chemical pesticides, the use of conventional chemical pesticides may not be desirable or permissible because of health and environmental concerns (including for organically certified crops) or because the development of pest resistance has reduced the efficacy of conventional chemical pesticides. The Company delivers EPA-approved and registered biopesticide products and other bio-based products that address the global demand for effective, safe and environmentally responsible products.

The Company is an early stage company with a limited operating history and has a limited number of commercialized products. As of June 30, 2015, the Company had an accumulated deficit of $182,747,000, has incurred significant losses since inception and expects to continue to incur losses for the foreseeable future. Until the completion of the initial public offering (“IPO”) in August 2013, the Company had funded operations primarily with net proceeds from the private placements of convertible preferred stock, convertible notes, promissory notes and term loans, as well as with the proceeds from the sale of its products and payments under strategic collaboration agreements and government grants. The Company will need to generate significant revenue growth to achieve and maintain profitability. As of June 30, 2015, the Company had working capital of $2,478,000, including cash and cash equivalents of $12,196,000. In addition, as of June 30, 2015, the Company had debt totaling $22,238,000 for which the underlying debt agreements contain various financial and non-financial covenants, as well as certain material adverse change clauses. If the Company breaches any of the covenants contained within the debt agreements or if the material adverse change clauses are triggered, the entire unpaid principal and interest balance would be due and payable upon demand. The Company believes that currently available resources combined with the additional $40,000,000 in proceeds raised from the issuance of senior secured promissory notes in August 2015 (see Note 10) will be sufficient to fund the Company’s cash requirements through at least June 30, 2016.

The Company participates in a heavily regulated and highly competitive crop protection industry and believes that adverse changes in any of the following areas could have a material effect on the Company’s future financial position, results of operations or cash flows: inability to obtain regulatory approvals, increased competition in the pesticide market, market acceptance of the Company’s products, weather and other seasonal factors beyond the Company’s control, litigation or claims against the Company related to intellectual property, patents, products or governmental regulation, and the Company’s ability to support increased growth.

Although the Company recognizes that it will likely need to raise additional funds in the future, there can be no assurance that such efforts will be successful or that, in the event that they are successful, the terms and conditions of such financing will not be unfavorable. Any future equity financing may result in dilution to existing shareholders and any debt financing may include additional restrictive covenants. Any failure to obtain additional financing or not to achieve the revenue growth necessary to fund the Company with cash flows from operations will have a material adverse effect upon the Company and will likely result in a substantial reduction in the scope of the Company’s operations and impact the Company’s ability to achieve its planned business objectives. In addition, any future breach of covenants included in the Company’s debt agreements which could result in the lender demanding payment of the unpaid principal and interest balances will have a material adverse effect upon the Company and would likely require the Company to seek to renegotiate these debt arrangements with the lenders. If such negotiations are unsuccessful, the Company may be required to seek protection from creditors through bankruptcy proceedings.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).
+ References
No definition available.
+ Details

Name: us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 20 R43.htm IDEA: XBRL DOCUMENT v3.3.0.814

Subsequent Events - Additional Information (Detail) - USD ($)
1 Months Ended 6 Months Ended

Aug. 31, 2015

Aug. 20, 2015

Sep. 30, 2015

Aug. 31, 2015

Jun. 30, 2015

Sep. 02, 2015

Dec. 31, 2014

Subsequent Event [Line Items]

Restricted cash and cash equivalents under covenants $ 1,560,000 $ 1,560,000

Warrants exercise price $ 8.40

Entities Affiliated with Waddell & Reed Financial, Inc. [Member] | Senior Secured Promissory Note Bearing Interest Rate at 8% [Member]

Subsequent Event [Line Items]

Debt instrument, frequency of periodic payment of interest Semi-annually

Subsequent Event [Member]

Subsequent Event [Line Items]

Consideration received under purchase agreement $ 40,000,000

Warrants exercise price $ 1.91

Warrants exercisable date Aug. 20, 2023 Oct. 02, 2017

Loan agreement amendment date Aug. 19, 2015

Subsequent Event [Member] | Entities Affiliated with Waddell & Reed Financial, Inc. [Member]

Subsequent Event [Line Items]

Consideration received under purchase agreement $ 40,000,000

Ownership percentage 5.00%

Subsequent Event [Member] | Entities Affiliated with Waddell & Reed Financial, Inc. [Member] | Senior Secured Promissory Note Bearing Interest Rate at 8% [Member]

Subsequent Event [Line Items]

Debt instrument to be issued, principal amount $ 40,000,000

Debt instrument, interest rate 8.00%

Debt instrument principal amount, payable three years $ 10,000,000

Debt instrument principal amount, payable four years 10,000,000

Debt instrument principal amount, payable five years $ 20,000,000

Minimum percentage of acquisition of beneficial ownership considered as event of default 40.00%

Subsequent Event [Member] | James Iademarco [Member]

Subsequent Event [Line Items]

One-twelfth of prior base salary $ 290,000

Salary rate entitlement 8.3333%

Subsequent Event [Member] | Loan [Member] | October 2012 and April 2013 Secured Promissory Notes [Member]

Subsequent Event [Line Items]

Debt instrument, interest rate 12.00% 12.00% 18.00%

Maximum [Member] | Subsequent Event [Member] | Entities Affiliated with Waddell & Reed Financial, Inc. [Member]

Subsequent Event [Line Items]

Number of common shares to be purchased from warrants 4,000,000

Minimum [Member] | Subsequent Event [Member] | Entities Affiliated with Waddell & Reed Financial, Inc. [Member] | Senior Secured Promissory Note Bearing Interest Rate at 8% [Member]

Subsequent Event [Line Items]

Restricted cash and cash equivalents under covenants $ 15,000,000

X

- Definition
Class of warrant or rights end date of warrants or rights exercisable.
+ References
No definition available.
+ Details

Name: mbii_ClassOfWarrantOrRightsEndDateOfWarrantsOrRightsExercisable

Namespace Prefix: mbii_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
Debt instrument to be issued face amount.
+ References
No definition available.
+ Details

Name: mbii_DebtInstrumentToBeIssuedFaceAmount

Namespace Prefix: mbii_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The percentage of ownership in the entity's stock for consideration of a related party, where one party can exercise control or significant influence over another party.
+ References
No definition available.
+ Details

Name: mbii_InvestmentOwnershipPercentageRelatedParty

Namespace Prefix: mbii_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Loan amendment date.
+ References
No definition available.
+ Details

Name: mbii_LoanAmendmentDate

Namespace Prefix: mbii_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
Minimum percentage of acquisition of beneficial ownership considered as events of default of debt instrument.
+ References
No definition available.
+ Details

Name: mbii_MinimumPercentageOfAcquisitionOfBeneficialOwnershipConsideredAsEventsOfDefaultOfDebtInstrument

Namespace Prefix: mbii_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
The monthly rate as a percentage of annual salary that an employee is entitled to receive.
+ References
No definition available.
+ Details

Name: mbii_MonthlySalaryRateToWhichEmployeesAreEntitled

Namespace Prefix: mbii_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Exercise price per share or per unit of warrants or rights outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(i)(4))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name: us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(i)(2))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name: us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Description of the frequency of periodic payments (monthly, quarterly, annual).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 470

-Section 50

-Paragraph 3

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentFrequencyOfPeriodicPayment

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Contractual interest rate for funds borrowed, under the debt agreement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentInterestRateStatedPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 3

-Subparagraph (SX 210.12-04.(a))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690

+ Details

Name: us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 3

-Subparagraph (SX 210.12-04.(a))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601

+ Details

Name: us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 3

-Subparagraph (SX 210.12-04.(a))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690

+ Details

Name: us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The cash inflow from a borrowing supported by a written promise to pay an obligation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_ProceedsFromNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Cash and equivalents whose use in whole or in part is restricted for the long-term, generally by contractual agreements or regulatory requirements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_RestrictedCashAndCashEquivalentsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Expenditures for salaries other than officers. Does not include allocated share-based compensation, pension and post-retirement benefit expense or other labor-related non-salary expense. For commercial and industrial companies, excludes any direct and overhead labor that is included in cost of goods sold.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_SalariesAndWages

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.
+ References
No definition available.
+ Details

Name: us-gaap_SubsequentEventLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_BeneficialOwnerMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=mbii_SeniorSecuredPromissoryNoteInterestRateAtEightPercentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mbii_JamesIademarcoMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=mbii_SecuredPromissoryNotesInterestRateAtTwelvePercentThroughOctoberTwoThousandFifteenMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 21 R29.htm IDEA: XBRL DOCUMENT v3.3.0.814

Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - Money market funds [Member] - USD ($)
$ in Thousands

Jun. 30, 2015

Dec. 31, 2014

Assets

Assets at fair value $ 3,749 $ 14,746

Level 1 [Member]

Assets

Assets at fair value 3,749 14,746

Level 2 [Member]

Assets

Assets at fair value 0 0

Level 3 [Member]

Assets

Assets at fair value $ 0 $ 0

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsFairValueDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
This element represents the aggregate of the assets reported on the balance sheet at period end measured at fair value on a recurring basis by the entity. This element is intended to be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements.
+ References
No definition available.
+ Details

Name: us-gaap_AssetsFairValueDisclosureRecurring

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 22 R28.htm IDEA: XBRL DOCUMENT v3.3.0.814

Significant Accounting Policies - Schedule of Concentration of Credit Risk Percentage (Parenthetical) (Detail)
6 Months Ended

Jun. 30, 2015

Maximum [Member] | Accounts receivable [Member] | Customer concentration risk [Member]

Concentration Risk [Line Items]

Customers accounted for percentage of company's total revenues and accounts receivable 1.00%

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ConcentrationRiskLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 18

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6351-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13531-108611

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6404-108592

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13537-108611

+ Details

Name: us-gaap_ConcentrationRiskPercentage1

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 23 R30.htm IDEA: XBRL DOCUMENT v3.3.0.814

Inventories - Schedule of Inventories, Net (Detail) - USD ($)
$ in Thousands

Jun. 30, 2015

Dec. 31, 2014

Inventory [Line Items]

Raw materials $ 5,708 $ 5,692

Work in progress 916 1,150

Finished goods 3,601 5,378

Inventories, total 10,607 12,644

Customers [Member]

Inventory [Line Items]

Finished goods $ 382 $ 424

X

- Definition
Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 5.BB)

-URI http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 5

-Section BB

+ Details

Name: us-gaap_InventoryFinishedGoodsNetOfReserves

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_InventoryLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 35

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=51655945&loc=d3e3927-108312

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

+ Details

Name: us-gaap_InventoryNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 5.BB)

-URI http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a)(4))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 5

-Section BB

+ Details

Name: us-gaap_InventoryRawMaterialsNetOfReserves

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a)(3))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 5.BB)

-URI http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 5

-Section BB

+ Details

Name: us-gaap_InventoryWorkInProcessNetOfReserves

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_TitleOfIndividualAxis=mbii_CustomersMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 24 R31.htm IDEA: XBRL DOCUMENT v3.3.0.814

Inventories - Additional Information (Detail) - USD ($)

Jun. 30, 2015

Dec. 31, 2014

Inventory Disclosure [Abstract]

Reserves against inventories $ 668,000 $ 668,000

X

- References
No definition available.
+ Details

Name: us-gaap_InventoryDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of valuation reserve for inventory.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 5.BB)

-URI http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 4

-Subparagraph (SX 210.12-09)

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24092-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 35

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=51655945&loc=d3e3927-108312

+ Details

Name: us-gaap_InventoryValuationReserves

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 25 R8.htm IDEA: XBRL DOCUMENT v3.3.0.814

Condensed Consolidated Statements of Cash Flows (Parenthetical) - USD ($)
$ in Thousands
6 Months Ended

Jun. 30, 2015

Jun. 30, 2014

Statement of Cash Flows [Abstract]

Cash paid for interest, net of capitalized interest $ 4 $ 648

X

- Definition
The amount of cash paid during the current period for interest that is capitalized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

+ Details

Name: us-gaap_InterestPaidCapitalized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_StatementOfCashFlowsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 26 R32.htm IDEA: XBRL DOCUMENT v3.3.0.814

Accrued Liabilities - Schedule of Accrued Liabilities (Detail) - USD ($)
$ in Thousands

Jun. 30, 2015

Dec. 31, 2014

Payables and Accruals [Abstract]

Accrued compensation $ 1,258 $ 1,348

Accrued expenses 4,915 4,771

Accrued warranty costs 323 202

Accrued liabilities, total $ 6,496 $ 6,321

X

- Definition
Carrying value as of the balance sheet date of obligations incurred through that date and payable arising from transactions not otherwise specified in the taxonomy. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
No definition available.
+ Details

Name: mbii_AccruedExpensesCurrent

Namespace Prefix: mbii_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_EmployeeRelatedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_PayablesAndAccrualsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 25

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=51667650&loc=d3e11281-110244

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=51674963&loc=d3e12524-110249

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_ProductWarrantyAccrualClassifiedCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 27 R40.htm IDEA: XBRL DOCUMENT v3.3.0.814

Share-Based Plans - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended

Jun. 30, 2015

Jun. 30, 2014

Jun. 30, 2015

Jun. 30, 2014

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock options outstanding 2,633,000 2,633,000

Share-based awards available for grant 2,142,000 2,142,000

Share-based compensation expense $ 1,095 $ 1,200 $ 2,185 $ 2,722

Number of options granted 0 0

Number of options exercised 0 0

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Gross number of share options (or share units) granted during the period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of options outstanding, including both vested and non-vested options.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(i)-(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of share options (or share units) exercised during the current period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28,29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 28 R2.htm IDEA: XBRL DOCUMENT v3.3.0.814

Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands

Jun. 30, 2015

Dec. 31, 2014

Current assets:

Cash and cash equivalents $ 12,196 $ 35,324

Restricted cash, current portion 1,856 1,856

Accounts receivable 2,951 1,787

Inventories, net 10,607 12,644

Deferred cost of product revenues, including deferred cost of product revenues to related parties of $138 and $333 as of June 30, 2015 and December 31, 2014, respectively 1,597 1,797

Prepaid expenses and other current assets 1,018 1,315

Total current assets 30,225 54,723

Property, plant and equipment, net 20,062 20,166

Restricted cash, less current portion 1,560 1,560

Other assets 695 733

Total assets 52,542 77,182

Current liabilities:

Accounts payable 3,202 5,841

Accrued liabilities 6,496 6,321

Deferred revenue, current portion 2,652 2,861

Deferred revenue from related parties 278 660

Customer refund liabilities 1,019 1,044

Capital lease obligations, current portion 1,351 1,839

Debt, current portion 12,749 12,636

Total current liabilities 27,747 31,202

Deferred revenue, less current portion 1,884 2,050

Capital lease obligations, less current portion 151 185

Debt, less current portion 9,489 9,667

Other liabilities 754 847

Total liabilities $ 40,025 $ 43,951

Commitments and contingencies (Note 8)

Stockholders' equity:

Common stock: $0.00001 par value; 250,000 shares authorized, 24,465 shares issued and outstanding as of June 30, 2015 and December 31, 2014 $ 0 $ 0

Additional paid in capital 195,264 193,079

Accumulated deficit (182,747) (159,848)

Total stockholders' equity 12,517 33,231

Total liabilities and stockholders' equity $ 52,542 $ 77,182

X

- Definition
Amount of cost of goods produced and sold that have been deferred as of balance sheet date for which revenue has not yet been recognized. Generally, an entity records deferred revenue and deferred cost of goods sold when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.
+ References
No definition available.
+ Details

Name: mbii_DeferredCostOfProductRevenues

Namespace Prefix: mbii_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The carrying amount of consideration received or receivable from related parties as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year including sales, license fees and royalties.
+ References
No definition available.
+ Details

Name: mbii_DeferredRevenueCurrentRelatedParties

Namespace Prefix: mbii_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccountsPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3-4)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3

-Subparagraph a(1)

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 4

-Article 5

+ Details

Name: us-gaap_AccountsReceivableNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.30(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.18)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 12

-Article 7

+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.9)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6801-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of capital lease obligation due within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6455398&loc=d3e45280-112737

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6455314&loc=d3e45023-112735

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Article 5

+ Details

Name: us-gaap_CapitalLeaseObligationsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6455398&loc=d3e45280-112737

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6455314&loc=d3e45023-112735

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CapitalLeaseObligationsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3044-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.(a),19)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.17)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CommitmentsAndContingencies

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Current regulatory liabilities generally represent obligations to make refunds to customers for various reasons including overpayment.
+ References
No definition available.
+ Details

Name: us-gaap_CustomerRefundLiabilityCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 8

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.A.4(a).Q1)

-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 13

-Section A

+ Details

Name: us-gaap_DeferredRevenueCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The noncurrent portion of deferred revenue amount as of balance sheet date. Deferred revenue is a liability related to a revenue producing activity for which revenue has not yet been recognized, and is not expected to be recognized in the next twelve months. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 8

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.A.4(a).Q1)

-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 13

-Section A

+ Details

Name: us-gaap_DeferredRevenueNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 35

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=51655945&loc=d3e3927-108312

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

+ Details

Name: us-gaap_InventoryNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19-26)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.32)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 25

-Article 7

+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.21)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of long-term debt, after unamortized discount or premium, scheduled to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LongTermDebtCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying amount of long-term debt, net of unamortized discount or premium, excluding amounts to be repaid within one year or the normal operating cycle, if longer (current maturities). Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LongTermDebtNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.17)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_OtherAssetsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Aggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.24)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_OtherLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 8

-Article 5

+ Details

Name: us-gaap_PrepaidExpenseAndOtherAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 13

-Subparagraph a

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 8

-Article 7

+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The carrying amounts of cash and cash equivalent items which are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. For a classified balance sheet represents the current portion only (the noncurrent portion has a separate concept); there is a separate and distinct element for unclassified presentations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Cash and equivalents whose use in whole or in part is restricted for the long-term, generally by contractual agreements or regulatory requirements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_RestrictedCashAndCashEquivalentsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.31(a)(3))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 29 R6.htm IDEA: XBRL DOCUMENT v3.3.0.814

Condensed Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended

Jun. 30, 2015

Jun. 30, 2014

Jun. 30, 2015

Jun. 30, 2014

Statement of Comprehensive Income [Abstract]

Net loss $ (10,985) $ (10,711) $ (22,899) $ (21,026)

Other comprehensive loss 0 0 0 0

Comprehensive loss $ (10,985) $ (10,711) $ (22,899) $ (21,026)

X

- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831223

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e557-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-Subparagraph (c)(3)

-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569616-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569643-111683

+ Details

Name: us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 30 R35.htm IDEA: XBRL DOCUMENT v3.3.0.814

Debt - Schedule of Debt (Parenthetical) (Detail) - Secured Debt [Member] - USD ($)
$ in Thousands
1 Months Ended 6 Months Ended

Jun. 30, 2014

Jun. 30, 2015

Dec. 31, 2014

April 2016 Term loan bearing interest at 7.00% [Member]

Debt Instrument [Line Items]

Debt instrument, interest rate 7.00% 7.00%

Debt instrument, payment terms Payable monthly through April 2016

October 2012 and April 2013 Secured Promissory Notes [Member]

Debt Instrument [Line Items]

Debt instrument, interest rate 12.00% 12.00%

Debt instrument, payment terms Payable monthly through October 2015

Unamortized debt discount $ 76 $ 203

June 2014 Secured Promissory Note [Member]

Debt Instrument [Line Items]

Debt instrument, prime rate 2.00% 2.00%

Debt instrument, interest rate 5.25%

Debt instrument, payment terms Payable monthly through June 2036

X

- Definition
Percentage points added to the reference rate to compute the variable rate on the debt instrument.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentBasisSpreadOnVariableRate1

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Contractual interest rate for funds borrowed, under the debt agreement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentInterestRateStatedPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Description of the payment terms of the debt instrument (for example, whether periodic payments include principal and frequency of payments) and discussion about any contingencies associated with the payment.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(a)(3))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 470

-Section 50

-Paragraph 3

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

+ Details

Name: us-gaap_DebtInstrumentPaymentTerms

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of debt discount that was originally recognized at the issuance of the instrument that has yet to be amortized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 55

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

+ Details

Name: us-gaap_DebtInstrumentUnamortizedDiscount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_DebtInstrumentAxis=mbii_TermLoanBearingInterestRateAtSevenPointZeroZeroPercentThroughAprilTwoThousandSixteenMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=mbii_SecuredPromissoryNotesInterestRateAtTwelvePercentThroughOctoberTwoThousandFifteenMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=mbii_SecuredPromissoryNoteInterestRateAtPrimePlusTwoPercentThroughJuneTwoThousandThirtySixMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 31 R22.htm IDEA: XBRL DOCUMENT v3.3.0.814

Inventories (Tables)
6 Months Ended

Jun. 30, 2015

Inventory Disclosure [Abstract]

Schedule of Inventories, Net

Inventories, net consist of the following (in thousands):

 JUNE 30,
2015 DECEMBER 31,
2014

Raw materials
 $ 5,708 $ 5,692

Work in progress
 916 1,150

Finished goods
 3,601 5,378

Finished goods held at customers
 382 424





 $ 10,607 $ 12,644





X

- References
No definition available.
+ Details

Name: us-gaap_InventoryDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 2

-Paragraph 6

-Subparagraph a,b,c

-Article 5

+ Details

Name: us-gaap_ScheduleOfInventoryCurrentTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 32 R36.htm IDEA: XBRL DOCUMENT v3.3.0.814

Debt - Additional Information (Detail) - USD ($)
1 Months Ended 6 Months Ended 12 Months Ended

Jun. 14, 2013

Apr. 10, 2013

Oct. 02, 2012

Aug. 31, 2015

Jun. 30, 2015

Jun. 30, 2014

Apr. 30, 2013

Oct. 31, 2011

Jun. 30, 2015

Jun. 30, 2014

Dec. 31, 2014

Aug. 20, 2015

Apr. 28, 2014

Apr. 14, 2014

Mar. 31, 2012

Debt Instrument [Line Items]

Agent fee percentage 5.00%

Additional credit facility financing-related costs and primarily legal fees $ 24,000 $ 304,000 $ 304,000

Exercise price of the Common Stock Warrants $ 8.40 $ 8.40

Accrued interest on promissory notes 74,000

Warrants exercise price percentage 70.00% 70.00%

Exercise price of warrants as percentage of common stock 70.00%

Common stock warrants issued to purchase common stock percentage 20.00%

Fair value of common stock warrants on issuance 465,000

Gain on extinguishment of debt $ 49,000

Funds borrowed $ 3,700,000 $ 3,700,000

Fair value of the Warrants at the date of issuance as deferred financing cost $ 435,000

Repayment of line of credit $ 4,687,000 0 $ 4,687,000

Required deposit balance $ 1,856,000 $ 1,856,000 $ 1,856,000

Prepay percentage of outstanding principal loan 20.00%

Prepayment fee percentage 10.00%

Exceed percentage of principal payment 20.00%

Decrease percentage of prepayment fee 1.00%

Loan term for repayment 10 years

Current ratio 125.00%

Debt to worth ratio 400.00%

Percentage of loan to value ratio 70.00%

Subsequent Event [Member]

Debt Instrument [Line Items]

Debt instrument borrowing amount $ 40,000,000

Exercise price of the Common Stock Warrants $ 1.91

Level 3 [Member]

Debt Instrument [Line Items]

Fair value of debt $ 22,348,000 $ 22,348,000 $ 22,587,000

Level 3 [Member] | Fixed rate debt [Member]

Debt Instrument [Line Items]

Estimated market rate of interest 11.25% 11.25%

Level 3 [Member] | Variable rate debt [Member]

Debt Instrument [Line Items]

Estimated market rate of interest 5.25% 5.25%

June 2013 credit facility [Member]

Debt Instrument [Line Items]

Line of credit facility maximum borrowing limit 7,000,000 $ 7,000,000

Additional credit facility financing-related costs and primarily legal fees 10,000 $ 10,000

Credit facility expiry date Jun. 30, 2014

Credit facility accrued interest 10.00%

Credit facility fee paid 2.00%

Revolving line of credit [Member]

Debt Instrument [Line Items]

Percentage of borrowings limited to qualifying accounts receivable 75.00%

Line of credit facility maximum borrowing limit $ 500,000 $ 5,000,000 $ 3,000,000

Maximum [Member] | June 2013 credit facility [Member]

Debt Instrument [Line Items]

Amount permit to draw $ 5,000,000 $ 5,000,000

Common stock warrants [Member]

Debt Instrument [Line Items]

Debt discount 113,000

June 2013 warrants [Member]

Debt Instrument [Line Items]

Value of common stock in a sale of the Company or a qualified initial public offering 70.00% 70.00%

Exercise price of the Common Stock Warrants $ 8.40 $ 8.40

Warrants expire date Jun. 14, 2023

June 2013 warrants [Member] | Common stock warrants [Member]

Debt Instrument [Line Items]

Common stock warrants issued to purchase common stock percentage 10.00%

Senior Secured Promissory Note Bearing Interest Rate at 8% [Member] | Subsequent Event [Member]

Debt Instrument [Line Items]

Debt instrument issued, principal amount $ 40,000,000

October 2012 and April 2013 Secured Promissory Notes [Member]

Debt Instrument [Line Items]

Debt instrument maturity date Oct. 02, 2017

October 2012 and April 2013 Secured Promissory Notes [Member] | Subsequent Event [Member]

Debt Instrument [Line Items]

Debt instrument, interest rate 18.00%

Term Loan Bearing Interest at 7.00% [Member]

Debt Instrument [Line Items]

Line of credit facility maximum borrowing limit $ 500,000

Debt instrument, interest rate 7.00%

Debt instrument maturity date Apr. 01, 2016

Secured Debt [Member]

Debt Instrument [Line Items]

Debt issued in partial consideration, cash 3,700,000

Secured Debt [Member] | October 2012 Secured Promissory Notes [Member]

Debt Instrument [Line Items]

Debt instrument borrowing amount $ 7,500,000

Debt instrument borrowing terms The October 2012 Secured Promissory Notes have an initial term of three years and can be extended for an additional two years in one year increments at the option of the Company. During the initial three-year term, the October 2012 Secured Promissory Notes bear interest at 12% per annum. If the term of the October 2012 Secured Promissory Notes is extended an additional year, the interest rate is 13% during the fourth year. If the term of the October 2012 Secured Promissory Notes is extended for an additional two years, the interest rate is 14% during the fifth year. Interest on the October 2012 Secured Promissory Notes is payable monthly through the initial maturity date of the loan, which is October 2, 2015, or through any extension period. The principal and all unpaid interest are due on the maturity date, as may be extended.

Agent fee percentage 5.00%

Additional fee percentage 1.00%

Unpaid Agent Fee $ 261,000 $ 261,000

Warrants issued to purchase common stock funded principal percentage 15.00%

Value of common stock in a sale of the Company or a qualified initial public offering 70.00% 70.00%

Fair value of Common Stock Warrants $ 282,000 $ 282,000

Exercise price of the Common Stock Warrants $ 8.40 $ 8.40

Covenant requirements minimum cash balance $ 5,000,000 $ 5,000,000

Amount borrowed under amended loan agreement 12,450,000

Secured Debt [Member] | October 2012 Secured Promissory Notes [Member] | Maximum [Member]

Debt Instrument [Line Items]

Additional debt cash balance $ 2,000,000 $ 2,000,000

Increase in amount available under loan agreement 5,000,000

Secured Debt [Member] | October 2012 Secured Promissory Notes [Member] | Debt instrument maturity period year three [Member]

Debt Instrument [Line Items]

Debt instrument, interest rate 12.00% 12.00%

Secured Debt [Member] | October 2012 Secured Promissory Notes [Member] | Extended fourth year [Member]

Debt Instrument [Line Items]

Debt instrument, interest rate 13.00% 13.00%

Secured Debt [Member] | October 2012 Secured Promissory Notes [Member] | Extended fifth year [Member]

Debt Instrument [Line Items]

Debt instrument, interest rate 14.00% 14.00%

Secured Debt [Member] | April 2013 secured promissory note [Member]

Debt Instrument [Line Items]

Unpaid Agent Fee $ 172,000 $ 172,000

Fees amount 603,000 603,000

Additional credit facility financing-related costs and primarily legal fees 66,000 66,000

Additional debt issued under amendment 4,950,000

Debt issued in cash consideration and in partial conversion for cancellation of principal balance 1,250,000

Convertible debt, fair value 3,459,000

Debt instrument, additional borrowings 2,500,000

Promissory notes issued 3,750,000

Fair value of Additional Common Stock Warrants issued 352,000 352,000

Funds borrowed $ 4,950,000 $ 4,950,000

Secured Debt [Member] | October 2012 subordinated convertible note [Member]

Debt Instrument [Line Items]

Convertible debt instrument, face value 1,250,000

Convertible debt, fair value $ 1,360,000 $ 1,360,000

Secured Debt [Member] | June 2014 Secured Promissory Note [Member]

Debt Instrument [Line Items]

Debt instrument, interest rate 5.25% 5.25%

Debt instrument maturity date Jun. 30, 2036

Debt instrument borrowing amount $ 10,000,000

Prime rate 3.25%

Debt instrument, prime rate 2.00% 2.00%

Debt instrument description Promissory note ("June 2014 Secured Promissory Note") with the bank ("Lender") which bears interest at prime rate (3.25% as of June 30, 2015) plus 2.00% per annum.

Maximum rate of interest 5.25%

Debt instrument monthly payment $ 64,390

Debt instrument date of payment Jul. 31, 2014

Required deposit balance $ 1,560,000 $ 1,560,000

X

- Definition
The amount of interest accrued on convertible promissory notes.
+ References
No definition available.
+ Details

Name: mbii_AccruedInterestOnConvertiblePromissoryNotes

Namespace Prefix: mbii_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The carrying balance of unpaid agent fees relating to debt.
+ References
No definition available.
+ Details

Name: mbii_AgentFeesUnpaid

Namespace Prefix: mbii_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The expiration date of common stock warrants.
+ References
No definition available.
+ Details

Name: mbii_CommonStockWarrantExpirationDate

Namespace Prefix: mbii_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The fair value amount of common stock warrants relating to debt issued recorded as a debt discount.
+ References
No definition available.
+ Details

Name: mbii_CommonStockWarrantFairValueDisclosure

Namespace Prefix: mbii_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The percentage of the total commitment amount used in determining the number of warrants issued.
+ References
No definition available.
+ Details

Name: mbii_CommonStockWarrantsIssuedToPurchaseCommonStockFundedPrincipalPercentage

Namespace Prefix: mbii_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The percentage of the total commitment amount used in determining the number of warrants issued.
+ References
No definition available.
+ Details

Name: mbii_CommonStockWarrantsIssuedToPurchaseCommonStockPercentage

Namespace Prefix: mbii_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The minimum current ratio to be maintained under a debt agreement.
+ References
No definition available.
+ Details

Name: mbii_CurrentRatio

Namespace Prefix: mbii_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Additional percentage of total commitment amount used in determining the amount of the Agent Fee owed on debt issued.
+ References
No definition available.
+ Details

Name: mbii_DebtInstrumentAdditionalFeePercentage

Namespace Prefix: mbii_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The principal amount of additional debt issued.
+ References
No definition available.
+ Details

Name: mbii_DebtInstrumentAdditionalIssuedPrincipalAmount

Namespace Prefix: mbii_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of debt issued in exchange for the cancellation of convertible notes.
+ References
No definition available.
+ Details

Name: mbii_DebtInstrumentCancellationOfConvertibleNotes

Namespace Prefix: mbii_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Cash balance requirement if less than indebtedness identified in debt instrument.
+ References
No definition available.
+ Details

Name: mbii_DebtInstrumentCovenantUnrestrictedCashBalanceRequirement

Namespace Prefix: mbii_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Percentage of total commitment amount used in determining the amount of the Agent Fee owed on debt issued.
+ References
No definition available.
+ Details

Name: mbii_DebtInstrumentFeePercentage

Namespace Prefix: mbii_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The Maximum debt to worth ratio allowed under the debt agreement.
+ References
No definition available.
+ Details

Name: mbii_DebtToTangibleNetWorthRatio

Namespace Prefix: mbii_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The percentage of the value of common stock offered in sale of company or initial public offering used in determining the exercise price of warrants.
+ References
No definition available.
+ Details

Name: mbii_ExercisePriceOfWarrantsAsPercentageOfCommonStock

Namespace Prefix: mbii_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The estimated fair value of common stock warrants issued on date of issuance.
+ References
No definition available.
+ Details

Name: mbii_FairValueOfAdditionalCommonStockWarrantsIssued

Namespace Prefix: mbii_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The fair value of common stock warrants on issue date.
+ References
No definition available.
+ Details

Name: mbii_FairValueOfCommonStockWarrantsIssued

Namespace Prefix: mbii_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of the fair value of warrants recorded as a deferred financing cost.
+ References
No definition available.
+ Details

Name: mbii_FairValueOfWarrantsRecordedAsDeferredFinancingCost

Namespace Prefix: mbii_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The fair value of common stock warrants issued recorded as a debt discount.
+ References
No definition available.
+ Details

Name: mbii_FairValueWarrantsDebtDiscount

Namespace Prefix: mbii_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The increase or decrease in the percentage charged for amounts prepaid in excess of the statement amount in the loan agreement.
+ References
No definition available.
+ Details

Name: mbii_IncreaseDecreasePercentageOfPrepaymentFee

Namespace Prefix: mbii_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The maximum borrowing capacity of a line of credit facility as a percentage of accounts receivable.
+ References
No definition available.
+ Details

Name: mbii_LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable

Namespace Prefix: mbii_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The fee percentage charged for amounts prepaid in excess of the stated amount in the loan agreement.
+ References
No definition available.
+ Details

Name: mbii_LineOfCreditFacilityPrepaymentFeePercentage

Namespace Prefix: mbii_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The minimum loan to value ratio required to be maintained under a debt agreement.
+ References
No definition available.
+ Details

Name: mbii_LoansToValueRatioMinimumPercentage

Namespace Prefix: mbii_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The percentage of the value of common stock offered in sale of company or initial public offering used in determining the number of warrants issued.
+ References
No definition available.
+ Details

Name: mbii_PercentageOfCommonStockOfferedInInitialPublicOffering

Namespace Prefix: mbii_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
The percentage of the value of common stock offered in sale of company or initial public offering used in determining the number of warrants issued.
+ References
No definition available.
+ Details

Name: mbii_PercentageOfCommonStockPurchasedAsWarrant

Namespace Prefix: mbii_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
The percentage of the outstanding principal loan balance that if exceeded will result in a prepayment fee.
+ References
No definition available.
+ Details

Name: mbii_PrepaymentOfDebtMaximumPercentageOfOutstandingPrincipalAmount

Namespace Prefix: mbii_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The maximum 20% of outstanding loan principal that may be prepaid without penalty.
+ References
No definition available.
+ Details

Name: mbii_PrepaymentPercentageOfOutstandingPrincipalLoan

Namespace Prefix: mbii_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Prime interest rate in effect at the end of the reporting period.
+ References
No definition available.
+ Details

Name: mbii_PrimeRate

Namespace Prefix: mbii_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Exercise price per share or per unit of warrants or rights outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(i)(4))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name: us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16(a))

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20, 22

-Article 5

+ Details

Name: us-gaap_ConvertibleNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying values as of the balance sheet date of all debt, including all short-term borrowings, long-term debt, and capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.13,16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

+ Details

Name: us-gaap_DebtAndCapitalLeaseObligations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Percentage points added to the reference rate to compute the variable rate on the debt instrument.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentBasisSpreadOnVariableRate1

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Date the debt agreement requires the first payment to be made, in CCYY-MM-DD format.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 470

-Section 50

-Paragraph 3

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentDateOfFirstRequiredPayment1

Namespace Prefix: us-gaap_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The reference rate for the variable rate of the debt instrument, such as LIBOR or the US Treasury rate and the maturity of the reference rate used, such as three months or six months LIBOR.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentDescriptionOfVariableRateBasis

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Face (par) amount of debt instrument at time of issuance.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 55

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

+ Details

Name: us-gaap_DebtInstrumentFaceAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 10

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13433-108611

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13476-108611

+ Details

Name: us-gaap_DebtInstrumentFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of the fee that accompanies borrowing money under the debt instrument.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(b))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentFeeAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Net increase or decrease in the carrying amount of the debt instrument for the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(f))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name: us-gaap_DebtInstrumentIncreaseDecreaseForPeriodNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
When presenting a range of interest rates, the highest effective rate for funds borrowed under the debt agreement as of the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentInterestRateEffectivePercentageRateRangeMaximum

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Contractual interest rate for funds borrowed, under the debt agreement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentInterestRateStatedPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(a)(2))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentMaturityDate

Namespace Prefix: us-gaap_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(a)(2))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentMaturityDateDescription

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of the required periodic payments including both interest and principal payments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 470

-Section 50

-Paragraph 3

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

+ Details

Name: us-gaap_DebtInstrumentPeriodicPayment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentTerm

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
For an unclassified balance sheet, the carrying amount (net of accumulated amortization) as of the balance sheet date of capitalized costs associated with the issuance of debt instruments (for example, legal, accounting, underwriting, printing, and registration costs) that will be charged against earnings over the life of the debt instruments to which such costs pertain.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28555-108399

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.17)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DeferredFinanceCostsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Interest rate used to find the present value of an amount to be paid or received in the future as an input to measure fair value. For example, but not limited to, weighted average cost of capital (WACC), cost of capital, cost of equity and cost of debt.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (bbb)

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

+ Details

Name: us-gaap_FairValueInputsDiscountRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=49170532&loc=d3e12317-112629

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=49170532&loc=d3e12355-112629

+ Details

Name: us-gaap_GainsLossesOnExtinguishmentOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Including the current and noncurrent portions, carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Junior Subordinated Notes, which have a lower priority than senior instruments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16(a))

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20, 22

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 13, 16

-Article 9

+ Details

Name: us-gaap_JuniorSubordinatedNotes

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20, 22

-Article 5

+ Details

Name: us-gaap_LineOfCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.
+ References
No definition available.
+ Details

Name: us-gaap_LineOfCreditFacilityCommitmentFeePercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Date the credit facility terminates, in CCYY-MM-DD format.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(b),22(b))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LineOfCreditFacilityExpirationDate1

Namespace Prefix: us-gaap_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The effective interest rate during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(b),22(b))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LineOfCreditFacilityInterestRateDuringPeriod

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(b),22(b))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.
+ References
No definition available.
+ Details

Name: us-gaap_LongTermDebtFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LongTermNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 13, 16

-Article 9

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20, 22

-Article 5

+ Details

Name: us-gaap_NotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_ProceedsFromIssuanceOfLongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from a borrowing supported by a written promise to pay an obligation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_ProceedsFromNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(f))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name: us-gaap_RepaymentsOfLinesOfCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The carrying amounts of cash and cash equivalent items which are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. For a classified balance sheet represents the current portion only (the noncurrent portion has a separate concept); there is a separate and distinct element for unclassified presentations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Including the current and noncurrent portions, carrying value as of the balance sheet date of subordinated debt (with initial maturities beyond one year or beyond the operating cycle if longer). Subordinated debt places a lender in a lien position behind debt having a higher priority of repayment in liquidation of the entity's assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Article 5

-Subsection 19, 20, 22

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 10

-Section F

+ Details

Name: us-gaap_SubordinatedDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TradingActivityByTypeAxis=us-gaap_FixedIncomeInterestRateMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TradingActivityByTypeAxis=us-gaap_VariableIncomeInterestRateMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LineOfCreditFacilityAxis=mbii_JuneTwoThousandAndThirteenCreditFacilityMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ClassOfWarrantOrRightAxis=mbii_JuneTwoThousandThirteenWarrantMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=mbii_SeniorSecuredPromissoryNoteInterestRateAtEightPercentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=mbii_OctoberTwoThousandTwelveAndAprilTwoThousandThirteenSecuredPromissoryNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=mbii_TermLoanBearingInterestRateAtSevenPercentageMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=mbii_OctoberTwoThousandTwelveSecuredPromissoryNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=mbii_AprilTwoThousandThirteenSecuredPromissoryNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=mbii_OctoberTwoThousandTwelveSubordinatedConvertibleNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=mbii_SecuredPromissoryNoteInterestRateAtPrimePlusTwoPercentThroughJuneTwoThousandThirtySixMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 33 R24.htm IDEA: XBRL DOCUMENT v3.3.0.814

Debt (Tables)
6 Months Ended

Jun. 30, 2015

Debt Disclosure [Abstract]

Schedule of Debt

Debt consists of the following (in thousands):

 JUNE 30,
2015 DECEMBER 31,
2014

Term Loan (“Term Loan”) bearing interest at 7.00% per annum, which is payable monthly through April 2016, collateralized by all of the Company’s inventories, chattel paper, accounts receivable, equipment and general intangibles (excluding certain financed equipment and intellectual property) pledged as collateral under the Term Loan, subordinated
 $ 116 $ 183

Secured promissory notes (“October 2012 and April 2013 Secured Promissory Notes”) bearing interest at 12.00% per annum, which are payable monthly through October 2015, collateralized by substantially all of the Company’s assets, net of unamortized debt discount as of June 30, 2015 and December 31, 2014 of $76 and $203, respectively
 12,374 12,247

Secured promissory note (“June 2014 Secured Promissory Note”) bearing interest at prime plus 2% (5.25% as of June 30, 2015) per annum, which is payable monthly through June 2036, collateralized by all of the Company’s deposit accounts and MMM LLC’s inventories, chattel paper, accounts, equipment and general intangibles
 9,748 9,873



Debt
 22,238 22,303

Less current portion
 (12,749 ) (12,636 )



 $ 9,489 $ 9,667



Consideration Received, Fair Values of Notes, Common Stock Warrants Issued and Calculation of the Gain on Extinguishment of Debt

The following table shows the consideration received, fair values of the notes and common stock warrants issued and calculation of the gain on extinguishment of debt for the $3,750,000 Notes (in thousands):

Consideration received


Fair value of October 2012 Subordinated Convertible Note
 $ 1,360

Cash
 2,500



Total consideration received (a)
 $ 3,860

Notes and warrants issued


Principal balance of notes issued
 $ 3,750

Debt discount ⁽¹⁾
 (291 )



Fair value of notes issued
 3,459

Fair value of Additional Common Stock Warrants issued
 352



Total fair value of notes and warrants issued (b)
 $ 3,811



Gain on extinguishment of debt (a-b)
 $ 49



⁽¹⁾ The amortization of this account is being recorded in interest expense in the condensed consolidated statements of operations over the term of the arrangement.

Activity Related to Secured Promissory Note

Activity related to the October 2012 and April 2013 Secured Promissory Notes from December 31, 2014 through June 30, 2015 consisted of the following (in thousands):

 DECEMBER 31,
2014 ADDITIONS AMORTIZATION
OF DEBT
DISCOUNT PRINCIPAL
PAYMENTS JUNE 30,
2015

Principal
 $ 12,450 $ — $ — $ — $ 12,450

Debt discount related to the issuance of common stock warrants ⁽¹⁾
 (106 ) — 69 — (37 )

Discount related to the $3,750,000 Notes ⁽¹⁾
 (97 ) — 58 — (39 )









 $ 12,247 $ — $ 127 $ — $ 12,374









⁽¹⁾ The amortization of this account is included in interest expense in the condensed consolidated statements of operations and as non-cash interest expense in the condensed consolidated statements of cash flows.

X

- References
No definition available.
+ Details

Name: us-gaap_DebtDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 470

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(e),(f))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 55

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21521-112644

+ Details

Name: us-gaap_ScheduleOfDebtInstrumentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfDebtTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of debt extinguished which may include, amount of gain (loss), the income tax effect and the per share amount of the aggregate gain (loss), net of the related income tax.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=7516071&loc=d3e13374-112631

+ Details

Name: us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 34 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 35 R7.htm IDEA: XBRL DOCUMENT v3.3.0.814

Condensed Consolidated Statements of Cash Flows - USD ($)
6 Months Ended

Jun. 30, 2015

Jun. 30, 2014

Cash flows from operating activities

Net loss $ (22,899,000) $ (21,026,000)

Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation and amortization 1,707,000 1,081,000

Loss (gain) on disposal of equipment (35,000) 85,000

Share-based compensation 2,185,000 2,722,000

Non-cash interest expense 265,000 528,000

Amortization of investment securities premiums/discounts, net 0 10,000

Net changes in operating assets and liabilities:

Accounts receivable (1,164,000) (216,000)

Accounts receivable from related parties 0 413,000

Inventories 2,037,000 (540,000)

Deferred cost of product revenues 200,000 (163,000)

Prepaid Expenses and other assets 130,000 (443,000)

Accounts payable (2,263,000) 330,000

Accrued and other liabilities 223,000 (843,000)

Deferred revenue (375,000) 177,000

Deferred revenue from related parties (382,000) (333,000)

Customer refund liabilities (25,000) 1,883,000

Net cash used in operating activities (20,396,000) (16,335,000)

Cash flows from investing activities

Purchases of property, plant and equipment (1,398,000) (9,425,000)

Sale of property and equipment 7,000 0

Purchase of short-term investments 0 (49,000)

Maturities of short-term investments 0 13,467,000

Net cash provided by (used in) investing activities (1,391,000) 3,993,000

Cash flows from financing activities

Proceeds from public offerings, net of offering costs and underwriter commissions 0 39,959,000

Proceeds from issuance of debt, net of financing costs 0 9,621,000

Proceeds from line of Credit 0 4,687,000

Repayment of line of credit 0 (4,687,000)

Repayment of debt (192,000) (137,000)

Repayment of capital leases (1,149,000) (219,000)

Change in restricted cash 0 (4,885,000)

Proceeds from exercise of stock options 0 1,128,000

Proceeds from exercise of common stock warrants 0 50,000

Net cash provided by (used in) financing activities (1,341,000) 45,517,000

Net increase (decrease) in cash and cash equivalents (23,128,000) 33,175,000

Cash and cash equivalents, beginning of period 35,324,000 24,455,000

Cash and cash equivalents, end of period 12,196,000 57,630,000

Supplemental disclosure of cash flow information

Cash paid for interest, net of capitalized interest of $4 and $648 for the six months ended June 30, 2015 and 2014, respectively 1,069,000 922,000

Supplemental disclosure of non-cash investing and financing activities

Property, plant and equipment included in accounts payable and accrued liabilities 12,000 834,000

Equipment acquired under capital leases $ 787,000 $ 646,000

X

- Definition
The increase (decrease) during the reporting period for the amount of cost of goods produced and sold that have been deferred as of balance sheet date for which revenue has not yet been recognized.
+ References
No definition available.
+ Details

Name: mbii_IncreaseDecreaseInDeferredCostOfProductRevenues

Namespace Prefix: mbii_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue from related parties yet to be earned for with cash or other forms of consideration was received or recorded as a receivable.
+ References
No definition available.
+ Details

Name: mbii_IncreaseDecreaseInDeferredRevenueRelatedParties

Namespace Prefix: mbii_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash inflow associated with the amount received from holders exercising their common stock warrants. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.
+ References
No definition available.
+ Details

Name: mbii_NetProceedsFromExerciseOfCommonStockWarrants

Namespace Prefix: mbii_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Future cash outflow to pay for purchases of fixed assets that have occurred.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4313-108586

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586

+ Details

Name: us-gaap_CapitalExpendituresIncurredButNotYetPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase during the period in capital lease obligations due to entering into new capital leases.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4313-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586

+ Details

Name: us-gaap_CapitalLeaseObligationsIncurred

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3044-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes effect from exchange rate changes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_DepreciationDepletionAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=51824106&loc=d3e2443-110228

+ Details

Name: us-gaap_GainLossOnDispositionOfAssets1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayableTrade

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the amount due to the reporting entity for good and services provided to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management, an entity and its principal owners, management, member of their immediate families, affiliates, or other parties with the ability to exert significant influence.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the amount of prepayments by customers for goods or services to be provided at a later date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInCustomerAdvances

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInDeferredRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInInventories

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOperatingCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets, or income taxes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of cash paid for interest during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585

+ Details

Name: us-gaap_InterestPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of accretion (amortization) of purchase discount (premium) on nonoperating securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.8)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3574-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3574-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_PaidInKindInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow associated with the purchase of all investments (debt, security, other) during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquireInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash inflow from the additional capital contribution to the entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromIssuanceOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.
+ References
No definition available.
+ Details

Name: us-gaap_ProceedsFromIssuanceOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(f))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name: us-gaap_ProceedsFromLinesOfCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net cash inflow or outflow from cash and cash items that are not available for withdrawal or usage.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

+ Details

Name: us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from long-term debt wholly or partially secured by collateral. Excludes tax exempt secured debt.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_ProceedsFromRepaymentsOfSecuredDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 45

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=49167202&loc=d3e26853-111562

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 12

-Subparagraph (a),(b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3179-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

+ Details

Name: us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 12

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3179-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

+ Details

Name: us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow associated with the amount received from holders exercising their stock options. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (j)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_ProceedsFromStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(f))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name: us-gaap_RepaymentsOfLinesOfCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow for the obligation for a lease meeting the criteria for capitalization (with maturities exceeding one year or beyond the operating cycle of the entity, if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

+ Details

Name: us-gaap_RepaymentsOfLongTermCapitalLeaseObligations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SupplementalCashFlowInformationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 36 R3.htm IDEA: XBRL DOCUMENT v3.3.0.814

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands

Jun. 30, 2015

Dec. 31, 2014

Statement of Financial Position [Abstract]

Deferred cost of product revenues to related parties $ 138 $ 333

Common stock, par value $ 0.00001 $ 0.00001

Common stock, shares authorized 250,000,000 250,000,000

Common stock, shares issued 24,465,000 24,465,000

Common stock, shares outstanding 24,465,000 24,465,000

X

- Definition
Amount of cost of goods produced and sold to related parties that have been deferred as of balance sheet date for which revenue has not yet been recognized. Generally, an entity records deferred revenue and deferred cost of goods sold when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.
+ References
No definition available.
+ Details

Name: mbii_DeferredCostOfProductRevenuesToRelatedPartiesCurrent

Namespace Prefix: mbii_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StatementOfFinancialPositionAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 37 R17.htm IDEA: XBRL DOCUMENT v3.3.0.814

Related Party Transactions
6 Months Ended

Jun. 30, 2015

Related Party Transactions [Abstract]

Related Party Transactions

9. Related Party Transactions

Les Lyman, a member of the Company’s board of directors, is the chairman and significant indirect shareholder of The Tremont Group, Inc. For the three months ended June 30, 2015 and 2014, revenue of $183,000 and $201,000, respectively, was recognized on a sell-through basis relating to product purchased by The Tremont Group, Inc. that was resold by The Tremont Group, Inc. during the period. For the six months ended June 30, 2015 and 2014, revenue of $382,000 and $478,000, respectively, was recognized on a sell-through basis relating to product purchased by The Tremont Group, Inc. that was resold by The Tremont Group, Inc. during the period. As of June 30, 2015 and December 31, 2014, the Company had no outstanding accounts receivable due from The Tremont Group, Inc. As of June 30, 2015 and December 31, 2014, the Company recorded deferred cost of product revenues of $138,000 and $333,000, respectively, and current deferred product revenues of $278,000 and $660,000, respectively, relating to product sold to The Tremont Group, Inc. where title has transferred but the criteria for revenue recognition have not been met. Although the Company anticipates sales of its products to The Tremont Group, Inc. to continue through 2015, the Company cannot estimate the amount of those sales.

The Company has a strategic collaboration and distribution agreement with Syngenta, an affiliate of a former 5% stockholder, Syngenta Ventures. In connection with the Company’s secondary offering in June 2014, Syngenta Ventures sold 600,000 shares of the Company’s common stock, reducing its ownership percentage below 5%. Accordingly, revenue recognized under this agreement subsequent to June 2014 has not been included in related party revenues. For the three and six months ended June 30, 2014, the Company recognized $8,000 and $332,000, respectively, of related party revenues under this agreement prior to Syngenta Ventures reducing its ownership stake.

X

- References
No definition available.
+ Details

Name: us-gaap_RelatedPartyTransactionsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39678-107864

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph b

-Article 3A

+ Details

Name: us-gaap_RelatedPartyTransactionsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 38 R1.htm IDEA: XBRL DOCUMENT v3.3.0.814

Document and Entity Information - shares
6 Months Ended

Jun. 30, 2015

Nov. 02, 2015

Document And Entity Information [Abstract]

Document Type 10-Q

Amendment Flag false

Document Period End Date Jun. 30, 2015

Document Fiscal Year Focus 2015

Document Fiscal Period Focus Q2

Trading Symbol MBII

Entity Registrant Name MARRONE BIO INNOVATIONS INC

Entity Central Index Key 0001441693

Current Fiscal Year End Date --12-31

Entity Filer Category Smaller Reporting Company

Entity Common Stock, Shares Outstanding 24,464,582

X

- Definition
If the value is true, then the document is an amendment to previously-filed/accepted document.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
No definition available.
+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details

Name: dei_TradingSymbol

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Document And Entity Information [Abstract]
+ References
No definition available.
+ Details

Name: mbii_DocumentAndEntityInformationAbstract

Namespace Prefix: mbii_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 39 R18.htm IDEA: XBRL DOCUMENT v3.3.0.814

Subsequent Events
6 Months Ended

Jun. 30, 2015

Subsequent Events [Abstract]

Subsequent Events

10. Subsequent Events

Sale of Notes and Warrants

On August 20, 2015, the Company issued and sold to entities affiliated with Waddell & Reed Financial, Inc., one of its 5% stockholders, senior secured promissory notes in the aggregate principal amount of $40,000,000 and warrants to purchase up to 4,000,000 shares of common stock of the Company for aggregate consideration of $40,000,000, pursuant to a purchase agreement dated August 20, 2015.

The notes will bear interest at a rate of 8% per annum payable semi-annually on June 30 or December 31 of each year, commencing on December 31, 2015, with $10,000,000 payable three years from the closing, $10,000,000 payable four years from the closing and $20,000,000 payable five years from the closing. The notes contain customary covenants, in addition to the obligation to maintain cash and cash equivalents of at least $15,000,000. The notes provide for various events of default, including, among others, default in payment of principal or interest, breach of any representation or warranty by the Company or any subsidiary under any agreement or document delivered in connection with the notes, a continued breach of any other condition or obligation under any loan document, certain bankruptcy, liquidation, reorganization or change of control events, the acquisition by any person or persons acting as group, other than the lenders, of beneficial ownership of 40% or more of the outstanding voting stock of the Company and certain events in which Pamela G. Marrone Ph.D. ceases to serve as the Company’s Chief Executive Officer. As of September 30, 2015, the Company was in breach of its covenants under the August 2015 Senior Secured Promissory Notes as the Company was in breach of its covenants under its October 2012 and April 2013 Secured Promissory Notes and June 2014 Secured Promissory Note. However, this covenant breach was cured in November 2015 as a result of the Company obtaining an extension to deliver its annual financial statements with respect to the October 2012 and April 2013 Secured Promissory Notes and the waiver of certain of the Company’s covenants with respect to the June 2014 Secured Promissory Note. See Note 6 for further discussion.

The notes are secured by substantially all the Company’s personal property assets. The agent, acting behalf of the lenders, shall be entitled to have a first priority lien on the Company’s intellectual property assets, pursuant to intercreditor arrangements with certain of the Company’s existing lenders.

The warrants are immediately exercisable at an exercise price of $1.91 per share (subject to adjustments) and may be exercised at a holder’s option at any time on or before August 20, 2023 (subject to certain exceptions). Proceeds from the sale of the notes and warrants will be allocated to the notes and warrants based on the relative fair value.

In connection with the above transaction, on August 19, 2015, the Company amended the October 2012 and April 2013 Secured Promissory Notes. As a result of the amendment, interest on loans was accrued at a rate of 12% per annum until September 1, 2015, and thereafter is accrued at a rate of 18% per annum, and the Company is permitted to prepay the outstanding indebtedness under the agreement without penalty at any time. In addition, in September 2015, the Company provided a written notice exercising its right to extend the maturity through October 2, 2017. The amendments will be accounted for as a modification of the loan agreement with the effective interest rate adjusted prospectively from the amendment date.

Separation Agreement

On January 14, 2015, James Iademarco was appointed as the Company’s President and Chief Operating Officer, effective January 14, 2015. On August 20, 2015, the Company entered into a separation agreement with James Iademarco whereby he resigned effective August 31, 2015, but agreed to remain available to advise the Company in a consulting capacity for an additional period of up to 90 days to assist with the transition of various pending matters. Pursuant to the separation agreement, Mr. Iademarco is entitled to receive, among other things, an amount equal to one-twelfth of his prior base salary of $290,000 on or before the 15th day of each of the twelve months following August 31, 2015 and certain premium payments for health and vision insurance coverage, in partial consideration for Mr. Iademarco granting the Company a general release of liability and claims.

X

- References
No definition available.
+ Details

Name: us-gaap_SubsequentEventsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
+ References
No definition available.
+ Details

Name: us-gaap_SubsequentEventsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 40 R4.htm IDEA: XBRL DOCUMENT v3.3.0.814

Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended

Jun. 30, 2015

Jun. 30, 2014

Jun. 30, 2015

Jun. 30, 2014

Revenues:

Product $ 3,091 $ 2,877 $ 4,865 $ 4,931

License 83 51 166 96

Related party 183 206 382 811

Total revenues 3,357 3,134 5,413 5,838

Cost of product revenues, including cost of product revenues to related parties of $113 and $130 for the three months ended June 30, 2015 and 2014, respectively, and $195 and $291 for the six months ended June 30, 2015 and 2014, respectively 2,994 2,711 4,992 4,504

Gross profit 363 423 421 1,334

Operating Expenses:

Research, development and patent 3,328 4,264 6,750 8,561

Selling, general and administrative 7,411 5,920 15,298 12,244

Total operating expenses 10,739 10,184 22,048 20,805

Loss from operations (10,376) (9,761) (21,627) (19,471)

Other income (expense):

Interest income 6 11 15 21

Interest expense (659) (863) (1,328) (1,469)

Other income (expense), net 44 (98) 41 (107)

Total other expense, net (609) (950) (1,272) (1,555)

Loss before income taxes (10,985) (10,711) (22,899) (21,026)

Income taxes 0 0 0 0

Net loss $ (10,985) $ (10,711) $ (22,899) $ (21,026)

Basic and diluted net loss per common share $ (0.45) $ (0.52) $ (0.94) $ (1.04)

Weighted-average shares outstanding used in computing net loss per common share 24,465 20,775 24,465 20,150

X

- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, or (3) to pertaining to the exclusive legal rights granted to the owner of the patent to exploit an invention or a process for a period of time specified by law. Such costs may have been expended to directly apply and receive patent rights, to acquire such rights, or to defend such rights.
+ References
No definition available.
+ Details

Name: mbii_ResearchDevelopmentAndPatentExpenses

Namespace Prefix: mbii_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate cost of goods produced and sold and services rendered during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.2)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_CostOfRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1,2)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_GrossProfit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 940

-SubTopic 20

-Section 25

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51673353&loc=d3e41242-110953

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 10

-Article 5

+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (a),(b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Income Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6515339

+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the cost of borrowed funds accounted for as interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.9)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

+ Details

Name: us-gaap_InterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.7(b))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_InvestmentIncomeInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Revenue earned during the period relating to consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(e))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_LicensesRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.7)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_NonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NonoperatingIncomeExpenseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OperatingExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.9)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_OtherNonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(e))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Related Parties

-URI http://asc.fasb.org/extlink&oid=16382449

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 946

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.6-07.1(c))

-URI http://asc.fasb.org/extlink&oid=6488393&loc=d3e606610-122999

+ Details

Name: us-gaap_RevenueFromRelatedParties

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_Revenues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_RevenuesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(a))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_SalesRevenueGoodsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 30

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=51677171&loc=d3e3636-108311

+ Details

Name: us-gaap_SellingGeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).
+ References
No definition available.
+ Details

Name: us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 41 R12.htm IDEA: XBRL DOCUMENT v3.3.0.814

Inventories
6 Months Ended

Jun. 30, 2015

Inventory Disclosure [Abstract]

Inventories

4. Inventories

Inventories, net consist of the following (in thousands):

 JUNE 30,
2015 DECEMBER 31,
2014

Raw materials
 $ 5,708 $ 5,692

Work in progress
 916 1,150

Finished goods
 3,601 5,378

Finished goods held at customers
 382 424





 $ 10,607 $ 12,644





As of each of June 30, 2015 and December 31, 2014, the Company had $668,000 in reserves against its inventories.

X

- References
No definition available.
+ Details

Name: us-gaap_InventoryDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 6

-Subparagraph a, b, c

-Article 5

+ Details

Name: us-gaap_InventoryDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 42 R11.htm IDEA: XBRL DOCUMENT v3.3.0.814

Fair Value Measurements
6 Months Ended

Jun. 30, 2015

Fair Value Disclosures [Abstract]

Fair Value Measurements

3. Fair Value Measurements

Accounting Standards Codification (“ASC”) 820, Fair Value Measurements (“ASC 820”), clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability.

ASC 820 requires that the valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. ASC 820 establishes a three tier value hierarchy, which prioritizes inputs that may be used to measure fair value as follows:

• Level 1—Quoted prices in active markets for identical assets or liabilities.

• Level 2—Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

• Level 3—Inputs that are generally unobservable and typically reflect management’s estimate of assumptions that market participants would use in pricing the asset or liability.

The following table presents the Company’s financial assets measured at fair value on a recurring basis as of June 30, 2015 and December 31, 2014 (in thousands):

 JUNE 30, 2015

 TOTAL LEVEL 1 LEVEL 2 LEVEL 3

Assets


Money market funds
 $ 3,749 $ 3,749 $ — $ —









 DECEMBER 31, 2014

 TOTAL LEVEL 1 LEVEL 2 LEVEL 3

Assets


Money market funds
 $ 14,746 $ 14,746 $ — $ —









The Company’s money market funds are held at registered investment companies and as of June 30, 2015 and December 31, 2014 were in active markets and, therefore, are measured based on the Level 1 valuation hierarchy.

X

- References
No definition available.
+ Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13537-108611

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13504-108611

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13433-108611

+ Details

Name: us-gaap_FairValueDisclosuresTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 43 R23.htm IDEA: XBRL DOCUMENT v3.3.0.814

Accrued Liabilities (Tables)
6 Months Ended

Jun. 30, 2015

Payables and Accruals [Abstract]

Schedule of Accrued Liabilities

Accrued liabilities consist of the following (in thousands):

 JUNE 30,
2015 DECEMBER 31,
2014

Accrued compensation
 $ 1,258 $ 1,348

Accrued expenses
 4,915 4,771

Accrued warranty costs
 323 202





 $ 6,496 $ 6,321





Schedule of Changes in Accrued Warranty Costs

Changes in the Company’s accrued warranty costs during the period are as follows (in thousands):

Balance as of December 31, 2014
 $ 202

Warranties issued during the period
 137

Settlements made during the period
 (16 )



Balance as of June 30, 2015
 $ 323



X

- References
No definition available.
+ Details

Name: us-gaap_PayablesAndAccrualsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the components of accrued liabilities.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=51674963&loc=d3e12565-110249

+ Details

Name: us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 44 R19.htm IDEA: XBRL DOCUMENT v3.3.0.814

Significant Accounting Policies (Policies)
6 Months Ended

Jun. 30, 2015

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.

The accompanying financial information as of June 30, 2015, and for the three and six months ended June 30, 2015 and 2014, has been prepared by the Company, without audit, in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such SEC rules and regulations and accounting principles applicable for interim periods. However, the Company believes that the disclosures are adequate to make the information presented not misleading. The information included in this Quarterly Report on Form 10-Q should be read in connection with the consolidated financial statements and accompanying notes included in the Company’s Annual Report filed on Form 10-K for the fiscal year ended December 31, 2014.

In the opinion of management, the condensed consolidated financial statements as of June 30, 2015, and for the three and six months ended June 30, 2015 and 2014, reflect all adjustments, which are normal recurring adjustments, necessary to present a fair statement of financial position, results of operations, comprehensive loss and cash flows. The results of operations for the three and six months ended June 30, 2015 are not necessarily indicative of the operating results for the full fiscal year or any future periods.

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents

Cash and Cash Equivalents

The Company considers all highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents. Cash and cash equivalents consists of cash on deposit, money market funds and certificates of deposit accounts with United States (“U.S.”) financial institutions. The Company is exposed to credit risk in the event of default by financial institutions to the extent that cash and cash equivalents balances with financial institutions are in excess of amounts that are insured by the Federal Deposit Insurance Corporation. The Company has not experienced any losses on these deposits.

Restricted Cash

Restricted Cash

The Company’s restricted cash consists of cash that the Company is contractually obligated to maintain on deposit at a bank in accordance with the promissory note entered into in June 2014. See Note 6 for further discussion.

Concentration of Credit Risk

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents, accounts receivable and debt. The Company deposits its cash and cash equivalents with high credit quality domestic financial institutions with locations in the U.S. Such deposits may exceed federal deposit insurance limits. The Company believes the financial risks associated with these financial instruments are minimal.

The Company’s customer base is dispersed across many different geographic areas, and currently most customers are pest management distributors in the U.S. Generally, receivables are due up to 120 days from the invoice date and are considered past due after this date, although the Company may offer extended terms from time to time.

For the three months ended June 30, 2015 and 2014, 9% and 6%, respectively, and for the six months ended June 30, 2015 and 2014, 6% and 11%, respectively, of the Company’s revenues were generated from international customers.

The Company’s principal sources of revenues are its Regalia and Grandevo product lines. These two product lines accounted for 92% and 98% of the Company’s total revenues for the three months ended June 30, 2015 and 2014, respectively, and 94% and 93% for the six months ended June 30, 2015 and 2014, respectively.

Customers to which 10% or more of the Company’s total revenues are attributable for any one of the periods presented consist of the following:

 CUSTOMER A CUSTOMER B CUSTOMER C

For the three months ended June 30,


2015
 34 % 11 % 4 %

2014
 37 % 7 % 12 %

For the six months ended June 30,


2015
 27 % 8 % 8 %

2014
 31 % 6 % 13 %

Customers to which 10% or more of the Company’s outstanding accounts receivable are attributable as of either June 30, 2015 or December 31, 2014 consist of the following:

 CUSTOMER A CUSTOMER B CUSTOMER C CUSTOMER D

June 30, 2015
 46 % 10 % 8 % *

December 31, 2014
 10 % * 37 % 23 %

* Represents less than 1% of outstanding accounts receivable

Concentrations of Supplier Dependence

Concentrations of Supplier Dependence

The active ingredient in the Company’s Regalia product line is derived from the giant knotweed plant, which the Company obtains from China. The Company’s single supplier acquires raw knotweed from numerous regional sources and performs an extraction process on this plant, creating a dried extract that is shipped to the Company’s manufacturing plant. A disruption at this supplier’s manufacturing site or a disruption in trade between the U.S. and China could negatively impact sales of Regalia. The Company currently uses one supplier and does not have a long-term supply contract with this supplier. Although the Company has identified additional sources of raw knotweed, there can be no assurance that the Company will continue to be able to obtain dried extract from China at a competitive price.

Inventories

Inventories

Inventories are stated at the lower of cost or market value (net realizable value or replacement cost) and include the cost of material and external and internal labor and manufacturing costs. Cost is determined on the first-in, first-out basis. The Company provides for inventory reserves when conditions indicate that the selling price may be less than cost due to physical deterioration, obsolescence, changes in price levels or other factors. Additionally, the Company provides reserves for excess and slow-moving inventory on hand that is not expected to be sold to reduce the carrying amount of excess and slow-moving inventory to its estimated net realizable value. The reserves are based upon estimates about future demand from the Company’s customers and distributors and market conditions.

Deferred Cost of Product Revenues

Deferred Cost of Product Revenues

Deferred cost of product revenues are stated at the lower of cost or net realizable value and include product sold where title has transferred but the criteria for revenue recognition have not been met. As of June 30, 2015 and December 31, 2014, the Company recorded deferred cost of product revenues of $1,597,000 and $1,797,000, respectively, including deferred cost of product revenues to related parties of $138,000 and $333,000, respectively.

Revenue Recognition

Revenue Recognition

The Company recognizes revenues when persuasive evidence of an arrangement exists, transfer of title has occurred or services have been rendered, the price is fixed or determinable and collectability is reasonably assured. If contractual obligations, acceptance provisions or other contingencies exist which indicate that the price is not fixed or determinable, revenue is recognized after such obligations or provisions are fulfilled or expire.

Product revenues consist of revenues generated from sales of the Company’s products to distributors and direct customers, net of rebates and cash discounts. For sales of products made to distributors, the Company recognizes revenue either on a sell-in or sell-through basis depending on the specific facts and circumstances of the transaction(s) with the distributor. Factors considered include, but are not limited to, whether the payment terms offered to the distributor are structured to correspond to when product is resold, the distributor history of adhering to the terms of its contractual arrangements with the Company, whether the Company has a pattern of granting concessions for the benefit of the distributor and whether there are other conditions that may indicate that the sale to the distributor is not substantive.

In some cases, the Company recognizes distributor revenue as title and risk of loss passes, provided all other revenue recognition criteria have been satisfied (the “sell-in” method). For certain sales to certain distributors, the revenue recognition criteria for distributor sales are not satisfied at the time title and risk of loss passes to the distributor; specifically, in instances where “inventory protection” arrangements were offered to distributors that would permit these distributors to return to the Company certain unsold products, the Company considers the arrangement not to be fixed or determinable, and accordingly, revenue is deferred until products are resold to customers of the distributor (the “sell-through” method). As of June 30, 2015 and December 31, 2014, the Company recorded current deferred product revenues of $2,600,000 and $3,190,000, respectively, including current deferred product revenues from related parties of $278,000 and $660,000, respectively. The cost of product revenues associated with such deferral are also deferred and classified as deferred cost of product revenues in the condensed consolidated balance sheets. Cash received from customers related to delivered product that may not represent a true sale is classified as customer refund liabilities in the condensed consolidated balance sheets and the related cost of inventory remains in inventory in the condensed consolidated balance sheets until the product is returned or is resold to customers of the distributor and revenue is recognized. For the three months ended June 30, 2015 and 2014, 58% and 51%, respectively, and for the six months ended June 30, 2015 and 2014, 48% and 51%, respectively, of total revenues were recognized on a sell-through basis.

From time to time, the Company offers certain product rebates to its distributors and growers, which are estimated and recorded as reductions to product revenues, and an accrued liability is recorded at the later of when the revenues are recorded or the rebate is being offered.

The Company recognizes license revenues pursuant to strategic collaboration and distribution agreements under which the Company receives payments for the achievement of testing validation, regulatory progress and commercialization events. As these activities and payments are associated with exclusive rights that the Company provides in connection with strategic collaboration and distribution agreements over the term of the agreements, revenues related to the payments received are deferred and recognized over the term of the exclusive distribution period of the respective agreement. For the six months ended June 30, 2015, the Company received payments totaling $750,000 under these agreements. No payments were received under these agreements for the three months ended June 30, 2015 and the three and six months ended June 30, 2014. For the three months ended June 30, 2015 and 2014, the Company recognized $83,000 and $51,000, respectively, as license revenues, excluding related party revenues. For the six months ended June 30, 2015 and 2014, the Company recognized $166,000 and $96,000, respectively, as license revenues, excluding related party revenues.

The Company has a strategic collaboration and distribution agreement with Syngenta, an affiliate of a former 5% stockholder, Syngenta Ventures Pte. LTD (Syngenta Ventures). In connection with the Company’s secondary offering in June 2014, Syngenta Ventures sold 600,000 shares of the Company’s common stock, reducing its ownership percentage below 5%. Accordingly, revenue recognized under this agreement subsequent to June 2014 has not been included in related party revenues. For the three and six months ended June 30, 2014, the Company recognized $8,000 and $332,000, respectively, of related party revenues under this agreement prior to Syngenta Ventures reducing its ownership stake.

As of June 30, 2015, the Company recorded current and non-current deferred revenues of $331,000 and $1,884,000, respectively, related to payments received under these agreements. As of December 31, 2014, the Company recorded current and non-current deferred revenues of $331,000 and $2,050,000, respectively, related to payments received under these agreements.

Research, Development and Patent Expenses

Research, Development and Patent Expenses

Research and development expenses include payroll-related expenses, field trial costs, toxicology costs, regulatory costs, consulting costs and lab costs. Patent expenses include legal costs relating to the patents and patent filing costs. These costs are expensed to operations as incurred. For the three months ended June 30, 2015 and 2014, research and development expenses totaled $3,073,000 and $4,055,000, respectively, and patent expenses totaled $255,000 and $209,000, respectively. For the six months ended June 30, 2015 and 2014, research and development expenses totaled $6,189,000 and $8,053,000, respectively, and patent expenses totaled $561,000 and $508,000, respectively.

Net Loss Per Share

Net Loss per Share

Net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding for the period. The calculation of basic and diluted net loss per share is the same for all periods presented as the effect of the potential common stock equivalents, which consist of stock options and warrants to purchase common stock, are anti-dilutive due to the Company’s net loss position. Anti-dilutive common stock equivalents are excluded from diluted net loss per share. The anti-dilutive stock options that were not included in diluted net loss per share were 2,633,000 and 2,871,000 as of June 30, 2015 and 2014, respectively. The anti-dilutive warrants to purchase common stock that were not included in diluted net loss per share were 145,000 as of both June 30, 2015 and 2014.

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

In July 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory (“ASU 2015-11”), which applies guidance on the subsequent measurement of inventory. ASU 2015-11 states that an entity should measure inventory at the lower of cost and net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonable predictable costs of completion, disposal and transportation. The guidance excludes inventory measured using last-in, first-out or the retail inventory method. ASU 2015-11 is effective for interim and annual reporting periods beginning after December 15, 2016. Early adoption is permitted. The Company is not planning to early adopt ASU 2015-11 and is currently evaluating ASU 2015-11 to determine the potential impact to its condensed consolidated financial statements and related disclosures.

In April 2015, the FASB issued Accounting Standards Update No. 2015-03, Interest—Imputation of Interest (Topic 835-30): Simplifying the Presentation of Debt Issuance Costs (“ASU 2015-03”). ASU 2015-03 requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs is not affected by ASU 2015-03. ASU 2015-03 is effective for financial statements issued for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. Early adoption is permitted. Upon adoption, the Company will reclassify debt issuance costs from prepaid expenses and other current assets and other assets as a reduction to debt in the condensed consolidated balance sheets. The Company is not planning to early adopt ASU 2015-03 and does not anticipate that the adoption of ASU 2015-03will materially impact its condensed consolidated financial statements.

In August 2014, the FASB issued Accounting Standards Update No. 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (“ASU 2014-15”). ASU 2014-15 requires management to evaluate for each annual and interim reporting period whether conditions or events give rise to substantial doubt that an entity has the ability to continue as a going concern within one year following issuance of the financial statements and requires specific disclosures regarding the conditions or events leading to substantial doubt. The new guidance is effective for annual and interim periods ending after December 15, 2016, with early adoption permitted. The Company is currently evaluating ASU 2014-15 to determine the potential impact to its condensed consolidated financial statements and related disclosures.

In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”). ASU 2014-09 provides new, globally applicable converged guidance concerning recognition and measurement of revenue. As a result, significant additional disclosures are required about the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The new guidance is effective for annual and interim periods beginning on or after December 15, 2018. Companies are allowed to transition using either the modified retrospective or full retrospective adoption method. If full retrospective adoption is chosen, three years of financial information must be presented in accordance with the new standard. The Company is currently evaluating the alternative methods of adoption and the effect on its condensed consolidated financial statements and related disclosures.

X

- Definition
Disclosure of accounting policy for concentrations of supplier dependence risk.
+ References
No definition available.
+ Details

Name: mbii_ConcentrationsOfSupplierRiskPolicyTextBlock

Namespace Prefix: mbii_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).
+ References
No definition available.
+ Details

Name: us-gaap_BasisOfAccountingPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 305

-SubTopic 10

-Section 05

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6375392&loc=d3e26790-107797

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4273-108586

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Financial Reporting Release (FRR)

-Number 203

-Paragraph 02-03

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

+ Details

Name: us-gaap_CashAndCashEquivalentsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.1(a))

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 305

-SubTopic 10

-Section 05

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6375392&loc=d3e26790-107797

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4273-108586

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Financial Reporting Release (FRR)

-Number 203

-Paragraph 02-03

+ Details

Name: us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for credit risk.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 55

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6875567&loc=d3e14489-108613

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 825

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=51676700&loc=d3e61082-112788

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 825

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28088331&loc=SL29635902-196195

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13537-108611

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13531-108611

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 825

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51676700&loc=d3e61044-112788

+ Details

Name: us-gaap_ConcentrationRiskCreditRisk

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for deferral and amortization of significant deferred charges.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.17)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

+ Details

Name: us-gaap_DeferredChargesPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

+ Details

Name: us-gaap_EarningsPerSharePolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for major classes of inventories, bases of stating inventories (for example, lower of cost or market), methods by which amounts are added and removed from inventory classes (for example, FIFO, LIFO, or average cost), loss recognition on impairment of inventories, and situations in which inventories are stated above cost. If inventory is carried at cost, this disclosure includes the nature of the cost elements included in inventory.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28360613&loc=d3e4492-108314

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(b))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=28360613&loc=d3e4556-108314

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Financial Reporting Release (FRR)

-Number 206

-Paragraph b

-Subparagraph i, ii

-Chapter 2

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 6

-Subparagraph a

-Article 5

+ Details

Name: us-gaap_InventoryPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.
+ References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 730

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Research and Development

-URI http://asc.fasb.org/extlink&oid=6523717

+ Details

Name: us-gaap_ResearchAndDevelopmentExpensePolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18823-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18726-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.B.Q1)

-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 13

-Section B

-Paragraph Question 1

+ Details

Name: us-gaap_RevenueRecognitionPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6061-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6143-108592

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6132-108592

+ Details

Name: us-gaap_UseOfEstimates

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 45 R15.htm IDEA: XBRL DOCUMENT v3.3.0.814

Share-Based Plans
6 Months Ended

Jun. 30, 2015

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Share-Based Plans

7. Share-Based Plans

As of June 30, 2015, there were 2,633,000 options outstanding and 2,142,000 share-based awards available for grant under the outstanding equity incentive plans.

For the three months ended June 30, 2015 and 2014, the Company recognized share-based compensation of $1,095,000 and $1,200,000, respectively. For the six months ended June 30, 2015 and 2014, the Company recognized share-based compensation of $2,185,000 and $2,722,000, respectively.

During the three and six months ended June 30, 2015, the Company did not grant any options and no options were exercised.

X

- Definition
The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 40

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51659978&loc=d3e25284-112666

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 14

+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 46 R13.htm IDEA: XBRL DOCUMENT v3.3.0.814

Accrued Liabilities
6 Months Ended

Jun. 30, 2015

Payables and Accruals [Abstract]

Accrued Liabilities

5. Accrued Liabilities

Accrued liabilities consist of the following (in thousands):

 JUNE 30,
2015 DECEMBER 31,
2014

Accrued compensation
 $ 1,258 $ 1,348

Accrued expenses
 4,915 4,771

Accrued warranty costs
 323 202





 $ 6,496 $ 6,321





The Company warrants the specifications and/or performance of its products through implied product warranties and has extended product warranties to qualifying customers on a contractual basis. The Company estimates the costs that may be incurred during the warranty period and records a liability in the amount of such costs at the time product is shipped. The Company’s estimate is based on historical experience and estimates of future warranty costs as a result of increasing usage of the Company’s products. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary. Changes in the Company’s accrued warranty costs during the period are as follows (in thousands):

Balance as of December 31, 2014
 $ 202

Warranties issued during the period
 137

Settlements made during the period
 (16 )



Balance as of June 30, 2015
 $ 323



X

- Definition
The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.
+ References
No definition available.
+ Details

Name: us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_PayablesAndAccrualsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 47 R14.htm IDEA: XBRL DOCUMENT v3.3.0.814

Debt
6 Months Ended

Jun. 30, 2015

Debt Disclosure [Abstract]

Debt

6. Debt

Debt consists of the following (in thousands):

 JUNE 30,
2015 DECEMBER 31,
2014

Term Loan (“Term Loan”) bearing interest at 7.00% per annum, which is payable monthly through April 2016, collateralized by all of the Company’s inventories, chattel paper, accounts receivable, equipment and general intangibles (excluding certain financed equipment and intellectual property) pledged as collateral under the Term Loan, subordinated
 $ 116 $ 183

Secured promissory notes (“October 2012 and April 2013 Secured Promissory Notes”) bearing interest at 12.00% per annum, which are payable monthly through October 2015, collateralized by substantially all of the Company’s assets, net of unamortized debt discount as of June 30, 2015 and December 31, 2014 of $76 and $203, respectively
 12,374 12,247

Secured promissory note (“June 2014 Secured Promissory Note”) bearing interest at prime plus 2% (5.25% as of June 30, 2015) per annum, which is payable monthly through June 2036, collateralized by all of the Company’s deposit accounts and MMM LLC’s inventories, chattel paper, accounts, equipment and general intangibles
 9,748 9,873



Debt
 22,238 22,303

Less current portion
 (12,749 ) (12,636 )



 $ 9,489 $ 9,667



The fair value of the Company’s outstanding debt obligations as of June 30, 2015 and December 31, 2014 was $22,348,000 and $22,587,000, respectively, which was estimated based on a discounted cash flow model using an estimated market rate of interest of 11.25% for the fixed rate debt and 5.25% for the variable rate debt, and is classified as Level 3 within the fair value hierarchy.

Term Loan

In March 2009, October 2010 and October 2011, the Company and Five Star Bank agreed to modify the terms of its existing revolving line of credit (“Revolver”). Under the modified terms of the Revolver, the Company’s borrowings under the Revolver were limited to 75% of qualifying accounts receivable with a maximum borrowing limit of $500,000. In March 2012, the Company entered into a change in terms agreement with the bank under which the existing Revolver was replaced by the Term Loan in the amount of $500,000 with a rate of 7% per annum, maturing April 1, 2016. The Company’s inventories, chattel paper, accounts receivable, equipment and general intangibles (excluding certain financed equipment and intellectual property) have been pledged as collateral under the Term Loan. The Term Loan provides for various events of default including breach of any term, obligation, covenant or condition under any other agreement between the Company and Five Star Bank. As of June 30, 2015, the Company was in breach of its covenants under the Term Loan as the Company was in breach of its covenants under its June 2014 Secured Promissory Note. However, this breach was cured in November 2015 as a result of the Company obtaining a waiver of certain of the Company’s covenants with respect to the June 2014 Secured Promissory Note as discussed below. The Term Loan was fully paid off in August 2015.

Secured Promissory Notes

On October 2, 2012, the Company borrowed $7,500,000 pursuant to senior notes (“October 2012 Secured Promissory Notes”) with a group of lenders. The October 2012 Secured Promissory Notes have an initial term of three years and can be extended for an additional two years in one year increments at the option of the Company. During the initial three-year term, the October 2012 Secured Promissory Notes bear interest at 12% per annum. If the term of the October 2012 Secured Promissory Notes is extended an additional year, the interest rate is 13% during the fourth year. If the term of the October 2012 Secured Promissory Notes is extended for an additional two years, the interest rate is 14% during the fifth year. Interest on the October 2012 Secured Promissory Notes is payable monthly through the initial maturity date of the loan, which is October 2, 2015, or through any extension period. The principal and all unpaid interest are due on the maturity date, as may be extended.

As part of the terms of the October 2012 Secured Promissory Notes, the Company is required to pay a fee of 5% of the funded principal amount to the agent that facilitated the borrowing and provides management of the relationship with the group of lenders (“Agent Fee”). This Agent Fee is payable within 30 days after all interest and principal have been paid. For each year the Company extends the maturity date of the October 2012 Secured Promissory Notes beyond the initial term, the agent will receive an additional 1% fee based on the funded principal amount. The present value of the unpaid Agent Fee, based on 5% of the funded principal amount, or $261,000, as of the closing date of the October 2012 Secured Promissory Notes was recorded as both deferred financing costs as a component of current and non-current other assets and non-current other liabilities. The amortization of the deferred

financing costs and the accretion of the Agent Fee are recorded to interest expense over the term of the arrangement. As of June 30, 2015, $603,000 of the Agent Fee, including the amounts relating to the additional funds received from the issuance of the April 2013 Secured Promissory Notes discussed below, was recorded under accrued liabilities. In addition, the Company incurred an additional $66,000 in financing-related costs, primarily legal fees. These costs were recorded as deferred financing costs as a component of current and non-current other assets and are being amortized to interest expense over the term of the arrangement.

The October 2012 Secured Promissory Notes are secured by the Company’s ownership interest in MMM LLC, a security interest in the assets of the Company’s manufacturing plant and all of the Company’s other assets, subject to certain permitted liens. This security interest was subordinate to the security interest held by the holder of a previously outstanding promissory note issued in April 2012 and repaid in January 2013 (“April 2012 Note”), which also had a security interest in MMM LLC.

The Company also issued warrants (“Common Stock Warrants”) to the group of lenders to purchase a number of shares of common stock equal to 15% of the funded principal amount of the October 2012 Secured Promissory Notes divided by 70% of the value of common stock in a sale of the Company or a Qualified IPO, with such Common Stock Warrants having an exercise price of 70% of the value of common stock in a sale of the Company or a Qualified IPO. The Common Stock Warrants would be automatically exercised immediately prior to expiration on the earlier to occur of a Qualified IPO or a sale of the Company or the maturity of the October 2012 Secured Promissory Notes. The October 2012 Secured Promissory Notes could be prepaid six months after the initial funding date or earlier if a Qualified IPO or a sale of the Company occurs. As the predominant settlement feature of the Common Stock Warrants is to settle a fixed monetary amount in a variable number of shares, the Common Stock Warrants were accounted for under ASC 480, Distinguishing Liabilities from Equity (“ASC 480”). Accordingly, the Common Stock Warrants were recorded at estimated fair value on their issuance date and were adjusted to their estimated fair value as of each reporting date with the change in estimated fair value recorded as a component of change in estimated fair value of financial instruments in the Company’s condensed consolidated statements of operations. The fair value of the Common Stock Warrants at the date of issuance of $282,000 was recorded as a discount to the October 2012 Secured Promissory Notes and is being amortized to interest expense over the term of the arrangement. Until the effective date of the IPO, the Company estimated the fair value of the Common Stock Warrants using a Probability-Weighted Expected Return Method (“PWERM”) valuation based on unobservable inputs, and, therefore, the Common Stock Warrants were classified as Level 3 liabilities in the fair value hierarchy. Upon closing of the IPO, the exercise price of the Common Stock Warrants was determined to be $8.40 per share and the number of shares to be issued upon exercise of the warrants was no longer variable. As a result of the IPO, the Common Stock Warrants were considered to be indexed to the Company’s stock, and accordingly, the common stock warrants liability was reclassified and included in stockholders’ equity (deficit) during the year ended December 31, 2013.

The October 2012 Secured Promissory Notes contain certain covenant requirements, which include a requirement to maintain a minimum cash balance of the lesser of the April 2012 Note indebtedness described above or $5,000,000. As the April 2012 Note was fully paid off in January 2013, the Company no longer has a minimum cash balance requirement under the October 2012 Secured Promissory Notes. The Company is also precluded from adding additional debt without lender approval but allowance is made if such debt is subordinated to the October 2012 Secured Promissory Notes or if such additional debt is not more than $2,000,000 in the aggregate. In the event of default on the October 2012 Secured Promissory Notes, the lenders may declare the entire unpaid principal and interest immediately due and payable.

On April 10, 2013 (“Conversion Date”), the Company entered an amendment to increase, by up to $5,000,000, the amount available under the terms of the loan agreement with respect to the October 2012 Secured Promissory Notes. Under this amendment, an additional $4,950,000 was issued in partial consideration for $3,700,000 in cash received and in partial conversion for the cancellation of $1,250,000 of the total principal balance of the October 2012 Subordinated Convertible Note described below (collectively, “April 2013 Secured Promissory Notes”). The total amount borrowed under the amended loan agreement for the October 2012 Secured Promissory Notes and the April 2013 Secured Promissory Notes increased from $7,500,000 to $12,450,000 as of the Conversion Date. The accrued interest of $74,000 for the partially converted October 2012 Subordinated Convertible Note as of the Conversion Date shall be repaid or converted on the applicable maturity date of the October 2012 Subordinated Convertible Note.

In connection with the issuance of the April 2013 Secured Promissory Notes, the Company issued additional warrants (“Additional Common Stock Warrants”) to purchase a number of shares of common stock equal to 20% of the funded principal amount of the April 2013 Secured Promissory Notes divided by 70% of the value of common stock in a sale of the Company or a Qualified IPO, with such Additional Common Stock Warrants to have an exercise price of 70% of the value of common stock in a sale of the Company or a Qualified IPO. As the predominant settlement feature of the Additional Common Stock Warrants was to settle a fixed monetary amount in a variable number of shares, the Additional Common Stock Warrants were accounted for under ASC 480. Accordingly, the Additional Common Stock Warrants were recorded at estimated fair value on their issuance date and were adjusted to their estimated fair value as of each reporting date with the change in estimated fair value recorded as a component of change in estimated fair value of financial instruments in the Company’s condensed consolidated statements of operations. The fair value of the Additional Common Stock Warrants at the date of issuance was estimated to be $465,000. The Company estimated the fair value of the Additional Common Stock Warrants using a PWERM valuation based on unobservable inputs and, therefore, the Additional Common Stock Warrants were classified as Level 3 liabilities in the fair value hierarchy. Upon closing of the IPO, the exercise price of the Additional Common Stock Warrants was determined to be $8.40 per share and the number of shares to be issued upon exercise of the warrants was no longer variable. As a result of the IPO, the Additional Common Stock Warrants were considered to be indexed to the Company’s stock, and accordingly, the common stock warrants liability was reclassified and included in stockholders’ equity (deficit) during the year ended December 31, 2013.

The debt holder who converted $1,250,000 principal balance of the October 2012 Subordinated Convertible Note (with a fair value of $1,360,000 on the date of conversion) also loaned an additional $2,500,000 in cash as part of the April 2013 Secured Promissory Notes (collectively, the “$3,750,000 Notes”). The Company accounted for the conversion as an extinguishment of debt in accordance with ASC 470-50-40, Modifications and Extinguishments (“ASC 470-50-40”). The $1,360,000 fair value of the partially converted October 2012 Subordinated Convertible Note on the Conversion Date was derecognized and the fair value of the $3,750,000 Notes with the portion of the fair value of the Additional Common Stock Warrants issued to this debt holder on the date of issuance was recorded. The Company recorded the $49,000 excess of the total fair value of the $3,750,000 Notes and the related Additional Common Stock Warrants on the issuance date over total consideration received as a gain on extinguishment of debt in the condensed consolidated statements of operations for the year ended December 31, 2013.

The following table shows the consideration received, fair values of the notes and common stock warrants issued and calculation of the gain on extinguishment of debt for the $3,750,000 Notes (in thousands):

Consideration received


Fair value of October 2012 Subordinated Convertible Note
 $ 1,360

Cash
 2,500



Total consideration received (a)
 $ 3,860

Notes and warrants issued


Principal balance of notes issued
 $ 3,750

Debt discount ⁽¹⁾
 (291 )



Fair value of notes issued
 3,459

Fair value of Additional Common Stock Warrants issued
 352



Total fair value of notes and warrants issued (b)
 $ 3,811



Gain on extinguishment of debt (a-b)
 $ 49



⁽¹⁾ The amortization of this account is being recorded in interest expense in the condensed consolidated statements of operations over the term of the arrangement.

The remaining fair value of the Additional Common Stock Warrants of $113,000, net of the fair value of the Additional Common Stock Warrants issued of $352,000 related to the $3,750,000 Notes discussed above, was recorded as a debt discount to the April 2013 Secured Promissory Notes and is being amortized to interest expense over the term of the arrangement.

As a result of the amendment described above, the Company is also required to pay the Agent Fee, 5% of the $3,700,000 in cash received from the April 2013 Secured Promissory Notes, under the same terms as the October 2012 Secured Promissory Notes. In addition, the portion of the Agent Fee relating to the converted October 2012 Subordinated Convertible Note that would be due under the terms of the October 2012 Subordinated Convertible Note will be paid under the terms of the October 2012 and April 2013 Secured Promissory Notes. The present value of the unpaid Agent Fee of $172,000, based on 5% of the funded principal amount of $4,950,000, as of the closing date of the April 2013 Secured Promissory Notes was recorded as both deferred financing costs as a component of current and non-current other assets and non-current other liabilities. The amortization of the deferred financing costs and the accretion of the Agent Fee are being amortized to interest expense over the term of the arrangement.

In addition, the Company incurred an additional $24,000 in financing-related costs, primarily legal fees. These costs were recorded as deferred financing costs as a component of current and non-current other assets and are being amortized to interest expense over the term of the arrangement.

The amendment to the loan agreement also amended the interest provision applicable to the October 2012 and April 2013 Secured Promissory Notes to allow any holder of the October 2012 and April 2013 Secured Promissory Notes to request the Company to defer all interest due monthly to the applicable maturity date, and the optional prepayment provision applicable to the October 2012 and April 2013 Secured Promissory Notes to allow the Company to repay the outstanding amount of the October 2012 and April 2013 Secured Promissory Notes either (i) with the written consent of the lender or the agent on such lenders’ behalf or (ii) without such consent provided that the Company pays the interest that would have been due from the prepayment date to the initial maturity date.

Activity related to the October 2012 and April 2013 Secured Promissory Notes from December 31, 2014 through June 30, 2015 consisted of the following (in thousands):

 DECEMBER 31,
2014 ADDITIONS AMORTIZATION
OF DEBT
DISCOUNT PRINCIPAL
PAYMENTS JUNE 30,
2015

Principal
 $ 12,450 $ — $ — $ — $ 12,450

Debt discount related to the issuance of common stock warrants ⁽¹⁾
 (106 ) — 69 — (37 )

Discount related to the $3,750,000 Notes ⁽¹⁾
 (97 ) — 58 — (39 )









 $ 12,247 $ — $ 127 $ — $ 12,374









⁽¹⁾ The amortization of this account is included in interest expense in the condensed consolidated statements of operations and as non-cash interest expense in the condensed consolidated statements of cash flows.

As of June 30, 2015 and December 31, 2014, the Company was in breach of its covenants under the October 2012 and April 2013 Secured Promissory Notes as a result of its failure to provide annual financial statements in a timely manner and as the Company was in breach of certain of its covenants under its June 2014 Secured Promissory Note as described below. However, in November 2015, the Company received an extension from the lending agent with respect to compliance with the requirements to deliver annual financial statements to the earlier of (i) November 15, 2015 or (ii) such time such financial statements are filed with the SEC. Further, the covenant breach was cured in November 2015 as a result of obtaining this extension and the waiver of certain of the Company’s covenants with respect to the June 2014 Secured Promissory Note as described below.

In August 2015, the terms of the notes were amended, resulting in an increase in the interest rate to 18% effective September 1, 2015 for the remaining term of the notes. The Company also provided a written notice in September 2015 to extend the maturity date to October 2, 2017.

Credit Facility

On June 14, 2013, the Company entered into a credit facility agreement (“June 2013 Credit Facility”) with a group of lenders that are, or that are affiliated with, existing investors in the Company. Under the June 2013 Credit Facility, the lenders have committed to permit the Company to draw an aggregate of up to $5,000,000, and, subject to the Company’s obtaining additional commitments from lenders, such amount may be increased to up to $7,000,000. The June 2013 Credit Facility expired on June 30, 2014 without having been drawn upon.

During the term of the June 2013 Credit Facility, the Company could request from the lenders up to four advances, with each advance equal to one-quarter of each lender’s aggregate commitment amount. The Company would issue a promissory note in the principal amount of each such advance that would accrue interest at a rate of 10% per annum. The principal and all unpaid interest under the promissory notes would be due on the maturity date, and the Company could not prepay the promissory notes prior to the maturity date without consent of at least a majority in interest of the aggregate principal amount of the promissory notes then outstanding under the June 2013 Credit Facility.

In connection with the June 2013 Credit Facility, the Company agreed to pay a fee of 2% of the total commitment amount to the lenders. In addition, the Company incurred an additional $10,000 in financing-related costs, primarily legal fees. These costs were recorded as deferred financing costs as a component of current other assets and were fully amortized to interest expense as of December 31, 2014.

In connection with the June 2013 Credit Facility, the Company issued warrants (“June 2013 Warrants”) to purchase a number of shares of common stock equal to 10% of the total committed amount of the June 2013 Credit Facility divided by 70% of the value of common stock in a sale of the Company or a Qualified IPO, with such June 2013 Warrants to have an exercise price of 70% of the value of common stock in a sale of the Company or a Qualified IPO. The June 2013 Warrants expire upon the earlier of June 14, 2023 or the sale of the Company. As the predominant settlement feature of the June 2013 Warrants was to settle a fixed monetary amount in a variable number of shares, the June 2013 Warrants were accounted for under ASC 480. Accordingly, the June 2013 Warrants were recorded at estimated fair value on their issuance date and were adjusted to their estimated fair value as of each reporting date with the change in estimated fair value recorded as a component of change in estimated fair value of financial instruments in the Company’s condensed consolidated statements of operations. The fair value of the June 2013 Warrants at the date of issuance of $435,000 was recorded as a deferred financing cost as a current other asset and was being amortized to interest expense over the term of the arrangement. Until the effective date of the IPO, the Company estimated the fair value of the June 2013 Warrants using a PWERM valuation based on unobservable inputs and, therefore, the June 2013 Warrants were classified as Level 3 liabilities in the fair value hierarchy. Upon closing of the IPO, the exercise price of the June 2013 Warrants was determined to be $8.40 per share and the number of shares to be issued upon exercise of the warrants was no longer variable. As a result of the IPO, the June 2013 Warrants were considered to be indexed to the Company’s stock, and accordingly, the common stock warrants liability was reclassified and included in stockholders’ equity (deficit) during the year ended December 31, 2013.

Secured Promissory Note

On April 11, 2014, the Company entered into a $3,000,000 promissory note with Five Star Bank. On April 14, 2014, the Company entered into an agreement with the bank to modify the terms of the promissory note from a single payment loan to a revolving line of credit, which allowed the Company to borrow up to $3,000,000. On April 28, 2014, the Company entered into an agreement to modify the terms of the revolving line of credit to increase the borrowing limit up to $5,000,000. In June 2014, the $4,687,000 balance on the revolving line of credit was paid off and the line was closed when the Company borrowed $10,000,000 pursuant to a business loan agreement and promissory note (“June 2014 Secured Promissory Note”) with the bank (“Lender”) which bears interest at prime rate (3.25% as of June 30, 2015) plus 2.00% per annum. The interest rate is subject to change from time to time to reflect changes in the prime rate; however, the interest rate shall not be less than 5.25% or more than the maximum rate allowed by applicable law. If the interest rate increases, the Lender, may, at its option, increase the amount of each monthly payment to ensure that the note would be paid in full by the maturity date, increase the amount of each monthly payment to reflect the change in interest rate, increase the number of monthly payments or keep the monthly payments the same and increase the final payment amount.

The June 2014 Secured Promissory Note is repayable in monthly payments of $64,390 commencing in July 2014, with the final payment due in June 2036. Certain of the Company’s deposit accounts and MMM, LLC’s inventories, chattel paper, accounts, equipment and general intangibles have been pledged as collateral for the promissory note. The Company is required to maintain a deposit balance with the Lender of $1,560,000, which is recorded as restricted cash included in non-current assets. In addition, until the Company provides documentation that the proceeds were used for construction of the Company’s manufacturing plant, proceeds from the loan will be maintained in a restricted deposit account. As of June 30, 2015, the Company had $1,856,000 remaining in this restricted deposit account, which is recorded as restricted cash included in current assets.

In addition, the Company incurred an additional $304,000 in financing-related costs, including USDA guarantee fees. These costs were recorded as deferred financing costs as a component of current and non-current other assets on the date of issuance and are being amortized to interest expense over the term of the arrangement.

The Company may prepay 20% of the outstanding principal loan balance each year without penalty. A prepayment fee of 10% will be charged if prepayments exceed 20% in the first year, and the prepayment fee will decrease by 1% each year for the first ten years of the loan.

The Company is required to maintain a current ratio of not less than 1.25-to-1.0, a debt-to-worth ratio of no greater than 4.0-to-1.0 and a loan-to-value ratio of no greater than 70% as determined by the lender. The Company is also required to comply with certain affirmative and negative covenants under the loan agreement discussed above. In the event of default on the debt, the lender may declare the entire unpaid principal and interest immediately due and payable. As of June 30, 2015 and December 31, 2014, the Company was in breach of certain of its covenants under the loan agreement as a result of its annual and quarterly reports not being filed within the prescribed time period and its being in breach of covenants on the October 2012 and April 2013 Secured Promissory Notes described above. Effective September 30, 2015, the Company’s debt-to-worth ratio was greater than 4.0-to-1.0 as a result of the issuance of $40,000,000 in promissory notes in August 2015 as described in Note 10, which increased the Company’s debt while the Company continued to incur net losses, which decreased stockholders’ equity. However, in November 2015, the Company received a waiver from the Lender with respect to compliance with the requirements to (i) deliver annual financial statements (extended to November 15, 2015), (ii) maintain a current ratio greater than 1.25-to-1.0 (extended to December 31, 2015) and (iii) maintain a debt-to-worth ratio less than 4.0-to-1.0 (extended to December 31, 2016). The receipt of this waiver and the extension to provide financial statements under the October 2012 and April 2013 Secured Promissory Notes cured the Company of being in breach of the covenants under the loan agreement.

X

- References
No definition available.
+ Details

Name: us-gaap_DebtDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20,22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 48 R16.htm IDEA: XBRL DOCUMENT v3.3.0.814

Commitments and Contingencies
6 Months Ended

Jun. 30, 2015

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

8. Commitments and Contingencies

Operating Leases

The Company has a non-cancelable lease for an aggregate of approximately 24,500 square feet of non-contiguous office space in an office complex in Davis, California under which a portion of the covered space terminated beginning in February 2014. The remaining portion of the space will terminate by October 2016. The lease includes negotiated annual increases in the monthly rental payments.

In September 2013 and then amended in April 2014, the Company entered into a lease agreement for approximately 27,300 square feet of office and laboratory space located in Davis, California. The initial term of the lease is for a period of 60 months and commenced in August 2014. The monthly base rent is $44,000 per month for the first 12 months with a 3% increase each year thereafter. Concurrent with this amendment, in April 2014, the Company entered into a lease agreement with an affiliate of the landlord to lease approximately 17,400 square feet of office and laboratory space in the same building complex in Davis, California. The initial term of the lease is for a period of 60 months and commenced in August 2014. The monthly base rent is $28,000 with a 3% increase each year thereafter.

Litigation

On September 5, 2014, September 8, 2014, September 11, 2014, September 15, 2014 and November 3, 2014, the Company, along with certain of its current and former officers and directors and others were named as defendants in putative securities class action lawsuits filed in the U.S. District Court for the Eastern District of California. On February 13, 2015, these actions were consolidated as Special Situations Fund III QP, L.P. et al v. Marrone Bio Innovations, Inc. et al, Case No 2:14-cv-02571-MCE-KJN. On September 2, 2015, an initial consolidated complaint was filed on behalf of (i) all persons who purchased or otherwise acquired the Company’s publicly traded common stock directly in or traceable to the Company’s August 1, 2013 initial public offering; (ii) all persons who purchased or otherwise acquired the Company’s publicly traded common stock directly in the Company’s June 6, 2014 secondary offering; and (iii) all persons who purchased or otherwise acquired the Company’s publicly traded common stock on the open market between March 7, 2014 and September 2, 2014 (the “Class Action”). In addition to the Company, the initial consolidated complaint names certain of the Company’s current and former officers and directors and the Company’s independent registered public accounting firm as defendants. The initial consolidated complaint alleges violations of the Securities Act of 1933, the Securities Exchange Act of 1934 and SEC Rule 10b-5, arising out of the issuance of allegedly false and misleading statements about the Company’s business and prospects, including its financial statements, product revenues and system of internal controls. Plaintiffs contend that such statements caused the Company’s stock price to be artificially inflated. The action includes claims for damages, fees and expenses, including an award of attorneys’ and experts’ fees to the putative class. Pursuant to a stipulation between the parties, and by order of the Court, defendants need not respond to the initial consolidated complaint. An amended consolidated complaint is to be filed no later than 60 days after the Company announces the restatement(s) after which defendants will have 60 days to respond. The outcome of this matter is not presently determinable.

On September 9, 2014 and November 25, 2014, shareholder derivative actions were filed in the Superior Court of California, County of Yolo (Case No. CV14-1481) and the U.S. District Court for the Eastern District of California (Case No. 1:14-cv-02779-JAM-CKD), purportedly on the Company’s behalf, against certain current and former officers and members of its board of directors (the “2014 Derivative Actions”). The plaintiffs in the 2014 Derivative Actions allege that the defendants breached their fiduciary duties, committed waste, were unjustly enriched and aided and abetted breaches of fiduciary duty by causing the Company to issue allegedly false and misleading statements. The issues in the 2014 Derivative Actions overlap substantially with those at issue in the Class Action described above. The plaintiffs in the 2014 Derivative Actions seek, purportedly on behalf of the Company, an unspecified award of damages including, but not limited to, various corporate governance reforms, an award of restitution, an award of reasonable costs and expenses, including attorneys’ fees, and other further relief as the Court may deem just and proper. The Courts have granted the parties’ stipulations to defer litigation activity, subject to certain conditions and pending certain developments in the Class Action.

On October 14, 2015, a shareholder derivative action was filed in the Superior Court of California, County of Yolo (Case No. CV15-1423), purportedly on the Company’s behalf, against certain current and former officers and members of the Company’s board of directors and the Company’s independent registered public accounting firm (the “2015 Derivative Action,” and with the 2014 Derivative Actions, the “Derivative Actions”). The plaintiff in the 2015 Derivative Action alleges that the director and officer defendants breached their fiduciary duties, committed waste and were unjustly enriched by causing the Company to issue allegedly false and misleading statements. The plaintiff in the 2015 Derivative Action also alleges that the Company’s independent registered public accounting firm committed professional negligence and malpractice. The issues in the 2015 Derivative Action overlap substantially with those at issue in the 2014 Derivative Actions and the Class Action described above. The parties are negotiating a date by which the defendants’ response to the newly filed complaint will be due. Given the preliminary nature of the Derivative Actions, the Company is not in a position to express any opinion regarding the outcome in these matters.

The Company is currently unable to estimate a range of reasonably possible loss for the litigation because these matters involve significant uncertainties. Those uncertainties include the legal theory or the nature of the claims, the complexity of the facts, the results of any investigation or litigation and the timing of resolution of the investigations or litigation. Although the Company cannot estimate a reasonable range of loss based on currently available information, the resolution of these matters could have a material adverse effect on its financial position, results of operations or cash flows.

SEC Investigation

The Company advised the staff of the Division of Enforcement of the SEC in September 2014 that the Audit Committee of the Company’s board of directors had commenced an internal investigation. The SEC commenced a formal investigation of these matters, with which the Company is cooperating. Though the investigation continues, the Company has engaged in discussions with the Division of Enforcement staff concerning the resolution of any enforcement action that it may recommend. In accordance with ASC 450, Contingencies, the Company has accrued $1,750,000 in its condensed consolidated balance sheets as of June 30, 2015 and December 31, 2014 for its estimate of the penalties arising from such enforcement action and has estimated the range of the reasonably possible loss to be between $1,750,000 and $4,000,000.

Publicity surrounding the foregoing or any enforcement action as a result of the Division of Enforcement’s investigation, even if ultimately resolved favorably, could have an adverse impact on the Company’s reputation, business, financial position, results of operations or cash flows.

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for commitments and contingencies.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=51674963&loc=d3e12565-110249

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 440

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 49 R34.htm IDEA: XBRL DOCUMENT v3.3.0.814

Debt - Schedule of Debt (Detail) - USD ($)
$ in Thousands

Jun. 30, 2015

Dec. 31, 2014

Debt Instrument [Line Items]

Debt $ 22,238 $ 22,303

Less current portion (12,749) (12,636)

Debt, less current portion 9,489 9,667

Secured Debt [Member] | April 2016 Term loan bearing interest at 7.00% [Member]

Debt Instrument [Line Items]

Debt 116 183

Secured Debt [Member] | October 2012 and April 2013 Secured Promissory Notes [Member]

Debt Instrument [Line Items]

Debt 12,374 12,247

Secured Debt [Member] | June 2014 Secured Promissory Note [Member]

Debt Instrument [Line Items]

Debt $ 9,748 $ 9,873

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Carrying amount of long-term debt, net of unamortized discount or premium, including current and noncurrent amounts. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20, 22

-Article 5

+ Details

Name: us-gaap_LongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of long-term debt, after unamortized discount or premium, scheduled to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LongTermDebtCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying amount of long-term debt, net of unamortized discount or premium, excluding amounts to be repaid within one year or the normal operating cycle, if longer (current maturities). Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LongTermDebtNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=mbii_TermLoanBearingInterestRateAtSevenPointZeroZeroPercentThroughAprilTwoThousandSixteenMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=mbii_SecuredPromissoryNotesInterestRateAtTwelvePercentThroughOctoberTwoThousandFifteenMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=mbii_SecuredPromissoryNoteInterestRateAtPrimePlusTwoPercentThroughJuneTwoThousandThirtySixMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 50 R21.htm IDEA: XBRL DOCUMENT v3.3.0.814

Fair Value Measurements (Tables)
6 Months Ended

Jun. 30, 2015

Fair Value Disclosures [Abstract]

Assets and Liabilities Measured at Fair Value on Recurring Basis

The following table presents the Company’s financial assets measured at fair value on a recurring basis as of June 30, 2015 and December 31, 2014 (in thousands):

 JUNE 30, 2015

 TOTAL LEVEL 1 LEVEL 2 LEVEL 3

Assets


Money market funds
 $ 3,749 $ 3,749 $ — $ —









 DECEMBER 31, 2014

 TOTAL LEVEL 1 LEVEL 2 LEVEL 3

Assets


Money market funds
 $ 14,746 $ 14,746 $ — $ —









X

- References
No definition available.
+ Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19190-110258

+ Details

Name: us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 51 R26.htm IDEA: XBRL DOCUMENT v3.3.0.814

Significant Accounting Policies - Additional Information (Detail) - USD ($)
3 Months Ended 6 Months Ended

Jun. 30, 2015

Jun. 30, 2014

Jun. 30, 2015

Jun. 30, 2014

Dec. 31, 2014

Significant Accounting Policies [Line Items]

Concentration risk, supplier The active ingredient in the Company’s Regalia product line is derived from the giant knotweed plant, which the Company obtains from China. The Company’s single supplier acquires raw knotweed from numerous regional sources and performs an extraction process on this plant, creating a dried extract that is shipped to the Company’s manufacturing plant. A disruption at this supplier’s manufacturing site or a disruption in trade between the U.S. and China could negatively impact sales of Regalia. The Company currently uses one supplier and does not have a long-term supply contract with this supplier. Although the Company has identified additional sources of raw knotweed, there can be no assurance that the Company will continue to be able to obtain dried extract from China at a competitive price.

Deferred cost of product revenues $ 1,597,000 $ 1,597,000 $ 1,797,000

Deferred cost of product revenues to related parties 138,000 138,000 333,000

Current deferred product revenues 2,600,000 2,600,000 3,190,000

Current deferred product revenues from related parties $ 278,000 $ 278,000 660,000

Percentage of total revenue recognized on sell-through basis 58.00% 51.00% 48.00% 51.00%

Deferred payments received $ 0 $ 0 $ 750,000 $ 0

Recognized license revenues 83,000 51,000 166,000 96,000

Related party revenues 183,000 206,000 382,000 811,000

Current deferred product revenues 2,652,000 2,652,000 2,861,000

Non-current deferred revenues 1,884,000 1,884,000 2,050,000

Research and development expenses 3,073,000 4,055,000 6,189,000 8,053,000

Patent expenses 255,000 $ 209,000 $ 561,000 $ 508,000

Stock options outstanding [Member]

Significant Accounting Policies [Line Items]

Anti-dilutive securities not included in diluted net loss per share 2,633,000 2,871,000

Warrants to purchase common stock [Member]

Significant Accounting Policies [Line Items]

Anti-dilutive securities not included in diluted net loss per share 145,000 145,000

Strategic collaboration and distribution agreements [Member]

Significant Accounting Policies [Line Items]

Current deferred product revenues 331,000 $ 331,000 331,000

Non-current deferred revenues $ 1,884,000 $ 1,884,000 $ 2,050,000

Sales revenue, net [Member] | Customer concentration risk [Member] | International [Member]

Significant Accounting Policies [Line Items]

Customers accounted for percentage of company's total revenues and accounts receivable 9.00% 6.00% 6.00% 11.00%

Sales revenue, net [Member] | Product concentration risk [Member]

Significant Accounting Policies [Line Items]

Customers accounted for percentage of company's total revenues and accounts receivable 92.00% 98.00% 94.00% 93.00%

Syngenta Ventures [Member]

Significant Accounting Policies [Line Items]

Recognized license revenues $ 8,000 $ 332,000

Affiliate revenues percent 5.00% 5.00%

Number of common shares sold 600,000 600,000

Related party revenues $ 8,000 $ 332,000

Maximum [Member]

Significant Accounting Policies [Line Items]

Receivables due period 120 days

X

- Definition
The maximum number of days from the invoice date that receivables are generally due.
+ References
No definition available.
+ Details

Name: mbii_AccountsReceivableDuePeriod

Namespace Prefix: mbii_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cost of goods produced and sold that have been deferred as of balance sheet date for which revenue has not yet been recognized. Generally, an entity records deferred revenue and deferred cost of goods sold when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.
+ References
No definition available.
+ Details

Name: mbii_DeferredCostOfProductRevenues

Namespace Prefix: mbii_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of cost of goods produced and sold to related parties that have been deferred as of balance sheet date for which revenue has not yet been recognized. Generally, an entity records deferred revenue and deferred cost of goods sold when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.
+ References
No definition available.
+ Details

Name: mbii_DeferredCostOfProductRevenuesToRelatedPartiesCurrent

Namespace Prefix: mbii_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The carrying amount of consideration received or receivable from related parties as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year including sales, license fees and royalties.
+ References
No definition available.
+ Details

Name: mbii_DeferredRevenueCurrentRelatedParties

Namespace Prefix: mbii_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The carrying amount of consideration received or receivable from customers as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year relating to product sales.
+ References
No definition available.
+ Details

Name: mbii_DeferredRevenueProductCurrent

Namespace Prefix: mbii_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The percentage of ownership in the entity's stock for consideration of a related party, where one party can exercise control or significant influence over another party.
+ References
No definition available.
+ Details

Name: mbii_InvestmentOwnershipPercentageRelatedParty

Namespace Prefix: mbii_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
The amount of consideration received from another party for the right to use, but not own, certain of the entity's intangible assets which are deferred and recognized over the term of the exclusive distribution period of the agreement and recognized as license revenue.
+ References
No definition available.
+ Details

Name: mbii_LicenseAgreementsDeferredPaymentsReceived

Namespace Prefix: mbii_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate costs incurred pertaining to the exclusive legal rights granted to the owner of the patent to exploit an invention or a process for a period of time specified by law. Such costs may have been expended to directly apply and receive patent rights, to acquire such rights, or to defend such rights.
+ References
No definition available.
+ Details

Name: mbii_PatentExpenses

Namespace Prefix: mbii_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The percentage of the net revenue recognized for the period when the product was resold to customers of the entity's distributors, the "sell-through" method.
+ References
No definition available.
+ Details

Name: mbii_PercentageOfRevenueRecognizedOnSellThroughBasis

Namespace Prefix: mbii_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of shares of common stock sold by a related party during the period.
+ References
No definition available.
+ Details

Name: mbii_RelatedPartyTransactionNumberOfCommonSharesSoldByRelatedParty

Namespace Prefix: mbii_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Significant Accounting Policies [Line Items]
+ References
No definition available.
+ Details

Name: mbii_SignificantAccountingPoliciesLineItems

Namespace Prefix: mbii_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Antidilution

-URI http://asc.fasb.org/extlink&oid=6505113

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Diluted Earnings Per Share

-URI http://asc.fasb.org/extlink&oid=6510752

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Contingent Stock Agreement

-URI http://asc.fasb.org/extlink&oid=6508534

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 18

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6351-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13531-108611

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6404-108592

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13537-108611

+ Details

Name: us-gaap_ConcentrationRiskPercentage1

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Description of risks that arise due to the volume of business transacted with a particular supplier or reliance placed on that supplier. At a minimum, the description informs financial statement users of the general nature of the risk.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6404-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6327-108592

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 55

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=51801474&loc=d3e7102-108593

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 18

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6351-108592

+ Details

Name: us-gaap_ConcentrationRiskSupplier

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 8

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.A.4(a).Q1)

-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 13

-Section A

+ Details

Name: us-gaap_DeferredRevenueCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The noncurrent portion of deferred revenue amount as of balance sheet date. Deferred revenue is a liability related to a revenue producing activity for which revenue has not yet been recognized, and is not expected to be recognized in the next twelve months. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 8

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.A.4(a).Q1)

-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 13

-Section A

+ Details

Name: us-gaap_DeferredRevenueNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Revenue earned during the period relating to consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(e))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_LicensesRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 730

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 985

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

+ Details

Name: us-gaap_ResearchAndDevelopmentExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(e))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Related Parties

-URI http://asc.fasb.org/extlink&oid=16382449

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 946

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.6-07.1(c))

-URI http://asc.fasb.org/extlink&oid=6488393&loc=d3e606610-122999

+ Details

Name: us-gaap_RevenueFromRelatedParties

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=mbii_WarrantsToPurchaseCommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DeferredRevenueArrangementTypeAxis=mbii_StrategicCollaborationAndDistributionAgreementsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=mbii_InternationalMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mbii_SyngentaMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 52 R41.htm IDEA: XBRL DOCUMENT v3.3.0.814

Commitments and Contingencies - Additional Information (Detail)
1 Months Ended 6 Months Ended

Apr. 30, 2014

USD ($)

ft²

Jun. 30, 2015

USD ($)

ft²

Dec. 31, 2014

USD ($)

Operating Leased Assets [Line Items]

Accrued commitment and contingencies $ 1,750,000 $ 1,750,000

Estimated range of reasonably possible loss, minimum 1,750,000 1,750,000

Estimated range of reasonably possible loss, maximum $ 4,000,000 $ 4,000,000

Non-contiguous office space [Member]

Operating Leased Assets [Line Items]

Office facility lease agreement | ft² 24,500

Non-contiguous office space [Member] | Minimum [Member]

Operating Leased Assets [Line Items]

Leased office facilities expiration period Feb. 28, 2014

Non-contiguous office space [Member] | Maximum [Member]

Operating Leased Assets [Line Items]

Leased office facilities expiration period Oct. 31, 2016

Office and laboratory space one [Member]

Operating Leased Assets [Line Items]

Lease agreement date 2013-09

Office and laboratory space one [Member] | Amendment [Member]

Operating Leased Assets [Line Items]

Office facility lease agreement | ft² 27,300

Lease agreement period 60 months

Monthly base rent $ 44,000

Initial base rent term 12 months

Percentage of annual increase in base rent 3.00%

Lease commenced date 2014-08

Office and laboratory space two [Member]

Operating Leased Assets [Line Items]

Office facility lease agreement | ft² 17,400

Lease agreement period 60 months

Monthly base rent $ 28,000

Percentage of annual increase in base rent 3.00%

Lease commenced date 2014-08

X

- Definition
The length of time that the initial base rent is in effect.
+ References
No definition available.
+ Details

Name: mbii_InitialBaseRentTerm

Namespace Prefix: mbii_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
The initial term of a leasing arrangement.
+ References
No definition available.
+ Details

Name: mbii_InitialTermOfLease

Namespace Prefix: mbii_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Operating lease agreement date.
+ References
No definition available.
+ Details

Name: mbii_OperatingLeaseAgreementDate

Namespace Prefix: mbii_

Data Type: xbrli:gYearMonthItemType

Balance Type: na

Period Type: duration

X

- Definition
Operating lease commencement date.
+ References
No definition available.
+ Details

Name: mbii_OperatingLeaseCommencementDate

Namespace Prefix: mbii_

Data Type: xbrli:gYearMonthItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of annual increase in base rent.
+ References
No definition available.
+ Details

Name: mbii_PercentageOfIncreaseInRentExpense

Namespace Prefix: mbii_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The square footage of office space that is leased.
+ References
No definition available.
+ Details

Name: mbii_SquareFootageOfOfficeSpaceLeased

Namespace Prefix: mbii_

Data Type: num:areaItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
+ References
No definition available.
+ Details

Name: us-gaap_LeaseAndRentalExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Date which lease or group of leases is set to expire, in CCYY-MM-DD format.
+ References
No definition available.
+ Details

Name: us-gaap_LeaseExpirationDate1

Namespace Prefix: us-gaap_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of loss contingency liability expected to be resolved after one year or beyond the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349

+ Details

Name: us-gaap_LossContingencyAccrualCarryingValueNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The estimated maximum amount of possible loss from the contingency.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 4

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 9

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14557-108349

+ Details

Name: us-gaap_LossContingencyRangeOfPossibleLossMaximum

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The estimated minimum amount of possible loss from the contingency.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 4

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 9

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14557-108349

+ Details

Name: us-gaap_LossContingencyRangeOfPossibleLossMinimum

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingLeasedAssetsLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_MajorPropertyClassAxis=mbii_NoncontiguousOfficeSpaceMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MajorPropertyClassAxis=mbii_OfficeAndLaboratorySpaceOneMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RestructuringPlanAxis=mbii_AmendmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MajorPropertyClassAxis=mbii_OfficeAndLaboratorySpaceTwoMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 53 R5.htm IDEA: XBRL DOCUMENT v3.3.0.814

Condensed Consolidated Statements of Operations (Parenthetical) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended

Jun. 30, 2015

Jun. 30, 2014

Jun. 30, 2015

Jun. 30, 2014

Income Statement [Abstract]

Cost of product revenues to related parties $ 113 $ 130 $ 195 $ 291

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeStatementAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Direct costs arising from transactions with related parties who are not affiliates or joint Ventures. These costs are categorized as cost of goods sold.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k)(1))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.2)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_RelatedPartyCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 54 R10.htm IDEA: XBRL DOCUMENT v3.3.0.814

Significant Accounting Policies
6 Months Ended

Jun. 30, 2015

Accounting Policies [Abstract]

Significant Accounting Policies

2. Significant Accounting Policies

Basis of Presentation

The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.

The accompanying financial information as of June 30, 2015, and for the three and six months ended June 30, 2015 and 2014, has been prepared by the Company, without audit, in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such SEC rules and regulations and accounting principles applicable for interim periods. However, the Company believes that the disclosures are adequate to make the information presented not misleading. The information included in this Quarterly Report on Form 10-Q should be read in connection with the consolidated financial statements and accompanying notes included in the Company’s Annual Report filed on Form 10-K for the fiscal year ended December 31, 2014.

In the opinion of management, the condensed consolidated financial statements as of June 30, 2015, and for the three and six months ended June 30, 2015 and 2014, reflect all adjustments, which are normal recurring adjustments, necessary to present a fair statement of financial position, results of operations, comprehensive loss and cash flows. The results of operations for the three and six months ended June 30, 2015 are not necessarily indicative of the operating results for the full fiscal year or any future periods.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents

The Company considers all highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents. Cash and cash equivalents consists of cash on deposit, money market funds and certificates of deposit accounts with United States (“U.S.”) financial institutions. The Company is exposed to credit risk in the event of default by financial institutions to the extent that cash and cash equivalents balances with financial institutions are in excess of amounts that are insured by the Federal Deposit Insurance Corporation. The Company has not experienced any losses on these deposits.

Restricted Cash

The Company’s restricted cash consists of cash that the Company is contractually obligated to maintain on deposit at a bank in accordance with the promissory note entered into in June 2014. See Note 6 for further discussion.

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents, accounts receivable and debt. The Company deposits its cash and cash equivalents with high credit quality domestic financial institutions with locations in the U.S. Such deposits may exceed federal deposit insurance limits. The Company believes the financial risks associated with these financial instruments are minimal.

The Company’s customer base is dispersed across many different geographic areas, and currently most customers are pest management distributors in the U.S. Generally, receivables are due up to 120 days from the invoice date and are considered past due after this date, although the Company may offer extended terms from time to time.

For the three months ended June 30, 2015 and 2014, 9% and 6%, respectively, and for the six months ended June 30, 2015 and 2014, 6% and 11%, respectively, of the Company’s revenues were generated from international customers.

The Company’s principal sources of revenues are its Regalia and Grandevo product lines. These two product lines accounted for 92% and 98% of the Company’s total revenues for the three months ended June 30, 2015 and 2014, respectively, and 94% and 93% for the six months ended June 30, 2015 and 2014, respectively.

Customers to which 10% or more of the Company’s total revenues are attributable for any one of the periods presented consist of the following:

 CUSTOMER A CUSTOMER B CUSTOMER C

For the three months ended June 30,


2015
 34 % 11 % 4 %

2014
 37 % 7 % 12 %

For the six months ended June 30,


2015
 27 % 8 % 8 %

2014
 31 % 6 % 13 %

Customers to which 10% or more of the Company’s outstanding accounts receivable are attributable as of either June 30, 2015 or December 31, 2014 consist of the following:

 CUSTOMER A CUSTOMER B CUSTOMER C CUSTOMER D

June 30, 2015
 46 % 10 % 8 % *

December 31, 2014
 10 % * 37 % 23 %

* Represents less than 1% of outstanding accounts receivable

Concentrations of Supplier Dependence

The active ingredient in the Company’s Regalia product line is derived from the giant knotweed plant, which the Company obtains from China. The Company’s single supplier acquires raw knotweed from numerous regional sources and performs an extraction process on this plant, creating a dried extract that is shipped to the Company’s manufacturing plant. A disruption at this supplier’s manufacturing site or a disruption in trade between the U.S. and China could negatively impact sales of Regalia. The Company currently uses one supplier and does not have a long-term supply contract with this supplier. Although the Company has identified additional sources of raw knotweed, there can be no assurance that the Company will continue to be able to obtain dried extract from China at a competitive price.

Inventories

Inventories are stated at the lower of cost or market value (net realizable value or replacement cost) and include the cost of material and external and internal labor and manufacturing costs. Cost is determined on the first-in, first-out basis. The Company provides for inventory reserves when conditions indicate that the selling price may be less than cost due to physical deterioration, obsolescence, changes in price levels or other factors. Additionally, the Company provides reserves for excess and slow-moving inventory on hand that is not expected to be sold to reduce the carrying amount of excess and slow-moving inventory to its estimated net realizable value. The reserves are based upon estimates about future demand from the Company’s customers and distributors and market conditions.

Deferred Cost of Product Revenues

Deferred cost of product revenues are stated at the lower of cost or net realizable value and include product sold where title has transferred but the criteria for revenue recognition have not been met. As of June 30, 2015 and December 31, 2014, the Company recorded deferred cost of product revenues of $1,597,000 and $1,797,000, respectively, including deferred cost of product revenues to related parties of $138,000 and $333,000, respectively.

Revenue Recognition

The Company recognizes revenues when persuasive evidence of an arrangement exists, transfer of title has occurred or services have been rendered, the price is fixed or determinable and collectability is reasonably assured. If contractual obligations, acceptance provisions or other contingencies exist which indicate that the price is not fixed or determinable, revenue is recognized after such obligations or provisions are fulfilled or expire.

Product revenues consist of revenues generated from sales of the Company’s products to distributors and direct customers, net of rebates and cash discounts. For sales of products made to distributors, the Company recognizes revenue either on a sell-in or sell-through basis depending on the specific facts and circumstances of the transaction(s) with the distributor. Factors considered include, but are not limited to, whether the payment terms offered to the distributor are structured to correspond to when product is resold, the distributor history of adhering to the terms of its contractual arrangements with the Company, whether the Company has a pattern of granting concessions for the benefit of the distributor and whether there are other conditions that may indicate that the sale to the distributor is not substantive.

In some cases, the Company recognizes distributor revenue as title and risk of loss passes, provided all other revenue recognition criteria have been satisfied (the “sell-in” method). For certain sales to certain distributors, the revenue recognition criteria for distributor sales are not satisfied at the time title and risk of loss passes to the distributor; specifically, in instances where “inventory protection” arrangements were offered to distributors that would permit these distributors to return to the Company certain unsold products, the Company considers the arrangement not to be fixed or determinable, and accordingly, revenue is deferred until products are resold to customers of the distributor (the “sell-through” method). As of June 30, 2015 and December 31, 2014, the Company recorded current deferred product revenues of $2,600,000 and $3,190,000, respectively, including current deferred product revenues from related parties of $278,000 and $660,000, respectively. The cost of product revenues associated with such deferral are also deferred and classified as deferred cost of product revenues in the condensed consolidated balance sheets. Cash received from customers related to delivered product that may not represent a true sale is classified as customer refund liabilities in the condensed consolidated balance sheets and the related cost of inventory remains in inventory in the condensed consolidated balance sheets until the product is returned or is resold to customers of the distributor and revenue is recognized. For the three months ended June 30, 2015 and 2014, 58% and 51%, respectively, and for the six months ended June 30, 2015 and 2014, 48% and 51%, respectively, of total revenues were recognized on a sell-through basis.

From time to time, the Company offers certain product rebates to its distributors and growers, which are estimated and recorded as reductions to product revenues, and an accrued liability is recorded at the later of when the revenues are recorded or the rebate is being offered.

The Company recognizes license revenues pursuant to strategic collaboration and distribution agreements under which the Company receives payments for the achievement of testing validation, regulatory progress and commercialization events. As these activities and payments are associated with exclusive rights that the Company provides in connection with strategic collaboration and distribution agreements over the term of the agreements, revenues related to the payments received are deferred and recognized over the term of the exclusive distribution period of the respective agreement. For the six months ended June 30, 2015, the Company received payments totaling $750,000 under these agreements. No payments were received under these agreements for the three months ended June 30, 2015 and the three and six months ended June 30, 2014. For the three months ended June 30, 2015 and 2014, the Company recognized $83,000 and $51,000, respectively, as license revenues, excluding related party revenues. For the six months ended June 30, 2015 and 2014, the Company recognized $166,000 and $96,000, respectively, as license revenues, excluding related party revenues.

The Company has a strategic collaboration and distribution agreement with Syngenta, an affiliate of a former 5% stockholder, Syngenta Ventures Pte. LTD (Syngenta Ventures). In connection with the Company’s secondary offering in June 2014, Syngenta Ventures sold 600,000 shares of the Company’s common stock, reducing its ownership percentage below 5%. Accordingly, revenue recognized under this agreement subsequent to June 2014 has not been included in related party revenues. For the three and six months ended June 30, 2014, the Company recognized $8,000 and $332,000, respectively, of related party revenues under this agreement prior to Syngenta Ventures reducing its ownership stake.

As of June 30, 2015, the Company recorded current and non-current deferred revenues of $331,000 and $1,884,000, respectively, related to payments received under these agreements. As of December 31, 2014, the Company recorded current and non-current deferred revenues of $331,000 and $2,050,000, respectively, related to payments received under these agreements.

Research, Development and Patent Expenses

Research and development expenses include payroll-related expenses, field trial costs, toxicology costs, regulatory costs, consulting costs and lab costs. Patent expenses include legal costs relating to the patents and patent filing costs. These costs are expensed to operations as incurred. For the three months ended June 30, 2015 and 2014, research and development expenses totaled $3,073,000 and $4,055,000, respectively, and patent expenses totaled $255,000 and $209,000, respectively. For the six months ended June 30, 2015 and 2014, research and development expenses totaled $6,189,000 and $8,053,000, respectively, and patent expenses totaled $561,000 and $508,000, respectively.

Net Loss per Share

Net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding for the period. The calculation of basic and diluted net loss per share is the same for all periods presented as the effect of the potential common stock equivalents, which consist of stock options and warrants to purchase common stock, are anti-dilutive due to the Company’s net loss position. Anti-dilutive common stock equivalents are excluded from diluted net loss per share. The anti-dilutive stock options that were not included in diluted net loss per share were 2,633,000 and 2,871,000 as of June 30, 2015 and 2014, respectively. The anti-dilutive warrants to purchase common stock that were not included in diluted net loss per share were 145,000 as of both June 30, 2015 and 2014.

Recently Issued Accounting Pronouncements

In July 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory (“ASU 2015-11”), which applies guidance on the subsequent measurement of inventory. ASU 2015-11 states that an entity should measure inventory at the lower of cost and net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonable predictable costs of completion, disposal and transportation. The guidance excludes inventory measured using last-in, first-out or the retail inventory method. ASU 2015-11 is effective for interim and annual reporting periods beginning after December 15, 2016. Early adoption is permitted. The Company is not planning to early adopt ASU 2015-11 and is currently evaluating ASU 2015-11 to determine the potential impact to its condensed consolidated financial statements and related disclosures.

In April 2015, the FASB issued Accounting Standards Update No. 2015-03, Interest—Imputation of Interest (Topic 835-30): Simplifying the Presentation of Debt Issuance Costs (“ASU 2015-03”). ASU 2015-03 requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs is not affected by ASU 2015-03. ASU 2015-03 is effective for financial statements issued for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. Early adoption is permitted. Upon adoption, the Company will reclassify debt issuance costs from prepaid expenses and other current assets and other assets as a reduction to debt in the condensed consolidated balance sheets. The Company is not planning to early adopt ASU 2015-03 and does not anticipate that the adoption of ASU 2015-03will materially impact its condensed consolidated financial statements.

In August 2014, the FASB issued Accounting Standards Update No. 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (“ASU 2014-15”). ASU 2014-15 requires management to evaluate for each annual and interim reporting period whether conditions or events give rise to substantial doubt that an entity has the ability to continue as a going concern within one year following issuance of the financial statements and requires specific disclosures regarding the conditions or events leading to substantial doubt. The new guidance is effective for annual and interim periods ending after December 15, 2016, with early adoption permitted. The Company is currently evaluating ASU 2014-15 to determine the potential impact to its condensed consolidated financial statements and related disclosures.

In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”). ASU 2014-09 provides new, globally applicable converged guidance concerning recognition and measurement of revenue. As a result, significant additional disclosures are required about the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The new guidance is effective for annual and interim periods beginning on or after December 15, 2018. Companies are allowed to transition using either the modified retrospective or full retrospective adoption method. If full retrospective adoption is chosen, three years of financial information must be presented in accordance with the new standard. The Company is currently evaluating the alternative methods of adoption and the effect on its condensed consolidated financial statements and related disclosures.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for all significant accounting policies of the reporting entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18861-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18726-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18743-107790

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18854-107790

+ Details

Name: us-gaap_SignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 55 R27.htm IDEA: XBRL DOCUMENT v3.3.0.814

Significant Accounting Policies - Schedule of Concentration of Credit Risk Percentage (Detail) - Customer concentration risk [Member]
3 Months Ended 6 Months Ended 12 Months Ended

Jun. 30, 2015

Jun. 30, 2014

Jun. 30, 2015

Jun. 30, 2014

Dec. 31, 2014

Customer A [Member] | Sales revenue, net [Member]

Concentration Risk [Line Items]

Customers accounted for percentage of company's total revenues and accounts receivable 34.00% 37.00% 27.00% 31.00%

Customer A [Member] | Accounts receivable [Member]

Concentration Risk [Line Items]

Customers accounted for percentage of company's total revenues and accounts receivable 46.00% 10.00%

Customer B [Member] | Sales revenue, net [Member]

Concentration Risk [Line Items]

Customers accounted for percentage of company's total revenues and accounts receivable 11.00% 7.00% 8.00% 6.00%

Customer B [Member] | Accounts receivable [Member]

Concentration Risk [Line Items]

Customers accounted for percentage of company's total revenues and accounts receivable 10.00%

Customer C [Member] | Sales revenue, net [Member]

Concentration Risk [Line Items]

Customers accounted for percentage of company's total revenues and accounts receivable 4.00% 12.00% 8.00% 13.00%

Customer C [Member] | Accounts receivable [Member]

Concentration Risk [Line Items]

Customers accounted for percentage of company's total revenues and accounts receivable 8.00% 37.00%

Customer D [Member] | Accounts receivable [Member]

Concentration Risk [Line Items]

Customers accounted for percentage of company's total revenues and accounts receivable 23.00%

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ConcentrationRiskLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 18

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6351-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13531-108611

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6404-108592

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13537-108611

+ Details

Name: us-gaap_ConcentrationRiskPercentage1

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_MajorCustomersAxis=mbii_CustomerAMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MajorCustomersAxis=mbii_CustomerBMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MajorCustomersAxis=mbii_CustomerCMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MajorCustomersAxis=mbii_CustomerDMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 56 FilingSummary.xml IDEA: XBRL DOCUMENT 3.3.0.814 html 150 256 1 false 52 0 false 5 false false R1.htm 101 - Document - Document and Entity Information Sheet http://www.marronebioinnovations.com/taxonomy/role/DocumentandEntityInformation Document and Entity Information Cover 1 false false R2.htm 103 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.marronebioinnovations.com/taxonomy/role/StatementOfFinancialPositionClassified Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 104 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.marronebioinnovations.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 105 - Statement - Condensed Consolidated Statements of Operations Sheet http://www.marronebioinnovations.com/taxonomy/role/StatementOfIncome Condensed Consolidated Statements of Operations Statements 4 false false R5.htm 106 - Statement - Condensed Consolidated Statements of Operations (Parenthetical) Sheet http://www.marronebioinnovations.com/taxonomy/role/StatementOfIncomeParenthetical Condensed Consolidated Statements of Operations (Parenthetical) Statements 5 false false R6.htm 107 - Statement - Condensed Consolidated Statements of Comprehensive Loss Sheet http://www.marronebioinnovations.com/taxonomy/role/StatementOfOtherComprehensiveIncome Condensed Consolidated Statements of Comprehensive Loss Statements 6 false false R7.htm 108 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.marronebioinnovations.com/taxonomy/role/StatementOfCashFlowsIndirect Condensed Consolidated Statements of Cash Flows Statements 7 false false R8.htm 109 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical) Sheet http://www.marronebioinnovations.com/taxonomy/role/StatementOfCashFlowsIndirectParenthetical Condensed Consolidated Statements of Cash Flows (Parenthetical) Statements 8 false false R9.htm 110 - Disclosure - Summary of Business, and Liquidity Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsBusinessDescriptionAndBasisOfPresentationTextBlock Summary of Business, and Liquidity Notes 9 false false R10.htm 111 - Disclosure - Significant Accounting Policies Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock Significant Accounting Policies Notes 10 false false R11.htm 112 - Disclosure - Fair Value Measurements Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock Fair Value Measurements Notes 11 false false R12.htm 113 - Disclosure - Inventories Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock Inventories Notes 12 false false R13.htm 114 - Disclosure - Accrued Liabilities Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock Accrued Liabilities Notes 13 false false R14.htm 115 - Disclosure - Debt Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock Debt Notes 14 false false R15.htm 116 - Disclosure - Share-Based Plans Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock Share-Based Plans Notes 15 false false R16.htm 117 - Disclosure - Commitments and Contingencies Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock Commitments and Contingencies Notes 16 false false R17.htm 118 - Disclosure - Related Party Transactions Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock Related Party Transactions Notes 17 false false R18.htm 119 - Disclosure - Subsequent Events Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsSubsequentEventsTextBlock Subsequent Events Notes 18 false false R19.htm 120 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies Significant Accounting Policies (Policies) Policies http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock 19 false false R20.htm 121 - Disclosure - Significant Accounting Policies (Tables) Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockTables Significant Accounting Policies (Tables) Tables http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock 20 false false R21.htm 122 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlockTables Fair Value Measurements (Tables) Tables http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock 21 false false R22.htm 123 - Disclosure - Inventories (Tables) Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables Inventories (Tables) Tables http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock 22 false false R23.htm 124 - Disclosure - Accrued Liabilities (Tables) Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlockTables Accrued Liabilities (Tables) Tables http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock 23 false false R24.htm 125 - Disclosure - Debt (Tables) Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlockTables Debt (Tables) Tables http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock 24 false false R25.htm 126 - Disclosure - Summary of Business, and Liquidity - Additional Information (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureSummaryOfBusinessAndLiquidityAdditionalInformation Summary of Business, and Liquidity - Additional Information (Detail) Details 25 false false R26.htm 127 - Disclosure - Significant Accounting Policies - Additional Information (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformation Significant Accounting Policies - Additional Information (Detail) Details 26 false false R27.htm 128 - Disclosure - Significant Accounting Policies - Schedule of Concentration of Credit Risk Percentage (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfConcentrationOfCreditRiskPercentage Significant Accounting Policies - Schedule of Concentration of Credit Risk Percentage (Detail) Details 27 false false R28.htm 129 - Disclosure - Significant Accounting Policies - Schedule of Concentration of Credit Risk Percentage (Parenthetical) (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfConcentrationOfCreditRiskPercentageParenthetical Significant Accounting Policies - Schedule of Concentration of Credit Risk Percentage (Parenthetical) (Detail) Details 28 false false R29.htm 130 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureFairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasis Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) Details 29 false false R30.htm 131 - Disclosure - Inventories - Schedule of Inventories, Net (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureInventoriesScheduleOfInventoriesNet Inventories - Schedule of Inventories, Net (Detail) Details 30 false false R31.htm 132 - Disclosure - Inventories - Additional Information (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureInventoriesAdditionalInformation Inventories - Additional Information (Detail) Details 31 false false R32.htm 133 - Disclosure - Accrued Liabilities - Schedule of Accrued Liabilities (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilities Accrued Liabilities - Schedule of Accrued Liabilities (Detail) Details 32 false false R33.htm 134 - Disclosure - Accrued Liabilities - Schedule of Changes in Accrued Warranty Costs (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureAccruedLiabilitiesScheduleOfChangesInAccruedWarrantyCosts Accrued Liabilities - Schedule of Changes in Accrued Warranty Costs (Detail) Details 33 false false R34.htm 135 - Disclosure - Debt - Schedule of Debt (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureDebtScheduleOfDebt Debt - Schedule of Debt (Detail) Details 34 false false R35.htm 136 - Disclosure - Debt - Schedule of Debt (Parenthetical) (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureDebtScheduleOfDebtParenthetical Debt - Schedule of Debt (Parenthetical) (Detail) Details 35 false false R36.htm 137 - Disclosure - Debt - Additional Information (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureDebtAdditionalInformation Debt - Additional Information (Detail) Details 36 false false R37.htm 138 - Disclosure - Debt - Consideration Received, Fair Values of Notes, Common Stock Warrants Issued and Calculation of the Gain on Extinguishment of Debt (Detail) Notes http://www.marronebioinnovations.com/taxonomy/role/DisclosureDebtConsiderationReceivedFairValuesOfNotesCommonStockWarrantsIssuedAndCalculationOfTheGainOnExtinguishmentOfDebt Debt - Consideration Received, Fair Values of Notes, Common Stock Warrants Issued and Calculation of the Gain on Extinguishment of Debt (Detail) Details 37 false false R38.htm 139 - Disclosure - Debt - Activity Related to Secured Promissory Note (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureDebtActivityRelatedToSecuredPromissoryNote Debt - Activity Related to Secured Promissory Note (Detail) Details 38 false false R39.htm 140 - Disclosure - Debt - Activity Related to Secured Promissory Note (Parenthetical) (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureDebtActivityRelatedToSecuredPromissoryNoteParenthetical Debt - Activity Related to Secured Promissory Note (Parenthetical) (Detail) Details 39 false false R40.htm 141 - Disclosure - Share-Based Plans - Additional Information (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureShareBasedPlansAdditionalInformation Share-Based Plans - Additional Information (Detail) Details 40 false false R41.htm 142 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformation Commitments and Contingencies - Additional Information (Detail) Details 41 false false R42.htm 143 - Disclosure - Related Party Transactions - Additional Information (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformation Related Party Transactions - Additional Information (Detail) Details 42 false false R43.htm 144 - Disclosure - Subsequent Events - Additional Information (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureSubsequentEventsAdditionalInformation Subsequent Events - Additional Information (Detail) Details 43 false false All Reports Book All Reports In ''Condensed Consolidated Balance Sheets'', column(s) 3, 4 are contained in other reports, so were removed by flow through suppression. In ''Condensed Consolidated Statements of Cash Flows'', column(s) 1, 2, 3 are contained in other reports, so were removed by flow through suppression. mbii-20150630.xml mbii-20150630_cal.xml mbii-20150630_def.xml mbii-20150630_lab.xml mbii-20150630_pre.xml mbii-20150630.xsd true true XML 57 R38.htm IDEA: XBRL DOCUMENT v3.3.0.814

Debt - Activity Related to Secured Promissory Note (Detail)
$ in Thousands
6 Months Ended

Jun. 30, 2015

USD ($)

Debt Instrument [Line Items]

Debt, beginning balance $ 22,303

Debt, ending balance 22,238

October 2012 and April 2013 Secured Promissory Notes [Member]

Debt Instrument [Line Items]

Debt, beginning balance 12,247

Additions 0

Amortization of debt discount 127

Debt, ending balance 12,374

Principal payments 0

October 2012 and April 2013 Secured Promissory Notes [Member] | Principal [Member]

Debt Instrument [Line Items]

Debt, beginning balance 12,450

Additions 0

Amortization of debt discount 0

Debt, ending balance 12,450

Principal payments 0

October 2012 and April 2013 Secured Promissory Notes [Member] | Discount Related To Issuance Of Common Stock Warrants [Member]

Debt Instrument [Line Items]

Debt, beginning balance (106)

Additions 0

Amortization of debt discount 69

Debt, ending balance (37)

Principal payments 0

October 2012 and April 2013 Secured Promissory Notes [Member] | Discount Related to the $3,750,000 Notes [Member]

Debt Instrument [Line Items]

Debt, beginning balance (97)

Additions 0

Amortization of debt discount 58

Debt, ending balance (39)

Principal payments $ 0

X

- Definition
Information on additions to long term debt.
+ References
No definition available.
+ Details

Name: mbii_LongTermDebtIssued

Namespace Prefix: mbii_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.8)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_AmortizationOfDebtDiscountPremium

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of the required periodic payments applied to principal.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentPeriodicPaymentPrincipal

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Carrying amount of long-term debt, net of unamortized discount or premium, including current and noncurrent amounts. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20, 22

-Article 5

+ Details

Name: us-gaap_LongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=mbii_OctoberTwoThousandTwelveAndAprilTwoThousandThirteenSecuredPromissoryNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=mbii_DebtPrincipalMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=mbii_DiscountRelatedToIssuanceOfCommonStockWarrantsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=mbii_DiscountRelatedToNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 58 R20.htm IDEA: XBRL DOCUMENT v3.3.0.814

Significant Accounting Policies (Tables)
6 Months Ended

Jun. 30, 2015

Accounting Policies [Abstract]

Schedule of Concentration of Credit Risk Percentage

Customers to which 10% or more of the Company’s total revenues are attributable for any one of the periods presented consist of the following:

 CUSTOMER A CUSTOMER B CUSTOMER C

For the three months ended June 30,


2015
 34 % 11 % 4 %

2014
 37 % 7 % 12 %

For the six months ended June 30,


2015
 27 % 8 % 8 %

2014
 31 % 6 % 13 %

Customers to which 10% or more of the Company’s outstanding accounts receivable are attributable as of either June 30, 2015 or December 31, 2014 consist of the following:

 CUSTOMER A CUSTOMER B CUSTOMER C CUSTOMER D

June 30, 2015
 46 % 10 % 8 % *

December 31, 2014
 10 % * 37 % 23 %

* Represents less than 1% of outstanding accounts receivable

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 18

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6351-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13537-108611

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13531-108611

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 21

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6442-108592

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6327-108592

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6404-108592

+ Details

Name: us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

Accrued Liabilities - Schedule of Changes in Accrued Warranty Costs (Detail) $ in Thousands	6 Months Ended
	Jun. 30, 2015 USD ($)
Payables and Accruals [Abstract]
Beginning Balance	$ 202
Warranties issued during the period	137
Settlements made during the period	(16)
Ending Balance	$ 323

Summary of Business, and Liquidity - Additional Information (Detail) - USD ($)	1 Months Ended	6 Months Ended
	Aug. 31, 2015	Jun. 30, 2015	Dec. 31, 2014	Jun. 30, 2014	Dec. 31, 2013
Schedule Of Description Of Business [Line Items]
Date of incorporation		Jun. 15, 2006
Accumulated deficit		$ (182,747,000)	$ (159,848,000)
Debt		$ 22,238,000	22,303,000
Debt agreements financial and non-financial covenants		As of June 30, 2015, the Company had debt totaling $22,238,000 for which the underlying debt agreements contain various financial and non-financial covenants, as well as certain material adverse change clauses. If the Company breaches any of the covenants contained within the debt agreements or if the material adverse change clauses are triggered, the entire unpaid principal and interest balance would be due and payable upon demand. The Company believes that currently available resources combined with the additional $40,000,000 in proceeds raised from the issuance of senior secured promissory notes in August 2015 (see Note 10) will be sufficient to fund the Company’s cash requirements through at least June 30, 2016.
Working capital		$ 2,478,000
Cash and cash equivalents		$ 12,196,000	$ 35,324,000	$ 57,630,000	$ 24,455,000
Subsequent Event [Member]
Schedule Of Description Of Business [Line Items]
Proceeds raised from issuance of senior secured promissory notes	$ 40,000,000

Debt - Consideration Received, Fair Values of Notes, Common Stock Warrants Issued and Calculation of the Gain on Extinguishment of Debt (Detail) - USD ($)		1 Months Ended
	Apr. 10, 2013	Apr. 30, 2013
Consideration received
Total consideration received		$ 3,860,000
Notes and warrants issued
Total fair value of notes and warrants issued		3,811,000
Gain on extinguishment of debt		49,000
Secured Debt [Member] \| October 2012 subordinated convertible note [Member]
Consideration received
Fair value of notes	$ 1,360,000	1,360,000
Notes and warrants issued
Fair value of notes	1,360,000	1,360,000
Secured Debt [Member] \| April 2013 secured promissory note [Member]
Consideration received
Fair value of notes		3,459,000
Cash		2,500,000
Notes and warrants issued
Principal balance of notes issued		3,750,000
Debt discount		(291,000)
Fair value of notes		3,459,000
Fair value of Additional Common Stock Warrants issued	$ 352,000	$ 352,000

Summary of Business, and Liquidity	6 Months Ended
Summary of Business, and Liquidity	Jun. 30, 2015
Accounting Policies [Abstract]
Summary of Business, and Liquidity	1. Summary of Business, and Liquidity Marrone Bio Innovations, Inc. (“Company”), formerly Marrone Organic Innovations, Inc., was incorporated under the laws of the State of Delaware on June 15, 2006, and is located in Davis, California. In July 2012, the Company formed a wholly-owned subsidiary, Marrone Michigan Manufacturing LLC (“MMM LLC”), which holds the assets of a manufacturing plant the Company purchased in July 2012. The Company makes bio-based pest management and plant health products. The Company targets the major markets that use conventional chemical pesticides, including certain agricultural and water markets where its bio-based products are used as alternatives for, or mixed with, conventional chemical pesticides. The Company also targets new markets for which there are no available conventional chemical pesticides, the use of conventional chemical pesticides may not be desirable or permissible because of health and environmental concerns (including for organically certified crops) or because the development of pest resistance has reduced the efficacy of conventional chemical pesticides. The Company delivers EPA-approved and registered biopesticide products and other bio-based products that address the global demand for effective, safe and environmentally responsible products. The Company is an early stage company with a limited operating history and has a limited number of commercialized products. As of June 30, 2015, the Company had an accumulated deficit of $182,747,000, has incurred significant losses since inception and expects to continue to incur losses for the foreseeable future. Until the completion of the initial public offering (“IPO”) in August 2013, the Company had funded operations primarily with net proceeds from the private placements of convertible preferred stock, convertible notes, promissory notes and term loans, as well as with the proceeds from the sale of its products and payments under strategic collaboration agreements and government grants. The Company will need to generate significant revenue growth to achieve and maintain profitability. As of June 30, 2015, the Company had working capital of $2,478,000, including cash and cash equivalents of $12,196,000. In addition, as of June 30, 2015, the Company had debt totaling $22,238,000 for which the underlying debt agreements contain various financial and non-financial covenants, as well as certain material adverse change clauses. If the Company breaches any of the covenants contained within the debt agreements or if the material adverse change clauses are triggered, the entire unpaid principal and interest balance would be due and payable upon demand. The Company believes that currently available resources combined with the additional $40,000,000 in proceeds raised from the issuance of senior secured promissory notes in August 2015 (see Note 10) will be sufficient to fund the Company’s cash requirements through at least June 30, 2016. The Company participates in a heavily regulated and highly competitive crop protection industry and believes that adverse changes in any of the following areas could have a material effect on the Company’s future financial position, results of operations or cash flows: inability to obtain regulatory approvals, increased competition in the pesticide market, market acceptance of the Company’s products, weather and other seasonal factors beyond the Company’s control, litigation or claims against the Company related to intellectual property, patents, products or governmental regulation, and the Company’s ability to support increased growth. Although the Company recognizes that it will likely need to raise additional funds in the future, there can be no assurance that such efforts will be successful or that, in the event that they are successful, the terms and conditions of such financing will not be unfavorable. Any future equity financing may result in dilution to existing shareholders and any debt financing may include additional restrictive covenants. Any failure to obtain additional financing or not to achieve the revenue growth necessary to fund the Company with cash flows from operations will have a material adverse effect upon the Company and will likely result in a substantial reduction in the scope of the Company’s operations and impact the Company’s ability to achieve its planned business objectives. In addition, any future breach of covenants included in the Company’s debt agreements which could result in the lender demanding payment of the unpaid principal and interest balances will have a material adverse effect upon the Company and would likely require the Company to seek to renegotiate these debt arrangements with the lenders. If such negotiations are unsuccessful, the Company may be required to seek protection from creditors through bankruptcy proceedings.

Subsequent Events - Additional Information (Detail) - USD ($)			1 Months Ended		6 Months Ended
	Aug. 31, 2015	Aug. 20, 2015	Sep. 30, 2015	Aug. 31, 2015	Jun. 30, 2015	Sep. 02, 2015	Dec. 31, 2014
Subsequent Event [Line Items]
Restricted cash and cash equivalents under covenants					$ 1,560,000		$ 1,560,000
Warrants exercise price					$ 8.40
Entities Affiliated with Waddell & Reed Financial, Inc. [Member] \| Senior Secured Promissory Note Bearing Interest Rate at 8% [Member]
Subsequent Event [Line Items]
Debt instrument, frequency of periodic payment of interest					Semi-annually
Subsequent Event [Member]
Subsequent Event [Line Items]
Consideration received under purchase agreement				$ 40,000,000
Warrants exercise price		$ 1.91
Warrants exercisable date		Aug. 20, 2023	Oct. 02, 2017
Loan agreement amendment date	Aug. 19, 2015
Subsequent Event [Member] \| Entities Affiliated with Waddell & Reed Financial, Inc. [Member]
Subsequent Event [Line Items]
Consideration received under purchase agreement		$ 40,000,000
Ownership percentage		5.00%
Subsequent Event [Member] \| Entities Affiliated with Waddell & Reed Financial, Inc. [Member] \| Senior Secured Promissory Note Bearing Interest Rate at 8% [Member]
Subsequent Event [Line Items]
Debt instrument to be issued, principal amount		$ 40,000,000
Debt instrument, interest rate		8.00%
Debt instrument principal amount, payable three years		$ 10,000,000
Debt instrument principal amount, payable four years		10,000,000
Debt instrument principal amount, payable five years		$ 20,000,000
Minimum percentage of acquisition of beneficial ownership considered as event of default		40.00%
Subsequent Event [Member] \| James Iademarco [Member]
Subsequent Event [Line Items]
One-twelfth of prior base salary				$ 290,000
Salary rate entitlement				8.3333%
Subsequent Event [Member] \| Loan [Member] \| October 2012 and April 2013 Secured Promissory Notes [Member]
Subsequent Event [Line Items]
Debt instrument, interest rate	12.00%			12.00%		18.00%
Maximum [Member] \| Subsequent Event [Member] \| Entities Affiliated with Waddell & Reed Financial, Inc. [Member]
Subsequent Event [Line Items]
Number of common shares to be purchased from warrants		4,000,000
Minimum [Member] \| Subsequent Event [Member] \| Entities Affiliated with Waddell & Reed Financial, Inc. [Member] \| Senior Secured Promissory Note Bearing Interest Rate at 8% [Member]
Subsequent Event [Line Items]
Restricted cash and cash equivalents under covenants		$ 15,000,000

Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - Money market funds [Member] - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
Assets
Assets at fair value	$ 3,749	$ 14,746
Level 1 [Member]
Assets
Assets at fair value	3,749	14,746
Level 2 [Member]
Assets
Assets at fair value	0	0
Level 3 [Member]
Assets
Assets at fair value	$ 0	$ 0

Significant Accounting Policies - Schedule of Concentration of Credit Risk Percentage (Parenthetical) (Detail)	6 Months Ended
	Jun. 30, 2015
Maximum [Member] \| Accounts receivable [Member] \| Customer concentration risk [Member]
Concentration Risk [Line Items]
Customers accounted for percentage of company's total revenues and accounts receivable	1.00%

Inventories - Schedule of Inventories, Net (Detail) - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
Inventory [Line Items]
Raw materials	$ 5,708	$ 5,692
Work in progress	916	1,150
Finished goods	3,601	5,378
Inventories, total	10,607	12,644
Customers [Member]
Inventory [Line Items]
Finished goods	$ 382	$ 424

Inventories - Additional Information (Detail) - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Inventory Disclosure [Abstract]
Reserves against inventories	$ 668,000	$ 668,000

Condensed Consolidated Statements of Cash Flows (Parenthetical) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Statement of Cash Flows [Abstract]
Cash paid for interest, net of capitalized interest	$ 4	$ 648

Accrued Liabilities - Schedule of Accrued Liabilities (Detail) - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
Payables and Accruals [Abstract]
Accrued compensation	$ 1,258	$ 1,348
Accrued expenses	4,915	4,771
Accrued warranty costs	323	202
Accrued liabilities, total	$ 6,496	$ 6,321

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents	$ 12,196	$ 35,324
Restricted cash, current portion	1,856	1,856
Accounts receivable	2,951	1,787
Inventories, net	10,607	12,644
Deferred cost of product revenues, including deferred cost of product revenues to related parties of $138 and $333 as of June 30, 2015 and December 31, 2014, respectively	1,597	1,797
Prepaid expenses and other current assets	1,018	1,315
Total current assets	30,225	54,723
Property, plant and equipment, net	20,062	20,166
Restricted cash, less current portion	1,560	1,560
Other assets	695	733
Total assets	52,542	77,182
Current liabilities:
Accounts payable	3,202	5,841
Accrued liabilities	6,496	6,321
Deferred revenue, current portion	2,652	2,861
Deferred revenue from related parties	278	660
Customer refund liabilities	1,019	1,044
Capital lease obligations, current portion	1,351	1,839
Debt, current portion	12,749	12,636
Total current liabilities	27,747	31,202
Deferred revenue, less current portion	1,884	2,050
Capital lease obligations, less current portion	151	185
Debt, less current portion	9,489	9,667
Other liabilities	754	847
Total liabilities	$ 40,025	$ 43,951
Commitments and contingencies (Note 8)
Stockholders' equity:
Common stock: $0.00001 par value; 250,000 shares authorized, 24,465 shares issued and outstanding as of June 30, 2015 and December 31, 2014	$ 0	$ 0
Additional paid in capital	195,264	193,079
Accumulated deficit	(182,747)	(159,848)
Total stockholders' equity	12,517	33,231
Total liabilities and stockholders' equity	$ 52,542	$ 77,182

Debt - Additional Information (Detail) - USD ($)				1 Months Ended					6 Months Ended		12 Months Ended
Debt - Additional Information (Detail) - USD ($)	Jun. 14, 2013	Apr. 10, 2013	Oct. 02, 2012	Aug. 31, 2015	Jun. 30, 2015	Jun. 30, 2014	Apr. 30, 2013	Oct. 31, 2011	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014	Aug. 20, 2015	Apr. 28, 2014	Apr. 14, 2014	Mar. 31, 2012
Debt Instrument [Line Items]
Agent fee percentage									5.00%
Additional credit facility financing-related costs and primarily legal fees		$ 24,000			$ 304,000				$ 304,000
Exercise price of the Common Stock Warrants					$ 8.40				$ 8.40
Accrued interest on promissory notes		74,000
Warrants exercise price percentage					70.00%				70.00%
Exercise price of warrants as percentage of common stock									70.00%
Common stock warrants issued to purchase common stock percentage									20.00%
Fair value of common stock warrants on issuance		465,000
Gain on extinguishment of debt							$ 49,000
Funds borrowed					$ 3,700,000				$ 3,700,000
Fair value of the Warrants at the date of issuance as deferred financing cost	$ 435,000
Repayment of line of credit						$ 4,687,000			0	$ 4,687,000
Required deposit balance					$ 1,856,000				$ 1,856,000		$ 1,856,000
Prepay percentage of outstanding principal loan									20.00%
Prepayment fee percentage									10.00%
Exceed percentage of principal payment									20.00%
Decrease percentage of prepayment fee									1.00%
Loan term for repayment									10 years
Current ratio									125.00%
Debt to worth ratio									400.00%
Percentage of loan to value ratio					70.00%
Subsequent Event [Member]
Debt Instrument [Line Items]
Debt instrument borrowing amount				$ 40,000,000
Exercise price of the Common Stock Warrants												$ 1.91
Level 3 [Member]
Debt Instrument [Line Items]
Fair value of debt					$ 22,348,000				$ 22,348,000		$ 22,587,000
Level 3 [Member] \| Fixed rate debt [Member]
Debt Instrument [Line Items]
Estimated market rate of interest									11.25%		11.25%
Level 3 [Member] \| Variable rate debt [Member]
Debt Instrument [Line Items]
Estimated market rate of interest									5.25%		5.25%
June 2013 credit facility [Member]
Debt Instrument [Line Items]
Line of credit facility maximum borrowing limit					7,000,000				$ 7,000,000
Additional credit facility financing-related costs and primarily legal fees					10,000				$ 10,000
Credit facility expiry date									Jun. 30, 2014
Credit facility accrued interest									10.00%
Credit facility fee paid									2.00%
Revolving line of credit [Member]
Debt Instrument [Line Items]
Percentage of borrowings limited to qualifying accounts receivable								75.00%
Line of credit facility maximum borrowing limit								$ 500,000					$ 5,000,000	$ 3,000,000
Maximum [Member] \| June 2013 credit facility [Member]
Debt Instrument [Line Items]
Amount permit to draw					$ 5,000,000				$ 5,000,000
Common stock warrants [Member]
Debt Instrument [Line Items]
Debt discount		113,000
June 2013 warrants [Member]
Debt Instrument [Line Items]
Value of common stock in a sale of the Company or a qualified initial public offering					70.00%				70.00%
Exercise price of the Common Stock Warrants					$ 8.40				$ 8.40
Warrants expire date									Jun. 14, 2023
June 2013 warrants [Member] \| Common stock warrants [Member]
Debt Instrument [Line Items]
Common stock warrants issued to purchase common stock percentage									10.00%
Senior Secured Promissory Note Bearing Interest Rate at 8% [Member] \| Subsequent Event [Member]
Debt Instrument [Line Items]
Debt instrument issued, principal amount				$ 40,000,000
October 2012 and April 2013 Secured Promissory Notes [Member]
Debt Instrument [Line Items]
Debt instrument maturity date									Oct. 02, 2017
October 2012 and April 2013 Secured Promissory Notes [Member] \| Subsequent Event [Member]
Debt Instrument [Line Items]
Debt instrument, interest rate				18.00%
Term Loan Bearing Interest at 7.00% [Member]
Debt Instrument [Line Items]
Line of credit facility maximum borrowing limit															$ 500,000
Debt instrument, interest rate															7.00%
Debt instrument maturity date									Apr. 01, 2016
Secured Debt [Member]
Debt Instrument [Line Items]
Debt issued in partial consideration, cash		3,700,000
Secured Debt [Member] \| October 2012 Secured Promissory Notes [Member]
Debt Instrument [Line Items]
Debt instrument borrowing amount			$ 7,500,000
Debt instrument borrowing terms									The October 2012 Secured Promissory Notes have an initial term of three years and can be extended for an additional two years in one year increments at the option of the Company. During the initial three-year term, the October 2012 Secured Promissory Notes bear interest at 12% per annum. If the term of the October 2012 Secured Promissory Notes is extended an additional year, the interest rate is 13% during the fourth year. If the term of the October 2012 Secured Promissory Notes is extended for an additional two years, the interest rate is 14% during the fifth year. Interest on the October 2012 Secured Promissory Notes is payable monthly through the initial maturity date of the loan, which is October 2, 2015, or through any extension period. The principal and all unpaid interest are due on the maturity date, as may be extended.
Agent fee percentage									5.00%
Additional fee percentage									1.00%
Unpaid Agent Fee					$ 261,000				$ 261,000
Warrants issued to purchase common stock funded principal percentage									15.00%
Value of common stock in a sale of the Company or a qualified initial public offering					70.00%				70.00%
Fair value of Common Stock Warrants					$ 282,000				$ 282,000
Exercise price of the Common Stock Warrants					$ 8.40				$ 8.40
Covenant requirements minimum cash balance					$ 5,000,000				$ 5,000,000
Amount borrowed under amended loan agreement		12,450,000
Secured Debt [Member] \| October 2012 Secured Promissory Notes [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Additional debt cash balance					$ 2,000,000				$ 2,000,000
Increase in amount available under loan agreement		5,000,000
Secured Debt [Member] \| October 2012 Secured Promissory Notes [Member] \| Debt instrument maturity period year three [Member]
Debt Instrument [Line Items]
Debt instrument, interest rate					12.00%				12.00%
Secured Debt [Member] \| October 2012 Secured Promissory Notes [Member] \| Extended fourth year [Member]
Debt Instrument [Line Items]
Debt instrument, interest rate					13.00%				13.00%
Secured Debt [Member] \| October 2012 Secured Promissory Notes [Member] \| Extended fifth year [Member]
Debt Instrument [Line Items]
Debt instrument, interest rate					14.00%				14.00%
Secured Debt [Member] \| April 2013 secured promissory note [Member]
Debt Instrument [Line Items]
Unpaid Agent Fee					$ 172,000				$ 172,000
Fees amount					603,000				603,000
Additional credit facility financing-related costs and primarily legal fees					66,000				66,000
Additional debt issued under amendment		4,950,000
Debt issued in cash consideration and in partial conversion for cancellation of principal balance		1,250,000
Convertible debt, fair value							3,459,000
Debt instrument, additional borrowings		2,500,000
Promissory notes issued		3,750,000
Fair value of Additional Common Stock Warrants issued		352,000					352,000
Funds borrowed					$ 4,950,000				$ 4,950,000
Secured Debt [Member] \| October 2012 subordinated convertible note [Member]
Debt Instrument [Line Items]
Convertible debt instrument, face value		1,250,000
Convertible debt, fair value		$ 1,360,000					$ 1,360,000
Secured Debt [Member] \| June 2014 Secured Promissory Note [Member]
Debt Instrument [Line Items]
Debt instrument, interest rate					5.25%				5.25%
Debt instrument maturity date									Jun. 30, 2036
Debt instrument borrowing amount						$ 10,000,000
Prime rate									3.25%
Debt instrument, prime rate						2.00%			2.00%
Debt instrument description									Promissory note ("June 2014 Secured Promissory Note") with the bank ("Lender") which bears interest at prime rate (3.25% as of June 30, 2015) plus 2.00% per annum.
Maximum rate of interest						5.25%
Debt instrument monthly payment									$ 64,390
Debt instrument date of payment									Jul. 31, 2014
Required deposit balance					$ 1,560,000				$ 1,560,000

Condensed Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Cash flows from operating activities
Net loss	$ (22,899,000)	$ (21,026,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,707,000	1,081,000
Loss (gain) on disposal of equipment	(35,000)	85,000
Share-based compensation	2,185,000	2,722,000
Non-cash interest expense	265,000	528,000
Amortization of investment securities premiums/discounts, net	0	10,000
Net changes in operating assets and liabilities:
Accounts receivable	(1,164,000)	(216,000)
Accounts receivable from related parties	0	413,000
Inventories	2,037,000	(540,000)
Deferred cost of product revenues	200,000	(163,000)
Prepaid Expenses and other assets	130,000	(443,000)
Accounts payable	(2,263,000)	330,000
Accrued and other liabilities	223,000	(843,000)
Deferred revenue	(375,000)	177,000
Deferred revenue from related parties	(382,000)	(333,000)
Customer refund liabilities	(25,000)	1,883,000
Net cash used in operating activities	(20,396,000)	(16,335,000)
Cash flows from investing activities
Purchases of property, plant and equipment	(1,398,000)	(9,425,000)
Sale of property and equipment	7,000	0
Purchase of short-term investments	0	(49,000)
Maturities of short-term investments	0	13,467,000
Net cash provided by (used in) investing activities	(1,391,000)	3,993,000
Cash flows from financing activities
Proceeds from public offerings, net of offering costs and underwriter commissions	0	39,959,000
Proceeds from issuance of debt, net of financing costs	0	9,621,000
Proceeds from line of Credit	0	4,687,000
Repayment of line of credit	0	(4,687,000)
Repayment of debt	(192,000)	(137,000)
Repayment of capital leases	(1,149,000)	(219,000)
Change in restricted cash	0	(4,885,000)
Proceeds from exercise of stock options	0	1,128,000
Proceeds from exercise of common stock warrants	0	50,000
Net cash provided by (used in) financing activities	(1,341,000)	45,517,000
Net increase (decrease) in cash and cash equivalents	(23,128,000)	33,175,000
Cash and cash equivalents, beginning of period	35,324,000	24,455,000
Cash and cash equivalents, end of period	12,196,000	57,630,000
Supplemental disclosure of cash flow information
Cash paid for interest, net of capitalized interest of $4 and $648 for the six months ended June 30, 2015 and 2014, respectively	1,069,000	922,000
Supplemental disclosure of non-cash investing and financing activities
Property, plant and equipment included in accounts payable and accrued liabilities	12,000	834,000
Equipment acquired under capital leases	$ 787,000	$ 646,000

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
Statement of Financial Position [Abstract]
Deferred cost of product revenues to related parties	$ 138	$ 333
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	250,000,000	250,000,000
Common stock, shares issued	24,465,000	24,465,000
Common stock, shares outstanding	24,465,000	24,465,000

Related Party Transactions	6 Months Ended
Related Party Transactions	Jun. 30, 2015
Related Party Transactions [Abstract]
Related Party Transactions	9. Related Party Transactions Les Lyman, a member of the Company’s board of directors, is the chairman and significant indirect shareholder of The Tremont Group, Inc. For the three months ended June 30, 2015 and 2014, revenue of $183,000 and $201,000, respectively, was recognized on a sell-through basis relating to product purchased by The Tremont Group, Inc. that was resold by The Tremont Group, Inc. during the period. For the six months ended June 30, 2015 and 2014, revenue of $382,000 and $478,000, respectively, was recognized on a sell-through basis relating to product purchased by The Tremont Group, Inc. that was resold by The Tremont Group, Inc. during the period. As of June 30, 2015 and December 31, 2014, the Company had no outstanding accounts receivable due from The Tremont Group, Inc. As of June 30, 2015 and December 31, 2014, the Company recorded deferred cost of product revenues of $138,000 and $333,000, respectively, and current deferred product revenues of $278,000 and $660,000, respectively, relating to product sold to The Tremont Group, Inc. where title has transferred but the criteria for revenue recognition have not been met. Although the Company anticipates sales of its products to The Tremont Group, Inc. to continue through 2015, the Company cannot estimate the amount of those sales. The Company has a strategic collaboration and distribution agreement with Syngenta, an affiliate of a former 5% stockholder, Syngenta Ventures. In connection with the Company’s secondary offering in June 2014, Syngenta Ventures sold 600,000 shares of the Company’s common stock, reducing its ownership percentage below 5%. Accordingly, revenue recognized under this agreement subsequent to June 2014 has not been included in related party revenues. For the three and six months ended June 30, 2014, the Company recognized $8,000 and $332,000, respectively, of related party revenues under this agreement prior to Syngenta Ventures reducing its ownership stake.

Document and Entity Information - shares	6 Months Ended
Document and Entity Information - shares	Jun. 30, 2015	Nov. 02, 2015
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2015
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q2
Trading Symbol	MBII
Entity Registrant Name	MARRONE BIO INNOVATIONS INC
Entity Central Index Key	0001441693
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		24,464,582

Subsequent Events	6 Months Ended
Subsequent Events	Jun. 30, 2015
Subsequent Events [Abstract]
Subsequent Events	10. Subsequent Events *Sale of Notes and Warrants* On August 20, 2015, the Company issued and sold to entities affiliated with Waddell & Reed Financial, Inc., one of its 5% stockholders, senior secured promissory notes in the aggregate principal amount of $40,000,000 and warrants to purchase up to 4,000,000 shares of common stock of the Company for aggregate consideration of $40,000,000, pursuant to a purchase agreement dated August 20, 2015. The notes will bear interest at a rate of 8% per annum payable semi-annually on June 30 or December 31 of each year, commencing on December 31, 2015, with $10,000,000 payable three years from the closing, $10,000,000 payable four years from the closing and $20,000,000 payable five years from the closing. The notes contain customary covenants, in addition to the obligation to maintain cash and cash equivalents of at least $15,000,000. The notes provide for various events of default, including, among others, default in payment of principal or interest, breach of any representation or warranty by the Company or any subsidiary under any agreement or document delivered in connection with the notes, a continued breach of any other condition or obligation under any loan document, certain bankruptcy, liquidation, reorganization or change of control events, the acquisition by any person or persons acting as group, other than the lenders, of beneficial ownership of 40% or more of the outstanding voting stock of the Company and certain events in which Pamela G. Marrone Ph.D. ceases to serve as the Company’s Chief Executive Officer. As of September 30, 2015, the Company was in breach of its covenants under the August 2015 Senior Secured Promissory Notes as the Company was in breach of its covenants under its October 2012 and April 2013 Secured Promissory Notes and June 2014 Secured Promissory Note. However, this covenant breach was cured in November 2015 as a result of the Company obtaining an extension to deliver its annual financial statements with respect to the October 2012 and April 2013 Secured Promissory Notes and the waiver of certain of the Company’s covenants with respect to the June 2014 Secured Promissory Note. See Note 6 for further discussion. The notes are secured by substantially all the Company’s personal property assets. The agent, acting behalf of the lenders, shall be entitled to have a first priority lien on the Company’s intellectual property assets, pursuant to intercreditor arrangements with certain of the Company’s existing lenders. The warrants are immediately exercisable at an exercise price of $1.91 per share (subject to adjustments) and may be exercised at a holder’s option at any time on or before August 20, 2023 (subject to certain exceptions). Proceeds from the sale of the notes and warrants will be allocated to the notes and warrants based on the relative fair value. In connection with the above transaction, on August 19, 2015, the Company amended the October 2012 and April 2013 Secured Promissory Notes. As a result of the amendment, interest on loans was accrued at a rate of 12% per annum until September 1, 2015, and thereafter is accrued at a rate of 18% per annum, and the Company is permitted to prepay the outstanding indebtedness under the agreement without penalty at any time. In addition, in September 2015, the Company provided a written notice exercising its right to extend the maturity through October 2, 2017. The amendments will be accounted for as a modification of the loan agreement with the effective interest rate adjusted prospectively from the amendment date. *Separation Agreement* On January 14, 2015, James Iademarco was appointed as the Company’s President and Chief Operating Officer, effective January 14, 2015. On August 20, 2015, the Company entered into a separation agreement with James Iademarco whereby he resigned effective August 31, 2015, but agreed to remain available to advise the Company in a consulting capacity for an additional period of up to 90 days to assist with the transition of various pending matters. Pursuant to the separation agreement, Mr. Iademarco is entitled to receive, among other things, an amount equal to one-twelfth of his prior base salary of $290,000 on or before the 15th day of each of the twelve months following August 31, 2015 and certain premium payments for health and vision insurance coverage, in partial consideration for Mr. Iademarco granting the Company a general release of liability and claims.

Share-Based Plans	6 Months Ended
Share-Based Plans	Jun. 30, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Share-Based Plans	7. Share-Based Plans As of June 30, 2015, there were 2,633,000 options outstanding and 2,142,000 share-based awards available for grant under the outstanding equity incentive plans. For the three months ended June 30, 2015 and 2014, the Company recognized share-based compensation of $1,095,000 and $1,200,000, respectively. For the six months ended June 30, 2015 and 2014, the Company recognized share-based compensation of $2,185,000 and $2,722,000, respectively. During the three and six months ended June 30, 2015, the Company did not grant any options and no options were exercised.

Commitments and Contingencies	6 Months Ended
Commitments and Contingencies	Jun. 30, 2015
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	8. Commitments and Contingencies *Operating Leases* The Company has a non-cancelable lease for an aggregate of approximately 24,500 square feet of non-contiguous office space in an office complex in Davis, California under which a portion of the covered space terminated beginning in February 2014. The remaining portion of the space will terminate by October 2016. The lease includes negotiated annual increases in the monthly rental payments. In September 2013 and then amended in April 2014, the Company entered into a lease agreement for approximately 27,300 square feet of office and laboratory space located in Davis, California. The initial term of the lease is for a period of 60 months and commenced in August 2014. The monthly base rent is $44,000 per month for the first 12 months with a 3% increase each year thereafter. Concurrent with this amendment, in April 2014, the Company entered into a lease agreement with an affiliate of the landlord to lease approximately 17,400 square feet of office and laboratory space in the same building complex in Davis, California. The initial term of the lease is for a period of 60 months and commenced in August 2014. The monthly base rent is $28,000 with a 3% increase each year thereafter. *Litigation* On September 5, 2014, September 8, 2014, September 11, 2014, September 15, 2014 and November 3, 2014, the Company, along with certain of its current and former officers and directors and others were named as defendants in putative securities class action lawsuits filed in the U.S. District Court for the Eastern District of California. On February 13, 2015, these actions were consolidated as Special Situations Fund III QP, L.P. et al v. Marrone Bio Innovations, Inc. et al, Case No 2:14-cv-02571-MCE-KJN. On September 2, 2015, an initial consolidated complaint was filed on behalf of (i) all persons who purchased or otherwise acquired the Company’s publicly traded common stock directly in or traceable to the Company’s August 1, 2013 initial public offering; (ii) all persons who purchased or otherwise acquired the Company’s publicly traded common stock directly in the Company’s June 6, 2014 secondary offering; and (iii) all persons who purchased or otherwise acquired the Company’s publicly traded common stock on the open market between March 7, 2014 and September 2, 2014 (the “Class Action”). In addition to the Company, the initial consolidated complaint names certain of the Company’s current and former officers and directors and the Company’s independent registered public accounting firm as defendants. The initial consolidated complaint alleges violations of the Securities Act of 1933, the Securities Exchange Act of 1934 and SEC Rule 10b-5, arising out of the issuance of allegedly false and misleading statements about the Company’s business and prospects, including its financial statements, product revenues and system of internal controls. Plaintiffs contend that such statements caused the Company’s stock price to be artificially inflated. The action includes claims for damages, fees and expenses, including an award of attorneys’ and experts’ fees to the putative class. Pursuant to a stipulation between the parties, and by order of the Court, defendants need not respond to the initial consolidated complaint. An amended consolidated complaint is to be filed no later than 60 days after the Company announces the restatement(s) after which defendants will have 60 days to respond. The outcome of this matter is not presently determinable. On September 9, 2014 and November 25, 2014, shareholder derivative actions were filed in the Superior Court of California, County of Yolo (Case No. CV14-1481) and the U.S. District Court for the Eastern District of California (Case No. 1:14-cv-02779-JAM-CKD), purportedly on the Company’s behalf, against certain current and former officers and members of its board of directors (the “2014 Derivative Actions”). The plaintiffs in the 2014 Derivative Actions allege that the defendants breached their fiduciary duties, committed waste, were unjustly enriched and aided and abetted breaches of fiduciary duty by causing the Company to issue allegedly false and misleading statements. The issues in the 2014 Derivative Actions overlap substantially with those at issue in the Class Action described above. The plaintiffs in the 2014 Derivative Actions seek, purportedly on behalf of the Company, an unspecified award of damages including, but not limited to, various corporate governance reforms, an award of restitution, an award of reasonable costs and expenses, including attorneys’ fees, and other further relief as the Court may deem just and proper. The Courts have granted the parties’ stipulations to defer litigation activity, subject to certain conditions and pending certain developments in the Class Action. On October 14, 2015, a shareholder derivative action was filed in the Superior Court of California, County of Yolo (Case No. CV15-1423), purportedly on the Company’s behalf, against certain current and former officers and members of the Company’s board of directors and the Company’s independent registered public accounting firm (the “2015 Derivative Action,” and with the 2014 Derivative Actions, the “Derivative Actions”). The plaintiff in the 2015 Derivative Action alleges that the director and officer defendants breached their fiduciary duties, committed waste and were unjustly enriched by causing the Company to issue allegedly false and misleading statements. The plaintiff in the 2015 Derivative Action also alleges that the Company’s independent registered public accounting firm committed professional negligence and malpractice. The issues in the 2015 Derivative Action overlap substantially with those at issue in the 2014 Derivative Actions and the Class Action described above. The parties are negotiating a date by which the defendants’ response to the newly filed complaint will be due. Given the preliminary nature of the Derivative Actions, the Company is not in a position to express any opinion regarding the outcome in these matters. The Company is currently unable to estimate a range of reasonably possible loss for the litigation because these matters involve significant uncertainties. Those uncertainties include the legal theory or the nature of the claims, the complexity of the facts, the results of any investigation or litigation and the timing of resolution of the investigations or litigation. Although the Company cannot estimate a reasonable range of loss based on currently available information, the resolution of these matters could have a material adverse effect on its financial position, results of operations or cash flows. *SEC Investigation* The Company advised the staff of the Division of Enforcement of the SEC in September 2014 that the Audit Committee of the Company’s board of directors had commenced an internal investigation. The SEC commenced a formal investigation of these matters, with which the Company is cooperating. Though the investigation continues, the Company has engaged in discussions with the Division of Enforcement staff concerning the resolution of any enforcement action that it may recommend. In accordance with ASC 450, Contingencies, the Company has accrued $1,750,000 in its condensed consolidated balance sheets as of June 30, 2015 and December 31, 2014 for its estimate of the penalties arising from such enforcement action and has estimated the range of the reasonably possible loss to be between $1,750,000 and $4,000,000. Publicity surrounding the foregoing or any enforcement action as a result of the Division of Enforcement’s investigation, even if ultimately resolved favorably, could have an adverse impact on the Company’s reputation, business, financial position, results of operations or cash flows.

Debt - Schedule of Debt (Detail) - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
Debt Instrument [Line Items]
Debt	$ 22,238	$ 22,303
Less current portion	(12,749)	(12,636)
Debt, less current portion	9,489	9,667
Secured Debt [Member] \| April 2016 Term loan bearing interest at 7.00% [Member]
Debt Instrument [Line Items]
Debt	116	183
Secured Debt [Member] \| October 2012 and April 2013 Secured Promissory Notes [Member]
Debt Instrument [Line Items]
Debt	12,374	12,247
Secured Debt [Member] \| June 2014 Secured Promissory Note [Member]
Debt Instrument [Line Items]
Debt	$ 9,748	$ 9,873

Commitments and Contingencies - Additional Information (Detail)	1 Months Ended	6 Months Ended
	Apr. 30, 2014 USD ($) ft²	Jun. 30, 2015 USD ($) ft²	Dec. 31, 2014 USD ($)
Operating Leased Assets [Line Items]
Accrued commitment and contingencies		$ 1,750,000	$ 1,750,000
Estimated range of reasonably possible loss, minimum		1,750,000	1,750,000
Estimated range of reasonably possible loss, maximum		$ 4,000,000	$ 4,000,000
Non-contiguous office space [Member]
Operating Leased Assets [Line Items]
Office facility lease agreement \| ft²		24,500
Non-contiguous office space [Member] \| Minimum [Member]
Operating Leased Assets [Line Items]
Leased office facilities expiration period		Feb. 28, 2014
Non-contiguous office space [Member] \| Maximum [Member]
Operating Leased Assets [Line Items]
Leased office facilities expiration period		Oct. 31, 2016
Office and laboratory space one [Member]
Operating Leased Assets [Line Items]
Lease agreement date		2013-09
Office and laboratory space one [Member] \| Amendment [Member]
Operating Leased Assets [Line Items]
Office facility lease agreement \| ft²	27,300
Lease agreement period	60 months
Monthly base rent	$ 44,000
Initial base rent term	12 months
Percentage of annual increase in base rent	3.00%
Lease commenced date	2014-08
Office and laboratory space two [Member]
Operating Leased Assets [Line Items]
Office facility lease agreement \| ft²	17,400
Lease agreement period	60 months
Monthly base rent	$ 28,000
Percentage of annual increase in base rent	3.00%
Lease commenced date	2014-08

Debt - Activity Related to Secured Promissory Note (Detail) $ in Thousands	6 Months Ended
	Jun. 30, 2015 USD ($)
Debt Instrument [Line Items]
Debt, beginning balance	$ 22,303
Debt, ending balance	22,238
October 2012 and April 2013 Secured Promissory Notes [Member]
Debt Instrument [Line Items]
Debt, beginning balance	12,247
Additions	0
Amortization of debt discount	127
Debt, ending balance	12,374
Principal payments	0
October 2012 and April 2013 Secured Promissory Notes [Member] \| Principal [Member]
Debt Instrument [Line Items]
Debt, beginning balance	12,450
Additions	0
Amortization of debt discount	0
Debt, ending balance	12,450
Principal payments	0
October 2012 and April 2013 Secured Promissory Notes [Member] \| Discount Related To Issuance Of Common Stock Warrants [Member]
Debt Instrument [Line Items]
Debt, beginning balance	(106)
Additions	0
Amortization of debt discount	69
Debt, ending balance	(37)
Principal payments	0
October 2012 and April 2013 Secured Promissory Notes [Member] \| Discount Related to the $3,750,000 Notes [Member]
Debt Instrument [Line Items]
Debt, beginning balance	(97)
Additions	0
Amortization of debt discount	58
Debt, ending balance	(39)
Principal payments	$ 0